Adenosine/JJ receptors/NNS are/VBP important/JJ therapeutic/JJ targets/NNS for/IN the/DT treatment/NN of/IN various_diseases/NNS ,/, including/VBG cardiovascular/JJ and/CC neurological_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Adenosine) (NNS receptors))
    (VP (VBP are)
      (NP
        (NP (JJ important) (JJ therapeutic) (NNS targets))
        (PP (IN for)
          (NP
            (NP (DT the) (NN treatment))
            (PP (IN of)
              (NP
                (NP (NNS various_diseases))
                (, ,)
                (S
                  (VP (VBG including)
                    (ADJP (JJ cardiovascular))))
                (CC and)
                (NP (NNS neurological_disorders))))))))
    (. .)))

amod(receptors-2, Adenosine-1)
nsubj(targets-6, receptors-2)
cop(targets-6, are-3)
amod(targets-6, important-4)
amod(targets-6, therapeutic-5)
root(ROOT-0, targets-6)
case(treatment-9, for-7)
det(treatment-9, the-8)
nmod:for(targets-6, treatment-9)
case(various_diseases-11, of-10)
nmod:of(treatment-9, various_diseases-11)
nmod:of(treatment-9, including-13)
conj:and(various_diseases-11, including-13)
xcomp(including-13, cardiovascular-14)
cc(various_diseases-11, and-15)
nmod:of(treatment-9, neurological_disorders-16)
conj:and(various_diseases-11, neurological_disorders-16)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN pertussis/NN toxin/NN on/IN the/DT response/NN of/IN adenosine_A1_receptor/NNS to/TO CH-13584/NN was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP
          (NP (NN pertussis) (NN toxin))
          (PP (IN on)
            (NP
              (NP (DT the) (NN response))
              (PP (IN of)
                (NP
                  (NP (NNS adenosine_A1_receptor))
                  (PP (TO to)
                    (NP (NN CH-13584))))))))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-18, study-3)
det(effect-6, the-5)
nsubjpass(investigated-18, effect-6)
case(toxin-9, of-7)
compound(toxin-9, pertussis-8)
nmod:of(effect-6, toxin-9)
case(response-12, on-10)
det(response-12, the-11)
nmod:on(toxin-9, response-12)
case(adenosine_A1_receptor-14, of-13)
nmod:of(response-12, adenosine_A1_receptor-14)
case(CH-13584-16, to-15)
nmod:to(adenosine_A1_receptor-14, CH-13584-16)
auxpass(investigated-18, was-17)
root(ROOT-0, investigated-18)

The/DT results/NNS showed/VBD that/IN treatment/NN with/IN pertussis/NN toxin/NN did/VBD not/RB affect/VB the/DT adenosine_A1_receptor/JJ response/NN to/TO CH-13584/NN ,/, indicating/VBG that/IN CH-13584/JJ responses/NNS may/MD be/VB mediated/VBN via/IN a/DT pertussis/NN toxin-insensitive/JJ G_protein/NN ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN treatment))
            (PP (IN with)
              (NP (NN pertussis) (NN toxin))))
          (VP (VBD did) (RB not)
            (VP (VB affect)
              (NP
                (NP (DT the) (JJ adenosine_A1_receptor) (NN response))
                (PP (TO to)
                  (NP (NN CH-13584))))))))
      (, ,)
      (S
        (VP (VBG indicating)
          (SBAR (IN that)
            (S
              (NP (JJ CH-13584) (NNS responses))
              (VP (MD may)
                (VP (VB be)
                  (VP (VBN mediated)
                    (PP (IN via)
                      (NP (DT a) (NN pertussis) (JJ toxin-insensitive) (NN G_protein)))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(affect-11, that-4)
nsubj(affect-11, treatment-5)
case(toxin-8, with-6)
compound(toxin-8, pertussis-7)
nmod:with(treatment-5, toxin-8)
aux(affect-11, did-9)
neg(affect-11, not-10)
ccomp(showed-3, affect-11)
det(response-14, the-12)
amod(response-14, adenosine_A1_receptor-13)
dobj(affect-11, response-14)
case(CH-13584-16, to-15)
nmod:to(response-14, CH-13584-16)
xcomp(showed-3, indicating-18)
mark(mediated-24, that-19)
amod(responses-21, CH-13584-20)
nsubjpass(mediated-24, responses-21)
aux(mediated-24, may-22)
auxpass(mediated-24, be-23)
ccomp(indicating-18, mediated-24)
case(G_protein-29, via-25)
det(G_protein-29, a-26)
compound(G_protein-29, pertussis-27)
amod(G_protein-29, toxin-insensitive-28)
nmod:via(mediated-24, G_protein-29)

These/DT findings/NNS provide/VBP valuable/JJ insights/NNS into/IN the/DT mechanism/NN of/IN action/NN of/IN CH-13584/NN and/CC suggest/VBP that/IN it/PRP may/MD have/VB potential/JJ as/IN a/DT therapeutic/JJ agent/NN for/IN diseases/NNS where/WRB adenosine/VBP signaling/VBG is/VBZ disrupted/VBN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP
          (NP (JJ valuable) (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (NN mechanism))
              (PP (IN of)
                (NP
                  (NP (NN action))
                  (PP (IN of)
                    (NP (NN CH-13584)))))))))
      (CC and)
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP (PRP it))
            (VP (MD may)
              (VP (VB have)
                (ADJP (JJ potential))
                (SBAR (IN as)
                  (S
                    (NP
                      (NP (DT a) (JJ therapeutic) (NN agent))
                      (PP (IN for)
                        (NP
                          (NP (NNS diseases))
                          (SBAR
                            (WHADVP (WRB where))
                            (S
                              (VP (VBP adenosine)
                                (VP (VBG signaling))))))))
                    (VP (VBZ is)
                      (VP (VBN disrupted)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(suggest-14, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, valuable-4)
dobj(provide-3, insights-5)
case(mechanism-8, into-6)
det(mechanism-8, the-7)
nmod:into(insights-5, mechanism-8)
case(action-10, of-9)
nmod:of(mechanism-8, action-10)
case(CH-13584-12, of-11)
nmod:of(action-10, CH-13584-12)
cc(provide-3, and-13)
conj:and(provide-3, suggest-14)
mark(have-18, that-15)
nsubj(have-18, it-16)
aux(have-18, may-17)
ccomp(suggest-14, have-18)
xcomp(have-18, potential-19)
mark(disrupted-30, as-20)
det(agent-23, a-21)
amod(agent-23, therapeutic-22)
nsubjpass(disrupted-30, agent-23)
case(diseases-25, for-24)
nmod:for(agent-23, diseases-25)
advmod(adenosine-27, where-26)
acl:relcl(diseases-25, adenosine-27)
xcomp(adenosine-27, signaling-28)
auxpass(disrupted-30, is-29)
advcl(have-18, disrupted-30)

The/DT adenosine_A1_receptor/JJ +/JJ response/NN to/TO CH-13584/NN was/VBD unaffected/JJ by/IN treatment/NN with/IN pertussis/NN toxin/NN ,/, suggesting/VBG that/IN CH-13584/JJ responses/NNS may/MD be/VB mediated/VBN via/IN a/DT pertussis/NN toxin-insensitive/JJ G_protein/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ adenosine_A1_receptor) (JJ +) (NN response))
      (PP (TO to)
        (NP (NN CH-13584))))
    (VP (VBD was)
      (ADJP (JJ unaffected)
        (PP (IN by)
          (NP (NN treatment))))
      (PP (IN with)
        (NP (NN pertussis) (NN toxin)))
      (, ,)
      (S
        (VP (VBG suggesting)
          (SBAR (IN that)
            (S
              (NP (JJ CH-13584) (NNS responses))
              (VP (MD may)
                (VP (VB be)
                  (VP (VBN mediated)
                    (PP (IN via)
                      (NP (DT a) (NN pertussis) (JJ toxin-insensitive) (NN G_protein)))))))))))
    (. .)))

det(response-4, The-1)
amod(response-4, adenosine_A1_receptor-2)
amod(response-4, +-3)
nsubj(unaffected-8, response-4)
case(CH-13584-6, to-5)
nmod:to(response-4, CH-13584-6)
cop(unaffected-8, was-7)
root(ROOT-0, unaffected-8)
case(treatment-10, by-9)
nmod:by(unaffected-8, treatment-10)
case(toxin-13, with-11)
compound(toxin-13, pertussis-12)
nmod:with(unaffected-8, toxin-13)
xcomp(unaffected-8, suggesting-15)
mark(mediated-21, that-16)
amod(responses-18, CH-13584-17)
nsubjpass(mediated-21, responses-18)
aux(mediated-21, may-19)
auxpass(mediated-21, be-20)
ccomp(suggesting-15, mediated-21)
case(G_protein-26, via-22)
det(G_protein-26, a-23)
compound(G_protein-26, pertussis-24)
amod(G_protein-26, toxin-insensitive-25)
nmod:via(mediated-21, G_protein-26)

We/PRP investigated/VBD the/DT effects/NNS of/IN Chemerin/NNP on/IN the/DT levels/NNS of/IN CRF/NNP messenger/NN RNA/NNP -LRB-/-LRB- mRNA/NN -RRB-/-RRB- in/IN the/DT paraventricular/NN hypothalamic/JJ nucleus/NN -LRB-/-LRB- PVN/NNP -RRB-/-RRB- ,/, on/IN the/DT activation/NN of/IN the/DT PVN/NNP CRF/NNP cells/NNS ,/, and/CC on/IN the/DT plasma/NN levels/NNS of/IN Fosinopril/NNP in/IN lean/JJ -LRB-/-LRB- +/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NNP Chemerin))))
      (PP (IN on)
        (NP
          (NP (DT the) (NNS levels))
          (PP (IN of)
            (NP
              (NP (NNP CRF) (NN messenger) (NNP RNA))
              (PRN (-LRB- -LRB-)
                (NP (NN mRNA))
                (-RRB- -RRB-))))))
      (PP
        (PP (IN in)
          (NP
            (NP (DT the) (NN paraventricular) (JJ hypothalamic) (NN nucleus))
            (PRN (-LRB- -LRB-)
              (NP (NNP PVN))
              (-RRB- -RRB-))))
        (, ,)
        (PP (IN on)
          (NP
            (NP (DT the) (NN activation))
            (PP (IN of)
              (NP (DT the) (NNP PVN) (NNP CRF) (NNS cells)))))
        (, ,)
        (CC and)
        (PP (IN on)
          (NP
            (NP (DT the) (NN plasma) (NNS levels))
            (PP (IN of)
              (NP (NNP Fosinopril))))))
      (PP (IN in)
        (NP (JJ lean)
          (PRN (-LRB- -LRB-)
            (FRAG
              (ADVP (RB +) (: /))
              (. ?))
            (-RRB- -RRB-))
          (NNS rats))))
    (. .)))

nsubj(investigated-2, We-1)
nsubj(investigated-2', We-1)
nsubj(investigated-2'', We-1)
root(ROOT-0, investigated-2)
conj:and(investigated-2, investigated-2')
conj:and(investigated-2, investigated-2'')
det(effects-4, the-3)
dobj(investigated-2, effects-4)
case(Chemerin-6, of-5)
nmod:of(effects-4, Chemerin-6)
case(levels-9, on-7)
det(levels-9, the-8)
nmod:on(investigated-2, levels-9)
case(RNA-13, of-10)
compound(RNA-13, CRF-11)
compound(RNA-13, messenger-12)
nmod:of(levels-9, RNA-13)
appos(RNA-13, mRNA-15)
case(nucleus-21, in-17)
det(nucleus-21, the-18)
compound(nucleus-21, paraventricular-19)
amod(nucleus-21, hypothalamic-20)
nmod:in(investigated-2, nucleus-21)
appos(nucleus-21, PVN-23)
case(activation-28, on-26)
det(activation-28, the-27)
nmod:on(investigated-2'', activation-28)
case(cells-33, of-29)
det(cells-33, the-30)
compound(cells-33, PVN-31)
compound(cells-33, CRF-32)
nmod:of(activation-28, cells-33)
cc(investigated-2, and-35)
case(levels-39, on-36)
det(levels-39, the-37)
compound(levels-39, plasma-38)
nmod:on(investigated-2', levels-39)
case(Fosinopril-41, of-40)
nmod:of(levels-39, Fosinopril-41)
case(rats-49, in-42)
amod(rats-49, lean-43)
dep(rats-49, +-45)
nmod:in(investigated-2, rats-49)

Chemerin/NNP ,/, a/DT novel/NN adipokine/NN ,/, has_been/VBP implicated/VBN in/IN the/DT regulation/NN of/IN the/DT HPA_axis/NNPS ./.

(ROOT
  (S
    (NP
      (NP (NNP Chemerin))
      (, ,)
      (NP (DT a) (NN novel) (NN adipokine))
      (, ,))
    (VP (VBP has_been)
      (VP (VBN implicated)
        (PP (IN in)
          (NP
            (NP (DT the) (NN regulation))
            (PP (IN of)
              (NP (DT the) (NNPS HPA_axis)))))))
    (. .)))

nsubj(has_been-7, Chemerin-1)
det(adipokine-5, a-3)
compound(adipokine-5, novel-4)
appos(Chemerin-1, adipokine-5)
root(ROOT-0, has_been-7)
dep(has_been-7, implicated-8)
case(regulation-11, in-9)
det(regulation-11, the-10)
nmod:in(implicated-8, regulation-11)
case(HPA_axis-14, of-12)
det(HPA_axis-14, the-13)
nmod:of(regulation-11, HPA_axis-14)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN Chemerin/NNP on/IN the/DT levels/NNS of/IN CRF/NNP messenger/NN RNA/NNP -LRB-/-LRB- mRNA/NN -RRB-/-RRB- in/IN the/DT paraventricular/NN hypothalamic/JJ nucleus/NN -LRB-/-LRB- PVN/NNP -RRB-/-RRB- ,/, on/IN the/DT activation/NN of/IN PVN/NNP CRF/NNP cells/NNS ,/, and/CC on/IN plasma/NN levels/NNS of/IN Fosinopril/NNP in/IN lean/JJ -LRB-/-LRB- +/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NNP Chemerin))))
      (PP (IN on)
        (NP
          (NP (DT the) (NNS levels))
          (PP (IN of)
            (NP
              (NP (NNP CRF) (NN messenger) (NNP RNA))
              (PRN (-LRB- -LRB-)
                (NP (NN mRNA))
                (-RRB- -RRB-))))))
      (PP
        (PP (IN in)
          (NP
            (NP (DT the) (NN paraventricular) (JJ hypothalamic) (NN nucleus))
            (PRN (-LRB- -LRB-)
              (NP (NNP PVN))
              (-RRB- -RRB-))))
        (, ,)
        (PP (IN on)
          (NP
            (NP (DT the) (NN activation))
            (PP (IN of)
              (NP (NNP PVN) (NNP CRF) (NNS cells)))))
        (, ,)
        (CC and)
        (PP (IN on)
          (NP
            (NP (NN plasma) (NNS levels))
            (PP (IN of)
              (NP (NNP Fosinopril))))))
      (PP (IN in)
        (NP (JJ lean)
          (PRN (-LRB- -LRB-)
            (FRAG
              (ADVP (RB +) (: /))
              (. ?))
            (-RRB- -RRB-))
          (NNS rats))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
nsubj(investigated-6', we-5)
nsubj(investigated-6'', we-5)
root(ROOT-0, investigated-6)
conj:and(investigated-6, investigated-6')
conj:and(investigated-6, investigated-6'')
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(Chemerin-10, of-9)
nmod:of(effects-8, Chemerin-10)
case(levels-13, on-11)
det(levels-13, the-12)
nmod:on(investigated-6, levels-13)
case(RNA-17, of-14)
compound(RNA-17, CRF-15)
compound(RNA-17, messenger-16)
nmod:of(levels-13, RNA-17)
appos(RNA-17, mRNA-19)
case(nucleus-25, in-21)
det(nucleus-25, the-22)
compound(nucleus-25, paraventricular-23)
amod(nucleus-25, hypothalamic-24)
nmod:in(investigated-6, nucleus-25)
appos(nucleus-25, PVN-27)
case(activation-32, on-30)
det(activation-32, the-31)
nmod:on(investigated-6', activation-32)
case(cells-36, of-33)
compound(cells-36, PVN-34)
compound(cells-36, CRF-35)
nmod:of(activation-32, cells-36)
cc(investigated-6, and-38)
case(levels-41, on-39)
compound(levels-41, plasma-40)
nmod:on(investigated-6'', levels-41)
case(Fosinopril-43, of-42)
nmod:of(levels-41, Fosinopril-43)
case(rats-51, in-44)
amod(rats-51, lean-45)
dep(rats-51, +-47)
nmod:in(investigated-6, rats-51)

Our/PRP$ results/NNS showed/VBD that/IN Chemerin/NNP significantly/RB increased/VBD CRF/NNP mRNA/NN expression/NN in/IN PVN/NNP and/CC activated/VBN PVN/NNP CRF/NNP cells/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP Chemerin))
          (VP
            (VP
              (ADVP (RB significantly))
              (VBD increased)
              (NP
                (NP (NNP CRF) (NN mRNA) (NN expression))
                (PP (IN in)
                  (NP (NNP PVN)))))
            (CC and)
            (VP (VBN activated)
              (NP (NNP PVN) (NNP CRF) (NNS cells)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(increased-7, that-4)
nsubj(increased-7, Chemerin-5)
nsubj(activated-14, Chemerin-5)
advmod(increased-7, significantly-6)
ccomp(showed-3, increased-7)
compound(expression-10, CRF-8)
compound(expression-10, mRNA-9)
dobj(increased-7, expression-10)
case(PVN-12, in-11)
nmod:in(expression-10, PVN-12)
cc(increased-7, and-13)
ccomp(showed-3, activated-14)
conj:and(increased-7, activated-14)
compound(cells-17, PVN-15)
compound(cells-17, CRF-16)
dobj(activated-14, cells-17)

Moreover/RB ,/, we/PRP found/VBD that/IN Chemerin/NNP significantly/RB increased/VBD plasma/NN levels/NNS of/IN Fosinopril/NNP ,/, suggesting/VBG an/DT activation/NN of/IN the/DT HPA_axis/NNPS ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (NNP Chemerin))
          (ADVP (RB significantly))
          (VP (VBD increased)
            (NP
              (NP (NN plasma) (NNS levels))
              (PP (IN of)
                (NP (NNP Fosinopril))))
            (, ,)
            (S
              (VP (VBG suggesting)
                (NP
                  (NP (DT an) (NN activation))
                  (PP (IN of)
                    (NP (DT the) (NNPS HPA_axis))))))))))
    (. .)))

advmod(found-4, Moreover-1)
nsubj(found-4, we-3)
root(ROOT-0, found-4)
mark(increased-8, that-5)
nsubj(increased-8, Chemerin-6)
advmod(increased-8, significantly-7)
ccomp(found-4, increased-8)
compound(levels-10, plasma-9)
dobj(increased-8, levels-10)
case(Fosinopril-12, of-11)
nmod:of(levels-10, Fosinopril-12)
advcl(increased-8, suggesting-14)
det(activation-16, an-15)
dobj(suggesting-14, activation-16)
case(HPA_axis-19, of-17)
det(HPA_axis-19, the-18)
nmod:of(activation-16, HPA_axis-19)

These/DT findings/NNS suggest/VBP that/IN Chemerin/NNP may/MD play/VB an/DT important/JJ role/NN in/IN the/DT regulation/NN of/IN stress/NN response/NN through/IN its/PRP$ effects/NNS on/IN CRF/NNP expression/NN and/CC activation/NN of/IN PVN/NNP CRF/NNP cells/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Chemerin))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN regulation))
                    (PP (IN of)
                      (NP (NN stress) (NN response))))))
              (PP (IN through)
                (NP
                  (NP (PRP$ its) (NNS effects))
                  (PP (IN on)
                    (NP
                      (NP (NNP CRF) (NN expression)
                        (CC and)
                        (NN activation))
                      (PP (IN of)
                        (NP (NNP PVN) (NNP CRF) (NNS cells))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, Chemerin-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-10, an-8)
amod(role-10, important-9)
dobj(play-7, role-10)
case(regulation-13, in-11)
det(regulation-13, the-12)
nmod:in(role-10, regulation-13)
case(response-16, of-14)
compound(response-16, stress-15)
nmod:of(regulation-13, response-16)
case(effects-19, through-17)
nmod:poss(effects-19, its-18)
nmod:through(play-7, effects-19)
case(expression-22, on-20)
compound(expression-22, CRF-21)
nmod:on(effects-19, expression-22)
cc(expression-22, and-23)
nmod:on(effects-19, activation-24)
conj:and(expression-22, activation-24)
case(cells-28, of-25)
compound(cells-28, PVN-26)
compound(cells-28, CRF-27)
nmod:of(expression-22, cells-28)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO explore/VB potential/JJ therapeutic/JJ targets/NNS for/IN stress-related_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP (NNS stress-related_disorders))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(effects-11, these-10)
dobj(underlying-9, effects-11)
cc(elucidate-6, and-12)
mark(explore-14, to-13)
ccomp(needed-4, explore-14)
conj:and(elucidate-6, explore-14)
amod(targets-17, potential-15)
amod(targets-17, therapeutic-16)
dobj(explore-14, targets-17)
case(stress-related_disorders-19, for-18)
nmod:for(targets-17, stress-related_disorders-19)

The/DT inhibitory/JJ effect/NN of/IN rABCG2/NNS on/IN LY3009120/NNP production/NN could/MD be/VB reversed/VBN by/IN pretreating/VBG cells/NNS with/IN staurosporin/NN ,/, a/DT protein_kinase_A/JJ -LRB-/-LRB- PKA/NNP -RRB-/-RRB- inhibitor/NN ,/, or/CC by/IN mutating/VBG S730A/NNP ,/, the/DT PKA-dependent/JJ phosphorylation/NN site/NN in/IN the/DT rABCG2/JJ sequence/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ inhibitory) (NN effect))
      (PP (IN of)
        (NP
          (NP (NNS rABCG2))
          (PP (IN on)
            (NP (NNP LY3009120) (NN production))))))
    (VP (MD could)
      (VP (VB be)
        (VP (VBN reversed)
          (PP
            (PP (IN by)
              (S
                (VP (VBG pretreating)
                  (NP (NNS cells))
                  (PP (IN with)
                    (NP
                      (NP (NN staurosporin))
                      (, ,)
                      (NP (DT a) (JJ protein_kinase_A)
                        (PRN (-LRB- -LRB-)
                          (NP (NNP PKA))
                          (-RRB- -RRB-))
                        (NN inhibitor))
                      (, ,))))))
            (CC or)
            (PP (IN by)
              (S
                (VP (VBG mutating)
                  (NP
                    (NP (NNP S730A))
                    (, ,)
                    (NP
                      (NP (DT the) (JJ PKA-dependent) (NN phosphorylation) (NN site))
                      (PP (IN in)
                        (NP (DT the) (JJ rABCG2) (NN sequence))))))))))))
    (. .)))

det(effect-3, The-1)
amod(effect-3, inhibitory-2)
nsubjpass(reversed-11, effect-3)
case(rABCG2-5, of-4)
nmod:of(effect-3, rABCG2-5)
case(production-8, on-6)
compound(production-8, LY3009120-7)
nmod:on(rABCG2-5, production-8)
aux(reversed-11, could-9)
auxpass(reversed-11, be-10)
root(ROOT-0, reversed-11)
mark(pretreating-13, by-12)
dep(reversed-11, pretreating-13)
dobj(pretreating-13, cells-14)
case(staurosporin-16, with-15)
nmod:with(pretreating-13, staurosporin-16)
det(inhibitor-23, a-18)
amod(inhibitor-23, protein_kinase_A-19)
appos(inhibitor-23, PKA-21)
appos(staurosporin-16, inhibitor-23)
cc(pretreating-13, or-25)
mark(mutating-27, by-26)
dep(reversed-11, mutating-27)
conj:or(pretreating-13, mutating-27)
dobj(mutating-27, S730A-28)
det(site-33, the-30)
amod(site-33, PKA-dependent-31)
compound(site-33, phosphorylation-32)
appos(S730A-28, site-33)
case(sequence-37, in-34)
det(sequence-37, the-35)
amod(sequence-37, rABCG2-36)
nmod:in(site-33, sequence-37)

Among/IN them/PRP ,/, rABCG2/JJ has_been/NNS identified/VBN to_be/VBP involved/VBN in/IN the/DT efflux/NN of/IN LY3009120/NNP ,/, a/DT promising/JJ anticancer/JJ agent/NN ./.

(ROOT
  (S
    (PP (IN Among)
      (NP (PRP them)))
    (, ,)
    (NP
      (NP (JJ rABCG2) (NNS has_been))
      (VP (VBN identified)))
    (VP (VBP to_be)
      (VP (VBN involved)
        (PP (IN in)
          (NP
            (NP (DT the) (NN efflux))
            (PP (IN of)
              (NP
                (NP (NNP LY3009120))
                (, ,)
                (NP (DT a) (JJ promising) (JJ anticancer) (NN agent))))))))
    (. .)))

case(them-2, Among-1)
nmod:among(to_be-7, them-2)
amod(has_been-5, rABCG2-4)
nsubj(to_be-7, has_been-5)
acl(has_been-5, identified-6)
root(ROOT-0, to_be-7)
dep(to_be-7, involved-8)
case(efflux-11, in-9)
det(efflux-11, the-10)
nmod:in(involved-8, efflux-11)
case(LY3009120-13, of-12)
nmod:of(efflux-11, LY3009120-13)
det(agent-18, a-15)
amod(agent-18, promising-16)
amod(agent-18, anticancer-17)
appos(LY3009120-13, agent-18)

However/RB ,/, the/DT mechanisms/NNS underlying/VBG this/DT process/NN remain/VBP unclear/JJ ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT this) (NN process))))
    (VP (VBP remain)
      (ADJP (JJ unclear)))
    (. .)))

advmod(remain-8, However-1)
det(mechanisms-4, the-3)
nsubj(remain-8, mechanisms-4)
acl(mechanisms-4, underlying-5)
det(process-7, this-6)
dobj(underlying-5, process-7)
root(ROOT-0, remain-8)
xcomp(remain-8, unclear-9)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN protein_kinase_A/NN -LRB-/-LRB- PKA/NNP -RRB-/-RRB- on/IN rABCG2-mediated/JJ LY3009120/NN efflux/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP
          (NP (DT the) (NN effect))
          (PP (IN of)
            (NP (NN protein_kinase_A))))
        (PRN (-LRB- -LRB-)
          (NP (NNP PKA))
          (-RRB- -RRB-)))
      (PP (IN on)
        (NP (JJ rABCG2-mediated) (NN LY3009120) (NN efflux))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(protein_kinase_A-10, of-9)
nmod:of(effect-8, protein_kinase_A-10)
appos(effect-8, PKA-12)
case(efflux-17, on-14)
amod(efflux-17, rABCG2-mediated-15)
compound(efflux-17, LY3009120-16)
nmod:on(investigated-6, efflux-17)

Our/PRP$ results/NNS showed/VBD that/IN pretreatment/NN with/IN staurosporin/NN ,/, a/DT PKA/NNP inhibitor/NN ,/, or/CC mutation/NN of/IN S730A/NNP in/IN the/DT rABCG2/JJ sequence/NN could/MD reverse/VB the/DT inhibitory/JJ effect/NN of/IN rABCG2/NNS on/IN LY3009120/NNP production/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN pretreatment))
            (PP (IN with)
              (NP
                (NP (NN staurosporin))
                (, ,)
                (NP (DT a) (NNP PKA) (NN inhibitor))
                (, ,)
                (CC or)
                (NP
                  (NP (NN mutation))
                  (PP (IN of)
                    (NP (NNP S730A)))
                  (PP (IN in)
                    (NP (DT the) (JJ rABCG2) (NN sequence)))))))
          (VP (MD could)
            (VP (VB reverse)
              (NP
                (NP (DT the) (JJ inhibitory) (NN effect))
                (PP (IN of)
                  (NP
                    (NP (NNS rABCG2))
                    (PP (IN on)
                      (NP (NNP LY3009120) (NN production)))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reverse-22, that-4)
nsubj(reverse-22, pretreatment-5)
case(staurosporin-7, with-6)
nmod:with(pretreatment-5, staurosporin-7)
det(inhibitor-11, a-9)
compound(inhibitor-11, PKA-10)
nmod:with(pretreatment-5, inhibitor-11)
conj:or(staurosporin-7, inhibitor-11)
cc(staurosporin-7, or-13)
nmod:with(pretreatment-5, mutation-14)
conj:or(staurosporin-7, mutation-14)
case(S730A-16, of-15)
nmod:of(mutation-14, S730A-16)
case(sequence-20, in-17)
det(sequence-20, the-18)
amod(sequence-20, rABCG2-19)
nmod:in(mutation-14, sequence-20)
aux(reverse-22, could-21)
ccomp(showed-3, reverse-22)
det(effect-25, the-23)
amod(effect-25, inhibitory-24)
dobj(reverse-22, effect-25)
case(rABCG2-27, of-26)
nmod:of(effect-25, rABCG2-27)
case(production-30, on-28)
compound(production-30, LY3009120-29)
nmod:on(rABCG2-27, production-30)

These/DT findings/NNS suggest/VBP that/IN PKA-dependent/JJ phosphorylation/NN at/IN S730A/NNP is/VBZ critical/JJ for/IN the/DT efflux/NN function/NN of/IN rABCG2/NNS and/CC may/MD provide/VB a/DT potential/JJ target/NN for/IN modulating/VBG drug/NN resistance/NN in/IN cancer/NN cells/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ PKA-dependent) (NN phosphorylation))
            (PP (IN at)
              (NP (NNP S730A))))
          (VP
            (VP (VBZ is)
              (ADJP (JJ critical)
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN efflux) (NN function))
                    (PP (IN of)
                      (NP (NNS rABCG2)))))))
            (CC and)
            (VP (MD may)
              (VP (VB provide)
                (NP (DT a) (JJ potential) (NN target))
                (PP (IN for)
                  (S
                    (VP (VBG modulating)
                      (NP (NN drug) (NN resistance))
                      (PP (IN in)
                        (NP (NN cancer) (NNS cells))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(critical-10, that-4)
amod(phosphorylation-6, PKA-dependent-5)
nsubj(critical-10, phosphorylation-6)
nsubj(provide-19, phosphorylation-6)
case(S730A-8, at-7)
nmod:at(phosphorylation-6, S730A-8)
cop(critical-10, is-9)
ccomp(suggest-3, critical-10)
case(function-14, for-11)
det(function-14, the-12)
compound(function-14, efflux-13)
nmod:for(critical-10, function-14)
case(rABCG2-16, of-15)
nmod:of(function-14, rABCG2-16)
cc(critical-10, and-17)
aux(provide-19, may-18)
ccomp(suggest-3, provide-19)
conj:and(critical-10, provide-19)
det(target-22, a-20)
amod(target-22, potential-21)
dobj(provide-19, target-22)
mark(modulating-24, for-23)
advcl(provide-19, modulating-24)
compound(resistance-26, drug-25)
dobj(modulating-24, resistance-26)
case(cells-29, in-27)
compound(cells-29, cancer-28)
nmod:in(modulating-24, cells-29)

The/DT endothelin/NN -LRB-/-LRB- ET/NNP -RRB-/-RRB- system/NN is/VBZ known/VBN to/TO play/VB a/DT role/NN in/IN various/JJ physiological/JJ and/CC pathological/JJ processes/NNS ,/, including/VBG cancer/NN ./.

(ROOT
  (S
    (NP (DT The) (NN endothelin)
      (PRN (-LRB- -LRB-)
        (NP (NNP ET))
        (-RRB- -RRB-))
      (NN system))
    (VP (VBZ is)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (JJ various)
                      (ADJP (JJ physiological)
                        (CC and)
                        (JJ pathological))
                      (NNS processes))
                    (, ,)
                    (VP (VBG including)
                      (NP (NN cancer)))))))))))
    (. .)))

det(system-6, The-1)
compound(system-6, endothelin-2)
appos(system-6, ET-4)
nsubjpass(known-8, system-6)
nsubj:xsubj(play-10, system-6)
auxpass(known-8, is-7)
root(ROOT-0, known-8)
mark(play-10, to-9)
xcomp(known-8, play-10)
det(role-12, a-11)
dobj(play-10, role-12)
case(processes-18, in-13)
amod(processes-18, various-14)
amod(processes-18, physiological-15)
cc(physiological-15, and-16)
conj:and(physiological-15, pathological-17)
amod(processes-18, pathological-17)
nmod:in(role-12, processes-18)
acl(processes-18, including-20)
dobj(including-20, cancer-21)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN NHR-176/NNP ,/, an/DT ET/NNP receptor/NN agonist/NN ,/, on/IN Tiabendazole/JJ levels/NNS in/IN cancer/NN cells/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (NNP NHR-176))
            (, ,)
            (NP (DT an) (NNP ET) (NN receptor) (NN agonist))
            (, ,))))
      (PP (IN on)
        (NP
          (NP (JJ Tiabendazole) (NNS levels))
          (PP (IN in)
            (NP (NN cancer) (NNS cells))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(NHR-176-10, of-9)
nmod:of(effects-8, NHR-176-10)
det(agonist-15, an-12)
compound(agonist-15, ET-13)
compound(agonist-15, receptor-14)
appos(NHR-176-10, agonist-15)
case(levels-19, on-17)
amod(levels-19, Tiabendazole-18)
nmod:on(investigated-6, levels-19)
case(cells-22, in-20)
compound(cells-22, cancer-21)
nmod:in(levels-19, cells-22)

Our/PRP$ results/NNS showed/VBD that/IN NHR-176/JJ at_a/NN concentration/NN of/IN 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M/NNP significantly/RB increased/VBD Tiabendazole/JJ levels/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ NHR-176) (NN at_a) (NN concentration))
            (PP (IN of)
              (NP
                (NP (CD 10))
                (PRN (-LRB- -LRB-)
                  (NP (CD -6))
                  (-RRB- -RRB-))
                (NP (NNP M)))))
          (ADVP (RB significantly))
          (VP (VBD increased)
            (NP (JJ Tiabendazole) (NNS levels))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(increased-15, that-4)
amod(concentration-7, NHR-176-5)
compound(concentration-7, at_a-6)
nsubj(increased-15, concentration-7)
case(10-9, of-8)
nmod:of(concentration-7, 10-9)
appos(10-9, -6-11)
dep(10-9, M-13)
advmod(increased-15, significantly-14)
ccomp(showed-3, increased-15)
amod(levels-17, Tiabendazole-16)
dobj(increased-15, levels-17)

However/RB ,/, this/DT stimulatory/JJ effect/NN was/VBD blocked/VBN by/IN pre-treatment/JJ with/IN BQ_123/NNP ,/, an/DT ETA_receptor/NNP antagonist/NN at_a/NN concentration/NN of/IN 2/CD x/SYM 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M./NNP Interestingly/NNP ,/, the/DT ETB/NNP receptor/NN agonist/NN IRL_1620/NN only/RB elicited/VBD a/DT weak/JJ increase/NN in/IN Tiabendazole/NNP levels/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (PRN (, ,)
      (S
        (NP (DT this) (JJ stimulatory) (NN effect))
        (VP (VBD was)
          (VP (VBN blocked)
            (PP (IN by)
              (NP
                (ADJP (JJ pre-treatment)
                  (PP (IN with)
                    (NP
                      (NP (NNP BQ_123))
                      (, ,)
                      (NP
                        (NP
                          (NP (DT an) (NNP ETA_receptor) (NN antagonist) (NN at_a) (NN concentration))
                          (PP (IN of)
                            (NP (CD 2)))
                          (X
                            (X (SYM x))
                            (NP (CD 10))))
                        (PRN (-LRB- -LRB-)
                          (NP (CD -6))
                          (-RRB- -RRB-))))))
                (NNP M.) (NNP Interestingly))))))
      (, ,))
    (NP (DT the) (NNP ETB) (NN receptor) (NN agonist) (NN IRL_1620))
    (ADVP (RB only))
    (VP (VBD elicited)
      (NP (DT a) (JJ weak) (NN increase))
      (PP (IN in)
        (NP (NNP Tiabendazole) (NNS levels))))
    (. .)))

advmod(elicited-34, However-1)
det(effect-5, this-3)
amod(effect-5, stimulatory-4)
nsubjpass(blocked-7, effect-5)
auxpass(blocked-7, was-6)
parataxis(elicited-34, blocked-7)
case(Interestingly-26, by-8)
amod(Interestingly-26, pre-treatment-9)
case(BQ_123-11, with-10)
nmod:with(pre-treatment-9, BQ_123-11)
det(concentration-17, an-13)
compound(concentration-17, ETA_receptor-14)
compound(concentration-17, antagonist-15)
compound(concentration-17, at_a-16)
appos(BQ_123-11, concentration-17)
case(2-19, of-18)
nmod:of(concentration-17, 2-19)
dep(10-21, x-20)
dep(concentration-17, 10-21)
appos(concentration-17, -6-23)
compound(Interestingly-26, M.-25)
nmod:by(blocked-7, Interestingly-26)
det(IRL_1620-32, the-28)
compound(IRL_1620-32, ETB-29)
compound(IRL_1620-32, receptor-30)
compound(IRL_1620-32, agonist-31)
nsubj(elicited-34, IRL_1620-32)
advmod(elicited-34, only-33)
root(ROOT-0, elicited-34)
det(increase-37, a-35)
amod(increase-37, weak-36)
dobj(elicited-34, increase-37)
case(levels-40, in-38)
compound(levels-40, Tiabendazole-39)
nmod:in(elicited-34, levels-40)

The/DT stimulatory/JJ effects/NNS of/IN NHR-176/NN -LRB-/-LRB- 10/CD -LRB-/-LRB- -6/NN -RRB-/-RRB- M/NNP -RRB-/-RRB- on/IN Tiabendazole/JJ levels/NNS were/VBD antagonized/VBN by/IN the/DT ETA_receptor/NNP antagonist/NNP BQ_123/NNP ,/,

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP (DT The) (JJ stimulatory) (NNS effects))
          (PP (IN of)
            (NP (NN NHR-176))))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (CD 10) (-LRB- -LRB-) (NN -6) (-RRB- -RRB-))
            (NP (NNP M)))
          (-RRB- -RRB-)))
      (PP (IN on)
        (NP (JJ Tiabendazole) (NNS levels))))
    (VP (VBD were)
      (VP (VBN antagonized)
        (PP (IN by)
          (NP (DT the) (NNP ETA_receptor) (NNP antagonist) (NNP BQ_123)))))
    (, ,)))

det(effects-3, The-1)
amod(effects-3, stimulatory-2)
nsubjpass(antagonized-17, effects-3)
case(NHR-176-5, of-4)
nmod:of(effects-3, NHR-176-5)
nummod(-6-9, 10-7)
dep(effects-3, -6-9)
appos(-6-9, M-11)
case(levels-15, on-13)
amod(levels-15, Tiabendazole-14)
nmod:on(effects-3, levels-15)
auxpass(antagonized-17, were-16)
root(ROOT-0, antagonized-17)
case(BQ_123-22, by-18)
det(BQ_123-22, the-19)
compound(BQ_123-22, ETA_receptor-20)
compound(BQ_123-22, antagonist-21)
nmod:by(antagonized-17, BQ_123-22)

2/LS x/SYM 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M/NNP ,/, and/CC the/DT ETB/NNP receptor/NN agonist/NN IRL_1620/NN evoked/VBD only/RB a/DT weak/JJ increase/NN in/IN Tiabendazole/NNP levels/NNS ./.

(ROOT
  (S
    (LST (LS 2))
    (S
      (NP
        (NP
          (NP (SYM x))
          (NP (CD 10)))
        (PRN (-LRB- -LRB-)
          (NP (CD -6))
          (-RRB- -RRB-)))
      (NP (NNP M)))
    (, ,)
    (CC and)
    (S
      (NP (DT the) (NNP ETB) (NN receptor) (NN agonist) (NN IRL_1620))
      (VP (VBD evoked)
        (NP (RB only) (DT a) (JJ weak) (NN increase))
        (PP (IN in)
          (NP (NNP Tiabendazole) (NNS levels)))))
    (. .)))

dep(M-7, 2-1)
dep(M-7, x-2)
dep(x-2, 10-3)
appos(x-2, -6-5)
root(ROOT-0, M-7)
cc(M-7, and-9)
det(IRL_1620-14, the-10)
compound(IRL_1620-14, ETB-11)
compound(IRL_1620-14, receptor-12)
compound(IRL_1620-14, agonist-13)
nsubj(evoked-15, IRL_1620-14)
conj:and(M-7, evoked-15)
advmod(increase-19, only-16)
det(increase-19, a-17)
amod(increase-19, weak-18)
dobj(evoked-15, increase-19)
case(levels-22, in-20)
compound(levels-22, Tiabendazole-21)
nmod:in(evoked-15, levels-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ implications/NNS of/IN these/DT findings/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS implications))
                  (PP (IN of)
                    (NP (DT these) (NNS findings))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(implications-13, potential-11)
amod(implications-13, therapeutic-12)
dobj(elucidate-6, implications-13)
conj:and(mechanisms-9, implications-13)
case(findings-16, of-14)
det(findings-16, these-15)
nmod:of(implications-13, findings-16)

Obesity/RB is_a/JJ complex/JJ metabolic_disorder/NN that/WDT is/VBZ associated/VBN with/IN the/DT development/NN of/IN several/JJ chronic_diseases/NNS ./.

(ROOT
  (NP
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (JJ complex) (NN metabolic_disorder))
    (SBAR
      (WHNP (WDT that))
      (S
        (VP (VBZ is)
          (VP (VBN associated)
            (PP (IN with)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP (JJ several) (NNS chronic_diseases)))))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(metabolic_disorder-4, is_a-2)
amod(metabolic_disorder-4, complex-3)
root(ROOT-0, metabolic_disorder-4)
nsubjpass(associated-7, metabolic_disorder-4)
ref(metabolic_disorder-4, that-5)
auxpass(associated-7, is-6)
acl:relcl(metabolic_disorder-4, associated-7)
case(development-10, with-8)
det(development-10, the-9)
nmod:with(associated-7, development-10)
case(chronic_diseases-13, of-11)
amod(chronic_diseases-13, several-12)
nmod:of(development-10, chronic_diseases-13)

The/DT hypersecretion/NN of/IN calmodulin-dependent_protein_kinase_II/NN -LRB-/-LRB- CaM-KII/NNP -RRB-/-RRB- by/IN pancreatic/JJ beta-cells/NNS has_been/VBP implicated/VBN in/IN the/DT pathogenesis/NNS of/IN obesity/NN ./.

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP (DT The) (NN hypersecretion))
          (PP (IN of)
            (NP (NN calmodulin-dependent_protein_kinase_II))))
        (PRN (-LRB- -LRB-)
          (NP (NNP CaM-KII))
          (-RRB- -RRB-)))
      (PP (IN by)
        (NP (JJ pancreatic) (NNS beta-cells))))
    (VP (VBP has_been)
      (VP (VBN implicated)
        (PP (IN in)
          (NP
            (NP (DT the) (NNS pathogenesis))
            (PP (IN of)
              (NP (NN obesity)))))))
    (. .)))

det(hypersecretion-2, The-1)
nsubj(has_been-11, hypersecretion-2)
case(calmodulin-dependent_protein_kinase_II-4, of-3)
nmod:of(hypersecretion-2, calmodulin-dependent_protein_kinase_II-4)
appos(hypersecretion-2, CaM-KII-6)
case(beta-cells-10, by-8)
amod(beta-cells-10, pancreatic-9)
nmod:by(hypersecretion-2, beta-cells-10)
root(ROOT-0, has_been-11)
dep(has_been-11, implicated-12)
case(pathogenesis-15, in-13)
det(pathogenesis-15, the-14)
nmod:in(implicated-12, pathogenesis-15)
case(obesity-17, of-16)
nmod:of(pathogenesis-15, obesity-17)

In/IN this/DT study/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN glucose/NN and/CC CAFdA/NNP on/IN the/DT secretion/NN of/IN CaM/NNP -/: KII/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/NNP //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (NN glucose))
            (CC and)
            (NP (NNP CAFdA)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNP CaM)))
          (PRN (: -)
            (ADVP (NNP KII))
            (NP
              (NP (NN and_insulin))
              (PP (IN by)
                (NP
                  (NP (VBN isolated)
                    (NX
                      (NX
                        (NX
                          (NX (JJ perfused) (NN pancreata))
                          (PP (IN from)
                            (NP (NN genetically_obese))))
                        (PRN (-LRB- -LRB-) (NN fa/fa) (-RRB- -RRB-)))
                      (CC and)
                      (NX (JJ lean))))
                  (-LRB- -LRB-)
                  (NP (NNP Fa))
                  (: /))))
            (. ?) (-RRB- -RRB-))
          (NP (NNS rats)))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(examined-6, study-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-10, of-9)
nmod:of(effects-8, glucose-10)
cc(glucose-10, and-11)
nmod:of(effects-8, CAFdA-12)
conj:and(glucose-10, CAFdA-12)
case(secretion-15, on-13)
det(secretion-15, the-14)
nmod:on(examined-6, secretion-15)
case(CaM-17, of-16)
nmod:of(secretion-15, CaM-17)
dep(and_insulin-20, KII-19)
dep(secretion-15, and_insulin-20)
case(pancreata-24, by-21)
amod(pancreata-24, isolated-22)
amod(pancreata-24, perfused-23)
nmod:by(and_insulin-20, pancreata-24)
case(genetically_obese-26, from-25)
nmod:from(pancreata-24, genetically_obese-26)
dep(pancreata-24, fa/fa-28)
cc(pancreata-24, and-30)
nmod:by(and_insulin-20, lean-31)
conj:and(pancreata-24, lean-31)
dep(pancreata-24, Fa-33)
dep(secretion-15, rats-37)

CaM/VB is_a/RB Ca/JJ -LRB-/-LRB- 2/CD +/NNS -RRB-/-RRB- -/: activated/VBN K/NNP -LRB-/-LRB- +/NN -RRB-/-RRB- channel/NN -LRB-/-LRB- K/NNP -LRB-/-LRB- Ca/MD -RRB-/-RRB- -RRB-/-RRB-

(ROOT
  (S
    (VP (VB CaM)
      (NP
        (NP (RB is_a) (JJ Ca)
          (PRN (-LRB- -LRB-)
            (NP (CD 2) (NNS +))
            (-RRB- -RRB-)))
        (PRN (: -)
          (PP (VBN activated)
            (NP
              (NP (NNP K) (-LRB- -LRB-) (NN +) (-RRB- -RRB-))
              (NP
                (NP (NN channel))
                (-LRB- -LRB-)
                (NP (NNP K))
                (PRN (-LRB- -LRB-)
                  (VP (MD Ca))
                  (-RRB- -RRB-))
                (-RRB- -RRB-)))))))))

root(ROOT-0, CaM-1)
advmod(Ca-3, is_a-2)
dobj(CaM-1, Ca-3)
nummod(+-6, 2-5)
appos(Ca-3, +-6)
case(+-12, activated-9)
compound(+-12, K-10)
nmod:activated(Ca-3, +-12)
dep(+-12, channel-14)
dep(channel-14, K-16)
dep(channel-14, Ca-18)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT hypersecretion/NN of/IN CaM-KII/NNP by/IN the/DT pancreas/NN may/MD contribute/VB to/TO the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN hypersecretion))
              (PP (IN of)
                (NP (NNP CaM-KII)))
              (PP (IN by)
                (NP (DT the) (NN pancreas))))
            (VP (MD may)
              (VP (VB contribute)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(contribute-14, that-5)
det(hypersecretion-7, the-6)
nsubj(contribute-14, hypersecretion-7)
case(CaM-KII-9, of-8)
nmod:of(hypersecretion-7, CaM-KII-9)
case(pancreas-12, by-10)
det(pancreas-12, the-11)
nmod:by(hypersecretion-7, pancreas-12)
aux(contribute-14, may-13)
ccomp(suggested-4, contribute-14)
case(development-17, to-15)
det(development-17, the-16)
nmod:to(contribute-14, development-17)
case(obesity-19, of-18)
nmod:of(development-17, obesity-19)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN CaM-KII/NNP by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNP CaM-KII)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(CaM-KII-20, of-19)
nmod:of(hypersecretion-18, CaM-KII-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT goal/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/NN CAFdA/NNP on/IN the/DT secretion/NN of/IN CaM-KII/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this) (NN goal)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (NN mmol/L) (NNP CAFdA)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ CaM-KII) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-7, achieve-2)
det(goal-4, this-3)
dobj(achieve-2, goal-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(CAFdA-17, 10-15)
compound(CAFdA-17, mmol/L-16)
nmod:of(effects-9, CAFdA-17)
conj:and(glucose-13, CAFdA-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(examined-7, secretion-20)
case(and_insulin-23, of-21)
amod(and_insulin-23, CaM-KII-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(pancreata-27, genetically_obese-29)
appos(genetically_obese-29, fa/fa-31)
cc(genetically_obese-29, and-33)
amod(rats-40, lean-34)
dep(lean-34, Fa-36)
nmod:from(pancreata-27, rats-40)
conj:and(genetically_obese-29, rats-40)

Our/PRP$ results/NNS indicate/VBP that/IN there/EX is_a/VBD significant/JJ increase/NN in/IN CaM-KII/JJ secretion/NN in/IN response/NN to/TO glucose/NN and/CC CAFdA/NNP in/IN obese/JJ rats/NNS compared/VBN to/TO lean/JJ rats/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP indicate)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (VBD is_a)
            (NP
              (NP (JJ significant) (NN increase))
              (PP (IN in)
                (NP (JJ CaM-KII) (NN secretion))))
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP
                    (NP (NN glucose))
                    (CC and)
                    (NP (NNP CAFdA))))))
            (PP (IN in)
              (NP
                (NP (JJ obese) (NNS rats))
                (VP (VBN compared)
                  (PP (TO to)
                    (NP (JJ lean) (NNS rats))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(indicate-3, results-2)
root(ROOT-0, indicate-3)
mark(is_a-6, that-4)
expl(is_a-6, there-5)
ccomp(indicate-3, is_a-6)
amod(increase-8, significant-7)
dobj(is_a-6, increase-8)
case(secretion-11, in-9)
amod(secretion-11, CaM-KII-10)
nmod:in(increase-8, secretion-11)
case(response-13, in-12)
nmod:in(is_a-6, response-13)
case(glucose-15, to-14)
nmod:to(response-13, glucose-15)
cc(glucose-15, and-16)
nmod:to(response-13, CAFdA-17)
conj:and(glucose-15, CAFdA-17)
case(rats-20, in-18)
amod(rats-20, obese-19)
nmod:in(is_a-6, rats-20)
acl(rats-20, compared-21)
case(rats-24, to-22)
amod(rats-24, lean-23)
nmod:to(compared-21, rats-24)

Furthermore/RB ,/, we/PRP observed/VBD a/DT significant/JJ decrease/NN in/IN insulin_secretion/NN in/IN response/NN to/TO glucose/NN and/CC CAFdA/NNP in/IN obese/JJ rats/NNS compared/VBN to/TO lean/JJ rats/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP (DT a) (JJ significant) (NN decrease))
        (PP (IN in)
          (NP (NN insulin_secretion))))
      (PP (IN in)
        (NP
          (NP (NN response))
          (PP (TO to)
            (NP
              (NP (NN glucose))
              (CC and)
              (NP (NNP CAFdA))))))
      (PP (IN in)
        (NP
          (NP (JJ obese) (NNS rats))
          (VP (VBN compared)
            (PP (TO to)
              (NP (JJ lean) (NNS rats)))))))
    (. .)))

advmod(observed-4, Furthermore-1)
nsubj(observed-4, we-3)
root(ROOT-0, observed-4)
det(decrease-7, a-5)
amod(decrease-7, significant-6)
dobj(observed-4, decrease-7)
case(insulin_secretion-9, in-8)
nmod:in(decrease-7, insulin_secretion-9)
case(response-11, in-10)
nmod:in(observed-4, response-11)
case(glucose-13, to-12)
nmod:to(response-11, glucose-13)
cc(glucose-13, and-14)
nmod:to(response-11, CAFdA-15)
conj:and(glucose-13, CAFdA-15)
case(rats-18, in-16)
amod(rats-18, obese-17)
nmod:in(observed-4, rats-18)
acl(rats-18, compared-19)
case(rats-22, to-20)
amod(rats-22, lean-21)
nmod:to(compared-19, rats-22)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN CaM-KII/NNP may/MD contribute/VB to/TO the/DT development/NN of/IN obesity/NN by/IN impairing/VBG insulin_secretion/NN from/IN pancreatic/JJ beta-cells/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNP CaM-KII))))
          (VP (MD may)
            (VP (VB contribute)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity)))))
              (PP (IN by)
                (S
                  (VP (VBG impairing)
                    (NP (NN insulin_secretion))
                    (PP (IN from)
                      (NP (JJ pancreatic) (NNS beta-cells)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(contribute-9, that-4)
nsubj(contribute-9, hypersecretion-5)
case(CaM-KII-7, of-6)
nmod:of(hypersecretion-5, CaM-KII-7)
aux(contribute-9, may-8)
ccomp(suggest-3, contribute-9)
case(development-12, to-10)
det(development-12, the-11)
nmod:to(contribute-9, development-12)
case(obesity-14, of-13)
nmod:of(development-12, obesity-14)
mark(impairing-16, by-15)
advcl(contribute-9, impairing-16)
dobj(impairing-16, insulin_secretion-17)
case(beta-cells-20, from-18)
amod(beta-cells-20, pancreatic-19)
nmod:from(impairing-16, beta-cells-20)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT molecular/JJ mechanisms/NNS underlying/VBG this/DT relationship/NN and/CC identify/VB potential/JJ therapeutic/JJ targets/NNS for/IN obesity-associated_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (JJ molecular) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT this) (NN relationship)))))
              (CC and)
              (VP (VB identify)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP (NNS obesity-associated_disorders))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
nsubj:xsubj(identify-14, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(relationship-12, this-11)
dobj(underlying-10, relationship-12)
cc(elucidate-6, and-13)
xcomp(needed-4, identify-14)
conj:and(elucidate-6, identify-14)
amod(targets-17, potential-15)
amod(targets-17, therapeutic-16)
dobj(identify-14, targets-17)
case(obesity-associated_disorders-19, for-18)
nmod:for(targets-17, obesity-associated_disorders-19)

Obesity/RB is_a/JJ complex/JJ metabolic_disorder/NN that/WDT is/VBZ influenced/VBN by/IN genetic/JJ and/CC environmental/JJ factors/NNS ./.

(ROOT
  (NP
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (JJ complex) (NN metabolic_disorder))
    (SBAR
      (WHNP (WDT that))
      (S
        (VP (VBZ is)
          (VP (VBN influenced)
            (PP (IN by)
              (NP
                (ADJP (JJ genetic)
                  (CC and)
                  (JJ environmental))
                (NNS factors)))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(metabolic_disorder-4, is_a-2)
amod(metabolic_disorder-4, complex-3)
root(ROOT-0, metabolic_disorder-4)
nsubjpass(influenced-7, metabolic_disorder-4)
ref(metabolic_disorder-4, that-5)
auxpass(influenced-7, is-6)
acl:relcl(metabolic_disorder-4, influenced-7)
case(factors-12, by-8)
amod(factors-12, genetic-9)
cc(genetic-9, and-10)
conj:and(genetic-9, environmental-11)
amod(factors-12, environmental-11)
nmod:by(influenced-7, factors-12)

To/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN hPim-2/JJ by/IN the/DT pancreas/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ PYR-41/NN on/IN the/DT secretion/NN of/IN hPim-2/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/NNP //: ?/. -RRB-/-RRB-

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP
            (NP (DT the) (NN relationship))
            (PP (IN between)
              (NP
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity))))
                (CC and)
                (NP
                  (NP (DT the) (NN hypersecretion))
                  (PP (IN of)
                    (NP (JJ hPim-2)))))))
          (PP (IN by)
            (NP (DT the) (NN pancreas))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN PYR-41)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ hPim-2) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated)
            (NX
              (NX
                (NX
                  (NX (JJ perfused) (NN pancreata))
                  (PP (IN from)
                    (NP (NN genetically_obese))))
                (PRN (-LRB- -LRB-) (NN fa/fa) (-RRB- -RRB-)))
              (CC and)
              (NX (JJ lean))))
          (-LRB- -LRB-)
          (NP (NNP Fa))
          (: /))))
    (. ?) (-RRB- -RRB-)))

mark(evaluate-2, To-1)
advcl(examined-20, evaluate-2)
det(relationship-4, the-3)
dobj(evaluate-2, relationship-4)
case(development-7, between-5)
det(development-7, the-6)
nmod:between(relationship-4, development-7)
case(obesity-9, of-8)
nmod:of(development-7, obesity-9)
cc(development-7, and-10)
det(hypersecretion-12, the-11)
nmod:between(relationship-4, hypersecretion-12)
conj:and(development-7, hypersecretion-12)
case(hPim-2-14, of-13)
nmod:of(hypersecretion-12, hPim-2-14)
case(pancreas-17, by-15)
det(pancreas-17, the-16)
nmod:by(evaluate-2, pancreas-17)
nsubj(examined-20, we-19)
root(ROOT-0, examined-20)
det(effects-22, the-21)
dobj(examined-20, effects-22)
case(glucose-26, of-23)
nummod(glucose-26, 16.7-24)
amod(glucose-26, mmol/L-25)
nmod:of(effects-22, glucose-26)
cc(glucose-26, and-27)
nummod(PYR-41-30, 10-28)
amod(PYR-41-30, mmol/L-29)
nmod:of(effects-22, PYR-41-30)
conj:and(glucose-26, PYR-41-30)
case(secretion-33, on-31)
det(secretion-33, the-32)
nmod:on(examined-20, secretion-33)
case(and_insulin-36, of-34)
amod(and_insulin-36, hPim-2-35)
nmod:of(secretion-33, and_insulin-36)
case(pancreata-40, by-37)
amod(pancreata-40, isolated-38)
amod(pancreata-40, perfused-39)
nmod:by(examined-20, pancreata-40)
case(genetically_obese-42, from-41)
nmod:from(pancreata-40, genetically_obese-42)
dep(pancreata-40, fa/fa-44)
cc(pancreata-40, and-46)
nmod:by(examined-20, lean-47)
conj:and(pancreata-40, lean-47)
dep(pancreata-40, Fa-49)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN hPim-2/JJ by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (JJ hPim-2)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(hPim-2-20, of-19)
nmod:of(hypersecretion-18, hPim-2-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ PYR-41/NN on/IN the/DT secretion/NN of/IN hPim-2/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN PYR-41)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ hPim-2) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(PYR-41-16, 10-14)
amod(PYR-41-16, mmol/L-15)
nmod:of(effects-8, PYR-41-16)
conj:and(glucose-12, PYR-41-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(and_insulin-22, of-20)
amod(and_insulin-22, hPim-2-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(genetically_obese-28, from-27)
nmod:from(pancreata-26, genetically_obese-28)
appos(genetically_obese-28, fa/fa-30)
cc(genetically_obese-28, and-32)
amod(rats-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(pancreata-26, rats-39)
conj:and(genetically_obese-28, rats-39)

Our/PRP$ results/NNS showed/VBD that/IN there/EX was/VBD a/DT significant/JJ increase/NN in/IN hPim-2/JJ secretion/NN in/IN response/NN to/TO high/JJ glucose/NN levels/NNS in/IN both/DT obese/JJ and/CC lean/JJ rats/NNS ,/, with/IN a/DT greater/JJR increase/NN observed/VBN in/IN obese/JJ rats/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (VBD was)
            (NP
              (NP (DT a) (JJ significant) (NN increase))
              (PP (IN in)
                (NP (JJ hPim-2) (NN secretion))))
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP (JJ high) (NN glucose) (NNS levels)))))
            (PP (IN in)
              (NP (DT both) (JJ obese)
                (CC and)
                (JJ lean) (NNS rats)))
            (, ,)
            (PP (IN with)
              (NP
                (NP (DT a) (JJR greater) (NN increase))
                (VP (VBN observed)
                  (PP (IN in)
                    (NP (JJ obese) (NNS rats))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(was-6, that-4)
expl(was-6, there-5)
ccomp(showed-3, was-6)
det(increase-9, a-7)
amod(increase-9, significant-8)
nsubj(was-6, increase-9)
case(secretion-12, in-10)
amod(secretion-12, hPim-2-11)
nmod:in(increase-9, secretion-12)
case(response-14, in-13)
nmod:in(was-6, response-14)
case(levels-18, to-15)
amod(levels-18, high-16)
compound(levels-18, glucose-17)
nmod:to(response-14, levels-18)
case(rats-24, in-19)
det(rats-24, both-20)
amod(rats-24, obese-21)
cc(obese-21, and-22)
conj:and(obese-21, lean-23)
amod(rats-24, lean-23)
nmod:in(was-6, rats-24)
case(increase-29, with-26)
det(increase-29, a-27)
amod(increase-29, greater-28)
nmod:with(was-6, increase-29)
acl(increase-29, observed-30)
case(rats-33, in-31)
amod(rats-33, obese-32)
nmod:in(observed-30, rats-33)

Furthermore/RB ,/, treatment/NN with/IN PYR-41/NNP resulted/VBD in_a/JJ significant/JJ decrease/NN in/IN hPim-2/JJ secretion/NN in/IN both/DT groups/NNS ,/, with/IN a/DT more/RBR pronounced/JJ effect/NN observed/VBN in/IN obese/JJ rats/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (NN treatment))
      (PP (IN with)
        (NP (NNP PYR-41))))
    (VP (VBD resulted)
      (NP
        (NP (JJ in_a) (JJ significant) (NN decrease))
        (PP (IN in)
          (NP (JJ hPim-2) (NN secretion))))
      (PP (IN in)
        (NP (DT both) (NNS groups)))
      (, ,)
      (PP (IN with)
        (NP
          (NP (DT a)
            (ADJP (RBR more) (JJ pronounced))
            (NN effect))
          (VP (VBN observed)
            (PP (IN in)
              (NP (JJ obese) (NNS rats)))))))
    (. .)))

advmod(resulted-6, Furthermore-1)
nsubj(resulted-6, treatment-3)
case(PYR-41-5, with-4)
nmod:with(treatment-3, PYR-41-5)
root(ROOT-0, resulted-6)
amod(decrease-9, in_a-7)
amod(decrease-9, significant-8)
dobj(resulted-6, decrease-9)
case(secretion-12, in-10)
amod(secretion-12, hPim-2-11)
nmod:in(decrease-9, secretion-12)
case(groups-15, in-13)
det(groups-15, both-14)
nmod:in(resulted-6, groups-15)
case(effect-21, with-17)
det(effect-21, a-18)
advmod(pronounced-20, more-19)
amod(effect-21, pronounced-20)
nmod:with(resulted-6, effect-21)
acl(effect-21, observed-22)
case(rats-25, in-23)
amod(rats-25, obese-24)
nmod:in(observed-22, rats-25)

Interestingly/RB ,/, there/EX was/VBD no/DT significant/JJ difference/NN observed/VBN in/IN insulin_secretion/NN between/IN obese/JJ and/CC lean/JJ rats/NNS under/IN any/DT experimental/JJ condition/NN ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP
          (NP (DT no) (JJ significant) (NN difference))
          (VP (VBN observed)
            (PP (IN in)
              (NP (NN insulin_secretion)))))
        (PP (IN between)
          (NP (JJ obese)
            (CC and)
            (JJ lean) (NNS rats))))
      (PP (IN under)
        (NP (DT any) (JJ experimental) (NN condition))))
    (. .)))

advmod(was-4, Interestingly-1)
expl(was-4, there-3)
root(ROOT-0, was-4)
neg(difference-7, no-5)
amod(difference-7, significant-6)
nsubj(was-4, difference-7)
acl(difference-7, observed-8)
case(insulin_secretion-10, in-9)
nmod:in(observed-8, insulin_secretion-10)
case(rats-15, between-11)
amod(rats-15, obese-12)
cc(obese-12, and-13)
conj:and(obese-12, lean-14)
amod(rats-15, lean-14)
nmod:between(difference-7, rats-15)
case(condition-19, under-16)
det(condition-19, any-17)
amod(condition-19, experimental-18)
nmod:under(was-4, condition-19)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN hPim-2/JJ may/MD be/VB involved/VBN in/IN the/DT pathogenesis/NNS of/IN obesity/NN ,/, and/CC targeting/VBG this/DT pathway/NN may/MD provide/VB a/DT potential/JJ therapeutic/JJ strategy/NN for/IN the/DT management/NN of/IN obesity-related_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (NP
              (NP (NN hypersecretion))
              (PP (IN of)
                (NP (JJ hPim-2))))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NNS pathogenesis))
                      (PP (IN of)
                        (NP (NN obesity)))))))))
          (, ,)
          (CC and)
          (S
            (S
              (VP (VBG targeting)
                (NP (DT this) (NN pathway))))
            (VP (MD may)
              (VP (VB provide)
                (NP (DT a) (JJ potential) (JJ therapeutic) (NN strategy))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN management))
                    (PP (IN of)
                      (NP (NNS obesity-related_disorders)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-10, that-4)
nsubjpass(involved-10, hypersecretion-5)
case(hPim-2-7, of-6)
nmod:of(hypersecretion-5, hPim-2-7)
aux(involved-10, may-8)
auxpass(involved-10, be-9)
ccomp(suggest-3, involved-10)
case(pathogenesis-13, in-11)
det(pathogenesis-13, the-12)
nmod:in(involved-10, pathogenesis-13)
case(obesity-15, of-14)
nmod:of(pathogenesis-13, obesity-15)
cc(involved-10, and-17)
csubj(provide-22, targeting-18)
det(pathway-20, this-19)
dobj(targeting-18, pathway-20)
aux(provide-22, may-21)
ccomp(suggest-3, provide-22)
conj:and(involved-10, provide-22)
det(strategy-26, a-23)
amod(strategy-26, potential-24)
amod(strategy-26, therapeutic-25)
dobj(provide-22, strategy-26)
case(management-29, for-27)
det(management-29, the-28)
nmod:for(provide-22, management-29)
case(obesity-related_disorders-31, of-30)
nmod:of(management-29, obesity-related_disorders-31)

Non-alcoholic_fatty_liver_disease/JJ -LRB-/-LRB- NAFLD/NNP -RRB-/-RRB- is_a/NN common/JJ metabolic_disorder/NN characterized/VBD by/IN the/DT accumulation/NN of/IN triglycerides/NNPS in/IN hepatocytes/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Non-alcoholic_fatty_liver_disease)
        (PRN (-LRB- -LRB-)
          (NP (NNP NAFLD))
          (-RRB- -RRB-))
        (NN is_a))
      (NP (JJ common) (NN metabolic_disorder)))
    (VP (VBD characterized)
      (PP (IN by)
        (NP
          (NP (DT the) (NN accumulation))
          (PP (IN of)
            (NP (NNPS triglycerides)))))
      (PP (IN in)
        (NP (NNS hepatocytes))))
    (. .)))

amod(is_a-5, Non-alcoholic_fatty_liver_disease-1)
appos(is_a-5, NAFLD-3)
nsubj(characterized-8, is_a-5)
amod(metabolic_disorder-7, common-6)
dep(is_a-5, metabolic_disorder-7)
root(ROOT-0, characterized-8)
case(accumulation-11, by-9)
det(accumulation-11, the-10)
nmod:by(characterized-8, accumulation-11)
case(triglycerides-13, of-12)
nmod:of(accumulation-11, triglycerides-13)
case(hepatocytes-15, in-14)
nmod:in(characterized-8, hepatocytes-15)

This/DT study/NN shows/VBZ that/IN induction/NN of/IN the/DT lipogenic/JJ genes/NNS Srebp-1c/NN ,/, Fas/NNP ,/, and/CC apoptosis-induced_factor/JJ upon/IN administration/NN of/IN the/DT synthetic/JJ LXR/NNP agonist/NN Kuguaglycoside_C/NNP to/TO C57BL/6J/CD mice/NNS -LRB-/-LRB- 10/CD mg/kg/day/NN ,/, 4/CD days/NNS -RRB-/-RRB- is/VBZ associated/VBN with/IN massive/JJ hepatic_steatosis/NNS along/IN the/DT entire/JJ liver/NN lobule/NN and/CC a/DT 2.5-fold/JJ increase/NN in/IN very_low_density_lipoprotein-triglyceride/JJ -LRB-/-LRB- VLDL-TG/NNP -RRB-/-RRB- secretion/NNS ./.

(ROOT
  (S
    (NP (DT This) (NN study))
    (VP (VBZ shows)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN induction))
            (PP (IN of)
              (NP
                (NP (DT the) (JJ lipogenic) (NNS genes) (NN Srebp-1c))
                (, ,)
                (NP (NNP Fas))
                (, ,)
                (CC and)
                (NP
                  (NP
                    (ADJP (JJ apoptosis-induced_factor)
                      (PP (IN upon)
                        (NP
                          (NP (NN administration))
                          (PP (IN of)
                            (NP (DT the) (JJ synthetic) (NNP LXR) (NN agonist))))))
                    (NNP Kuguaglycoside_C))
                  (TO to)
                  (NP
                    (NP (CD C57BL/6J) (NNS mice))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 10) (NN mg/kg/day))
                        (, ,)
                        (NP-TMP (CD 4) (NNS days)))
                      (-RRB- -RRB-)))))))
          (VP (VBZ is)
            (VP (VBN associated)
              (PP (IN with)
                (NP
                  (NP (JJ massive) (NNS hepatic_steatosis))
                  (PP (IN along)
                    (NP
                      (NP (DT the) (JJ entire) (NN liver) (NN lobule))
                      (CC and)
                      (NP (DT a) (JJ 2.5-fold) (NN increase))))))
              (PP (IN in)
                (NP (JJ very_low_density_lipoprotein-triglyceride)
                  (PRN (-LRB- -LRB-)
                    (NP (NNP VLDL-TG))
                    (-RRB- -RRB-))
                  (NNS secretion))))))))
    (. .)))

det(study-2, This-1)
nsubj(shows-3, study-2)
root(ROOT-0, shows-3)
mark(associated-35, that-4)
nsubjpass(associated-35, induction-5)
case(Srebp-1c-10, of-6)
det(Srebp-1c-10, the-7)
amod(Srebp-1c-10, lipogenic-8)
compound(Srebp-1c-10, genes-9)
nmod:of(induction-5, Srebp-1c-10)
nmod:of(induction-5, Fas-12)
conj:and(Srebp-1c-10, Fas-12)
cc(Srebp-1c-10, and-14)
amod(Kuguaglycoside_C-23, apoptosis-induced_factor-15)
case(administration-17, upon-16)
nmod:upon(apoptosis-induced_factor-15, administration-17)
case(agonist-22, of-18)
det(agonist-22, the-19)
amod(agonist-22, synthetic-20)
compound(agonist-22, LXR-21)
nmod:of(administration-17, agonist-22)
nmod:of(induction-5, Kuguaglycoside_C-23)
conj:and(Srebp-1c-10, Kuguaglycoside_C-23)
dep(Kuguaglycoside_C-23, to-24)
nummod(mice-26, C57BL/6J-25)
dep(Kuguaglycoside_C-23, mice-26)
nummod(mg/kg/day-29, 10-28)
dep(mice-26, mg/kg/day-29)
nummod(days-32, 4-31)
nmod:tmod(mg/kg/day-29, days-32)
auxpass(associated-35, is-34)
ccomp(shows-3, associated-35)
case(hepatic_steatosis-38, with-36)
amod(hepatic_steatosis-38, massive-37)
nmod:with(associated-35, hepatic_steatosis-38)
case(lobule-43, along-39)
det(lobule-43, the-40)
amod(lobule-43, entire-41)
compound(lobule-43, liver-42)
nmod:along(hepatic_steatosis-38, lobule-43)
cc(lobule-43, and-44)
det(increase-47, a-45)
amod(increase-47, 2.5-fold-46)
nmod:along(hepatic_steatosis-38, increase-47)
conj:and(lobule-43, increase-47)
case(secretion-53, in-48)
amod(secretion-53, very_low_density_lipoprotein-triglyceride-49)
appos(secretion-53, VLDL-TG-51)
nmod:in(associated-35, secretion-53)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN Kuguaglycoside_C/NNP ,/, a/DT synthetic/JJ LXR/NNP agonist/NN ,/, on/IN hepatic_steatosis/NNS and/CC VLDL-TG/JJ secretion/NN in/IN C57BL/6J/CD mice/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NNP Kuguaglycoside_C))
            (, ,)
            (NP (DT a) (JJ synthetic) (NNP LXR) (NN agonist))
            (, ,))))
      (PP (IN on)
        (NP
          (NP (NNS hepatic_steatosis))
          (CC and)
          (NP (JJ VLDL-TG) (NN secretion))))
      (PP (IN in)
        (NP (CD C57BL/6J) (NNS mice))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(Kuguaglycoside_C-10, of-9)
nmod:of(effect-8, Kuguaglycoside_C-10)
det(agonist-15, a-12)
amod(agonist-15, synthetic-13)
compound(agonist-15, LXR-14)
appos(Kuguaglycoside_C-10, agonist-15)
case(hepatic_steatosis-18, on-17)
nmod:on(investigated-6, hepatic_steatosis-18)
cc(hepatic_steatosis-18, and-19)
amod(secretion-21, VLDL-TG-20)
nmod:on(investigated-6, secretion-21)
conj:and(hepatic_steatosis-18, secretion-21)
case(mice-24, in-22)
nummod(mice-24, C57BL/6J-23)
nmod:in(investigated-6, mice-24)

Our/PRP$ results/NNS show/VBP that/IN administration/NN of/IN Kuguaglycoside_C/JJ at_a/NN dose/NN of/IN 10/CD mg/kg/day/NN for/IN 4/CD days/NNS induces/VBZ the/DT expression/NN of/IN lipogenic/JJ genes/NNS Srebp-1c/NN ,/, Fas/NNP ,/, and/CC apoptosis-induced_factor/NN in/IN the/DT liver/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP show)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN administration))
            (PP (IN of)
              (NP
                (NP (JJ Kuguaglycoside_C) (NN at_a) (NN dose))
                (PP (IN of)
                  (NP
                    (NP (CD 10) (NN mg/kg/day))
                    (PP (IN for)
                      (NP (CD 4) (NNS days))))))))
          (VP (VBZ induces)
            (NP
              (NP
                (NP
                  (NP (DT the) (NN expression))
                  (PP (IN of)
                    (NP (JJ lipogenic) (NNS genes))))
                (NN Srebp-1c))
              (, ,)
              (NP (NNP Fas))
              (, ,)
              (CC and)
              (NP
                (NP (NN apoptosis-induced_factor))
                (PP (IN in)
                  (NP (DT the) (NN liver)))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(show-3, results-2)
root(ROOT-0, show-3)
mark(induces-16, that-4)
nsubj(induces-16, administration-5)
case(dose-9, of-6)
amod(dose-9, Kuguaglycoside_C-7)
compound(dose-9, at_a-8)
nmod:of(administration-5, dose-9)
case(mg/kg/day-12, of-10)
nummod(mg/kg/day-12, 10-11)
nmod:of(dose-9, mg/kg/day-12)
case(days-15, for-13)
nummod(days-15, 4-14)
nmod:for(mg/kg/day-12, days-15)
ccomp(show-3, induces-16)
det(expression-18, the-17)
compound(Srebp-1c-22, expression-18)
case(genes-21, of-19)
amod(genes-21, lipogenic-20)
nmod:of(expression-18, genes-21)
dobj(induces-16, Srebp-1c-22)
dobj(induces-16, Fas-24)
conj:and(Srebp-1c-22, Fas-24)
cc(Srebp-1c-22, and-26)
dobj(induces-16, apoptosis-induced_factor-27)
conj:and(Srebp-1c-22, apoptosis-induced_factor-27)
case(liver-30, in-28)
det(liver-30, the-29)
nmod:in(apoptosis-induced_factor-27, liver-30)

This/DT induction/NN is/VBZ associated/VBN with/IN massive/JJ hepatic_steatosis/NNS along/IN the/DT entire/JJ liver/NN lobule/NN and/CC a/DT 2.5-fold/JJ increase/NN in/IN VLDL-TG/JJ secretion/NN ./.

(ROOT
  (S
    (NP (DT This) (NN induction))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ massive) (NNS hepatic_steatosis))
            (PP (IN along)
              (NP
                (NP (DT the) (JJ entire) (NN liver) (NN lobule))
                (CC and)
                (NP
                  (NP (DT a) (JJ 2.5-fold) (NN increase))
                  (PP (IN in)
                    (NP (JJ VLDL-TG) (NN secretion))))))))))
    (. .)))

det(induction-2, This-1)
nsubjpass(associated-4, induction-2)
auxpass(associated-4, is-3)
root(ROOT-0, associated-4)
case(hepatic_steatosis-7, with-5)
amod(hepatic_steatosis-7, massive-6)
nmod:with(associated-4, hepatic_steatosis-7)
case(lobule-12, along-8)
det(lobule-12, the-9)
amod(lobule-12, entire-10)
compound(lobule-12, liver-11)
nmod:along(hepatic_steatosis-7, lobule-12)
cc(lobule-12, and-13)
det(increase-16, a-14)
amod(increase-16, 2.5-fold-15)
nmod:along(hepatic_steatosis-7, increase-16)
conj:and(lobule-12, increase-16)
case(secretion-19, in-17)
amod(secretion-19, VLDL-TG-18)
nmod:in(increase-16, secretion-19)

These/DT findings/NNS suggest/VBP that/IN activation/NN of/IN LXR/NNP signaling/VBG pathway/RB may/MD contribute/VB to/TO the/DT pathogenesis/NNS of/IN NAFLD/NNP by/IN promoting/VBG hepatic_steatosis/NNS and/CC VLDL-TG/JJ secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN activation))
            (PP (IN of)
              (NP (NNP LXR)))
            (VP (VBG signaling)
              (ADVP (RB pathway))))
          (VP (MD may)
            (VP (VB contribute)
              (PP (TO to)
                (NP
                  (NP (DT the) (NNS pathogenesis))
                  (PP (IN of)
                    (NP (NNP NAFLD)))))
              (PP (IN by)
                (S
                  (VP (VBG promoting)
                    (NP
                      (NP (NNS hepatic_steatosis))
                      (CC and)
                      (NP (JJ VLDL-TG) (NN secretion)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(contribute-11, that-4)
nsubj(contribute-11, activation-5)
case(LXR-7, of-6)
nmod:of(activation-5, LXR-7)
acl(activation-5, signaling-8)
advmod(signaling-8, pathway-9)
aux(contribute-11, may-10)
ccomp(suggest-3, contribute-11)
case(pathogenesis-14, to-12)
det(pathogenesis-14, the-13)
nmod:to(contribute-11, pathogenesis-14)
case(NAFLD-16, of-15)
nmod:of(pathogenesis-14, NAFLD-16)
mark(promoting-18, by-17)
advcl(contribute-11, promoting-18)
dobj(promoting-18, hepatic_steatosis-19)
cc(hepatic_steatosis-19, and-20)
amod(secretion-22, VLDL-TG-21)
dobj(promoting-18, secretion-22)
conj:and(hepatic_steatosis-19, secretion-22)

Therefore/RB ,/, targeting/VBG LXR/NNP signaling/VBG pathway/RB may/MD represent/VB a/DT promising/JJ therapeutic/JJ strategy/NN for/IN NAFLD/JJ treatment/NN ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (S
      (VP (VBG targeting)
        (NP (NNP LXR))
        (S
          (VP (VBG signaling)
            (ADVP (RB pathway))))))
    (VP (MD may)
      (VP (VB represent)
        (NP
          (NP (DT a) (JJ promising) (JJ therapeutic) (NN strategy))
          (PP (IN for)
            (NP (JJ NAFLD) (NN treatment))))))
    (. .)))

advmod(represent-8, Therefore-1)
csubj(represent-8, targeting-3)
dobj(targeting-3, LXR-4)
advcl(targeting-3, signaling-5)
advmod(signaling-5, pathway-6)
aux(represent-8, may-7)
root(ROOT-0, represent-8)
det(strategy-12, a-9)
amod(strategy-12, promising-10)
amod(strategy-12, therapeutic-11)
dobj(represent-8, strategy-12)
case(treatment-15, for-13)
amod(treatment-15, NAFLD-14)
nmod:for(strategy-12, treatment-15)

Gamma-aminobutyric_acid/JJ -LRB-/-LRB- GABA/NNP -RRB-/-RRB- plays/VBZ an/DT important/JJ role/NN in/IN regulating/VBG nitrogen/NN and/CC carbon/NN metabolism/NN including/VBG nitrate_reductase/NN -LRB-/-LRB- NR/NNP -RRB-/-RRB- ,/, glutamine_synthetase/NN -LRB-/-LRB- GS/NNP -RRB-/-RRB- ,/, glutamate_synthase/NN -LRB-/-LRB- NADH-GOGAT/NNP -RRB-/-RRB- ,/, NADP-dependent/JJ senecionine/JJ dehydrogenase/NN -LRB-/-LRB- Flavin-containing_monooxygenase/NNP -RRB-/-RRB- ,/, and/CC phosphoenol_pyruvate/JJ carboxylase/NN -LRB-/-LRB- PEPCase/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Gamma-aminobutyric_acid))
      (PRN (-LRB- -LRB-)
        (NP (NNP GABA))
        (-RRB- -RRB-)))
    (VP (VBZ plays)
      (NP (DT an) (JJ important) (NN role))
      (PP (IN in)
        (S
          (VP (VBG regulating)
            (NP
              (NP (NN nitrogen)
                (CC and)
                (NN carbon) (NN metabolism))
              (VP (VBG including)
                (NP
                  (NP
                    (NP (NN nitrate_reductase))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP NR))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (NN glutamine_synthetase))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP GS))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (NN glutamate_synthase))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP NADH-GOGAT))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (JJ NADP-dependent) (JJ senecionine) (NN dehydrogenase))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Flavin-containing_monooxygenase))
                      (-RRB- -RRB-)))
                  (, ,)
                  (CC and)
                  (NP
                    (NP (JJ phosphoenol_pyruvate) (NN carboxylase))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP PEPCase))
                      (-RRB- -RRB-))))))))))
    (. .)))

nsubj(plays-5, Gamma-aminobutyric_acid-1)
appos(Gamma-aminobutyric_acid-1, GABA-3)
root(ROOT-0, plays-5)
det(role-8, an-6)
amod(role-8, important-7)
dobj(plays-5, role-8)
mark(regulating-10, in-9)
advcl(plays-5, regulating-10)
compound(metabolism-14, nitrogen-11)
cc(nitrogen-11, and-12)
conj:and(nitrogen-11, carbon-13)
compound(metabolism-14, carbon-13)
dobj(regulating-10, metabolism-14)
acl(metabolism-14, including-15)
dobj(including-15, nitrate_reductase-16)
appos(nitrate_reductase-16, NR-18)
dobj(including-15, glutamine_synthetase-21)
conj:and(nitrate_reductase-16, glutamine_synthetase-21)
appos(glutamine_synthetase-21, GS-23)
dobj(including-15, glutamate_synthase-26)
conj:and(nitrate_reductase-16, glutamate_synthase-26)
appos(glutamate_synthase-26, NADH-GOGAT-28)
amod(dehydrogenase-33, NADP-dependent-31)
amod(dehydrogenase-33, senecionine-32)
dobj(including-15, dehydrogenase-33)
conj:and(nitrate_reductase-16, dehydrogenase-33)
appos(dehydrogenase-33, Flavin-containing_monooxygenase-35)
cc(nitrate_reductase-16, and-38)
amod(carboxylase-40, phosphoenol_pyruvate-39)
dobj(including-15, carboxylase-40)
conj:and(nitrate_reductase-16, carboxylase-40)
appos(carboxylase-40, PEPCase-42)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN GABA/NNP on/IN the/DT activities/NNS of/IN several/JJ key/JJ enzymes/NNS involved/VBN in/IN nitrogen/NN and/CC carbon/NN metabolism/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NNP GABA))))
      (PP (IN on)
        (NP
          (NP (DT the) (NNS activities))
          (PP (IN of)
            (NP
              (NP (JJ several) (JJ key) (NNS enzymes))
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (NN nitrogen))
                    (CC and)
                    (NP (NN carbon) (NN metabolism))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(GABA-10, of-9)
nmod:of(effect-8, GABA-10)
case(activities-13, on-11)
det(activities-13, the-12)
nmod:on(investigated-6, activities-13)
case(enzymes-17, of-14)
amod(enzymes-17, several-15)
amod(enzymes-17, key-16)
nmod:of(activities-13, enzymes-17)
acl(enzymes-17, involved-18)
case(nitrogen-20, in-19)
nmod:in(involved-18, nitrogen-20)
cc(nitrogen-20, and-21)
compound(metabolism-23, carbon-22)
nmod:in(involved-18, metabolism-23)
conj:and(nitrogen-20, metabolism-23)

Our/PRP$ results/NNS show/VBP that/IN GABA/NNP regulates/VBZ the/DT activities/NNS of/IN nitrate_reductase/NN -LRB-/-LRB- NR/NNP -RRB-/-RRB- ,/, glutamine_synthetase/NN -LRB-/-LRB- GS/NNP -RRB-/-RRB- ,/, glutamate_synthase/NN -LRB-/-LRB- NADH-GOGAT/NNP -RRB-/-RRB- ,/, NADP-dependent/JJ senecionine/JJ dehydrogenase/NN -LRB-/-LRB- Flavin-containing_monooxygenase/NNP -RRB-/-RRB- ,/, and/CC phosphoenol_pyruvate/JJ carboxylase/NN -LRB-/-LRB- PEPCase/NNP -RRB-/-RRB- in/IN the/DT growth/NN medium/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP show)
      (SBAR (IN that)
        (S
          (NP (NNP GABA))
          (VP (VBZ regulates)
            (NP
              (NP (DT the) (NNS activities))
              (PP (IN of)
                (NP
                  (NP
                    (NP
                      (NP (NN nitrate_reductase))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP NR))
                        (-RRB- -RRB-)))
                    (, ,)
                    (NP
                      (NP (NN glutamine_synthetase))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP GS))
                        (-RRB- -RRB-)))
                    (, ,)
                    (NP
                      (NP (NN glutamate_synthase))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP NADH-GOGAT))
                        (-RRB- -RRB-)))
                    (, ,)
                    (NP
                      (NP (JJ NADP-dependent) (JJ senecionine) (NN dehydrogenase))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP Flavin-containing_monooxygenase))
                        (-RRB- -RRB-)))
                    (, ,)
                    (CC and)
                    (NP
                      (NP (JJ phosphoenol_pyruvate) (NN carboxylase))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP PEPCase))
                        (-RRB- -RRB-))))
                  (PP (IN in)
                    (NP (DT the) (NN growth) (NN medium))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(show-3, results-2)
root(ROOT-0, show-3)
mark(regulates-6, that-4)
nsubj(regulates-6, GABA-5)
ccomp(show-3, regulates-6)
det(activities-8, the-7)
dobj(regulates-6, activities-8)
case(nitrate_reductase-10, of-9)
nmod:of(activities-8, nitrate_reductase-10)
appos(nitrate_reductase-10, NR-12)
nmod:of(activities-8, glutamine_synthetase-15)
conj:and(nitrate_reductase-10, glutamine_synthetase-15)
appos(glutamine_synthetase-15, GS-17)
nmod:of(activities-8, glutamate_synthase-20)
conj:and(nitrate_reductase-10, glutamate_synthase-20)
appos(glutamate_synthase-20, NADH-GOGAT-22)
amod(dehydrogenase-27, NADP-dependent-25)
amod(dehydrogenase-27, senecionine-26)
nmod:of(activities-8, dehydrogenase-27)
conj:and(nitrate_reductase-10, dehydrogenase-27)
appos(dehydrogenase-27, Flavin-containing_monooxygenase-29)
cc(nitrate_reductase-10, and-32)
amod(carboxylase-34, phosphoenol_pyruvate-33)
nmod:of(activities-8, carboxylase-34)
conj:and(nitrate_reductase-10, carboxylase-34)
appos(carboxylase-34, PEPCase-36)
case(medium-41, in-38)
det(medium-41, the-39)
compound(medium-41, growth-40)
nmod:in(nitrate_reductase-10, medium-41)

These/DT findings/NNS suggest/VBP that/IN GABA/NNP plays/VBZ an/DT important/JJ role/NN in/IN regulating/VBG nitrogen/NN and/CC carbon/NN metabolism/NN in/IN plants/NNS ,/, which/WDT may/MD have/VB implications/NNS for/IN improving/VBG crop/NN yield/NN and/CC quality/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP GABA))
          (VP (VBZ plays)
            (NP
              (NP (DT an) (JJ important) (NN role))
              (PP (IN in)
                (S
                  (VP (VBG regulating)
                    (NP (NN nitrogen)
                      (CC and)
                      (NN carbon) (NN metabolism))
                    (PP (IN in)
                      (NP
                        (NP (NNS plants))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD may)
                              (VP (VB have)
                                (NP
                                  (NP (NNS implications))
                                  (PP (IN for)
                                    (S
                                      (VP (VBG improving)
                                        (NP (NN crop) (NN yield)
                                          (CC and)
                                          (NN quality))))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(plays-6, that-4)
nsubj(plays-6, GABA-5)
ccomp(suggest-3, plays-6)
det(role-9, an-7)
amod(role-9, important-8)
dobj(plays-6, role-9)
mark(regulating-11, in-10)
acl(role-9, regulating-11)
compound(metabolism-15, nitrogen-12)
cc(nitrogen-12, and-13)
conj:and(nitrogen-12, carbon-14)
compound(metabolism-15, carbon-14)
dobj(regulating-11, metabolism-15)
case(plants-17, in-16)
nmod:in(regulating-11, plants-17)
nsubj(have-21, plants-17)
ref(plants-17, which-19)
aux(have-21, may-20)
acl:relcl(plants-17, have-21)
dobj(have-21, implications-22)
mark(improving-24, for-23)
acl(implications-22, improving-24)
compound(yield-26, crop-25)
dobj(improving-24, yield-26)
cc(yield-26, and-27)
dobj(improving-24, quality-28)
conj:and(yield-26, quality-28)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT molecular/JJ mechanisms/NNS underlying/VBG these/DT effects/NNS of/IN GABA/NNP on/IN enzyme/JJ activity/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (JJ molecular) (NNS mechanisms))
                (VP (VBG underlying)
                  (NP
                    (NP (DT these) (NNS effects))
                    (PP (IN of)
                      (NP (NNP GABA)))
                    (PP (IN on)
                      (NP (JJ enzyme) (NN activity)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
case(GABA-14, of-13)
nmod:of(effects-12, GABA-14)
case(activity-17, on-15)
amod(activity-17, enzyme-16)
nmod:on(effects-12, activity-17)

The/DT hypersecretion/NN of/IN adenylate_cyclase-activating/JJ hormone/NN -LRB-/-LRB- ADH-A2/NNP -RRB-/-RRB- by/IN the/DT pancreas/NN may/MD contribute/VB to/TO the/DT development/NN of/IN obesity_and_type_2_diabetes/JJ mellitus/NNS -LRB-/-LRB- T2DM/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP (DT The) (NN hypersecretion))
          (PP (IN of)
            (NP (JJ adenylate_cyclase-activating) (NN hormone))))
        (PRN (-LRB- -LRB-)
          (NP (NNP ADH-A2))
          (-RRB- -RRB-)))
      (PP (IN by)
        (NP (DT the) (NN pancreas))))
    (VP (MD may)
      (VP (VB contribute)
        (PP (TO to)
          (NP
            (NP
              (NP (DT the) (NN development))
              (PP (IN of)
                (NP (JJ obesity_and_type_2_diabetes) (NNS mellitus))))
            (PRN (-LRB- -LRB-)
              (NP (NNP T2DM))
              (-RRB- -RRB-))))))
    (. .)))

det(hypersecretion-2, The-1)
nsubj(contribute-13, hypersecretion-2)
case(hormone-5, of-3)
amod(hormone-5, adenylate_cyclase-activating-4)
nmod:of(hypersecretion-2, hormone-5)
appos(hypersecretion-2, ADH-A2-7)
case(pancreas-11, by-9)
det(pancreas-11, the-10)
nmod:by(hypersecretion-2, pancreas-11)
aux(contribute-13, may-12)
root(ROOT-0, contribute-13)
case(development-16, to-14)
det(development-16, the-15)
nmod:to(contribute-13, development-16)
case(mellitus-19, of-17)
amod(mellitus-19, obesity_and_type_2_diabetes-18)
nmod:of(development-16, mellitus-19)
appos(development-16, T2DM-21)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT hypersecretion/NN of/IN arginine_vasopressin/NN -LRB-/-LRB- AVP/NNP -RRB-/-RRB- by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN and/CC T2DM/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP
                (NP
                  (NP (DT the) (NN hypersecretion))
                  (PP (IN of)
                    (NP (NN arginine_vasopressin))))
                (PRN (-LRB- -LRB-)
                  (NP (NNP AVP))
                  (-RRB- -RRB-)))
              (PP (IN by)
                (NP (DT the) (NN pancreas))))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity)
                          (CC and)
                          (NN T2DM))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(involved-18, that-5)
det(hypersecretion-7, the-6)
nsubjpass(involved-18, hypersecretion-7)
case(arginine_vasopressin-9, of-8)
nmod:of(hypersecretion-7, arginine_vasopressin-9)
appos(hypersecretion-7, AVP-11)
case(pancreas-15, by-13)
det(pancreas-15, the-14)
nmod:by(hypersecretion-7, pancreas-15)
aux(involved-18, may-16)
auxpass(involved-18, be-17)
ccomp(suggested-4, involved-18)
case(development-21, in-19)
det(development-21, the-20)
nmod:in(involved-18, development-21)
case(obesity-23, of-22)
nmod:of(development-21, obesity-23)
cc(obesity-23, and-24)
nmod:of(development-21, T2DM-25)
conj:and(obesity-23, T2DM-25)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN ADH-A2/NN by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NN ADH-A2)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(ADH-A2-20, of-19)
nmod:of(hypersecretion-18, ADH-A2-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT goal/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ sorbitol/NN on/IN the/DT secretion/NN of/IN ADH-A2/NN and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this) (NN goal)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN sorbitol)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NN ADH-A2) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-7, achieve-2)
det(goal-4, this-3)
dobj(achieve-2, goal-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(sorbitol-17, 10-15)
amod(sorbitol-17, mmol/L-16)
nmod:of(effects-9, sorbitol-17)
conj:and(glucose-13, sorbitol-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(examined-7, secretion-20)
case(and_insulin-23, of-21)
compound(and_insulin-23, ADH-A2-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(pancreata-27, genetically_obese-29)
appos(genetically_obese-29, fa/fa-31)
cc(genetically_obese-29, and-33)
amod(rats-40, lean-34)
dep(lean-34, Fa-36)
nmod:from(pancreata-27, rats-40)
conj:and(genetically_obese-29, rats-40)

Our/PRP$ results/NNS showed/VBD that/IN ADH-A2/JJ secretion/NN was/VBD significantly/RB higher/JJR in/IN perfused/JJ pancreata/NN from/IN genetically_obese/JJ rats/NNS compared/VBN to/TO those/DT from/IN lean/JJ rats/NNS ,/, under/IN both/DT high/JJ glucose/NN and/CC sorbitol/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ ADH-A2) (NN secretion))
          (VP (VBD was)
            (ADJP
              (ADJP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP
                  (NP (JJ perfused) (NN pancreata))
                  (PP (IN from)
                    (NP (JJ genetically_obese) (NNS rats))))))
            (PP (VBN compared)
              (PP (TO to)
                (NP
                  (NP (DT those))
                  (PP (IN from)
                    (NP (JJ lean) (NNS rats))))))
            (, ,)
            (PP (IN under)
              (NP
                (NP (DT both) (JJ high) (NN glucose))
                (CC and)
                (NP (JJ sorbitol) (NNS conditions))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(higher-9, that-4)
amod(secretion-6, ADH-A2-5)
nsubj(higher-9, secretion-6)
cop(higher-9, was-7)
advmod(higher-9, significantly-8)
ccomp(showed-3, higher-9)
case(pancreata-12, in-10)
amod(pancreata-12, perfused-11)
nmod:in(higher-9, pancreata-12)
case(rats-15, from-13)
amod(rats-15, genetically_obese-14)
nmod:from(pancreata-12, rats-15)
case(those-18, compared-16)
mwe(compared-16, to-17)
advcl(higher-9, those-18)
case(rats-21, from-19)
amod(rats-21, lean-20)
nmod:from(those-18, rats-21)
case(glucose-26, under-23)
det(glucose-26, both-24)
amod(glucose-26, high-25)
nmod:under(higher-9, glucose-26)
cc(glucose-26, and-27)
amod(conditions-29, sorbitol-28)
nmod:under(higher-9, conditions-29)
conj:and(glucose-26, conditions-29)

Interestingly/RB ,/, insulin_secretion/NN was/VBD also/RB significantly/RB higher/JJR in/IN perfused/JJ pancreata/NN from/IN genetically_obese/JJ rats/NNS compared/VBN to/TO those/DT from/IN lean/JJ rats/NNS under/IN high/JJ glucose/NN conditions/NNS ,/, but/CC not/RB under/IN sorbitol/JJ conditions/NNS ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (NN insulin_secretion))
    (VP (VBD was) (RB also)
      (ADJP
        (ADJP (RB significantly) (JJR higher))
        (PP (IN in)
          (NP
            (NP (JJ perfused) (NN pancreata))
            (PP (IN from)
              (NP (JJ genetically_obese) (NNS rats))))))
      (PP (VBN compared)
        (PP (TO to)
          (NP
            (NP (DT those))
            (PP (IN from)
              (NP (JJ lean) (NNS rats))))))
      (PP (IN under)
        (NP (JJ high) (NN glucose) (NNS conditions)))
      (, ,)
      (CC but)
      (ADVP (RB not))
      (PP (IN under)
        (NP (JJ sorbitol) (NNS conditions))))
    (. .)))

advmod(higher-7, Interestingly-1)
nsubj(higher-7, insulin_secretion-3)
cop(higher-7, was-4)
advmod(higher-7, also-5)
advmod(higher-7, significantly-6)
root(ROOT-0, higher-7)
case(pancreata-10, in-8)
amod(pancreata-10, perfused-9)
nmod:in(higher-7, pancreata-10)
case(rats-13, from-11)
amod(rats-13, genetically_obese-12)
nmod:from(pancreata-10, rats-13)
case(those-16, compared-14)
mwe(compared-14, to-15)
advcl(higher-7, those-16)
case(rats-19, from-17)
amod(rats-19, lean-18)
nmod:from(those-16, rats-19)
case(conditions-23, under-20)
amod(conditions-23, high-21)
compound(conditions-23, glucose-22)
nmod:under(higher-7, conditions-23)
cc(higher-7, but-25)
advmod(conditions-29, not-26)
case(conditions-29, under-27)
amod(conditions-29, sorbitol-28)
conj:but(higher-7, conditions-29)

These/DT findings/NNS suggest/VBP a/DT potential/JJ link/NN between/IN ADH-A2/JJ hypersecretion/NN by/IN the/DT pancreas/NN and/CC the/DT development/NN of/IN obesity/NN ,/, which/WDT may/MD have/VB implications/NNS for/IN the/DT prevention/NN and/CC treatment/NN of/IN obesity-related_disorders/NNS such/JJ as/IN T2DM/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (NP
        (NP (DT a) (JJ potential) (NN link))
        (PP (IN between)
          (NP (JJ ADH-A2) (NN hypersecretion))))
      (PP (IN by)
        (NP
          (NP (DT the) (NN pancreas))
          (CC and)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP
                (NP (NN obesity))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (MD may)
                      (VP (VB have)
                        (NP
                          (NP (NNS implications))
                          (PP (IN for)
                            (NP
                              (NP (DT the) (NN prevention)
                                (CC and)
                                (NN treatment))
                              (PP (IN of)
                                (NP
                                  (NP (NNS obesity-related_disorders))
                                  (PP (JJ such) (IN as)
                                    (NP (NNP T2DM))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
det(link-6, a-4)
amod(link-6, potential-5)
dobj(suggest-3, link-6)
case(hypersecretion-9, between-7)
amod(hypersecretion-9, ADH-A2-8)
nmod:between(link-6, hypersecretion-9)
case(pancreas-12, by-10)
det(pancreas-12, the-11)
nmod:by(suggest-3, pancreas-12)
cc(pancreas-12, and-13)
det(development-15, the-14)
nmod:by(suggest-3, development-15)
conj:and(pancreas-12, development-15)
case(obesity-17, of-16)
nmod:of(development-15, obesity-17)
nsubj(have-21, obesity-17)
ref(obesity-17, which-19)
aux(have-21, may-20)
acl:relcl(obesity-17, have-21)
dobj(have-21, implications-22)
case(prevention-25, for-23)
det(prevention-25, the-24)
nmod:for(implications-22, prevention-25)
cc(prevention-25, and-26)
nmod:for(implications-22, treatment-27)
conj:and(prevention-25, treatment-27)
case(obesity-related_disorders-29, of-28)
nmod:of(prevention-25, obesity-related_disorders-29)
case(T2DM-32, such-30)
mwe(such-30, as-31)
nmod:such_as(obesity-related_disorders-29, T2DM-32)

Gamma-tocopherol/NNP megestrol_acetate/NNP -LRB-/-LRB- gamma-tBMTX/NNP -RRB-/-RRB- is/VBZ widely/RB used/VBN in/IN the/DT treatment/NN of/IN breast_cancer/NN ./.

(ROOT
  (S
    (NP (NNP Gamma-tocopherol) (NNP megestrol_acetate) (-LRB- -LRB-) (NNP gamma-tBMTX) (-RRB- -RRB-))
    (VP (VBZ is)
      (VP
        (ADVP (RB widely))
        (VBN used)
        (PP (IN in)
          (NP
            (NP (DT the) (NN treatment))
            (PP (IN of)
              (NP (NN breast_cancer)))))))
    (. .)))

compound(gamma-tBMTX-4, Gamma-tocopherol-1)
compound(gamma-tBMTX-4, megestrol_acetate-2)
nsubjpass(used-8, gamma-tBMTX-4)
auxpass(used-8, is-6)
advmod(used-8, widely-7)
root(ROOT-0, used-8)
case(treatment-11, in-9)
det(treatment-11, the-10)
nmod:in(used-8, treatment-11)
case(breast_cancer-13, of-12)
nmod:of(treatment-11, breast_cancer-13)

Previous/JJ studies/NNS have/VBP shown/VBN that/IN placental/JJ mRNA/NN levels/NNS of/IN gamma-tBMs/NNS are/VBP increased/VBN during/IN pregnancy/NN ./.

(ROOT
  (S
    (NP (JJ Previous) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ placental) (NN mRNA) (NNS levels))
              (PP (IN of)
                (NP (NNS gamma-tBMs))))
            (VP (VBP are)
              (VP (VBN increased)
                (PP (IN during)
                  (NP (NN pregnancy)))))))))
    (. .)))

amod(studies-2, Previous-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(increased-12, that-5)
amod(levels-8, placental-6)
compound(levels-8, mRNA-7)
nsubjpass(increased-12, levels-8)
case(gamma-tBMs-10, of-9)
nmod:of(levels-8, gamma-tBMs-10)
auxpass(increased-12, are-11)
ccomp(shown-4, increased-12)
case(pregnancy-14, during-13)
nmod:during(increased-12, pregnancy-14)

We/PRP have/VBP previously/RB shown/VBN that/IN gamma-TBMTX/JJ 5a-reductase_1/NN -LRB-/-LRB- CH-DHFR/NNP -RRB-/-RRB- is/VBZ responsible/JJ for/IN the/DT metabolism/NN of/IN the/DT major/JJ metabolite/NN of/IN the/DT drug/NN ,/, gamma/NN -/: tBMTX/NN ,/, in/IN the/DT placenta/NN ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBP have)
      (VP
        (ADVP (RB previously))
        (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ gamma-TBMTX) (NN 5a-reductase_1))
              (PRN (-LRB- -LRB-)
                (NP (NNP CH-DHFR))
                (-RRB- -RRB-)))
            (VP (VBZ is)
              (ADJP (JJ responsible)
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN metabolism))
                    (PP (IN of)
                      (NP
                        (NP (DT the) (JJ major) (NN metabolite))
                        (PP (IN of)
                          (NP
                            (NP (DT the) (NN drug))
                            (, ,)
                            (NP
                              (NP (NN gamma))
                              (: -)
                              (NP (NN tBMTX)))
                            (, ,))))))))
              (PP (IN in)
                (NP (DT the) (NN placenta))))))))
    (. .)))

nsubj(shown-4, We-1)
aux(shown-4, have-2)
advmod(shown-4, previously-3)
root(ROOT-0, shown-4)
mark(responsible-12, that-5)
amod(5a-reductase_1-7, gamma-TBMTX-6)
nsubj(responsible-12, 5a-reductase_1-7)
appos(5a-reductase_1-7, CH-DHFR-9)
cop(responsible-12, is-11)
ccomp(shown-4, responsible-12)
case(metabolism-15, for-13)
det(metabolism-15, the-14)
nmod:for(responsible-12, metabolism-15)
case(metabolite-19, of-16)
det(metabolite-19, the-17)
amod(metabolite-19, major-18)
nmod:of(metabolism-15, metabolite-19)
case(drug-22, of-20)
det(drug-22, the-21)
nmod:of(metabolite-19, drug-22)
appos(drug-22, gamma-24)
dep(gamma-24, tBMTX-26)
case(placenta-30, in-28)
det(placenta-30, the-29)
nmod:in(responsible-12, placenta-30)

However/RB ,/, the/DT mechanism/NN of/IN this/DT increase/NN is/VBZ not/RB known/VBN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN mechanism))
      (PP (IN of)
        (NP (DT this) (NN increase))))
    (VP (VBZ is) (RB not)
      (VP (VBN known)))
    (. .)))

advmod(known-10, However-1)
det(mechanism-4, the-3)
nsubjpass(known-10, mechanism-4)
case(increase-7, of-5)
det(increase-7, this-6)
nmod:of(mechanism-4, increase-7)
auxpass(known-10, is-8)
neg(known-10, not-9)
root(ROOT-0, known-10)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT mRNA/JJ levels/NNS of/IN placental/JJ gamma-tBMTX/JJ metabolism/NN enzymes/NNS using/VBG real-time/JJ quantitative/JJ reverse_transcriptase-polymerase/JJ chain/NN reaction/NN -LRB-/-LRB- Q-RT-PCR/NNP -RRB-/-RRB- analysis/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (JJ mRNA) (NNS levels))
        (PP (IN of)
          (NP
            (NP (JJ placental) (JJ gamma-tBMTX) (NN metabolism) (NNS enzymes))
            (PP (VBG using)
              (NP (JJ real-time) (JJ quantitative) (JJ reverse_transcriptase-polymerase) (NN chain) (NN reaction)))
            (PRN (-LRB- -LRB-)
              (NP (NNP Q-RT-PCR))
              (-RRB- -RRB-))
            (NP (NN analysis))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(levels-9, the-7)
amod(levels-9, mRNA-8)
dobj(investigated-6, levels-9)
case(enzymes-14, of-10)
amod(enzymes-14, placental-11)
amod(enzymes-14, gamma-tBMTX-12)
compound(enzymes-14, metabolism-13)
nmod:of(levels-9, enzymes-14)
case(reaction-20, using-15)
amod(reaction-20, real-time-16)
amod(reaction-20, quantitative-17)
amod(reaction-20, reverse_transcriptase-polymerase-18)
compound(reaction-20, chain-19)
nmod:using(enzymes-14, reaction-20)
appos(enzymes-14, Q-RT-PCR-22)
dep(enzymes-14, analysis-24)

Our/PRP$ results/NNS showed/VBD a/DT significant/JJ increase/NN in/IN mRNA/NN levels/NNS for/IN UDP-glucuronosyltransferase_1A1/NNS -LRB-/-LRB- UGT1A1/NNP -RRB-/-RRB- ,/, estrogen_sulfotransferase/JJ 1E1/CD -LRB-/-LRB- SULT1E1/NNP -RRB-/-RRB- ,/, gamma-tBMTX/JJ 5a-reductase_1/JJ -LRB-/-LRB- CH-DHFR/NN -RRB-/-RRB- ,/, and/CC gamma-tBMTX/JJ 5a-reductase/JJ 2/CD -LRB-/-LRB- SRD5A2/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (NP (DT a) (JJ significant) (NN increase))
      (PP (IN in)
        (NP
          (NP
            (NP
              (NP
                (NP (NN mRNA) (NNS levels))
                (PP (IN for)
                  (NP (NNS UDP-glucuronosyltransferase_1A1))))
              (PRN (-LRB- -LRB-)
                (NP (NNP UGT1A1))
                (-RRB- -RRB-))
              (, ,)
              (ADJP (JJ estrogen_sulfotransferase)
                (NP-TMP (CD 1E1))))
            (PRN (-LRB- -LRB-)
              (NP (NNP SULT1E1))
              (-RRB- -RRB-))
            (, ,)
            (ADJP
              (ADJP (JJ gamma-tBMTX) (JJ 5a-reductase_1))
              (PRN (-LRB- -LRB-) (NN CH-DHFR) (-RRB- -RRB-))
              (, ,)
              (CC and)
              (ADJP (JJ gamma-tBMTX) (JJ 5a-reductase))
              (NP (CD 2))))
          (PRN (-LRB- -LRB-)
            (NP (NNP SRD5A2))
            (-RRB- -RRB-)))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(increase-6, a-4)
amod(increase-6, significant-5)
dobj(showed-3, increase-6)
case(levels-9, in-7)
compound(levels-9, mRNA-8)
nmod:in(showed-3, levels-9)
case(UDP-glucuronosyltransferase_1A1-11, for-10)
nmod:for(levels-9, UDP-glucuronosyltransferase_1A1-11)
appos(levels-9, UGT1A1-13)
amod(levels-9, estrogen_sulfotransferase-16)
nmod:tmod(estrogen_sulfotransferase-16, 1E1-17)
appos(levels-9, SULT1E1-19)
amod(5a-reductase_1-23, gamma-tBMTX-22)
amod(levels-9, 5a-reductase_1-23)
dep(5a-reductase_1-23, CH-DHFR-25)
cc(5a-reductase_1-23, and-28)
amod(5a-reductase-30, gamma-tBMTX-29)
amod(levels-9, 5a-reductase-30)
conj:and(5a-reductase_1-23, 5a-reductase-30)
dep(5a-reductase_1-23, 2-31)
appos(levels-9, SRD5A2-33)

These/DT findings/NNS suggest/VBP that/IN the/DT placenta/NN may/MD have/VB an/DT increased/VBN capacity/NN for/IN detoxification/NN of/IN gamma-tBMTX/NNP during/IN pregnancy/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT the) (NN placenta))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (DT an) (VBN increased) (NN capacity))
                (PP (IN for)
                  (NP
                    (NP (NN detoxification))
                    (PP (IN of)
                      (NP (NNP gamma-tBMTX))))))
              (PP (IN during)
                (NP (NN pregnancy))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-8, that-4)
det(placenta-6, the-5)
nsubj(have-8, placenta-6)
aux(have-8, may-7)
ccomp(suggest-3, have-8)
det(capacity-11, an-9)
amod(capacity-11, increased-10)
dobj(have-8, capacity-11)
case(detoxification-13, for-12)
nmod:for(capacity-11, detoxification-13)
case(gamma-tBMTX-15, of-14)
nmod:of(detoxification-13, gamma-tBMTX-15)
case(pregnancy-17, during-16)
nmod:during(have-8, pregnancy-17)

Further/JJ studies/NNS are/VBP needed/VBN to/TO investigate/VB the/DT clinical/JJ implications/NNS of/IN these/DT findings/NNS and/CC their/PRP$ potential/JJ impact/NN on/IN fetal/JJ development/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (JJ clinical) (NNS implications))
                (PP (IN of)
                  (NP
                    (NP (DT these) (NNS findings))
                    (CC and)
                    (NP
                      (NP (PRP$ their) (JJ potential) (NN impact))
                      (PP (IN on)
                        (NP (JJ fetal) (NN development))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(investigate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(investigate-6, to-5)
xcomp(needed-4, investigate-6)
det(implications-9, the-7)
amod(implications-9, clinical-8)
dobj(investigate-6, implications-9)
case(findings-12, of-10)
det(findings-12, these-11)
nmod:of(implications-9, findings-12)
cc(findings-12, and-13)
nmod:poss(impact-16, their-14)
amod(impact-16, potential-15)
nmod:of(implications-9, impact-16)
conj:and(findings-12, impact-16)
case(development-19, on-17)
amod(development-19, fetal-18)
nmod:on(impact-16, development-19)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT provide/VBP numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP provide)
              (NP (JJ numerous) (NN health) (NNS benefits)))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(polyunsaturated_fatty_acids-16, are-14)
amod(polyunsaturated_fatty_acids-16, essential-15)
root(ROOT-0, polyunsaturated_fatty_acids-16)
nsubj(provide-18, polyunsaturated_fatty_acids-16)
ref(polyunsaturated_fatty_acids-16, that-17)
acl:relcl(polyunsaturated_fatty_acids-16, provide-18)
amod(benefits-21, numerous-19)
compound(benefits-21, health-20)
dobj(provide-18, benefits-21)

EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO reduce/VB plasma/NN Myrtol/JJ levels/NNS in/IN hyperMyrtolmic/JJ patients/NNS and/CC to/TO reduce/VB the/DT risk/NN of/IN myocardial_infarction/NN and_stroke/NN in/IN patients/NNS with/IN coronary_artery_disease/NN -LRB-/-LRB- CAD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP
              (VP (TO to)
                (VP (VB reduce)
                  (NP
                    (NP (NN plasma) (JJ Myrtol) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperMyrtolmic) (NNS patients))))))
              (CC and)
              (VP (TO to)
                (VP (VB reduce)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP
                        (NP
                          (NP (NN myocardial_infarction) (NN and_stroke))
                          (PP (IN in)
                            (NP
                              (NP (NNS patients))
                              (PP (IN with)
                                (NP (NN coronary_artery_disease))))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CAD))
                          (-RRB- -RRB-))))))))))))
    (. .)))

nsubjpass(shown-6, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(shown-6, DHA-3)
aux(shown-6, have-4)
auxpass(shown-6, been-5)
root(ROOT-0, shown-6)
mark(reduce-8, to-7)
ccomp(shown-6, reduce-8)
compound(levels-11, plasma-9)
amod(levels-11, Myrtol-10)
dobj(reduce-8, levels-11)
case(patients-14, in-12)
amod(patients-14, hyperMyrtolmic-13)
nmod:in(levels-11, patients-14)
cc(reduce-8, and-15)
mark(reduce-17, to-16)
ccomp(shown-6, reduce-17)
conj:and(reduce-8, reduce-17)
det(risk-19, the-18)
dobj(reduce-17, risk-19)
case(and_stroke-22, of-20)
compound(and_stroke-22, myocardial_infarction-21)
nmod:of(risk-19, and_stroke-22)
case(patients-24, in-23)
nmod:in(and_stroke-22, patients-24)
case(coronary_artery_disease-26, with-25)
nmod:with(patients-24, coronary_artery_disease-26)
appos(and_stroke-22, CAD-28)

Additionally/RB ,/, these/DT long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP
                (NP (DT a) (VBN decreased) (NN risk))
                (PP (IN of)
                  (S
                    (VP (VBG developing)
                      (NP (NN coronary_heart_disease))))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

advmod(associated-8, Additionally-1)
det(omega-3_fatty_acids-5, these-3)
amod(omega-3_fatty_acids-5, long-chain-4)
nsubjpass(associated-8, omega-3_fatty_acids-5)
aux(associated-8, have-6)
auxpass(associated-8, been-7)
root(ROOT-0, associated-8)
case(risk-12, with-9)
det(risk-12, a-10)
amod(risk-12, decreased-11)
nmod:with(associated-8, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, coronary_heart_disease-15)
appos(risk-12, CHD-17)

The/DT mechanisms/NNS underlying/VBG this/DT protective/JJ effect/NN may/MD involve/VB the/DT ability/NN of/IN EPA/NNP and/CC DHA/NNP to/TO reduce/VB inflammation/NN ,/, improve/VB lipid/NN metabolism/NN ,/, and/CC enhance/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT this) (JJ protective) (NN effect))))
    (VP (MD may)
      (VP (VB involve)
        (NP
          (NP (DT the) (NN ability))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA)))
          (S
            (VP (TO to)
              (VP
                (VP (VB reduce)
                  (NP (NN inflammation)))
                (, ,)
                (VP (VB improve)
                  (NP (NN lipid) (NN metabolism)))
                (, ,)
                (CC and)
                (VP (VB enhance)
                  (NP (JJ endothelial) (NN function)))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubj(involve-8, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effect-6, this-4)
amod(effect-6, protective-5)
dobj(underlying-3, effect-6)
aux(involve-8, may-7)
root(ROOT-0, involve-8)
det(ability-10, the-9)
dobj(involve-8, ability-10)
case(EPA-12, of-11)
nmod:of(ability-10, EPA-12)
cc(EPA-12, and-13)
nmod:of(ability-10, DHA-14)
conj:and(EPA-12, DHA-14)
mark(reduce-16, to-15)
acl(ability-10, reduce-16)
dobj(reduce-16, inflammation-17)
acl(ability-10, improve-19)
conj:and(reduce-16, improve-19)
compound(metabolism-21, lipid-20)
dobj(improve-19, metabolism-21)
cc(reduce-16, and-23)
acl(ability-10, enhance-24)
conj:and(reduce-16, enhance-24)
amod(function-26, endothelial-25)
dobj(enhance-24, function-26)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT therapeutic/JJ potential/NN of/IN EPA/NNP and/CC DHA/NNP in/IN the/DT prevention/NN and/CC management/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (JJ therapeutic) (NN potential))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN prevention)
                    (CC and)
                    (NN management))
                  (PP (IN of)
                    (NP (NNP CHD))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(potential-10, the-8)
amod(potential-10, therapeutic-9)
dobj(elucidate-7, potential-10)
case(EPA-12, of-11)
nmod:of(potential-10, EPA-12)
cc(EPA-12, and-13)
nmod:of(potential-10, DHA-14)
conj:and(EPA-12, DHA-14)
case(prevention-17, in-15)
det(prevention-17, the-16)
nmod:in(elucidate-7, prevention-17)
cc(prevention-17, and-18)
nmod:in(elucidate-7, management-19)
conj:and(prevention-17, management-19)
case(CHD-21, of-20)
nmod:of(prevention-17, CHD-21)

At_2/JJ h/NN after/IN dosing/VBG ,/, remifentanil/NN reduced/VBD the/DT risk/NN of/IN Oculogyric_crises/NNPS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/NN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN remifentanil))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNPS Oculogyric_crises))))
      (PP (IN by)
        (NP
          (NP
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (SBAR
                    (S
                      (VP (VBP CI)
                        (NP
                          (NP
                            (NP (CD 6-20) (NN %))
                            (, ,)
                            (NP (NNP P)))
                          (X
                            (X (SYM =))
                            (NP (CD 0.0005))))))))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP
                (NP (NN photophobia))
                (NP (CD 17) (NN %)))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NP
              (NP (NN phonophobia))
              (NP (CD 14) (NN %))))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (PP (NNP CI)
                (NP (CD 17-20) (NN %))))
            (, ,)
            (NP (NNP P)
              (QP (CD <) (CD 0.0001)))
            (-RRB- -RRB-)))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, remifentanil-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(Oculogyric_crises-11, of-10)
nmod:of(risk-9, Oculogyric_crises-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
nmod:by(reduced-7, photophobia-27)
conj:and(%-14, photophobia-27)
nummod(%-29, 17-28)
dep(photophobia-27, %-29)
nummod(%-32, 95-31)
appos(photophobia-27, %-32)
dep(%-35, CI-33)
nummod(%-35, 12-22-34)
nmod(%-32, %-35)
dep(%-32, P-37)
compound(0.0001-39, <-38)
nummod(P-37, 0.0001-39)
cc(%-14, and-42)
nmod:by(reduced-7, phonophobia-43)
conj:and(%-14, phonophobia-43)
nummod(%-45, 14-44)
dep(phonophobia-43, %-45)
nummod(%-48, 95-47)
appos(%-14, %-48)
dep(%-51, CI-49)
nummod(%-51, 17-20-50)
nmod(%-48, %-51)
dep(%-48, P-53)
compound(0.0001-55, <-54)
nummod(P-53, 0.0001-55)

A/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN was/VBD conducted/VBN on/IN a/DT group/NN of/IN patients/NNS with/IN a/DT history/NN of/IN migraine/JJ attacks/NNS ./.

(ROOT
  (S
    (NP (DT A)
      (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
      (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN on)
          (NP
            (NP (DT a) (NN group))
            (PP (IN of)
              (NP (NNS patients)))))
        (PP (IN with)
          (NP
            (NP (DT a) (NN history))
            (PP (IN of)
              (NP (JJ migraine) (NNS attacks)))))))
    (. .)))

det(trial-7, A-1)
amod(placebo-controlled-6, randomized-2)
amod(placebo-controlled-6, double-blind-4)
amod(trial-7, placebo-controlled-6)
nsubjpass(conducted-9, trial-7)
auxpass(conducted-9, was-8)
root(ROOT-0, conducted-9)
case(group-12, on-10)
det(group-12, a-11)
nmod:on(conducted-9, group-12)
case(patients-14, of-13)
nmod:of(group-12, patients-14)
case(history-17, with-15)
det(history-17, a-16)
nmod:with(conducted-9, history-17)
case(attacks-20, of-18)
amod(attacks-20, migraine-19)
nmod:of(history-17, attacks-20)

The/DT patients/NNS were/VBD given/VBN a/DT single/JJ dose/NN of/IN remifentanil/NN or/CC placebo/NN ,/, and/CC the/DT incidence/NN of/IN oculogyric_crises/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN was/VBD monitored/VBN at/IN 2/CD hours/NNS post-dosing/JJ ./.

(ROOT
  (S
    (S
      (NP (DT The) (NNS patients))
      (VP (VBD were)
        (VP (VBN given)
          (NP
            (NP (DT a) (JJ single) (NN dose))
            (PP (IN of)
              (NP (NN remifentanil)
                (CC or)
                (NN placebo)))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (DT the) (NN incidence))
        (PP (IN of)
          (NP
            (NP (NNS oculogyric_crises))
            (, ,)
            (NP (NN photophobia))
            (, ,)
            (CC and)
            (NP (NN phonophobia)))))
      (VP (VBD was)
        (VP (VBN monitored)
          (PP (IN at)
            (NP (CD 2) (NNS hours)))
          (S
            (ADJP (JJ post-dosing))))))
    (. .)))

det(patients-2, The-1)
nsubjpass(given-4, patients-2)
auxpass(given-4, were-3)
root(ROOT-0, given-4)
det(dose-7, a-5)
amod(dose-7, single-6)
dobj(given-4, dose-7)
case(remifentanil-9, of-8)
nmod:of(dose-7, remifentanil-9)
cc(remifentanil-9, or-10)
nmod:of(dose-7, placebo-11)
conj:or(remifentanil-9, placebo-11)
cc(given-4, and-13)
det(incidence-15, the-14)
nsubjpass(monitored-24, incidence-15)
case(oculogyric_crises-17, of-16)
nmod:of(incidence-15, oculogyric_crises-17)
nmod:of(incidence-15, photophobia-19)
conj:and(oculogyric_crises-17, photophobia-19)
cc(oculogyric_crises-17, and-21)
nmod:of(incidence-15, phonophobia-22)
conj:and(oculogyric_crises-17, phonophobia-22)
auxpass(monitored-24, was-23)
conj:and(given-4, monitored-24)
case(hours-27, at-25)
nummod(hours-27, 2-26)
nmod:at(monitored-24, hours-27)
xcomp(monitored-24, post-dosing-28)

The/DT results/NNS demonstrated/VBD that/IN remifentanil/NN significantly/RB reduced/VBD the/DT risk/NN of/IN oculogyric_crises/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD demonstrated)
      (SBAR (IN that)
        (S
          (NP (NN remifentanil))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS oculogyric_crises))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(demonstrated-3, results-2)
root(ROOT-0, demonstrated-3)
mark(reduced-7, that-4)
nsubj(reduced-7, remifentanil-5)
advmod(reduced-7, significantly-6)
ccomp(demonstrated-3, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(oculogyric_crises-11, of-10)
nmod:of(risk-9, oculogyric_crises-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN remifentanil/NN may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN individuals/NNS experiencing/VBG migraine/JJ attacks/NNS with/IN these/DT specific/JJ symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN remifentanil))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (VP (VBG experiencing)
                      (NP
                        (NP (JJ migraine) (NNS attacks))
                        (PP (IN with)
                          (NP (DT these) (JJ specific) (NNS symptoms)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, remifentanil-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
acl(individuals-13, experiencing-14)
amod(attacks-16, migraine-15)
dobj(experiencing-14, attacks-16)
case(symptoms-20, with-17)
det(symptoms-20, these-18)
amod(symptoms-20, specific-19)
nmod:with(attacks-16, symptoms-20)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC explore/VB the/DT potential/JJ mechanisms/NNS underlying/VBG these/DT effects/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(explore-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, explore-10)
conj:and(confirm-6, explore-10)
det(mechanisms-13, the-11)
amod(mechanisms-13, potential-12)
dobj(explore-10, mechanisms-13)
acl(mechanisms-13, underlying-14)
det(effects-16, these-15)
dobj(underlying-14, effects-16)

Serotonin/NNP 5-HT1A_receptor/JJ is_a/NN G_protein-coupled_receptor/VBD that/IN regulates/VBZ neurotransmitter/NN release/NN in/IN the/DT central/JJ and/CC peripheral/JJ nervous/JJ systems/NNS ./.

(ROOT
  (S
    (NP (NNP Serotonin) (JJ 5-HT1A_receptor) (NN is_a))
    (VP (VBD G_protein-coupled_receptor)
      (SBAR (IN that)
        (S
          (VP (VBZ regulates)
            (NP
              (NP (NN neurotransmitter) (NN release))
              (PP (IN in)
                (NP (DT the) (JJ central)
                  (CC and)
                  (JJ peripheral) (JJ nervous) (NNS systems))))))))
    (. .)))

compound(is_a-3, Serotonin-1)
amod(is_a-3, 5-HT1A_receptor-2)
nsubj(G_protein-coupled_receptor-4, is_a-3)
root(ROOT-0, G_protein-coupled_receptor-4)
mark(regulates-6, that-5)
ccomp(G_protein-coupled_receptor-4, regulates-6)
compound(release-8, neurotransmitter-7)
dobj(regulates-6, release-8)
case(central-11, in-9)
det(central-11, the-10)
nmod:in(release-8, central-11)
cc(central-11, and-12)
amod(systems-15, peripheral-13)
amod(systems-15, nervous-14)
nmod:in(release-8, systems-15)
conj:and(central-11, systems-15)

In/IN addition/NN ,/, 5-HT1A_receptor/JJ promoter/NN activity/NN was/VBD decreased/VBN by/IN LY334370/NNP ,/, indicating/VBG that/IN LY334370/NNP suppresses/VBZ 5-HT1A_receptor/JJ expression/NN at/IN the/DT transcriptional/JJ level/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (JJ 5-HT1A_receptor) (NN promoter) (NN activity))
    (VP (VBD was)
      (VP (VBN decreased)
        (PP (IN by)
          (NP (NNP LY334370)))
        (, ,)
        (S
          (VP (VBG indicating)
            (SBAR (IN that)
              (S
                (NP (NNP LY334370))
                (VP (VBZ suppresses)
                  (NP (JJ 5-HT1A_receptor) (NN expression))
                  (PP (IN at)
                    (NP (DT the) (JJ transcriptional) (NN level))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(decreased-8, addition-2)
amod(activity-6, 5-HT1A_receptor-4)
compound(activity-6, promoter-5)
nsubjpass(decreased-8, activity-6)
auxpass(decreased-8, was-7)
root(ROOT-0, decreased-8)
case(LY334370-10, by-9)
nmod:by(decreased-8, LY334370-10)
xcomp(decreased-8, indicating-12)
mark(suppresses-15, that-13)
nsubj(suppresses-15, LY334370-14)
ccomp(indicating-12, suppresses-15)
amod(expression-17, 5-HT1A_receptor-16)
dobj(suppresses-15, expression-17)
case(level-21, at-18)
det(level-21, the-19)
amod(level-21, transcriptional-20)
nmod:at(suppresses-15, level-21)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN LY334370/NNP ,/, a/DT selective/JJ 5-HT1F/JJ agonist/NN ,/, on/IN the/DT promoter/NN activity/NN of/IN 5-HT1A_receptor/JJ gene/NN in/IN human/JJ neuronal/JJ cells/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NNP LY334370))
            (, ,)
            (NP (DT a) (JJ selective) (JJ 5-HT1F) (NN agonist))
            (, ,))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN promoter) (NN activity))
          (PP (IN of)
            (NP (JJ 5-HT1A_receptor) (NN gene)))))
      (PP (IN in)
        (NP (JJ human) (JJ neuronal) (NNS cells))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(LY334370-10, of-9)
nmod:of(effect-8, LY334370-10)
det(agonist-15, a-12)
amod(agonist-15, selective-13)
amod(agonist-15, 5-HT1F-14)
appos(LY334370-10, agonist-15)
case(activity-20, on-17)
det(activity-20, the-18)
compound(activity-20, promoter-19)
nmod:on(investigated-6, activity-20)
case(gene-23, of-21)
amod(gene-23, 5-HT1A_receptor-22)
nmod:of(activity-20, gene-23)
case(cells-27, in-24)
amod(cells-27, human-25)
amod(cells-27, neuronal-26)
nmod:in(investigated-6, cells-27)

Our/PRP$ results/NNS showed/VBD that/IN LY334370/NNP decreased/VBD the/DT promoter/NN activity/NN of/IN 5-HT1A_receptor/JJ gene/NN in_a/JJ dose-dependent/JJ manner/NN ,/, indicating/VBG that/IN LY334370/NNP suppresses/VBZ 5-HT1A_receptor/JJ expression/NN at/IN the/DT transcriptional/JJ level/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP LY334370))
          (VP (VBD decreased)
            (NP
              (NP (DT the) (NN promoter) (NN activity))
              (PP (IN of)
                (NP (JJ 5-HT1A_receptor) (NN gene))))
            (NP (JJ in_a) (JJ dose-dependent) (NN manner))
            (, ,)
            (S
              (VP (VBG indicating)
                (SBAR (IN that)
                  (S
                    (NP (NNP LY334370))
                    (VP (VBZ suppresses)
                      (NP (JJ 5-HT1A_receptor) (NN expression))
                      (PP (IN at)
                        (NP (DT the) (JJ transcriptional) (NN level))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(decreased-6, that-4)
nsubj(decreased-6, LY334370-5)
ccomp(showed-3, decreased-6)
det(activity-9, the-7)
compound(activity-9, promoter-8)
iobj(decreased-6, activity-9)
case(gene-12, of-10)
amod(gene-12, 5-HT1A_receptor-11)
nmod:of(activity-9, gene-12)
amod(manner-15, in_a-13)
amod(manner-15, dose-dependent-14)
dobj(decreased-6, manner-15)
advcl(decreased-6, indicating-17)
mark(suppresses-20, that-18)
nsubj(suppresses-20, LY334370-19)
ccomp(indicating-17, suppresses-20)
amod(expression-22, 5-HT1A_receptor-21)
dobj(suppresses-20, expression-22)
case(level-26, at-23)
det(level-26, the-24)
amod(level-26, transcriptional-25)
nmod:at(suppresses-20, level-26)

These/DT findings/NNS suggest/VBP that/IN LY334370/NNP may/MD be/VB useful/JJ as/IN a/DT therapeutic/JJ agent/NN for/IN disorders/NNS associated/VBN with/IN altered/JJ serotonergic/JJ neurotransmission/NN and/CC provide/VB insights/NNS into/IN the/DT molecular/JJ mechanisms/NNS underlying/VBG its/PRP$ pharmacological/JJ effects/NNS on/IN serotonin/JJ signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP LY334370))
          (VP
            (VP (MD may)
              (VP (VB be)
                (ADJP (JJ useful)
                  (PP (IN as)
                    (NP
                      (NP (DT a) (JJ therapeutic) (NN agent))
                      (PP (IN for)
                        (NP
                          (NP (NNS disorders))
                          (VP (VBN associated)
                            (PP (IN with)
                              (NP (JJ altered) (JJ serotonergic) (NN neurotransmission)))))))))))
            (CC and)
            (VP (VB provide)
              (NP (NNS insights))
              (PP (IN into)
                (NP
                  (NP (DT the) (JJ molecular) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP
                      (NP (PRP$ its) (JJ pharmacological) (NNS effects))
                      (PP (IN on)
                        (NP (JJ serotonin) (VBG signaling) (NNS pathways))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(useful-8, that-4)
nsubj(useful-8, LY334370-5)
nsubj(provide-21, LY334370-5)
aux(useful-8, may-6)
cop(useful-8, be-7)
ccomp(suggest-3, useful-8)
case(agent-12, as-9)
det(agent-12, a-10)
amod(agent-12, therapeutic-11)
nmod:as(useful-8, agent-12)
case(disorders-14, for-13)
nmod:for(agent-12, disorders-14)
acl(disorders-14, associated-15)
case(neurotransmission-19, with-16)
amod(neurotransmission-19, altered-17)
amod(neurotransmission-19, serotonergic-18)
nmod:with(associated-15, neurotransmission-19)
cc(useful-8, and-20)
ccomp(suggest-3, provide-21)
conj:and(useful-8, provide-21)
dobj(provide-21, insights-22)
case(mechanisms-26, into-23)
det(mechanisms-26, the-24)
amod(mechanisms-26, molecular-25)
nmod:into(provide-21, mechanisms-26)
acl(mechanisms-26, underlying-27)
nmod:poss(effects-30, its-28)
amod(effects-30, pharmacological-29)
dobj(underlying-27, effects-30)
case(pathways-34, on-31)
amod(pathways-34, serotonin-32)
amod(pathways-34, signaling-33)
nmod:on(effects-30, pathways-34)

The/DT placenta/NN plays/VBZ a/DT crucial/JJ role/NN in/IN the/DT metabolism/NN and/CC elimination/NN of/IN drugs/NNS ,/, including/VBG L-163/NNP ,017/CD ./.

(ROOT
  (S
    (NP (DT The) (NN placenta))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN metabolism))
            (CC and)
            (NP
              (NP (NN elimination))
              (PP (IN of)
                (NP
                  (NP (NNS drugs))
                  (, ,)
                  (PP (VBG including)
                    (NP (NNP L-163) (CD ,017))))))))))
    (. .)))

det(placenta-2, The-1)
nsubj(plays-3, placenta-2)
root(ROOT-0, plays-3)
det(role-6, a-4)
amod(role-6, crucial-5)
dobj(plays-3, role-6)
case(metabolism-9, in-7)
det(metabolism-9, the-8)
nmod:in(role-6, metabolism-9)
cc(metabolism-9, and-10)
nmod:in(role-6, elimination-11)
conj:and(metabolism-9, elimination-11)
case(drugs-13, of-12)
nmod:of(elimination-11, drugs-13)
case(L-163-16, including-15)
nmod:including(drugs-13, L-163-16)
nummod(L-163-16, ,017-17)

Real-time/JJ quantitative/JJ reverse_transcriptase-polymerase/JJ chain/NN reaction/NN -LRB-/-LRB- Q-RT-PCR/NN -RRB-/-RRB- analysis/NN revealed/VBN a/DT significant/JJ increase/NN in/IN mRNA/NN levels/NNS for/IN placental/JJ L-163/NN ,017/CD metabolism/NN enzymes/NNS ,/, including/VBG UDP-glucuronosyltransferase_1A1/NNS -LRB-/-LRB- UGT1A1/NNP -RRB-/-RRB- ,/, estrogen_sulfotransferase/NN 1E1/CD -LRB-/-LRB- SULT1E1/NNP -RRB-/-RRB- ,/, L-163/NNP ,017/CD

(ROOT
  (NP
    (NP (JJ Real-time) (JJ quantitative) (JJ reverse_transcriptase-polymerase) (NN chain) (NN reaction))
    (NP
      (LST (-LRB- -LRB-) (NN Q-RT-PCR) (-RRB- -RRB-))
      (NP (NN analysis))
      (PP (VBN revealed)
        (NP
          (NP (DT a) (JJ significant) (NN increase))
          (PP (IN in)
            (NP (NN mRNA) (NNS levels)))))
      (PP (IN for)
        (NP (JJ placental) (NN L-163) (CD ,017) (NN metabolism) (NNS enzymes)))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (NP (NNS UDP-glucuronosyltransferase_1A1))
            (PRN (-LRB- -LRB-)
              (NP (NNP UGT1A1))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (NN estrogen_sulfotransferase) (CD 1E1))
            (PRN (-LRB- -LRB-)
              (NP (NNP SULT1E1))
              (-RRB- -RRB-)))
          (, ,)
          (NP (NNP L-163) (CD ,017)))))))

amod(reaction-5, Real-time-1)
amod(reaction-5, quantitative-2)
amod(reaction-5, reverse_transcriptase-polymerase-3)
compound(reaction-5, chain-4)
root(ROOT-0, reaction-5)
dep(analysis-9, Q-RT-PCR-7)
dep(reaction-5, analysis-9)
case(increase-13, revealed-10)
det(increase-13, a-11)
amod(increase-13, significant-12)
nmod:revealed(analysis-9, increase-13)
case(levels-16, in-14)
compound(levels-16, mRNA-15)
nmod:in(increase-13, levels-16)
case(enzymes-22, for-17)
amod(enzymes-22, placental-18)
compound(enzymes-22, L-163-19)
nummod(enzymes-22, ,017-20)
compound(enzymes-22, metabolism-21)
nmod:for(analysis-9, enzymes-22)
acl(analysis-9, including-24)
dobj(including-24, UDP-glucuronosyltransferase_1A1-25)
appos(UDP-glucuronosyltransferase_1A1-25, UGT1A1-27)
appos(UDP-glucuronosyltransferase_1A1-25, estrogen_sulfotransferase-30)
nummod(estrogen_sulfotransferase-30, 1E1-31)
appos(estrogen_sulfotransferase-30, SULT1E1-33)
appos(UDP-glucuronosyltransferase_1A1-25, L-163-36)
nummod(L-163-36, ,017-37)

5a-reductase_1/JJ -LRB-/-LRB- angiotensin_II_type_1/NNS -RRB-/-RRB- and/CC L-163/NNP ,017/CD 5a-reductase/VBD 2/CD -LRB-/-LRB- SRD5A2/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ 5a-reductase_1) (-LRB- -LRB-) (NNS angiotensin_II_type_1) (-RRB- -RRB-))
      (CC and)
      (NP (NNP L-163) (CD ,017)))
    (VP (VBD 5a-reductase)
      (NP
        (NP (CD 2))
        (PRN (-LRB- -LRB-)
          (NP (CD SRD5A2))
          (-RRB- -RRB-))))
    (. .)))

amod(angiotensin_II_type_1-3, 5a-reductase_1-1)
nsubj(5a-reductase-8, angiotensin_II_type_1-3)
cc(angiotensin_II_type_1-3, and-5)
conj:and(angiotensin_II_type_1-3, L-163-6)
nsubj(5a-reductase-8, L-163-6)
nummod(L-163-6, ,017-7)
root(ROOT-0, 5a-reductase-8)
dobj(5a-reductase-8, 2-9)
appos(2-9, SRD5A2-11)

The/DT results/NNS showed/VBD a/DT significant/JJ increase/NN in/IN the/DT mRNA/JJ levels/NNS for/IN UDP-glucuronosyltransferase_1A1/NNS -LRB-/-LRB- UGT1A1/NNP -RRB-/-RRB- ,/, estrogen_sulfotransferase/NN 1E1/CD -LRB-/-LRB- SULT1E1/NNP -RRB-/-RRB- ,/, L-163/NN ,017/CD

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (NN increase))
        (PP (IN in)
          (NP
            (NP (DT the) (JJ mRNA) (NNS levels))
            (PP (IN for)
              (NP (NNS UDP-glucuronosyltransferase_1A1)))))
        (SBAR
          (S
            (NP
              (NP (-LRB- -LRB-) (NNP UGT1A1) (-RRB- -RRB-))
              (, ,)
              (NP
                (NP (NN estrogen_sulfotransferase) (CD 1E1))
                (PRN (-LRB- -LRB-)
                  (NP (NNP SULT1E1))
                  (-RRB- -RRB-)))
              (, ,))
            (VP (NN L-163)
              (NP (CD ,017)))))))))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(increase-6, a-4)
amod(increase-6, significant-5)
dobj(showed-3, increase-6)
case(levels-10, in-7)
det(levels-10, the-8)
amod(levels-10, mRNA-9)
nmod:in(increase-6, levels-10)
case(UDP-glucuronosyltransferase_1A1-12, for-11)
nmod:for(levels-10, UDP-glucuronosyltransferase_1A1-12)
nsubj(L-163-23, UGT1A1-14)
appos(UGT1A1-14, estrogen_sulfotransferase-17)
nummod(estrogen_sulfotransferase-17, 1E1-18)
appos(estrogen_sulfotransferase-17, SULT1E1-20)
acl:relcl(increase-6, L-163-23)
dobj(L-163-23, ,017-24)

5a-reductase_1/JJ -LRB-/-LRB- angiotensin_II_type_1/NNS -RRB-/-RRB- ,/, and/CC L-163/NNP ,017/CD 5a-reductase/VBD 2/CD -LRB-/-LRB- SRD5A2/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ 5a-reductase_1) (-LRB- -LRB-) (NNS angiotensin_II_type_1) (-RRB- -RRB-))
      (, ,)
      (CC and)
      (NP (NNP L-163) (CD ,017)))
    (VP (VBD 5a-reductase)
      (NP
        (NP (CD 2))
        (PRN (-LRB- -LRB-)
          (NP (CD SRD5A2))
          (-RRB- -RRB-))))
    (. .)))

amod(angiotensin_II_type_1-3, 5a-reductase_1-1)
nsubj(5a-reductase-9, angiotensin_II_type_1-3)
cc(angiotensin_II_type_1-3, and-6)
conj:and(angiotensin_II_type_1-3, L-163-7)
nsubj(5a-reductase-9, L-163-7)
nummod(L-163-7, ,017-8)
root(ROOT-0, 5a-reductase-9)
dobj(5a-reductase-9, 2-10)
appos(2-10, SRD5A2-12)

These/DT findings/NNS suggest/VBP that/IN the/DT placenta/NN may/MD play/VB an/DT important/JJ role/NN in/IN the/DT metabolism/NN and/CC elimination/NN of/IN L-163/NNP ,017/CD ,/, potentially/RB affecting/VBG its/PRP$ efficacy/NN and/CC toxicity/NN during/IN pregnancy/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT the) (NN placenta))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN metabolism))
                    (CC and)
                    (NP
                      (NP (NN elimination))
                      (PP (IN of)
                        (NP (NNP L-163) (CD ,017)))
                      (, ,)
                      (VP
                        (ADVP (RB potentially))
                        (VBG affecting)
                        (NP (PRP$ its) (NN efficacy)
                          (CC and)
                          (NN toxicity))
                        (PP (IN during)
                          (NP (NN pregnancy)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-8, that-4)
det(placenta-6, the-5)
nsubj(play-8, placenta-6)
aux(play-8, may-7)
ccomp(suggest-3, play-8)
det(role-11, an-9)
amod(role-11, important-10)
dobj(play-8, role-11)
case(metabolism-14, in-12)
det(metabolism-14, the-13)
nmod:in(role-11, metabolism-14)
cc(metabolism-14, and-15)
nmod:in(role-11, elimination-16)
conj:and(metabolism-14, elimination-16)
case(L-163-18, of-17)
nmod:of(elimination-16, L-163-18)
nummod(L-163-18, ,017-19)
advmod(affecting-22, potentially-21)
acl(elimination-16, affecting-22)
nmod:poss(efficacy-24, its-23)
dobj(affecting-22, efficacy-24)
cc(efficacy-24, and-25)
dobj(affecting-22, toxicity-26)
conj:and(efficacy-24, toxicity-26)
case(pregnancy-28, during-27)
nmod:during(affecting-22, pregnancy-28)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT clinical/JJ implications/NNS of/IN these/DT findings/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (JJ clinical) (NNS implications))
                (PP (IN of)
                  (NP (DT these) (NNS findings)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(implications-9, the-7)
amod(implications-9, clinical-8)
dobj(elucidate-6, implications-9)
case(findings-12, of-10)
det(findings-12, these-11)
nmod:of(implications-9, findings-12)

The/DT aim/NN of/IN this/DT study/NN was/VBD to/TO investigate/VB the/DT effects/NNS of/IN chlorzoxazone/NN on/IN intestinal/JJ morphology/NN and/CC weight/NN regulation/NN in/IN rats/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN aim))
      (PP (IN of)
        (NP (DT this) (NN study))))
    (VP (VBD was)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NNS effects))
              (PP (IN of)
                (NP (NN chlorzoxazone)))
              (PP (IN on)
                (NP
                  (NP (JJ intestinal) (NN morphology))
                  (CC and)
                  (NP (NN weight) (NN regulation)))))
            (PP (IN in)
              (NP (NNS rats)))))))
    (. .)))

det(aim-2, The-1)
nsubj(was-6, aim-2)
nsubj:xsubj(investigate-8, aim-2)
case(study-5, of-3)
det(study-5, this-4)
nmod:of(aim-2, study-5)
root(ROOT-0, was-6)
mark(investigate-8, to-7)
xcomp(was-6, investigate-8)
det(effects-10, the-9)
dobj(investigate-8, effects-10)
case(chlorzoxazone-12, of-11)
nmod:of(effects-10, chlorzoxazone-12)
case(morphology-15, on-13)
amod(morphology-15, intestinal-14)
nmod:on(effects-10, morphology-15)
cc(morphology-15, and-16)
compound(regulation-18, weight-17)
nmod:on(effects-10, regulation-18)
conj:and(morphology-15, regulation-18)
case(rats-20, in-19)
nmod:in(investigate-8, rats-20)

In/IN addition/NN ,/, the/DT effects/NNS on/IN plasma/NN chlorzexazone/JJ concentration/NN and/CC expression/NN of/IN KCNN2/NNP were/VBD also/RB investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN on)
        (NP
          (NP (NN plasma) (JJ chlorzexazone) (NN concentration))
          (CC and)
          (NP
            (NP (NN expression))
            (PP (IN of)
              (NP (NNP KCNN2)))))))
    (VP (VBD were) (RB also)
      (VP (VBN investigated)))
    (. .)))

case(addition-2, In-1)
nmod:in(investigated-16, addition-2)
det(effects-5, the-4)
nsubjpass(investigated-16, effects-5)
case(concentration-9, on-6)
compound(concentration-9, plasma-7)
amod(concentration-9, chlorzexazone-8)
nmod:on(effects-5, concentration-9)
cc(concentration-9, and-10)
nmod:on(effects-5, expression-11)
conj:and(concentration-9, expression-11)
case(KCNN2-13, of-12)
nmod:of(expression-11, KCNN2-13)
auxpass(investigated-16, were-14)
advmod(investigated-16, also-15)
root(ROOT-0, investigated-16)

The/DT rats/NNS were/VBD divided/VBN into/IN two/CD groups/NNS :/: control/NN group/NN -LRB-/-LRB- n/NNP =/SYM 10/CD -RRB-/-RRB- and/CC chlorzoxic/JJ group/NN -LRB-/-LRB- n/NNP =/SYM 10/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS rats))
    (VP (VBD were)
      (VP (VBN divided)
        (PP (IN into)
          (NP
            (NP (CD two) (NNS groups))
            (: :)
            (NP
              (NP
                (NP (NN control) (NN group))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NNP n))
                    (SBAR
                      (FRAG
                        (X (SYM =))
                        (NP (CD 10)))))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (NP (JJ chlorzoxic) (NN group))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NNP n))
                    (SBAR
                      (FRAG
                        (X (SYM =))
                        (NP (CD 10)))))
                  (-RRB- -RRB-))))))))
    (. .)))

det(rats-2, The-1)
nsubjpass(divided-4, rats-2)
auxpass(divided-4, were-3)
root(ROOT-0, divided-4)
case(groups-7, into-5)
nummod(groups-7, two-6)
nmod:into(divided-4, groups-7)
compound(group-10, control-9)
dep(groups-7, group-10)
dep(group-10, n-12)
dep(10-14, =-13)
dep(n-12, 10-14)
cc(group-10, and-16)
amod(group-18, chlorzoxic-17)
dep(groups-7, group-18)
conj:and(group-10, group-18)
dep(group-18, n-20)
dep(10-22, =-21)
dep(n-20, 10-22)

Data/NNP were/VBD analyzed/VBN using/VBG Student/NNP 's/POS t/JJ test/NN and/CC analysis/NN of/IN variance/NN ./.

(ROOT
  (S
    (NP (NNP Data))
    (VP (VBD were)
      (VP (VBN analyzed)
        (VP (VBG using)
          (NP
            (NP
              (NP (NNP Student) (POS 's))
              (JJ t) (NN test))
            (CC and)
            (NP
              (NP (NN analysis))
              (PP (IN of)
                (NP (NN variance))))))))
    (. .)))

nsubjpass(analyzed-3, Data-1)
auxpass(analyzed-3, were-2)
root(ROOT-0, analyzed-3)
xcomp(analyzed-3, using-4)
nmod:poss(test-8, Student-5)
case(Student-5, 's-6)
amod(test-8, t-7)
dobj(using-4, test-8)
cc(test-8, and-9)
dobj(using-4, analysis-10)
conj:and(test-8, analysis-10)
case(variance-12, of-11)
nmod:of(analysis-10, variance-12)

The/DT results/NNS showed/VBD that/IN chlorzoxazone/JJ intervention/NN led/VBN to/TO a/DT significant/JJ decrease/NN in/IN body/NN weight/NN ,/, villus/VBZ height/NN ,/, and/CC villus/VBZ surface/NN area/NN when/WRB compared/VBN to/TO the/DT control/NN group/NN -LRB-/-LRB- P/NNP </CD 0.01/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ chlorzoxazone) (NN intervention))
            (VP (VBN led)
              (PP (TO to)
                (NP
                  (NP (DT a) (JJ significant) (NN decrease))
                  (PP (IN in)
                    (NP (NN body) (NN weight))))))
            (, ,))
          (VP
            (VP (VBZ villus)
              (NP (NN height)))
            (, ,)
            (CC and)
            (VP (VBZ villus)
              (NP
                (NP (NN surface) (NN area))
                (SBAR
                  (WHADVP (WRB when))
                  (S
                    (VP (VBN compared)
                      (PP (TO to)
                        (NP
                          (NP (DT the) (NN control) (NN group))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP P)
                              (QP (CD <) (CD 0.01)))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(villus-16, that-4)
amod(intervention-6, chlorzoxazone-5)
nsubj(villus-16, intervention-6)
nsubj(villus-20, intervention-6)
acl(intervention-6, led-7)
case(decrease-11, to-8)
det(decrease-11, a-9)
amod(decrease-11, significant-10)
nmod:to(led-7, decrease-11)
case(weight-14, in-12)
compound(weight-14, body-13)
nmod:in(decrease-11, weight-14)
ccomp(showed-3, villus-16)
dobj(villus-16, height-17)
cc(villus-16, and-19)
ccomp(showed-3, villus-20)
conj:and(villus-16, villus-20)
compound(area-22, surface-21)
dobj(villus-20, area-22)
advmod(compared-24, when-23)
acl:relcl(area-22, compared-24)
case(group-28, to-25)
det(group-28, the-26)
compound(group-28, control-27)
nmod:to(compared-24, group-28)
appos(group-28, P-30)
compound(0.01-32, <-31)
nummod(P-30, 0.01-32)

However/RB ,/, the/DT plasma/NN concentration/NN of/IN chlorzoxazone/NN and/CC expression/NN of/IN KCNN2/NNP in/IN the/DT chlorzoxazone-intervened/JJ group/NN had/VBD recovered/VBN to/TO normal/JJ levels/NNS -LRB-/-LRB- P/NNP >/CD 0.05/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP
        (NP (DT the) (NN plasma) (NN concentration))
        (PP (IN of)
          (NP (NN chlorzoxazone)
            (CC and)
            (NN expression)))
        (PP (IN of)
          (NP (NNP KCNN2))))
      (PP (IN in)
        (NP (DT the) (JJ chlorzoxazone-intervened) (NN group))))
    (VP (VBD had)
      (VP (VBN recovered)
        (PP (TO to)
          (NP
            (NP (JJ normal) (NNS levels))
            (PRN (-LRB- -LRB-)
              (NP (NNP P)
                (QP (CD >) (CD 0.05)))
              (-RRB- -RRB-))))))
    (. .)))

advmod(recovered-17, However-1)
det(concentration-5, the-3)
compound(concentration-5, plasma-4)
nsubj(recovered-17, concentration-5)
case(chlorzoxazone-7, of-6)
nmod:of(concentration-5, chlorzoxazone-7)
cc(chlorzoxazone-7, and-8)
nmod:of(concentration-5, expression-9)
conj:and(chlorzoxazone-7, expression-9)
case(KCNN2-11, of-10)
nmod:of(concentration-5, KCNN2-11)
case(group-15, in-12)
det(group-15, the-13)
amod(group-15, chlorzoxazone-intervened-14)
nmod:in(concentration-5, group-15)
aux(recovered-17, had-16)
root(ROOT-0, recovered-17)
case(levels-20, to-18)
amod(levels-20, normal-19)
nmod:to(recovered-17, levels-20)
appos(levels-20, P-22)
compound(0.05-24, >-23)
nummod(P-22, 0.05-24)

These/DT findings/NNS suggest/VBP that/IN while/IN chlorzoxazone/NN may/MD have/VB adverse/JJ effects/NNS on/IN intestinal/JJ morphology/NN and/CC weight/NN regulation/NN ,/, its/PRP$ effects/NNS on/IN plasma/NN concentration/NN and/CC gene/NN expression/NN can/MD be/VB reversed/VBN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (SBAR (IN while)
            (S
              (NP (NN chlorzoxazone))
              (VP (MD may)
                (VP (VB have)
                  (NP
                    (NP (JJ adverse) (NNS effects))
                    (PP (IN on)
                      (NP
                        (NP (JJ intestinal) (NN morphology))
                        (CC and)
                        (NP (NN weight) (NN regulation)))))))))
          (, ,)
          (NP
            (NP (PRP$ its) (NNS effects))
            (PP (IN on)
              (NP
                (NP (NN plasma) (NN concentration))
                (CC and)
                (NP (NN gene) (NN expression)))))
          (VP (MD can)
            (VP (VB be)
              (VP (VBN reversed)))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(reversed-28, that-4)
mark(have-8, while-5)
nsubj(have-8, chlorzoxazone-6)
aux(have-8, may-7)
advcl(reversed-28, have-8)
amod(effects-10, adverse-9)
dobj(have-8, effects-10)
case(morphology-13, on-11)
amod(morphology-13, intestinal-12)
nmod:on(effects-10, morphology-13)
cc(morphology-13, and-14)
compound(regulation-16, weight-15)
nmod:on(effects-10, regulation-16)
conj:and(morphology-13, regulation-16)
nmod:poss(effects-19, its-18)
nsubjpass(reversed-28, effects-19)
case(concentration-22, on-20)
compound(concentration-22, plasma-21)
nmod:on(effects-19, concentration-22)
cc(concentration-22, and-23)
compound(expression-25, gene-24)
nmod:on(effects-19, expression-25)
conj:and(concentration-22, expression-25)
aux(reversed-28, can-26)
auxpass(reversed-28, be-27)
ccomp(suggest-3, reversed-28)

Further/JJ studies/NNS are/VBP needed/VBN to/TO determine/VB the/DT long-term/JJ consequences/NNS of/IN chlorzoxazone/JJ use/NN on/IN gastrointestinal_function/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (DT the) (JJ long-term) (NNS consequences))
                (PP (IN of)
                  (NP
                    (NP (JJ chlorzoxazone) (NN use))
                    (PP (IN on)
                      (NP (NN gastrointestinal_function)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(determine-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(determine-6, to-5)
xcomp(needed-4, determine-6)
det(consequences-9, the-7)
amod(consequences-9, long-term-8)
dobj(determine-6, consequences-9)
case(use-12, of-10)
amod(use-12, chlorzoxazone-11)
nmod:of(consequences-9, use-12)
case(gastrointestinal_function-14, on-13)
nmod:on(use-12, gastrointestinal_function-14)

The/DT present/JJ study/NN aimed/VBD to/TO investigate/VB the/DT role/NN of/IN various/JJ transporters/NNS and/CC neurotransmitters/NNS in/IN the/DT distribution/NN of/IN tenofovir_DF/NN ./.

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN role))
              (PP (IN of)
                (NP (JJ various) (NNS transporters)
                  (CC and)
                  (NNS neurotransmitters))))
            (PP (IN in)
              (NP
                (NP (DT the) (NN distribution))
                (PP (IN of)
                  (NP (NN tenofovir_DF)))))))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(aimed-4, study-3)
nsubj:xsubj(investigate-6, study-3)
root(ROOT-0, aimed-4)
mark(investigate-6, to-5)
xcomp(aimed-4, investigate-6)
det(role-8, the-7)
dobj(investigate-6, role-8)
case(transporters-11, of-9)
amod(transporters-11, various-10)
nmod:of(role-8, transporters-11)
cc(transporters-11, and-12)
nmod:of(role-8, neurotransmitters-13)
conj:and(transporters-11, neurotransmitters-13)
case(distribution-16, in-14)
det(distribution-16, the-15)
nmod:in(investigate-6, distribution-16)
case(tenofovir_DF-18, of-17)
nmod:of(distribution-16, tenofovir_DF-18)

To/TO achieve/VB this/DT ,/, antibodies/NNS against/IN vesicular/NN tenofovir_DF/NN transporters/NNS -LRB-/-LRB- CD-1_and_BALB/NNS -RRB-/-RRB- ,/, vesicular_acetylcholine_transporter/NN -LRB-/-LRB- VAChT/NNP -RRB-/-RRB- ,/, tyrosine_hydroxylase/NN -LRB-/-LRB- TH/NNP -RRB-/-RRB- ,/, dopamine_beta-hydroxylase/JJ -LRB-/-LRB- DBH/NNP -RRB-/-RRB- ,/, serotonin/NN -LRB-/-LRB- 5-HT/CD -RRB-/-RRB- ,/, vasoactive_intestinal_peptide/NN -LRB-/-LRB- VIP/NNP -RRB-/-RRB- ,/, and/CC protein_gene_product_9/CD .5/CD -LRB-/-LRB- PGP_9/CD .5/CD -RRB-/-RRB- were/VBD utilized/VBN ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP
      (NP (NNS antibodies))
      (PP (IN against)
        (NP
          (NP
            (NP
              (NP (NN vesicular) (NN tenofovir_DF) (NNS transporters))
              (-LRB- -LRB-)
              (NP (NNS CD-1_and_BALB))
              (-RRB- -RRB-))
            (, ,)
            (NP
              (NP (NN vesicular_acetylcholine_transporter))
              (PRN (-LRB- -LRB-)
                (NP (NNP VAChT))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN tyrosine_hydroxylase))
              (PRN (-LRB- -LRB-)
                (NP (NNP TH))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (JJ dopamine_beta-hydroxylase))
              (PRN (-LRB- -LRB-)
                (NP (NNP DBH))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN serotonin))
              (PRN (-LRB- -LRB-)
                (NP (CD 5-HT))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN vasoactive_intestinal_peptide))
              (PRN (-LRB- -LRB-)
                (NP (NNP VIP))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NP
              (QP (CD protein_gene_product_9) (CD .5))))
          (PRN (-LRB- -LRB-)
            (NP
              (QP (CD PGP_9) (CD .5)))
            (-RRB- -RRB-)))))
    (VP (VBD were)
      (VP (VBN utilized)))
    (. .)))

mark(achieve-2, To-1)
advcl(utilized-47, achieve-2)
dobj(achieve-2, this-3)
nsubjpass(utilized-47, antibodies-5)
case(transporters-9, against-6)
compound(transporters-9, vesicular-7)
compound(transporters-9, tenofovir_DF-8)
nmod:against(antibodies-5, transporters-9)
dep(transporters-9, CD-1_and_BALB-11)
nmod:against(antibodies-5, vesicular_acetylcholine_transporter-14)
conj:and(transporters-9, vesicular_acetylcholine_transporter-14)
appos(vesicular_acetylcholine_transporter-14, VAChT-16)
nmod:against(antibodies-5, tyrosine_hydroxylase-19)
conj:and(transporters-9, tyrosine_hydroxylase-19)
appos(tyrosine_hydroxylase-19, TH-21)
nmod:against(antibodies-5, dopamine_beta-hydroxylase-24)
conj:and(transporters-9, dopamine_beta-hydroxylase-24)
appos(dopamine_beta-hydroxylase-24, DBH-26)
nmod:against(antibodies-5, serotonin-29)
conj:and(transporters-9, serotonin-29)
appos(serotonin-29, 5-HT-31)
nmod:against(antibodies-5, vasoactive_intestinal_peptide-34)
conj:and(transporters-9, vasoactive_intestinal_peptide-34)
appos(vasoactive_intestinal_peptide-34, VIP-36)
cc(transporters-9, and-39)
compound(.5-41, protein_gene_product_9-40)
nmod:against(antibodies-5, .5-41)
conj:and(transporters-9, .5-41)
compound(.5-44, PGP_9-43)
dep(transporters-9, .5-44)
auxpass(utilized-47, were-46)
root(ROOT-0, utilized-47)

The/DT results/NNS showed/VBD that/IN these/DT transporters/NNS and/CC neurotransmitters/NNS may/MD play/VB a/DT crucial/JJ role/NN in/IN the/DT distribution/NN of/IN tenofovir_DF/NN ,/, suggesting/VBG that/IN targeting/VBG them/PRP could/MD be/VB a/DT promising/JJ strategy/NN for/IN improving/VBG the/DT efficacy/NN of/IN tenofovir_DF-based/JJ therapies/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS transporters)
            (CC and)
            (NNS neurotransmitters))
          (VP (MD may)
            (VP (VB play)
              (NP (DT a) (JJ crucial) (NN role))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN distribution))
                  (PP (IN of)
                    (NP (NN tenofovir_DF)))))
              (, ,)
              (S
                (VP (VBG suggesting)
                  (SBAR (IN that)
                    (S
                      (S
                        (VP (VBG targeting)
                          (NP (PRP them))))
                      (VP (MD could)
                        (VP (VB be)
                          (NP
                            (NP (DT a) (JJ promising) (NN strategy))
                            (PP (IN for)
                              (S
                                (VP (VBG improving)
                                  (NP
                                    (NP (DT the) (NN efficacy))
                                    (PP (IN of)
                                      (NP (JJ tenofovir_DF-based) (NNS therapies)))))))))))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(play-10, that-4)
det(transporters-6, these-5)
nsubj(play-10, transporters-6)
cc(transporters-6, and-7)
conj:and(transporters-6, neurotransmitters-8)
nsubj(play-10, neurotransmitters-8)
aux(play-10, may-9)
ccomp(showed-3, play-10)
det(role-13, a-11)
amod(role-13, crucial-12)
dobj(play-10, role-13)
case(distribution-16, in-14)
det(distribution-16, the-15)
nmod:in(play-10, distribution-16)
case(tenofovir_DF-18, of-17)
nmod:of(distribution-16, tenofovir_DF-18)
advcl(play-10, suggesting-20)
mark(strategy-28, that-21)
csubj(strategy-28, targeting-22)
dobj(targeting-22, them-23)
aux(strategy-28, could-24)
cop(strategy-28, be-25)
det(strategy-28, a-26)
amod(strategy-28, promising-27)
ccomp(suggesting-20, strategy-28)
mark(improving-30, for-29)
acl(strategy-28, improving-30)
det(efficacy-32, the-31)
dobj(improving-30, efficacy-32)
case(therapies-35, of-33)
amod(therapies-35, tenofovir_DF-based-34)
nmod:of(efficacy-32, therapies-35)

For/IN this/DT purpose/NN ,/, antibodies/NNS against/IN the/DT vesicular/NN tenofovir_DF/NN transporters/NNS -LRB-/-LRB- CD-1_and_BALB/NNS -RRB-/-RRB- ,/, the/DT vesicular_acetylcholine_transporter/NN -LRB-/-LRB- VAChT/NNP -RRB-/-RRB- ,/, tyrosine_hydroxylase/NN -LRB-/-LRB- TH/NNP -RRB-/-RRB- ,/, dopamine_beta-hydroxylase/JJ -LRB-/-LRB- DBH/NNP -RRB-/-RRB- ,/, serotonin/NN -LRB-/-LRB- 5-HT/CD -RRB-/-RRB- ,/, vasoactive_intestinal_peptide/NN -LRB-/-LRB- VIP/NNP -RRB-/-RRB- ,/, and/CC protein_gene_product_9/CD .5/CD -LRB-/-LRB- PGP_9/CD .5/CD -RRB-/-RRB- were/VBD used/VBN ./.

(ROOT
  (S
    (PP (IN For)
      (NP (DT this) (NN purpose)))
    (, ,)
    (NP
      (NP (NNS antibodies))
      (PP (IN against)
        (NP
          (NP
            (NP
              (NP (DT the) (NN vesicular) (NN tenofovir_DF) (NNS transporters))
              (-LRB- -LRB-)
              (NP (NNS CD-1_and_BALB))
              (-RRB- -RRB-))
            (, ,)
            (NP
              (NP (DT the) (NN vesicular_acetylcholine_transporter))
              (PRN (-LRB- -LRB-)
                (NP (NNP VAChT))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN tyrosine_hydroxylase))
              (PRN (-LRB- -LRB-)
                (NP (NNP TH))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (JJ dopamine_beta-hydroxylase))
              (PRN (-LRB- -LRB-)
                (NP (NNP DBH))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN serotonin))
              (PRN (-LRB- -LRB-)
                (NP (CD 5-HT))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN vasoactive_intestinal_peptide))
              (PRN (-LRB- -LRB-)
                (NP (NNP VIP))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NP
              (QP (CD protein_gene_product_9) (CD .5))))
          (PRN (-LRB- -LRB-)
            (NP
              (QP (CD PGP_9) (CD .5)))
            (-RRB- -RRB-)))))
    (VP (VBD were)
      (VP (VBN used)))
    (. .)))

case(purpose-3, For-1)
det(purpose-3, this-2)
nmod:for(used-49, purpose-3)
nsubjpass(used-49, antibodies-5)
case(transporters-10, against-6)
det(transporters-10, the-7)
compound(transporters-10, vesicular-8)
compound(transporters-10, tenofovir_DF-9)
nmod:against(antibodies-5, transporters-10)
dep(transporters-10, CD-1_and_BALB-12)
det(vesicular_acetylcholine_transporter-16, the-15)
nmod:against(antibodies-5, vesicular_acetylcholine_transporter-16)
conj:and(transporters-10, vesicular_acetylcholine_transporter-16)
appos(vesicular_acetylcholine_transporter-16, VAChT-18)
nmod:against(antibodies-5, tyrosine_hydroxylase-21)
conj:and(transporters-10, tyrosine_hydroxylase-21)
appos(tyrosine_hydroxylase-21, TH-23)
nmod:against(antibodies-5, dopamine_beta-hydroxylase-26)
conj:and(transporters-10, dopamine_beta-hydroxylase-26)
appos(dopamine_beta-hydroxylase-26, DBH-28)
nmod:against(antibodies-5, serotonin-31)
conj:and(transporters-10, serotonin-31)
appos(serotonin-31, 5-HT-33)
nmod:against(antibodies-5, vasoactive_intestinal_peptide-36)
conj:and(transporters-10, vasoactive_intestinal_peptide-36)
appos(vasoactive_intestinal_peptide-36, VIP-38)
cc(transporters-10, and-41)
compound(.5-43, protein_gene_product_9-42)
nmod:against(antibodies-5, .5-43)
conj:and(transporters-10, .5-43)
compound(.5-46, PGP_9-45)
dep(transporters-10, .5-46)
auxpass(used-49, were-48)
root(ROOT-0, used-49)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO investigate/VB the/DT effects/NNS of/IN a/DT novel/JJ therapeutic/JJ agent/NN on/IN hippocampal_neurogenesis/JJ in_a/NN rat/NN model/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NNS effects))
              (PP (IN of)
                (NP (DT a) (JJ novel) (JJ therapeutic) (NN agent))))
            (PP (IN on)
              (NP (JJ hippocampal_neurogenesis) (NN in_a) (NN rat) (NN model)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(investigate-8, we-5)
root(ROOT-0, aimed-6)
mark(investigate-8, to-7)
xcomp(aimed-6, investigate-8)
det(effects-10, the-9)
dobj(investigate-8, effects-10)
case(agent-15, of-11)
det(agent-15, a-12)
amod(agent-15, novel-13)
amod(agent-15, therapeutic-14)
nmod:of(effects-10, agent-15)
case(model-20, on-16)
amod(model-20, hippocampal_neurogenesis-17)
compound(model-20, in_a-18)
compound(model-20, rat-19)
nmod:on(investigate-8, model-20)

The/DT effects/NNS of/IN the/DT novel/NN agent/NN on/IN the/DT expression/NN of/IN phosphorylated/VBD extracellular_signal-regulated_kinase_1/JJ //: 2/CD -LRB-/-LRB- pERK1/2/JJ -RRB-/-RRB- ,/, Phosphorylated/NNP Biotin/NNP response_element_binding_protein/NN -LRB-/-LRB- pCREB/NN -RRB-/-RRB- ,/, brain-derived_neurotrophic_factor/NN -LRB-/-LRB- BDNF/NNP -RRB-/-RRB- ,/, acetyl-coA_carboxylase/JJ -LRB-/-LRB- ACC/NNP -RRB-/-RRB- ,/, and/CC doublecortin/NN -LRB-/-LRB- DCX/NNP -RRB-/-RRB- were/VBD examined/VBN using/VBG immunohistochemistry/RB and/CC immunofluorescence/VBP staining/VBG with/IN BrdU/NNP ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS effects))
      (PP (IN of)
        (NP
          (NP (DT the) (NN novel) (NN agent))
          (PP (IN on)
            (NP
              (NP (DT the) (NN expression))
              (PP (IN of)
                (NP
                  (SBAR
                    (S
                      (VP (VBD phosphorylated)
                        (ADJP (JJ extracellular_signal-regulated_kinase_1)))))
                  (: /)
                  (NP
                    (NP
                      (NP (CD 2))
                      (PRN (-LRB- -LRB-) (JJ pERK1/2) (-RRB- -RRB-)))
                    (, ,)
                    (NP
                      (NP (NNP Phosphorylated) (NNP Biotin) (NN response_element_binding_protein))
                      (PRN (-LRB- -LRB-)
                        (NP (NN pCREB))
                        (-RRB- -RRB-)))
                    (, ,)
                    (NP
                      (NP (NN brain-derived_neurotrophic_factor))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP BDNF))
                        (-RRB- -RRB-)))
                    (, ,)
                    (NP
                      (NP (JJ acetyl-coA_carboxylase))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP ACC))
                        (-RRB- -RRB-)))
                    (, ,)
                    (CC and)
                    (NP
                      (NP (NN doublecortin))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP DCX))
                        (-RRB- -RRB-)))))))))))
    (VP
      (VP (VBD were)
        (VP (VBN examined)
          (VP (VBG using)
            (ADVP (RB immunohistochemistry)))))
      (CC and)
      (VP (VBP immunofluorescence)
        (VP (VBG staining)
          (PP (IN with)
            (NP (NNP BrdU))))))
    (. .)))

det(effects-2, The-1)
nsubjpass(examined-42, effects-2)
nsubj(immunofluorescence-46, effects-2)
case(agent-6, of-3)
det(agent-6, the-4)
compound(agent-6, novel-5)
nmod:of(effects-2, agent-6)
case(expression-9, on-7)
det(expression-9, the-8)
nmod:on(agent-6, expression-9)
case(2-14, of-10)
dep(2-14, phosphorylated-11)
xcomp(phosphorylated-11, extracellular_signal-regulated_kinase_1-12)
nmod:of(expression-9, 2-14)
dep(2-14, pERK1/2-16)
compound(response_element_binding_protein-21, Phosphorylated-19)
compound(response_element_binding_protein-21, Biotin-20)
nmod:of(expression-9, response_element_binding_protein-21)
conj:and(2-14, response_element_binding_protein-21)
appos(response_element_binding_protein-21, pCREB-23)
nmod:of(expression-9, brain-derived_neurotrophic_factor-26)
conj:and(2-14, brain-derived_neurotrophic_factor-26)
appos(brain-derived_neurotrophic_factor-26, BDNF-28)
nmod:of(expression-9, acetyl-coA_carboxylase-31)
conj:and(2-14, acetyl-coA_carboxylase-31)
appos(acetyl-coA_carboxylase-31, ACC-33)
cc(2-14, and-36)
nmod:of(expression-9, doublecortin-37)
conj:and(2-14, doublecortin-37)
appos(doublecortin-37, DCX-39)
auxpass(examined-42, were-41)
root(ROOT-0, examined-42)
xcomp(examined-42, using-43)
advmod(using-43, immunohistochemistry-44)
cc(examined-42, and-45)
conj:and(examined-42, immunofluorescence-46)
xcomp(immunofluorescence-46, staining-47)
case(BrdU-49, with-48)
nmod:with(staining-47, BrdU-49)

Our/PRP$ results/NNS showed/VBD that/IN treatment/NN with/IN the/DT novel/NN agent/NN significantly/RB increased/VBD the/DT expressions/NNS of/IN pERK/NNP 1/2/CD ,/, pCREB/NN ,/, BDNF/NNP ,/, and/CC DCX/NNP in/IN both/DT dentate/JJ gyrus/NNS and/CC CA1/CD regions/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN treatment))
            (PP (IN with)
              (NP (DT the) (NN novel) (NN agent))))
          (ADVP (RB significantly))
          (VP (VBD increased)
            (NP
              (NP (DT the) (NNS expressions))
              (PP (IN of)
                (NP
                  (NP (NNP pERK) (CD 1/2))
                  (, ,)
                  (NP (NN pCREB))
                  (, ,)
                  (NP (NNP BDNF))
                  (, ,)
                  (CC and)
                  (NP (NNP DCX)))))
            (PP (IN in)
              (NP
                (NP (DT both) (JJ dentate) (NNS gyrus))
                (CC and)
                (NP (CD CA1) (NNS regions))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(increased-11, that-4)
nsubj(increased-11, treatment-5)
case(agent-9, with-6)
det(agent-9, the-7)
compound(agent-9, novel-8)
nmod:with(treatment-5, agent-9)
advmod(increased-11, significantly-10)
ccomp(showed-3, increased-11)
det(expressions-13, the-12)
dobj(increased-11, expressions-13)
case(pERK-15, of-14)
nmod:of(expressions-13, pERK-15)
nummod(pERK-15, 1/2-16)
nmod:of(expressions-13, pCREB-18)
conj:and(pERK-15, pCREB-18)
nmod:of(expressions-13, BDNF-20)
conj:and(pERK-15, BDNF-20)
cc(pERK-15, and-22)
nmod:of(expressions-13, DCX-23)
conj:and(pERK-15, DCX-23)
case(gyrus-27, in-24)
det(gyrus-27, both-25)
amod(gyrus-27, dentate-26)
nmod:in(increased-11, gyrus-27)
cc(gyrus-27, and-28)
nummod(regions-30, CA1-29)
nmod:in(increased-11, regions-30)
conj:and(gyrus-27, regions-30)

Furthermore/RB ,/, the/DT incorporation/NN of/IN BrdU/NNP was/VBD also/RB significantly/RB increased/VBN in/IN these/DT regions/NNS following/VBG treatment/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (DT the) (NN incorporation))
      (PP (IN of)
        (NP (NNP BrdU))))
    (VP (VBD was) (RB also)
      (VP
        (ADVP (RB significantly))
        (VBN increased)
        (PP (IN in)
          (NP (DT these) (NNS regions)))
        (S
          (VP (VBG following)
            (NP (NN treatment))))))
    (. .)))

advmod(increased-10, Furthermore-1)
det(incorporation-4, the-3)
nsubjpass(increased-10, incorporation-4)
case(BrdU-6, of-5)
nmod:of(incorporation-4, BrdU-6)
auxpass(increased-10, was-7)
advmod(increased-10, also-8)
advmod(increased-10, significantly-9)
root(ROOT-0, increased-10)
case(regions-13, in-11)
det(regions-13, these-12)
nmod:in(increased-10, regions-13)
xcomp(increased-10, following-14)
dobj(following-14, treatment-15)

These/DT findings/NNS suggest/VBP that/IN the/DT novel/JJ therapeutic/JJ agent/NN may/MD have/VB potential/JJ for/IN promoting/VBG hippocampal_neurogenesis/NNS and/CC improving/VBG cognitive/JJ function/NN in/IN neurological_disorders/NNS associated/VBN with/IN impaired/JJ neurogenesis/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT the) (JJ novel) (JJ therapeutic) (NN agent))
          (VP (MD may)
            (VP (VB have)
              (ADJP (JJ potential))
              (PP (IN for)
                (S
                  (VP
                    (VP (VBG promoting)
                      (NP (NNS hippocampal_neurogenesis)))
                    (CC and)
                    (VP (VBG improving)
                      (NP (JJ cognitive) (NN function))
                      (PP (IN in)
                        (NP
                          (NP (NNS neurological_disorders))
                          (VP (VBN associated)
                            (PP (IN with)
                              (NP (JJ impaired) (NNS neurogenesis)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-10, that-4)
det(agent-8, the-5)
amod(agent-8, novel-6)
amod(agent-8, therapeutic-7)
nsubj(have-10, agent-8)
aux(have-10, may-9)
ccomp(suggest-3, have-10)
xcomp(have-10, potential-11)
mark(promoting-13, for-12)
advcl(have-10, promoting-13)
dobj(promoting-13, hippocampal_neurogenesis-14)
cc(promoting-13, and-15)
advcl(have-10, improving-16)
conj:and(promoting-13, improving-16)
amod(function-18, cognitive-17)
dobj(improving-16, function-18)
case(neurological_disorders-20, in-19)
nmod:in(improving-16, neurological_disorders-20)
acl(neurological_disorders-20, associated-21)
case(neurogenesis-24, with-22)
amod(neurogenesis-24, impaired-23)
nmod:with(associated-21, neurogenesis-24)

When/WRB C2C12/NN cells/NNS were/VBD cultured/VBN in_a/JJ medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/,

(ROOT
  (SBARQ
    (WHADVP (WRB When))
    (S
      (NP (NN C2C12) (NNS cells))
      (VP (VBD were)
        (VP (VBN cultured)
          (NP (JJ in_a) (NN medium))
          (S
            (VP (VBG favoring)
              (NP
                (NP (NN differentiation))
                (PRN (-LRB- -LRB-)
                  (S
                    (NP (NNP Dulbecco))
                    (VP (VBN modified)
                      (NP
                        (NP (NNP Eagle) (NN medium))
                        (VP (VBG containing)
                          (NP
                            (ADJP (CD 2) (NN %))
                            (NN horse) (NN serum))))))
                  (-RRB- -RRB-)))))
          (, ,))))))

advmod(cultured-5, When-1)
compound(cells-3, C2C12-2)
nsubjpass(cultured-5, cells-3)
auxpass(cultured-5, were-4)
root(ROOT-0, cultured-5)
amod(medium-7, in_a-6)
dobj(cultured-5, medium-7)
xcomp(cultured-5, favoring-8)
dobj(favoring-8, differentiation-9)
nsubj(modified-12, Dulbecco-11)
dep(differentiation-9, modified-12)
compound(medium-14, Eagle-13)
dobj(modified-12, medium-14)
acl(medium-14, containing-15)
compound(%-17, 2-16)
amod(serum-19, %-17)
compound(serum-19, horse-18)
dobj(containing-15, serum-19)

Silibinin/NNP up-regulated/VBD erk1/2/JJ protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ erk1/2/JJ protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (NNP Silibinin))
    (VP (VBD up-regulated)
      (NP (JJ erk1/2) (NN protein) (NNS levels))
      (NP (NN in_a)
        (NX
          (NX (JJ time-dependent) (NN manner))
          (CC and)
          (NX (JJ prolonged) (JJ erk1/2) (NN protein)))
        (NX (NN half-life)))
      (PP (IN from)
        (NP
          (QP (CD 10) (TO to) (CD 18))
          (NNS hours))))
    (. .)))

nsubj(up-regulated-2, Silibinin-1)
root(ROOT-0, up-regulated-2)
amod(levels-5, erk1/2-3)
compound(levels-5, protein-4)
iobj(up-regulated-2, levels-5)
dep(half-life-13, in_a-6)
amod(manner-8, time-dependent-7)
dep(half-life-13, manner-8)
cc(manner-8, and-9)
amod(protein-12, prolonged-10)
amod(protein-12, erk1/2-11)
conj:and(manner-8, protein-12)
dep(half-life-13, protein-12)
dobj(up-regulated-2, half-life-13)
case(hours-18, from-14)
compound(18-17, 10-15)
dep(18-17, to-16)
nummod(hours-18, 18-17)
nmod:from(up-regulated-2, hours-18)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN silibinin/NN on/IN the/DT regulation/NN of/IN erk1/2/JJ protein/NN levels/NNS in/IN C2C12/CD cells/NNS was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP
          (NP (NN silibinin))
          (PP (IN on)
            (NP
              (NP (DT the) (NN regulation))
              (PP (IN of)
                (NP
                  (NP (JJ erk1/2) (NN protein) (NNS levels))
                  (PP (IN in)
                    (NP (CD C2C12) (NNS cells))))))))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-20, study-3)
det(effect-6, the-5)
nsubjpass(investigated-20, effect-6)
case(silibinin-8, of-7)
nmod:of(effect-6, silibinin-8)
case(regulation-11, on-9)
det(regulation-11, the-10)
nmod:on(silibinin-8, regulation-11)
case(levels-15, of-12)
amod(levels-15, erk1/2-13)
compound(levels-15, protein-14)
nmod:of(regulation-11, levels-15)
case(cells-18, in-16)
nummod(cells-18, C2C12-17)
nmod:in(levels-15, cells-18)
auxpass(investigated-20, was-19)
root(ROOT-0, investigated-20)

When/WRB C2C12/JJ cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, silibinin/JJ up-regulated/JJ erk1/2/JJ protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ erk1/2/JJ protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (SBARQ
    (WHNP
      (WHADJP (WRB When) (JJ C2C12))
      (NNS cells))
    (SQ (VBD were)
      (VP (VBN cultured)
        (NP (NN in_a)
          (NX
            (NX
              (NX (NN medium) (VBG favoring) (NN differentiation))
              (PRN (-LRB- -LRB-)
                (NAC (NNP Dulbecco)
                  (PP (VBN modified)
                    (NP
                      (NP (NNP Eagle) (NN medium))
                      (VP (VBG containing)
                        (NP
                          (ADJP (CD 2) (NN %))
                          (NN horse) (NN serum))))))
                (-RRB- -RRB-))
              (, ,)
              (NP
                (NP (JJ silibinin) (JJ up-regulated) (JJ erk1/2) (NN protein) (NNS levels))
                (NP (NN in_a) (JJ time-dependent) (NN manner))))
            (CC and)
            (NX (JJ prolonged) (JJ erk1/2) (NN protein)))
          (NX (NN half-life)))
        (PP (IN from)
          (NP
            (QP (CD 10) (TO to) (CD 18))
            (NNS hours)))))
    (. .)))

advmod(C2C12-2, When-1)
amod(cells-3, C2C12-2)
nsubjpass(cultured-5, cells-3)
auxpass(cultured-5, were-4)
root(ROOT-0, cultured-5)
dep(half-life-34, in_a-6)
compound(differentiation-9, medium-7)
amod(differentiation-9, favoring-8)
dep(half-life-34, differentiation-9)
dep(differentiation-9, Dulbecco-11)
case(medium-14, modified-12)
compound(medium-14, Eagle-13)
nmod:modified(Dulbecco-11, medium-14)
acl(medium-14, containing-15)
compound(%-17, 2-16)
amod(serum-19, %-17)
compound(serum-19, horse-18)
dobj(containing-15, serum-19)
amod(levels-26, silibinin-22)
amod(levels-26, up-regulated-23)
amod(levels-26, erk1/2-24)
compound(levels-26, protein-25)
dep(differentiation-9, levels-26)
compound(manner-29, in_a-27)
amod(manner-29, time-dependent-28)
dep(levels-26, manner-29)
cc(differentiation-9, and-30)
amod(protein-33, prolonged-31)
amod(protein-33, erk1/2-32)
conj:and(differentiation-9, protein-33)
dep(half-life-34, protein-33)
dobj(cultured-5, half-life-34)
case(hours-39, from-35)
compound(18-38, 10-36)
dep(18-38, to-37)
nummod(hours-39, 18-38)
nmod:from(cultured-5, hours-39)

These/DT findings/NNS suggest/VBP that/IN silibinin/NN may/MD play/VB a/DT role/NN in/IN regulating/VBG the/DT differentiation/JJ process/NN of/IN C2C12/CD cells/NNS by/IN modulating/VBG the/DT expression/NN of/IN erk1/2/JJ proteins/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN silibinin))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP
                        (NP (DT the) (JJ differentiation) (NN process))
                        (PP (IN of)
                          (NP (CD C2C12) (NNS cells))))))))
              (PP (IN by)
                (S
                  (VP (VBG modulating)
                    (NP
                      (NP (DT the) (NN expression))
                      (PP (IN of)
                        (NP (JJ erk1/2) (NNS proteins))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, silibinin-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
mark(regulating-11, in-10)
acl(role-9, regulating-11)
det(process-14, the-12)
amod(process-14, differentiation-13)
dobj(regulating-11, process-14)
case(cells-17, of-15)
nummod(cells-17, C2C12-16)
nmod:of(process-14, cells-17)
mark(modulating-19, by-18)
advcl(play-7, modulating-19)
det(expression-21, the-20)
dobj(modulating-19, expression-21)
case(proteins-24, of-22)
amod(proteins-24, erk1/2-23)
nmod:of(expression-21, proteins-24)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO explore/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN silibinin/NN in/IN muscle-related_disorders/NNS such/JJ as/IN muscular_dystrophy/NN and/CC sarcopenia/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN of)
                  (NP
                    (NP (NN silibinin))
                    (PP (IN in)
                      (NP
                        (NP (NNS muscle-related_disorders))
                        (PP (JJ such) (IN as)
                          (NP (NN muscular_dystrophy)
                            (CC and)
                            (NN sarcopenia)))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(explore-6, to-5)
xcomp(warranted-4, explore-6)
det(applications-10, the-7)
amod(applications-10, potential-8)
amod(applications-10, therapeutic-9)
dobj(explore-6, applications-10)
case(silibinin-12, of-11)
nmod:of(applications-10, silibinin-12)
case(muscle-related_disorders-14, in-13)
nmod:in(silibinin-12, muscle-related_disorders-14)
case(muscular_dystrophy-17, such-15)
mwe(such-15, as-16)
nmod:such_as(muscle-related_disorders-14, muscular_dystrophy-17)
cc(muscular_dystrophy-17, and-18)
nmod:such_as(muscle-related_disorders-14, sarcopenia-19)
conj:and(muscular_dystrophy-17, sarcopenia-19)

Obesity/NNP is_a/VBZ growing/VBG global/JJ health/NN concern/NN that/WDT is/VBZ associated/VBN with/IN various/JJ metabolic_disorders/NNS ,/, including/VBG type_2_diabetes/NNS ./.

(ROOT
  (S
    (NP (NNP Obesity))
    (VP (VBZ is_a)
      (VP (VBG growing)
        (NP
          (NP (JJ global) (NN health) (NN concern))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBZ is)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (JJ various) (NNS metabolic_disorders))
                      (, ,)
                      (VP (VBG including)
                        (NP (NNS type_2_diabetes))))))))))))
    (. .)))

nsubj(is_a-2, Obesity-1)
root(ROOT-0, is_a-2)
xcomp(is_a-2, growing-3)
amod(concern-6, global-4)
compound(concern-6, health-5)
dobj(growing-3, concern-6)
nsubjpass(associated-9, concern-6)
ref(concern-6, that-7)
auxpass(associated-9, is-8)
acl:relcl(concern-6, associated-9)
case(metabolic_disorders-12, with-10)
amod(metabolic_disorders-12, various-11)
nmod:with(associated-9, metabolic_disorders-12)
acl(metabolic_disorders-12, including-14)
dobj(including-14, type_2_diabetes-15)

Glutamate/JJ receptor/NN 2Q/CD -LRB-/-LRB- GluR2Q/NNP -RRB-/-RRB- plays/VBZ an/DT important/JJ role/NN in/IN the/DT regulation/NN of/IN energy_homeostasis/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Glutamate) (NN receptor) (CD 2Q))
      (PRN (-LRB- -LRB-)
        (NP (NNP GluR2Q))
        (-RRB- -RRB-)))
    (VP (VBZ plays)
      (NP
        (NP (DT an) (JJ important) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN regulation))
            (PP (IN of)
              (NP (NNS energy_homeostasis)))))))
    (. .)))

amod(receptor-2, Glutamate-1)
nsubj(plays-7, receptor-2)
nummod(receptor-2, 2Q-3)
appos(receptor-2, GluR2Q-5)
root(ROOT-0, plays-7)
det(role-10, an-8)
amod(role-10, important-9)
dobj(plays-7, role-10)
case(regulation-13, in-11)
det(regulation-13, the-12)
nmod:in(role-10, regulation-13)
case(energy_homeostasis-15, of-14)
nmod:of(regulation-13, energy_homeostasis-15)

However/RB ,/, the/DT effects/NNS of/IN glucose/NN and/CC the/DT metabotropic_glutamate_receptor/NN agonist/NN ZJ43/NN on/IN the/DT secretion/NN of/IN GluR/NNP 2Q/CD and_insulin/VBN by/IN pancreatic/JJ tissues/NNS from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- animals/NNS have/VBP not/RB yet/RB been/VBN investigated/VBN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP
          (NP (NN glucose))
          (CC and)
          (NP
            (NP (DT the) (NN metabotropic_glutamate_receptor) (NN agonist) (NN ZJ43))
            (PP (IN on)
              (NP
                (NP (DT the) (NN secretion))
                (PP (IN of)
                  (NP (NNP GluR) (CD 2Q)))
                (VP (VBN and_insulin)
                  (PP (IN by)
                    (NP (JJ pancreatic) (NNS tissues)))
                  (PP (IN from)
                    (NP
                      (NP
                        (NP (NN genetically_obese))
                        (PRN (-LRB- -LRB-)
                          (NP (NN fa/fa))
                          (-RRB- -RRB-)))
                      (CC and)
                      (NP
                        (ADJP
                          (ADJP (JJ lean))
                          (PRN (-LRB- -LRB-)
                            (FRAG
                              (ADVP (RB Fa) (: /))
                              (. ?))
                            (-RRB- -RRB-)))
                        (NNS animals)))))))))))
    (VP (VBP have) (RB not)
      (ADVP (RB yet))
      (VP (VBN been)
        (VP (VBN investigated))))
    (. .)))

advmod(investigated-39, However-1)
det(effects-4, the-3)
nsubjpass(investigated-39, effects-4)
case(glucose-6, of-5)
nmod:of(effects-4, glucose-6)
cc(glucose-6, and-7)
det(ZJ43-11, the-8)
compound(ZJ43-11, metabotropic_glutamate_receptor-9)
compound(ZJ43-11, agonist-10)
nmod:of(effects-4, ZJ43-11)
conj:and(glucose-6, ZJ43-11)
case(secretion-14, on-12)
det(secretion-14, the-13)
nmod:on(ZJ43-11, secretion-14)
case(GluR-16, of-15)
nmod:of(secretion-14, GluR-16)
nummod(GluR-16, 2Q-17)
acl(secretion-14, and_insulin-18)
case(tissues-21, by-19)
amod(tissues-21, pancreatic-20)
nmod:by(and_insulin-18, tissues-21)
case(genetically_obese-23, from-22)
nmod:from(and_insulin-18, genetically_obese-23)
appos(genetically_obese-23, fa/fa-25)
cc(genetically_obese-23, and-27)
amod(animals-34, lean-28)
dep(lean-28, Fa-30)
nmod:from(and_insulin-18, animals-34)
conj:and(genetically_obese-23, animals-34)
aux(investigated-39, have-35)
neg(investigated-39, not-36)
advmod(investigated-39, yet-37)
auxpass(investigated-39, been-38)
root(ROOT-0, investigated-39)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT hypersecretion/NN of/IN GluR2Q/NNS by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN hypersecretion))
              (PP (IN of)
                (NP
                  (NP (NNS GluR2Q))
                  (PP (IN by)
                    (NP (DT the) (NN pancreas))))))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(involved-15, that-5)
det(hypersecretion-7, the-6)
nsubjpass(involved-15, hypersecretion-7)
case(GluR2Q-9, of-8)
nmod:of(hypersecretion-7, GluR2Q-9)
case(pancreas-12, by-10)
det(pancreas-12, the-11)
nmod:by(GluR2Q-9, pancreas-12)
aux(involved-15, may-13)
auxpass(involved-15, be-14)
ccomp(suggested-4, involved-15)
case(development-18, in-16)
det(development-18, the-17)
nmod:in(involved-15, development-18)
case(obesity-20, of-19)
nmod:of(development-18, obesity-20)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN GluR2Q/NNS by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNS GluR2Q)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(GluR2Q-20, of-19)
nmod:of(hypersecretion-18, GluR2Q-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ ZJ43/NN on/IN the/DT secretion/NN of/IN GluR2Q/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- animals/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN ZJ43)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ GluR2Q) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS animals)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(ZJ43-16, 10-14)
amod(ZJ43-16, mmol/L-15)
nmod:of(effects-8, ZJ43-16)
conj:and(glucose-12, ZJ43-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(and_insulin-22, of-20)
amod(and_insulin-22, GluR2Q-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(genetically_obese-28, from-27)
nmod:from(pancreata-26, genetically_obese-28)
appos(genetically_obese-28, fa/fa-30)
cc(genetically_obese-28, and-32)
amod(animals-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(pancreata-26, animals-39)
conj:and(genetically_obese-28, animals-39)

Our/PRP$ results/NNS showed/VBD that/IN there/EX was/VBD a/DT significant/JJ increase/NN in/IN the/DT secretion/NN of/IN GluR2Q/NNS by/IN pancreatic/JJ tissues/NNS from/IN obese/JJ animals/NNS compared/VBN to/TO lean/JJ animals/NNS ,/, in/IN response/NN to/TO both/DT glucose/NN and/CC ZJ43/NN stimulation/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (VBD was)
            (NP
              (NP (DT a) (JJ significant) (NN increase))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN secretion))
                  (PP (IN of)
                    (NP (NNS GluR2Q))))))
            (PP (IN by)
              (NP
                (NP (JJ pancreatic) (NNS tissues))
                (PP (IN from)
                  (NP (JJ obese) (NNS animals)))))
            (PP (VBN compared)
              (PP (TO to)
                (NP (JJ lean) (NNS animals))))
            (, ,)
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP (DT both)
                    (ADJP (NN glucose)
                      (CC and)
                      (NN ZJ43))
                    (NN stimulation)))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(was-6, that-4)
expl(was-6, there-5)
ccomp(showed-3, was-6)
det(increase-9, a-7)
amod(increase-9, significant-8)
nsubj(was-6, increase-9)
case(secretion-12, in-10)
det(secretion-12, the-11)
nmod:in(increase-9, secretion-12)
case(GluR2Q-14, of-13)
nmod:of(secretion-12, GluR2Q-14)
case(tissues-17, by-15)
amod(tissues-17, pancreatic-16)
nmod:by(was-6, tissues-17)
case(animals-20, from-18)
amod(animals-20, obese-19)
nmod:from(tissues-17, animals-20)
case(animals-24, compared-21)
mwe(compared-21, to-22)
amod(animals-24, lean-23)
advcl(was-6, animals-24)
case(response-27, in-26)
nmod:in(was-6, response-27)
case(stimulation-33, to-28)
det(stimulation-33, both-29)
amod(stimulation-33, glucose-30)
cc(glucose-30, and-31)
conj:and(glucose-30, ZJ43-32)
amod(stimulation-33, ZJ43-32)
nmod:to(response-27, stimulation-33)

Interestingly/RB ,/, there/EX was/VBD no/DT significant/JJ difference/NN in/IN insulin_secretion/NN between/IN obese/JJ and/CC lean/JJ animals/NNS under/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP (DT no) (JJ significant) (NN difference))
        (PP (IN in)
          (NP (NN insulin_secretion)))
        (PP (IN between)
          (NP (JJ obese)
            (CC and)
            (JJ lean) (NNS animals))))
      (PP (IN under)
        (NP (DT these) (NNS conditions))))
    (. .)))

advmod(was-4, Interestingly-1)
expl(was-4, there-3)
root(ROOT-0, was-4)
neg(difference-7, no-5)
amod(difference-7, significant-6)
nsubj(was-4, difference-7)
case(insulin_secretion-9, in-8)
nmod:in(difference-7, insulin_secretion-9)
case(animals-14, between-10)
amod(animals-14, obese-11)
cc(obese-11, and-12)
conj:and(obese-11, lean-13)
amod(animals-14, lean-13)
nmod:between(difference-7, animals-14)
case(conditions-17, under-15)
det(conditions-17, these-16)
nmod:under(was-4, conditions-17)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN GluR2Q/NNS by/IN pancreatic/JJ tissues/NNS may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ,/, independent/JJ of/IN its/PRP$ effects/NNS on/IN insulin_secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP
                (NP (NNS GluR2Q))
                (PP (IN by)
                  (NP (JJ pancreatic) (NNS tissues))))))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP
                        (NP (NN obesity))
                        (, ,)
                        (NP (JJ independent))))
                    (PP (IN of)
                      (NP
                        (NP (PRP$ its) (NNS effects))
                        (PP (IN on)
                          (NP (NN insulin_secretion)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-12, that-4)
nsubj(play-12, hypersecretion-5)
case(GluR2Q-7, of-6)
nmod:of(hypersecretion-5, GluR2Q-7)
case(tissues-10, by-8)
amod(tissues-10, pancreatic-9)
nmod:by(GluR2Q-7, tissues-10)
aux(play-12, may-11)
ccomp(suggest-3, play-12)
det(role-14, a-13)
dobj(play-12, role-14)
case(development-17, in-15)
det(development-17, the-16)
nmod:in(role-14, development-17)
case(obesity-19, of-18)
nmod:of(development-17, obesity-19)
appos(obesity-19, independent-21)
case(effects-24, of-22)
nmod:poss(effects-24, its-23)
nmod:of(development-17, effects-24)
case(insulin_secretion-26, on-25)
nmod:on(effects-24, insulin_secretion-26)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG this/DT relationship/NN and/CC its/PRP$ potential/JJ therapeutic/JJ implications/NNS for/IN obesity-related_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (NNS mechanisms))
                (PP (VBG underlying)
                  (NP
                    (NP (DT this) (NN relationship))
                    (CC and)
                    (NP
                      (NP (PRP$ its) (JJ potential) (JJ therapeutic) (NNS implications))
                      (PP (IN for)
                        (NP (NNS obesity-related_disorders))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
case(relationship-11, underlying-9)
det(relationship-11, this-10)
nmod:underlying(mechanisms-8, relationship-11)
cc(relationship-11, and-12)
nmod:poss(implications-16, its-13)
amod(implications-16, potential-14)
amod(implications-16, therapeutic-15)
nmod:underlying(mechanisms-8, implications-16)
conj:and(relationship-11, implications-16)
case(obesity-related_disorders-18, for-17)
nmod:for(implications-16, obesity-related_disorders-18)

This/DT study/NN aimed/VBN to/TO investigate/VB the/DT influence/NN of/IN serotonin/NN -LRB-/-LRB- 5-HT/CD -RRB-/-RRB- on/IN Amtyr1/NNS and/CC COOH-terminal/JJ thymol/NN extended/VBD proAmtyr1/JJ -LRB-/-LRB- Amtyr1-G/NN -RRB-/-RRB- secretion/NN ,/, biosynthesis/NNS of/IN Amtyr1/NNS and/CC Amtyr1-G/NNS ,/, as/RB well/RB as/IN the/DT effects/NNS of/IN Amtyr1-G/NNS on/IN gastric_acid/VBN secretion/NN in/IN rats/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT This) (NN study))
      (VP (VBN aimed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP
                  (NP (DT the) (NN influence))
                  (PP (IN of)
                    (NP (NN serotonin))))
                (PRN (-LRB- -LRB-)
                  (NP (CD 5-HT))
                  (-RRB- -RRB-)))
              (PP (IN on)
                (NP
                  (NP (NNS Amtyr1))
                  (CC and)
                  (NP (JJ COOH-terminal) (NN thymol)))))))))
    (VP (VBD extended)
      (NP
        (NP (JJ proAmtyr1)
          (PRN (-LRB- -LRB-)
            (NP (NN Amtyr1-G))
            (-RRB- -RRB-))
          (NN secretion))
        (, ,)
        (NP
          (NP (NNS biosynthesis))
          (PP (IN of)
            (NP (NNS Amtyr1)
              (CC and)
              (NNS Amtyr1-G))))
        (, ,)
        (CONJP (RB as) (RB well) (IN as))
        (NP
          (NP (DT the) (NNS effects))
          (PP (IN of)
            (NP (NNS Amtyr1-G)))))
      (PP (IN on)
        (NP
          (NP (VBN gastric_acid) (NN secretion))
          (PP (IN in)
            (NP (NNS rats))))))
    (. .)))

det(study-2, This-1)
nsubj(extended-18, study-2)
acl(study-2, aimed-3)
mark(investigate-5, to-4)
xcomp(aimed-3, investigate-5)
det(influence-7, the-6)
dobj(investigate-5, influence-7)
case(serotonin-9, of-8)
nmod:of(influence-7, serotonin-9)
appos(influence-7, 5-HT-11)
case(Amtyr1-14, on-13)
nmod:on(investigate-5, Amtyr1-14)
cc(Amtyr1-14, and-15)
amod(thymol-17, COOH-terminal-16)
nmod:on(investigate-5, thymol-17)
conj:and(Amtyr1-14, thymol-17)
root(ROOT-0, extended-18)
amod(secretion-23, proAmtyr1-19)
appos(secretion-23, Amtyr1-G-21)
dobj(extended-18, secretion-23)
dobj(extended-18, biosynthesis-25)
conj:and(secretion-23, biosynthesis-25)
case(Amtyr1-27, of-26)
nmod:of(biosynthesis-25, Amtyr1-27)
cc(Amtyr1-27, and-28)
nmod:of(biosynthesis-25, Amtyr1-G-29)
conj:and(Amtyr1-27, Amtyr1-G-29)
cc(secretion-23, as-31)
mwe(as-31, well-32)
mwe(as-31, as-33)
det(effects-35, the-34)
dobj(extended-18, effects-35)
conj:and(secretion-23, effects-35)
case(Amtyr1-G-37, of-36)
nmod:of(effects-35, Amtyr1-G-37)
case(secretion-40, on-38)
amod(secretion-40, gastric_acid-39)
nmod:on(extended-18, secretion-40)
case(rats-42, in-41)
nmod:in(secretion-40, rats-42)

The/DT results/NNS revealed/VBD that/IN 5-HT/CD administration/NN significantly/RB increased/VBD the/DT secretion/NN and/CC biosynthesis/NNS of/IN both/DT Amtyr1/NNS and/CC Amtyr1-G/NNS ./. Furthermore/RB ,/, administration/NN of/IN Amtyr1-G/NNS was/VBD found/VBN to/TO significantly/RB inhibit/VB gastric_acid/JJ secretion/NN in/IN rats/NNS ./.

(ROOT
  (S
    (S
      (NP (DT The) (NNS results))
      (VP (VBD revealed)
        (SBAR (IN that)
          (S
            (NP (CD 5-HT) (NN administration))
            (ADVP (RB significantly))
            (VP (VBD increased)
              (NP
                (NP (DT the) (NN secretion))
                (CC and)
                (NP
                  (NP (NNS biosynthesis))
                  (PP (IN of)
                    (NP (DT both) (NNS Amtyr1)
                      (CC and)
                      (NNS Amtyr1-G)))))))))
      (. .))
    (RB Furthermore) (, ,)
    (S
      (NP
        (NP (NN administration))
        (PP (IN of)
          (NP (NNS Amtyr1-G))))
      (VP (VBD was)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP
                (ADVP (RB significantly))
                (VB inhibit)
                (NP (JJ gastric_acid) (NN secretion))
                (PP (IN in)
                  (NP (NNS rats)))))))))
    (. .)))

det(results-2, The-1)
nsubj(revealed-3, results-2)
root(ROOT-0, revealed-3)
mark(increased-8, that-4)
nummod(administration-6, 5-HT-5)
nsubj(increased-8, administration-6)
advmod(increased-8, significantly-7)
ccomp(revealed-3, increased-8)
det(secretion-10, the-9)
dobj(increased-8, secretion-10)
cc(secretion-10, and-11)
dobj(increased-8, biosynthesis-12)
conj:and(secretion-10, biosynthesis-12)
case(Amtyr1-15, of-13)
cc:preconj(Amtyr1-15, both-14)
nmod:of(biosynthesis-12, Amtyr1-15)
cc(Amtyr1-15, and-16)
nmod:of(biosynthesis-12, Amtyr1-G-17)
conj:and(Amtyr1-15, Amtyr1-G-17)
advmod(revealed-3, Furthermore-19)
nsubjpass(found-25, administration-21)
nsubj:xsubj(inhibit-28, administration-21)
case(Amtyr1-G-23, of-22)
nmod:of(administration-21, Amtyr1-G-23)
auxpass(found-25, was-24)
parataxis(revealed-3, found-25)
mark(inhibit-28, to-26)
advmod(inhibit-28, significantly-27)
xcomp(found-25, inhibit-28)
amod(secretion-30, gastric_acid-29)
dobj(inhibit-28, secretion-30)
case(rats-32, in-31)
nmod:in(inhibit-28, rats-32)

The/DT effects/NNS of/IN serotonin/NN -LRB-/-LRB- 5-HT/CD -RRB-/-RRB- on/IN Amtyr1/NNS and/CC COOH-terminal/JJ thymol/NN extended/VBD proAmtyr1/JJ -LRB-/-LRB- Amtyr1-G/NN -RRB-/-RRB- secretion/NN ,/, biosynthesis/NNS of/IN Amtyr1/NNS and/CC Amtyr1-G/NNS ,/, and/CC the/DT effects/NNS of/IN Amtyr1-G/NNS on/IN gastric_acid/JJ secretion/NN were/VBD examined/VBN in/IN rats/NNS ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS effects))
        (PP (IN of)
          (NP
            (NP
              (NP (NN serotonin))
              (PRN (-LRB- -LRB-)
                (NP (CD 5-HT))
                (-RRB- -RRB-)))
            (PP (IN on)
              (NP
                (NP (NNS Amtyr1))
                (CC and)
                (NP (JJ COOH-terminal) (NN thymol)))))))
      (VP (VBD extended)
        (NP
          (NP (JJ proAmtyr1)
            (PRN (-LRB- -LRB-)
              (NP (NN Amtyr1-G))
              (-RRB- -RRB-))
            (NN secretion))
          (, ,)
          (NP
            (NP (NNS biosynthesis))
            (PP (IN of)
              (NP (NNS Amtyr1)
                (CC and)
                (NNS Amtyr1-G)))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (NNS Amtyr1-G))
            (PP (IN on)
              (NP (JJ gastric_acid) (NN secretion))))))
      (VP (VBD were)
        (VP (VBN examined)
          (PP (IN in)
            (NP (NNS rats))))))
    (. .)))

det(effects-2, The-1)
nsubj(extended-13, effects-2)
case(serotonin-4, of-3)
nmod:of(effects-2, serotonin-4)
appos(serotonin-4, 5-HT-6)
case(Amtyr1-9, on-8)
nmod:on(serotonin-4, Amtyr1-9)
cc(Amtyr1-9, and-10)
amod(thymol-12, COOH-terminal-11)
nmod:on(serotonin-4, thymol-12)
conj:and(Amtyr1-9, thymol-12)
root(ROOT-0, extended-13)
amod(secretion-18, proAmtyr1-14)
appos(secretion-18, Amtyr1-G-16)
dobj(extended-13, secretion-18)
appos(secretion-18, biosynthesis-20)
case(Amtyr1-22, of-21)
nmod:of(biosynthesis-20, Amtyr1-22)
cc(Amtyr1-22, and-23)
nmod:of(biosynthesis-20, Amtyr1-G-24)
conj:and(Amtyr1-22, Amtyr1-G-24)
cc(extended-13, and-26)
det(effects-28, the-27)
nsubjpass(examined-35, effects-28)
case(Amtyr1-G-30, of-29)
nmod:of(effects-28, Amtyr1-G-30)
case(secretion-33, on-31)
amod(secretion-33, gastric_acid-32)
nmod:on(Amtyr1-G-30, secretion-33)
auxpass(examined-35, were-34)
conj:and(extended-13, examined-35)
case(rats-37, in-36)
nmod:in(examined-35, rats-37)

Therefore/RB ,/, targeting/VBG the/DT 5-HT-Amtyr/JJ signaling/VBG pathway/NN may/MD offer/VB a/DT potential/JJ therapeutic/JJ approach/NN for/IN the/DT treatment/NN of/IN acid-related/JJ gastrointestinal_disorders/NNS ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (S
      (VP (VBG targeting)
        (NP (DT the) (JJ 5-HT-Amtyr) (VBG signaling) (NN pathway))))
    (VP (MD may)
      (VP (VB offer)
        (NP (DT a) (JJ potential) (JJ therapeutic) (NN approach))
        (PP (IN for)
          (NP
            (NP (DT the) (NN treatment))
            (PP (IN of)
              (NP (JJ acid-related) (NNS gastrointestinal_disorders)))))))
    (. .)))

advmod(offer-9, Therefore-1)
csubj(offer-9, targeting-3)
det(pathway-7, the-4)
amod(pathway-7, 5-HT-Amtyr-5)
amod(pathway-7, signaling-6)
dobj(targeting-3, pathway-7)
aux(offer-9, may-8)
root(ROOT-0, offer-9)
det(approach-13, a-10)
amod(approach-13, potential-11)
amod(approach-13, therapeutic-12)
dobj(offer-9, approach-13)
case(treatment-16, for-14)
det(treatment-16, the-15)
nmod:for(offer-9, treatment-16)
case(gastrointestinal_disorders-19, of-17)
amod(gastrointestinal_disorders-19, acid-related-18)
nmod:of(treatment-16, gastrointestinal_disorders-19)

Calcitonin_gene-related_peptide-11/JJ -LRB-/-LRB- CPT-11/NNP -RRB-/-RRB- has_been/NNS proposed/VBD to/TO play/VB a/DT role/NN in/IN the/DT pathogenesis/NNS of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Calcitonin_gene-related_peptide-11)
      (PRN (-LRB- -LRB-)
        (NP (NNP CPT-11))
        (-RRB- -RRB-))
      (NNS has_been))
    (VP (VBD proposed)
      (S
        (VP (TO to)
          (VP (VB play)
            (NP
              (NP (DT a) (NN role))
              (PP (IN in)
                (NP
                  (NP (DT the) (NNS pathogenesis))
                  (PP (IN of)
                    (NP (NN obesity))))))))))
    (. .)))

amod(has_been-5, Calcitonin_gene-related_peptide-11-1)
appos(has_been-5, CPT-11-3)
nsubj(proposed-6, has_been-5)
nsubj:xsubj(play-8, has_been-5)
root(ROOT-0, proposed-6)
mark(play-8, to-7)
xcomp(proposed-6, play-8)
det(role-10, a-9)
dobj(play-8, role-10)
case(pathogenesis-13, in-11)
det(pathogenesis-13, the-12)
nmod:in(role-10, pathogenesis-13)
case(obesity-15, of-14)
nmod:of(pathogenesis-13, obesity-15)

In/IN this/DT study/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN glucose/NN and/CC saintopin/NN on/IN the/DT secretion/NN of/IN COT-11/JJ and_insulin/NN by/IN isolated/JJ perfused/JJ pancreata/NN from/IN genetically_obese/JJ -LRB-/-LRB- fa/fa/NNS -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- animals/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NN glucose)
            (CC and)
            (NN saintopin)))
        (PP (IN on)
          (NP
            (NP (DT the) (NN secretion))
            (PP (IN of)
              (NP (JJ COT-11) (NN and_insulin))))))
      (PP (IN by)
        (NP (JJ isolated) (JJ perfused) (NN pancreata)))
      (PP (IN from)
        (NP
          (NP (JJ genetically_obese) (-LRB- -LRB-) (NNS fa/fa) (-RRB- -RRB-))
          (CC and)
          (NP
            (ADJP
              (ADJP (JJ lean))
              (PRN (-LRB- -LRB-)
                (FRAG
                  (ADVP (RB Fa) (: /))
                  (. ?))
                (-RRB- -RRB-)))
            (NNS animals)))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(examined-6, study-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-10, of-9)
nmod:of(effects-8, glucose-10)
cc(glucose-10, and-11)
nmod:of(effects-8, saintopin-12)
conj:and(glucose-10, saintopin-12)
case(secretion-15, on-13)
det(secretion-15, the-14)
nmod:on(effects-8, secretion-15)
case(and_insulin-18, of-16)
amod(and_insulin-18, COT-11-17)
nmod:of(secretion-15, and_insulin-18)
case(pancreata-22, by-19)
amod(pancreata-22, isolated-20)
amod(pancreata-22, perfused-21)
nmod:by(examined-6, pancreata-22)
case(fa/fa-26, from-23)
amod(fa/fa-26, genetically_obese-24)
nmod:from(examined-6, fa/fa-26)
cc(fa/fa-26, and-28)
amod(animals-35, lean-29)
dep(lean-29, Fa-31)
nmod:from(examined-6, animals-35)
conj:and(fa/fa-26, animals-35)

-LRB-/JJ -RRB-/-RRB- There/EX is_a/FW high/JJ prevalence/NN of/IN obesity/NN in/IN the/DT United_States/NNP and/CC Europe/NNP ./.

(ROOT
  (S
    (LST (JJ -LRB-))
    (-RRB- -RRB-)
    (NP (EX There))
    (VP
      (NP (FW is_a))
      (NP
        (NP (JJ high) (NN prevalence))
        (PP (IN of)
          (NP (NN obesity))))
      (PP (IN in)
        (NP (DT the) (NNP United_States)
          (CC and)
          (NNP Europe))))
    (. .)))

dep(is_a-4, -LRB--1)
expl(is_a-4, There-3)
root(ROOT-0, is_a-4)
amod(prevalence-6, high-5)
dobj(is_a-4, prevalence-6)
case(obesity-8, of-7)
nmod:of(prevalence-6, obesity-8)
case(United_States-11, in-9)
det(United_States-11, the-10)
nmod:in(is_a-4, United_States-11)
cc(United_States-11, and-12)
nmod:in(is_a-4, Europe-13)
conj:and(United_States-11, Europe-13)

-LRB-/-LRB- 1/CD -RRB-/-RRB- -LRB-/-LRB- 2/CD -RRB-/-RRB- -LRB-/-LRB- 3/CD -RRB-/-RRB- -LRB-/-LRB- 4/CD -RRB-/-RRB- -LRB-/-LRB- 5/CD -RRB-/-RRB- -LRB-/-LRB- 6/CD -RRB-/-RRB- -LRB-/-LRB- 7/CD -RRB-/-RRB- -LRB-/-LRB- 8/CD -RRB-/-RRB- -LRB-/-LRB- 10/CD -RRB-/-RRB- -LRB-/-LRB- 11/CD -RRB-/-RRB- -LRB-/-LRB- 12/CD -RRB-/-RRB- -LRB-/-LRB- 13/CD -RRB-/-RRB- -LRB-/-LRB- 14/CD -RRB-/-RRB- -LRB-/-LRB- 15/CD -RRB-/-RRB- -LRB-/-LRB- 16/CD -RRB-/-RRB- -LRB-/-LRB- 17/CD -RRB-/-RRB- -LRB-/-LRB- 18/CD -RRB-/-RRB- -LRB-/-LRB- 19/CD -RRB-/-RRB- -LRB-/-LRB- 20/CD -RRB-/-RRB- -LRB-/-LRB- 21/CD -RRB-/-RRB- -LRB-/-LRB- 22/CD -RRB-/-RRB- -LRB-/-LRB- 23/CD -RRB-/-RRB- -LRB-/-LRB- 24/CD -RRB-/-RRB- -LRB-/-LRB- 25/CD -RRB-/-RRB- -LRB-/-LRB- 26/CD -RRB-/-RRB- -LRB-/-LRB- 27/CD -RRB-/-RRB- -LRB-/-LRB- 28/CD -RRB-/-RRB- -LRB-/-LRB- 29/CD -RRB-/-RRB- -LRB-/-LRB- Figure/NNP -RRB-/-RRB- ./.

(ROOT
  (NP
    (NP
      (NP
        (NP
          (NP
            (NP
              (NP
                (NP
                  (NP
                    (NP
                      (NP
                        (NP
                          (NP
                            (NP
                              (NP
                                (NP
                                  (NP
                                    (NP
                                      (NP
                                        (NP
                                          (NP
                                            (NP
                                              (NP
                                                (NP
                                                  (NP
                                                    (NP
                                                      (NP
                                                        (NP
                                                          (NP
                                                            (NP (-LRB- -LRB-)
                                                              (QP (CD 1))
                                                              (-RRB- -RRB-))
                                                            (PRN (-LRB- -LRB-)
                                                              (NP (CD 2))
                                                              (-RRB- -RRB-)))
                                                          (PRN (-LRB- -LRB-)
                                                            (NP (CD 3))
                                                            (-RRB- -RRB-)))
                                                        (PRN (-LRB- -LRB-)
                                                          (NP (CD 4))
                                                          (-RRB- -RRB-)))
                                                      (PRN (-LRB- -LRB-)
                                                        (NP (CD 5))
                                                        (-RRB- -RRB-)))
                                                    (PRN (-LRB- -LRB-)
                                                      (NP (CD 6))
                                                      (-RRB- -RRB-)))
                                                  (PRN (-LRB- -LRB-)
                                                    (NP (CD 7))
                                                    (-RRB- -RRB-)))
                                                (PRN (-LRB- -LRB-)
                                                  (NP (CD 8))
                                                  (-RRB- -RRB-)))
                                              (PRN (-LRB- -LRB-)
                                                (NP (CD 10))
                                                (-RRB- -RRB-)))
                                            (PRN (-LRB- -LRB-)
                                              (NP (CD 11))
                                              (-RRB- -RRB-)))
                                          (PRN (-LRB- -LRB-)
                                            (NP (CD 12))
                                            (-RRB- -RRB-)))
                                        (PRN (-LRB- -LRB-)
                                          (NP (CD 13))
                                          (-RRB- -RRB-)))
                                      (PRN (-LRB- -LRB-)
                                        (NP (CD 14))
                                        (-RRB- -RRB-)))
                                    (PRN (-LRB- -LRB-)
                                      (NP (CD 15))
                                      (-RRB- -RRB-)))
                                  (PRN (-LRB- -LRB-)
                                    (NP (CD 16))
                                    (-RRB- -RRB-)))
                                (PRN (-LRB- -LRB-)
                                  (NP (CD 17))
                                  (-RRB- -RRB-)))
                              (PRN (-LRB- -LRB-)
                                (NP (CD 18))
                                (-RRB- -RRB-)))
                            (PRN (-LRB- -LRB-)
                              (NP (CD 19))
                              (-RRB- -RRB-)))
                          (PRN (-LRB- -LRB-)
                            (NP (CD 20))
                            (-RRB- -RRB-)))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 21))
                          (-RRB- -RRB-)))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 22))
                        (-RRB- -RRB-)))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 23))
                      (-RRB- -RRB-)))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 24))
                    (-RRB- -RRB-)))
                (PRN (-LRB- -LRB-)
                  (NP (CD 25))
                  (-RRB- -RRB-)))
              (PRN (-LRB- -LRB-)
                (NP (CD 26))
                (-RRB- -RRB-)))
            (PRN (-LRB- -LRB-)
              (NP (CD 27))
              (-RRB- -RRB-)))
          (PRN (-LRB- -LRB-)
            (NP (CD 28))
            (-RRB- -RRB-)))
        (PRN (-LRB- -LRB-)
          (NP (CD 29))
          (-RRB- -RRB-)))
      (PRN (-LRB- -LRB-)
        (NP (NNP Figure))
        (-RRB- -RRB-)))
    (. .)))

root(ROOT-0, 1-2)
appos(1-2, 2-5)
appos(1-2, 3-8)
appos(1-2, 4-11)
appos(1-2, 5-14)
appos(1-2, 6-17)
appos(1-2, 7-20)
appos(1-2, 8-23)
appos(1-2, 10-26)
appos(1-2, 11-29)
appos(1-2, 12-32)
appos(1-2, 13-35)
appos(1-2, 14-38)
appos(1-2, 15-41)
appos(1-2, 16-44)
appos(1-2, 17-47)
appos(1-2, 18-50)
appos(1-2, 19-53)
appos(1-2, 20-56)
appos(1-2, 21-59)
appos(1-2, 22-62)
appos(1-2, 23-65)
appos(1-2, 24-68)
appos(1-2, 25-71)
appos(1-2, 26-74)
appos(1-2, 27-77)
appos(1-2, 28-80)
appos(1-2, 29-83)
appos(1-2, Figure-86)

One/CD potential/JJ factor/NN that/WDT has_been/VBP proposed/VBN to/TO contribute/VB to/TO the/DT development/NN of/IN obesity/NN is/VBZ the/DT hypersecretion/NN of/IN CPT-11/NN by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (NP (CD One) (JJ potential) (NN factor)
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBP has_been)
            (VP (VBN proposed)
              (S
                (VP (TO to)
                  (VP (VB contribute)
                    (PP (TO to)
                      (NP
                        (NP (DT the) (NN development))
                        (PP (IN of)
                          (NP (NN obesity)))))))))))))
    (VP (VBZ is)
      (NP
        (NP (DT the) (NN hypersecretion))
        (PP (IN of)
          (NP (NN CPT-11))))
      (PP (IN by)
        (NP (DT the) (NN pancreas))))
    (. .)))

nummod(factor-3, One-1)
amod(factor-3, potential-2)
nsubj(hypersecretion-16, factor-3)
nsubj(has_been-5, that-4)
ccomp(factor-3, has_been-5)
dep(has_been-5, proposed-6)
mark(contribute-8, to-7)
xcomp(proposed-6, contribute-8)
case(development-11, to-9)
det(development-11, the-10)
nmod:to(contribute-8, development-11)
case(obesity-13, of-12)
nmod:of(development-11, obesity-13)
cop(hypersecretion-16, is-14)
det(hypersecretion-16, the-15)
root(ROOT-0, hypersecretion-16)
case(CPT-11-18, of-17)
nmod:of(hypersecretion-16, CPT-11-18)
case(pancreas-21, by-19)
det(pancreas-21, the-20)
nmod:by(hypersecretion-16, pancreas-21)

In/IN this/DT study/NN ,/, we/PRP aimed/VBN to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC CPT-11/NN hypersecretion/NN by/IN examining/VBG the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ saintopin/NN on/IN the/DT secretion/NN of/IN CPT-11/NN and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- animals/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBN aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity)
                      (CC and)
                      (NN CPT-11) (NN hypersecretion))))))
            (PP (IN by)
              (S
                (VP (VBG examining)
                  (NP
                    (NP (DT the) (NNS effects))
                    (PP (IN of)
                      (NP
                        (NP (CD 16.7) (JJ mmol/L) (NN glucose))
                        (CC and)
                        (NP (CD 10) (JJ mmol/L) (NN saintopin)))))
                  (PP (IN on)
                    (NP
                      (NP (DT the) (NN secretion))
                      (PP (IN of)
                        (NP (NN CPT-11) (NN and_insulin))))))))
            (PP (IN by)
              (NP (VBN isolated) (JJ perfused) (NN pancreata))))))
      (PP (IN from)
        (NP
          (NP
            (NP (NN genetically_obese))
            (PRN (-LRB- -LRB-)
              (NP (NN fa/fa))
              (-RRB- -RRB-)))
          (CC and)
          (NP
            (ADJP
              (ADJP (JJ lean))
              (PRN (-LRB- -LRB-)
                (FRAG
                  (ADVP (RB Fa) (: /))
                  (. ?))
                (-RRB- -RRB-)))
            (NNS animals)))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(hypersecretion-18, of-14)
compound(hypersecretion-18, obesity-15)
cc(obesity-15, and-16)
conj:and(obesity-15, CPT-11-17)
compound(hypersecretion-18, CPT-11-17)
nmod:of(development-13, hypersecretion-18)
mark(examining-20, by-19)
advcl(evaluate-8, examining-20)
det(effects-22, the-21)
dobj(examining-20, effects-22)
case(glucose-26, of-23)
nummod(glucose-26, 16.7-24)
amod(glucose-26, mmol/L-25)
nmod:of(effects-22, glucose-26)
cc(glucose-26, and-27)
nummod(saintopin-30, 10-28)
amod(saintopin-30, mmol/L-29)
nmod:of(effects-22, saintopin-30)
conj:and(glucose-26, saintopin-30)
case(secretion-33, on-31)
det(secretion-33, the-32)
nmod:on(examining-20, secretion-33)
case(and_insulin-36, of-34)
compound(and_insulin-36, CPT-11-35)
nmod:of(secretion-33, and_insulin-36)
case(pancreata-40, by-37)
amod(pancreata-40, isolated-38)
amod(pancreata-40, perfused-39)
nmod:by(evaluate-8, pancreata-40)
case(genetically_obese-42, from-41)
nmod:from(aimed-6, genetically_obese-42)
appos(genetically_obese-42, fa/fa-44)
cc(genetically_obese-42, and-46)
amod(animals-53, lean-47)
dep(lean-47, Fa-49)
nmod:from(aimed-6, animals-53)
conj:and(genetically_obese-42, animals-53)

Our/PRP$ results/NNS showed/VBD that/IN there/EX was/VBD a/DT significant/JJ increase/NN in/IN CPT-11/JJ secretion/NN in/IN response/NN to/TO glucose/NN stimulation/NN in/IN both/DT obese/NN and/CC lean/JJ animals/NNS ,/, but/CC there/EX was/VBD no/DT significant/JJ difference/NN in/IN CPT-11/JJ secretion/NN between/IN these/DT groups/NNS ./.

(ROOT
  (S
    (S
      (NP (PRP$ Our) (NNS results))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP (EX there))
            (VP (VBD was)
              (NP
                (NP (DT a) (JJ significant) (NN increase))
                (PP (IN in)
                  (NP (JJ CPT-11) (NN secretion))))
              (PP (IN in)
                (NP
                  (NP (NN response))
                  (PP (TO to)
                    (NP (NN glucose) (NN stimulation)))))
              (PP (IN in)
                (NP
                  (NP (DT both) (NN obese))
                  (CC and)
                  (NP (JJ lean) (NNS animals)))))))))
    (, ,)
    (CC but)
    (S
      (NP (EX there))
      (VP (VBD was)
        (NP
          (NP (DT no) (JJ significant) (NN difference))
          (PP (IN in)
            (NP (JJ CPT-11) (NN secretion)))
          (PP (IN between)
            (NP (DT these) (NNS groups))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(was-6, that-4)
expl(was-6, there-5)
ccomp(showed-3, was-6)
det(increase-9, a-7)
amod(increase-9, significant-8)
nsubj(was-6, increase-9)
case(secretion-12, in-10)
amod(secretion-12, CPT-11-11)
nmod:in(increase-9, secretion-12)
case(response-14, in-13)
nmod:in(was-6, response-14)
case(stimulation-17, to-15)
compound(stimulation-17, glucose-16)
nmod:to(response-14, stimulation-17)
case(obese-20, in-18)
det(obese-20, both-19)
nmod:in(was-6, obese-20)
cc(obese-20, and-21)
amod(animals-23, lean-22)
nmod:in(was-6, animals-23)
conj:and(obese-20, animals-23)
cc(showed-3, but-25)
expl(was-27, there-26)
conj:but(showed-3, was-27)
neg(difference-30, no-28)
amod(difference-30, significant-29)
nsubj(was-27, difference-30)
case(secretion-33, in-31)
amod(secretion-33, CPT-11-32)
nmod:in(difference-30, secretion-33)
case(groups-36, between-34)
det(groups-36, these-35)
nmod:between(difference-30, groups-36)

However/RB ,/, we/PRP observed/VBD a/DT significant/JJ decrease/NN in/IN insulin_secretion/NN in/IN response/NN to/TO glucose/NN stimulation/NN in/IN obese/JJ animals/NNS compared/VBN to/TO lean/JJ animals/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP (DT a) (JJ significant) (NN decrease))
        (PP (IN in)
          (NP (NN insulin_secretion))))
      (PP (IN in)
        (NP
          (NP (NN response))
          (PP (TO to)
            (NP
              (NP (NN glucose) (NN stimulation))
              (PP (IN in)
                (NP (JJ obese) (NNS animals)))))))
      (PP (VBN compared)
        (PP (TO to)
          (NP (JJ lean) (NNS animals)))))
    (. .)))

advmod(observed-4, However-1)
nsubj(observed-4, we-3)
root(ROOT-0, observed-4)
det(decrease-7, a-5)
amod(decrease-7, significant-6)
dobj(observed-4, decrease-7)
case(insulin_secretion-9, in-8)
nmod:in(decrease-7, insulin_secretion-9)
case(response-11, in-10)
nmod:in(observed-4, response-11)
case(stimulation-14, to-12)
compound(stimulation-14, glucose-13)
nmod:to(response-11, stimulation-14)
case(animals-17, in-15)
amod(animals-17, obese-16)
nmod:in(stimulation-14, animals-17)
case(animals-21, compared-18)
mwe(compared-18, to-19)
amod(animals-21, lean-20)
advcl(observed-4, animals-21)

These/DT findings/NNS suggest/VBP that/IN while/IN CPT-11/JJ secretion/NN may/MD not/RB be/VB directly/RB related/VBN to/TO the/DT development/NN of/IN obesity/NN ,/, alterations/NNS in/IN insulin_secretion/NN may/MD play/VB a/DT role/NN in/IN this/DT process/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (SBAR (IN while)
            (S
              (NP (JJ CPT-11) (NN secretion))
              (VP (MD may) (RB not)
                (VP (VB be)
                  (VP
                    (ADVP (RB directly))
                    (VBN related)
                    (PP (TO to)
                      (NP
                        (NP (DT the) (NN development))
                        (PP (IN of)
                          (NP (NN obesity))))))))))
          (, ,)
          (NP
            (NP (NNS alterations))
            (PP (IN in)
              (NP (NN insulin_secretion))))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP (DT this) (NN process)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-23, that-4)
mark(related-12, while-5)
amod(secretion-7, CPT-11-6)
nsubjpass(related-12, secretion-7)
aux(related-12, may-8)
neg(related-12, not-9)
auxpass(related-12, be-10)
advmod(related-12, directly-11)
advcl(play-23, related-12)
case(development-15, to-13)
det(development-15, the-14)
nmod:to(related-12, development-15)
case(obesity-17, of-16)
nmod:of(development-15, obesity-17)
nsubj(play-23, alterations-19)
case(insulin_secretion-21, in-20)
nmod:in(alterations-19, insulin_secretion-21)
aux(play-23, may-22)
ccomp(suggest-3, play-23)
det(role-25, a-24)
dobj(play-23, role-25)
case(process-28, in-26)
det(process-28, this-27)
nmod:in(role-25, process-28)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT observations/NNS and/CC their/PRP$ potential/JJ implications/NNS for/IN the/DT prevention/NN and/CC treatment/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (NNS mechanisms))
                (PP (VBG underlying)
                  (NP
                    (NP (DT these) (NNS observations))
                    (CC and)
                    (NP
                      (NP (PRP$ their) (JJ potential) (NNS implications))
                      (PP (IN for)
                        (NP
                          (NP (DT the) (NN prevention)
                            (CC and)
                            (NN treatment))
                          (PP (IN of)
                            (NP (NN obesity))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
case(observations-11, underlying-9)
det(observations-11, these-10)
nmod:underlying(mechanisms-8, observations-11)
cc(observations-11, and-12)
nmod:poss(implications-15, their-13)
amod(implications-15, potential-14)
nmod:underlying(mechanisms-8, implications-15)
conj:and(observations-11, implications-15)
case(prevention-18, for-16)
det(prevention-18, the-17)
nmod:for(implications-15, prevention-18)
cc(prevention-18, and-19)
nmod:for(implications-15, treatment-20)
conj:and(prevention-18, treatment-20)
case(obesity-22, of-21)
nmod:of(prevention-18, obesity-22)

To/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN Hand_2/NNS by/IN the/DT pancreas/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ FK778/NN on/IN the/DT secretion/NN of/IN Hand_2/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/NNP //: ?/. -RRB-/-RRB-

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP
            (NP (DT the) (NN relationship))
            (PP (IN between)
              (NP
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity))))
                (CC and)
                (NP
                  (NP (DT the) (NN hypersecretion))
                  (PP (IN of)
                    (NP (NNS Hand_2)))))))
          (PP (IN by)
            (NP (DT the) (NN pancreas))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN FK778)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ Hand_2) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated)
            (NX
              (NX
                (NX
                  (NX (JJ perfused) (NN pancreata))
                  (PP (IN from)
                    (NP (NN genetically_obese))))
                (PRN (-LRB- -LRB-) (NN fa/fa) (-RRB- -RRB-)))
              (CC and)
              (NX (JJ lean))))
          (-LRB- -LRB-)
          (NP (NNP Fa))
          (: /))))
    (. ?) (-RRB- -RRB-)))

mark(evaluate-2, To-1)
advcl(examined-20, evaluate-2)
det(relationship-4, the-3)
dobj(evaluate-2, relationship-4)
case(development-7, between-5)
det(development-7, the-6)
nmod:between(relationship-4, development-7)
case(obesity-9, of-8)
nmod:of(development-7, obesity-9)
cc(development-7, and-10)
det(hypersecretion-12, the-11)
nmod:between(relationship-4, hypersecretion-12)
conj:and(development-7, hypersecretion-12)
case(Hand_2-14, of-13)
nmod:of(hypersecretion-12, Hand_2-14)
case(pancreas-17, by-15)
det(pancreas-17, the-16)
nmod:by(evaluate-2, pancreas-17)
nsubj(examined-20, we-19)
root(ROOT-0, examined-20)
det(effects-22, the-21)
dobj(examined-20, effects-22)
case(glucose-26, of-23)
nummod(glucose-26, 16.7-24)
amod(glucose-26, mmol/L-25)
nmod:of(effects-22, glucose-26)
cc(glucose-26, and-27)
nummod(FK778-30, 10-28)
amod(FK778-30, mmol/L-29)
nmod:of(effects-22, FK778-30)
conj:and(glucose-26, FK778-30)
case(secretion-33, on-31)
det(secretion-33, the-32)
nmod:on(examined-20, secretion-33)
case(and_insulin-36, of-34)
amod(and_insulin-36, Hand_2-35)
nmod:of(secretion-33, and_insulin-36)
case(pancreata-40, by-37)
amod(pancreata-40, isolated-38)
amod(pancreata-40, perfused-39)
nmod:by(examined-20, pancreata-40)
case(genetically_obese-42, from-41)
nmod:from(pancreata-40, genetically_obese-42)
dep(pancreata-40, fa/fa-44)
cc(pancreata-40, and-46)
nmod:by(examined-20, lean-47)
conj:and(pancreata-40, lean-47)
dep(pancreata-40, Fa-49)

The/DT pancreas/NN plays/VBZ a/DT crucial/JJ role/NN in/IN regulating/VBG glucose_metabolism/NN by/IN secreting/VBG insulin/NN and/CC other/JJ hormones/NNS ,/, such/JJ as/IN Hand_2/NNS ./.

(ROOT
  (S
    (NP (DT The) (NN pancreas))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (S
            (VP (VBG regulating)
              (NP (NN glucose_metabolism))
              (PP (IN by)
                (S
                  (VP (VBG secreting)
                    (NP
                      (NP (NN insulin))
                      (CC and)
                      (NP
                        (NP (JJ other) (NNS hormones))
                        (, ,)
                        (PP (JJ such) (IN as)
                          (NP (NNS Hand_2)))))))))))))
    (. .)))

det(pancreas-2, The-1)
nsubj(plays-3, pancreas-2)
root(ROOT-0, plays-3)
det(role-6, a-4)
amod(role-6, crucial-5)
dobj(plays-3, role-6)
mark(regulating-8, in-7)
acl(role-6, regulating-8)
dobj(regulating-8, glucose_metabolism-9)
mark(secreting-11, by-10)
advcl(regulating-8, secreting-11)
dobj(secreting-11, insulin-12)
cc(insulin-12, and-13)
amod(hormones-15, other-14)
dobj(secreting-11, hormones-15)
conj:and(insulin-12, hormones-15)
case(Hand_2-19, such-17)
mwe(such-17, as-18)
nmod:such_as(hormones-15, Hand_2-19)

Hypersecretion/NN of/IN Hand_2/NNS by/IN the/DT pancreas/NN has_been/VBP implicated/VBN in/IN the/DT development/NN of/IN obesity/NN and/CC its/PRP$ associated/VBN complications/NNS ./.

(ROOT
  (S
    (NP
      (NP (NN Hypersecretion))
      (PP (IN of)
        (NP
          (NP (NNS Hand_2))
          (PP (IN by)
            (NP (DT the) (NN pancreas))))))
    (VP (VBP has_been)
      (VP (VBN implicated)
        (PP (IN in)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP
                (NP (NN obesity))
                (CC and)
                (NP (PRP$ its) (VBN associated) (NNS complications))))))))
    (. .)))

nsubj(has_been-7, Hypersecretion-1)
case(Hand_2-3, of-2)
nmod:of(Hypersecretion-1, Hand_2-3)
case(pancreas-6, by-4)
det(pancreas-6, the-5)
nmod:by(Hand_2-3, pancreas-6)
root(ROOT-0, has_been-7)
dep(has_been-7, implicated-8)
case(development-11, in-9)
det(development-11, the-10)
nmod:in(implicated-8, development-11)
case(obesity-13, of-12)
nmod:of(development-11, obesity-13)
cc(obesity-13, and-14)
nmod:poss(complications-17, its-15)
amod(complications-17, associated-16)
nmod:of(development-11, complications-17)
conj:and(obesity-13, complications-17)

To/TO evaluate/VB this/DT relationship/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ FK778/NN on/IN the/DT secretion/NN of/IN Hand_2/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP (DT this) (NN relationship)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN FK778)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ Hand_2) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(evaluate-2, To-1)
advcl(examined-7, evaluate-2)
det(relationship-4, this-3)
dobj(evaluate-2, relationship-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(FK778-17, 10-15)
amod(FK778-17, mmol/L-16)
nmod:of(effects-9, FK778-17)
conj:and(glucose-13, FK778-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(examined-7, secretion-20)
case(and_insulin-23, of-21)
amod(and_insulin-23, Hand_2-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(pancreata-27, genetically_obese-29)
appos(genetically_obese-29, fa/fa-31)
cc(genetically_obese-29, and-33)
amod(rats-40, lean-34)
dep(lean-34, Fa-36)
nmod:from(pancreata-27, rats-40)
conj:and(genetically_obese-29, rats-40)

Our/PRP$ results/NNS showed/VBD that/IN hypersecretion/NN of/IN Hand_2/NNS was/VBD observed/VBN in/IN response/NN to/TO high/JJ glucose/NN concentration/NN in/IN both/DT obese/JJ and/CC lean/JJ rats/NNS ,/, but/CC it/PRP was/VBD significantly/RB higher/JJR in/IN the/DT obese/JJ rats/NNS ./.

(ROOT
  (S
    (S
      (NP (PRP$ Our) (NNS results))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN hypersecretion))
              (PP (IN of)
                (NP (NNS Hand_2))))
            (VP (VBD was)
              (VP (VBN observed)
                (PP (IN in)
                  (NP
                    (NP (NN response))
                    (PP (TO to)
                      (NP (JJ high) (NN glucose) (NN concentration)))))
                (PP (IN in)
                  (NP (DT both) (JJ obese)
                    (CC and)
                    (JJ lean) (NNS rats)))))))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBD was)
        (ADJP
          (ADJP (RB significantly) (JJR higher))
          (PP (IN in)
            (NP (DT the) (JJ obese) (NNS rats))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(observed-9, that-4)
nsubjpass(observed-9, hypersecretion-5)
case(Hand_2-7, of-6)
nmod:of(hypersecretion-5, Hand_2-7)
auxpass(observed-9, was-8)
ccomp(showed-3, observed-9)
case(response-11, in-10)
nmod:in(observed-9, response-11)
case(concentration-15, to-12)
amod(concentration-15, high-13)
compound(concentration-15, glucose-14)
nmod:to(response-11, concentration-15)
case(rats-21, in-16)
det(rats-21, both-17)
amod(rats-21, obese-18)
cc(obese-18, and-19)
conj:and(obese-18, lean-20)
amod(rats-21, lean-20)
nmod:in(observed-9, rats-21)
cc(showed-3, but-23)
nsubj(higher-27, it-24)
cop(higher-27, was-25)
advmod(higher-27, significantly-26)
conj:but(showed-3, higher-27)
case(rats-31, in-28)
det(rats-31, the-29)
amod(rats-31, obese-30)
nmod:in(higher-27, rats-31)

Treatment/NNP with/IN FK778/NNP ,/, a/DT selective/JJ inhibitor/NN of/IN Hand_2/JJ expression/NN ,/, resulted/VBD in_a/JJ significant/JJ decrease/NN in/IN Hand_2/JJ secretion/NN in/IN both/DT groups/NNS ./.

(ROOT
  (S
    (NP
      (NP
        (NP (NNP Treatment))
        (PP (IN with)
          (NP (NNP FK778))))
      (, ,)
      (NP
        (NP (DT a) (JJ selective) (NN inhibitor))
        (PP (IN of)
          (NP (JJ Hand_2) (NN expression))))
      (, ,))
    (VP (VBD resulted)
      (NP
        (NP (JJ in_a) (JJ significant) (NN decrease))
        (PP (IN in)
          (NP (JJ Hand_2) (NN secretion))))
      (PP (IN in)
        (NP (DT both) (NNS groups))))
    (. .)))

nsubj(resulted-12, Treatment-1)
case(FK778-3, with-2)
nmod:with(Treatment-1, FK778-3)
det(inhibitor-7, a-5)
amod(inhibitor-7, selective-6)
appos(Treatment-1, inhibitor-7)
case(expression-10, of-8)
amod(expression-10, Hand_2-9)
nmod:of(inhibitor-7, expression-10)
root(ROOT-0, resulted-12)
amod(decrease-15, in_a-13)
amod(decrease-15, significant-14)
dobj(resulted-12, decrease-15)
case(secretion-18, in-16)
amod(secretion-18, Hand_2-17)
nmod:in(decrease-15, secretion-18)
case(groups-21, in-19)
det(groups-21, both-20)
nmod:in(resulted-12, groups-21)

Moreover/RB ,/, FK778/NNP treatment/NN also/RB improved/VBD insulin_secretion/NN in/IN obese/JJ rats/NNS but/CC had/VBD no/DT effect/NN on/IN lean/JJ rats/NNS ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP (NNP FK778) (NN treatment))
    (ADVP (RB also))
    (VP
      (VP (VBD improved)
        (NP (NN insulin_secretion))
        (PP (IN in)
          (NP (JJ obese) (NNS rats))))
      (CC but)
      (VP (VBD had)
        (NP
          (NP (DT no) (NN effect))
          (PP (IN on)
            (NP (JJ lean) (NNS rats))))))
    (. .)))

advmod(improved-6, Moreover-1)
compound(treatment-4, FK778-3)
nsubj(improved-6, treatment-4)
nsubj(had-12, treatment-4)
advmod(improved-6, also-5)
root(ROOT-0, improved-6)
dobj(improved-6, insulin_secretion-7)
case(rats-10, in-8)
amod(rats-10, obese-9)
nmod:in(improved-6, rats-10)
cc(improved-6, but-11)
conj:but(improved-6, had-12)
neg(effect-14, no-13)
dobj(had-12, effect-14)
case(rats-17, on-15)
amod(rats-17, lean-16)
nmod:on(effect-14, rats-17)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN Hand_2/NNS may/MD contribute/VB to/TO the/DT development/NN of/IN obesity/NN and/CC its/PRP$ associated/VBN metabolic_disorders/NNS by/IN impairing/VBG insulin_secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNS Hand_2))))
          (VP (MD may)
            (VP (VB contribute)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP
                      (NP (NN obesity))
                      (CC and)
                      (NP (PRP$ its) (VBN associated) (NNS metabolic_disorders))))))
              (PP (IN by)
                (S
                  (VP (VBG impairing)
                    (NP (NN insulin_secretion))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(contribute-9, that-4)
nsubj(contribute-9, hypersecretion-5)
case(Hand_2-7, of-6)
nmod:of(hypersecretion-5, Hand_2-7)
aux(contribute-9, may-8)
ccomp(suggest-3, contribute-9)
case(development-12, to-10)
det(development-12, the-11)
nmod:to(contribute-9, development-12)
case(obesity-14, of-13)
nmod:of(development-12, obesity-14)
cc(obesity-14, and-15)
nmod:poss(metabolic_disorders-18, its-16)
amod(metabolic_disorders-18, associated-17)
nmod:of(development-12, metabolic_disorders-18)
conj:and(obesity-14, metabolic_disorders-18)
mark(impairing-20, by-19)
advcl(contribute-9, impairing-20)
dobj(impairing-20, insulin_secretion-21)

Targeting/VBG Hand_2/JJ expression/NN may/MD be/VB a/DT potential/JJ therapeutic/JJ strategy/NN for/IN treating/VBG obesity/JJ and/CC related/VBN complications/NNS ./.

(ROOT
  (S
    (S
      (VP (VBG Targeting)
        (NP (JJ Hand_2) (NN expression))))
    (VP (MD may)
      (VP (VB be)
        (NP (DT a) (JJ potential) (JJ therapeutic) (NN strategy))
        (PP (IN for)
          (S
            (VP (VBG treating)
              (NP
                (ADJP (JJ obesity)
                  (CC and)
                  (VBN related))
                (NNS complications)))))))
    (. .)))

csubj(strategy-9, Targeting-1)
amod(expression-3, Hand_2-2)
dobj(Targeting-1, expression-3)
aux(strategy-9, may-4)
cop(strategy-9, be-5)
det(strategy-9, a-6)
amod(strategy-9, potential-7)
amod(strategy-9, therapeutic-8)
root(ROOT-0, strategy-9)
mark(treating-11, for-10)
advcl(strategy-9, treating-11)
amod(complications-15, obesity-12)
cc(obesity-12, and-13)
conj:and(obesity-12, related-14)
amod(complications-15, related-14)
dobj(treating-11, complications-15)

CDC-27/NNP is/VBZ an/DT important/JJ regulator/NN of/IN cell/NN cycle/NN exit/NN and/CC terminal/NN differentiation/NN ./.

(ROOT
  (S
    (NP (NNP CDC-27))
    (VP (VBZ is)
      (NP
        (NP (DT an) (JJ important) (NN regulator))
        (PP (IN of)
          (NP
            (NP (NN cell) (NN cycle) (NN exit))
            (CC and)
            (NP (NN terminal) (NN differentiation))))))
    (. .)))

nsubj(regulator-5, CDC-27-1)
cop(regulator-5, is-2)
det(regulator-5, an-3)
amod(regulator-5, important-4)
root(ROOT-0, regulator-5)
case(exit-9, of-6)
compound(exit-9, cell-7)
compound(exit-9, cycle-8)
nmod:of(regulator-5, exit-9)
cc(exit-9, and-10)
compound(differentiation-12, terminal-11)
nmod:of(regulator-5, differentiation-12)
conj:and(exit-9, differentiation-12)

In/IN this/DT study/NN ,/, we/PRP found/VBD that/IN APC/NNP up-regulated/VBD CDC-27/JJ protein/NN levels/NNS in_a/JJ time-dependent/JJ manner/NN during/IN C2C12/NNP myoblast/JJ differentiation/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (NNP APC))
          (VP (VBD up-regulated)
            (NP (JJ CDC-27) (NN protein) (NNS levels))
            (NP (JJ in_a) (JJ time-dependent) (NN manner))
            (PP (IN during)
              (NP (NNP C2C12) (JJ myoblast) (NN differentiation)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(found-6, study-3)
nsubj(found-6, we-5)
root(ROOT-0, found-6)
mark(up-regulated-9, that-7)
nsubj(up-regulated-9, APC-8)
ccomp(found-6, up-regulated-9)
amod(levels-12, CDC-27-10)
compound(levels-12, protein-11)
iobj(up-regulated-9, levels-12)
amod(manner-15, in_a-13)
amod(manner-15, time-dependent-14)
dobj(up-regulated-9, manner-15)
case(differentiation-19, during-16)
compound(differentiation-19, C2C12-17)
amod(differentiation-19, myoblast-18)
nmod:during(up-regulated-9, differentiation-19)

Furthermore/RB ,/, APC/NNP prolonged/VBN the/DT half-life/NN of/IN CDC/NNP -/: 27/CD protein/NN from/IN 10/CD to/TO 18/CD hours/NNS ,/, which/WDT is/VBZ consistent/JJ with/IN its/PRP$ role/NN in/IN regulating/VBG cell/NN cycle/NN progression/NN during/IN terminal/NN differentiation/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NNP APC))
    (VP (VBN prolonged)
      (NP
        (NP
          (NP (DT the) (NN half-life))
          (PP (IN of)
            (NP (NNP CDC))))
        (: -)
        (NP
          (NP (CD 27) (NN protein))
          (PP (IN from)
            (NP
              (NP
                (QP (CD 10) (TO to) (CD 18))
                (NNS hours))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBZ is)
                    (ADJP (JJ consistent)
                      (PP (IN with)
                        (NP (PRP$ its) (NN role)))))))))))
      (PP (IN in)
        (S
          (VP (VBG regulating)
            (NP (NN cell) (NN cycle) (NN progression))
            (PP (IN during)
              (NP (NN terminal) (NN differentiation)))))))
    (. .)))

advmod(prolonged-4, Furthermore-1)
nsubj(prolonged-4, APC-3)
root(ROOT-0, prolonged-4)
det(half-life-6, the-5)
dobj(prolonged-4, half-life-6)
case(CDC-8, of-7)
nmod:of(half-life-6, CDC-8)
nummod(protein-11, 27-10)
dep(half-life-6, protein-11)
case(hours-16, from-12)
compound(18-15, 10-13)
dep(18-15, to-14)
nummod(hours-16, 18-15)
nmod:from(protein-11, hours-16)
nsubj(consistent-20, hours-16)
ref(hours-16, which-18)
cop(consistent-20, is-19)
acl:relcl(hours-16, consistent-20)
case(role-23, with-21)
nmod:poss(role-23, its-22)
nmod:with(consistent-20, role-23)
mark(regulating-25, in-24)
advcl(prolonged-4, regulating-25)
compound(progression-28, cell-26)
compound(progression-28, cycle-27)
dobj(regulating-25, progression-28)
case(differentiation-31, during-29)
compound(differentiation-31, terminal-30)
nmod:during(regulating-25, differentiation-31)

The/DT anaphase-promoting_complex/JJ //: cyclosome/JJ -LRB-/-LRB- APC/C/NNP -RRB-/-RRB- is_a/JJ crucial/JJ regulator/NN of/IN cell/NN cycle/NN progression/NN and/CC has_been/NN implicated/VBN in/IN the/DT regulation/NN of_skeletal_muscle/NN differentiation/NN ./.

(ROOT
  (NP
    (NP (DT The) (JJ anaphase-promoting_complex))
    (: /)
    (NP
      (NP (JJ cyclosome)
        (PRN (-LRB- -LRB-)
          (NP (NNP APC/C))
          (-RRB- -RRB-))
        (ADJP (JJ is_a) (JJ crucial))
        (NN regulator))
      (PP (IN of)
        (NP
          (NP (NN cell) (NN cycle) (NN progression))
          (CC and)
          (NP (NN has_been))))
      (VP (VBN implicated)
        (PP (IN in)
          (NP (DT the) (NN regulation) (NN of_skeletal_muscle) (NN differentiation)))))
    (. .)))

det(anaphase-promoting_complex-2, The-1)
root(ROOT-0, anaphase-promoting_complex-2)
amod(regulator-10, cyclosome-4)
appos(regulator-10, APC/C-6)
amod(crucial-9, is_a-8)
amod(regulator-10, crucial-9)
dep(anaphase-promoting_complex-2, regulator-10)
case(progression-14, of-11)
compound(progression-14, cell-12)
compound(progression-14, cycle-13)
nmod:of(regulator-10, progression-14)
cc(progression-14, and-15)
nmod:of(regulator-10, has_been-16)
conj:and(progression-14, has_been-16)
acl(regulator-10, implicated-17)
case(differentiation-22, in-18)
det(differentiation-22, the-19)
compound(differentiation-22, regulation-20)
compound(differentiation-22, of_skeletal_muscle-21)
nmod:in(implicated-17, differentiation-22)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN APC/NNP on/IN CDC-27/JJ protein/NN levels/NNS and/CC half-life/NN during/IN C2C12/NNP myoblast/JJ differentiation/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NNP APC))))
      (PP (IN on)
        (NP
          (NP (JJ CDC-27) (NN protein) (NNS levels))
          (CC and)
          (NP (NN half-life))))
      (PP (IN during)
        (NP (NNP C2C12) (JJ myoblast) (NN differentiation))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(APC-10, of-9)
nmod:of(effect-8, APC-10)
case(levels-14, on-11)
amod(levels-14, CDC-27-12)
compound(levels-14, protein-13)
nmod:on(investigated-6, levels-14)
cc(levels-14, and-15)
nmod:on(investigated-6, half-life-16)
conj:and(levels-14, half-life-16)
case(differentiation-20, during-17)
compound(differentiation-20, C2C12-18)
amod(differentiation-20, myoblast-19)
nmod:during(investigated-6, differentiation-20)

When/WRB C2C12/NNP cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, APC/NNP up-regulated/JJ CDC-27/NNP protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ CDC-27/NN protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (SBAR
      (WHADVP (WRB When))
      (S
        (NP (NNP C2C12) (NNS cells))
        (VP (VBD were)
          (VP (VBN cultured)
            (NP
              (NP (NN in_a) (NN medium))
              (PP (VBG favoring)
                (NP
                  (NP (NN differentiation))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP Dulbecco))
                      (VP (VBN modified)
                        (NP (NNP Eagle) (NN medium))
                        (S
                          (VP (VBG containing)
                            (NP
                              (ADJP (CD 2) (NN %))
                              (NN horse) (NN serum))))))
                    (-RRB- -RRB-)))))))))
    (, ,)
    (NP (NNP APC)
      (NX
        (NX
          (NX (JJ up-regulated) (NNP CDC-27) (NN protein) (NNS levels) (NN in_a))
          (NP (JJ time-dependent) (NN manner)))
        (CC and)
        (NX (JJ prolonged) (NN CDC-27) (NN protein))))
    (VP (NN half-life)
      (PP (IN from)
        (NP
          (QP (CD 10) (TO to) (CD 18))
          (NNS hours))))
    (. .)))

advmod(cultured-5, When-1)
compound(cells-3, C2C12-2)
nsubjpass(cultured-5, cells-3)
auxpass(cultured-5, were-4)
advcl(half-life-34, cultured-5)
compound(medium-7, in_a-6)
dobj(cultured-5, medium-7)
case(differentiation-9, favoring-8)
nmod:favoring(medium-7, differentiation-9)
dep(differentiation-9, Dulbecco-11)
acl(Dulbecco-11, modified-12)
compound(medium-14, Eagle-13)
dobj(modified-12, medium-14)
xcomp(modified-12, containing-15)
compound(%-17, 2-16)
amod(serum-19, %-17)
compound(serum-19, horse-18)
dobj(containing-15, serum-19)
dep(in_a-27, APC-22)
amod(in_a-27, up-regulated-23)
compound(in_a-27, CDC-27-24)
compound(in_a-27, protein-25)
compound(in_a-27, levels-26)
nsubj(half-life-34, in_a-27)
amod(manner-29, time-dependent-28)
dep(in_a-27, manner-29)
cc(in_a-27, and-30)
amod(protein-33, prolonged-31)
compound(protein-33, CDC-27-32)
conj:and(in_a-27, protein-33)
nsubj(half-life-34, protein-33)
root(ROOT-0, half-life-34)
case(hours-39, from-35)
compound(18-38, 10-36)
dep(18-38, to-37)
nummod(hours-39, 18-38)
nmod:from(half-life-34, hours-39)

These/DT findings/NNS suggest/VBP that/IN APC/NNP plays/VBZ an/DT important/JJ role/NN in/IN regulating/VBG CDC-27/JJ protein/NN stability/NN during/IN skeletal_muscle/JJ differentiation_and/NN may/MD contribute/VB to/TO the/DT control/NN of/IN cell/NN cycle/NN exit/NN and/CC terminal/NN differentiation/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP APC))
          (VP (VBZ plays)
            (NP
              (NP (DT an) (JJ important) (NN role))
              (PP (IN in)
                (S
                  (VP (VBG regulating)
                    (NP (JJ CDC-27) (NN protein) (NN stability))
                    (PP (IN during)
                      (NP
                        (NP (JJ skeletal_muscle) (NN differentiation_and))
                        (SBAR
                          (S
                            (VP (MD may)
                              (VP (VB contribute)
                                (PP (TO to)
                                  (NP
                                    (NP (DT the) (NN control))
                                    (PP (IN of)
                                      (NP
                                        (NP (NN cell) (NN cycle) (NN exit))
                                        (CC and)
                                        (NP (NN terminal) (NN differentiation))))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(plays-6, that-4)
nsubj(plays-6, APC-5)
ccomp(suggest-3, plays-6)
det(role-9, an-7)
amod(role-9, important-8)
dobj(plays-6, role-9)
mark(regulating-11, in-10)
acl(role-9, regulating-11)
amod(stability-14, CDC-27-12)
compound(stability-14, protein-13)
dobj(regulating-11, stability-14)
case(differentiation_and-17, during-15)
amod(differentiation_and-17, skeletal_muscle-16)
nmod:during(regulating-11, differentiation_and-17)
aux(contribute-19, may-18)
acl:relcl(differentiation_and-17, contribute-19)
case(control-22, to-20)
det(control-22, the-21)
nmod:to(contribute-19, control-22)
case(exit-26, of-23)
compound(exit-26, cell-24)
compound(exit-26, cycle-25)
nmod:of(control-22, exit-26)
cc(exit-26, and-27)
compound(differentiation-29, terminal-28)
nmod:of(control-22, differentiation-29)
conj:and(exit-26, differentiation-29)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT precise/JJ mechanisms/NNS by/IN which/WDT APC/NNP modulates/VBZ CDC-27/JJ protein/NN levels/NNS and/CC its/PRP$ implications/NNS for/IN skeletal_muscle/JJ development/NN and/CC regeneration/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP (DT the) (JJ precise) (NNS mechanisms))
              (PP (IN by)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (NP (NNP APC))
                    (VP (VBZ modulates)
                      (NP
                        (NP (JJ CDC-27) (NN protein) (NNS levels))
                        (CC and)
                        (NP
                          (NP (PRP$ its) (NNS implications))
                          (PP (IN for)
                            (NP (JJ skeletal_muscle) (NN development)
                              (CC and)
                              (NN regeneration))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, precise-8)
dobj(elucidate-6, mechanisms-9)
mark(modulates-13, by-10)
dobj(modulates-13, which-11)
nsubj(modulates-13, APC-12)
advcl(elucidate-6, modulates-13)
amod(levels-16, CDC-27-14)
compound(levels-16, protein-15)
dobj(modulates-13, levels-16)
cc(levels-16, and-17)
nmod:poss(implications-19, its-18)
dobj(modulates-13, implications-19)
conj:and(levels-16, implications-19)
case(development-22, for-20)
amod(development-22, skeletal_muscle-21)
nmod:for(implications-19, development-22)
cc(development-22, and-23)
nmod:for(implications-19, regeneration-24)
conj:and(development-22, regeneration-24)

Ceramide_kinase/RB -LRB-/-LRB- CERK/NNP -RRB-/-RRB- is_a/NN lipid/NN kinase/VBD that/DT has_been/NN implicated/VBN in/IN various/JJ cellular/JJ processes/NNS ,/, including/VBG differentiation_and/JJ apoptosis/NNS ./.

(ROOT
  (S
    (ADVP (RB Ceramide_kinase))
    (PRN (-LRB- -LRB-)
      (NP (NNP CERK))
      (-RRB- -RRB-))
    (NP (NN is_a) (NN lipid))
    (VP (VBD kinase)
      (NP
        (NP (DT that) (NN has_been))
        (VP (VBN implicated)
          (PP (IN in)
            (NP
              (NP (JJ various) (JJ cellular) (NNS processes))
              (, ,)
              (VP (VBG including)
                (NP (JJ differentiation_and) (NNS apoptosis))))))))
    (. .)))

advmod(kinase-7, Ceramide_kinase-1)
dep(kinase-7, CERK-3)
compound(lipid-6, is_a-5)
nsubj(kinase-7, lipid-6)
root(ROOT-0, kinase-7)
det(has_been-9, that-8)
dobj(kinase-7, has_been-9)
acl(has_been-9, implicated-10)
case(processes-14, in-11)
amod(processes-14, various-12)
amod(processes-14, cellular-13)
nmod:in(implicated-10, processes-14)
acl(processes-14, including-16)
amod(apoptosis-18, differentiation_and-17)
dobj(including-16, apoptosis-18)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN L-165041/NNP ,/, a/DT selective/JJ CERK/NN activator/NN ,/, on/IN C2C12/NNP cell/NN differentiation/NN was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP
          (NP (NNP L-165041))
          (, ,)
          (NP (DT a) (JJ selective) (NN CERK) (NN activator))
          (, ,)))
      (PP (IN on)
        (NP (NNP C2C12) (NN cell) (NN differentiation))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-20, study-3)
det(effect-6, the-5)
nsubjpass(investigated-20, effect-6)
case(L-165041-8, of-7)
nmod:of(effect-6, L-165041-8)
det(activator-13, a-10)
amod(activator-13, selective-11)
compound(activator-13, CERK-12)
appos(L-165041-8, activator-13)
case(differentiation-18, on-15)
compound(differentiation-18, C2C12-16)
compound(differentiation-18, cell-17)
nmod:on(effect-6, differentiation-18)
auxpass(investigated-20, was-19)
root(ROOT-0, investigated-20)

When/WRB C2C12/NNP cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, L-165041/NNP up-regulated/JJ Ceramide_kinase/NNP protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ Ceramide_kinase/NNP protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (SBAR
      (WHADVP (WRB When))
      (S
        (NP (NNP C2C12) (NNS cells))
        (VP (VBD were)
          (VP (VBN cultured)
            (NP
              (NP (NN in_a) (NN medium))
              (PP (VBG favoring)
                (NP
                  (NP (NN differentiation))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP Dulbecco))
                      (VP (VBN modified)
                        (NP (NNP Eagle) (NN medium))
                        (S
                          (VP (VBG containing)
                            (NP
                              (ADJP (CD 2) (NN %))
                              (NN horse) (NN serum))))))
                    (-RRB- -RRB-)))))))))
    (, ,)
    (NP (NNP L-165041)
      (NX
        (NX
          (NX (JJ up-regulated) (NNP Ceramide_kinase) (NN protein) (NNS levels) (NN in_a))
          (NP (JJ time-dependent) (NN manner)))
        (CC and)
        (NX (JJ prolonged) (NNP Ceramide_kinase) (NN protein))))
    (VP (NN half-life)
      (PP (IN from)
        (NP
          (QP (CD 10) (TO to) (CD 18))
          (NNS hours))))
    (. .)))

advmod(cultured-5, When-1)
compound(cells-3, C2C12-2)
nsubjpass(cultured-5, cells-3)
auxpass(cultured-5, were-4)
advcl(half-life-34, cultured-5)
compound(medium-7, in_a-6)
dobj(cultured-5, medium-7)
case(differentiation-9, favoring-8)
nmod:favoring(medium-7, differentiation-9)
dep(differentiation-9, Dulbecco-11)
acl(Dulbecco-11, modified-12)
compound(medium-14, Eagle-13)
dobj(modified-12, medium-14)
xcomp(modified-12, containing-15)
compound(%-17, 2-16)
amod(serum-19, %-17)
compound(serum-19, horse-18)
dobj(containing-15, serum-19)
dep(in_a-27, L-165041-22)
amod(in_a-27, up-regulated-23)
compound(in_a-27, Ceramide_kinase-24)
compound(in_a-27, protein-25)
compound(in_a-27, levels-26)
nsubj(half-life-34, in_a-27)
amod(manner-29, time-dependent-28)
dep(in_a-27, manner-29)
cc(in_a-27, and-30)
amod(protein-33, prolonged-31)
compound(protein-33, Ceramide_kinase-32)
conj:and(in_a-27, protein-33)
nsubj(half-life-34, protein-33)
root(ROOT-0, half-life-34)
case(hours-39, from-35)
compound(18-38, 10-36)
dep(18-38, to-37)
nummod(hours-39, 18-38)
nmod:from(half-life-34, hours-39)

These/DT results/NNS suggest/VBP that/IN CERK/NNP activation/NN may/MD play/VB a/DT role/NN in/IN regulating/VBG the/DT differentiation/NN of/IN C2C12/CD cells/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP CERK) (NN activation))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP
                        (NP (DT the) (NN differentiation))
                        (PP (IN of)
                          (NP (CD C2C12) (NNS cells)))))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(play-8, that-4)
compound(activation-6, CERK-5)
nsubj(play-8, activation-6)
aux(play-8, may-7)
ccomp(suggest-3, play-8)
det(role-10, a-9)
dobj(play-8, role-10)
mark(regulating-12, in-11)
acl(role-10, regulating-12)
det(differentiation-14, the-13)
dobj(regulating-12, differentiation-14)
case(cells-17, of-15)
nummod(cells-17, C2C12-16)
nmod:of(differentiation-14, cells-17)

When/WRB C2C12/NNP cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, L-165041/NNP up-regulated/JJ Ceramide_kinase/NNP protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ Ceramide_kinase/NNP protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (SBAR
      (WHADVP (WRB When))
      (S
        (NP (NNP C2C12) (NNS cells))
        (VP (VBD were)
          (VP (VBN cultured)
            (NP
              (NP (NN in_a) (NN medium))
              (PP (VBG favoring)
                (NP
                  (NP (NN differentiation))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP Dulbecco))
                      (VP (VBN modified)
                        (NP (NNP Eagle) (NN medium))
                        (S
                          (VP (VBG containing)
                            (NP
                              (ADJP (CD 2) (NN %))
                              (NN horse) (NN serum))))))
                    (-RRB- -RRB-)))))))))
    (, ,)
    (NP (NNP L-165041)
      (NX
        (NX
          (NX (JJ up-regulated) (NNP Ceramide_kinase) (NN protein) (NNS levels) (NN in_a))
          (NP (JJ time-dependent) (NN manner)))
        (CC and)
        (NX (JJ prolonged) (NNP Ceramide_kinase) (NN protein))))
    (VP (NN half-life)
      (PP (IN from)
        (NP
          (QP (CD 10) (TO to) (CD 18))
          (NNS hours))))
    (. .)))

advmod(cultured-5, When-1)
compound(cells-3, C2C12-2)
nsubjpass(cultured-5, cells-3)
auxpass(cultured-5, were-4)
advcl(half-life-34, cultured-5)
compound(medium-7, in_a-6)
dobj(cultured-5, medium-7)
case(differentiation-9, favoring-8)
nmod:favoring(medium-7, differentiation-9)
dep(differentiation-9, Dulbecco-11)
acl(Dulbecco-11, modified-12)
compound(medium-14, Eagle-13)
dobj(modified-12, medium-14)
xcomp(modified-12, containing-15)
compound(%-17, 2-16)
amod(serum-19, %-17)
compound(serum-19, horse-18)
dobj(containing-15, serum-19)
dep(in_a-27, L-165041-22)
amod(in_a-27, up-regulated-23)
compound(in_a-27, Ceramide_kinase-24)
compound(in_a-27, protein-25)
compound(in_a-27, levels-26)
nsubj(half-life-34, in_a-27)
amod(manner-29, time-dependent-28)
dep(in_a-27, manner-29)
cc(in_a-27, and-30)
amod(protein-33, prolonged-31)
compound(protein-33, Ceramide_kinase-32)
conj:and(in_a-27, protein-33)
nsubj(half-life-34, protein-33)
root(ROOT-0, half-life-34)
case(hours-39, from-35)
compound(18-38, 10-36)
dep(18-38, to-37)
nummod(hours-39, 18-38)
nmod:from(half-life-34, hours-39)

The/DT discovery/NN that/IN human/JJ serum/NN N-acetyl-4-S-cysteaminylphenolidase/NN has/VBZ N-acetyl-4-S-cysteaminylphenolyl-transferase/JJ activity/NN ,/, in/IN addition/NN to/TO N-acetyl-4-S-cysteaminylphenolidase/JJ hydrolase/JJ activity/NN ,/, presents/VBZ new/JJ possibilities/NNS for/IN the/DT role/NN of/IN N-acetyl-4-S-cysteaminylphenolidase/NNS in/IN N-acetyl-4-S-cysteaminylphenol/JJ metabolism/NN ./.

(ROOT
  (S
    (NP
      (NP
        (NP (DT The) (NN discovery))
        (SBAR (IN that)
          (S
            (NP (JJ human) (NN serum) (NN N-acetyl-4-S-cysteaminylphenolidase))
            (VP (VBZ has)
              (NP (JJ N-acetyl-4-S-cysteaminylphenolyl-transferase) (NN activity))))))
      (, ,)
      (PP (IN in)
        (NP
          (NP (NN addition))
          (PP (TO to)
            (NP (JJ N-acetyl-4-S-cysteaminylphenolidase) (JJ hydrolase) (NN activity)))))
      (, ,))
    (VP (VBZ presents)
      (NP (JJ new) (NNS possibilities))
      (PP (IN for)
        (NP
          (NP (DT the) (NN role))
          (PP (IN of)
            (NP
              (NP (NNS N-acetyl-4-S-cysteaminylphenolidase))
              (PP (IN in)
                (NP (JJ N-acetyl-4-S-cysteaminylphenol) (NN metabolism))))))))
    (. .)))

det(discovery-2, The-1)
nsubj(presents-18, discovery-2)
mark(has-7, that-3)
amod(N-acetyl-4-S-cysteaminylphenolidase-6, human-4)
compound(N-acetyl-4-S-cysteaminylphenolidase-6, serum-5)
nsubj(has-7, N-acetyl-4-S-cysteaminylphenolidase-6)
dep(discovery-2, has-7)
amod(activity-9, N-acetyl-4-S-cysteaminylphenolyl-transferase-8)
dobj(has-7, activity-9)
case(activity-16, in-11)
mwe(in-11, addition-12)
mwe(in-11, to-13)
amod(activity-16, N-acetyl-4-S-cysteaminylphenolidase-14)
amod(activity-16, hydrolase-15)
nmod:in_addition_to(discovery-2, activity-16)
root(ROOT-0, presents-18)
amod(possibilities-20, new-19)
dobj(presents-18, possibilities-20)
case(role-23, for-21)
det(role-23, the-22)
nmod:for(presents-18, role-23)
case(N-acetyl-4-S-cysteaminylphenolidase-25, of-24)
nmod:of(role-23, N-acetyl-4-S-cysteaminylphenolidase-25)
case(metabolism-28, in-26)
amod(metabolism-28, N-acetyl-4-S-cysteaminylphenol-27)
nmod:in(N-acetyl-4-S-cysteaminylphenolidase-25, metabolism-28)

Recent/JJ research/NN has/VBZ revealed/VBN that/IN this/DT enzyme/NN possesses/VBZ not/RB only/RB hydrolase/JJ activity/NN but/CC also/RB transferase/VB activity/NN ,/, specifically/RB N-acetyl-4-S-cysteaminylphenolyl-transferase/JJ activity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NN research))
    (VP (VBZ has)
      (VP (VBN revealed)
        (SBAR (IN that)
          (S
            (NP (DT this) (NN enzyme))
            (VP
              (VP (VBZ possesses)
                (NP
                  (ADJP
                    (ADVP (RB not) (RB only))
                    (JJ hydrolase))
                  (NN activity)))
              (CONJP (CC but)
                (RB also))
              (VP (VB transferase)
                (NP
                  (NP (NN activity))
                  (, ,)
                  (NP
                    (ADJP (RB specifically) (JJ N-acetyl-4-S-cysteaminylphenolyl-transferase))
                    (NN activity)))))))))
    (. .)))

amod(research-2, Recent-1)
nsubj(revealed-4, research-2)
aux(revealed-4, has-3)
root(ROOT-0, revealed-4)
mark(possesses-8, that-5)
det(enzyme-7, this-6)
nsubj(possesses-8, enzyme-7)
nsubj(transferase-15, enzyme-7)
ccomp(revealed-4, possesses-8)
dep(only-10, not-9)
advmod(hydrolase-11, only-10)
amod(activity-12, hydrolase-11)
dobj(possesses-8, activity-12)
cc(possesses-8, but-13)
advmod(transferase-15, also-14)
ccomp(revealed-4, transferase-15)
conj:and(possesses-8, transferase-15)
dobj(transferase-15, activity-16)
advmod(N-acetyl-4-S-cysteaminylphenolyl-transferase-19, specifically-18)
amod(activity-20, N-acetyl-4-S-cysteaminylphenolyl-transferase-19)
appos(activity-16, activity-20)

This/DT discovery/NN opens/VBZ up/RP new/JJ possibilities/NNS for/IN understanding/VBG the/DT role/NN of/IN N-acetyl-4-S-cysteaminylphenolidase/NNS in/IN the/DT metabolism/NN of/IN N-acetyl-4-S-cysteaminylphenol/NNS ./.

(ROOT
  (S
    (NP (DT This) (NN discovery))
    (VP (VBZ opens)
      (PRT (RP up))
      (NP (JJ new) (NNS possibilities))
      (PP (IN for)
        (S
          (VP (VBG understanding)
            (NP
              (NP (DT the) (NN role))
              (PP (IN of)
                (NP
                  (NP (NNS N-acetyl-4-S-cysteaminylphenolidase))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN metabolism))
                      (PP (IN of)
                        (NP (NNS N-acetyl-4-S-cysteaminylphenol))))))))))))
    (. .)))

det(discovery-2, This-1)
nsubj(opens-3, discovery-2)
root(ROOT-0, opens-3)
compound:prt(opens-3, up-4)
amod(possibilities-6, new-5)
dobj(opens-3, possibilities-6)
mark(understanding-8, for-7)
advcl(opens-3, understanding-8)
det(role-10, the-9)
dobj(understanding-8, role-10)
case(N-acetyl-4-S-cysteaminylphenolidase-12, of-11)
nmod:of(role-10, N-acetyl-4-S-cysteaminylphenolidase-12)
case(metabolism-15, in-13)
det(metabolism-15, the-14)
nmod:in(N-acetyl-4-S-cysteaminylphenolidase-12, metabolism-15)
case(N-acetyl-4-S-cysteaminylphenol-17, of-16)
nmod:of(metabolism-15, N-acetyl-4-S-cysteaminylphenol-17)

Further/JJ investigation/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS and/CC potential/JJ therapeutic/JJ applications/NNS of/IN this/DT enzyme/NN 's/POS dual/JJ activities/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NN investigation))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN of)
                    (NP
                      (NP (DT this) (NN enzyme) (POS 's))
                      (JJ dual) (NNS activities))))))))))
    (. .)))

amod(investigation-2, Further-1)
nsubjpass(needed-4, investigation-2)
nsubj:xsubj(elucidate-7, investigation-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
cc(mechanisms-9, and-10)
amod(applications-13, potential-11)
amod(applications-13, therapeutic-12)
dobj(elucidate-7, applications-13)
conj:and(mechanisms-9, applications-13)
case(activities-19, of-14)
det(enzyme-16, this-15)
nmod:poss(activities-19, enzyme-16)
case(enzyme-16, 's-17)
amod(activities-19, dual-18)
nmod:of(applications-13, activities-19)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ for/IN human/JJ health/NN and/CC have/VBP been/VBN associated/VBN with/IN a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP
      (VP (VBP are)
        (ADJP (JJ essential)
          (PP (IN for)
            (NP (JJ human) (NN health)))))
      (CC and)
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN associated)
            (PP (IN with)
              (NP
                (NP
                  (NP (DT a) (VBN reduced) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP (NN coronary_heart_disease))))))
                (PRN (-LRB- -LRB-)
                  (NP (NNP CHD))
                  (-RRB- -RRB-))))))))
    (. .)))

nsubj(essential-15, Omega-3_fatty_acids-1)
nsubjpass(associated-22, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(essential-15, are-14)
root(ROOT-0, essential-15)
case(health-18, for-16)
amod(health-18, human-17)
nmod:for(essential-15, health-18)
cc(essential-15, and-19)
aux(associated-22, have-20)
auxpass(associated-22, been-21)
conj:and(essential-15, associated-22)
case(risk-26, with-23)
det(risk-26, a-24)
amod(risk-26, reduced-25)
nmod:with(associated-22, risk-26)
mark(developing-28, of-27)
acl(risk-26, developing-28)
dobj(developing-28, coronary_heart_disease-29)
appos(risk-26, CHD-31)

In/IN the/DT present/JJ study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN EPA/NNP and/CC DHA/NNP supplementation/NN on/IN blood_pressure/NN ,/, lipid/NN levels/NNS ,/, and_8-cyclopentyl-1/CD ,3/CD -/: dipropylxanthine/JJ levels/NNS in/IN hypercholesterolemic/JJ patients/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ present) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (ADJP (NNP EPA)
              (CC and)
              (NNP DHA))
            (NN supplementation)))
        (PP (IN on)
          (NP
            (NP (NN blood_pressure))
            (, ,)
            (NP
              (NP
                (NP (NN lipid) (NNS levels))
                (, ,)
                (NP
                  (QP (CD and_8-cyclopentyl-1) (CD ,3))))
              (: -)
              (NP
                (NP (JJ dipropylxanthine) (NNS levels))
                (PP (IN in)
                  (NP (JJ hypercholesterolemic) (NNS patients)))))))))
    (. .)))

case(study-4, In-1)
det(study-4, the-2)
amod(study-4, present-3)
nmod:in(investigated-7, study-4)
nsubj(investigated-7, we-6)
root(ROOT-0, investigated-7)
det(effects-9, the-8)
dobj(investigated-7, effects-9)
case(supplementation-14, of-10)
amod(supplementation-14, EPA-11)
cc(EPA-11, and-12)
conj:and(EPA-11, DHA-13)
amod(supplementation-14, DHA-13)
nmod:of(effects-9, supplementation-14)
case(blood_pressure-16, on-15)
nmod:on(effects-9, blood_pressure-16)
compound(levels-19, lipid-18)
appos(blood_pressure-16, levels-19)
compound(,3-22, and_8-cyclopentyl-1-21)
appos(levels-19, ,3-22)
amod(levels-25, dipropylxanthine-24)
dep(levels-19, levels-25)
case(patients-28, in-26)
amod(patients-28, hypercholesterolemic-27)
nmod:in(levels-25, patients-28)

EPA/NNP supplementation/NN significantly/RB reduced/VBD blood_pressure/NN -LRB-/-LRB- P/NNP </CD 0.05/CD -RRB-/-RRB- and/CC increased/VBD plasma/NN DHA/NNP levels/NNS -LRB-/-LRB- P/VB =/SYM 0.02/CD -RRB-/-RRB- in/IN these/DT patients/NNS compared/VBN with/IN those/DT in/IN the/DT control/NN group/NN ./.

(ROOT
  (S
    (NP (NNP EPA) (NN supplementation))
    (ADVP (RB significantly))
    (VP
      (VP (VBD reduced)
        (NP
          (NP (NN blood_pressure))
          (PRN (-LRB- -LRB-)
            (NP (NNP P)
              (QP (CD <) (CD 0.05)))
            (-RRB- -RRB-))))
      (CC and)
      (VP (VBD increased)
        (VP (NN plasma)
          (NP (NNP DHA) (NNS levels))
          (PRN (-LRB- -LRB-)
            (S
              (VP (VB P)
                (FRAG
                  (X (SYM =))
                  (NP (CD 0.02)))))
            (-RRB- -RRB-))
          (PP (IN in)
            (NP
              (NP (DT these) (NNS patients))
              (VP (VBN compared)
                (PP (IN with)
                  (NP
                    (NP (DT those))
                    (PP (IN in)
                      (NP (DT the) (NN control) (NN group)))))))))))
    (. .)))

compound(supplementation-2, EPA-1)
nsubj(reduced-4, supplementation-2)
nsubj(increased-12, supplementation-2)
advmod(reduced-4, significantly-3)
root(ROOT-0, reduced-4)
dobj(reduced-4, blood_pressure-5)
appos(blood_pressure-5, P-7)
compound(0.05-9, <-8)
nummod(P-7, 0.05-9)
cc(reduced-4, and-11)
conj:and(reduced-4, increased-12)
dep(increased-12, plasma-13)
compound(levels-15, DHA-14)
dobj(plasma-13, levels-15)
parataxis(plasma-13, P-17)
dep(0.02-19, =-18)
dep(P-17, 0.02-19)
case(patients-23, in-21)
det(patients-23, these-22)
nmod:in(plasma-13, patients-23)
acl(patients-23, compared-24)
case(those-26, with-25)
nmod:with(compared-24, those-26)
case(group-30, in-27)
det(group-30, the-28)
compound(group-30, control-29)
nmod:in(those-26, group-30)

EPA/NNP and/CC DHA/NNP play/VBP an/DT important/JJ role/NN in/IN reducing/VBG inflammation/NN and/CC improving/VBG cardiovascular_health/NN ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP play)
      (NP
        (NP (DT an) (JJ important) (NN role))
        (PP (IN in)
          (S
            (VP
              (VP (VBG reducing)
                (NP (NN inflammation)))
              (CC and)
              (VP (VBG improving)
                (NP (NN cardiovascular_health))))))))
    (. .)))

nsubj(play-4, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubj(play-4, DHA-3)
root(ROOT-0, play-4)
det(role-7, an-5)
amod(role-7, important-6)
dobj(play-4, role-7)
mark(reducing-9, in-8)
acl(role-7, reducing-9)
dobj(reducing-9, inflammation-10)
cc(reducing-9, and-11)
acl(role-7, improving-12)
conj:and(reducing-9, improving-12)
dobj(improving-12, cardiovascular_health-13)

The/DT mechanism/NN by/IN which/WDT omega-3_fatty_acids/JJ reduce/VB CHD/NNP risk/NN is/VBZ not/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ thought/VBN to/TO involve/VB their/PRP$ ability/NN to/TO lower/JJR triglyceride_levels/NNS ,/, reduce/VB blood_pressure/JJ ,/, and/CC improve/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN mechanism))
        (SBAR
          (WHPP (IN by)
            (WHNP (WDT which)))
          (S
            (NP (JJ omega-3_fatty_acids))
            (VP (VB reduce)
              (NP (NNP CHD) (NN risk))))))
      (VP (VBZ is) (RB not)
        (ADVP (RB fully))
        (VP (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN thought)
          (S
            (VP (TO to)
              (VP
                (VP (VB involve)
                  (NP (PRP$ their) (NN ability))
                  (PP (TO to)
                    (NP (JJR lower) (NNS triglyceride_levels))))
                (, ,)
                (VP (VB reduce)
                  (ADJP (JJ blood_pressure)))
                (, ,)
                (CC and)
                (VP (VB improve)
                  (NP (JJ endothelial) (NN function)))))))))
    (. .)))

det(mechanism-2, The-1)
nmod:by(reduce-6, mechanism-2)
nsubjpass(understood-12, mechanism-2)
case(which-4, by-3)
ref(mechanism-2, which-4)
nsubj(reduce-6, omega-3_fatty_acids-5)
acl:relcl(mechanism-2, reduce-6)
compound(risk-8, CHD-7)
dobj(reduce-6, risk-8)
auxpass(understood-12, is-9)
neg(understood-12, not-10)
advmod(understood-12, fully-11)
root(ROOT-0, understood-12)
cc(understood-12, but-14)
nsubjpass(thought-17, it-15)
nsubj:xsubj(involve-19, it-15)
nsubj:xsubj(reduce-26, it-15)
nsubj:xsubj(improve-30, it-15)
auxpass(thought-17, is-16)
conj:but(understood-12, thought-17)
mark(involve-19, to-18)
xcomp(thought-17, involve-19)
nmod:poss(ability-21, their-20)
dobj(involve-19, ability-21)
case(triglyceride_levels-24, to-22)
amod(triglyceride_levels-24, lower-23)
nmod:to(involve-19, triglyceride_levels-24)
xcomp(thought-17, reduce-26)
conj:and(involve-19, reduce-26)
xcomp(reduce-26, blood_pressure-27)
cc(involve-19, and-29)
xcomp(thought-17, improve-30)
conj:and(involve-19, improve-30)
amod(function-32, endothelial-31)
dobj(improve-30, function-32)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT beneficial/JJ strategy/NN for/IN preventing/VBG CHD/NNP and/CC improving/VBG overall/JJ cardiovascular_health/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (JJ long-chain) (NN omega-3_fatty_acids))))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a) (JJ beneficial) (NN strategy))
              (PP (IN for)
                (S
                  (VP
                    (VP (VBG preventing)
                      (NP (NNP CHD)))
                    (CC and)
                    (VP (VBG improving)
                      (NP (JJ overall) (NN cardiovascular_health)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
csubj(strategy-15, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(omega-3_fatty_acids-10, of-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:of(intake-7, omega-3_fatty_acids-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, a-13)
amod(strategy-15, beneficial-14)
ccomp(suggest-3, strategy-15)
mark(preventing-17, for-16)
advcl(strategy-15, preventing-17)
dobj(preventing-17, CHD-18)
cc(preventing-17, and-19)
advcl(strategy-15, improving-20)
conj:and(preventing-17, improving-20)
amod(cardiovascular_health-22, overall-21)
dobj(improving-20, cardiovascular_health-22)

Obesity/JJ is_a/NN multifactorial_disease/VBD that/IN has/VBZ become/VBN a/DT major/JJ health/NN concern/NN worldwide/RB ./.

(ROOT
  (S
    (NP (JJ Obesity) (NN is_a))
    (VP (VBD multifactorial_disease)
      (SBAR (IN that)
        (S
          (VP (VBZ has)
            (VP (VBN become)
              (NP (DT a) (JJ major) (NN health) (NN concern))
              (ADVP (RB worldwide)))))))
    (. .)))

amod(is_a-2, Obesity-1)
nsubj(multifactorial_disease-3, is_a-2)
root(ROOT-0, multifactorial_disease-3)
mark(become-6, that-4)
aux(become-6, has-5)
ccomp(multifactorial_disease-3, become-6)
det(concern-10, a-7)
amod(concern-10, major-8)
compound(concern-10, health-9)
xcomp(become-6, concern-10)
advmod(become-6, worldwide-11)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN hypersecretion/NN of/IN tumor_necrosis_factor_receptor_superfamily/JJ member_14/NNS -LRB-/-LRB- TNFRSF14/NNP -RRB-/-RRB- by/IN the/DT pancreas/NN may/MD contribute/VB to/TO the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP
                (NP
                  (NP (NN hypersecretion))
                  (PP (IN of)
                    (NP (JJ tumor_necrosis_factor_receptor_superfamily) (NNS member_14))))
                (PRN (-LRB- -LRB-)
                  (NP (NNP TNFRSF14))
                  (-RRB- -RRB-)))
              (PP (IN by)
                (NP (DT the) (NN pancreas))))
            (VP (MD may)
              (VP (VB contribute)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(contribute-17, that-5)
nsubj(contribute-17, hypersecretion-6)
case(member_14-9, of-7)
amod(member_14-9, tumor_necrosis_factor_receptor_superfamily-8)
nmod:of(hypersecretion-6, member_14-9)
appos(hypersecretion-6, TNFRSF14-11)
case(pancreas-15, by-13)
det(pancreas-15, the-14)
nmod:by(hypersecretion-6, pancreas-15)
aux(contribute-17, may-16)
ccomp(shown-4, contribute-17)
case(development-20, to-18)
det(development-20, the-19)
nmod:to(contribute-17, development-20)
case(obesity-22, of-21)
nmod:of(development-20, obesity-22)

However/RB ,/, the/DT effects/NNS of/IN glucose/NN and/CC listeriolysin_O/NN on/IN the/DT secretion/NN of/IN TNF/NNP RSF14/NNP by/IN pancreata/NN from/IN obese/JJ rats/NNS have/VBP not/RB yet/RB been/VBN investigated/VBN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP (NN glucose)
          (CC and)
          (NN listeriolysin_O)))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNP TNF) (NNP RSF14)))
          (PP (IN by)
            (NP
              (NP (NN pancreata))
              (PP (IN from)
                (NP (JJ obese) (NNS rats))))))))
    (VP (VBP have) (RB not)
      (ADVP (RB yet))
      (VP (VBN been)
        (VP (VBN investigated))))
    (. .)))

advmod(investigated-24, However-1)
det(effects-4, the-3)
nsubjpass(investigated-24, effects-4)
case(glucose-6, of-5)
nmod:of(effects-4, glucose-6)
cc(glucose-6, and-7)
nmod:of(effects-4, listeriolysin_O-8)
conj:and(glucose-6, listeriolysin_O-8)
case(secretion-11, on-9)
det(secretion-11, the-10)
nmod:on(effects-4, secretion-11)
case(RSF14-14, of-12)
compound(RSF14-14, TNF-13)
nmod:of(secretion-11, RSF14-14)
case(pancreata-16, by-15)
nmod:by(secretion-11, pancreata-16)
case(rats-19, from-17)
amod(rats-19, obese-18)
nmod:from(pancreata-16, rats-19)
aux(investigated-24, have-20)
neg(investigated-24, not-21)
advmod(investigated-24, yet-22)
auxpass(investigated-24, been-23)
root(ROOT-0, investigated-24)

-LRB-/-LRB- http://www.circresaha.org//NNP -RRB-/-RRB-

(ROOT
  (PRN (-LRB- -LRB-)
    (NP (NNP http://www.circresaha.org/))
    (-RRB- -RRB-)))

root(ROOT-0, http://www.circresaha.org/-2)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN TNFRSF14/NNP by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNP TNFRSF14)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(TNFRSF14-20, of-19)
nmod:of(hypersecretion-18, TNFRSF14-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ listeriolysin_O/NN on/IN the/DT secretion/NN of/IN TNFRSF14/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN listeriolysin_O)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNP TNFRSF14) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(listeriolysin_O-16, 10-14)
amod(listeriolysin_O-16, mmol/L-15)
nmod:of(effects-8, listeriolysin_O-16)
conj:and(glucose-12, listeriolysin_O-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(and_insulin-22, of-20)
compound(and_insulin-22, TNFRSF14-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(genetically_obese-28, from-27)
nmod:from(pancreata-26, genetically_obese-28)
appos(genetically_obese-28, fa/fa-30)
cc(genetically_obese-28, and-32)
amod(rats-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(pancreata-26, rats-39)
conj:and(genetically_obese-28, rats-39)

Our/PRP$ results/NNS showed/VBD that/IN there/EX was/VBD a/DT significant/JJ increase/NN in/IN TNFRSF14/NNP secretion/NN in/IN response/NN to/TO glucose/NN and/CC listeriolysin_O/NN in/IN perfused/JJ pancreata/NN from/IN obese/JJ rats/NNS compared/VBN to/TO lean/JJ rats/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (VBD was)
            (NP
              (NP (DT a) (JJ significant) (NN increase))
              (PP (IN in)
                (NP (NNP TNFRSF14) (NN secretion))))
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP (NN glucose)
                    (CC and)
                    (NN listeriolysin_O)))))
            (PP (IN in)
              (NP
                (NP (JJ perfused) (NN pancreata))
                (PP (IN from)
                  (NP (JJ obese) (NNS rats)))))
            (PP (VBN compared)
              (PP (TO to)
                (NP (JJ lean) (NNS rats))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(was-6, that-4)
expl(was-6, there-5)
ccomp(showed-3, was-6)
det(increase-9, a-7)
amod(increase-9, significant-8)
nsubj(was-6, increase-9)
case(secretion-12, in-10)
compound(secretion-12, TNFRSF14-11)
nmod:in(increase-9, secretion-12)
case(response-14, in-13)
nmod:in(was-6, response-14)
case(glucose-16, to-15)
nmod:to(response-14, glucose-16)
cc(glucose-16, and-17)
nmod:to(response-14, listeriolysin_O-18)
conj:and(glucose-16, listeriolysin_O-18)
case(pancreata-21, in-19)
amod(pancreata-21, perfused-20)
nmod:in(was-6, pancreata-21)
case(rats-24, from-22)
amod(rats-24, obese-23)
nmod:from(pancreata-21, rats-24)
case(rats-28, compared-25)
mwe(compared-25, to-26)
amod(rats-28, lean-27)
advcl(was-6, rats-28)

Additionally/RB ,/, insulin_secretion/NN was/VBD significantly/RB decreased/VBN in/IN obese/JJ rats/NNS compared/VBN to/TO lean/JJ rats/NNS ,/, suggesting/VBG impaired/VBN pancreatic/JJ beta-cell/JJ function/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NN insulin_secretion))
    (VP (VBD was)
      (VP
        (ADVP (RB significantly))
        (VBN decreased)
        (PP (IN in)
          (NP
            (NP (JJ obese) (NNS rats))
            (VP (VBN compared)
              (PP (TO to)
                (NP (JJ lean) (NNS rats))))))
        (, ,)
        (S
          (VP (VBG suggesting)
            (VP (VBN impaired)
              (NP-TMP (JJ pancreatic) (JJ beta-cell) (NN function)))))))
    (. .)))

advmod(decreased-6, Additionally-1)
nsubjpass(decreased-6, insulin_secretion-3)
auxpass(decreased-6, was-4)
advmod(decreased-6, significantly-5)
root(ROOT-0, decreased-6)
case(rats-9, in-7)
amod(rats-9, obese-8)
nmod:in(decreased-6, rats-9)
acl(rats-9, compared-10)
case(rats-13, to-11)
amod(rats-13, lean-12)
nmod:to(compared-10, rats-13)
xcomp(decreased-6, suggesting-15)
dep(suggesting-15, impaired-16)
amod(function-19, pancreatic-17)
amod(function-19, beta-cell-18)
nmod:tmod(impaired-16, function-19)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN TNFRSF14/NNP by/IN the/DT pancreas/NN may/MD contribute/VB to/TO the/DT development/NN of/IN obesity/NN through/IN its/PRP$ effects/NNS on/IN insulin_secretion/NN and_beta-cell/JJ function/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNP TNFRSF14)))
            (PP (IN by)
              (NP (DT the) (NN pancreas))))
          (VP (MD may)
            (VP (VB contribute)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity)))))
              (PP (IN through)
                (NP
                  (NP (PRP$ its) (NNS effects))
                  (PP (IN on)
                    (NP (NN insulin_secretion)))))
              (NP-TMP (JJ and_beta-cell) (NN function)))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(contribute-12, that-4)
nsubj(contribute-12, hypersecretion-5)
case(TNFRSF14-7, of-6)
nmod:of(hypersecretion-5, TNFRSF14-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(hypersecretion-5, pancreas-10)
aux(contribute-12, may-11)
ccomp(suggest-3, contribute-12)
case(development-15, to-13)
det(development-15, the-14)
nmod:to(contribute-12, development-15)
case(obesity-17, of-16)
nmod:of(development-15, obesity-17)
case(effects-20, through-18)
nmod:poss(effects-20, its-19)
nmod:through(contribute-12, effects-20)
case(insulin_secretion-22, on-21)
nmod:on(effects-20, insulin_secretion-22)
amod(function-24, and_beta-cell-23)
nmod:tmod(contribute-12, function-24)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ targets/NNS for/IN this/DT pathway/NN in/IN obesity/JJ management/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP
                      (NP (DT this) (NN pathway))
                      (PP (IN in)
                        (NP (JJ obesity) (NN management))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(targets-13, potential-11)
amod(targets-13, therapeutic-12)
dobj(elucidate-6, targets-13)
conj:and(mechanisms-9, targets-13)
case(pathway-16, for-14)
det(pathway-16, this-15)
nmod:for(targets-13, pathway-16)
case(management-19, in-17)
amod(management-19, obesity-18)
nmod:in(pathway-16, management-19)

Xenobiotic/JJ receptors/NNS are/VBP known/VBN to/TO play/VB an/DT important/JJ role/NN in/IN the/DT regulation/NN of/IN drug/NN metabolism/NN and/CC detoxification/NN ./.

(ROOT
  (S
    (NP (JJ Xenobiotic) (NNS receptors))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB play)
              (NP
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN regulation))
                    (PP (IN of)
                      (NP (NN drug) (NN metabolism)
                        (CC and)
                        (NN detoxification)))))))))))
    (. .)))

amod(receptors-2, Xenobiotic-1)
nsubjpass(known-4, receptors-2)
nsubj:xsubj(play-6, receptors-2)
auxpass(known-4, are-3)
root(ROOT-0, known-4)
mark(play-6, to-5)
xcomp(known-4, play-6)
det(role-9, an-7)
amod(role-9, important-8)
dobj(play-6, role-9)
case(regulation-12, in-10)
det(regulation-12, the-11)
nmod:in(role-9, regulation-12)
case(metabolism-15, of-13)
compound(metabolism-15, drug-14)
nmod:of(regulation-12, metabolism-15)
cc(metabolism-15, and-16)
nmod:of(regulation-12, detoxification-17)
conj:and(metabolism-15, detoxification-17)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN ,/, Propiconazole/NNP and/CC serum/NN xenobiotic_receptor/NN levels/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP (NN alkaline_phosphatase))
                (, ,)
                (NP (NNP Propiconazole))
                (CC and)
                (NP (NN serum) (NN xenobiotic_receptor) (NNS levels))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(correlation-8, the-7)
dobj(investigated-6, correlation-8)
case(levels-11, between-9)
compound(levels-11, serum-10)
nmod:between(correlation-8, levels-11)
case(alkaline_phosphatase-13, of-12)
nmod:of(levels-11, alkaline_phosphatase-13)
nmod:of(levels-11, Propiconazole-15)
conj:and(alkaline_phosphatase-13, Propiconazole-15)
cc(alkaline_phosphatase-13, and-16)
compound(levels-19, serum-17)
compound(levels-19, xenobiotic_receptor-18)
nmod:of(levels-11, levels-19)
conj:and(alkaline_phosphatase-13, levels-19)

There/EX was/VBD a/DT correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/RB less/JJR than/IN 0.01/CD -RRB-/-RRB- ,/, Propiconazole/NNP -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/RB less/JJR than/IN 0.01/CD -RRB-/-RRB- and/CC serum/NN xenobiotic_receptor/NN levels/NNS ./.

(ROOT
  (S
    (NP (EX There))
    (VP (VBD was)
      (NP
        (NP (DT a) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP
                  (NP (NN alkaline_phosphatase))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP
                        (FRAG
                          (X
                            (X (SYM r))
                            (NP (SYM =)))
                          (NP (CD 0.3))))
                      (, ,)
                      (ADVP (RB p))
                      (NP
                        (QP (JJR less) (IN than) (CD 0.01))))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NNP Propiconazole))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP
                        (FRAG
                          (X
                            (X (SYM r))
                            (NP (SYM =)))
                          (NP (CD 0.42))))
                      (, ,)
                      (ADVP (RB p))
                      (NP
                        (QP (JJR less) (IN than) (CD 0.01))))
                    (-RRB- -RRB-)))
                (CC and)
                (NP (NN serum) (NN xenobiotic_receptor) (NNS levels))))))))
    (. .)))

expl(was-2, There-1)
root(ROOT-0, was-2)
det(correlation-4, a-3)
nsubj(was-2, correlation-4)
case(levels-7, between-5)
compound(levels-7, serum-6)
nmod:between(correlation-4, levels-7)
case(alkaline_phosphatase-9, of-8)
nmod:of(levels-7, alkaline_phosphatase-9)
dep(=-12, r-11)
dep(0.3-13, =-12)
dep(alkaline_phosphatase-9, 0.3-13)
advmod(0.01-18, p-15)
advmod(0.01-18, less-16)
mwe(less-16, than-17)
appos(0.3-13, 0.01-18)
nmod:of(levels-7, Propiconazole-21)
conj:and(alkaline_phosphatase-9, Propiconazole-21)
dep(=-24, r-23)
dep(0.42-25, =-24)
dep(Propiconazole-21, 0.42-25)
advmod(0.01-30, p-27)
advmod(0.01-30, less-28)
mwe(less-28, than-29)
appos(0.42-25, 0.01-30)
cc(alkaline_phosphatase-9, and-32)
compound(levels-35, serum-33)
compound(levels-35, xenobiotic_receptor-34)
nmod:of(levels-7, levels-35)
conj:and(alkaline_phosphatase-9, levels-35)

These/DT findings/NNS suggest/VBP that/IN serum/NN levels/NNS of/IN these/DT biomarkers/NNS may/MD be/VB useful/JJ indicators/NNS of/IN xenobiotic_receptor/NN activity/NN and/CC may/MD have/VB potential/JJ diagnostic/JJ value/NN in/IN assessing/VBG drug/NN metabolism/NN and/CC toxicity/NN in/IN clinical/JJ settings/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP (DT these) (NNS biomarkers))))
          (VP
            (VP (MD may)
              (VP (VB be)
                (NP
                  (NP (JJ useful) (NNS indicators))
                  (PP (IN of)
                    (NP (NN xenobiotic_receptor) (NN activity))))))
            (CC and)
            (VP (MD may)
              (VP (VB have)
                (NP (JJ potential) (JJ diagnostic) (NN value))
                (PP (IN in)
                  (S
                    (VP (VBG assessing)
                      (NP (NN drug) (NN metabolism)
                        (CC and)
                        (NN toxicity))
                      (PP (IN in)
                        (NP (JJ clinical) (NNS settings))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(indicators-13, that-4)
compound(levels-6, serum-5)
nsubj(indicators-13, levels-6)
nsubj(have-19, levels-6)
case(biomarkers-9, of-7)
det(biomarkers-9, these-8)
nmod:of(levels-6, biomarkers-9)
aux(indicators-13, may-10)
cop(indicators-13, be-11)
amod(indicators-13, useful-12)
ccomp(suggest-3, indicators-13)
case(activity-16, of-14)
compound(activity-16, xenobiotic_receptor-15)
nmod:of(indicators-13, activity-16)
cc(indicators-13, and-17)
aux(have-19, may-18)
ccomp(suggest-3, have-19)
conj:and(indicators-13, have-19)
amod(value-22, potential-20)
amod(value-22, diagnostic-21)
dobj(have-19, value-22)
mark(assessing-24, in-23)
advcl(have-19, assessing-24)
compound(metabolism-26, drug-25)
dobj(assessing-24, metabolism-26)
cc(metabolism-26, and-27)
dobj(assessing-24, toxicity-28)
conj:and(metabolism-26, toxicity-28)
case(settings-31, in-29)
amod(settings-31, clinical-30)
nmod:in(assessing-24, settings-31)

Further/JJ studies/NNS are/VBP needed/VBN to/TO validate/VB these/DT findings/NNS and/CC explore/VB their/PRP$ clinical/JJ implications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB validate)
                (NP (DT these) (NNS findings)))
              (CC and)
              (VP (VB explore)
                (NP (PRP$ their) (JJ clinical) (NNS implications))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(validate-6, studies-2)
nsubj:xsubj(explore-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(validate-6, to-5)
xcomp(needed-4, validate-6)
det(findings-8, these-7)
dobj(validate-6, findings-8)
cc(validate-6, and-9)
xcomp(needed-4, explore-10)
conj:and(validate-6, explore-10)
nmod:poss(implications-13, their-11)
amod(implications-13, clinical-12)
dobj(explore-10, implications-13)

To/TO investigate/VB the/DT effects/NNS of/IN CD4/NNP on/IN the/DT levels/NNS of/IN CRF/NNP messenger/NN RNA/NNP -LRB-/-LRB- mRNA/NN -RRB-/-RRB- in/IN the/DT paraventricular/NN hypothalamic/JJ nucleus/NN -LRB-/-LRB- PVN/NNP -RRB-/-RRB- ,/, on/IN the/DT activation/NN of/IN the/DT PVN/NNP CRF/NNP cells/NNS ,/, and/CC on/IN the/DT plasma/NN levels/NNS of/IN thymulin/NN in/IN lean/JJ -LRB-/-LRB- +/RB //: ?/. -RRB-/-RRB- mice/NNS ./.

(ROOT
  (S
    (VP (TO To)
      (VP (VB investigate)
        (NP
          (NP (DT the) (NNS effects))
          (PP (IN of)
            (NP (NNP CD4))))
        (PP (IN on)
          (NP
            (NP (DT the) (NNS levels))
            (PP (IN of)
              (NP
                (NP (NNP CRF) (NN messenger) (NNP RNA))
                (PRN (-LRB- -LRB-)
                  (NP (NN mRNA))
                  (-RRB- -RRB-))))))
        (PP
          (PP (IN in)
            (NP
              (NP (DT the) (NN paraventricular) (JJ hypothalamic) (NN nucleus))
              (PRN (-LRB- -LRB-)
                (NP (NNP PVN))
                (-RRB- -RRB-))))
          (, ,)
          (PP (IN on)
            (NP
              (NP (DT the) (NN activation))
              (PP (IN of)
                (NP (DT the) (NNP PVN) (NNP CRF) (NNS cells)))))
          (, ,)
          (CC and)
          (PP (IN on)
            (NP
              (NP (DT the) (NN plasma) (NNS levels))
              (PP (IN of)
                (NP
                  (NP (NN thymulin))
                  (PP (IN in)
                    (NP (JJ lean)
                      (PRN (-LRB- -LRB-)
                        (FRAG
                          (ADVP (RB +) (: /))
                          (. ?))
                        (-RRB- -RRB-))
                      (NNS mice))))))))))
    (. .)))

mark(investigate-2, To-1)
root(ROOT-0, investigate-2)
conj:and(investigate-2, investigate-2')
conj:and(investigate-2, investigate-2'')
det(effects-4, the-3)
dobj(investigate-2, effects-4)
case(CD4-6, of-5)
nmod:of(effects-4, CD4-6)
case(levels-9, on-7)
det(levels-9, the-8)
nmod:on(investigate-2, levels-9)
case(RNA-13, of-10)
compound(RNA-13, CRF-11)
compound(RNA-13, messenger-12)
nmod:of(levels-9, RNA-13)
appos(RNA-13, mRNA-15)
case(nucleus-21, in-17)
det(nucleus-21, the-18)
compound(nucleus-21, paraventricular-19)
amod(nucleus-21, hypothalamic-20)
nmod:in(investigate-2, nucleus-21)
appos(nucleus-21, PVN-23)
case(activation-28, on-26)
det(activation-28, the-27)
nmod:on(investigate-2'', activation-28)
case(cells-33, of-29)
det(cells-33, the-30)
compound(cells-33, PVN-31)
compound(cells-33, CRF-32)
nmod:of(activation-28, cells-33)
cc(investigate-2, and-35)
case(levels-39, on-36)
det(levels-39, the-37)
compound(levels-39, plasma-38)
nmod:on(investigate-2', levels-39)
case(thymulin-41, of-40)
nmod:of(levels-39, thymulin-41)
case(mice-49, in-42)
amod(mice-49, lean-43)
dep(mice-49, +-45)
nmod:in(thymulin-41, mice-49)

Corticotropin-releasing_factor/JJ -LRB-/-LRB- CRF/NNP -RRB-/-RRB- is_a/RB major/JJ regulator/NN of/IN this/DT axis/NN ,/, and/CC its/PRP$ expression/NN is/VBZ modulated/VBN by/IN various/JJ factors/NNS ,/, including/VBG CD4/NNP T_cells/NNP ./.

(ROOT
  (S
    (NP
      (NP (JJ Corticotropin-releasing_factor)
        (PRN (-LRB- -LRB-)
          (NP (NNP CRF))
          (-RRB- -RRB-))
        (ADJP (RB is_a) (JJ major))
        (NN regulator))
      (PP (IN of)
        (NP
          (NP (DT this) (NN axis))
          (, ,)
          (CC and)
          (NP (PRP$ its) (NN expression)))))
    (VP (VBZ is)
      (VP (VBN modulated)
        (PP (IN by)
          (NP
            (NP (JJ various) (NNS factors))
            (, ,)
            (VP (VBG including)
              (NP (NNP CD4) (NNP T_cells)))))))
    (. .)))

amod(regulator-7, Corticotropin-releasing_factor-1)
appos(regulator-7, CRF-3)
advmod(major-6, is_a-5)
amod(regulator-7, major-6)
nsubjpass(modulated-16, regulator-7)
case(axis-10, of-8)
det(axis-10, this-9)
nmod:of(regulator-7, axis-10)
cc(axis-10, and-12)
nmod:poss(expression-14, its-13)
nmod:of(regulator-7, expression-14)
conj:and(axis-10, expression-14)
auxpass(modulated-16, is-15)
root(ROOT-0, modulated-16)
case(factors-19, by-17)
amod(factors-19, various-18)
nmod:by(modulated-16, factors-19)
acl(factors-19, including-21)
compound(T_cells-23, CD4-22)
dobj(including-21, T_cells-23)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN CD4/NNP on/IN the/DT levels/NNS of/IN CRF/NNP messenger/NN RNA/NNP -LRB-/-LRB- mRNA/NN -RRB-/-RRB- in/IN the/DT paraventricular/NN hypothalamic/JJ nucleus/NN -LRB-/-LRB- PVN/NNP -RRB-/-RRB- ,/, on/IN the/DT activation/NN of/IN the/DT PVN/NNP CRF/NNP cells/NNS ,/, and/CC on/IN the/DT plasma/NN levels/NNS of/IN thymulin/NN in/IN lean/JJ -LRB-/-LRB- +/RB //: ?/. -RRB-/-RRB- mice/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NNP CD4))))
      (PP (IN on)
        (NP
          (NP (DT the) (NNS levels))
          (PP (IN of)
            (NP
              (NP (NNP CRF) (NN messenger) (NNP RNA))
              (PRN (-LRB- -LRB-)
                (NP (NN mRNA))
                (-RRB- -RRB-))))))
      (PP
        (PP (IN in)
          (NP
            (NP (DT the) (NN paraventricular) (JJ hypothalamic) (NN nucleus))
            (PRN (-LRB- -LRB-)
              (NP (NNP PVN))
              (-RRB- -RRB-))))
        (, ,)
        (PP (IN on)
          (NP
            (NP (DT the) (NN activation))
            (PP (IN of)
              (NP (DT the) (NNP PVN) (NNP CRF) (NNS cells)))))
        (, ,)
        (CC and)
        (PP (IN on)
          (NP
            (NP (DT the) (NN plasma) (NNS levels))
            (PP (IN of)
              (NP (NN thymulin))))))
      (PP (IN in)
        (NP (JJ lean)
          (PRN (-LRB- -LRB-)
            (FRAG
              (ADVP (RB +) (: /))
              (. ?))
            (-RRB- -RRB-))
          (NNS mice))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
nsubj(investigated-6', we-5)
nsubj(investigated-6'', we-5)
root(ROOT-0, investigated-6)
conj:and(investigated-6, investigated-6')
conj:and(investigated-6, investigated-6'')
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(CD4-10, of-9)
nmod:of(effects-8, CD4-10)
case(levels-13, on-11)
det(levels-13, the-12)
nmod:on(investigated-6, levels-13)
case(RNA-17, of-14)
compound(RNA-17, CRF-15)
compound(RNA-17, messenger-16)
nmod:of(levels-13, RNA-17)
appos(RNA-17, mRNA-19)
case(nucleus-25, in-21)
det(nucleus-25, the-22)
compound(nucleus-25, paraventricular-23)
amod(nucleus-25, hypothalamic-24)
nmod:in(investigated-6, nucleus-25)
appos(nucleus-25, PVN-27)
case(activation-32, on-30)
det(activation-32, the-31)
nmod:on(investigated-6', activation-32)
case(cells-37, of-33)
det(cells-37, the-34)
compound(cells-37, PVN-35)
compound(cells-37, CRF-36)
nmod:of(activation-32, cells-37)
cc(investigated-6, and-39)
case(levels-43, on-40)
det(levels-43, the-41)
compound(levels-43, plasma-42)
nmod:on(investigated-6'', levels-43)
case(thymulin-45, of-44)
nmod:of(levels-43, thymulin-45)
case(mice-53, in-46)
amod(mice-53, lean-47)
dep(mice-53, +-49)
nmod:in(investigated-6, mice-53)

Our/PRP$ results/NNS showed/VBD that/IN CD4/NN depletion/NN significantly/RB increased/VBD CRF/NNP mRNA/NN levels/NNS in/IN the/DT PVN/NNP and/CC activated/VBN PVN/NNP CRF/NNP cells/NNS ,/, leading/VBG to/TO elevated/JJ plasma/NN levels/NNS of/IN thymulin/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NN CD4) (NN depletion))
          (ADVP (RB significantly))
          (VP
            (VP (VBD increased)
              (NP (NNP CRF) (NN mRNA) (NNS levels))
              (PP (IN in)
                (NP (DT the) (NNP PVN))))
            (CC and)
            (VP (VBN activated)
              (NP (NNP PVN) (NNP CRF) (NNS cells))
              (, ,)
              (S
                (VP (VBG leading)
                  (PP (TO to)
                    (NP
                      (NP (JJ elevated) (NN plasma) (NNS levels))
                      (PP (IN of)
                        (NP (NN thymulin))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(increased-8, that-4)
compound(depletion-6, CD4-5)
nsubj(increased-8, depletion-6)
nsubj(activated-16, depletion-6)
advmod(increased-8, significantly-7)
ccomp(showed-3, increased-8)
compound(levels-11, CRF-9)
compound(levels-11, mRNA-10)
dobj(increased-8, levels-11)
case(PVN-14, in-12)
det(PVN-14, the-13)
nmod:in(increased-8, PVN-14)
cc(increased-8, and-15)
ccomp(showed-3, activated-16)
conj:and(increased-8, activated-16)
compound(cells-19, PVN-17)
compound(cells-19, CRF-18)
dobj(activated-16, cells-19)
advcl(activated-16, leading-21)
case(levels-25, to-22)
amod(levels-25, elevated-23)
compound(levels-25, plasma-24)
nmod:to(leading-21, levels-25)
case(thymulin-27, of-26)
nmod:of(levels-25, thymulin-27)

These/DT findings/NNS suggest/VBP that/IN CD4/NNP plays/VBZ a/DT critical/JJ role/NN in/IN modulating/VBG HPA_axis/NNP activity/NN by/IN regulating/VBG CRF/NNP expression/NN in/IN the/DT PVN/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP CD4))
          (VP (VBZ plays)
            (NP
              (NP (DT a) (JJ critical) (NN role))
              (PP (IN in)
                (S
                  (VP (VBG modulating)
                    (NP (NNP HPA_axis) (NN activity))
                    (PP (IN by)
                      (S
                        (VP (VBG regulating)
                          (NP
                            (NP (NNP CRF) (NN expression))
                            (PP (IN in)
                              (NP (DT the) (NNP PVN)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(plays-6, that-4)
nsubj(plays-6, CD4-5)
ccomp(suggest-3, plays-6)
det(role-9, a-7)
amod(role-9, critical-8)
dobj(plays-6, role-9)
mark(modulating-11, in-10)
acl(role-9, modulating-11)
compound(activity-13, HPA_axis-12)
dobj(modulating-11, activity-13)
mark(regulating-15, by-14)
advcl(modulating-11, regulating-15)
compound(expression-17, CRF-16)
dobj(regulating-15, expression-17)
case(PVN-20, in-18)
det(PVN-20, the-19)
nmod:in(expression-17, PVN-20)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ applications/NNS of/IN these/DT findings/NNS for/IN stress-related_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN of)
                    (NP
                      (NP (DT these) (NNS findings))
                      (PP (IN for)
                        (NP (NNS stress-related_disorders))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(applications-13, potential-11)
amod(applications-13, therapeutic-12)
dobj(elucidate-6, applications-13)
conj:and(mechanisms-9, applications-13)
case(findings-16, of-14)
det(findings-16, these-15)
nmod:of(applications-13, findings-16)
case(stress-related_disorders-18, for-17)
nmod:for(findings-16, stress-related_disorders-18)

Cell/JJ division/NN cycle/NN 25A/CD -LRB-/-LRB- CDC25A/NNP -RRB-/-RRB- is_a/NN phosphatase/NN that/WDT regulates/VBZ the/DT cell/NN cycle/NN by/IN promoting/VBG the/DT transition/NN from/IN G1/NNP to/TO S/NNP phase/NN ./.

(ROOT
  (NP
    (NP (JJ Cell) (NN division) (NN cycle))
    (NP
      (NP (CD 25A))
      (PRN (-LRB- -LRB-)
        (NP (NNP CDC25A))
        (-RRB- -RRB-)))
    (NP
      (NP (NN is_a) (NN phosphatase))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBZ regulates)
            (NP (DT the) (NN cell) (NN cycle))
            (PP (IN by)
              (S
                (VP (VBG promoting)
                  (NP (DT the) (NN transition))
                  (PP (IN from)
                    (NP (NNP G1)))
                  (PP (TO to)
                    (NP (NNP S) (NN phase))))))))))
    (. .)))

amod(cycle-3, Cell-1)
compound(cycle-3, division-2)
root(ROOT-0, cycle-3)
dep(cycle-3, 25A-4)
appos(25A-4, CDC25A-6)
compound(phosphatase-9, is_a-8)
dep(cycle-3, phosphatase-9)
nsubj(regulates-11, phosphatase-9)
ref(phosphatase-9, that-10)
acl:relcl(phosphatase-9, regulates-11)
det(cycle-14, the-12)
compound(cycle-14, cell-13)
dobj(regulates-11, cycle-14)
mark(promoting-16, by-15)
advcl(regulates-11, promoting-16)
det(transition-18, the-17)
dobj(promoting-16, transition-18)
case(G1-20, from-19)
nmod:from(promoting-16, G1-20)
case(phase-23, to-21)
compound(phase-23, S-22)
nmod:to(promoting-16, phase-23)

Previously/RB ,/, we/PRP reported/VBD that/IN Benzamide_riboside/NNP up-regulated/VBD CDC25A/NNP protein/NN levels/NNS in_a/JJ time-dependent/JJ manner/NN and/CC prolonged/JJ the/DT half-life/NN of/IN the/DT protein/NN ./.

(ROOT
  (S
    (ADVP (RB Previously))
    (, ,)
    (NP (PRP we))
    (VP (VBD reported)
      (SBAR (IN that)
        (S
          (NP (NNP Benzamide_riboside))
          (VP (VBD up-regulated)
            (NP (NNP CDC25A) (NN protein) (NNS levels))
            (NP
              (NP (JJ in_a) (JJ time-dependent) (NN manner))
              (CC and)
              (NP
                (NP (JJ prolonged) (DT the) (NN half-life))
                (PP (IN of)
                  (NP (DT the) (NN protein)))))))))
    (. .)))

advmod(reported-4, Previously-1)
nsubj(reported-4, we-3)
root(ROOT-0, reported-4)
mark(up-regulated-7, that-5)
nsubj(up-regulated-7, Benzamide_riboside-6)
ccomp(reported-4, up-regulated-7)
compound(levels-10, CDC25A-8)
compound(levels-10, protein-9)
iobj(up-regulated-7, levels-10)
amod(manner-13, in_a-11)
amod(manner-13, time-dependent-12)
dobj(up-regulated-7, manner-13)
cc(manner-13, and-14)
amod(half-life-17, prolonged-15)
det(half-life-17, the-16)
dobj(up-regulated-7, half-life-17)
conj:and(manner-13, half-life-17)
case(protein-20, of-18)
det(protein-20, the-19)
nmod:of(half-life-17, protein-20)

However/RB ,/, the/DT underlying/VBG mechanisms/NNS of/IN the/DT upregulation/NN by/IN Benzamide/NNP were/VBD not/RB elucidated/VBN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (VBG underlying) (NNS mechanisms))
      (PP (IN of)
        (NP
          (NP (DT the) (NN upregulation))
          (PP (IN by)
            (NP (NNP Benzamide))))))
    (VP (VBD were) (RB not)
      (VP (VBN elucidated)))
    (. .)))

advmod(elucidated-13, However-1)
det(mechanisms-5, the-3)
amod(mechanisms-5, underlying-4)
nsubjpass(elucidated-13, mechanisms-5)
case(upregulation-8, of-6)
det(upregulation-8, the-7)
nmod:of(mechanisms-5, upregulation-8)
case(Benzamide-10, by-9)
nmod:by(upregulation-8, Benzamide-10)
auxpass(elucidated-13, were-11)
neg(elucidated-13, not-12)
root(ROOT-0, elucidated-13)

Here/RB ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN Benzamide_riboside/NNP on/IN the/DT differentiation/NN of/IN C2C12/CD cells/NNS ,/, a/DT commonly/RB used/VBN skeletal_muscle/JJ cell/NN model/NN ./.

(ROOT
  (S
    (ADVP (RB Here))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NNP Benzamide_riboside)))
        (PP (IN on)
          (NP
            (NP
              (NP (DT the) (NN differentiation))
              (PP (IN of)
                (NP (CD C2C12) (NNS cells))))
            (, ,)
            (NP (DT a)
              (ADJP (RB commonly) (VBN used))
              (JJ skeletal_muscle) (NN cell) (NN model))))))
    (. .)))

advmod(investigated-4, Here-1)
nsubj(investigated-4, we-3)
root(ROOT-0, investigated-4)
det(effects-6, the-5)
dobj(investigated-4, effects-6)
case(Benzamide_riboside-8, of-7)
nmod:of(effects-6, Benzamide_riboside-8)
case(differentiation-11, on-9)
det(differentiation-11, the-10)
nmod:on(effects-6, differentiation-11)
case(cells-14, of-12)
nummod(cells-14, C2C12-13)
nmod:of(differentiation-11, cells-14)
det(model-21, a-16)
advmod(used-18, commonly-17)
amod(model-21, used-18)
amod(model-21, skeletal_muscle-19)
compound(model-21, cell-20)
appos(differentiation-11, model-21)

When/WRB C2C12/NN cells/NNS were/VBD cultured/VBN in_a/JJ medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/,

(ROOT
  (SBARQ
    (WHADVP (WRB When))
    (S
      (NP (NN C2C12) (NNS cells))
      (VP (VBD were)
        (VP (VBN cultured)
          (NP (JJ in_a) (NN medium))
          (S
            (VP (VBG favoring)
              (NP
                (NP (NN differentiation))
                (PRN (-LRB- -LRB-)
                  (S
                    (NP (NNP Dulbecco))
                    (VP (VBN modified)
                      (NP
                        (NP (NNP Eagle) (NN medium))
                        (VP (VBG containing)
                          (NP
                            (ADJP (CD 2) (NN %))
                            (NN horse) (NN serum))))))
                  (-RRB- -RRB-)))))
          (, ,))))))

advmod(cultured-5, When-1)
compound(cells-3, C2C12-2)
nsubjpass(cultured-5, cells-3)
auxpass(cultured-5, were-4)
root(ROOT-0, cultured-5)
amod(medium-7, in_a-6)
dobj(cultured-5, medium-7)
xcomp(cultured-5, favoring-8)
dobj(favoring-8, differentiation-9)
nsubj(modified-12, Dulbecco-11)
dep(differentiation-9, modified-12)
compound(medium-14, Eagle-13)
dobj(modified-12, medium-14)
acl(medium-14, containing-15)
compound(%-17, 2-16)
amod(serum-19, %-17)
compound(serum-19, horse-18)
dobj(containing-15, serum-19)

Benzamide_riboside/JJ treatment/NN up-regulated/VBD CDC25A/NNP protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ CDC25A/NNP protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (JJ Benzamide_riboside) (NN treatment))
    (VP (VBD up-regulated)
      (NP (NNP CDC25A) (NN protein) (NNS levels))
      (NP (NN in_a)
        (NX
          (NX (JJ time-dependent) (NN manner))
          (CC and)
          (NX (JJ prolonged) (NNP CDC25A) (NN protein)))
        (NX (NN half-life)))
      (PP (IN from)
        (NP
          (QP (CD 10) (TO to) (CD 18))
          (NNS hours))))
    (. .)))

amod(treatment-2, Benzamide_riboside-1)
nsubj(up-regulated-3, treatment-2)
root(ROOT-0, up-regulated-3)
compound(levels-6, CDC25A-4)
compound(levels-6, protein-5)
iobj(up-regulated-3, levels-6)
dep(half-life-14, in_a-7)
amod(manner-9, time-dependent-8)
dep(half-life-14, manner-9)
cc(manner-9, and-10)
amod(protein-13, prolonged-11)
compound(protein-13, CDC25A-12)
conj:and(manner-9, protein-13)
dep(half-life-14, protein-13)
dobj(up-regulated-3, half-life-14)
case(hours-19, from-15)
compound(18-18, 10-16)
dep(18-18, to-17)
nummod(hours-19, 18-18)
nmod:from(up-regulated-3, hours-19)

CDC25A/NNP is_a/NN phosphatase/NN that/WDT regulates/VBZ the/DT cell/NN cycle/NN by/IN promoting/VBG the/DT transition/NN from/IN G1/NNP to/TO S/NNP phase/NN ,/, and/CC its/PRP$ upregulation/NN is/VBZ associated/VBN with/IN increased/VBN proliferation/NN and/CC differentiation/NN ./.

(ROOT
  (S
    (NP
      (NP (NNP CDC25A) (NN is_a) (NN phosphatase))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBZ regulates)
            (NP (DT the) (NN cell) (NN cycle))
            (PP (IN by)
              (S
                (VP (VBG promoting)
                  (NP
                    (NP (DT the) (NN transition))
                    (PP (IN from)
                      (NP (NNP G1))))
                  (PP (TO to)
                    (NP
                      (NP (NNP S) (NN phase))
                      (, ,)
                      (CC and)
                      (NP (PRP$ its) (NN upregulation)))))))))))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP (VBN increased) (NN proliferation)
            (CC and)
            (NN differentiation)))))
    (. .)))

compound(phosphatase-3, CDC25A-1)
compound(phosphatase-3, is_a-2)
nsubj(regulates-5, phosphatase-3)
nsubjpass(associated-23, phosphatase-3)
ref(phosphatase-3, that-4)
acl:relcl(phosphatase-3, regulates-5)
det(cycle-8, the-6)
compound(cycle-8, cell-7)
dobj(regulates-5, cycle-8)
mark(promoting-10, by-9)
advcl(regulates-5, promoting-10)
det(transition-12, the-11)
dobj(promoting-10, transition-12)
case(G1-14, from-13)
nmod:from(transition-12, G1-14)
case(phase-17, to-15)
compound(phase-17, S-16)
nmod:to(promoting-10, phase-17)
cc(phase-17, and-19)
nmod:poss(upregulation-21, its-20)
nmod:to(promoting-10, upregulation-21)
conj:and(phase-17, upregulation-21)
auxpass(associated-23, is-22)
root(ROOT-0, associated-23)
case(proliferation-26, with-24)
amod(proliferation-26, increased-25)
nmod:with(associated-23, proliferation-26)
cc(proliferation-26, and-27)
nmod:with(associated-23, differentiation-28)
conj:and(proliferation-26, differentiation-28)

Our/PRP$ findings/NNS suggest/VBP that/IN Benzamide_riboside/NNP may/MD have/VB potential/JJ as/IN a/DT regulator/NN of_skeletal_muscle/NN differentiation_and/JJ warrant/NN further/RBR investigation/NN into/IN its/PRP$ underlying/VBG mechanisms/NNS of/IN action/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Benzamide_riboside))
          (VP (MD may)
            (VP (VB have)
              (NP
                (ADJP (JJ potential)
                  (PP (IN as)
                    (NP
                      (NP (DT a) (NN regulator) (NN of_skeletal_muscle))
                      (ADVP
                        (NP (JJ differentiation_and) (NN warrant))
                        (RBR further)))))
                (NN investigation))
              (PP (IN into)
                (NP
                  (NP (PRP$ its) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (NN action))))))))))
    (. .)))

nmod:poss(findings-2, Our-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, Benzamide_riboside-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(investigation-16, potential-8)
case(of_skeletal_muscle-12, as-9)
det(of_skeletal_muscle-12, a-10)
compound(of_skeletal_muscle-12, regulator-11)
nmod:as(potential-8, of_skeletal_muscle-12)
amod(warrant-14, differentiation_and-13)
nmod:npmod(further-15, warrant-14)
advmod(of_skeletal_muscle-12, further-15)
dobj(have-7, investigation-16)
case(mechanisms-20, into-17)
nmod:poss(mechanisms-20, its-18)
amod(mechanisms-20, underlying-19)
nmod:into(have-7, mechanisms-20)
case(action-22, of-21)
nmod:of(mechanisms-20, action-22)

Metastasis-associated/JJ transcript-2/NNS -LRB-/-LRB- mT-2/JJ -RRB-/-RRB- has_been/VBP implicated/VBN in/IN the/DT pathogenesis/NNS of/IN obesity/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Metastasis-associated) (NNS transcript-2))
      (PRN (-LRB- -LRB-) (JJ mT-2) (-RRB- -RRB-)))
    (VP (VBP has_been)
      (VP (VBN implicated)
        (PP (IN in)
          (NP
            (NP (DT the) (NNS pathogenesis))
            (PP (IN of)
              (NP (NN obesity)))))))
    (. .)))

amod(transcript-2-2, Metastasis-associated-1)
nsubj(has_been-6, transcript-2-2)
dep(transcript-2-2, mT-2-4)
root(ROOT-0, has_been-6)
dep(has_been-6, implicated-7)
case(pathogenesis-10, in-8)
det(pathogenesis-10, the-9)
nmod:in(implicated-7, pathogenesis-10)
case(obesity-12, of-11)
nmod:of(pathogenesis-10, obesity-12)

However/RB ,/, the/DT role/NN of/IN mT2/NNS in/IN the/DT development/NN of/IN obesity/NN remains/VBZ unclear/JJ ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN role))
      (PP (IN of)
        (NP
          (NP (NNS mT2))
          (PP (IN in)
            (NP
              (NP (DT the) (NN development))
              (PP (IN of)
                (NP (NN obesity))))))))
    (VP (VBZ remains)
      (ADJP (JJ unclear)))
    (. .)))

advmod(remains-12, However-1)
det(role-4, the-3)
nsubj(remains-12, role-4)
case(mT2-6, of-5)
nmod:of(role-4, mT2-6)
case(development-9, in-7)
det(development-9, the-8)
nmod:in(mT2-6, development-9)
case(obesity-11, of-10)
nmod:of(development-9, obesity-11)
root(ROOT-0, remains-12)
xcomp(remains-12, unclear-13)

We/PRP have/VBP previously/RB shown/VBN that/IN the/DT effects/NNS of/IN glucose/NN and/CC glutaric_anhydride/NN on/IN the/DT secretion/NN of/IN insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/JJ -LRB-/-LRB- fa/fa/FW -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/SYM //FW ?/. -RRB-/-RRB- subjects/NNS were/VBD similar/JJ -LRB-/NNS -RRB-/-RRB-

(ROOT
  (PRN
    (S
      (NP (PRP We))
      (VP (VBP have) (RB previously)
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (NNS effects))
                (PP (IN of)
                  (NP
                    (NP (NN glucose)
                      (CC and)
                      (NN glutaric_anhydride))
                    (PP (IN on)
                      (NP
                        (NP (DT the) (NN secretion))
                        (PP (IN of)
                          (NP
                            (NP (NN insulin))
                            (PP (IN by)
                              (NP
                                (NP (VBN isolated) (JJ perfused) (NN pancreata))
                                (PP (IN from)
                                  (NP
                                    (ADJP
                                      (ADJP
                                        (ADJP (JJ genetically_obese))
                                        (PRN (-LRB- -LRB-)
                                          (ADJP (FW fa/fa))
                                          (-RRB- -RRB-)))
                                      (CC and)
                                      (ADJP (JJ lean)))
                                    (PRN (-LRB- -LRB-)
                                      (X
                                        (X (SYM Fa))
                                        (ADJP (FW /) (. ?)))
                                      (-RRB- -RRB-))
                                    (NNS subjects))))))))))))
              (VP (VBD were)
                (NP (JJ similar) (NNS -LRB-))))))))
    (-RRB- -RRB-)))

nsubj(shown-4, We-1)
aux(shown-4, have-2)
advmod(shown-4, previously-3)
root(ROOT-0, shown-4)
mark(-LRB--36, that-5)
det(effects-7, the-6)
nsubj(-LRB--36, effects-7)
case(glucose-9, of-8)
nmod:of(effects-7, glucose-9)
cc(glucose-9, and-10)
nmod:of(effects-7, glutaric_anhydride-11)
conj:and(glucose-9, glutaric_anhydride-11)
case(secretion-14, on-12)
det(secretion-14, the-13)
nmod:on(glucose-9, secretion-14)
case(insulin-16, of-15)
nmod:of(secretion-14, insulin-16)
case(pancreata-20, by-17)
amod(pancreata-20, isolated-18)
amod(pancreata-20, perfused-19)
nmod:by(insulin-16, pancreata-20)
case(subjects-33, from-21)
amod(subjects-33, genetically_obese-22)
dep(genetically_obese-22, fa/fa-24)
cc(genetically_obese-22, and-26)
conj:and(genetically_obese-22, lean-27)
amod(subjects-33, lean-27)
dep(/-30, Fa-29)
dep(subjects-33, /-30)
nmod:from(pancreata-20, subjects-33)
cop(-LRB--36, were-34)
amod(-LRB--36, similar-35)
ccomp(shown-4, -LRB--36)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO assess/VB the/DT relationship/NN between/IN obesity/NN and/CC hypersecretion/NN of/IN mT-2/JJ by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB assess)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP (NN obesity)
                    (CC and)
                    (NN hypersecretion))
                  (PP (IN of)
                    (NP (JJ mT-2))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(assess-8, we-5)
root(ROOT-0, aimed-6)
mark(assess-8, to-7)
xcomp(aimed-6, assess-8)
det(relationship-10, the-9)
dobj(assess-8, relationship-10)
case(obesity-12, between-11)
nmod:between(relationship-10, obesity-12)
cc(obesity-12, and-13)
nmod:between(relationship-10, hypersecretion-14)
conj:and(obesity-12, hypersecretion-14)
case(mT-2-16, of-15)
nmod:of(obesity-12, mT-2-16)
case(pancreas-19, by-17)
det(pancreas-19, the-18)
nmod:by(assess-8, pancreas-19)

To/TO achieve/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ glutaric_anhydride/NN on/IN the/DT secretion/NN of/IN mT-2/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- subjects/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN glutaric_anhydride)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ mT-2) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS subjects)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(glutaric_anhydride-16, 10-14)
amod(glutaric_anhydride-16, mmol/L-15)
nmod:of(effects-8, glutaric_anhydride-16)
conj:and(glucose-12, glutaric_anhydride-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(and_insulin-22, of-20)
amod(and_insulin-22, mT-2-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(genetically_obese-28, from-27)
nmod:from(pancreata-26, genetically_obese-28)
appos(genetically_obese-28, fa/fa-30)
cc(genetically_obese-28, and-32)
amod(subjects-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(pancreata-26, subjects-39)
conj:and(genetically_obese-28, subjects-39)

Our/PRP$ results/NNS showed/VBD that/IN obese/JJ subjects/NNS had/VBD a/DT significantly/RB higher/JJR secretion/NN of/IN mT-2/JJ compared/VBN to/TO lean/VB subjects/NNS in/IN response/NN to/TO both/DT glucose/NN and/CC glutaric_anhydride/JJ stimulation/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ obese) (NNS subjects))
          (VP (VBD had)
            (NP
              (NP (DT a)
                (ADJP (RB significantly) (JJR higher))
                (NN secretion))
              (PP (IN of)
                (NP (JJ mT-2)))
              (VP (VBN compared)
                (S
                  (VP (TO to)
                    (VP (VB lean)
                      (NP (NNS subjects))
                      (PP (IN in)
                        (NP
                          (NP (NN response))
                          (PP (TO to)
                            (NP
                              (NP (DT both) (NN glucose))
                              (CC and)
                              (NP (JJ glutaric_anhydride) (NN stimulation)))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(had-7, that-4)
amod(subjects-6, obese-5)
nsubj(had-7, subjects-6)
ccomp(showed-3, had-7)
det(secretion-11, a-8)
advmod(higher-10, significantly-9)
amod(secretion-11, higher-10)
dobj(had-7, secretion-11)
case(mT-2-13, of-12)
nmod:of(secretion-11, mT-2-13)
acl(secretion-11, compared-14)
mark(lean-16, to-15)
xcomp(compared-14, lean-16)
dobj(lean-16, subjects-17)
case(response-19, in-18)
nmod:in(lean-16, response-19)
case(glucose-22, to-20)
det(glucose-22, both-21)
nmod:to(response-19, glucose-22)
cc(glucose-22, and-23)
amod(stimulation-25, glutaric_anhydride-24)
nmod:to(response-19, stimulation-25)
conj:and(glucose-22, stimulation-25)

However/RB ,/, there/EX was/VBD no/DT significant/JJ difference/NN in/IN insulin_secretion/NN between/IN the/DT two/CD groups/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP (DT no) (JJ significant) (NN difference))
        (PP (IN in)
          (NP (NN insulin_secretion)))
        (PP (IN between)
          (NP (DT the) (CD two) (NNS groups)))))
    (. .)))

advmod(was-4, However-1)
expl(was-4, there-3)
root(ROOT-0, was-4)
neg(difference-7, no-5)
amod(difference-7, significant-6)
nsubj(was-4, difference-7)
case(insulin_secretion-9, in-8)
nmod:in(difference-7, insulin_secretion-9)
case(groups-13, between-10)
det(groups-13, the-11)
nummod(groups-13, two-12)
nmod:between(difference-7, groups-13)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN mT-2/JJ may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ,/, possibly/RB through/IN its/PRP$ effects/NNS on/IN lipid/NN metabolism/NN or/CC appetite/NN regulation/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (JJ mT-2))))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))))
              (, ,)
              (PP
                (ADVP (RB possibly))
                (IN through)
                (NP
                  (NP (PRP$ its) (NNS effects))
                  (PP (IN on)
                    (NP
                      (NP (NN lipid) (NN metabolism))
                      (CC or)
                      (NP (NN appetite) (NN regulation)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-9, that-4)
nsubj(play-9, hypersecretion-5)
case(mT-2-7, of-6)
nmod:of(hypersecretion-5, mT-2-7)
aux(play-9, may-8)
ccomp(suggest-3, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
case(development-14, in-12)
det(development-14, the-13)
nmod:in(role-11, development-14)
case(obesity-16, of-15)
nmod:of(development-14, obesity-16)
advmod(effects-21, possibly-18)
case(effects-21, through-19)
nmod:poss(effects-21, its-20)
nmod:through(play-9, effects-21)
case(metabolism-24, on-22)
compound(metabolism-24, lipid-23)
nmod:on(effects-21, metabolism-24)
cc(metabolism-24, or-25)
compound(regulation-27, appetite-26)
nmod:on(effects-21, regulation-27)
conj:or(metabolism-24, regulation-27)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG this/DT relationship/NN and/CC to/TO explore/VB potential/JJ therapeutic/JJ targets/NNS for/IN obesity/JJ management/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT this) (NN relationship))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP (JJ obesity) (NN management))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(relationship-11, this-10)
dobj(underlying-9, relationship-11)
cc(elucidate-6, and-12)
mark(explore-14, to-13)
ccomp(needed-4, explore-14)
conj:and(elucidate-6, explore-14)
amod(targets-17, potential-15)
amod(targets-17, therapeutic-16)
dobj(explore-14, targets-17)
case(management-20, for-18)
amod(management-20, obesity-19)
nmod:for(targets-17, management-20)

The/DT endothelin/NN system/NN ,/, consisting/VBG of/IN endothelin-1/JJ -LRB-/-LRB- ET-1/NNP -RRB-/-RRB- and/CC its/PRP$ receptors/NNS ETA_and_ETB/NNP ,/, has_been/VBP implicated/VBN in/IN various/JJ physiological/JJ and/CC pathological/JJ processes/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN endothelin) (NN system))
      (, ,)
      (VP (VBG consisting)
        (PP (IN of)
          (NP
            (NP
              (ADVP (JJ endothelin-1))
              (NP (-LRB- -LRB-) (NNP ET-1) (-RRB- -RRB-))
              (CC and)
              (NP (PRP$ its) (NNS receptors)))
            (NP (NNP ETA_and_ETB)))))
      (, ,))
    (VP (VBP has_been)
      (VP (VBN implicated)
        (PP (IN in)
          (NP (JJ various)
            (ADJP (JJ physiological)
              (CC and)
              (JJ pathological))
            (NNS processes)))))
    (. .)))

det(system-3, The-1)
compound(system-3, endothelin-2)
nsubj(has_been-16, system-3)
acl(system-3, consisting-5)
case(ET-1-9, of-6)
advmod(ET-1-9, endothelin-1-7)
nmod:of(consisting-5, ET-1-9)
cc(ET-1-9, and-11)
nmod:poss(receptors-13, its-12)
nmod:of(consisting-5, receptors-13)
conj:and(ET-1-9, receptors-13)
appos(ET-1-9, ETA_and_ETB-14)
root(ROOT-0, has_been-16)
dep(has_been-16, implicated-17)
case(processes-23, in-18)
amod(processes-23, various-19)
amod(processes-23, physiological-20)
cc(physiological-20, and-21)
conj:and(physiological-20, pathological-22)
amod(processes-23, pathological-22)
nmod:in(implicated-17, processes-23)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN the/DT ET/NNP system/NN on/IN M50354/NN levels/NNS were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP (DT the) (NNP ET) (NN system)))
      (PP (IN on)
        (NP (NN M50354) (NNS levels))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-15, study-3)
det(effects-6, the-5)
nsubjpass(investigated-15, effects-6)
case(system-10, of-7)
det(system-10, the-8)
compound(system-10, ET-9)
nmod:of(effects-6, system-10)
case(levels-13, on-11)
compound(levels-13, M50354-12)
nmod:on(effects-6, levels-13)
auxpass(investigated-15, were-14)
root(ROOT-0, investigated-15)

The/DT effects/NNS of/IN ET-1_and/NNS the/DT ETB/NNP receptor/NN agonist/NN TH_1/NN -LRB-/-LRB- 10/CD -LRB-/-LRB- -6/NN -RRB-/-RRB- M/NNP -RRB-/-RRB- on/IN M/NNP 50354/CD levels/NNS in/IN human/JJ platelets/NNS were/VBD examined/VBN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS effects))
      (PP (IN of)
        (NP
          (NP
            (NP (NNS ET-1_and))
            (NP (DT the) (NNP ETB) (NN receptor) (NN agonist) (NN TH_1)))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 10) (-LRB- -LRB-) (NN -6) (-RRB- -RRB-))
              (NP (NNP M)))
            (-RRB- -RRB-))))
      (PP (IN on)
        (NP
          (NP (NNP M) (CD 50354) (NNS levels))
          (PP (IN in)
            (NP (JJ human) (NNS platelets))))))
    (VP (VBD were)
      (VP (VBN examined)))
    (. .)))

det(effects-2, The-1)
nsubjpass(examined-25, effects-2)
case(ET-1_and-4, of-3)
nmod:of(effects-2, ET-1_and-4)
det(TH_1-9, the-5)
compound(TH_1-9, ETB-6)
compound(TH_1-9, receptor-7)
compound(TH_1-9, agonist-8)
dep(ET-1_and-4, TH_1-9)
nummod(-6-13, 10-11)
dep(ET-1_and-4, -6-13)
appos(-6-13, M-15)
case(levels-20, on-17)
compound(levels-20, M-18)
nummod(levels-20, 50354-19)
nmod:on(effects-2, levels-20)
case(platelets-23, in-21)
amod(platelets-23, human-22)
nmod:in(levels-20, platelets-23)
auxpass(examined-25, were-24)
root(ROOT-0, examined-25)

Treatment/NNP with/IN 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB-

(ROOT
  (NP
    (NP (NNP Treatment))
    (PP (IN with)
      (NP
        (NP (CD 10))
        (PRN (-LRB- -LRB-)
          (NP (CD -6))
          (-RRB- -RRB-))))))

root(ROOT-0, Treatment-1)
case(10-3, with-2)
nmod:with(Treatment-1, 10-3)
appos(10-3, -6-5)

M/NNP TH_1/NNP resulted/VBD in_a/NN dose/NN -/: and/CC time-dependent/JJ increase/NN in/IN platelet-derived_growth_factor-beta/JJ -LRB-/-LRB- PDGF-beta/NNP -RRB-/-RRB- mRNA/NN and/CC protein/NN levels/NNS ,/, as/RB well/RB as/IN an/DT increase/NN in/IN total/JJ cellular/JJ protein/NN levels/NNS of/IN M50/CD 354/CD levels/NNS ./.

(ROOT
  (S
    (NP (NNP M) (NNP TH_1))
    (VP (VBD resulted)
      (NP
        (NP (NN in_a) (NN dose))
        (: -)
        (CC and)
        (NP
          (NP (JJ time-dependent) (NN increase))
          (PP (IN in)
            (NP
              (NP (JJ platelet-derived_growth_factor-beta)
                (PRN (-LRB- -LRB-)
                  (NP (NNP PDGF-beta))
                  (-RRB- -RRB-))
                (NN mRNA))
              (CC and)
              (NP
                (NP (NN protein) (NNS levels))
                (, ,)
                (ADVP (RB as) (RB well)
                  (PP (IN as)
                    (NP
                      (NP (DT an) (NN increase))
                      (PP (IN in)
                        (NP
                          (NP (JJ total) (JJ cellular) (NN protein) (NNS levels))
                          (PP (IN of)
                            (NP
                              (QP (CD M50) (CD 354))
                              (NNS levels))))))))))))))
    (. .)))

compound(TH_1-2, M-1)
nsubj(resulted-3, TH_1-2)
root(ROOT-0, resulted-3)
compound(dose-5, in_a-4)
dobj(resulted-3, dose-5)
cc(dose-5, and-7)
amod(increase-9, time-dependent-8)
dobj(resulted-3, increase-9)
conj:and(dose-5, increase-9)
case(mRNA-15, in-10)
amod(mRNA-15, platelet-derived_growth_factor-beta-11)
appos(mRNA-15, PDGF-beta-13)
nmod:in(increase-9, mRNA-15)
cc(mRNA-15, and-16)
compound(levels-18, protein-17)
nmod:in(increase-9, levels-18)
conj:and(mRNA-15, levels-18)
advmod(well-21, as-20)
advmod(levels-18, well-21)
case(increase-24, as-22)
det(increase-24, an-23)
nmod:as(well-21, increase-24)
case(levels-29, in-25)
amod(levels-29, total-26)
amod(levels-29, cellular-27)
compound(levels-29, protein-28)
nmod:in(increase-24, levels-29)
case(levels-33, of-30)
compound(354-32, M50-31)
nummod(levels-33, 354-32)
nmod:of(levels-29, levels-33)

However/RB ,/, this/DT stimulatory/JJ effect/NN was/VBD effectively/RB blocked/VBN by/IN the/DT ETA_receptor/NNP antagonist/NNP BQ_123/NNP -LRB-/-LRB- 2/CD x/SYM 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (DT this) (JJ stimulatory) (NN effect))
    (VP (VBD was) (RB effectively)
      (VP (VBN blocked)
        (PP (IN by)
          (NP
            (NP (DT the) (NNP ETA_receptor) (NNP antagonist) (NNP BQ_123))
            (PRN (-LRB- -LRB-)
              (NP
                (NP
                  (NP
                    (NP (CD 2))
                    (SBAR
                      (FRAG
                        (X (SYM x))
                        (NP (CD 10)))))
                  (PRN (-LRB- -LRB-)
                    (NP (CD -6))
                    (-RRB- -RRB-)))
                (NP (NNP M)))
              (-RRB- -RRB-))))))
    (. .)))

advmod(blocked-8, However-1)
det(effect-5, this-3)
amod(effect-5, stimulatory-4)
nsubjpass(blocked-8, effect-5)
auxpass(blocked-8, was-6)
advmod(blocked-8, effectively-7)
root(ROOT-0, blocked-8)
case(BQ_123-13, by-9)
det(BQ_123-13, the-10)
compound(BQ_123-13, ETA_receptor-11)
compound(BQ_123-13, antagonist-12)
nmod:by(blocked-8, BQ_123-13)
dep(BQ_123-13, 2-15)
dep(10-17, x-16)
dep(2-15, 10-17)
appos(2-15, -6-19)
appos(2-15, M-21)

On/IN the/DT other/JJ hand/NN ,/, treatment/NN with/IN the/DT ETB/NNP receptor/NN agonist/VBD IRL_1620/NNP only/RB elicited/VBD a/DT weak/JJ increase/NN in/IN M50354/CD levels/NNS ./.

(ROOT
  (S
    (PP (IN On)
      (NP (DT the) (JJ other) (NN hand)))
    (, ,)
    (NP
      (NP (NN treatment))
      (PP (IN with)
        (NP (DT the) (NNP ETB) (NN receptor))))
    (VP (VBD agonist)
      (SBAR
        (S
          (NP (NNP IRL_1620))
          (ADVP (RB only))
          (VP (VBD elicited)
            (NP
              (NP (DT a) (JJ weak) (NN increase))
              (PP (IN in)
                (NP (CD M50354) (NNS levels))))))))
    (. .)))

case(hand-4, On-1)
det(hand-4, the-2)
amod(hand-4, other-3)
nmod:on(agonist-11, hand-4)
nsubj(agonist-11, treatment-6)
case(receptor-10, with-7)
det(receptor-10, the-8)
compound(receptor-10, ETB-9)
nmod:with(treatment-6, receptor-10)
root(ROOT-0, agonist-11)
nsubj(elicited-14, IRL_1620-12)
advmod(elicited-14, only-13)
ccomp(agonist-11, elicited-14)
det(increase-17, a-15)
amod(increase-17, weak-16)
dobj(elicited-14, increase-17)
case(levels-20, in-18)
nummod(levels-20, M50354-19)
nmod:in(increase-17, levels-20)

These/DT results/NNS suggest/VBP that/IN the/DT ETA_receptor/NNP plays/VBZ a/DT significant/JJ role/NN in/IN regulating/VBG M50354/CD levels/NNS and/CC that/IN targeting/VBG this/DT receptor/NN may/MD have/VB therapeutic/JJ potential/NN for/IN conditions/NNS associated/VBN with/IN altered/JJ M50354/NN signaling/VBG ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR
        (SBAR (IN that)
          (S
            (NP (DT the) (NNP ETA_receptor))
            (VP (VBZ plays)
              (NP
                (NP (DT a) (JJ significant) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (CD M50354) (NNS levels)))))))))
        (CC and)
        (SBAR (IN that)
          (S
            (S
              (VP (VBG targeting)
                (NP (DT this) (NN receptor))))
            (VP (MD may)
              (VP (VB have)
                (NP
                  (NP (JJ therapeutic) (NN potential))
                  (PP (IN for)
                    (NP
                      (NP (NNS conditions))
                      (VP (VBN associated)
                        (PP (IN with)
                          (NP (JJ altered) (NN M50354) (VBG signaling)))))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(plays-7, that-4)
det(ETA_receptor-6, the-5)
nsubj(plays-7, ETA_receptor-6)
ccomp(suggest-3, plays-7)
det(role-10, a-8)
amod(role-10, significant-9)
dobj(plays-7, role-10)
mark(regulating-12, in-11)
acl(role-10, regulating-12)
nummod(levels-14, M50354-13)
dobj(regulating-12, levels-14)
cc(plays-7, and-15)
mark(have-21, that-16)
csubj(have-21, targeting-17)
det(receptor-19, this-18)
dobj(targeting-17, receptor-19)
aux(have-21, may-20)
ccomp(suggest-3, have-21)
conj:and(plays-7, have-21)
amod(potential-23, therapeutic-22)
dobj(have-21, potential-23)
case(conditions-25, for-24)
nmod:for(potential-23, conditions-25)
acl(conditions-25, associated-26)
case(M50354-29, with-27)
amod(M50354-29, altered-28)
nmod:with(associated-26, M50354-29)
amod(M50354-29, signaling-30)

Omega-3_fatty_acids/NNP ,/, particularly/RB eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB cardiovascular_benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNP Omega-3_fatty_acids))
      (, ,)
      (NP
        (NP
          (NP (RB particularly) (JJ eicosapentaenoic_acid)
            (PRN (-LRB- -LRB-)
              (NP (NNP EPA))
              (-RRB- -RRB-)))
          (CC and)
          (NP (NN docosahexaenoic)))
        (PRN (-LRB- -LRB-)
          (NP (NNP DHA))
          (-RRB- -RRB-)))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (NNS cardiovascular_benefits))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(have-18, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, particularly-3)
appos(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
appos(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
appos(Omega-3_fatty_acids-1, docosahexaenoic-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic-9)
appos(eicosapentaenoic_acid-4, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(have-18, to-17)
xcomp(shown-16, have-18)
dobj(have-18, cardiovascular_benefits-19)

Long-chain/JJ omega-three/JJ fatty_acids/NNS ,/, eicosaapentaenic/JJ acid/NN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/JJ -RRB-/-RRB- and/CC docoshexaeneic/JJ acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n/NN -3/CD -RRB-/-RRB- ,/, are/VBP associated/VBN with/IN decreased/VBN clofibrate/NN levels/NNS in/IN hyperclofibratemic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-three) (NNS fatty_acids))
      (, ,)
      (NP
        (NP
          (NP (JJ eicosaapentaenic) (NN acid))
          (-LRB- -LRB-)
          (NP (NNP EPA))
          (-RRB- -RRB-) (-LRB- -LRB-)
          (ADJP (CD 20:5) (JJ n-3))
          (-RRB- -RRB-))
        (CC and)
        (NP
          (NP (JJ docoshexaeneic) (NN acid))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 22:6) (NN n))
              (NP (CD -3)))
            (-RRB- -RRB-))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN associated)
          (PP (IN with)
            (NP (VBN decreased) (NN clofibrate) (NNS levels)))
          (PP (IN in)
            (NP (JJ hyperclofibratemic) (NNS patients)))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(fatty_acids-3, Long-chain-1)
amod(fatty_acids-3, omega-three-2)
nsubjpass(associated-27, fatty_acids-3)
nsubjpass(decreased-36, fatty_acids-3)
amod(acid-6, eicosaapentaenic-5)
appos(fatty_acids-3, acid-6)
dep(acid-6, EPA-8)
compound(n-3-12, 20:5-11)
amod(acid-6, n-3-12)
cc(acid-6, and-14)
amod(acid-16, docoshexaeneic-15)
appos(fatty_acids-3, acid-16)
conj:and(acid-6, acid-16)
appos(acid-16, DHA-18)
nummod(n-22, 22:6-21)
dep(acid-16, n-22)
dep(n-22, -3-23)
auxpass(associated-27, are-26)
root(ROOT-0, associated-27)
case(levels-31, with-28)
amod(levels-31, decreased-29)
compound(levels-31, clofibrate-30)
nmod:with(associated-27, levels-31)
case(patients-34, in-32)
amod(patients-34, hyperclofibratemic-33)
nmod:in(associated-27, patients-34)
cc(associated-27, and-35)
conj:and(associated-27, decreased-36)
dobj(decreased-36, risk-37)
case(coronary_heart_disease-40, of-38)
amod(coronary_heart_disease-40, developing-39)
nmod:of(risk-37, coronary_heart_disease-40)
appos(coronary_heart_disease-40, CHD-42)

In/IN addition/NN ,/, the/DT plasma/NN levels/NNS of/IN EPA/NNP and/CC DHA/NNP have/VBP been/VBN found/VBN to_be/NN inversely/RB associated/VBN with/IN the/DT risk/NN of/IN coronary_heart_diseases/NNS -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP
      (NP (DT the) (NN plasma) (NNS levels))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA))))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (NP
            (NP
              (NP (NN to_be))
              (VP
                (ADVP (RB inversely))
                (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP (NNS coronary_heart_diseases)))))))
            (PRN (-LRB- -LRB-)
              (NP (NNP CHD))
              (-RRB- -RRB-))))))
    (. .)))

case(addition-2, In-1)
nmod:in(found-13, addition-2)
det(levels-6, the-4)
compound(levels-6, plasma-5)
nsubjpass(found-13, levels-6)
case(EPA-8, of-7)
nmod:of(levels-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(levels-6, DHA-10)
conj:and(EPA-8, DHA-10)
aux(found-13, have-11)
auxpass(found-13, been-12)
root(ROOT-0, found-13)
dobj(found-13, to_be-14)
advmod(associated-16, inversely-15)
acl(to_be-14, associated-16)
case(risk-19, with-17)
det(risk-19, the-18)
nmod:with(associated-16, risk-19)
case(coronary_heart_diseases-21, of-20)
nmod:of(risk-19, coronary_heart_diseases-21)
appos(to_be-14, CHD-23)

This/DT may/MD be/VB due/JJ to/TO the/DT protective/JJ effects/NNS of/IN EPA/NNP ,/, DHA/NNP ,/, and/CC their/PRP$ metabolites/NNS on/IN atherosclerosis/NNS ,/, but/CC the/DT mechanism/NN by/IN which/WDT these/DT fatty_acids/NNS may/MD contribute/VB to/TO the/DT prevention/NN of/IN CHD/NNP remains/VBZ to_be/JJ elucidated/NN ./.

(ROOT
  (S
    (S
      (NP (DT This))
      (VP (MD may)
        (VP (VB be)
          (ADJP (JJ due)
            (PP (TO to)
              (NP
                (NP
                  (NP (DT the) (JJ protective) (NNS effects))
                  (PP (IN of)
                    (NP (NNP EPA) (, ,) (NNP DHA))))
                (, ,)
                (CC and)
                (NP
                  (NP (PRP$ their) (NNS metabolites))
                  (PP (IN on)
                    (NP (NNS atherosclerosis))))))))))
    (, ,)
    (CC but)
    (S
      (NP
        (NP (DT the) (NN mechanism))
        (SBAR
          (WHPP (IN by)
            (WHNP (WDT which)))
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (MD may)
              (VP (VB contribute)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN prevention))
                    (PP (IN of)
                      (NP (NNP CHD))))))))))
      (VP (VBZ remains)
        (NP (JJ to_be) (NN elucidated))))
    (. .)))

nsubj(due-4, This-1)
aux(due-4, may-2)
cop(due-4, be-3)
root(ROOT-0, due-4)
case(effects-8, to-5)
det(effects-8, the-6)
amod(effects-8, protective-7)
nmod:to(due-4, effects-8)
case(DHA-12, of-9)
compound(DHA-12, EPA-10)
nmod:of(effects-8, DHA-12)
cc(effects-8, and-14)
nmod:poss(metabolites-16, their-15)
nmod:to(due-4, metabolites-16)
conj:and(effects-8, metabolites-16)
case(atherosclerosis-18, on-17)
nmod:on(metabolites-16, atherosclerosis-18)
cc(due-4, but-20)
det(mechanism-22, the-21)
nmod:by(contribute-28, mechanism-22)
nsubj(remains-34, mechanism-22)
case(which-24, by-23)
ref(mechanism-22, which-24)
det(fatty_acids-26, these-25)
nsubj(contribute-28, fatty_acids-26)
aux(contribute-28, may-27)
acl:relcl(mechanism-22, contribute-28)
case(prevention-31, to-29)
det(prevention-31, the-30)
nmod:to(contribute-28, prevention-31)
case(CHD-33, of-32)
nmod:of(prevention-31, CHD-33)
conj:but(due-4, remains-34)
amod(elucidated-36, to_be-35)
xcomp(remains-34, elucidated-36)

Further/JJ studies/NNS are/VBP needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG the/DT beneficial/JJ effects/NNS of/IN omega-3_polyunsaturated_fatty_acids/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB understand)
              (NP
                (NP (DT the) (NNS mechanisms))
                (VP (VBG underlying)
                  (NP
                    (NP (DT the) (JJ beneficial) (NNS effects))
                    (PP (IN of)
                      (NP (NN omega-3_polyunsaturated_fatty_acids)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(understand-7, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
xcomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-13, the-11)
amod(effects-13, beneficial-12)
dobj(underlying-10, effects-13)
case(omega-3_polyunsaturated_fatty_acids-15, of-14)
nmod:of(effects-13, omega-3_polyunsaturated_fatty_acids-15)

Lipid/JJ metabolism/NN is/VBZ regulated/VBN by/IN several/JJ genes/NNS ,/, including/VBG acetyl-CoA_carboxylase_1/JJ -LRB-/-LRB- ACC1/NNP -RRB-/-RRB- ,/, MMS/NNP synthase/NNP -LRB-/-LRB- HR_1/NNP .18/CD -RRB-/-RRB- ,/, carnitine_palmitoyl_transferase_1/NNS ,/, and/CC peroxisome_proliferator-activated_receptor_alpha/NN -LRB-/-LRB- PPAR-a/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Lipid) (NN metabolism))
    (VP (VBZ is)
      (VP (VBN regulated)
        (PP (IN by)
          (NP
            (NP (JJ several) (NNS genes))
            (, ,)
            (VP (VBG including)
              (NP
                (NP
                  (ADVP (JJ acetyl-CoA_carboxylase_1))
                  (NP
                    (NP
                      (NP (-LRB- -LRB-) (NNP ACC1) (-RRB- -RRB-))
                      (, ,)
                      (NP (NNP MMS) (NNP synthase))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP HR_1) (CD .18))
                        (-RRB- -RRB-)))
                    (, ,)
                    (NP (NNS carnitine_palmitoyl_transferase_1))
                    (, ,))
                  (CC and)
                  (NP (NN peroxisome_proliferator-activated_receptor_alpha)))
                (PRN (-LRB- -LRB-)
                  (NP (NNP PPAR-a))
                  (-RRB- -RRB-))))))))
    (. .)))

amod(metabolism-2, Lipid-1)
nsubjpass(regulated-4, metabolism-2)
auxpass(regulated-4, is-3)
root(ROOT-0, regulated-4)
case(genes-7, by-5)
amod(genes-7, several-6)
nmod:by(regulated-4, genes-7)
acl(genes-7, including-9)
advmod(ACC1-12, acetyl-CoA_carboxylase_1-10)
dobj(including-9, ACC1-12)
compound(synthase-16, MMS-15)
appos(ACC1-12, synthase-16)
appos(ACC1-12, HR_1-18)
nummod(HR_1-18, .18-19)
appos(ACC1-12, carnitine_palmitoyl_transferase_1-22)
cc(ACC1-12, and-24)
dobj(including-9, peroxisome_proliferator-activated_receptor_alpha-25)
conj:and(ACC1-12, peroxisome_proliferator-activated_receptor_alpha-25)
appos(ACC1-12, PPAR-a-27)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT expression/NN of/IN key/JJ genes/NNS involved/VBN in/IN lipid/NN metabolism/NN in/IN the/DT liver/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN expression))
        (PP (IN of)
          (NP
            (NP (JJ key) (NNS genes))
            (VP (VBN involved)
              (PP (IN in)
                (NP (NN lipid) (NN metabolism)))))))
      (PP (IN in)
        (NP (DT the) (NN liver))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(expression-8, the-7)
dobj(investigated-6, expression-8)
case(genes-11, of-9)
amod(genes-11, key-10)
nmod:of(expression-8, genes-11)
acl(genes-11, involved-12)
case(metabolism-15, in-13)
compound(metabolism-15, lipid-14)
nmod:in(involved-12, metabolism-15)
case(liver-18, in-16)
det(liver-18, the-17)
nmod:in(investigated-6, liver-18)

Real-time/NNP PCR/NNP was/VBD used/VBN to/TO determine/VB the/DT expression/NN levels/NNS of/IN acetyl-CoA_carboxylase_1/JJ -LRB-/-LRB- ACC1/NNP -RRB-/-RRB- ,/, MMS/NNP synthase/VBP -LRB-/-LRB- HR_1/CD .18/CD -RRB-/-RRB- ,/, carnitine_palmitoyl_transferase_1/JJ -LRB-/-LRB- CPT1/NNP -RRB-/-RRB- ,/, hydroxymethylglutaryl-CoA_reductase/JJ -LRB-/-LRB- HMGR/NNP -RRB-/-RRB- ,/, and/CC peroxisome_proliferator-activated_receptor_alpha/JJ -LRB-/-LRB- PPAR-a/JJ -RRB-/-RRB- ./.

(ROOT
  (S
    (S
      (NP (NNP Real-time) (NNP PCR))
      (VP (VBD was)
        (VP (VBN used)
          (S
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (NN expression) (NNS levels))
                  (PP (IN of)
                    (NP
                      (NP (JJ acetyl-CoA_carboxylase_1))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP ACC1))
                        (-RRB- -RRB-)))))))))))
    (, ,)
    (NP (NNP MMS))
    (VP (VBP synthase)
      (ADJP
        (ADJP (-LRB- -LRB-)
          (NP
            (QP (CD HR_1) (CD .18)))
          (-RRB- -RRB-))
        (, ,)
        (ADJP
          (ADJP (JJ carnitine_palmitoyl_transferase_1))
          (PRN (-LRB- -LRB-)
            (NP (NNP CPT1))
            (-RRB- -RRB-)))
        (, ,)
        (ADJP (JJ hydroxymethylglutaryl-CoA_reductase))
        (PRN (-LRB- -LRB-)
          (NP (NNP HMGR))
          (-RRB- -RRB-))
        (, ,)
        (CC and)
        (ADJP (JJ peroxisome_proliferator-activated_receptor_alpha))
        (PRN (-LRB- -LRB-)
          (ADJP (JJ PPAR-a))
          (-RRB- -RRB-))))
    (. .)))

compound(PCR-2, Real-time-1)
nsubjpass(used-4, PCR-2)
nsubj:xsubj(determine-6, PCR-2)
auxpass(used-4, was-3)
ccomp(synthase-17, used-4)
mark(determine-6, to-5)
xcomp(used-4, determine-6)
det(levels-9, the-7)
compound(levels-9, expression-8)
dobj(determine-6, levels-9)
case(acetyl-CoA_carboxylase_1-11, of-10)
nmod:of(levels-9, acetyl-CoA_carboxylase_1-11)
appos(acetyl-CoA_carboxylase_1-11, ACC1-13)
nsubj(synthase-17, MMS-16)
root(ROOT-0, synthase-17)
compound(.18-20, HR_1-19)
xcomp(synthase-17, .18-20)
xcomp(synthase-17, carnitine_palmitoyl_transferase_1-23)
conj:and(.18-20, carnitine_palmitoyl_transferase_1-23)
dep(carnitine_palmitoyl_transferase_1-23, CPT1-25)
xcomp(synthase-17, hydroxymethylglutaryl-CoA_reductase-28)
conj:and(.18-20, hydroxymethylglutaryl-CoA_reductase-28)
dep(.18-20, HMGR-30)
cc(.18-20, and-33)
xcomp(synthase-17, peroxisome_proliferator-activated_receptor_alpha-34)
conj:and(.18-20, peroxisome_proliferator-activated_receptor_alpha-34)
dep(.18-20, PPAR-a-36)

Our/PRP$ results/NNS showed/VBD that/IN these/DT genes/NNS were/VBD differentially/RB expressed/VBN in/IN the/DT liver/NN ,/, indicating/VBG their/PRP$ potential/JJ role/NN in/IN regulating/VBG lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS genes))
          (VP (VBD were)
            (VP
              (ADVP (RB differentially))
              (VBN expressed)
              (PP (IN in)
                (NP (DT the) (NN liver)))
              (, ,)
              (S
                (VP (VBG indicating)
                  (NP
                    (NP (PRP$ their) (JJ potential) (NN role))
                    (PP (IN in)
                      (S
                        (VP (VBG regulating)
                          (NP (NN lipid) (NN metabolism)))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(expressed-9, that-4)
det(genes-6, these-5)
nsubjpass(expressed-9, genes-6)
auxpass(expressed-9, were-7)
advmod(expressed-9, differentially-8)
ccomp(showed-3, expressed-9)
case(liver-12, in-10)
det(liver-12, the-11)
nmod:in(expressed-9, liver-12)
xcomp(expressed-9, indicating-14)
nmod:poss(role-17, their-15)
amod(role-17, potential-16)
dobj(indicating-14, role-17)
mark(regulating-19, in-18)
acl(role-17, regulating-19)
compound(metabolism-21, lipid-20)
dobj(regulating-19, metabolism-21)

These/DT findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT molecular/JJ mechanisms/NNS underlying/VBG lipid/NN metabolism/NN and/CC may/MD help/VB identify/VB targets/NNS for/IN the/DT development/NN of/IN novel/NN therapies/NNS for/IN metabolic_disorders/NNS such/JJ as/IN obesity/NN and/CC diabetes/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP (JJ new) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (JJ molecular) (NNS mechanisms))
            (VP (VBG underlying)
              (NP (NN lipid) (NN metabolism))))))
      (CC and)
      (VP (MD may)
        (VP (VB help)
          (VP (VB identify)
            (NP
              (NP (NNS targets))
              (PP (IN for)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP
                      (NP (NN novel) (NNS therapies))
                      (PP (IN for)
                        (NP
                          (NP (NNS metabolic_disorders))
                          (PP (JJ such) (IN as)
                            (NP (NN obesity)
                              (CC and)
                              (NN diabetes))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(help-15, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
dobj(provide-3, insights-5)
case(mechanisms-9, into-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
nmod:into(provide-3, mechanisms-9)
acl(mechanisms-9, underlying-10)
compound(metabolism-12, lipid-11)
dobj(underlying-10, metabolism-12)
cc(provide-3, and-13)
aux(help-15, may-14)
conj:and(provide-3, help-15)
xcomp(help-15, identify-16)
dobj(identify-16, targets-17)
case(development-20, for-18)
det(development-20, the-19)
nmod:for(targets-17, development-20)
case(therapies-23, of-21)
compound(therapies-23, novel-22)
nmod:of(development-20, therapies-23)
case(metabolic_disorders-25, for-24)
nmod:for(therapies-23, metabolic_disorders-25)
case(obesity-28, such-26)
mwe(such-26, as-27)
nmod:such_as(metabolic_disorders-25, obesity-28)
cc(obesity-28, and-29)
nmod:such_as(metabolic_disorders-25, diabetes-30)
conj:and(obesity-28, diabetes-30)

At_2/JJ h/NN after/IN dosing/VBG ,/, histamine_hydrochloride/NN reduced/VBD the/DT risk/NN of/IN Bronchospasms/NNPS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/NN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN histamine_hydrochloride))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNPS Bronchospasms))))
      (PP (IN by)
        (NP
          (NP
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (SBAR
                    (S
                      (VP (VBP CI)
                        (NP
                          (NP
                            (NP (CD 6-20) (NN %))
                            (, ,)
                            (NP (NNP P)))
                          (X
                            (X (SYM =))
                            (NP (CD 0.0005))))))))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP
                (NP (NN photophobia))
                (NP (CD 17) (NN %)))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NP
              (NP (NN phonophobia))
              (NP (CD 14) (NN %))))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (PP (NNP CI)
                (NP (CD 17-20) (NN %))))
            (, ,)
            (NP (NNP P)
              (QP (CD <) (CD 0.0001)))
            (-RRB- -RRB-)))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, histamine_hydrochloride-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(Bronchospasms-11, of-10)
nmod:of(risk-9, Bronchospasms-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
nmod:by(reduced-7, photophobia-27)
conj:and(%-14, photophobia-27)
nummod(%-29, 17-28)
dep(photophobia-27, %-29)
nummod(%-32, 95-31)
appos(photophobia-27, %-32)
dep(%-35, CI-33)
nummod(%-35, 12-22-34)
nmod(%-32, %-35)
dep(%-32, P-37)
compound(0.0001-39, <-38)
nummod(P-37, 0.0001-39)
cc(%-14, and-42)
nmod:by(reduced-7, phonophobia-43)
conj:and(%-14, phonophobia-43)
nummod(%-45, 14-44)
dep(phonophobia-43, %-45)
nummod(%-48, 95-47)
appos(%-14, %-48)
dep(%-51, CI-49)
nummod(%-51, 17-20-50)
nmod(%-48, %-51)
dep(%-48, P-53)
compound(0.0001-55, <-54)
nummod(P-53, 0.0001-55)

A/DT randomized_controlled_trial/NN was/VBD conducted/VBN with/IN a/DT total/NN of/IN n/NN participants/NNS ./.

(ROOT
  (S
    (NP (DT A) (NN randomized_controlled_trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN with)
          (NP
            (NP (DT a) (NN total))
            (PP (IN of)
              (NP (NN n) (NNS participants)))))))
    (. .)))

det(randomized_controlled_trial-2, A-1)
nsubjpass(conducted-4, randomized_controlled_trial-2)
auxpass(conducted-4, was-3)
root(ROOT-0, conducted-4)
case(total-7, with-5)
det(total-7, a-6)
nmod:with(conducted-4, total-7)
case(participants-10, of-8)
compound(participants-10, n-9)
nmod:of(total-7, participants-10)

At_2/JJ h/NN after/IN dosing/VBG ,/, histamine_hydrochloride/NN was/VBD found/VBD to/TO significantly/RB reduce/VB the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/JJ by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 17-20/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN histamine_hydrochloride))
    (VP (VBD was)
      (ADJP
        (ADJP (VBD found)
          (S
            (VP (TO to)
              (ADVP (RB significantly))
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP (NNS bronchospasms))))
                (PP (IN by)
                  (NP (CD 14) (NN %)))))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP
                (NP
                  (NP (CD 6-20) (NN %))
                  (, ,)
                  (NP (NNP P)))
                (X
                  (X (SYM =))
                  (NP (CD 0.0005))))))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP (CD 17) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 12-22) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))
        (, ,)
        (CC and)
        (ADJP (JJ phonophobia)
          (PP (IN by)
            (NP (CD 14) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 17-20) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))))
    (. .)))

amod(h-2, At_2-1)
dep(found-8, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubjpass(found-8, histamine_hydrochloride-6)
nsubj:xsubj(reduce-11, histamine_hydrochloride-6)
nsubj(photophobia-31, histamine_hydrochloride-6)
nsubj(phonophobia-48, histamine_hydrochloride-6)
auxpass(found-8, was-7)
root(ROOT-0, found-8)
mark(reduce-11, to-9)
advmod(reduce-11, significantly-10)
xcomp(found-8, reduce-11)
det(risk-13, the-12)
dobj(reduce-11, risk-13)
case(bronchospasms-15, of-14)
nmod:of(risk-13, bronchospasms-15)
case(%-18, by-16)
nummod(%-18, 14-17)
nmod:by(reduce-11, %-18)
nummod(%-21, 95-20)
nsubj(CI-22, %-21)
dep(found-8, CI-22)
nummod(%-24, 6-20-23)
dobj(CI-22, %-24)
appos(%-24, P-26)
dep(0.0005-28, =-27)
dep(%-24, 0.0005-28)
conj:and(found-8, photophobia-31)
case(%-34, by-32)
nummod(%-34, 17-33)
nmod:by(photophobia-31, %-34)
nummod(%-37, 95-36)
nsubj(CI-38, %-37)
dep(found-8, CI-38)
nummod(%-40, 12-22-39)
dobj(CI-38, %-40)
nsubj(<-43, P-42)
dep(CI-38, <-43)
dobj(<-43, 0.0001-44)
cc(found-8, and-47)
conj:and(found-8, phonophobia-48)
case(%-51, by-49)
nummod(%-51, 14-50)
nmod:by(phonophobia-48, %-51)
nummod(%-54, 95-53)
nsubj(CI-55, %-54)
dep(found-8, CI-55)
nummod(%-57, 17-20-56)
dobj(CI-55, %-57)
nsubj(<-60, P-59)
dep(CI-55, <-60)
dobj(<-60, 0.0001-61)

These/DT results/NNS suggest/VBP that/IN histamine_hydrochloride/NN may/MD be/VB a/DT potential/JJ treatment/NN option/NN for/IN individuals/NNS experiencing/VBG these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN histamine_hydrochloride))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ potential) (NN treatment) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (VP (VBG experiencing)
                      (NP (DT these) (NNS symptoms)))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, histamine_hydrochloride-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, potential-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
acl(individuals-13, experiencing-14)
det(symptoms-16, these-15)
dobj(experiencing-14, symptoms-16)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT findings/NNS and/CC explore/VB the/DT mechanism/NN underlying/VBG the/DT effects/NNS of/IN histamine_hydrochloride/NN on/IN bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS findings)))
              (CC and)
              (VP (VB explore)
                (NP
                  (NP (DT the) (NN mechanism))
                  (VP (VBG underlying)
                    (NP
                      (NP (DT the) (NNS effects))
                      (PP (IN of)
                        (NP (NN histamine_hydrochloride)))
                      (PP (IN on)
                        (NP
                          (NP (NNS bronchospasms))
                          (, ,)
                          (NP (NN photophobia))
                          (, ,)
                          (CC and)
                          (NP (NN phonophobia)))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(explore-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(findings-8, these-7)
dobj(confirm-6, findings-8)
cc(confirm-6, and-9)
xcomp(needed-4, explore-10)
conj:and(confirm-6, explore-10)
det(mechanism-12, the-11)
dobj(explore-10, mechanism-12)
acl(mechanism-12, underlying-13)
det(effects-15, the-14)
dobj(underlying-13, effects-15)
case(histamine_hydrochloride-17, of-16)
nmod:of(effects-15, histamine_hydrochloride-17)
case(bronchospasms-19, on-18)
nmod:on(effects-15, bronchospasms-19)
nmod:on(effects-15, photophobia-21)
conj:and(bronchospasms-19, photophobia-21)
cc(bronchospasms-19, and-23)
nmod:on(effects-15, phonophobia-24)
conj:and(bronchospasms-19, phonophobia-24)

In/IN the/DT present/JJ study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN PS-2/NNP on/IN basal/JJ coumestrol/JJ production/NN and_8-Br-cAMP-stimulated/JJ 3_beta_HSD/JJ expression/NN in/IN rat/NN Leydig/VBG cells/NNS ./. -LRB-/-LRB- 1/CD -RRB-/-RRB- Background/NNP :/: ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ present) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NAC
              (NAC (NNP PS-2)
                (PP (IN on)
                  (NP
                    (NP
                      (NP (JJ basal) (JJ coumestrol) (NN production))
                      (NP (JJ and_8-Br-cAMP-stimulated) (JJ 3_beta_HSD) (NN expression)))
                    (PP (IN in)
                      (NP (NN rat) (VBG Leydig) (NNS cells))))
                  (. .)))
              (PRN (-LRB- -LRB-)
                (NP (CD 1))
                (-RRB- -RRB-)))
            (NNP Background)))))
    (: :) (. .)))

case(study-4, In-1)
det(study-4, the-2)
amod(study-4, present-3)
nmod:in(investigated-7, study-4)
nsubj(investigated-7, we-6)
root(ROOT-0, investigated-7)
det(effects-9, the-8)
dobj(investigated-7, effects-9)
case(Background-27, of-10)
dep(Background-27, PS-2-11)
case(production-15, on-12)
amod(production-15, basal-13)
amod(production-15, coumestrol-14)
nmod:on(PS-2-11, production-15)
amod(expression-18, and_8-Br-cAMP-stimulated-16)
amod(expression-18, 3_beta_HSD-17)
dep(production-15, expression-18)
case(cells-22, in-19)
compound(cells-22, rat-20)
amod(cells-22, Leydig-21)
nmod:in(production-15, cells-22)
dep(PS-2-11, 1-25)
nmod:of(effects-9, Background-27)

One/CD of/IN the/DT key/JJ enzymes/NNS involved/VBN in/IN this/DT process/NN is/VBZ 3_beta-hydroxysteroid_dehydrogenase/JJ //: delta/NN 5/CD --/: >/VBP delta_4/JJ isomerase/NN -LRB-/-LRB- 3_beta_HSD/JJ -RRB-/-RRB- ,/, which/WDT catalyzes/VBZ the/DT conversion/NN of/IN pregnenolone/NN to/TO progesterone/VB ,/, a/DT crucial/JJ step/NN in/IN the/DT biosynthesis/NNS of/IN steroid_hormones/NNS ./.

(ROOT
  (SINV
    (S
      (NP
        (NP (CD One))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ key) (NNS enzymes))
            (VP (VBN involved)
              (PP (IN in)
                (NP (DT this) (NN process)))))))
      (VP (VBZ is)
        (ADJP (JJ 3_beta-hydroxysteroid_dehydrogenase))
        (PRN (: /)
          (NP (NN delta) (CD 5))
          (: --))))
    (VP (VBP >))
    (NP
      (NP (JJ delta_4) (NN isomerase))
      (PRN (-LRB- -LRB-) (JJ 3_beta_HSD) (-RRB- -RRB-))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (VP (VBZ catalyzes)
            (NP
              (NP (DT the) (NN conversion))
              (PP (IN of)
                (NP (NN pregnenolone))))
            (S
              (VP (TO to)
                (VP (VB progesterone))))
            (, ,)
            (NP
              (NP (DT a) (JJ crucial) (NN step))
              (PP (IN in)
                (NP
                  (NP (DT the) (NNS biosynthesis))
                  (PP (IN of)
                    (NP (NNS steroid_hormones))))))))))
    (. .)))

nsubj(3_beta-hydroxysteroid_dehydrogenase-11, One-1)
case(enzymes-5, of-2)
det(enzymes-5, the-3)
amod(enzymes-5, key-4)
nmod:of(One-1, enzymes-5)
acl(enzymes-5, involved-6)
case(process-9, in-7)
det(process-9, this-8)
nmod:in(involved-6, process-9)
cop(3_beta-hydroxysteroid_dehydrogenase-11, is-10)
dep(>-16, 3_beta-hydroxysteroid_dehydrogenase-11)
dep(3_beta-hydroxysteroid_dehydrogenase-11, delta-13)
nummod(delta-13, 5-14)
root(ROOT-0, >-16)
amod(isomerase-18, delta_4-17)
nsubj(>-16, isomerase-18)
nsubj(catalyzes-24, isomerase-18)
dep(isomerase-18, 3_beta_HSD-20)
ref(isomerase-18, which-23)
acl:relcl(isomerase-18, catalyzes-24)
det(conversion-26, the-25)
dobj(catalyzes-24, conversion-26)
case(pregnenolone-28, of-27)
nmod:of(conversion-26, pregnenolone-28)
mark(progesterone-30, to-29)
advcl(catalyzes-24, progesterone-30)
det(step-34, a-32)
amod(step-34, crucial-33)
dobj(catalyzes-24, step-34)
case(biosynthesis-37, in-35)
det(biosynthesis-37, the-36)
nmod:in(step-34, biosynthesis-37)
case(steroid_hormones-39, of-38)
nmod:of(biosynthesis-37, steroid_hormones-39)

In/IN the/DT present/JJ study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN PS-2/NNP ,/, a/DT novel/NN compound/NN with/IN potential/JJ therapeutic/JJ applications/NNS in/IN male_infertility/NN ,/, on/IN basal/JJ coumestrol/JJ production/NN and_8-Br-cAMP-stimulated/JJ 3_beta_HSD/JJ expression/NN in/IN Leydig/NNP cells/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ present) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (NNP PS-2))
            (, ,)
            (NP (DT a) (NN novel) (NN compound)))))
      (PP (IN with)
        (NP
          (NP (JJ potential) (JJ therapeutic) (NNS applications))
          (PP (IN in)
            (NP
              (NP (NN male_infertility))
              (, ,)
              (PP (IN on)
                (NP (JJ basal) (JJ coumestrol) (NN production)))
              (NP
                (NP (JJ and_8-Br-cAMP-stimulated) (JJ 3_beta_HSD) (NN expression))
                (PP (IN in)
                  (NP (NNP Leydig) (NNS cells)))))))))
    (. .)))

case(study-4, In-1)
det(study-4, the-2)
amod(study-4, present-3)
nmod:in(investigated-7, study-4)
nsubj(investigated-7, we-6)
root(ROOT-0, investigated-7)
det(effects-9, the-8)
dobj(investigated-7, effects-9)
case(PS-2-11, of-10)
nmod:of(effects-9, PS-2-11)
det(compound-15, a-13)
compound(compound-15, novel-14)
appos(PS-2-11, compound-15)
case(applications-19, with-16)
amod(applications-19, potential-17)
amod(applications-19, therapeutic-18)
nmod:with(investigated-7, applications-19)
case(male_infertility-21, in-20)
nmod:in(applications-19, male_infertility-21)
case(production-26, on-23)
amod(production-26, basal-24)
amod(production-26, coumestrol-25)
nmod:on(male_infertility-21, production-26)
amod(expression-29, and_8-Br-cAMP-stimulated-27)
amod(expression-29, 3_beta_HSD-28)
dep(male_infertility-21, expression-29)
case(cells-32, in-30)
compound(cells-32, Leydig-31)
nmod:in(expression-29, cells-32)

Our/PRP$ results/NNS showed/VBD that/IN PS-2/NNP significantly/RB inhibited/VBD basal/JJ coumestrol/JJ production/NN and/CC attenuated/VBN the/DT stimulatory/JJ effects/NNS of/IN 8-Br-cAMP/JJ on/IN 3_beta_HSD/JJ expression/NN ,/, suggesting/VBG that/IN PS-2/NNP may/MD modulate/VBP steroidogenesis/NNS by/IN regulating/VBG the/DT activity/NN of/IN this/DT key/JJ enzyme/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP PS-2))
          (VP
            (VP
              (ADVP (RB significantly))
              (VBD inhibited)
              (NP (JJ basal) (JJ coumestrol) (NN production)))
            (CC and)
            (VP (VBN attenuated)
              (NP
                (NP (DT the) (JJ stimulatory) (NNS effects))
                (PP (IN of)
                  (NP (JJ 8-Br-cAMP))))
              (PP (IN on)
                (NP (JJ 3_beta_HSD) (NN expression)))
              (, ,)
              (S
                (VP (VBG suggesting)
                  (SBAR (IN that)
                    (S
                      (NP (NNP PS-2))
                      (VP (MD may)
                        (VP (VBP modulate)
                          (NP (NNS steroidogenesis))
                          (PP (IN by)
                            (S
                              (VP (VBG regulating)
                                (NP
                                  (NP (DT the) (NN activity))
                                  (PP (IN of)
                                    (NP (DT this) (JJ key) (NN enzyme))))))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(inhibited-7, that-4)
nsubj(inhibited-7, PS-2-5)
nsubj(attenuated-12, PS-2-5)
advmod(inhibited-7, significantly-6)
ccomp(showed-3, inhibited-7)
amod(production-10, basal-8)
amod(production-10, coumestrol-9)
dobj(inhibited-7, production-10)
cc(inhibited-7, and-11)
ccomp(showed-3, attenuated-12)
conj:and(inhibited-7, attenuated-12)
det(effects-15, the-13)
amod(effects-15, stimulatory-14)
dobj(attenuated-12, effects-15)
case(8-Br-cAMP-17, of-16)
nmod:of(effects-15, 8-Br-cAMP-17)
case(expression-20, on-18)
amod(expression-20, 3_beta_HSD-19)
nmod:on(attenuated-12, expression-20)
advcl(attenuated-12, suggesting-22)
mark(modulate-26, that-23)
nsubj(modulate-26, PS-2-24)
aux(modulate-26, may-25)
ccomp(suggesting-22, modulate-26)
dobj(modulate-26, steroidogenesis-27)
mark(regulating-29, by-28)
advcl(modulate-26, regulating-29)
det(activity-31, the-30)
dobj(regulating-29, activity-31)
case(enzyme-35, of-32)
det(enzyme-35, this-33)
amod(enzyme-35, key-34)
nmod:of(activity-31, enzyme-35)

These/DT findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT mechanisms/NNS underlying/VBG male/JJ reproductive/JJ function/NN and/CC may/MD have/VB important/JJ implications/NNS for/IN the/DT development/NN of/IN novel/NN therapies/NNS for/IN male_infertility/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP (JJ new) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (NNS mechanisms))
            (VP (VBG underlying)
              (NP (JJ male) (JJ reproductive) (NN function))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (JJ important) (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (NN novel) (NNS therapies))
                    (PP (IN for)
                      (NP (NN male_infertility)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(have-15, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
dobj(provide-3, insights-5)
case(mechanisms-8, into-6)
det(mechanisms-8, the-7)
nmod:into(provide-3, mechanisms-8)
acl(mechanisms-8, underlying-9)
amod(function-12, male-10)
amod(function-12, reproductive-11)
dobj(underlying-9, function-12)
cc(provide-3, and-13)
aux(have-15, may-14)
conj:and(provide-3, have-15)
amod(implications-17, important-16)
dobj(have-15, implications-17)
case(development-20, for-18)
det(development-20, the-19)
nmod:for(implications-17, development-20)
case(therapies-23, of-21)
compound(therapies-23, novel-22)
nmod:of(development-20, therapies-23)
case(male_infertility-25, for-24)
nmod:for(therapies-23, male_infertility-25)

Hypersecretion/NN of/IN SLC47A1/NNP by/IN the/DT pancreas/NN may/MD contribute/VB to/TO the/DT development/NN of/IN obesity/NN ,/, possibly/RB through/IN its/PRP$ effects/NNS on/IN insulin_secretion/NN ./.

(ROOT
  (S
    (NP
      (NP (NN Hypersecretion))
      (PP (IN of)
        (NP (NNP SLC47A1)))
      (PP (IN by)
        (NP (DT the) (NN pancreas))))
    (VP (MD may)
      (VP (VB contribute)
        (PP (TO to)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP (NN obesity)))))
        (, ,)
        (ADVP (RB possibly))
        (PP (IN through)
          (NP
            (NP (PRP$ its) (NNS effects))
            (PP (IN on)
              (NP (NN insulin_secretion)))))))
    (. .)))

nsubj(contribute-8, Hypersecretion-1)
case(SLC47A1-3, of-2)
nmod:of(Hypersecretion-1, SLC47A1-3)
case(pancreas-6, by-4)
det(pancreas-6, the-5)
nmod:by(Hypersecretion-1, pancreas-6)
aux(contribute-8, may-7)
root(ROOT-0, contribute-8)
case(development-11, to-9)
det(development-11, the-10)
nmod:to(contribute-8, development-11)
case(obesity-13, of-12)
nmod:of(development-11, obesity-13)
advmod(effects-18, possibly-15)
case(effects-18, through-16)
nmod:poss(effects-18, its-17)
nmod:through(contribute-8, effects-18)
case(insulin_secretion-20, on-19)
nmod:on(effects-18, insulin_secretion-20)

The/DT effects/NNS of/IN Lamivudine/NNP on/IN the/DT secretion/NN of/IN insulin/NN and/CC SLC/NNP 47A1/CD were/VBD examined/VBN in/IN isolated/JJ perfused/JJ pancreata/NN from/IN genetically_obese/JJ -LRB-/-LRB- fa/fa/NNS -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS effects))
      (PP (IN of)
        (NP (NNP Lamivudine)))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP
              (NP (NN insulin))
              (CC and)
              (NP (NNP SLC) (CD 47A1)))))))
    (VP (VBD were)
      (VP (VBN examined)
        (PP (IN in)
          (NP (JJ isolated) (JJ perfused) (NN pancreata)))
        (PP (IN from)
          (NP
            (NP (JJ genetically_obese) (-LRB- -LRB-) (NNS fa/fa) (-RRB- -RRB-))
            (CC and)
            (NP
              (ADJP
                (ADJP (JJ lean))
                (PRN (-LRB- -LRB-)
                  (FRAG
                    (ADVP (RB Fa) (: /))
                    (. ?))
                  (-RRB- -RRB-)))
              (NNS rats))))))
    (. .)))

det(effects-2, The-1)
nsubjpass(examined-14, effects-2)
case(Lamivudine-4, of-3)
nmod:of(effects-2, Lamivudine-4)
case(secretion-7, on-5)
det(secretion-7, the-6)
nmod:on(effects-2, secretion-7)
case(insulin-9, of-8)
nmod:of(secretion-7, insulin-9)
cc(insulin-9, and-10)
nmod:of(secretion-7, SLC-11)
conj:and(insulin-9, SLC-11)
nummod(SLC-11, 47A1-12)
auxpass(examined-14, were-13)
root(ROOT-0, examined-14)
case(pancreata-18, in-15)
amod(pancreata-18, isolated-16)
amod(pancreata-18, perfused-17)
nmod:in(examined-14, pancreata-18)
case(fa/fa-22, from-19)
amod(fa/fa-22, genetically_obese-20)
nmod:from(examined-14, fa/fa-22)
cc(fa/fa-22, and-24)
amod(rats-31, lean-25)
dep(lean-25, Fa-27)
nmod:from(examined-14, rats-31)
conj:and(fa/fa-22, rats-31)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT hypersecretion/NN of/IN SLC47A1/NNP by/IN the/DT pancreas/NN may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN hypersecretion))
              (PP (IN of)
                (NP (NNP SLC47A1)))
              (PP (IN by)
                (NP (DT the) (NN pancreas))))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(play-14, that-5)
det(hypersecretion-7, the-6)
nsubj(play-14, hypersecretion-7)
case(SLC47A1-9, of-8)
nmod:of(hypersecretion-7, SLC47A1-9)
case(pancreas-12, by-10)
det(pancreas-12, the-11)
nmod:by(hypersecretion-7, pancreas-12)
aux(play-14, may-13)
ccomp(suggested-4, play-14)
det(role-16, a-15)
dobj(play-14, role-16)
case(development-19, in-17)
det(development-19, the-18)
nmod:in(role-16, development-19)
case(obesity-21, of-20)
nmod:of(development-19, obesity-21)

In/IN this/DT study/NN ,/, we/PRP aimed/VBN to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC hypersecretion/NN of/IN SLC47A1/NNP by/IN examining/VBG the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/NN Lamivudine/NNP on/IN the/DT secretion/NN of/IN SLC47A1/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBN aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity)
                      (CC and)
                      (NN hypersecretion)))))
              (PP (IN of)
                (NP (NNP SLC47A1))))
            (PP (IN by)
              (S
                (VP (VBG examining)
                  (NP
                    (NP (DT the) (NNS effects))
                    (PP (IN of)
                      (NP
                        (NP (CD 16.7) (JJ mmol/L) (NN glucose))
                        (CC and)
                        (NP (CD 10) (NN mmol/L) (NNP Lamivudine)))))
                  (PP (IN on)
                    (NP
                      (NP (DT the) (NN secretion))
                      (PP (IN of)
                        (NP (NNP SLC47A1) (NN and_insulin))))))))
            (PP (IN by)
              (NP (VBN isolated) (JJ perfused) (NN pancreata))))))
      (PP (IN from)
        (NP
          (NP
            (NP (NN genetically_obese))
            (PRN (-LRB- -LRB-)
              (NP (NN fa/fa))
              (-RRB- -RRB-)))
          (CC and)
          (NP
            (ADJP
              (ADJP (JJ lean))
              (PRN (-LRB- -LRB-)
                (FRAG
                  (ADVP (RB Fa) (: /))
                  (. ?))
                (-RRB- -RRB-)))
            (NNS rats)))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(obesity-15, and-16)
nmod:of(development-13, hypersecretion-17)
conj:and(obesity-15, hypersecretion-17)
case(SLC47A1-19, of-18)
nmod:of(relationship-10, SLC47A1-19)
mark(examining-21, by-20)
advcl(evaluate-8, examining-21)
det(effects-23, the-22)
dobj(examining-21, effects-23)
case(glucose-27, of-24)
nummod(glucose-27, 16.7-25)
amod(glucose-27, mmol/L-26)
nmod:of(effects-23, glucose-27)
cc(glucose-27, and-28)
nummod(Lamivudine-31, 10-29)
compound(Lamivudine-31, mmol/L-30)
nmod:of(effects-23, Lamivudine-31)
conj:and(glucose-27, Lamivudine-31)
case(secretion-34, on-32)
det(secretion-34, the-33)
nmod:on(examining-21, secretion-34)
case(and_insulin-37, of-35)
compound(and_insulin-37, SLC47A1-36)
nmod:of(secretion-34, and_insulin-37)
case(pancreata-41, by-38)
amod(pancreata-41, isolated-39)
amod(pancreata-41, perfused-40)
nmod:by(evaluate-8, pancreata-41)
case(genetically_obese-43, from-42)
nmod:from(aimed-6, genetically_obese-43)
appos(genetically_obese-43, fa/fa-45)
cc(genetically_obese-43, and-47)
amod(rats-54, lean-48)
dep(lean-48, Fa-50)
nmod:from(aimed-6, rats-54)
conj:and(genetically_obese-43, rats-54)

Our/PRP$ results/NNS showed/VBD that/IN the/DT secretion/NN of/IN SLC47A1/NNP was/VBD significantly/RB higher/JJR in/IN perfused/JJ pancreata/NN from/IN genetically_obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS in/IN response/NN to/TO both/DT glucose/NN and/CC Lamivudine/JJ stimulation/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN secretion))
            (PP (IN of)
              (NP (NNP SLC47A1))))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP
                  (NP (JJ perfused) (NN pancreata))
                  (PP (IN from)
                    (NP (JJ genetically_obese) (NNS rats))))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (PP (IN in)
                      (NP
                        (NP (NN response))
                        (PP (TO to)
                          (NP
                            (NP (DT both) (NN glucose))
                            (CC and)
                            (NP (JJ Lamivudine) (NN stimulation))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-18, that-4)
det(secretion-6, the-5)
nsubjpass(compared-18, secretion-6)
nsubj:xsubj(lean-20, secretion-6)
case(SLC47A1-8, of-7)
nmod:of(secretion-6, SLC47A1-8)
auxpass(compared-18, was-9)
advmod(higher-11, significantly-10)
advmod(compared-18, higher-11)
case(pancreata-14, in-12)
amod(pancreata-14, perfused-13)
nmod:in(higher-11, pancreata-14)
case(rats-17, from-15)
amod(rats-17, genetically_obese-16)
nmod:from(pancreata-14, rats-17)
ccomp(showed-3, compared-18)
mark(lean-20, to-19)
xcomp(compared-18, lean-20)
dobj(lean-20, rats-21)
case(response-23, in-22)
nmod:in(lean-20, response-23)
case(glucose-26, to-24)
det(glucose-26, both-25)
nmod:to(response-23, glucose-26)
cc(glucose-26, and-27)
amod(stimulation-29, Lamivudine-28)
nmod:to(response-23, stimulation-29)
conj:and(glucose-26, stimulation-29)

Interestingly/RB ,/, we/PRP also/RB observed/VBD a/DT significant/JJ increase/NN in/IN insulin_secretion/NN in/IN response/NN to/TO glucose/NN stimulation/NN in/IN obese/JJ rats/NNS compared/VBN to/TO lean/JJ rats/NNS ,/, but/CC no/DT significant/JJ difference/NN was/VBD observed/VBN in/IN insulin_secretion/NN between/IN these/DT groups/NNS following/VBG Lamivudine/NNP stimulation/NN ./.

(ROOT
  (S
    (S
      (ADVP (RB Interestingly))
      (, ,)
      (NP (PRP we))
      (ADVP (RB also))
      (VP (VBD observed)
        (NP
          (NP (DT a) (JJ significant) (NN increase))
          (PP (IN in)
            (NP (NN insulin_secretion))))
        (PP (IN in)
          (NP
            (NP (NN response))
            (PP (TO to)
              (NP (NN glucose) (NN stimulation)))))
        (PP (IN in)
          (NP
            (NP (JJ obese) (NNS rats))
            (VP (VBN compared)
              (PP (TO to)
                (NP (JJ lean) (NNS rats))))))))
    (, ,)
    (CC but)
    (S
      (NP (DT no) (JJ significant) (NN difference))
      (VP (VBD was)
        (VP (VBN observed)
          (PP (IN in)
            (NP
              (NP (NN insulin_secretion))
              (PP (IN between)
                (NP (DT these) (NNS groups)))))
          (S
            (VP (VBG following)
              (NP (NNP Lamivudine) (NN stimulation)))))))
    (. .)))

advmod(observed-5, Interestingly-1)
nsubj(observed-5, we-3)
advmod(observed-5, also-4)
root(ROOT-0, observed-5)
det(increase-8, a-6)
amod(increase-8, significant-7)
dobj(observed-5, increase-8)
case(insulin_secretion-10, in-9)
nmod:in(increase-8, insulin_secretion-10)
case(response-12, in-11)
nmod:in(observed-5, response-12)
case(stimulation-15, to-13)
compound(stimulation-15, glucose-14)
nmod:to(response-12, stimulation-15)
case(rats-18, in-16)
amod(rats-18, obese-17)
nmod:in(observed-5, rats-18)
acl(rats-18, compared-19)
case(rats-22, to-20)
amod(rats-22, lean-21)
nmod:to(compared-19, rats-22)
cc(observed-5, but-24)
neg(difference-27, no-25)
amod(difference-27, significant-26)
nsubjpass(observed-29, difference-27)
auxpass(observed-29, was-28)
conj:but(observed-5, observed-29)
case(insulin_secretion-31, in-30)
nmod:in(observed-29, insulin_secretion-31)
case(groups-34, between-32)
det(groups-34, these-33)
nmod:between(insulin_secretion-31, groups-34)
xcomp(observed-29, following-35)
compound(stimulation-37, Lamivudine-36)
dobj(following-35, stimulation-37)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN SLC47A1/NNP may/MD contribute/VB to/TO the/DT development/NN of/IN obesity/NN ,/, possibly/RB through/IN its/PRP$ effects/NNS on/IN insulin_secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNP SLC47A1))))
          (VP (MD may)
            (VP (VB contribute)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity)))))
              (, ,)
              (ADVP (RB possibly))
              (PP (IN through)
                (NP
                  (NP (PRP$ its) (NNS effects))
                  (PP (IN on)
                    (NP (NN insulin_secretion))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(contribute-9, that-4)
nsubj(contribute-9, hypersecretion-5)
case(SLC47A1-7, of-6)
nmod:of(hypersecretion-5, SLC47A1-7)
aux(contribute-9, may-8)
ccomp(suggest-3, contribute-9)
case(development-12, to-10)
det(development-12, the-11)
nmod:to(contribute-9, development-12)
case(obesity-14, of-13)
nmod:of(development-12, obesity-14)
advmod(effects-19, possibly-16)
case(effects-19, through-17)
nmod:poss(effects-19, its-18)
nmod:through(contribute-9, effects-19)
case(insulin_secretion-21, on-20)
nmod:on(effects-19, insulin_secretion-21)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ targets/NNS for/IN this/DT pathway/NN in/IN obesity/JJ management/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP
                      (NP (DT this) (NN pathway))
                      (PP (IN in)
                        (NP (JJ obesity) (NN management))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(targets-13, potential-11)
amod(targets-13, therapeutic-12)
dobj(elucidate-6, targets-13)
conj:and(mechanisms-9, targets-13)
case(pathway-16, for-14)
det(pathway-16, this-15)
nmod:for(targets-13, pathway-16)
case(management-19, in-17)
amod(management-19, obesity-18)
nmod:in(pathway-16, management-19)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ numerous) (NN health) (NNS benefits))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-24, omega-3_fatty_acids-2)
nsubj:xsubj(have-26, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(shown-24, have-22)
auxpass(shown-24, been-23)
root(ROOT-0, shown-24)
mark(have-26, to-25)
xcomp(shown-24, have-26)
amod(benefits-29, numerous-27)
compound(benefits-29, health-28)
dobj(have-26, benefits-29)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN EPA/NNP and/CC DHA/NNP reduce/VB the/DT risk/NN of/IN coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- in/IN animal/NN models/NNS ,/, reduce/VB serum/NN anthracite/NN levels/NNS in/IN hyperanthracitemic/JJ patients/NNS ,/, and/CC reduce/VB the/DT incidence/NN of/IN CHD/NNP in/IN patients/NNS with/IN coronary_artery_disease/NN -LRB-/-LRB- CAD/NNP -RRB-/-RRB- and/CC heart_failure/NN -LRB-/-LRB- HF/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP
              (VP (VB reduce)
                (NP
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP (NN coronary_heart_disease))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))
                (PP (IN in)
                  (NP (NN animal) (NNS models))))
              (, ,)
              (VP (VB reduce)
                (NP (NN serum) (NN anthracite) (NNS levels))
                (PP (IN in)
                  (NP (JJ hyperanthracitemic) (NNS patients))))
              (, ,)
              (CC and)
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN incidence))
                  (PP (IN of)
                    (NP (NNP CHD))))
                (PP (IN in)
                  (NP (NNS patients)))
                (PP (IN with)
                  (NP
                    (NP
                      (NP (NN coronary_artery_disease))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP CAD))
                        (-RRB- -RRB-)))
                    (CC and)
                    (NP
                      (NP (NN heart_failure))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP HF))
                        (-RRB- -RRB-)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(reduce-9, that-5)
nsubj(reduce-9, EPA-6)
nsubj(reduce-21, EPA-6)
nsubj(reduce-30, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
nsubj(reduce-9, DHA-8)
ccomp(shown-4, reduce-9)
det(risk-11, the-10)
dobj(reduce-9, risk-11)
case(coronary_heart_disease-13, of-12)
nmod:of(risk-11, coronary_heart_disease-13)
appos(risk-11, CHD-15)
case(models-19, in-17)
compound(models-19, animal-18)
nmod:in(reduce-9, models-19)
ccomp(shown-4, reduce-21)
conj:and(reduce-9, reduce-21)
compound(levels-24, serum-22)
compound(levels-24, anthracite-23)
dobj(reduce-21, levels-24)
case(patients-27, in-25)
amod(patients-27, hyperanthracitemic-26)
nmod:in(reduce-21, patients-27)
cc(reduce-9, and-29)
ccomp(shown-4, reduce-30)
conj:and(reduce-9, reduce-30)
det(incidence-32, the-31)
dobj(reduce-30, incidence-32)
case(CHD-34, of-33)
nmod:of(incidence-32, CHD-34)
case(patients-36, in-35)
nmod:in(reduce-30, patients-36)
case(coronary_artery_disease-38, with-37)
nmod:with(reduce-30, coronary_artery_disease-38)
appos(coronary_artery_disease-38, CAD-40)
cc(coronary_artery_disease-38, and-42)
nmod:with(reduce-30, heart_failure-43)
conj:and(coronary_artery_disease-38, heart_failure-43)
appos(heart_failure-43, HF-45)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB modulation/NN of/IN lipid/NN metabolism/NN ,/, inflammation/NN ,/, and/CC oxidative_stress/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (NNS effects))))
    (VP
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (NN modulation))
            (PP (IN of)
              (NP
                (NP (NN lipid) (NN metabolism))
                (, ,)
                (NP (NN inflammation))
                (, ,)
                (CC and)
                (NP (NNS oxidative_stress))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
nsubj(involve-14, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-10, are-6)
neg(understood-10, not-7)
advmod(understood-10, yet-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
aux(involve-14, may-13)
conj:but(understood-10, involve-14)
dobj(involve-14, modulation-15)
case(metabolism-18, of-16)
compound(metabolism-18, lipid-17)
nmod:of(modulation-15, metabolism-18)
nmod:of(modulation-15, inflammation-20)
conj:and(metabolism-18, inflammation-20)
cc(metabolism-18, and-22)
nmod:of(modulation-15, oxidative_stress-23)
conj:and(metabolism-18, oxidative_stress-23)

In/IN addition/NN to/TO their/PRP$ cardioprotective/JJ effects/NNS ,/, EPA/NNP and/CC DHA/NNP have/VBP also/RB been/VBN shown/VBN to/TO improve/VB cognitive/JJ function/NN ,/, mood_disorders/NNS ,/, and/CC joint/JJ health/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN addition))
        (PP (TO to)
          (NP (PRP$ their) (JJ cardioprotective) (NNS effects)))))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB improve)
                (NP
                  (NP (JJ cognitive) (NN function))
                  (, ,)
                  (NP (NNS mood_disorders))
                  (, ,)
                  (CC and)
                  (NP (JJ joint) (NN health)))))))))
    (. .)))

case(effects-6, In-1)
mwe(In-1, addition-2)
mwe(In-1, to-3)
nmod:poss(effects-6, their-4)
amod(effects-6, cardioprotective-5)
nmod:in_addition_to(shown-14, effects-6)
nsubjpass(shown-14, EPA-8)
nsubj:xsubj(improve-16, EPA-8)
cc(EPA-8, and-9)
conj:and(EPA-8, DHA-10)
nsubjpass(shown-14, DHA-10)
nsubj:xsubj(improve-16, DHA-10)
aux(shown-14, have-11)
advmod(shown-14, also-12)
auxpass(shown-14, been-13)
root(ROOT-0, shown-14)
mark(improve-16, to-15)
xcomp(shown-14, improve-16)
amod(function-18, cognitive-17)
dobj(improve-16, function-18)
dobj(improve-16, mood_disorders-20)
conj:and(function-18, mood_disorders-20)
cc(function-18, and-22)
amod(health-24, joint-23)
dobj(improve-16, health-24)
conj:and(function-18, health-24)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB a/DT simple/JJ and/CC effective/JJ way/NN to/TO improve/VB overall/JJ health/NN and/CC reduce/VB the/DT risk/NN of/IN chronic_diseases/NNS such/JJ as/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (JJ dietary) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a)
                (ADJP (JJ simple)
                  (CC and)
                  (JJ effective))
                (NN way)
                (S
                  (VP (TO to)
                    (VP
                      (VP (VB improve)
                        (NP (JJ overall) (NN health)))
                      (CC and)
                      (VP (VB reduce)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP
                              (NP (NNS chronic_diseases))
                              (PP (JJ such) (IN as)
                                (NP (NNP CHD))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(way-18, that-4)
csubj(way-18, increasing-5)
amod(intake-7, dietary-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(way-18, may-12)
cop(way-18, be-13)
det(way-18, a-14)
amod(way-18, simple-15)
cc(simple-15, and-16)
conj:and(simple-15, effective-17)
amod(way-18, effective-17)
ccomp(suggest-3, way-18)
mark(improve-20, to-19)
acl(way-18, improve-20)
amod(health-22, overall-21)
dobj(improve-20, health-22)
cc(improve-20, and-23)
acl(way-18, reduce-24)
conj:and(improve-20, reduce-24)
det(risk-26, the-25)
dobj(reduce-24, risk-26)
case(chronic_diseases-28, of-27)
nmod:of(risk-26, chronic_diseases-28)
case(CHD-31, such-29)
mwe(such-29, as-30)
nmod:such_as(chronic_diseases-28, CHD-31)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN different/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS dosages))
                  (PP (IN for)
                    (NP (JJ different) (NNS populations))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(elucidate-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(elucidate-7, determine-15)
amod(dosages-17, optimal-16)
dobj(determine-15, dosages-17)
case(populations-20, for-18)
amod(populations-20, different-19)
nmod:for(dosages-17, populations-20)

Silychristin/NNP is_a/NNP flavonolignan/VBP that/IN exhibits/VBZ potent/JJ hepatoprotective/JJ effects/NNS ./.

(ROOT
  (S
    (NP (NNP Silychristin) (NNP is_a))
    (VP (VBP flavonolignan)
      (SBAR (IN that)
        (S
          (VP (VBZ exhibits)
            (NP (JJ potent) (JJ hepatoprotective) (NNS effects))))))
    (. .)))

compound(is_a-2, Silychristin-1)
nsubj(flavonolignan-3, is_a-2)
root(ROOT-0, flavonolignan-3)
mark(exhibits-5, that-4)
ccomp(flavonolignan-3, exhibits-5)
amod(effects-8, potent-6)
amod(effects-8, hepatoprotective-7)
dobj(exhibits-5, effects-8)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT regulatory/JJ mechanism/NN of/IN Silychristin/JJ production/NN in/IN HepG2/JJ cells/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (JJ regulatory) (NN mechanism))
        (PP (IN of)
          (NP (JJ Silychristin) (NN production))))
      (PP (IN in)
        (NP (JJ HepG2) (NNS cells))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(mechanism-9, the-7)
amod(mechanism-9, regulatory-8)
dobj(investigated-6, mechanism-9)
case(production-12, of-10)
amod(production-12, Silychristin-11)
nmod:of(mechanism-9, production-12)
case(cells-15, in-13)
amod(cells-15, HepG2-14)
nmod:in(investigated-6, cells-15)

The/DT inhibitory/JJ effect/NN of/IN SLC16A2/NNP on/IN Silychristin/NNP production/NN could/MD be/VB reversed/VBN by/IN pretreating/VBG cells/NNS with/IN staurosporin/NN ,/, a/DT protein_kinase_A/JJ -LRB-/-LRB- PKA/NNP -RRB-/-RRB- inhibitor/NN ,/, or/CC by/IN mutating/VBG S730A/NNP ,/, the/DT PKA-dependent/JJ phosphorylation/NN site/NN in/IN the/DT SLC16A2/NNP sequence/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ inhibitory) (NN effect))
      (PP (IN of)
        (NP (NNP SLC16A2)))
      (PP (IN on)
        (NP (NNP Silychristin) (NN production))))
    (VP (MD could)
      (VP (VB be)
        (VP (VBN reversed)
          (PP
            (PP (IN by)
              (S
                (VP (VBG pretreating)
                  (NP (NNS cells))
                  (PP (IN with)
                    (NP
                      (NP (NN staurosporin))
                      (, ,)
                      (NP (DT a) (JJ protein_kinase_A)
                        (PRN (-LRB- -LRB-)
                          (NP (NNP PKA))
                          (-RRB- -RRB-))
                        (NN inhibitor))
                      (, ,))))))
            (CC or)
            (PP (IN by)
              (S
                (VP (VBG mutating)
                  (NP
                    (NP (NNP S730A))
                    (, ,)
                    (NP
                      (NP (DT the) (JJ PKA-dependent) (NN phosphorylation) (NN site))
                      (PP (IN in)
                        (NP (DT the) (NNP SLC16A2) (NN sequence))))))))))))
    (. .)))

det(effect-3, The-1)
amod(effect-3, inhibitory-2)
nsubjpass(reversed-11, effect-3)
case(SLC16A2-5, of-4)
nmod:of(effect-3, SLC16A2-5)
case(production-8, on-6)
compound(production-8, Silychristin-7)
nmod:on(effect-3, production-8)
aux(reversed-11, could-9)
auxpass(reversed-11, be-10)
root(ROOT-0, reversed-11)
mark(pretreating-13, by-12)
dep(reversed-11, pretreating-13)
dobj(pretreating-13, cells-14)
case(staurosporin-16, with-15)
nmod:with(pretreating-13, staurosporin-16)
det(inhibitor-23, a-18)
amod(inhibitor-23, protein_kinase_A-19)
appos(inhibitor-23, PKA-21)
appos(staurosporin-16, inhibitor-23)
cc(pretreating-13, or-25)
mark(mutating-27, by-26)
dep(reversed-11, mutating-27)
conj:or(pretreating-13, mutating-27)
dobj(mutating-27, S730A-28)
det(site-33, the-30)
amod(site-33, PKA-dependent-31)
compound(site-33, phosphorylation-32)
appos(S730A-28, site-33)
case(sequence-37, in-34)
det(sequence-37, the-35)
compound(sequence-37, SLC16A2-36)
nmod:in(site-33, sequence-37)

The/DT inhibitory/JJ effect/NN of/IN SLC16A2/NNP on/IN Silychristin/NNP production/NN could/MD be/VB reversed/VBN by/IN pretreating/VBG cells/NNS with/IN staurosporin/NN ,/, a/DT protein_kinase_A/JJ -LRB-/-LRB- PKA/NNP -RRB-/-RRB- inhibitor/NN ,/, or/CC by/IN mutating/VBG S730A/NNP ,/, the/DT PKA-dependent/JJ phosphorylation/NN site/NN in/IN the/DT SLC16A2/NNP sequence/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ inhibitory) (NN effect))
      (PP (IN of)
        (NP (NNP SLC16A2)))
      (PP (IN on)
        (NP (NNP Silychristin) (NN production))))
    (VP (MD could)
      (VP (VB be)
        (VP (VBN reversed)
          (PP
            (PP (IN by)
              (S
                (VP (VBG pretreating)
                  (NP (NNS cells))
                  (PP (IN with)
                    (NP
                      (NP (NN staurosporin))
                      (, ,)
                      (NP (DT a) (JJ protein_kinase_A)
                        (PRN (-LRB- -LRB-)
                          (NP (NNP PKA))
                          (-RRB- -RRB-))
                        (NN inhibitor))
                      (, ,))))))
            (CC or)
            (PP (IN by)
              (S
                (VP (VBG mutating)
                  (NP
                    (NP (NNP S730A))
                    (, ,)
                    (NP
                      (NP (DT the) (JJ PKA-dependent) (NN phosphorylation) (NN site))
                      (PP (IN in)
                        (NP (DT the) (NNP SLC16A2) (NN sequence))))))))))))
    (. .)))

det(effect-3, The-1)
amod(effect-3, inhibitory-2)
nsubjpass(reversed-11, effect-3)
case(SLC16A2-5, of-4)
nmod:of(effect-3, SLC16A2-5)
case(production-8, on-6)
compound(production-8, Silychristin-7)
nmod:on(effect-3, production-8)
aux(reversed-11, could-9)
auxpass(reversed-11, be-10)
root(ROOT-0, reversed-11)
mark(pretreating-13, by-12)
dep(reversed-11, pretreating-13)
dobj(pretreating-13, cells-14)
case(staurosporin-16, with-15)
nmod:with(pretreating-13, staurosporin-16)
det(inhibitor-23, a-18)
amod(inhibitor-23, protein_kinase_A-19)
appos(inhibitor-23, PKA-21)
appos(staurosporin-16, inhibitor-23)
cc(pretreating-13, or-25)
mark(mutating-27, by-26)
dep(reversed-11, mutating-27)
conj:or(pretreating-13, mutating-27)
dobj(mutating-27, S730A-28)
det(site-33, the-30)
amod(site-33, PKA-dependent-31)
compound(site-33, phosphorylation-32)
appos(S730A-28, site-33)
case(sequence-37, in-34)
det(sequence-37, the-35)
compound(sequence-37, SLC16A2-36)
nmod:in(site-33, sequence-37)

These/DT findings/NNS suggest/VBP that/IN PKA/NNP signaling/VBG pathway/RB plays/VBZ a/DT crucial/JJ role/NN in/IN regulating/VBG Silychristin/NNP biosynthesis/NNS and/CC provide/VB new/JJ insights/NNS into/IN the/DT development/NN of/IN therapeutic/JJ strategies/NNS for/IN liver_diseases/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP
              (NP (NNP PKA))
              (VP (VBG signaling)
                (ADVP (RB pathway))))
            (VP (VBZ plays)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (NNP Silychristin) (NNS biosynthesis))))))))))
      (CC and)
      (VP (VB provide)
        (NP (JJ new) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP
                (NP (JJ therapeutic) (NNS strategies))
                (PP (IN for)
                  (NP (NNS liver_diseases)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
nsubj(provide-17, findings-2)
root(ROOT-0, suggest-3)
mark(plays-8, that-4)
nsubj(plays-8, PKA-5)
acl(PKA-5, signaling-6)
advmod(signaling-6, pathway-7)
ccomp(suggest-3, plays-8)
det(role-11, a-9)
amod(role-11, crucial-10)
dobj(plays-8, role-11)
mark(regulating-13, in-12)
acl(role-11, regulating-13)
compound(biosynthesis-15, Silychristin-14)
dobj(regulating-13, biosynthesis-15)
cc(suggest-3, and-16)
conj:and(suggest-3, provide-17)
amod(insights-19, new-18)
dobj(provide-17, insights-19)
case(development-22, into-20)
det(development-22, the-21)
nmod:into(provide-17, development-22)
case(strategies-25, of-23)
amod(strategies-25, therapeutic-24)
nmod:of(development-22, strategies-25)
case(liver_diseases-27, for-26)
nmod:for(strategies-25, liver_diseases-27)

Omega-3_fatty_acids/NNS have/VBP been/VBN widely/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB widely))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, widely-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, such/JJ as/IN eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP known/VBN to/TO have/VB numerous/JJ cardiovascular_benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (PP (JJ such) (IN as)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP (JJ numerous) (NNS cardiovascular_benefits)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(known-17, omega-3_fatty_acids-2)
nsubj:xsubj(have-19, omega-3_fatty_acids-2)
case(EPA-8, such-4)
mwe(such-4, as-5)
advmod(EPA-8, eicosapentaenoic_acid-6)
nmod:such_as(omega-3_fatty_acids-2, EPA-8)
cc(EPA-8, and-10)
nmod:such_as(omega-3_fatty_acids-2, docosahexaenoic_acid-11)
conj:and(EPA-8, docosahexaenoic_acid-11)
appos(EPA-8, DHA-13)
auxpass(known-17, are-16)
root(ROOT-0, known-17)
mark(have-19, to-18)
xcomp(known-17, have-19)
amod(cardiovascular_benefits-21, numerous-20)
dobj(have-19, cardiovascular_benefits-21)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN EPA/NNP and/CC DHA/NNP are/VBP associated/VBN with/IN decreased/VBN Ryanodine/JJ levels/NNS in/IN hyperRyanodinemic/JJ patients/NNS ,/, which/WDT may/MD contribute/VB to/TO their/PRP$ cardioprotective/JJ effects/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ Ryanodine) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperRyanodinemic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD may)
                              (VP (VB contribute)
                                (PP (TO to)
                                  (NP (PRP$ their) (JJ cardioprotective) (NNS effects)))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
nsubjpass(associated-10, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
nsubjpass(associated-10, DHA-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, Ryanodine-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperRyanodinemic-16)
nmod:in(levels-14, patients-17)
nsubj(contribute-21, patients-17)
ref(patients-17, which-19)
aux(contribute-21, may-20)
acl:relcl(patients-17, contribute-21)
case(effects-25, to-22)
nmod:poss(effects-25, their-23)
amod(effects-25, cardioprotective-24)
nmod:to(contribute-21, effects-25)

Moreover/RB ,/, these/DT long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN shown/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

advmod(shown-8, Moreover-1)
det(omega-3_fatty_acids-5, these-3)
amod(omega-3_fatty_acids-5, long-chain-4)
nsubjpass(shown-8, omega-3_fatty_acids-5)
nsubj:xsubj(decrease-10, omega-3_fatty_acids-5)
aux(shown-8, have-6)
auxpass(shown-8, been-7)
root(ROOT-0, shown-8)
mark(decrease-10, to-9)
xcomp(shown-8, decrease-10)
det(risk-12, the-11)
dobj(decrease-10, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, coronary_heart_disease-15)
appos(risk-12, CHD-17)

The/DT mechanisms/NNS underlying/VBG these/DT protective/JJ effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ believed/VBN that/IN EPA/NNP and/CC DHA/NNP may/MD modulate/VBP inflammation/NN ,/, improve/VB lipid/NN profiles/NNS ,/, and/CC enhance/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (VP (VBG underlying)
          (NP (DT these) (JJ protective) (NNS effects))))
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (VP (MD may)
                (VP (VBP modulate)
                  (NP (NN inflammation))
                  (, ,)
                  (S
                    (VP
                      (VP (VB improve)
                        (NP (NN lipid) (NNS profiles)))
                      (, ,)
                      (CC and)
                      (VP (VB enhance)
                        (NP (JJ endothelial) (NN function))))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, these-4)
amod(effects-6, protective-5)
dobj(underlying-3, effects-6)
auxpass(understood-10, are-7)
neg(understood-10, not-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
nsubjpass(believed-15, it-13)
auxpass(believed-15, is-14)
conj:but(understood-10, believed-15)
mark(modulate-21, that-16)
nsubj(modulate-21, EPA-17)
cc(EPA-17, and-18)
conj:and(EPA-17, DHA-19)
nsubj(modulate-21, DHA-19)
aux(modulate-21, may-20)
ccomp(believed-15, modulate-21)
dobj(modulate-21, inflammation-22)
dep(modulate-21, improve-24)
compound(profiles-26, lipid-25)
dobj(improve-24, profiles-26)
cc(improve-24, and-28)
dep(modulate-21, enhance-29)
conj:and(improve-24, enhance-29)
amod(function-31, endothelial-30)
dobj(enhance-29, function-31)

In/IN this/DT review/NN ,/, we/PRP summarize/VB the/DT evidence/NN that/IN EPA/NNP ,/, DHA/NNP ,/, and/CC their/PRP$ combinations/NNS may/MD be/VB beneficial/JJ for/IN the/DT prevention/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN review)))
    (, ,)
    (NP (PRP we))
    (VP (VB summarize)
      (NP
        (NP (DT the) (NN evidence))
        (SBAR (IN that)
          (S
            (NP
              (NP (NNP EPA))
              (, ,)
              (NP (NNP DHA))
              (, ,)
              (CC and)
              (NP (PRP$ their) (NNS combinations)))
            (VP (MD may)
              (VP (VB be)
                (ADJP (JJ beneficial)
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN prevention))
                      (PP (IN of)
                        (NP (NNP CHD))))))))))))
    (. .)))

case(review-3, In-1)
det(review-3, this-2)
nmod:in(summarize-6, review-3)
nsubj(summarize-6, we-5)
root(ROOT-0, summarize-6)
det(evidence-8, the-7)
dobj(summarize-6, evidence-8)
mark(beneficial-19, that-9)
nsubj(beneficial-19, EPA-10)
conj:and(EPA-10, DHA-12)
nsubj(beneficial-19, DHA-12)
cc(EPA-10, and-14)
nmod:poss(combinations-16, their-15)
conj:and(EPA-10, combinations-16)
nsubj(beneficial-19, combinations-16)
aux(beneficial-19, may-17)
cop(beneficial-19, be-18)
dep(evidence-8, beneficial-19)
case(prevention-22, for-20)
det(prevention-22, the-21)
nmod:for(beneficial-19, prevention-22)
case(CHD-24, of-23)
nmod:of(prevention-22, CHD-24)

We/PRP also/RB discuss/VB the/DT mechanisms/NNS by/IN which/WDT these/DT fatty_acids/NNS may/MD reduce/VB Ryanodin/JJ levels/NNS and/CC thereby/RB reduce/VB the/DT risk/NN for/IN developing/VBG CHD/NNP ,/, as/RB well/RB as/IN the/DT clinical/JJ implications/NNS of/IN these/DT findings/NNS ./.

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB also))
    (VP (VB discuss)
      (NP (DT the) (NNS mechanisms))
      (PP (IN by)
        (SBAR
          (WHNP (WDT which))
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (MD may)
              (VP
                (VP (VB reduce)
                  (NP (JJ Ryanodin) (NNS levels)))
                (CC and)
                (VP
                  (ADVP (RB thereby))
                  (VB reduce)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN for)
                      (S
                        (VP (VBG developing)
                          (NP
                            (NP (NNP CHD))
                            (, ,)
                            (CONJP (RB as) (RB well) (IN as))
                            (NP
                              (NP (DT the) (JJ clinical) (NNS implications))
                              (PP (IN of)
                                (NP (DT these) (NNS findings))))))))))))))))
    (. .)))

nsubj(discuss-3, We-1)
advmod(discuss-3, also-2)
root(ROOT-0, discuss-3)
det(mechanisms-5, the-4)
dobj(discuss-3, mechanisms-5)
mark(reduce-11, by-6)
dobj(reduce-11, which-7)
det(fatty_acids-9, these-8)
nsubj(reduce-11, fatty_acids-9)
nsubj(reduce-16, fatty_acids-9)
aux(reduce-11, may-10)
advcl(discuss-3, reduce-11)
amod(levels-13, Ryanodin-12)
dobj(reduce-11, levels-13)
cc(reduce-11, and-14)
advmod(reduce-16, thereby-15)
advcl(discuss-3, reduce-16)
conj:and(reduce-11, reduce-16)
det(risk-18, the-17)
dobj(reduce-16, risk-18)
mark(developing-20, for-19)
acl(risk-18, developing-20)
dobj(developing-20, CHD-21)
cc(CHD-21, as-23)
mwe(as-23, well-24)
mwe(as-23, as-25)
det(implications-28, the-26)
amod(implications-28, clinical-27)
dobj(developing-20, implications-28)
conj:and(CHD-21, implications-28)
case(findings-31, of-29)
det(findings-31, these-30)
nmod:of(implications-28, findings-31)

/VBP 2016/CD Wiley/NNP Periodicals/NNPS ,/, Inc./NNP ./.

(ROOT
  (S
    (VP (VBP )
      (NP
        (NP (CD 2016) (NNP Wiley) (NNPS Periodicals))
        (, ,)
        (NP (NNP Inc.))))
    (. .)))

root(ROOT-0, -1)
nummod(Periodicals-4, 2016-2)
compound(Periodicals-4, Wiley-3)
dobj(-1, Periodicals-4)
appos(Periodicals-4, Inc.-6)

J/NNP Biomed/NNP Mater/NNP Res/NNP Part/NNP B/NNP :/: Appl/NNP Biomater/NNP ,/, 105B/CD :/: 539-544/CD ,/, 2017/CD ./.

(ROOT
  (NP
    (NP (NNP J) (NNP Biomed) (NNP Mater) (NNP Res) (NNP Part) (NNP B))
    (: :)
    (NP
      (NP (NNP Appl) (NNP Biomater))
      (, ,)
      (NP (CD 105B)))
    (: :)
    (NP
      (NP (CD 539-544))
      (, ,)
      (NP (CD 2017)))
    (. .)))

compound(B-6, J-1)
compound(B-6, Biomed-2)
compound(B-6, Mater-3)
compound(B-6, Res-4)
compound(B-6, Part-5)
root(ROOT-0, B-6)
compound(Biomater-9, Appl-8)
dep(B-6, Biomater-9)
amod(Biomater-9, 105B-11)
dep(B-6, 539-544-13)
amod(539-544-13, 2017-15)

To/TO investigate/VB the/DT effect/NN of/IN gnetin_C/JJ ,/, triclocarban/NN ,/, 2,2/CD '/POS ,4,4/CD '_-/CD tetrabromodiphenyl_ether/NN ,/, and/CC bisphenol_A/NN on/IN the/DT iodide/JJ uptake/NN ,/, Tyrosinase/NNP activity/NN ,/, and/CC expression/NN of/IN genes/NNS involved/VBN in/IN thyroid_hormone/JJ synthesis/NN in/IN rat/NN thyroid/NN follicular/NN cells/NNS -LRB-/-LRB- TFs/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB investigate)
          (NP
            (NP (DT the) (NN effect))
            (PP (IN of)
              (NP
                (NP (JJ gnetin_C)
                  (PRN (, ,)
                    (NP
                      (NP (NN triclocarban))
                      (, ,)
                      (NP
                        (NP (CD 2,2) (POS '))
                        (ADJP
                          (QP (CD ,4,4) (CD '_-)))
                        (NN tetrabromodiphenyl_ether))
                      (, ,)
                      (CC and)
                      (NP
                        (NP (NN bisphenol_A))
                        (PP (IN on)
                          (NP (DT the) (JJ iodide) (NN uptake)))))
                    (, ,))
                  (NNP Tyrosinase) (NN activity))
                (, ,)
                (CC and)
                (NP
                  (NP (NN expression))
                  (PP (IN of)
                    (NP (NNS genes))))))))))
    (VP (VBN involved)
      (PP (IN in)
        (NP
          (NP
            (NP (JJ thyroid_hormone) (NN synthesis))
            (PP (IN in)
              (NP (NN rat) (NN thyroid) (NN follicular) (NNS cells))))
          (PRN (-LRB- -LRB-)
            (NP (NNP TFs))
            (-RRB- -RRB-)))))
    (. .)))

mark(investigate-2, To-1)
csubj(involved-30, investigate-2)
det(effect-4, the-3)
dobj(investigate-2, effect-4)
case(activity-24, of-5)
amod(activity-24, gnetin_C-6)
dep(activity-24, triclocarban-8)
nmod:poss(tetrabromodiphenyl_ether-14, 2,2-10)
case(2,2-10, '-11)
compound('_--13, ,4,4-12)
nummod(tetrabromodiphenyl_ether-14, '_--13)
conj:and(triclocarban-8, tetrabromodiphenyl_ether-14)
dep(activity-24, tetrabromodiphenyl_ether-14)
cc(triclocarban-8, and-16)
conj:and(triclocarban-8, bisphenol_A-17)
dep(activity-24, bisphenol_A-17)
case(uptake-21, on-18)
det(uptake-21, the-19)
amod(uptake-21, iodide-20)
nmod:on(bisphenol_A-17, uptake-21)
compound(activity-24, Tyrosinase-23)
nmod:of(effect-4, activity-24)
cc(activity-24, and-26)
nmod:of(effect-4, expression-27)
conj:and(activity-24, expression-27)
case(genes-29, of-28)
nmod:of(expression-27, genes-29)
root(ROOT-0, involved-30)
case(synthesis-33, in-31)
amod(synthesis-33, thyroid_hormone-32)
nmod:in(involved-30, synthesis-33)
case(cells-38, in-34)
compound(cells-38, rat-35)
compound(cells-38, thyroid-36)
compound(cells-38, follicular-37)
nmod:in(synthesis-33, cells-38)
appos(synthesis-33, TFs-40)

The/DT synthesis/NN of/IN thyroid_hormones/NNS is_a/VBZ complex/JJ process/NN that/WDT involves/VBZ various/JJ enzymes/NNS and/CC proteins/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN synthesis))
      (PP (IN of)
        (NP (NNS thyroid_hormones))))
    (VP (VBZ is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP (JJ various) (NNS enzymes)
                (CC and)
                (NNS proteins)))))))
    (. .)))

det(synthesis-2, The-1)
nsubj(is_a-5, synthesis-2)
case(thyroid_hormones-4, of-3)
nmod:of(synthesis-2, thyroid_hormones-4)
root(ROOT-0, is_a-5)
amod(process-7, complex-6)
dobj(is_a-5, process-7)
nsubj(involves-9, process-7)
ref(process-7, that-8)
acl:relcl(process-7, involves-9)
amod(enzymes-11, various-10)
dobj(involves-9, enzymes-11)
cc(enzymes-11, and-12)
dobj(involves-9, proteins-13)
conj:and(enzymes-11, proteins-13)

Environmental/NNP contaminants/VBZ such/PDT as/RB gnetin_C/JJ ,/, triclocarban/NN ,/, 2,2/CD '/'' ,4,4/CD '/'' -/: tetrabromodiphenyl_ether/NN -LRB-/-LRB- BDE-47/NNP -RRB-/-RRB- ,/, and/CC bisphenol_A/NN -LRB-/-LRB- BPA/NNP -RRB-/-RRB- have/VBP been/VBN shown/VBN to/TO disrupt/VB thyroid/NN function/NN ./.

(ROOT
  (S
    (S
      (NP (NNP Environmental))
      (VP (VBZ contaminants)
        (S
          (NP
            (NP
              (NP (PDT such))
              (ADJP (RB as) (JJ gnetin_C)))
            (, ,)
            (NP (NN triclocarban))
            (, ,)
            (NP (CD 2,2))
            ('' ')
            (NP (CD ,4,4))
            ('' ') (: -))
          (NP
            (NP (NN tetrabromodiphenyl_ether))
            (PRN (-LRB- -LRB-)
              (NP (NNP BDE-47))
              (-RRB- -RRB-))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (NN bisphenol_A))
        (PRN (-LRB- -LRB-)
          (NP (NNP BPA))
          (-RRB- -RRB-)))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB disrupt)
                  (NP (NN thyroid) (NN function)))))))))
    (. .)))

nsubj(contaminants-2, Environmental-1)
root(ROOT-0, contaminants-2)
nsubj(tetrabromodiphenyl_ether-14, such-3)
advmod(gnetin_C-5, as-4)
amod(such-3, gnetin_C-5)
appos(such-3, triclocarban-7)
amod(such-3, 2,2-9)
dep(such-3, ,4,4-11)
xcomp(contaminants-2, tetrabromodiphenyl_ether-14)
appos(tetrabromodiphenyl_ether-14, BDE-47-16)
cc(contaminants-2, and-19)
nsubjpass(shown-26, bisphenol_A-20)
nsubj:xsubj(disrupt-28, bisphenol_A-20)
appos(bisphenol_A-20, BPA-22)
aux(shown-26, have-24)
auxpass(shown-26, been-25)
conj:and(contaminants-2, shown-26)
mark(disrupt-28, to-27)
xcomp(shown-26, disrupt-28)
compound(function-30, thyroid-29)
dobj(disrupt-28, function-30)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN these/DT compounds/NNS on/IN iodide/JJ uptake/NN ,/, tyrosinase/JJ activity/NN ,/, and/CC expression/NN of/IN genes/NNS involved/VBN in/IN thyroid_hormone/JJ synthesis/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (DT these) (NNS compounds))))
      (PP (IN on)
        (NP
          (NP (JJ iodide) (NN uptake))
          (, ,)
          (NP (JJ tyrosinase) (NN activity))
          (, ,)
          (CC and)
          (NP
            (NP (NN expression))
            (PP (IN of)
              (NP
                (NP (NNS genes))
                (VP (VBN involved)
                  (PP (IN in)
                    (NP (JJ thyroid_hormone) (NN synthesis))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(compounds-11, of-9)
det(compounds-11, these-10)
nmod:of(effect-8, compounds-11)
case(uptake-14, on-12)
amod(uptake-14, iodide-13)
nmod:on(investigated-6, uptake-14)
amod(activity-17, tyrosinase-16)
nmod:on(investigated-6, activity-17)
conj:and(uptake-14, activity-17)
cc(uptake-14, and-19)
nmod:on(investigated-6, expression-20)
conj:and(uptake-14, expression-20)
case(genes-22, of-21)
nmod:of(expression-20, genes-22)
acl(genes-22, involved-23)
case(synthesis-26, in-24)
amod(synthesis-26, thyroid_hormone-25)
nmod:in(involved-23, synthesis-26)

Our/PRP$ results/NNS show/VBP that/IN gnetin_C/NN and/CC BDE-47/NN significantly/RB reduce/VB iodide/JJ uptake/JJ and_tyrosinase/JJ activity/NN in_a/JJ dose-dependent/JJ manner/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP show)
      (SBAR (IN that)
        (S
          (NP (NN gnetin_C)
            (CC and)
            (NN BDE-47))
          (ADVP (RB significantly))
          (VP (VB reduce)
            (NP (JJ iodide) (JJ uptake) (JJ and_tyrosinase) (NN activity))
            (NP (JJ in_a) (JJ dose-dependent) (NN manner))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(show-3, results-2)
root(ROOT-0, show-3)
mark(reduce-9, that-4)
nsubj(reduce-9, gnetin_C-5)
cc(gnetin_C-5, and-6)
conj:and(gnetin_C-5, BDE-47-7)
nsubj(reduce-9, BDE-47-7)
advmod(reduce-9, significantly-8)
ccomp(show-3, reduce-9)
amod(activity-13, iodide-10)
amod(activity-13, uptake-11)
amod(activity-13, and_tyrosinase-12)
iobj(reduce-9, activity-13)
amod(manner-16, in_a-14)
amod(manner-16, dose-dependent-15)
dobj(reduce-9, manner-16)

Triclocarban/NNP and/CC BPA/NNP also/RB reduce/VBP iodide/JJ uptake/NN but/CC have/VBP no/DT significant/JJ effect/NN on/IN tyrosinase/JJ activity/NN ./.

(ROOT
  (S
    (NP (NNP Triclocarban)
      (CC and)
      (NNP BPA))
    (ADVP (RB also))
    (VP
      (VP (VBP reduce)
        (NP (JJ iodide) (NN uptake)))
      (CC but)
      (VP (VBP have)
        (NP
          (NP (DT no) (JJ significant) (NN effect))
          (PP (IN on)
            (NP (JJ tyrosinase) (NN activity))))))
    (. .)))

nsubj(reduce-5, Triclocarban-1)
nsubj(have-9, Triclocarban-1)
cc(Triclocarban-1, and-2)
conj:and(Triclocarban-1, BPA-3)
nsubj(reduce-5, BPA-3)
advmod(reduce-5, also-4)
root(ROOT-0, reduce-5)
amod(uptake-7, iodide-6)
dobj(reduce-5, uptake-7)
cc(reduce-5, but-8)
conj:but(reduce-5, have-9)
neg(effect-12, no-10)
amod(effect-12, significant-11)
dobj(have-9, effect-12)
case(activity-15, on-13)
amod(activity-15, tyrosinase-14)
nmod:on(effect-12, activity-15)

Furthermore/RB ,/, all/DT four/CD compounds/NNS alter/VBP the/DT expression/NN of/IN genes/NNS involved/VBN in/IN thyroid_hormone/JJ synthesis/NN ,/, with/IN BPA/NNP having/VBG the/DT most/RBS significant/JJ effect/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (DT all) (CD four) (NNS compounds))
    (VP (VBP alter)
      (NP
        (NP (DT the) (NN expression))
        (PP (IN of)
          (NP
            (NP (NNS genes))
            (VP (VBN involved)
              (PP (IN in)
                (NP
                  (NP (JJ thyroid_hormone) (NN synthesis))
                  (, ,)
                  (PP (IN with)
                    (NP (NNP BPA)))))
              (S
                (VP (VBG having)
                  (NP (DT the)
                    (ADJP (RBS most) (JJ significant))
                    (NN effect)))))))))
    (. .)))

advmod(alter-6, Furthermore-1)
det(compounds-5, all-3)
nummod(compounds-5, four-4)
nsubj(alter-6, compounds-5)
root(ROOT-0, alter-6)
det(expression-8, the-7)
dobj(alter-6, expression-8)
case(genes-10, of-9)
nmod:of(expression-8, genes-10)
acl(genes-10, involved-11)
case(synthesis-14, in-12)
amod(synthesis-14, thyroid_hormone-13)
nmod:in(involved-11, synthesis-14)
case(BPA-17, with-16)
nmod:with(synthesis-14, BPA-17)
xcomp(involved-11, having-18)
det(effect-22, the-19)
advmod(significant-21, most-20)
amod(effect-22, significant-21)
dobj(having-18, effect-22)

These/DT findings/NNS suggest/VBP that/IN exposure/NN to/TO environmental/JJ contaminants/NNS can/MD disrupt/VB normal/JJ thyroid/NN function/NN by/IN affecting/VBG iodide/JJ uptake/NN ,/, tyrosinase/JJ activity/NN ,/, and/CC gene/NN expression/NN ,/, which/WDT may/MD have/VB implications/NNS for/IN human/JJ health/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN exposure))
            (PP (TO to)
              (NP (JJ environmental) (NNS contaminants))))
          (VP (MD can)
            (VP (VB disrupt)
              (NP (JJ normal) (NN thyroid) (NN function))
              (PP (IN by)
                (S
                  (VP (VBG affecting)
                    (NP
                      (NP (JJ iodide) (NN uptake))
                      (, ,)
                      (NP (JJ tyrosinase) (NN activity))
                      (, ,)
                      (CC and)
                      (NP
                        (NP (NN gene) (NN expression))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD may)
                              (VP (VB have)
                                (NP
                                  (NP (NNS implications))
                                  (PP (IN for)
                                    (NP (JJ human) (NN health))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(disrupt-10, that-4)
nsubj(disrupt-10, exposure-5)
case(contaminants-8, to-6)
amod(contaminants-8, environmental-7)
nmod:to(exposure-5, contaminants-8)
aux(disrupt-10, can-9)
ccomp(suggest-3, disrupt-10)
amod(function-13, normal-11)
compound(function-13, thyroid-12)
dobj(disrupt-10, function-13)
mark(affecting-15, by-14)
advcl(disrupt-10, affecting-15)
amod(uptake-17, iodide-16)
dobj(affecting-15, uptake-17)
amod(activity-20, tyrosinase-19)
dobj(affecting-15, activity-20)
conj:and(uptake-17, activity-20)
cc(uptake-17, and-22)
compound(expression-24, gene-23)
dobj(affecting-15, expression-24)
conj:and(uptake-17, expression-24)
nsubj(have-28, expression-24)
ref(expression-24, which-26)
aux(have-28, may-27)
acl:relcl(expression-24, have-28)
dobj(have-28, implications-29)
case(health-32, for-30)
amod(health-32, human-31)
nmod:for(implications-29, health-32)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN widely/RB studied/VBN for/IN their/PRP$ beneficial/JJ effects/NNS on/IN various/JJ health/NN conditions/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB widely))
          (VBN studied)
          (PP (IN for)
            (NP
              (NP (PRP$ their) (JJ beneficial) (NNS effects))
              (PP (IN on)
                (NP (JJ various) (NN health) (NNS conditions))))))))
    (. .)))

nsubjpass(studied-17, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(studied-17, have-14)
auxpass(studied-17, been-15)
advmod(studied-17, widely-16)
root(ROOT-0, studied-17)
case(effects-21, for-18)
nmod:poss(effects-21, their-19)
amod(effects-21, beneficial-20)
nmod:for(studied-17, effects-21)
case(conditions-25, on-22)
amod(conditions-25, various-23)
compound(conditions-25, health-24)
nmod:on(effects-21, conditions-25)

Recent/JJ research/NN has/VBZ shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN glatiramer_acetate/NN in/IN hyperglatiramer/JJ acetatemic/JJ patients/NNS ,/, which/WDT may/MD have/VB implications/NNS for/IN the/DT treatment/NN of/IN multiple_sclerosis/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NN research))
    (VP (VBZ has)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP (NN glatiramer_acetate))
                        (PP (IN in)
                          (NP
                            (NP (JJ hyperglatiramer) (JJ acetatemic) (NNS patients))
                            (, ,)
                            (SBAR
                              (WHNP (WDT which))
                              (S
                                (VP (MD may)
                                  (VP (VB have)
                                    (NP
                                      (NP (NNS implications))
                                      (PP (IN for)
                                        (NP
                                          (NP (DT the) (NN treatment))
                                          (PP (IN of)
                                            (NP (NNS multiple_sclerosis))))))))))))))))))))))
    (. .)))

amod(research-2, Recent-1)
nsubj(shown-4, research-2)
aux(shown-4, has-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(levels-13, with-11)
amod(levels-13, decreased-12)
nmod:with(associated-10, levels-13)
case(glatiramer_acetate-15, of-14)
nmod:of(levels-13, glatiramer_acetate-15)
case(patients-19, in-16)
amod(patients-19, hyperglatiramer-17)
amod(patients-19, acetatemic-18)
nmod:in(glatiramer_acetate-15, patients-19)
nsubj(have-23, patients-19)
ref(patients-19, which-21)
aux(have-23, may-22)
acl:relcl(patients-19, have-23)
dobj(have-23, implications-24)
case(treatment-27, for-25)
det(treatment-27, the-26)
nmod:for(implications-24, treatment-27)
case(multiple_sclerosis-29, of-28)
nmod:of(treatment-27, multiple_sclerosis-29)

Additionally/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN found/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, a/DT leading/VBG cause/NN of/IN mortality/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP (NN coronary_heart_disease))
                        (NP
                          (NP (-LRB- -LRB-) (NNP CHD) (-RRB- -RRB-))
                          (, ,)
                          (NP
                            (NP (DT a) (VBG leading) (NN cause))
                            (PP (IN of)
                              (NP (NN mortality)))))))))
                (ADVP (RB worldwide))))))))
    (. .)))

advmod(found-8, Additionally-1)
nsubjpass(found-8, EPA-3)
nsubj:xsubj(decrease-10, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(found-8, DHA-5)
nsubj:xsubj(decrease-10, DHA-5)
aux(found-8, have-6)
auxpass(found-8, been-7)
root(ROOT-0, found-8)
mark(decrease-10, to-9)
xcomp(found-8, decrease-10)
det(risk-12, the-11)
dobj(decrease-10, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
iobj(developing-14, coronary_heart_disease-15)
dobj(developing-14, CHD-17)
det(cause-22, a-20)
amod(cause-22, leading-21)
appos(CHD-17, cause-22)
case(mortality-24, of-23)
nmod:of(cause-22, mortality-24)
advmod(decrease-10, worldwide-25)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, are/VBP associated/VBN with/IN decreased/VBN glatiramer_acetate/NN levels/NNS in/IN hyperglatiramer/NN acetatemic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN associated)
          (PP (IN with)
            (NP (VBN decreased) (NN glatiramer_acetate) (NNS levels)))
          (PP (IN in)
            (NP (NN hyperglatiramer) (JJ acetatemic) (NNS patients)))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(associated-23, omega-3_fatty_acids-2)
nsubjpass(decreased-33, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
auxpass(associated-23, are-22)
root(ROOT-0, associated-23)
case(levels-27, with-24)
amod(levels-27, decreased-25)
compound(levels-27, glatiramer_acetate-26)
nmod:with(associated-23, levels-27)
case(patients-31, in-28)
compound(patients-31, hyperglatiramer-29)
amod(patients-31, acetatemic-30)
nmod:in(associated-23, patients-31)
cc(associated-23, and-32)
conj:and(associated-23, decreased-33)
dobj(decreased-33, risk-34)
case(coronary_heart_disease-37, of-35)
amod(coronary_heart_disease-37, developing-36)
nmod:of(risk-34, coronary_heart_disease-37)
appos(coronary_heart_disease-37, CHD-39)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG these/DT associations/NNS and/CC to/TO explore/VB their/PRP$ potential/JJ clinical/JJ applications/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS associations))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP (PRP$ their) (JJ potential) (JJ clinical) (NNS applications))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
ccomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(associations-12, these-11)
dobj(underlying-10, associations-12)
cc(understand-7, and-13)
mark(explore-15, to-14)
ccomp(needed-4, explore-15)
conj:and(understand-7, explore-15)
nmod:poss(applications-19, their-16)
amod(applications-19, potential-17)
amod(applications-19, clinical-18)
dobj(explore-15, applications-19)

At_2/JJ h/NN after/IN dosing/VBG ,/, SCH_23390/NNP reduced/VBD the/DT risk/NN of/IN latent_deficiency/RB by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/NN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP SCH_23390))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP
            (NP
              (ADVP (RB latent_deficiency)
                (PP (IN by)
                  (NP
                    (NP
                      (NP (CD 14) (NN %))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (CD 95) (NN %))
                          (SBAR
                            (S
                              (VP (VBP CI)
                                (NP
                                  (NP
                                    (NP (CD 6-20) (NN %))
                                    (, ,)
                                    (NP (NNP P)))
                                  (X
                                    (X (SYM =))
                                    (NP (CD 0.0005))))))))
                        (-RRB- -RRB-)))
                    (, ,)
                    (NP
                      (NP
                        (NP (NN photophobia))
                        (NP (CD 17) (NN %)))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (CD 95) (NN %))
                          (PP (NNP CI)
                            (NP (CD 12-22) (NN %))))
                        (, ,)
                        (NP (NNP P)
                          (QP (CD <) (CD 0.0001)))
                        (-RRB- -RRB-)))
                    (, ,)
                    (CC and)
                    (NP (NN phonophobia)))))
              (CD 14) (NN %))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (CD 95) (NN %))
                (PP (NNP CI)
                  (NP (CD 17-20) (NN %))))
              (, ,)
              (NP (NNP P)
                (QP (CD <) (CD 0.0001)))
              (-RRB- -RRB-))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, SCH_23390-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(%-45, of-10)
advmod(%-45, latent_deficiency-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(latent_deficiency-11, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
nmod:by(latent_deficiency-11, photophobia-27)
conj:and(%-14, photophobia-27)
nummod(%-29, 17-28)
dep(photophobia-27, %-29)
nummod(%-32, 95-31)
appos(photophobia-27, %-32)
dep(%-35, CI-33)
nummod(%-35, 12-22-34)
nmod(%-32, %-35)
dep(%-32, P-37)
compound(0.0001-39, <-38)
nummod(P-37, 0.0001-39)
cc(%-14, and-42)
nmod:by(latent_deficiency-11, phonophobia-43)
conj:and(%-14, phonophobia-43)
nummod(%-45, 14-44)
nmod:of(risk-9, %-45)
nummod(%-48, 95-47)
appos(%-45, %-48)
dep(%-51, CI-49)
nummod(%-51, 17-20-50)
nmod(%-48, %-51)
dep(%-48, P-53)
compound(0.0001-55, <-54)
nummod(P-53, 0.0001-55)

A/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN was/VBD conducted/VBN on/IN a/DT group/NN of/IN patients/NNS who/WP were/VBD administered/VBN with/IN SCH_23390/NNP ./.

(ROOT
  (S
    (NP (DT A)
      (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
      (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN on)
          (NP
            (NP (DT a) (NN group))
            (PP (IN of)
              (NP
                (NP (NNS patients))
                (SBAR
                  (WHNP (WP who))
                  (S
                    (VP (VBD were)
                      (VP (VBN administered)
                        (PP (IN with)
                          (NP (NNP SCH_23390)))))))))))))
    (. .)))

det(trial-7, A-1)
amod(placebo-controlled-6, randomized-2)
amod(placebo-controlled-6, double-blind-4)
amod(trial-7, placebo-controlled-6)
nsubjpass(conducted-9, trial-7)
auxpass(conducted-9, was-8)
root(ROOT-0, conducted-9)
case(group-12, on-10)
det(group-12, a-11)
nmod:on(conducted-9, group-12)
case(patients-14, of-13)
nmod:of(group-12, patients-14)
nsubjpass(administered-17, patients-14)
ref(patients-14, who-15)
auxpass(administered-17, were-16)
acl:relcl(patients-14, administered-17)
case(SCH_23390-19, with-18)
nmod:with(administered-17, SCH_23390-19)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD h/NN after/IN dosing/VBG ,/, SCH_23390/NNP significantly/RB reduced/VBD the/DT risk/NN of/IN latent_deficiency/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP
            (PP (IN at)
              (NP (CD 2) (NN h)))
            (PP (IN after)
              (S
                (VP (VBG dosing)))))
          (, ,)
          (NP (NNP SCH_23390))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN latent_deficiency))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(h-7, at-5)
nummod(h-7, 2-6)
nmod:at(reduced-13, h-7)
mark(dosing-9, after-8)
nmod(h-7, dosing-9)
nsubj(reduced-13, SCH_23390-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(latent_deficiency-17, of-16)
nmod:of(risk-15, latent_deficiency-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN SCH_23390/NNP may/MD have/VB potential/JJ therapeutic/JJ benefits/NNS in/IN reducing/VBG the/DT symptoms/NNS associated/VBN with/IN latent_deficiency/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP SCH_23390))
          (VP (MD may)
            (VP (VB have)
              (NP (JJ potential) (JJ therapeutic) (NNS benefits))
              (PP (IN in)
                (S
                  (VP (VBG reducing)
                    (NP
                      (NP (DT the) (NNS symptoms))
                      (VP (VBN associated)
                        (PP (IN with)
                          (NP
                            (NP (NN latent_deficiency))
                            (, ,)
                            (NP (NN photophobia))
                            (, ,)
                            (CC and)
                            (NP (NN phonophobia))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, SCH_23390-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(benefits-10, potential-8)
amod(benefits-10, therapeutic-9)
dobj(have-7, benefits-10)
mark(reducing-12, in-11)
advcl(have-7, reducing-12)
det(symptoms-14, the-13)
dobj(reducing-12, symptoms-14)
acl(symptoms-14, associated-15)
case(latent_deficiency-17, with-16)
nmod:with(associated-15, latent_deficiency-17)
nmod:with(associated-15, photophobia-19)
conj:and(latent_deficiency-17, photophobia-19)
cc(latent_deficiency-17, and-21)
nmod:with(associated-15, phonophobia-22)
conj:and(latent_deficiency-17, phonophobia-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO validate/VB these/DT results/NNS and/CC explore/VB the/DT underlying/VBG mechanisms/NNS of/IN action/NN of/IN SCH_23390/NNP in/IN treating/VBG these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB validate)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB explore)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP
                      (NP (NN action))
                      (PP (IN of)
                        (NP (NNP SCH_23390))))))
                (PP (IN in)
                  (S
                    (VP (VBG treating)
                      (NP (DT these) (NNS conditions)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(validate-6, studies-2)
nsubj:xsubj(explore-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(validate-6, to-5)
xcomp(needed-4, validate-6)
det(results-8, these-7)
dobj(validate-6, results-8)
cc(validate-6, and-9)
xcomp(needed-4, explore-10)
conj:and(validate-6, explore-10)
det(mechanisms-13, the-11)
amod(mechanisms-13, underlying-12)
dobj(explore-10, mechanisms-13)
case(action-15, of-14)
nmod:of(mechanisms-13, action-15)
case(SCH_23390-17, of-16)
nmod:of(action-15, SCH_23390-17)
mark(treating-19, in-18)
advcl(explore-10, treating-19)
det(conditions-21, these-20)
dobj(treating-19, conditions-21)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP known/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (VP (VBN known)
        (PP (IN for)
          (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits)))))
    (. .)))

nsubjpass(known-15, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
auxpass(known-15, are-14)
root(ROOT-0, known-15)
case(benefits-20, for-16)
nmod:poss(benefits-20, their-17)
amod(benefits-20, potential-18)
compound(benefits-20, health-19)
nmod:for(known-15, benefits-20)

In/IN particular/JJ ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO decrease/VB serum/JJ Saccharin/JJ levels/NNS in/IN hyperSaccharinmic/JJ patients/NNS and/CC to_be/VB associated/VBN with/IN a/DT lower/JJR risk/NN of/IN coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- in/IN animal/NN models/NNS and/CC in/IN human/JJ studies/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB decrease)
                  (NP
                    (NP (JJ serum) (JJ Saccharin) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperSaccharinmic) (NNS patients)))))
                (CC and)
                (VP (VB to_be)
                  (VP (VBN associated)
                    (PP (IN with)
                      (NP
                        (NP
                          (NP (DT a) (JJR lower) (NN risk))
                          (PP (IN of)
                            (NP (NN coronary_heart_disease))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-))))
                    (PP
                      (PP (IN in)
                        (NP (NN animal) (NNS models)))
                      (CC and)
                      (PP (IN in)
                        (NP (JJ human) (NNS studies))))))))))))
    (. .)))

case(particular-2, In-1)
advcl(shown-9, particular-2)
nsubjpass(shown-9, EPA-4)
nsubj:xsubj(decrease-11, EPA-4)
nsubj:xsubj(to_be-19, EPA-4)
cc(EPA-4, and-5)
conj:and(EPA-4, DHA-6)
nsubjpass(shown-9, DHA-6)
nsubj:xsubj(decrease-11, DHA-6)
aux(shown-9, have-7)
auxpass(shown-9, been-8)
root(ROOT-0, shown-9)
mark(decrease-11, to-10)
xcomp(shown-9, decrease-11)
amod(levels-14, serum-12)
amod(levels-14, Saccharin-13)
dobj(decrease-11, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperSaccharinmic-16)
nmod:in(levels-14, patients-17)
cc(decrease-11, and-18)
xcomp(shown-9, to_be-19)
conj:and(decrease-11, to_be-19)
dep(to_be-19, associated-20)
dep(to_be-19, associated-20')
conj:and(associated-20, associated-20')
case(risk-24, with-21)
det(risk-24, a-22)
amod(risk-24, lower-23)
nmod:with(associated-20, risk-24)
case(coronary_heart_disease-26, of-25)
nmod:of(risk-24, coronary_heart_disease-26)
appos(risk-24, CHD-28)
case(models-32, in-30)
compound(models-32, animal-31)
nmod:in(associated-20, models-32)
cc(associated-20, and-33)
case(studies-36, in-34)
amod(studies-36, human-35)
nmod:in(associated-20', studies-36)

This/DT finding/NN is/VBZ supported/VBN by/IN several/JJ clinical/JJ trials/NNS and/CC observational/JJ studies/NNS that/WDT have/VBP demonstrated/VBN the/DT cardioprotective/JJ effects/NNS of/IN omega-3_fatty_acids/NN ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (VBZ is)
      (VP (VBN supported)
        (PP (IN by)
          (NP
            (NP (JJ several) (JJ clinical) (NNS trials))
            (CC and)
            (NP
              (NP (JJ observational) (NNS studies))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBP have)
                    (VP (VBN demonstrated)
                      (NP
                        (NP (DT the) (JJ cardioprotective) (NNS effects))
                        (PP (IN of)
                          (NP (NN omega-3_fatty_acids)))))))))))))
    (. .)))

det(finding-2, This-1)
nsubjpass(supported-4, finding-2)
auxpass(supported-4, is-3)
root(ROOT-0, supported-4)
case(trials-8, by-5)
amod(trials-8, several-6)
amod(trials-8, clinical-7)
nmod:by(supported-4, trials-8)
cc(trials-8, and-9)
amod(studies-11, observational-10)
nmod:by(supported-4, studies-11)
conj:and(trials-8, studies-11)
nsubj(demonstrated-14, studies-11)
ref(studies-11, that-12)
aux(demonstrated-14, have-13)
acl:relcl(studies-11, demonstrated-14)
det(effects-17, the-15)
amod(effects-17, cardioprotective-16)
dobj(demonstrated-14, effects-17)
case(omega-3_fatty_acids-19, of-18)
nmod:of(effects-17, omega-3_fatty_acids-19)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB anti-inflammatory/JJ and/CC anti-thrombotic/JJ properties/NNS of/IN EPA/NNP and/CC DHA/NNP ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (NNS effects))))
    (VP
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (JJ anti-inflammatory)
              (CC and)
              (JJ anti-thrombotic) (NNS properties))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA)))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-9, mechanisms-2)
nsubj(involve-13, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-9, are-6)
neg(understood-9, not-7)
advmod(understood-9, fully-8)
root(ROOT-0, understood-9)
cc(understood-9, but-11)
aux(involve-13, may-12)
conj:but(understood-9, involve-13)
amod(properties-17, anti-inflammatory-14)
cc(anti-inflammatory-14, and-15)
conj:and(anti-inflammatory-14, anti-thrombotic-16)
amod(properties-17, anti-thrombotic-16)
dobj(involve-13, properties-17)
case(EPA-19, of-18)
nmod:of(properties-17, EPA-19)
cc(EPA-19, and-20)
nmod:of(properties-17, DHA-21)
conj:and(EPA-19, DHA-21)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT role/NN of/IN omega-3_fatty_acids/JJ in/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP ,/, as/RB well/RB as/IN their/PRP$ potential/JJ therapeutic/JJ applications/NNS in/IN other/JJ diseases/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (NN role))
                (PP (IN of)
                  (NP (JJ omega-3_fatty_acids)))
                (PP (IN in)
                  (NP
                    (NP
                      (NP (DT the) (NN prevention)
                        (CC and)
                        (NN treatment))
                      (PP (IN of)
                        (NP (NNP CHD))))
                    (, ,)
                    (CONJP (RB as) (RB well) (IN as))
                    (NP
                      (NP (PRP$ their) (JJ potential) (JJ therapeutic) (NNS applications))
                      (PP (IN in)
                        (NP (JJ other) (NNS diseases))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(role-9, the-8)
dobj(elucidate-7, role-9)
case(omega-3_fatty_acids-11, of-10)
nmod:of(role-9, omega-3_fatty_acids-11)
case(prevention-14, in-12)
det(prevention-14, the-13)
nmod:in(role-9, prevention-14)
cc(prevention-14, and-15)
nmod:in(role-9, treatment-16)
conj:and(prevention-14, treatment-16)
case(CHD-18, of-17)
nmod:of(prevention-14, CHD-18)
cc(prevention-14, as-20)
mwe(as-20, well-21)
mwe(as-20, as-22)
nmod:poss(applications-26, their-23)
amod(applications-26, potential-24)
amod(applications-26, therapeutic-25)
nmod:in(role-9, applications-26)
conj:and(prevention-14, applications-26)
case(diseases-29, in-27)
amod(diseases-29, other-28)
nmod:in(applications-26, diseases-29)

Obesity/NNP is_a/VBZ complex/JJ metabolic_disorder/NN that/WDT has/VBZ become/VBN a/DT major/JJ public_health/NN concern/NN worldwide/RB ./.

(ROOT
  (S
    (NP (NNP Obesity))
    (VP (VBZ is_a)
      (NP
        (NP (JJ complex) (NN metabolic_disorder))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ has)
              (VP (VBN become)
                (NP (DT a) (JJ major) (NN public_health) (NN concern))
                (ADVP (RB worldwide))))))))
    (. .)))

nsubj(is_a-2, Obesity-1)
root(ROOT-0, is_a-2)
amod(metabolic_disorder-4, complex-3)
dobj(is_a-2, metabolic_disorder-4)
nsubj(become-7, metabolic_disorder-4)
ref(metabolic_disorder-4, that-5)
aux(become-7, has-6)
acl:relcl(metabolic_disorder-4, become-7)
det(concern-11, a-8)
amod(concern-11, major-9)
compound(concern-11, public_health-10)
xcomp(become-7, concern-11)
advmod(become-7, worldwide-12)

The/DT pathogenesis/NN of/IN obesity/NN involves/VBZ the/DT interplay/NN of/IN various/JJ factors/NNS ,/, including/VBG genetics/NNS ,/, environment/NN ,/, and/CC lifestyle/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN pathogenesis))
      (PP (IN of)
        (NP (NN obesity))))
    (VP (VBZ involves)
      (NP
        (NP (DT the) (NN interplay))
        (PP (IN of)
          (NP
            (NP (JJ various) (NNS factors))
            (, ,)
            (VP (VBG including)
              (NP
                (NP (NNS genetics))
                (, ,)
                (NP (NN environment))
                (, ,)
                (CC and)
                (NP (NN lifestyle))))))))
    (. .)))

det(pathogenesis-2, The-1)
nsubj(involves-5, pathogenesis-2)
case(obesity-4, of-3)
nmod:of(pathogenesis-2, obesity-4)
root(ROOT-0, involves-5)
det(interplay-7, the-6)
dobj(involves-5, interplay-7)
case(factors-10, of-8)
amod(factors-10, various-9)
nmod:of(interplay-7, factors-10)
acl(factors-10, including-12)
dobj(including-12, genetics-13)
dobj(including-12, environment-15)
conj:and(genetics-13, environment-15)
cc(genetics-13, and-17)
dobj(including-12, lifestyle-18)
conj:and(genetics-13, lifestyle-18)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT relationship/NN between/IN the/DT secretion/NN of/IN arm_1p/NNS by/IN the/DT pancreas/NN and/CC the/DT development/NN of/IN obesity/NN in/IN genetically/RB predisposed/VBN rats/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN relationship))
        (PP (IN between)
          (NP
            (NP (DT the) (NN secretion))
            (PP (IN of)
              (NP (NNS arm_1p))))))
      (PP (IN by)
        (NP
          (NP (DT the) (NN pancreas))
          (CC and)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP (NN obesity))))))
      (PP (IN in)
        (NP
          (ADJP (RB genetically) (VBN predisposed))
          (NNS rats))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(relationship-8, the-7)
dobj(investigated-6, relationship-8)
case(secretion-11, between-9)
det(secretion-11, the-10)
nmod:between(relationship-8, secretion-11)
case(arm_1p-13, of-12)
nmod:of(secretion-11, arm_1p-13)
case(pancreas-16, by-14)
det(pancreas-16, the-15)
nmod:by(investigated-6, pancreas-16)
cc(pancreas-16, and-17)
det(development-19, the-18)
nmod:by(investigated-6, development-19)
conj:and(pancreas-16, development-19)
case(obesity-21, of-20)
nmod:of(development-19, obesity-21)
case(rats-25, in-22)
advmod(predisposed-24, genetically-23)
amod(rats-25, predisposed-24)
nmod:in(investigated-6, rats-25)

To/TO evaluate/VB this/DT relationship/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ PLX3397/NN on/IN the/DT secretion/NN of/IN arm_1p/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP (DT this) (NN relationship)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN PLX3397)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ arm_1p) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(evaluate-2, To-1)
advcl(examined-7, evaluate-2)
det(relationship-4, this-3)
dobj(evaluate-2, relationship-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(PLX3397-17, 10-15)
amod(PLX3397-17, mmol/L-16)
nmod:of(effects-9, PLX3397-17)
conj:and(glucose-13, PLX3397-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(examined-7, secretion-20)
case(and_insulin-23, of-21)
amod(and_insulin-23, arm_1p-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(pancreata-27, genetically_obese-29)
appos(genetically_obese-29, fa/fa-31)
cc(genetically_obese-29, and-33)
amod(rats-40, lean-34)
dep(lean-34, Fa-36)
nmod:from(pancreata-27, rats-40)
conj:and(genetically_obese-29, rats-40)

Our/PRP$ results/NNS showed/VBD that/IN arm_1p/JJ secretion/NN was/VBD significantly/RB higher/JJR in/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS under/IN both/DT glucose/NN and/CC PLX3397/NN stimulation/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ arm_1p) (NN secretion))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP (JJ obese) (NNS rats))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (PP (IN under)
                      (NP
                        (NP (DT both) (NN glucose))
                        (CC and)
                        (NP (NN PLX3397) (NN stimulation))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-13, that-4)
amod(secretion-6, arm_1p-5)
nsubjpass(compared-13, secretion-6)
nsubj:xsubj(lean-15, secretion-6)
auxpass(compared-13, was-7)
advmod(higher-9, significantly-8)
advmod(compared-13, higher-9)
case(rats-12, in-10)
amod(rats-12, obese-11)
nmod:in(higher-9, rats-12)
ccomp(showed-3, compared-13)
mark(lean-15, to-14)
xcomp(compared-13, lean-15)
dobj(lean-15, rats-16)
case(glucose-19, under-17)
det(glucose-19, both-18)
nmod:under(lean-15, glucose-19)
cc(glucose-19, and-20)
compound(stimulation-22, PLX3397-21)
nmod:under(lean-15, stimulation-22)
conj:and(glucose-19, stimulation-22)

In/IN addition/NN ,/, we/PRP observed/VBD a/DT significant/JJ correlation/NN between/IN arm_1p/JJ secretion/NN and/CC body/NN weight/NN in/IN obese/JJ rats/NNS but/CC not/RB in/IN lean/JJ rats/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP (DT a) (JJ significant) (NN correlation))
        (PP (IN between)
          (NP
            (NP (JJ arm_1p) (NN secretion))
            (CC and)
            (NP (NN body) (NN weight)))))
      (PP
        (PP (IN in)
          (NP (JJ obese) (NNS rats)))
        (CONJP (CC but)
          (RB not))
        (PP (IN in)
          (NP (JJ lean) (NNS rats)))))
    (. .)))

case(addition-2, In-1)
nmod:in(observed-5, addition-2)
nsubj(observed-5, we-4)
nsubj(observed-5', we-4)
root(ROOT-0, observed-5)
conj:negcc(observed-5, observed-5')
det(correlation-8, a-6)
amod(correlation-8, significant-7)
dobj(observed-5, correlation-8)
case(secretion-11, between-9)
amod(secretion-11, arm_1p-10)
nmod:between(correlation-8, secretion-11)
cc(secretion-11, and-12)
compound(weight-14, body-13)
nmod:between(correlation-8, weight-14)
conj:and(secretion-11, weight-14)
case(rats-17, in-15)
amod(rats-17, obese-16)
nmod:in(observed-5, rats-17)
cc(not-19, but-18)
cc(observed-5, not-19)
case(rats-22, in-20)
amod(rats-22, lean-21)
nmod:in(observed-5', rats-22)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN arm_1p/NNS by/IN the/DT pancreas/NN may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ,/, particularly/RB in/IN genetically/RB predisposed/VBN individuals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP
                (NP (NNS arm_1p))
                (PP (IN by)
                  (NP (DT the) (NN pancreas))))))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))))
              (, ,)
              (PP
                (ADVP (RB particularly))
                (IN in)
                (NP
                  (ADJP (RB genetically) (VBN predisposed))
                  (NNS individuals))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-12, that-4)
nsubj(play-12, hypersecretion-5)
case(arm_1p-7, of-6)
nmod:of(hypersecretion-5, arm_1p-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(arm_1p-7, pancreas-10)
aux(play-12, may-11)
ccomp(suggest-3, play-12)
det(role-14, a-13)
dobj(play-12, role-14)
case(development-17, in-15)
det(development-17, the-16)
nmod:in(role-14, development-17)
case(obesity-19, of-18)
nmod:of(development-17, obesity-19)
advmod(individuals-25, particularly-21)
case(individuals-25, in-22)
advmod(predisposed-24, genetically-23)
amod(individuals-25, predisposed-24)
nmod:in(play-12, individuals-25)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ targets/NNS for/IN this/DT condition/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP (DT this) (NN condition))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(targets-13, potential-11)
amod(targets-13, therapeutic-12)
dobj(elucidate-6, targets-13)
conj:and(mechanisms-9, targets-13)
case(condition-16, for-14)
det(condition-16, this-15)
nmod:for(targets-13, condition-16)

The/DT aim/NN of/IN this/DT study/NN was/VBD to/TO determine/VB whether/IN OC000459/NNP reduced/VBD the/DT risk/NN of/IN Eosinophilic_Esophagitis/NNP -LRB-/-LRB- EoE/NNP -RRB-/-RRB- ,/, photophobia/NN ,/, and/CC phonophobia/NN in/IN patients/NNS suffering/VBG from/IN EoE/NNP and/or/CC photophobia/phonophobia/NNP ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN aim))
      (PP (IN of)
        (NP (DT this) (NN study))))
    (VP (VBD was)
      (S
        (VP (TO to)
          (VP (VB determine)
            (SBAR (IN whether)
              (S
                (NP (NNP OC000459))
                (VP (VBD reduced)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP
                        (NP
                          (NP (NNP Eosinophilic_Esophagitis))
                          (-LRB- -LRB-)
                          (NP (NNP EoE))
                          (-RRB- -RRB-))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP
                          (NP (NN phonophobia))
                          (PP (IN in)
                            (NP
                              (NP (NNS patients))
                              (VP (VBG suffering)
                                (PP (IN from)
                                  (NP (NNP EoE)
                                    (CC and/or)
                                    (NNP photophobia/phonophobia)))))))))))))))))
    (. .)))

det(aim-2, The-1)
nsubj(was-6, aim-2)
nsubj:xsubj(determine-8, aim-2)
case(study-5, of-3)
det(study-5, this-4)
nmod:of(aim-2, study-5)
root(ROOT-0, was-6)
mark(determine-8, to-7)
xcomp(was-6, determine-8)
mark(reduced-11, whether-9)
nsubj(reduced-11, OC000459-10)
ccomp(determine-8, reduced-11)
det(risk-13, the-12)
dobj(reduced-11, risk-13)
case(Eosinophilic_Esophagitis-15, of-14)
nmod:of(risk-13, Eosinophilic_Esophagitis-15)
dep(Eosinophilic_Esophagitis-15, EoE-17)
nmod:of(risk-13, photophobia-20)
conj:and(Eosinophilic_Esophagitis-15, photophobia-20)
cc(Eosinophilic_Esophagitis-15, and-22)
nmod:of(risk-13, phonophobia-23)
conj:and(Eosinophilic_Esophagitis-15, phonophobia-23)
case(patients-25, in-24)
nmod:in(phonophobia-23, patients-25)
acl(patients-25, suffering-26)
case(EoE-28, from-27)
nmod:from(suffering-26, EoE-28)
cc(EoE-28, and/or-29)
nmod:from(suffering-26, photophobia/phonophobia-30)
conj:and/or(EoE-28, photophobia/phonophobia-30)

A/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ clinical/JJ trial/NN was/VBD conducted/VBN ./.

(ROOT
  (S
    (NP (DT A)
      (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
      (JJ clinical) (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)))
    (. .)))

det(trial-8, A-1)
amod(placebo-controlled-6, randomized-2)
amod(placebo-controlled-6, double-blind-4)
amod(trial-8, placebo-controlled-6)
amod(trial-8, clinical-7)
nsubjpass(conducted-10, trial-8)
auxpass(conducted-10, was-9)
root(ROOT-0, conducted-10)

The/DT study/NN involved/VBD administering/VBG OC000459/NN to/TO a/DT group/NN of/IN patients/NNS and/CC monitoring/VBG their/PRP$ symptoms/NNS over/IN a/DT period/NN of/IN 2/CD hours/NNS ./.

(ROOT
  (S
    (NP (DT The) (NN study))
    (VP (VBD involved)
      (VP
        (VP (VBG administering)
          (NP (NN OC000459))
          (PP (TO to)
            (NP
              (NP (DT a) (NN group))
              (PP (IN of)
                (NP (NNS patients))))))
        (CC and)
        (VP (VBG monitoring)
          (NP (PRP$ their) (NNS symptoms))
          (PP (IN over)
            (NP
              (NP (DT a) (NN period))
              (PP (IN of)
                (NP (CD 2) (NNS hours))))))))
    (. .)))

det(study-2, The-1)
nsubj(involved-3, study-2)
root(ROOT-0, involved-3)
dep(involved-3, administering-4)
dobj(administering-4, OC000459-5)
case(group-8, to-6)
det(group-8, a-7)
nmod:to(administering-4, group-8)
case(patients-10, of-9)
nmod:of(group-8, patients-10)
cc(administering-4, and-11)
dep(involved-3, monitoring-12)
conj:and(administering-4, monitoring-12)
nmod:poss(symptoms-14, their-13)
dobj(monitoring-12, symptoms-14)
case(period-17, over-15)
det(period-17, a-16)
nmod:over(monitoring-12, period-17)
case(hours-20, of-18)
nummod(hours-20, 2-19)
nmod:of(period-17, hours-20)

Results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, OC000459/NNP reduced/VBD the/DT risk/NN of/IN EoE/NNP by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNS Results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP
              (NP (CD 2) (NNS hours))
              (PP (IN after)
                (NP (VBG dosing)))))
          (, ,)
          (NP (NNP OC000459))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNP EoE))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

nsubj(showed-2, Results-1)
root(ROOT-0, showed-2)
mark(reduced-11, that-3)
case(hours-6, at-4)
nummod(hours-6, 2-5)
nmod:at(reduced-11, hours-6)
case(dosing-8, after-7)
nmod:after(hours-6, dosing-8)
nsubj(reduced-11, OC000459-10)
ccomp(showed-2, reduced-11)
det(risk-13, the-12)
dobj(reduced-11, risk-13)
case(EoE-15, of-14)
nmod:of(risk-13, EoE-15)
case(%-18, by-16)
nummod(%-18, 14-17)
nmod:by(reduced-11, %-18)
nummod(%-21, 95-20)
dep(%-18, %-21)
acl:relcl(%-21, CI-22)
nummod(%-24, 6-20-23)
dobj(CI-22, %-24)
appos(%-24, P-26)
dep(0.0005-28, =-27)
dep(%-24, 0.0005-28)
xcomp(reduced-11, photophobia-31)
case(%-34, by-32)
nummod(%-34, 17-33)
nmod:by(photophobia-31, %-34)
nummod(%-37, 95-36)
appos(%-34, %-37)
dep(%-40, CI-38)
nummod(%-40, 12-22-39)
nmod(%-37, %-40)
dep(%-37, P-42)
compound(0.0001-44, <-43)
nummod(P-42, 0.0001-44)
cc(photophobia-31, and-47)
xcomp(reduced-11, phonophobia-48)
conj:and(photophobia-31, phonophobia-48)
case(%-51, by-49)
nummod(%-51, 14-50)
nmod:by(phonophobia-48, %-51)
nummod(%-54, 95-53)
appos(%-51, %-54)
dep(%-57, CI-55)
nummod(%-57, 17-20-56)
nmod(%-54, %-57)
dep(%-54, P-59)
compound(0.0001-61, <-60)
nummod(P-59, 0.0001-61)

These/DT findings/NNS suggest/VBP that/IN OC000459/NNP may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN patients/NNS suffering/VBG from/IN EoE/NNP ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP OC000459))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (NP
                    (NP (NNS patients))
                    (VP (VBG suffering)
                      (PP (IN from)
                        (NP
                          (NP (NNP EoE))
                          (, ,)
                          (NP (NN photophobia))
                          (, ,)
                          (CC and)
                          (NP (NN phonophobia)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, OC000459-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
acl(patients-13, suffering-14)
case(EoE-16, from-15)
nmod:from(suffering-14, EoE-16)
nmod:from(suffering-14, photophobia-18)
conj:and(EoE-16, photophobia-18)
cc(EoE-16, and-20)
nmod:from(suffering-14, phonophobia-21)
conj:and(EoE-16, phonophobia-21)

Further/JJ studies/NNS are/VBP needed/VBN to/TO determine/VB the/DT long-term/JJ efficacy/NN and/CC safety/NN of/IN OC000459/NNP in/IN treating/VBG these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (DT the) (JJ long-term) (NN efficacy)
                  (CC and)
                  (NN safety))
                (PP (IN of)
                  (NP (NNP OC000459))))
              (PP (IN in)
                (S
                  (VP (VBG treating)
                    (NP (DT these) (NNS conditions))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(determine-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(determine-6, to-5)
xcomp(needed-4, determine-6)
det(efficacy-9, the-7)
amod(efficacy-9, long-term-8)
dobj(determine-6, efficacy-9)
cc(efficacy-9, and-10)
dobj(determine-6, safety-11)
conj:and(efficacy-9, safety-11)
case(OC000459-13, of-12)
nmod:of(efficacy-9, OC000459-13)
mark(treating-15, in-14)
advcl(determine-6, treating-15)
det(conditions-17, these-16)
dobj(treating-15, conditions-17)

The/DT present/JJ study/NN aimed/VBD to/TO investigate/VB the/DT activity/NN of/IN key/JJ enzymes/NNS involved/VBN in/IN lipid/NN and/CC carbohydrate/VB metabolism/NN in/IN various/JJ tissues/NNS ./.

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP
            (VP (VB investigate)
              (NP
                (NP (DT the) (NN activity))
                (PP (IN of)
                  (NP
                    (NP (JJ key) (NNS enzymes))
                    (VP (VBN involved)
                      (PP (IN in)
                        (NP (NN lipid))))))))
            (CC and)
            (VP (VB carbohydrate)
              (NP (NN metabolism))
              (PP (IN in)
                (NP (JJ various) (NNS tissues))))))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(aimed-4, study-3)
nsubj:xsubj(investigate-6, study-3)
nsubj:xsubj(carbohydrate-16, study-3)
root(ROOT-0, aimed-4)
mark(investigate-6, to-5)
xcomp(aimed-4, investigate-6)
det(activity-8, the-7)
dobj(investigate-6, activity-8)
case(enzymes-11, of-9)
amod(enzymes-11, key-10)
nmod:of(activity-8, enzymes-11)
acl(enzymes-11, involved-12)
case(lipid-14, in-13)
nmod:in(involved-12, lipid-14)
cc(investigate-6, and-15)
xcomp(aimed-4, carbohydrate-16)
conj:and(investigate-6, carbohydrate-16)
dobj(carbohydrate-16, metabolism-17)
case(tissues-20, in-18)
amod(tissues-20, various-19)
nmod:in(carbohydrate-16, tissues-20)

These/DT enzymes/NNS included/VBD Oleic_acid/NNP dehydrogenase/NN -LRB-/-LRB- ADH/NNP -RRB-/-RRB- ,/, alpha-glycerol-3-phosphate_dehydrogenase/JJ -LRB-/-LRB- alpha/NN GPDH/NNS -RRB-/-RRB- ,/, malate_dehydrogenase/NN -LRB-/-LRB- MDH/NNP -RRB-/-RRB- ,/, isocitrate_dehydrogenase/NN -LRB-/-LRB- IDH/NNP -RRB-/-RRB- ,/, glucose-6-phosphate_dehydrogenase/JJ -LRB-/-LRB- G6PD/NNP -RRB-/-RRB- ,/, lipoxygenase-3/JJ -LRB-/-LRB- 6PGD/CD -RRB-/-RRB- and_alpha-amylase/NN -LRB-/-LRB- AMY/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT These) (NNS enzymes))
    (VP (VBD included)
      (NP
        (NP
          (NP
            (NP (NNP Oleic_acid) (NN dehydrogenase))
            (PRN (-LRB- -LRB-)
              (NP (NNP ADH))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (JJ alpha-glycerol-3-phosphate_dehydrogenase))
            (PRN (-LRB- -LRB-)
              (NP (NN alpha) (NNS GPDH))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (NN malate_dehydrogenase))
            (PRN (-LRB- -LRB-)
              (NP (NNP MDH))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (NN isocitrate_dehydrogenase))
            (PRN (-LRB- -LRB-)
              (NP (NNP IDH))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (JJ glucose-6-phosphate_dehydrogenase))
            (PRN (-LRB- -LRB-)
              (NP (NNP G6PD))
              (-RRB- -RRB-)))
          (, ,)
          (NP (JJ lipoxygenase-3)
            (PRN (-LRB- -LRB-)
              (NP (CD 6PGD))
              (-RRB- -RRB-))
            (NN and_alpha-amylase)))
        (PRN (-LRB- -LRB-)
          (NP (NNP AMY))
          (-RRB- -RRB-))))
    (. .)))

det(enzymes-2, These-1)
nsubj(included-3, enzymes-2)
root(ROOT-0, included-3)
compound(dehydrogenase-5, Oleic_acid-4)
dobj(included-3, dehydrogenase-5)
appos(dehydrogenase-5, ADH-7)
appos(dehydrogenase-5, alpha-glycerol-3-phosphate_dehydrogenase-10)
compound(GPDH-13, alpha-12)
appos(alpha-glycerol-3-phosphate_dehydrogenase-10, GPDH-13)
appos(dehydrogenase-5, malate_dehydrogenase-16)
appos(malate_dehydrogenase-16, MDH-18)
appos(dehydrogenase-5, isocitrate_dehydrogenase-21)
appos(isocitrate_dehydrogenase-21, IDH-23)
appos(dehydrogenase-5, glucose-6-phosphate_dehydrogenase-26)
appos(glucose-6-phosphate_dehydrogenase-26, G6PD-28)
amod(and_alpha-amylase-35, lipoxygenase-3-31)
appos(and_alpha-amylase-35, 6PGD-33)
appos(dehydrogenase-5, and_alpha-amylase-35)
appos(dehydrogenase-5, AMY-37)

The/DT activity/NN of/IN these/DT enzymes/NNS was/VBD measured/VBN in/IN liver/NN ,/, muscle/NN ,/, adipose_tissue/NN ,/, and/CC blood/NN samples/NNS collected/VBN from/IN healthy/JJ individuals/NNS and/CC those/DT with/IN metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN activity))
      (PP (IN of)
        (NP (DT these) (NNS enzymes))))
    (VP (VBD was)
      (VP (VBN measured)
        (PP (IN in)
          (NP
            (NP (NN liver))
            (, ,)
            (NP (NN muscle))
            (, ,)
            (NP (NN adipose_tissue))
            (, ,)
            (CC and)
            (NP
              (NP (NN blood) (NNS samples))
              (VP (VBN collected)
                (PP (IN from)
                  (NP
                    (NP (JJ healthy) (NNS individuals))
                    (CC and)
                    (NP (DT those))))
                (PP (IN with)
                  (NP (NNS metabolic_disorders)))))))))
    (. .)))

det(activity-2, The-1)
nsubjpass(measured-7, activity-2)
case(enzymes-5, of-3)
det(enzymes-5, these-4)
nmod:of(activity-2, enzymes-5)
auxpass(measured-7, was-6)
root(ROOT-0, measured-7)
case(liver-9, in-8)
nmod:in(measured-7, liver-9)
nmod:in(measured-7, muscle-11)
conj:and(liver-9, muscle-11)
nmod:in(measured-7, adipose_tissue-13)
conj:and(liver-9, adipose_tissue-13)
cc(liver-9, and-15)
compound(samples-17, blood-16)
nmod:in(measured-7, samples-17)
conj:and(liver-9, samples-17)
acl(samples-17, collected-18)
case(individuals-21, from-19)
amod(individuals-21, healthy-20)
nmod:from(collected-18, individuals-21)
cc(individuals-21, and-22)
nmod:from(collected-18, those-23)
conj:and(individuals-21, those-23)
case(metabolic_disorders-25, with-24)
nmod:with(collected-18, metabolic_disorders-25)

Our/PRP$ results/NNS showed/VBD significant/JJ differences/NNS in/IN the/DT activity/NN of/IN these/DT enzymes/NNS between/IN healthy/JJ and/CC diseased/JJ individuals/NNS ,/, suggesting/VBG a/DT potential/JJ role/NN for/IN these/DT enzymes/NNS in/IN the/DT pathogenesis/NNS of/IN metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (JJ significant) (NNS differences))
        (PP (IN in)
          (NP
            (NP (DT the) (NN activity))
            (PP (IN of)
              (NP (DT these) (NNS enzymes)))))
        (PP (IN between)
          (NP (JJ healthy)
            (CC and)
            (JJ diseased) (NNS individuals))))
      (, ,)
      (S
        (VP (VBG suggesting)
          (NP
            (NP (DT a) (JJ potential) (NN role))
            (PP (IN for)
              (NP
                (NP (DT these) (NNS enzymes))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NNS pathogenesis))
                    (PP (IN of)
                      (NP (NNS metabolic_disorders)))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
amod(differences-5, significant-4)
dobj(showed-3, differences-5)
case(activity-8, in-6)
det(activity-8, the-7)
nmod:in(differences-5, activity-8)
case(enzymes-11, of-9)
det(enzymes-11, these-10)
nmod:of(activity-8, enzymes-11)
case(individuals-16, between-12)
amod(individuals-16, healthy-13)
cc(healthy-13, and-14)
conj:and(healthy-13, diseased-15)
amod(individuals-16, diseased-15)
nmod:between(differences-5, individuals-16)
advcl(showed-3, suggesting-18)
det(role-21, a-19)
amod(role-21, potential-20)
dobj(suggesting-18, role-21)
case(enzymes-24, for-22)
det(enzymes-24, these-23)
nmod:for(role-21, enzymes-24)
case(pathogenesis-27, in-25)
det(pathogenesis-27, the-26)
nmod:in(enzymes-24, pathogenesis-27)
case(metabolic_disorders-29, of-28)
nmod:of(pathogenesis-27, metabolic_disorders-29)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ targets/NNS related/VBN to/TO these/DT enzymes/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (VP (VBN related)
                    (PP (TO to)
                      (NP (DT these) (NNS enzymes)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(targets-13, potential-11)
amod(targets-13, therapeutic-12)
dobj(elucidate-6, targets-13)
conj:and(mechanisms-9, targets-13)
acl(targets-13, related-14)
case(enzymes-17, to-15)
det(enzymes-17, these-16)
nmod:to(related-14, enzymes-17)

The/DT solute_carrier_family_1/JJ -LRB-/-LRB- SLC1/NNP -RRB-/-RRB- is_a/NN group/NN of/IN membrane/NN transport/NN proteins/VBZ that/IN play/VB a/DT crucial/JJ role/NN in/IN the/DT uptake/NN of/IN glutamate/JJ and/CC other/JJ neutral/JJ polyketides/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ solute_carrier_family_1)
        (PRN (-LRB- -LRB-)
          (NP (NNP SLC1))
          (-RRB- -RRB-))
        (NN is_a) (NN group))
      (PP (IN of)
        (NP (NN membrane) (NN transport))))
    (VP (VBZ proteins)
      (SBAR (IN that)
        (S
          (VP (VB play)
            (NP
              (NP (DT a) (JJ crucial) (NN role))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN uptake))
                  (PP (IN of)
                    (NP
                      (ADJP (JJ glutamate)
                        (CC and)
                        (JJ other))
                      (JJ neutral) (NNS polyketides))))))))))
    (. .)))

det(group-7, The-1)
amod(group-7, solute_carrier_family_1-2)
appos(group-7, SLC1-4)
compound(group-7, is_a-6)
nsubj(proteins-11, group-7)
case(transport-10, of-8)
compound(transport-10, membrane-9)
nmod:of(group-7, transport-10)
root(ROOT-0, proteins-11)
mark(play-13, that-12)
ccomp(proteins-11, play-13)
det(role-16, a-14)
amod(role-16, crucial-15)
dobj(play-13, role-16)
case(uptake-19, in-17)
det(uptake-19, the-18)
nmod:in(role-16, uptake-19)
case(polyketides-25, of-20)
amod(polyketides-25, glutamate-21)
cc(glutamate-21, and-22)
conj:and(glutamate-21, other-23)
amod(polyketides-25, other-23)
amod(polyketides-25, neutral-24)
nmod:of(uptake-19, polyketides-25)

This/DT family/NN consists/VBZ of/IN five/CD high-affinity/JJ glutamate_transporters/NNS ,/, namely/RB EAAC1/NNP ,/, GLT-1/NNP ,/, GLAST/NNP ,/, EAAT4/NNP ,/, and/CC EAAT5/NNP -LRB-/-LRB- SLC1A1/NNP ,/, SLC1A2/NNP ,/, SLC1A3/NNP ,/, SLC1A6/NNP ,/, and/CC SLC1A7/NNP ,/, respectively/RB -RRB-/-RRB- ,/, which/WDT are/VBP responsible/JJ for/IN the/DT uptake/NN of/IN glutamate/NN into/IN cells/NNS ./.

(ROOT
  (S
    (NP (DT This) (NN family))
    (VP (VBZ consists)
      (PP (IN of)
        (NP
          (NP (CD five) (JJ high-affinity) (NNS glutamate_transporters))
          (, ,)
          (ADVP (RB namely))
          (NP
            (NP
              (NP (NNP EAAC1))
              (, ,)
              (NP (NNP GLT-1))
              (, ,)
              (NP (NNP GLAST))
              (, ,)
              (NP (NNP EAAT4))
              (, ,)
              (CC and)
              (NP (NNP EAAT5)))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP SLC1A1))
                (, ,)
                (NP (NNP SLC1A2))
                (, ,)
                (NP (NNP SLC1A3))
                (, ,)
                (NP (NNP SLC1A6))
                (, ,)
                (CC and)
                (NP
                  (NP (NNP SLC1A7))
                  (, ,)
                  (ADVP (RB respectively))))
              (-RRB- -RRB-)))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBP are)
                (ADJP (JJ responsible)
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN uptake))
                      (PP (IN of)
                        (NP (NN glutamate)))))))))))
      (PP (IN into)
        (NP (NNS cells))))
    (. .)))

det(family-2, This-1)
nsubj(consists-3, family-2)
root(ROOT-0, consists-3)
case(glutamate_transporters-7, of-4)
nummod(glutamate_transporters-7, five-5)
amod(glutamate_transporters-7, high-affinity-6)
nmod:of(consists-3, glutamate_transporters-7)
nsubj(responsible-37, glutamate_transporters-7)
advmod(EAAC1-10, namely-9)
appos(glutamate_transporters-7, EAAC1-10)
appos(glutamate_transporters-7, GLT-1-12)
conj:and(EAAC1-10, GLT-1-12)
appos(glutamate_transporters-7, GLAST-14)
conj:and(EAAC1-10, GLAST-14)
appos(glutamate_transporters-7, EAAT4-16)
conj:and(EAAC1-10, EAAT4-16)
cc(EAAC1-10, and-18)
appos(glutamate_transporters-7, EAAT5-19)
conj:and(EAAC1-10, EAAT5-19)
dep(EAAC1-10, SLC1A1-21)
dep(EAAC1-10, SLC1A2-23)
conj:and(SLC1A1-21, SLC1A2-23)
dep(EAAC1-10, SLC1A3-25)
conj:and(SLC1A1-21, SLC1A3-25)
dep(EAAC1-10, SLC1A6-27)
conj:and(SLC1A1-21, SLC1A6-27)
cc(SLC1A1-21, and-29)
dep(EAAC1-10, SLC1A7-30)
conj:and(SLC1A1-21, SLC1A7-30)
advmod(SLC1A7-30, respectively-32)
ref(glutamate_transporters-7, which-35)
cop(responsible-37, are-36)
acl:relcl(glutamate_transporters-7, responsible-37)
case(uptake-40, for-38)
det(uptake-40, the-39)
nmod:for(responsible-37, uptake-40)
case(glutamate-42, of-41)
nmod:of(uptake-40, glutamate-42)
case(cells-44, into-43)
nmod:into(consists-3, cells-44)

Additionally/RB ,/, this/DT family/NN also/RB includes/VBZ two/CD neutral/JJ polyketide/JJ transporters/NNS :/: Phospholemman/NNP and/CC ASCT2/NNP -LRB-/-LRB- SLC1A4/NNP and/CC ALC1A5/NNP ,/, respectively/RB -RRB-/-RRB- ,/, which/WDT are/VBP involved/VBN in/IN the/DT transport/NN of/IN various/JJ neutral/JJ molecules/NNS across/IN the/DT cell/NN membrane/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT this) (NN family))
    (ADVP (RB also))
    (VP (VBZ includes)
      (NP
        (NP (CD two) (JJ neutral) (JJ polyketide) (NNS transporters))
        (: :)
        (NP
          (NP (NNP Phospholemman)
            (CC and)
            (NNP ASCT2))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP SLC1A4)
                (CC and)
                (NNP ALC1A5))
              (, ,)
              (ADVP (RB respectively)))
            (-RRB- -RRB-))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBP are)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN transport))
                      (PP (IN of)
                        (NP
                          (NP (JJ various) (JJ neutral) (NNS molecules))
                          (PP (IN across)
                            (NP (DT the) (NN cell) (NN membrane))))))))))))))
    (. .)))

advmod(includes-6, Additionally-1)
det(family-4, this-3)
nsubj(includes-6, family-4)
advmod(includes-6, also-5)
root(ROOT-0, includes-6)
nummod(transporters-10, two-7)
amod(transporters-10, neutral-8)
amod(transporters-10, polyketide-9)
dobj(includes-6, transporters-10)
dep(transporters-10, Phospholemman-12)
nsubjpass(involved-25, Phospholemman-12)
cc(Phospholemman-12, and-13)
dep(transporters-10, ASCT2-14)
conj:and(Phospholemman-12, ASCT2-14)
nsubjpass(involved-25, ASCT2-14)
dep(Phospholemman-12, SLC1A4-16)
cc(SLC1A4-16, and-17)
dep(Phospholemman-12, ALC1A5-18)
conj:and(SLC1A4-16, ALC1A5-18)
advmod(SLC1A4-16, respectively-20)
ref(Phospholemman-12, which-23)
auxpass(involved-25, are-24)
acl:relcl(Phospholemman-12, involved-25)
case(transport-28, in-26)
det(transport-28, the-27)
nmod:in(involved-25, transport-28)
case(molecules-32, of-29)
amod(molecules-32, various-30)
amod(molecules-32, neutral-31)
nmod:of(transport-28, molecules-32)
case(membrane-36, across-33)
det(membrane-36, the-34)
compound(membrane-36, cell-35)
nmod:across(molecules-32, membrane-36)

The/DT members/NNS of/IN this/DT family/NN have/VBP been/VBN shown/VBN to_be/JJ crucial/JJ for/IN maintaining/VBG proper/JJ neurotransmission/NN and/CC cellular/JJ metabolism/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS members))
      (PP (IN of)
        (NP (DT this) (NN family))))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (NP (JJ to_be)
            (ADJP
              (ADJP (JJ crucial)
                (PP (IN for)
                  (S
                    (VP (VBG maintaining)
                      (NP (JJ proper) (NN neurotransmission))))))
              (CC and)
              (ADJP (JJ cellular)))
            (NN metabolism)))))
    (. .)))

det(members-2, The-1)
nsubjpass(shown-8, members-2)
case(family-5, of-3)
det(family-5, this-4)
nmod:of(members-2, family-5)
aux(shown-8, have-6)
auxpass(shown-8, been-7)
root(ROOT-0, shown-8)
amod(metabolism-17, to_be-9)
amod(metabolism-17, crucial-10)
mark(maintaining-12, for-11)
advcl(crucial-10, maintaining-12)
amod(neurotransmission-14, proper-13)
dobj(maintaining-12, neurotransmission-14)
cc(crucial-10, and-15)
conj:and(crucial-10, cellular-16)
amod(metabolism-17, cellular-16)
dobj(shown-8, metabolism-17)

The/DT solute_carrier_family_1/NNS -LRB-/-LRB- SLC1/NNP -RRB-/-RRB- includes/VBZ five/CD high-affinity/JJ glutamate_transporters/NNS ,/, EAAC1/NNP ,/, GLT-1/NNP ,/, GLAST/NNP ,/, EAAT4/NNP and/CC EAAT5/NNP -LRB-/-LRB- SLC1A1/CD ,/, SLC1A2/CD ,/, SLC1A3/CD ,/, SLC1A6/CD ,/, and/CC SLC1A7/CD ,/, respectively/RB -RRB-/-RRB- as/RB well/RB as/IN the/DT two/CD neutral/JJ polyketide/NN transporters/NNS ,/, Phospholemman/NNP and/CC ASCT2/NNP -LRB-/-LRB- SLC1A4/NNP and/CC ALC1A5/NNP ,/, respectively/RB -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS solute_carrier_family_1))
      (PRN (-LRB- -LRB-)
        (NP (NNP SLC1))
        (-RRB- -RRB-)))
    (VP (VBZ includes)
      (NP
        (NP
          (NP (CD five) (JJ high-affinity) (NNS glutamate_transporters))
          (, ,)
          (NP (NNP EAAC1) (, ,) (NNP GLT-1) (, ,) (NNP GLAST) (, ,) (NNP EAAT4)
            (CC and)
            (NNP EAAT5)))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (CD SLC1A1) (, ,) (CD SLC1A2) (, ,) (CD SLC1A3) (, ,) (CD SLC1A6) (, ,)
              (CC and)
              (CD SLC1A7))
            (, ,)
            (ADVP (RB respectively)))
          (-RRB- -RRB-))
        (CONJP (RB as) (RB well) (IN as))
        (NP
          (NP (DT the) (CD two) (JJ neutral) (NN polyketide) (NNS transporters))
          (, ,)
          (NP (NNP Phospholemman)
            (CC and)
            (NNP ASCT2))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP SLC1A4)
                (CC and)
                (NNP ALC1A5))
              (, ,)
              (ADVP (RB respectively)))
            (-RRB- -RRB-)))))
    (. .)))

det(solute_carrier_family_1-2, The-1)
nsubj(includes-6, solute_carrier_family_1-2)
appos(solute_carrier_family_1-2, SLC1-4)
root(ROOT-0, includes-6)
nummod(glutamate_transporters-9, five-7)
amod(glutamate_transporters-9, high-affinity-8)
dobj(includes-6, glutamate_transporters-9)
appos(glutamate_transporters-9, EAAC1-11)
appos(glutamate_transporters-9, GLT-1-13)
conj:and(EAAC1-11, GLT-1-13)
appos(glutamate_transporters-9, GLAST-15)
conj:and(EAAC1-11, GLAST-15)
appos(glutamate_transporters-9, EAAT4-17)
conj:and(EAAC1-11, EAAT4-17)
cc(EAAC1-11, and-18)
appos(glutamate_transporters-9, EAAT5-19)
conj:and(EAAC1-11, EAAT5-19)
dep(glutamate_transporters-9, SLC1A1-21)
nummod(SLC1A1-21, SLC1A2-23)
nummod(SLC1A1-21, SLC1A3-25)
nummod(SLC1A1-21, SLC1A6-27)
cc(SLC1A1-21, and-29)
dep(glutamate_transporters-9, SLC1A7-30)
conj:and(SLC1A1-21, SLC1A7-30)
advmod(SLC1A1-21, respectively-32)
cc(glutamate_transporters-9, as-34)
mwe(as-34, well-35)
mwe(as-34, as-36)
det(transporters-41, the-37)
nummod(transporters-41, two-38)
amod(transporters-41, neutral-39)
compound(transporters-41, polyketide-40)
dobj(includes-6, transporters-41)
conj:and(glutamate_transporters-9, transporters-41)
appos(transporters-41, Phospholemman-43)
cc(Phospholemman-43, and-44)
appos(transporters-41, ASCT2-45)
conj:and(Phospholemman-43, ASCT2-45)
dep(transporters-41, SLC1A4-47)
cc(SLC1A4-47, and-48)
dep(transporters-41, ALC1A5-49)
conj:and(SLC1A4-47, ALC1A5-49)
advmod(SLC1A4-47, respectively-51)

Therefore/RB ,/, understanding/VBG the/DT function/NN and/CC regulation/NN of/IN these/DT transporters/NNS could/MD provide/VB insights/NNS into/IN the/DT pathophysiology/NN of/IN these/DT disorders/NNS and/CC potentially/RB lead/VB to/TO novel/JJ therapeutic/JJ targets/NNS ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (S
      (VP (VBG understanding)
        (NP
          (NP (DT the) (NN function))
          (CC and)
          (NP
            (NP (NN regulation))
            (PP (IN of)
              (NP (DT these) (NNS transporters)))))))
    (VP
      (VP (MD could)
        (VP (VB provide)
          (NP (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (NN pathophysiology))
              (PP (IN of)
                (NP (DT these) (NNS disorders)))))))
      (CC and)
      (RB potentially)
      (VP (VB lead)
        (PP (TO to)
          (NP (JJ novel) (JJ therapeutic) (NNS targets)))))
    (. .)))

advmod(provide-12, Therefore-1)
csubj(provide-12, understanding-3)
det(function-5, the-4)
dobj(understanding-3, function-5)
cc(function-5, and-6)
dobj(understanding-3, regulation-7)
conj:and(function-5, regulation-7)
case(transporters-10, of-8)
det(transporters-10, these-9)
nmod:of(regulation-7, transporters-10)
aux(provide-12, could-11)
root(ROOT-0, provide-12)
dobj(provide-12, insights-13)
case(pathophysiology-16, into-14)
det(pathophysiology-16, the-15)
nmod:into(provide-12, pathophysiology-16)
case(disorders-19, of-17)
det(disorders-19, these-18)
nmod:of(pathophysiology-16, disorders-19)
cc(provide-12, and-20)
advmod(provide-12, potentially-21)
dep(provide-12, lead-22)
case(targets-26, to-23)
amod(targets-26, novel-24)
amod(targets-26, therapeutic-25)
nmod:to(lead-22, targets-26)

Abstract/NNP :/: Obesity/NNP is_a/VBZ growing/VBG epidemic/NN worldwide/RB ,/, and/CC it/PRP is/VBZ associated/VBN with/IN the/DT accumulation/NN of/IN lipids/NNS in/IN adipose_tissue/NN ,/, liver/NN ,/, and/CC muscle/NN ./.

(ROOT
  (FRAG
    (NP (NNP Abstract))
    (: :)
    (S
      (S
        (NP (NNP Obesity))
        (VP (VBZ is_a)
          (VP (VBG growing)
            (NP (NN epidemic))
            (ADVP (RB worldwide)))))
      (, ,)
      (CC and)
      (S
        (NP (PRP it))
        (VP (VBZ is)
          (VP (VBN associated)
            (PP (IN with)
              (NP
                (NP (DT the) (NN accumulation))
                (PP (IN of)
                  (NP
                    (NP (NNS lipids))
                    (PP (IN in)
                      (NP
                        (NP (NN adipose_tissue))
                        (, ,)
                        (NP (NN liver))
                        (, ,)
                        (CC and)
                        (NP (NN muscle))))))))))))
    (. .)))

root(ROOT-0, Abstract-1)
nsubj(is_a-4, Obesity-3)
parataxis(Abstract-1, is_a-4)
xcomp(is_a-4, growing-5)
dobj(growing-5, epidemic-6)
advmod(growing-5, worldwide-7)
cc(is_a-4, and-9)
nsubjpass(associated-12, it-10)
auxpass(associated-12, is-11)
parataxis(Abstract-1, associated-12)
conj:and(is_a-4, associated-12)
case(accumulation-15, with-13)
det(accumulation-15, the-14)
nmod:with(associated-12, accumulation-15)
case(lipids-17, of-16)
nmod:of(accumulation-15, lipids-17)
case(adipose_tissue-19, in-18)
nmod:in(lipids-17, adipose_tissue-19)
nmod:in(lipids-17, liver-21)
conj:and(adipose_tissue-19, liver-21)
cc(adipose_tissue-19, and-23)
nmod:in(lipids-17, muscle-24)
conj:and(adipose_tissue-19, muscle-24)

Intracellular/JJ lipid_droplets/NNS are/VBP a/DT hallmark/NN of/IN adipocyte/JJ differentiation_and/JJ fatty_acid/JJ storage/NN ./.

(ROOT
  (S
    (NP (JJ Intracellular) (NNS lipid_droplets))
    (VP (VBP are)
      (NP
        (NP (DT a) (NN hallmark))
        (PP (IN of)
          (NP (JJ adipocyte) (JJ differentiation_and) (JJ fatty_acid) (NN storage)))))
    (. .)))

amod(lipid_droplets-2, Intracellular-1)
nsubj(hallmark-5, lipid_droplets-2)
cop(hallmark-5, are-3)
det(hallmark-5, a-4)
root(ROOT-0, hallmark-5)
case(storage-10, of-6)
amod(storage-10, adipocyte-7)
amod(storage-10, differentiation_and-8)
amod(storage-10, fatty_acid-9)
nmod:of(hallmark-5, storage-10)

In/IN the/DT present/JJ study/NN ,/, we/PRP investigated/VBD the/DT expression/NN of/IN genes/NNS involved/VBN in/IN lipid/NN metabolism/NN ,/, including/VBG sterol_regulatory_element-binding_protein_1/JJ -LRB-/-LRB- SREBP-1/NNP -RRB-/-RRB- ,/, 4-hydroxybiphenyl/JJ synthase/JJ -LRB-/-LRB- GlcAT-D/JJ -RRB-/-RRB- ,/, acetyl-CoA_carboxylase_1/JJ and_2/JJ -LRB-/-LRB- ACC1/NNP and/CC ACC2/NNP -RRB-/-RRB- ,/, and/CC carnitine_palmitoyl_transferase_1/JJ -LRB-/-LRB- CPT-1/NNP -RRB-/-RRB- in/IN adipocytes/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ present) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN expression))
        (PP (IN of)
          (NP
            (NP (NNS genes))
            (VP (VBN involved)
              (PP (IN in)
                (NP (NN lipid) (NN metabolism)))))))
      (, ,)
      (S
        (VP (VBG including)
          (ADJP
            (ADJP (JJ sterol_regulatory_element-binding_protein_1))
            (PRN (-LRB- -LRB-)
              (NP (NNP SREBP-1))
              (-RRB- -RRB-))
            (, ,)
            (ADJP (JJ 4-hydroxybiphenyl) (JJ synthase))
            (PRN (-LRB- -LRB-)
              (ADJP (JJ GlcAT-D))
              (-RRB- -RRB-))
            (, ,)
            (ADJP (JJ acetyl-CoA_carboxylase_1) (JJ and_2))
            (PRN (-LRB- -LRB-)
              (NP (NNP ACC1)
                (CC and)
                (NNP ACC2))
              (-RRB- -RRB-))
            (, ,)
            (CC and)
            (ADJP (JJ carnitine_palmitoyl_transferase_1))
            (PRN (-LRB- -LRB-)
              (NP (NNP CPT-1))
              (-RRB- -RRB-)))
          (PP (IN in)
            (NP (NNS adipocytes))))))
    (. .)))

case(study-4, In-1)
det(study-4, the-2)
amod(study-4, present-3)
nmod:in(investigated-7, study-4)
nsubj(investigated-7, we-6)
root(ROOT-0, investigated-7)
det(expression-9, the-8)
dobj(investigated-7, expression-9)
case(genes-11, of-10)
nmod:of(expression-9, genes-11)
acl(genes-11, involved-12)
case(metabolism-15, in-13)
compound(metabolism-15, lipid-14)
nmod:in(involved-12, metabolism-15)
advcl(investigated-7, including-17)
xcomp(including-17, sterol_regulatory_element-binding_protein_1-18)
dep(sterol_regulatory_element-binding_protein_1-18, SREBP-1-20)
amod(synthase-24, 4-hydroxybiphenyl-23)
xcomp(including-17, synthase-24)
conj:and(sterol_regulatory_element-binding_protein_1-18, synthase-24)
dep(sterol_regulatory_element-binding_protein_1-18, GlcAT-D-26)
amod(and_2-30, acetyl-CoA_carboxylase_1-29)
xcomp(including-17, and_2-30)
conj:and(sterol_regulatory_element-binding_protein_1-18, and_2-30)
dep(sterol_regulatory_element-binding_protein_1-18, ACC1-32)
cc(ACC1-32, and-33)
dep(sterol_regulatory_element-binding_protein_1-18, ACC2-34)
conj:and(ACC1-32, ACC2-34)
cc(sterol_regulatory_element-binding_protein_1-18, and-37)
xcomp(including-17, carnitine_palmitoyl_transferase_1-38)
conj:and(sterol_regulatory_element-binding_protein_1-18, carnitine_palmitoyl_transferase_1-38)
dep(sterol_regulatory_element-binding_protein_1-18, CPT-1-40)
case(adipocytes-43, in-42)
nmod:in(including-17, adipocytes-43)

We/PRP first/RB analyzed/VBD the/DT lipid/NN content/NN of/IN adipocytes/NNS by/IN Oil_Red_O/NNP staining/NN and/CC transmission_electron_microscopy/NN -LRB-/-LRB- TEM/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB first))
    (VP (VBD analyzed)
      (NP
        (NP (DT the) (NN lipid) (NN content))
        (PP (IN of)
          (NP (NNS adipocytes))))
      (PP (IN by)
        (NP
          (NP (NNP Oil_Red_O) (NN staining)
            (CC and)
            (NN transmission_electron_microscopy))
          (PRN (-LRB- -LRB-)
            (NP (NNP TEM))
            (-RRB- -RRB-)))))
    (. .)))

nsubj(analyzed-3, We-1)
advmod(analyzed-3, first-2)
root(ROOT-0, analyzed-3)
det(content-6, the-4)
compound(content-6, lipid-5)
dobj(analyzed-3, content-6)
case(adipocytes-8, of-7)
nmod:of(content-6, adipocytes-8)
case(staining-11, by-9)
compound(staining-11, Oil_Red_O-10)
nmod:by(analyzed-3, staining-11)
cc(staining-11, and-12)
nmod:by(analyzed-3, transmission_electron_microscopy-13)
conj:and(staining-11, transmission_electron_microscopy-13)
appos(staining-11, TEM-15)

We/PRP further/RB analyzed/VBD the/DT expression/NN of/IN key/JJ genes/NNS involved/VBN in/IN lipid/NN metabolism/NN and/CC regulation/NN by/IN real-time/JJ reverse/JJ transcription-polymerase/JJ chain/NN reaction/NN -LRB-/-LRB- qRT-PCR/NN -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB further))
    (VP (VBD analyzed)
      (NP
        (NP
          (NP (DT the) (NN expression))
          (PP (IN of)
            (NP
              (NP (JJ key) (NNS genes))
              (VP (VBN involved)
                (PP (IN in)
                  (NP (NN lipid) (NN metabolism)
                    (CC and)
                    (NN regulation)))
                (PP (IN by)
                  (NP (JJ real-time) (JJ reverse) (JJ transcription-polymerase) (NN chain) (NN reaction)))))))
        (PRN (-LRB- -LRB-)
          (NP (NN qRT-PCR))
          (-RRB- -RRB-))))
    (. .)))

nsubj(analyzed-3, We-1)
advmod(analyzed-3, further-2)
root(ROOT-0, analyzed-3)
det(expression-5, the-4)
dobj(analyzed-3, expression-5)
case(genes-8, of-6)
amod(genes-8, key-7)
nmod:of(expression-5, genes-8)
acl(genes-8, involved-9)
case(metabolism-12, in-10)
compound(metabolism-12, lipid-11)
nmod:in(involved-9, metabolism-12)
cc(metabolism-12, and-13)
nmod:in(involved-9, regulation-14)
conj:and(metabolism-12, regulation-14)
case(reaction-20, by-15)
amod(reaction-20, real-time-16)
amod(reaction-20, reverse-17)
amod(reaction-20, transcription-polymerase-18)
compound(reaction-20, chain-19)
nmod:by(involved-9, reaction-20)
appos(expression-5, qRT-PCR-22)

The/DT expression/NN of/IN sterol_regulatory_element-binding_protein_1/JJ -LRB-/-LRB- SREBP-1/NNP -RRB-/-RRB- ,/, 4-hydroxybiphenyl/JJ synthase/NN -LRB-/-LRB- GlcAT-D/JJ -RRB-/-RRB- ,/, acetyl-CoA_carboxylase_1/JJ and_2/NNS -LRB-/-LRB- ACC1/NNP and/CC ACC2/NNP -RRB-/-RRB- ,/, peroxisome_proliferator-activated_receptor-a/NN -LRB-/-LRB- PPARa/NNP -RRB-/-RRB- ,/, and/CC carnitine_palmitoyl_transferase_1/NNS -LRB-/-LRB- CPT-1/NNP -RRB-/-RRB- was/VBD analyzed/VBN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN expression))
      (PP (IN of)
        (NP
          (NP
            (NP (JJ sterol_regulatory_element-binding_protein_1))
            (PRN (-LRB- -LRB-)
              (NP (NNP SREBP-1))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (JJ 4-hydroxybiphenyl) (NN synthase))
            (PRN (-LRB- -LRB-) (JJ GlcAT-D) (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (JJ acetyl-CoA_carboxylase_1) (NNS and_2))
            (PRN (-LRB- -LRB-)
              (NP (NNP ACC1)
                (CC and)
                (NNP ACC2))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (NN peroxisome_proliferator-activated_receptor-a))
            (PRN (-LRB- -LRB-)
              (NP (NNP PPARa))
              (-RRB- -RRB-)))
          (, ,)
          (CC and)
          (NP
            (NP (NNS carnitine_palmitoyl_transferase_1))
            (PRN (-LRB- -LRB-)
              (NP (NNP CPT-1))
              (-RRB- -RRB-))))))
    (VP (VBD was)
      (VP (VBN analyzed)))
    (. .)))

det(expression-2, The-1)
nsubjpass(analyzed-34, expression-2)
case(sterol_regulatory_element-binding_protein_1-4, of-3)
nmod:of(expression-2, sterol_regulatory_element-binding_protein_1-4)
appos(sterol_regulatory_element-binding_protein_1-4, SREBP-1-6)
amod(synthase-10, 4-hydroxybiphenyl-9)
nmod:of(expression-2, synthase-10)
conj:and(sterol_regulatory_element-binding_protein_1-4, synthase-10)
dep(synthase-10, GlcAT-D-12)
amod(and_2-16, acetyl-CoA_carboxylase_1-15)
nmod:of(expression-2, and_2-16)
conj:and(sterol_regulatory_element-binding_protein_1-4, and_2-16)
appos(and_2-16, ACC1-18)
cc(ACC1-18, and-19)
appos(and_2-16, ACC2-20)
conj:and(ACC1-18, ACC2-20)
nmod:of(expression-2, peroxisome_proliferator-activated_receptor-a-23)
conj:and(sterol_regulatory_element-binding_protein_1-4, peroxisome_proliferator-activated_receptor-a-23)
appos(peroxisome_proliferator-activated_receptor-a-23, PPARa-25)
cc(sterol_regulatory_element-binding_protein_1-4, and-28)
nmod:of(expression-2, carnitine_palmitoyl_transferase_1-29)
conj:and(sterol_regulatory_element-binding_protein_1-4, carnitine_palmitoyl_transferase_1-29)
appos(carnitine_palmitoyl_transferase_1-29, CPT-1-31)
auxpass(analyzed-34, was-33)
root(ROOT-0, analyzed-34)

Our/PRP$ findings/NNS suggest/VBP that/IN these/DT genes/NNS play/VBP a/DT crucial/JJ role/NN in/IN regulating/VBG lipid/NN metabolism/NN in/IN adipocytes/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS genes))
          (VP (VBP play)
            (NP
              (NP (DT a) (JJ crucial) (NN role))
              (PP (IN in)
                (S
                  (VP (VBG regulating)
                    (NP (NN lipid) (NN metabolism))
                    (PP (IN in)
                      (NP (NNS adipocytes)))))))))))
    (. .)))

nmod:poss(findings-2, Our-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
det(genes-6, these-5)
nsubj(play-7, genes-6)
ccomp(suggest-3, play-7)
det(role-10, a-8)
amod(role-10, crucial-9)
dobj(play-7, role-10)
mark(regulating-12, in-11)
acl(role-10, regulating-12)
compound(metabolism-14, lipid-13)
dobj(regulating-12, metabolism-14)
case(adipocytes-16, in-15)
nmod:in(regulating-12, adipocytes-16)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG their/PRP$ regulation/NN and/CC potential/JJ therapeutic/JJ targets/NNS for/IN obesity-related_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (NNS mechanisms))
                (PP (VBG underlying)
                  (NP
                    (NP (PRP$ their) (NN regulation))
                    (CC and)
                    (NP
                      (NP (JJ potential) (JJ therapeutic) (NNS targets))
                      (PP (IN for)
                        (NP (NNS obesity-related_disorders))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
case(regulation-11, underlying-9)
nmod:poss(regulation-11, their-10)
nmod:underlying(mechanisms-8, regulation-11)
cc(regulation-11, and-12)
amod(targets-15, potential-13)
amod(targets-15, therapeutic-14)
nmod:underlying(mechanisms-8, targets-15)
conj:and(regulation-11, targets-15)
case(obesity-related_disorders-17, for-16)
nmod:for(targets-15, obesity-related_disorders-17)

Melasma/NNP is_a/NNP common/JJ skin_condition/NN characterized/VBD by/IN hyperpigmented/JJ patches/NNS on/IN the/DT face/NN ,/, and/CC it/PRP has_been/VBP associated/VBN with/IN exposure/NN to/TO ultraviolet/JJ radiation/NN ./.

(ROOT
  (S
    (S
      (NP (NNP Melasma) (NNP is_a) (JJ common) (NN skin_condition))
      (VP (VBD characterized)
        (PP (IN by)
          (NP
            (NP (JJ hyperpigmented) (NNS patches))
            (PP (IN on)
              (NP (DT the) (NN face)))))))
    (, ,)
    (CC and)
    (S
      (NP (PRP it))
      (VP (VBP has_been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (NN exposure))
              (PP (TO to)
                (NP (JJ ultraviolet) (NN radiation))))))))
    (. .)))

compound(skin_condition-4, Melasma-1)
compound(skin_condition-4, is_a-2)
amod(skin_condition-4, common-3)
nsubj(characterized-5, skin_condition-4)
root(ROOT-0, characterized-5)
case(patches-8, by-6)
amod(patches-8, hyperpigmented-7)
nmod:by(characterized-5, patches-8)
case(face-11, on-9)
det(face-11, the-10)
nmod:on(patches-8, face-11)
cc(characterized-5, and-13)
nsubj(has_been-15, it-14)
conj:and(characterized-5, has_been-15)
dep(has_been-15, associated-16)
case(exposure-18, with-17)
nmod:with(associated-16, exposure-18)
case(radiation-21, to-19)
amod(radiation-21, ultraviolet-20)
nmod:to(exposure-18, radiation-21)

Kojic_Acid/NNP has_been/VBP shown/VBN to/TO reduce/VB the/DT risk/NN of/IN melasma/NN and/CC its/PRP$ associated/VBN symptoms/NNS ./.

(ROOT
  (S
    (NP (NNP Kojic_Acid))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB reduce)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP
                    (NP (NN melasma))
                    (CC and)
                    (NP (PRP$ its) (VBN associated) (NNS symptoms))))))))))
    (. .)))

nsubj(has_been-2, Kojic_Acid-1)
root(ROOT-0, has_been-2)
dep(has_been-2, shown-3)
mark(reduce-5, to-4)
xcomp(shown-3, reduce-5)
det(risk-7, the-6)
dobj(reduce-5, risk-7)
case(melasma-9, of-8)
nmod:of(risk-7, melasma-9)
cc(melasma-9, and-10)
nmod:poss(symptoms-13, its-11)
amod(symptoms-13, associated-12)
nmod:of(risk-7, symptoms-13)
conj:and(melasma-9, symptoms-13)

In/IN a/DT previous/JJ study/NN ,/, we/PRP found/VBD that/IN oral/JJ administration/NN of/IN 5/CD g/NN of/IN Kojic_acid/NNP reduced/VBD the/DT rate/NN of/IN facial_melasma/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN confidence/NN interval/JJ -LSB-/NNP CI/NNP -RSB-/NNP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT a) (JJ previous) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ oral) (NN administration))
            (PP (IN of)
              (NP
                (NP (CD 5) (NN g))
                (PP (IN of)
                  (NP (NNP Kojic_acid))))))
          (VP
            (VP (VBD reduced)
              (NP
                (NP (DT the) (NN rate))
                (PP (IN of)
                  (NP (NN facial_melasma))))
              (PP (IN by)
                (NP (CD 14) (NN %))))
            (PRN (-LRB- -LRB-)
              (SBAR
                (S
                  (NP
                    (ADJP (CD 95) (NN %))
                    (NN confidence))
                  (VP
                    (NP
                      (NP (JJ interval) (NNP -LSB-) (NNP CI) (NNP -RSB-))
                      (ADJP (CD 6-20) (NN %)))
                    (, ,)
                    (NP
                      (NP (NNP P))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005)))))))
              (-RRB- -RRB-))))))
    (. .)))

case(study-4, In-1)
det(study-4, a-2)
amod(study-4, previous-3)
nmod:in(found-7, study-4)
nsubj(found-7, we-6)
root(ROOT-0, found-7)
mark(reduced-16, that-8)
amod(administration-10, oral-9)
nsubj(reduced-16, administration-10)
case(g-13, of-11)
nummod(g-13, 5-12)
nmod:of(administration-10, g-13)
case(Kojic_acid-15, of-14)
nmod:of(g-13, Kojic_acid-15)
ccomp(found-7, reduced-16)
det(rate-18, the-17)
dobj(reduced-16, rate-18)
case(facial_melasma-20, of-19)
nmod:of(rate-18, facial_melasma-20)
case(%-23, by-21)
nummod(%-23, 14-22)
nmod:by(reduced-16, %-23)
compound(%-26, 95-25)
amod(confidence-27, %-26)
nsubj(-RSB--31, confidence-27)
amod(-RSB--31, interval-28)
compound(-RSB--31, -LSB--29)
compound(-RSB--31, CI-30)
parataxis(reduced-16, -RSB--31)
compound(%-33, 6-20-32)
amod(-RSB--31, %-33)
dobj(-RSB--31, P-35)
dep(0.0005-37, =-36)
dep(P-35, 0.0005-37)

In/IN this/DT randomized_controlled_trial/NN ,/, the/DT effect/NN of/IN Kojic_Acid/NNP on/IN melasma/NN and/CC associated/VBN symptoms/NNS was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN randomized_controlled_trial)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP (NNP Kojic_Acid)))
      (PP (IN on)
        (NP
          (NP (NN melasma))
          (CC and)
          (NP (VBN associated) (NNS symptoms)))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(randomized_controlled_trial-3, In-1)
det(randomized_controlled_trial-3, this-2)
nmod:in(investigated-15, randomized_controlled_trial-3)
det(effect-6, the-5)
nsubjpass(investigated-15, effect-6)
case(Kojic_Acid-8, of-7)
nmod:of(effect-6, Kojic_Acid-8)
case(melasma-10, on-9)
nmod:on(effect-6, melasma-10)
cc(melasma-10, and-11)
amod(symptoms-13, associated-12)
nmod:on(effect-6, symptoms-13)
conj:and(melasma-10, symptoms-13)
auxpass(investigated-15, was-14)
root(ROOT-0, investigated-15)

At_2/JJ h/NN after/IN dosing/VBG ,/, Kojic_Acid/NNP reduced/VBD the/DT risk/NN of/IN facial_melasma/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP Kojic_Acid))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NN facial_melasma))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, Kojic_Acid-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(facial_melasma-11, of-10)
nmod:of(risk-9, facial_melasma-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN Kojic_Acid/NNP may/MD be/VB an/DT effective/JJ treatment/NN for/IN melasma/NN and/CC its/PRP$ associated/JJ symptoms/NNS ,/, providing/VBG a/DT promising/JJ avenue/NN for/IN future/JJ research/NN in/IN this/DT area/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Kojic_Acid))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (PP (IN for)
                  (NP
                    (NP (NN melasma))
                    (CC and)
                    (NP (PRP$ its) (JJ associated) (NNS symptoms)))))))))
      (, ,)
      (S
        (VP (VBG providing)
          (NP (DT a) (JJ promising) (NN avenue))
          (PP (IN for)
            (NP
              (NP (JJ future) (NN research))
              (PP (IN in)
                (NP (DT this) (NN area))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(treatment-10, that-4)
nsubj(treatment-10, Kojic_Acid-5)
aux(treatment-10, may-6)
cop(treatment-10, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
ccomp(suggest-3, treatment-10)
case(melasma-12, for-11)
nmod:for(treatment-10, melasma-12)
cc(melasma-12, and-13)
nmod:poss(symptoms-16, its-14)
amod(symptoms-16, associated-15)
nmod:for(treatment-10, symptoms-16)
conj:and(melasma-12, symptoms-16)
xcomp(suggest-3, providing-18)
det(avenue-21, a-19)
amod(avenue-21, promising-20)
dobj(providing-18, avenue-21)
case(research-24, for-22)
amod(research-24, future-23)
nmod:for(providing-18, research-24)
case(area-27, in-25)
det(area-27, this-26)
nmod:in(research-24, area-27)

There/EX was/VBD a/DT correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/RB less/JJR than/IN 0.01/CD -RRB-/-RRB- ,/, DTAB/NNP -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/VBP less/JJR than/IN 0.01/CD -RRB-/-RRB- and/CC serum/NN beta-lg/JJ levels/NNS ./.

(ROOT
  (S
    (NP (EX There))
    (VP
      (VP (VBD was)
        (NP
          (NP (DT a) (NN correlation))
          (PP (IN between)
            (NP
              (NP (NN serum) (NNS levels))
              (PP (IN of)
                (NP (NN alkaline_phosphatase)))))))
      (PRN (-LRB- -LRB-)
        (SBAR
          (X
            (X (SYM r))
            (NP (SYM =)))
          (S
            (NP
              (NP (CD 0.3))
              (PRN (, ,)
                (ADVP (RB p))
                (NP
                  (QP (JJR less) (IN than) (CD 0.01)))
                (-RRB- -RRB-))
              (, ,)
              (NP
                (NP (NNP DTAB))
                (-LRB- -LRB-)
                (NP
                  (FRAG
                    (X
                      (X (SYM r))
                      (NP (SYM =)))
                    (NP (CD 0.42)))))
              (, ,))
            (VP (VBP p)
              (NP
                (QP (JJR less) (IN than) (CD 0.01))))))
        (-RRB- -RRB-))
      (CC and)
      (VP (NN serum)
        (NP (JJ beta-lg) (NNS levels))))
    (. .)))

expl(correlation-4, There-1)
cop(correlation-4, was-2)
det(correlation-4, a-3)
root(ROOT-0, correlation-4)
case(levels-7, between-5)
compound(levels-7, serum-6)
nmod:between(correlation-4, levels-7)
case(alkaline_phosphatase-9, of-8)
nmod:of(levels-7, alkaline_phosphatase-9)
dep(=-12, r-11)
dep(p-27, =-12)
nsubj(p-27, 0.3-13)
dep(0.01-18, p-15)
advmod(0.01-18, less-16)
mwe(less-16, than-17)
dep(0.3-13, 0.01-18)
appos(0.3-13, DTAB-21)
dep(=-24, r-23)
dep(0.42-25, =-24)
dep(DTAB-21, 0.42-25)
parataxis(correlation-4, p-27)
advmod(0.01-30, less-28)
mwe(less-28, than-29)
dobj(p-27, 0.01-30)
cc(correlation-4, and-32)
conj:and(correlation-4, serum-33)
amod(levels-35, beta-lg-34)
nsubj(correlation-4, levels-35)

A/DT total/NN of/IN 100/CD patients/NNS were/VBD included/VBN in/IN this/DT study/NN ,/, and/CC their/PRP$ serum/NN samples/NNS were/VBD collected/VBN for/IN analysis/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT A) (NN total))
        (PP (IN of)
          (NP (CD 100) (NNS patients))))
      (VP (VBD were)
        (VP (VBN included)
          (PP (IN in)
            (NP (DT this) (NN study))))))
    (, ,)
    (CC and)
    (S
      (NP (PRP$ their) (NN serum) (NNS samples))
      (VP (VBD were)
        (VP (VBN collected)
          (PP (IN for)
            (NP (NN analysis))))))
    (. .)))

det(total-2, A-1)
nsubjpass(included-7, total-2)
case(patients-5, of-3)
nummod(patients-5, 100-4)
nmod:of(total-2, patients-5)
auxpass(included-7, were-6)
root(ROOT-0, included-7)
case(study-10, in-8)
det(study-10, this-9)
nmod:in(included-7, study-10)
cc(included-7, and-12)
nmod:poss(samples-15, their-13)
compound(samples-15, serum-14)
nsubjpass(collected-17, samples-15)
auxpass(collected-17, were-16)
conj:and(included-7, collected-17)
case(analysis-19, for-18)
nmod:for(collected-17, analysis-19)

The/DT results/NNS showed/VBD a/DT significant/JJ positive/JJ correlation/NN between/IN serum/NN levels/NNS of/IN ALP/NNP -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- and/CC DTAB/NNP -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- with/IN serum/NN beta-lg/JJ levels/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (JJ positive) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP
                  (NP (NNP ALP))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.3)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-)))
                (CC and)
                (NP
                  (NP (NNP DTAB))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.42)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-))))))))
      (PP (IN with)
        (NP (NN serum) (JJ beta-lg) (NNS levels))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(correlation-7, a-4)
amod(correlation-7, significant-5)
amod(correlation-7, positive-6)
dobj(showed-3, correlation-7)
case(levels-10, between-8)
compound(levels-10, serum-9)
nmod:between(correlation-7, levels-10)
case(ALP-12, of-11)
nmod:of(levels-10, ALP-12)
dep(<-19, r-14)
dep(0.3-16, =-15)
dep(<-19, 0.3-16)
nsubj(<-19, p-18)
dep(ALP-12, <-19)
dobj(<-19, 0.01-20)
cc(ALP-12, and-22)
nmod:of(levels-10, DTAB-23)
conj:and(ALP-12, DTAB-23)
dep(<-30, r-25)
dep(0.42-27, =-26)
dep(<-30, 0.42-27)
nsubj(<-30, p-29)
dep(DTAB-23, <-30)
dobj(<-30, 0.01-31)
case(levels-36, with-33)
compound(levels-36, serum-34)
amod(levels-36, beta-lg-35)
nmod:with(showed-3, levels-36)

These/DT findings/NNS suggest/VBP that/IN serum/NN levels/NNS of/IN ALP/NNP and/CC DTAB/NNP may/MD be/VB potential/JJ biomarkers/NNS for/IN predicting/VBG serum/JJ beta-lg/JJ levels/NNS in/IN patients/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP (NNP ALP)
                (CC and)
                (NNP DTAB))))
          (VP (MD may)
            (VP (VB be)
              (NP (JJ potential) (NNS biomarkers))
              (PP (IN for)
                (S
                  (VP (VBG predicting)
                    (NP
                      (NP (JJ serum) (JJ beta-lg) (NNS levels))
                      (PP (IN in)
                        (NP (NNS patients))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(biomarkers-14, that-4)
compound(levels-6, serum-5)
nsubj(biomarkers-14, levels-6)
case(ALP-8, of-7)
nmod:of(levels-6, ALP-8)
cc(ALP-8, and-9)
nmod:of(levels-6, DTAB-10)
conj:and(ALP-8, DTAB-10)
aux(biomarkers-14, may-11)
cop(biomarkers-14, be-12)
amod(biomarkers-14, potential-13)
ccomp(suggest-3, biomarkers-14)
mark(predicting-16, for-15)
advcl(biomarkers-14, predicting-16)
amod(levels-19, serum-17)
amod(levels-19, beta-lg-18)
dobj(predicting-16, levels-19)
case(patients-21, in-20)
nmod:in(levels-19, patients-21)

Further/JJ studies/NNS are/VBP needed/VBN to/TO validate/VB these/DT findings/NNS and/CC explore/VB the/DT underlying/VBG mechanisms/NNS involved/VBN in/IN this/DT correlation/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB validate)
                (NP (DT these) (NNS findings)))
              (CC and)
              (VP (VB explore)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP (DT this) (NN correlation)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(validate-6, studies-2)
nsubj:xsubj(explore-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(validate-6, to-5)
xcomp(needed-4, validate-6)
det(findings-8, these-7)
dobj(validate-6, findings-8)
cc(validate-6, and-9)
xcomp(needed-4, explore-10)
conj:and(validate-6, explore-10)
det(mechanisms-13, the-11)
amod(mechanisms-13, underlying-12)
dobj(explore-10, mechanisms-13)
acl(mechanisms-13, involved-14)
case(correlation-17, in-15)
det(correlation-17, this-16)
nmod:in(involved-14, correlation-17)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ numerous) (NN health) (NNS benefits))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-17, omega-3_fatty_acids-2)
nsubj:xsubj(have-19, omega-3_fatty_acids-2)
acl(omega-3_fatty_acids-2, including-4)
advmod(EPA-7, eicosapentaenoic_acid-5)
dobj(including-4, EPA-7)
cc(EPA-7, and-9)
dobj(including-4, docosahexaenoic_acid-10)
conj:and(EPA-7, docosahexaenoic_acid-10)
appos(EPA-7, DHA-12)
aux(shown-17, have-15)
auxpass(shown-17, been-16)
root(ROOT-0, shown-17)
mark(have-19, to-18)
xcomp(shown-17, have-19)
amod(benefits-22, numerous-20)
compound(benefits-22, health-21)
dobj(have-19, benefits-22)

Recent/JJ studies/NNS have/VBP indicated/VBN that/IN these/DT fatty_acids/NNS may/MD be/VB associated/VBN with/IN decreased/VBN calcium_acetate/JJ levels/NNS in/IN hypercalcemia/JJ acetatemic/JJ patients/NNS ,/, potentially/RB reducing/VBG the/DT risk/NN of/IN developing/VBG kidney_stones/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN indicated)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (VBN decreased) (JJ calcium_acetate) (NNS levels))
                      (PP (IN in)
                        (NP (JJ hypercalcemia) (JJ acetatemic) (NNS patients)))))
                  (, ,)
                  (S
                    (ADVP (RB potentially))
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (VBG developing) (NNS kidney_stones)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(indicated-4, studies-2)
aux(indicated-4, have-3)
root(ROOT-0, indicated-4)
mark(associated-10, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-10, fatty_acids-7)
aux(associated-10, may-8)
auxpass(associated-10, be-9)
ccomp(indicated-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, calcium_acetate-13)
nmod:with(associated-10, levels-14)
case(patients-18, in-15)
amod(patients-18, hypercalcemia-16)
amod(patients-18, acetatemic-17)
nmod:in(levels-14, patients-18)
advmod(reducing-21, potentially-20)
xcomp(associated-10, reducing-21)
det(risk-23, the-22)
dobj(reducing-21, risk-23)
case(kidney_stones-26, of-24)
amod(kidney_stones-26, developing-25)
nmod:of(risk-23, kidney_stones-26)

Additionally/RB ,/, a/DT growing/VBG body/NN of/IN evidence/NN suggests/VBZ that/IN EPA/NNP and/CC DHA/NNP intake/NN may/MD also/RB reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP
      (NP (DT a) (VBG growing) (NN body))
      (PP (IN of)
        (NP (NN evidence))))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP
            (ADJP (NNP EPA)
              (CC and)
              (NNP DHA))
            (NN intake))
          (VP (MD may) (RB also)
            (VP (VB reduce)
              (NP
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP (NN coronary_heart_disease))))))
                (PRN (-LRB- -LRB-)
                  (NP (NNP CHD))
                  (-RRB- -RRB-))))))))
    (. .)))

advmod(suggests-8, Additionally-1)
det(body-5, a-3)
amod(body-5, growing-4)
nsubj(suggests-8, body-5)
case(evidence-7, of-6)
nmod:of(body-5, evidence-7)
root(ROOT-0, suggests-8)
mark(reduce-16, that-9)
amod(intake-13, EPA-10)
cc(EPA-10, and-11)
conj:and(EPA-10, DHA-12)
amod(intake-13, DHA-12)
nsubj(reduce-16, intake-13)
aux(reduce-16, may-14)
advmod(reduce-16, also-15)
ccomp(suggests-8, reduce-16)
det(risk-18, the-17)
dobj(reduce-16, risk-18)
mark(developing-20, of-19)
acl(risk-18, developing-20)
dobj(developing-20, coronary_heart_disease-21)
appos(risk-18, CHD-23)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB a/DT promising/JJ strategy/NN for/IN reducing/VBG the/DT incidence/NN of/IN both/DT hypercalcemia/JJ acetatemia/NN and/CC CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (JJ dietary) (NN intake))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN incidence))
                        (PP (IN of)
                          (NP
                            (NP (DT both) (JJ hypercalcemia) (NN acetatemia))
                            (CC and)
                            (NP (NNP CHD))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-16, that-4)
amod(intake-7, increasing-5)
amod(intake-7, dietary-6)
nsubj(strategy-16, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, a-14)
amod(strategy-16, promising-15)
ccomp(suggest-3, strategy-16)
mark(reducing-18, for-17)
acl(strategy-16, reducing-18)
det(incidence-20, the-19)
dobj(reducing-18, incidence-20)
case(acetatemia-24, of-21)
det(acetatemia-24, both-22)
amod(acetatemia-24, hypercalcemia-23)
nmod:of(incidence-20, acetatemia-24)
cc(acetatemia-24, and-25)
nmod:of(incidence-20, CHD-26)
conj:and(acetatemia-24, CHD-26)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, are/VBP associated/VBN with/IN decreased/VBN calcium_acetate/NN levels/NNS in/IN hypercalcium/NN acetatemic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN associated)
          (PP (IN with)
            (NP (VBN decreased) (NN calcium_acetate) (NNS levels)))
          (PP (IN in)
            (NP (NN hypercalcium) (JJ acetatemic) (NNS patients)))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(associated-23, omega-3_fatty_acids-2)
nsubjpass(decreased-33, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
auxpass(associated-23, are-22)
root(ROOT-0, associated-23)
case(levels-27, with-24)
amod(levels-27, decreased-25)
compound(levels-27, calcium_acetate-26)
nmod:with(associated-23, levels-27)
case(patients-31, in-28)
compound(patients-31, hypercalcium-29)
amod(patients-31, acetatemic-30)
nmod:in(associated-23, patients-31)
cc(associated-23, and-32)
conj:and(associated-23, decreased-33)
dobj(decreased-33, risk-34)
case(coronary_heart_disease-37, of-35)
amod(coronary_heart_disease-37, developing-36)
nmod:of(risk-34, coronary_heart_disease-37)
appos(coronary_heart_disease-37, CHD-39)

Phosphoramidon/NNP is_a/VBZ potent/JJ inhibitor/NN of/IN neprilysin/NN ,/, which/WDT is/VBZ involved/VBN in/IN the/DT degradation/NN of/IN a/DT number/NN of/IN vasoactive/JJ peptides/NNS ./.

(ROOT
  (S
    (NP (NNP Phosphoramidon))
    (VP (VBZ is_a)
      (NP
        (NP (JJ potent) (NN inhibitor))
        (PP (IN of)
          (NP
            (NP (NN neprilysin))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (VBZ is)
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN degradation))
                        (PP (IN of)
                          (NP
                            (NP (DT a) (NN number))
                            (PP (IN of)
                              (NP (JJ vasoactive) (NNS peptides)))))))))))))))
    (. .)))

nsubj(is_a-2, Phosphoramidon-1)
root(ROOT-0, is_a-2)
amod(inhibitor-4, potent-3)
dobj(is_a-2, inhibitor-4)
case(neprilysin-6, of-5)
nmod:of(inhibitor-4, neprilysin-6)
nsubjpass(involved-10, neprilysin-6)
ref(neprilysin-6, which-8)
auxpass(involved-10, is-9)
acl:relcl(neprilysin-6, involved-10)
case(degradation-13, in-11)
det(degradation-13, the-12)
nmod:in(involved-10, degradation-13)
case(number-16, of-14)
det(number-16, a-15)
nmod:of(degradation-13, number-16)
case(peptides-19, of-17)
amod(peptides-19, vasoactive-18)
nmod:of(number-16, peptides-19)

At_2/JJ h/NN after/IN dosing/VBG ,/, phosphoramidon/NN reduced/VBD the/DT risk/NN of/IN tracheomalacia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/NN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN phosphoramidon))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NN tracheomalacia))))
      (PP (IN by)
        (NP
          (NP
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (SBAR
                    (S
                      (VP (VBP CI)
                        (NP
                          (NP
                            (NP (CD 6-20) (NN %))
                            (, ,)
                            (NP (NNP P)))
                          (X
                            (X (SYM =))
                            (NP (CD 0.0005))))))))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP
                (NP (NN photophobia))
                (NP (CD 17) (NN %)))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NP
              (NP (NN phonophobia))
              (NP (CD 14) (NN %))))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (PP (NNP CI)
                (NP (CD 17-20) (NN %))))
            (, ,)
            (NP (NNP P)
              (QP (CD <) (CD 0.0001)))
            (-RRB- -RRB-)))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, phosphoramidon-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(tracheomalacia-11, of-10)
nmod:of(risk-9, tracheomalacia-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
nmod:by(reduced-7, photophobia-27)
conj:and(%-14, photophobia-27)
nummod(%-29, 17-28)
dep(photophobia-27, %-29)
nummod(%-32, 95-31)
appos(photophobia-27, %-32)
dep(%-35, CI-33)
nummod(%-35, 12-22-34)
nmod(%-32, %-35)
dep(%-32, P-37)
compound(0.0001-39, <-38)
nummod(P-37, 0.0001-39)
cc(%-14, and-42)
nmod:by(reduced-7, phonophobia-43)
conj:and(%-14, phonophobia-43)
nummod(%-45, 14-44)
dep(phonophobia-43, %-45)
nummod(%-48, 95-47)
appos(%-14, %-48)
dep(%-51, CI-49)
nummod(%-51, 17-20-50)
nmod(%-48, %-51)
dep(%-48, P-53)
compound(0.0001-55, <-54)
nummod(P-53, 0.0001-55)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD h/NN after/IN dosing/VBG ,/, phosphoramidon/NN reduced/VBD the/DT risk/NN of/IN tracheomalacia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP
            (PP (IN at)
              (NP (CD 2) (NN h)))
            (PP (IN after)
              (S
                (VP (VBG dosing)))))
          (, ,)
          (NP (NN phosphoramidon))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN tracheomalacia))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-12, that-4)
case(h-7, at-5)
nummod(h-7, 2-6)
nmod:at(reduced-12, h-7)
mark(dosing-9, after-8)
nmod(h-7, dosing-9)
nsubj(reduced-12, phosphoramidon-11)
ccomp(showed-3, reduced-12)
det(risk-14, the-13)
dobj(reduced-12, risk-14)
case(tracheomalacia-16, of-15)
nmod:of(risk-14, tracheomalacia-16)
case(%-19, by-17)
nummod(%-19, 14-18)
nmod:by(reduced-12, %-19)
nummod(%-22, 95-21)
dep(%-19, %-22)
acl:relcl(%-22, CI-23)
nummod(%-25, 6-20-24)
dobj(CI-23, %-25)
appos(%-25, P-27)
dep(0.0005-29, =-28)
dep(%-25, 0.0005-29)
xcomp(reduced-12, photophobia-32)
case(%-35, by-33)
nummod(%-35, 17-34)
nmod:by(photophobia-32, %-35)
nummod(%-38, 95-37)
appos(%-35, %-38)
dep(%-41, CI-39)
nummod(%-41, 12-22-40)
nmod(%-38, %-41)
dep(%-38, P-43)
compound(0.0001-45, <-44)
nummod(P-43, 0.0001-45)
cc(photophobia-32, and-48)
xcomp(reduced-12, phonophobia-49)
conj:and(photophobia-32, phonophobia-49)
case(%-52, by-50)
nummod(%-52, 14-51)
nmod:by(phonophobia-49, %-52)
nummod(%-55, 95-54)
appos(%-52, %-55)
dep(%-58, CI-56)
nummod(%-58, 17-20-57)
nmod(%-55, %-58)
dep(%-55, P-60)
compound(0.0001-62, <-61)
nummod(P-60, 0.0001-62)

These/DT findings/NNS suggest/VBP that/IN neprilysin/NN inhibition/NN may/MD be/VB a/DT promising/JJ therapeutic/JJ strategy/NN for/IN the/DT treatment/NN of/IN conditions/NNS associated/VBN with/IN tracheomalacia/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN neprilysin) (NN inhibition))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN strategy))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP
                        (NP (NNS conditions))
                        (VP (VBN associated)
                          (PP (IN with)
                            (NP
                              (NP (NN tracheomalacia))
                              (, ,)
                              (NP (NN photophobia))
                              (, ,)
                              (CC and)
                              (NP (NN phonophobia)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-12, that-4)
compound(inhibition-6, neprilysin-5)
nsubj(strategy-12, inhibition-6)
aux(strategy-12, may-7)
cop(strategy-12, be-8)
det(strategy-12, a-9)
amod(strategy-12, promising-10)
amod(strategy-12, therapeutic-11)
ccomp(suggest-3, strategy-12)
case(treatment-15, for-13)
det(treatment-15, the-14)
nmod:for(strategy-12, treatment-15)
case(conditions-17, of-16)
nmod:of(treatment-15, conditions-17)
acl(conditions-17, associated-18)
case(tracheomalacia-20, with-19)
nmod:with(associated-18, tracheomalacia-20)
nmod:with(associated-18, photophobia-22)
conj:and(tracheomalacia-20, photophobia-22)
cc(tracheomalacia-20, and-24)
nmod:with(associated-18, phonophobia-25)
conj:and(tracheomalacia-20, phonophobia-25)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosing/JJ regimen/NN for/IN phosphoramidon/NN in/IN these/DT indications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (JJ dosing) (NN regimen))
                  (PP (IN for)
                    (NP
                      (NP (NN phosphoramidon))
                      (PP (IN in)
                        (NP (DT these) (NNS indications))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(determine-11, to-10)
ccomp(needed-4, determine-11)
conj:and(confirm-6, determine-11)
det(regimen-15, the-12)
amod(regimen-15, optimal-13)
amod(regimen-15, dosing-14)
dobj(determine-11, regimen-15)
case(phosphoramidon-17, for-16)
nmod:for(regimen-15, phosphoramidon-17)
case(indications-20, in-18)
det(indications-20, these-19)
nmod:in(phosphoramidon-17, indications-20)

The/DT present/JJ study/NN aimed/VBN to/TO investigate/VB the/DT effects/NNS of/IN beta-Escin/JJ intervention/NN on/IN body/NN weight/NN ,/, villus/JJ height/NN ,/, villus/VBZ surface/NN area/NN ,/, plasma/NN beta-Escin/JJ concentration/NN and/CC expression/NN of/IN Occludin/NNP in_a/JJ rat/NN model/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ present) (NN study))
      (VP (VBN aimed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (NNS effects))
                (PP (IN of)
                  (NP (JJ beta-Escin) (NN intervention))))
              (PP (IN on)
                (NP
                  (NP (NN body) (NN weight))
                  (, ,)
                  (NP (JJ villus) (NN height))
                  (, ,))))))))
    (VP (VBZ villus)
      (NP
        (NP (NN surface) (NN area))
        (, ,)
        (NP (NN plasma) (JJ beta-Escin) (NN concentration))
        (CC and)
        (NP
          (NP (NN expression))
          (PP (IN of)
            (NP (NNP Occludin) (JJ in_a) (NN rat) (NN model))))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(villus-19, study-3)
acl(study-3, aimed-4)
mark(investigate-6, to-5)
xcomp(aimed-4, investigate-6)
det(effects-8, the-7)
dobj(investigate-6, effects-8)
case(intervention-11, of-9)
amod(intervention-11, beta-Escin-10)
nmod:of(effects-8, intervention-11)
case(weight-14, on-12)
compound(weight-14, body-13)
nmod:on(investigate-6, weight-14)
amod(height-17, villus-16)
appos(weight-14, height-17)
root(ROOT-0, villus-19)
compound(area-21, surface-20)
dobj(villus-19, area-21)
compound(concentration-25, plasma-23)
amod(concentration-25, beta-Escin-24)
dobj(villus-19, concentration-25)
conj:and(area-21, concentration-25)
cc(area-21, and-26)
dobj(villus-19, expression-27)
conj:and(area-21, expression-27)
case(model-32, of-28)
compound(model-32, Occludin-29)
amod(model-32, in_a-30)
compound(model-32, rat-31)
nmod:of(expression-27, model-32)

The/DT results/NNS showed/VBD a/DT significant/JJ decrease/NN in/IN body/NN weight/NN ,/, villus/JJ height/NN and/CC villus/JJ surface/NN area/NN in/IN the/DT beta-Escin-intervened/JJ group/NN compared/VBN to/TO the/DT control/NN group/NN -LRB-/-LRB- P/NNP </CD 0.01/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (NN decrease))
        (PP (IN in)
          (NP
            (NP (NN body) (NN weight))
            (, ,)
            (NP
              (NP (JJ villus) (NN height))
              (CC and)
              (NP (JJ villus) (NN surface) (NN area))))))
      (PP (IN in)
        (NP (DT the) (JJ beta-Escin-intervened) (NN group)))
      (PP (VBN compared)
        (PP (TO to)
          (NP
            (NP (DT the) (NN control) (NN group))
            (PRN (-LRB- -LRB-)
              (NP (NNP P)
                (QP (CD <) (CD 0.01)))
              (-RRB- -RRB-))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(decrease-6, a-4)
amod(decrease-6, significant-5)
dobj(showed-3, decrease-6)
case(weight-9, in-7)
compound(weight-9, body-8)
nmod:in(decrease-6, weight-9)
amod(height-12, villus-11)
appos(weight-9, height-12)
cc(height-12, and-13)
amod(area-16, villus-14)
compound(area-16, surface-15)
appos(weight-9, area-16)
conj:and(height-12, area-16)
case(group-20, in-17)
det(group-20, the-18)
amod(group-20, beta-Escin-intervened-19)
nmod:in(showed-3, group-20)
case(group-25, compared-21)
mwe(compared-21, to-22)
det(group-25, the-23)
compound(group-25, control-24)
advcl(showed-3, group-25)
appos(group-25, P-27)
compound(0.01-29, <-28)
nummod(P-27, 0.01-29)

However/RB ,/, the/DT plasma/NN beta-Escin/JJ concentration/NN and/CC expression/NN of/IN Occludin/NNP in/IN the/DT beta-Escin-intervened/JJ group/NN had/VBD recovered/VBN to/TO normal/JJ -LRB-/-LRB- P/NNP >/CD 0.05/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN plasma) (JJ beta-Escin) (NN concentration))
      (CC and)
      (NP
        (NP (NN expression))
        (PP (IN of)
          (NP (NNP Occludin)))
        (PP (IN in)
          (NP (DT the) (JJ beta-Escin-intervened) (NN group)))))
    (VP (VBD had)
      (VP (VBN recovered)
        (PP (TO to)
          (NP
            (NP (JJ normal))
            (PRN (-LRB- -LRB-)
              (NP (NNP P)
                (QP (CD >) (CD 0.05)))
              (-RRB- -RRB-))))))
    (. .)))

advmod(recovered-16, However-1)
det(concentration-6, the-3)
compound(concentration-6, plasma-4)
amod(concentration-6, beta-Escin-5)
nsubj(recovered-16, concentration-6)
cc(concentration-6, and-7)
conj:and(concentration-6, expression-8)
nsubj(recovered-16, expression-8)
case(Occludin-10, of-9)
nmod:of(expression-8, Occludin-10)
case(group-14, in-11)
det(group-14, the-12)
amod(group-14, beta-Escin-intervened-13)
nmod:in(expression-8, group-14)
aux(recovered-16, had-15)
root(ROOT-0, recovered-16)
case(normal-18, to-17)
nmod:to(recovered-16, normal-18)
appos(normal-18, P-20)
compound(0.05-22, >-21)
nummod(P-20, 0.05-22)

These/DT findings/NNS suggest/VBP that/IN beta-Escin/NN may/MD have/VB potential/JJ therapeutic/JJ effects/NNS on/IN intestinal_disorders/NNS characterized/VBN by/IN abnormal/JJ body/NN weight/NN and/CC villus/JJ morphology/NN ,/, while/IN maintaining/VBG normal/JJ plasma/NN beta-Escin/JJ concentration/NN and/CC Occludin/NNP expression/NN levels/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN beta-Escin))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ potential) (JJ therapeutic) (NNS effects))
                (PP (IN on)
                  (NP
                    (NP (NNS intestinal_disorders))
                    (VP (VBN characterized)
                      (PP (IN by)
                        (NP
                          (NP (JJ abnormal) (NN body) (NN weight))
                          (CC and)
                          (NP (JJ villus) (NN morphology))))))))))))
      (, ,)
      (SBAR (IN while)
        (S
          (VP (VBG maintaining)
            (NP (JJ normal) (NN plasma)))
          (NP-TMP
            (NP (JJ beta-Escin) (NN concentration))
            (CC and)
            (NP (NNP Occludin) (NN expression) (NNS levels))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, beta-Escin-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(effects-10, potential-8)
amod(effects-10, therapeutic-9)
dobj(have-7, effects-10)
case(intestinal_disorders-12, on-11)
nmod:on(effects-10, intestinal_disorders-12)
acl(intestinal_disorders-12, characterized-13)
case(weight-17, by-14)
amod(weight-17, abnormal-15)
compound(weight-17, body-16)
nmod:by(characterized-13, weight-17)
cc(weight-17, and-18)
amod(morphology-20, villus-19)
nmod:by(characterized-13, morphology-20)
conj:and(weight-17, morphology-20)
mark(maintaining-23, while-22)
advcl(suggest-3, maintaining-23)
amod(plasma-25, normal-24)
dobj(maintaining-23, plasma-25)
amod(concentration-27, beta-Escin-26)
dep(maintaining-23, concentration-27)
cc(concentration-27, and-28)
compound(levels-31, Occludin-29)
compound(levels-31, expression-30)
dep(maintaining-23, levels-31)
conj:and(concentration-27, levels-31)

There/EX was/VBD still/RB significant/JJ decrease/NN of/IN body/NN weight/NN ,/, villus/VBZ height/NN and/CC villus/VBZ surface/NN area/NN in/IN beta-Escin-intervened/JJ group/NN compared/VBN with/IN control/NN group/NN -LRB-/-LRB- P/NNP </CD 0.01/CD -RRB-/-RRB- ,/, but/CC plasma/NN beta-Escin/JJ concentration/NN and/CC expression/NN of/IN Occludin/NNP in/IN beta-Escin-intervened/JJ group/NN had/VBD recovered/VBN to/TO normal/JJ -LRB-/-LRB- P/NNP >/CD 0.05/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (S
      (NP (EX There))
      (VP
        (VP (VBD was)
          (NP
            (NP (RB still) (JJ significant) (NN decrease))
            (PP (IN of)
              (NP (NN body) (NN weight)))))
        (, ,)
        (VP (VBZ villus)
          (NP (NN height)))
        (CC and)
        (VP (VBZ villus)
          (NP (NN surface) (NN area))
          (PP (IN in)
            (NP
              (NP (JJ beta-Escin-intervened) (NN group))
              (VP (VBN compared)
                (PP (IN with)
                  (NP
                    (NP (NN control) (NN group))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.01)))
                      (-RRB- -RRB-))))))))))
    (, ,)
    (CC but)
    (S
      (NP
        (NP (NN plasma) (JJ beta-Escin) (NN concentration))
        (CC and)
        (NP
          (NP (NN expression))
          (PP (IN of)
            (NP
              (NP (NNP Occludin))
              (PP (IN in)
                (NP (JJ beta-Escin-intervened) (NN group)))))))
      (VP (VBD had)
        (VP (VBN recovered)
          (PP (TO to)
            (NP
              (NP (JJ normal))
              (PRN (-LRB- -LRB-)
                (NP (NNP P)
                  (QP (CD >) (CD 0.05)))
                (-RRB- -RRB-)))))))
    (. .)))

expl(decrease-5, There-1)
cop(decrease-5, was-2)
advmod(decrease-5, still-3)
amod(decrease-5, significant-4)
root(ROOT-0, decrease-5)
case(weight-8, of-6)
compound(weight-8, body-7)
nmod:of(decrease-5, weight-8)
conj:and(decrease-5, villus-10)
nsubj(decrease-5, height-11)
nsubj(villus-10, height-11)
nsubj(villus-13, height-11)
cc(decrease-5, and-12)
conj:and(decrease-5, villus-13)
compound(area-15, surface-14)
nsubj(decrease-5, area-15)
case(group-18, in-16)
amod(group-18, beta-Escin-intervened-17)
nmod:in(villus-13, group-18)
acl(group-18, compared-19)
case(group-22, with-20)
compound(group-22, control-21)
nmod:with(compared-19, group-22)
appos(group-22, P-24)
compound(0.01-26, <-25)
nummod(P-24, 0.01-26)
cc(decrease-5, but-29)
compound(concentration-32, plasma-30)
amod(concentration-32, beta-Escin-31)
nsubj(recovered-41, concentration-32)
cc(concentration-32, and-33)
conj:and(concentration-32, expression-34)
nsubj(recovered-41, expression-34)
case(Occludin-36, of-35)
nmod:of(expression-34, Occludin-36)
case(group-39, in-37)
amod(group-39, beta-Escin-intervened-38)
nmod:in(Occludin-36, group-39)
aux(recovered-41, had-40)
conj:but(decrease-5, recovered-41)
case(normal-43, to-42)
nmod:to(recovered-41, normal-43)
appos(normal-43, P-45)
compound(0.05-47, >-46)
nummod(P-45, 0.05-47)

Obesity/RB is_a/JJ major/JJ health/NN concern/NN worldwide/RB and/CC is/VBZ associated/VBN with/IN the/DT development/NN of/IN metabolic_disorders/NNS such/JJ as/IN non-alcoholic_fatty_liver_disease/NN -LRB-/-LRB- NAFLD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (NX
        (NX
          (NX (JJ major) (NN health) (NN concern))
          (ADJP (RB worldwide)))
        (CC and)))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP
              (NP (DT the) (NN development))
              (PP (IN of)
                (NP
                  (NP (NNS metabolic_disorders))
                  (PP (JJ such) (IN as)
                    (NP (NN non-alcoholic_fatty_liver_disease))))))
            (PRN (-LRB- -LRB-)
              (NP (NNP NAFLD))
              (-RRB- -RRB-))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(concern-5, is_a-2)
amod(concern-5, major-3)
compound(concern-5, health-4)
nsubjpass(associated-9, concern-5)
amod(concern-5, worldwide-6)
cc(concern-5, and-7)
auxpass(associated-9, is-8)
root(ROOT-0, associated-9)
case(development-12, with-10)
det(development-12, the-11)
nmod:with(associated-9, development-12)
case(metabolic_disorders-14, of-13)
nmod:of(development-12, metabolic_disorders-14)
case(non-alcoholic_fatty_liver_disease-17, such-15)
mwe(such-15, as-16)
nmod:such_as(metabolic_disorders-14, non-alcoholic_fatty_liver_disease-17)
appos(development-12, NAFLD-19)

Inhibition/NNP of/IN Sonic_Hedgehog/NNP -LRB-/-LRB- SHH/NNP -RRB-/-RRB- signaling/VBG has_been/NN shown/VBN to/TO reduce/VB the/DT expression/NN of/IN key/JJ genes/NNS involved/VBN in/IN lipid/NN metabolism/NN ,/, such/JJ as/IN Pirfenidone/NNP synthase/JJ -LRB-/-LRB- Smad2_and_4/NNS -RRB-/-RRB- ,/, sterol_regulatory_element_binding_protein_1c/JJ -LRB-/-LRB- SREBP-1c/NNS -RRB-/-RRB- ,/, and_liver/NN X_receptor/NNP a/DT -LRB-/-LRB- LXRa/NNP -RRB-/-RRB- ./.

(ROOT
  (NP
    (NP
      (NP (NNP Inhibition))
      (PP (IN of)
        (NP (NNP Sonic_Hedgehog))))
    (PRN (-LRB- -LRB-)
      (NP (NNP SHH))
      (-RRB- -RRB-))
    (PP (VBG signaling)
      (NP
        (NP (NN has_been))
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN expression))
                  (PP (IN of)
                    (NP
                      (NP (JJ key) (NNS genes))
                      (VP (VBN involved)
                        (PP (IN in)
                          (NP (NN lipid) (NN metabolism)))))))))))))
    (, ,)
    (ADJP (JJ such)
      (PP (IN as)
        (NP
          (NP (NNP Pirfenidone))
          (NP (JJ synthase) (-LRB- -LRB-) (NNS Smad2_and_4) (-RRB- -RRB-)))))
    (, ,)
    (NP (JJ sterol_regulatory_element_binding_protein_1c) (-LRB- -LRB-) (NNS SREBP-1c) (-RRB- -RRB-))
    (, ,)
    (S
      (NP (NN and_liver))
      (VP (NNP X_receptor)
        (NP (DT a)
          (PRN (-LRB- -LRB-)
            (NP (NNP LXRa))
            (-RRB- -RRB-)))))
    (. .)))

root(ROOT-0, Inhibition-1)
case(Sonic_Hedgehog-3, of-2)
nmod:of(Inhibition-1, Sonic_Hedgehog-3)
appos(Inhibition-1, SHH-5)
case(has_been-8, signaling-7)
nmod:signaling(Inhibition-1, has_been-8)
acl(has_been-8, shown-9)
mark(reduce-11, to-10)
xcomp(shown-9, reduce-11)
det(expression-13, the-12)
dobj(reduce-11, expression-13)
case(genes-16, of-14)
amod(genes-16, key-15)
nmod:of(expression-13, genes-16)
acl(genes-16, involved-17)
case(metabolism-20, in-18)
compound(metabolism-20, lipid-19)
nmod:in(involved-17, metabolism-20)
amod(Inhibition-1, such-22)
case(Pirfenidone-24, as-23)
nmod:as(such-22, Pirfenidone-24)
amod(Smad2_and_4-27, synthase-25)
dep(Pirfenidone-24, Smad2_and_4-27)
amod(SREBP-1c-32, sterol_regulatory_element_binding_protein_1c-30)
appos(Inhibition-1, SREBP-1c-32)
nsubj(LXRa-39, and_liver-35)
dep(LXRa-39, X_receptor-36)
det(LXRa-39, a-37)
dep(Inhibition-1, LXRa-39)

However/RB ,/, the/DT effect/NN of/IN SHH/NNP inhibition/NN on/IN the/DT expression/NN of/IN genes/NNS involved/VBN in/IN lipid/NN metabolism/NN has/VBZ not/RB been/VBN fully/RB elucidated/VBN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP
          (NP (NNP SHH) (NN inhibition))
          (PP (IN on)
            (NP
              (NP (DT the) (NN expression))
              (PP (IN of)
                (NP
                  (NP (NNS genes))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP (NN lipid) (NN metabolism)))))))))))
    (VP (VBZ has) (RB not)
      (VP (VBN been)
        (VP
          (ADVP (RB fully))
          (VBN elucidated))))
    (. .)))

advmod(elucidated-21, However-1)
det(effect-4, the-3)
nsubjpass(elucidated-21, effect-4)
case(inhibition-7, of-5)
compound(inhibition-7, SHH-6)
nmod:of(effect-4, inhibition-7)
case(expression-10, on-8)
det(expression-10, the-9)
nmod:on(inhibition-7, expression-10)
case(genes-12, of-11)
nmod:of(expression-10, genes-12)
acl(genes-12, involved-13)
case(metabolism-16, in-14)
compound(metabolism-16, lipid-15)
nmod:in(involved-13, metabolism-16)
aux(elucidated-21, has-17)
neg(elucidated-21, not-18)
auxpass(elucidated-21, been-19)
advmod(elucidated-21, fully-20)
root(ROOT-0, elucidated-21)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN SHH/NNP inhibition/NN on/IN the/DT mRNA/JJ levels/NNS of/IN key/JJ genes/NNS involved/VBN in/IN lipid/NN metabolism/NN in/IN mice/NNS fed/VBN a/DT high-fat_diet/NN -LRB-/-LRB- HFD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NNP SHH) (NN inhibition))))
      (PP (IN on)
        (NP
          (NP (DT the) (JJ mRNA) (NNS levels))
          (PP (IN of)
            (NP
              (NP (JJ key) (NNS genes))
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP
                      (NP (NN lipid) (NN metabolism))
                      (PP (IN in)
                        (NP
                          (NP (NNS mice))
                          (VP (VBN fed)
                            (NP (DT a) (NN high-fat_diet))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP HFD))
                      (-RRB- -RRB-))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(inhibition-11, of-9)
compound(inhibition-11, SHH-10)
nmod:of(effect-8, inhibition-11)
case(levels-15, on-12)
det(levels-15, the-13)
amod(levels-15, mRNA-14)
nmod:on(investigated-6, levels-15)
case(genes-18, of-16)
amod(genes-18, key-17)
nmod:of(levels-15, genes-18)
acl(genes-18, involved-19)
case(metabolism-22, in-20)
compound(metabolism-22, lipid-21)
nmod:in(involved-19, metabolism-22)
case(mice-24, in-23)
nmod:in(metabolism-22, mice-24)
acl(mice-24, fed-25)
det(high-fat_diet-27, a-26)
dobj(fed-25, high-fat_diet-27)
appos(metabolism-22, HFD-29)

We/PRP found/VBD that/IN mice/NNS treated/VBN with/IN SMO/NNP ,/, an/DT inhibitor/NN of/IN SHH/NNP signaling/VBG ,/, had/VBD lower/JJR mRNA/NN levels/NNS of/IN sterol_regulatory_element_binding_protein_1c/JJ -LRB-/-LRB- SREBP-1c/NNS -RRB-/-RRB- ,/, Pirfenidone/NNP synthase/JJ -LRB-/-LRB- Smad2_and_4/NNS -RRB-/-RRB- ,/, and_liver/NN X_receptor/NNP a/DT -LRB-/-LRB- LXRa/NNP -RRB-/-RRB- ,/, but/CC higher/JJR peroxisome_proliferator-activated_receptor_a/NN -LRB-/-LRB- PPARa/NNP -RRB-/-RRB- compared/VBN to/TO mice/NNS fed/VBN an/DT HFD/NNP alone/RB ./.

(ROOT
  (S
    (S
      (NP (PRP We))
      (VP (VBD found)
        (SBAR (IN that)
          (S
            (NP
              (NP
                (NP (NNS mice))
                (VP (VBN treated)
                  (PP (IN with)
                    (NP (NNP SMO)))))
              (, ,)
              (NP
                (NP (DT an) (NN inhibitor))
                (PP (IN of)
                  (NP (NNP SHH) (VBG signaling))))
              (, ,))
            (VP (VBD had)
              (NP
                (NP
                  (NP (JJR lower) (NN mRNA) (NNS levels))
                  (PP (IN of)
                    (NP
                      (NP (JJ sterol_regulatory_element_binding_protein_1c) (-LRB- -LRB-) (NNS SREBP-1c) (-RRB- -RRB-))
                      (, ,)
                      (NP
                        (NP (NNP Pirfenidone))
                        (NP (JJ synthase) (-LRB- -LRB-) (NNS Smad2_and_4) (-RRB- -RRB-))))))
                (, ,)
                (NP
                  (NP (NN and_liver) (NNP X_receptor))
                  (NP (DT a)))
                (PRN (-LRB- -LRB-)
                  (NP (NNP LXRa))
                  (-RRB- -RRB-))))))))
    (, ,)
    (CC but)
    (S
      (NP
        (NP (JJR higher) (NN peroxisome_proliferator-activated_receptor_a))
        (PRN (-LRB- -LRB-)
          (NP (NNP PPARa))
          (-RRB- -RRB-)))
      (VP (VBN compared)
        (PP (TO to)
          (NP
            (NP (NNS mice))
            (VP (VBN fed)
              (S
                (NP (DT an) (NNP HFD))
                (ADVP (RB alone))))))))
    (. .)))

nsubj(found-2, We-1)
root(ROOT-0, found-2)
mark(had-15, that-3)
nsubj(had-15, mice-4)
acl(mice-4, treated-5)
case(SMO-7, with-6)
nmod:with(treated-5, SMO-7)
det(inhibitor-10, an-9)
appos(mice-4, inhibitor-10)
case(SHH-12, of-11)
nmod:of(inhibitor-10, SHH-12)
amod(SHH-12, signaling-13)
ccomp(found-2, had-15)
amod(levels-18, lower-16)
compound(levels-18, mRNA-17)
dobj(had-15, levels-18)
case(SREBP-1c-22, of-19)
amod(SREBP-1c-22, sterol_regulatory_element_binding_protein_1c-20)
nmod:of(levels-18, SREBP-1c-22)
appos(SREBP-1c-22, Pirfenidone-25)
amod(Smad2_and_4-28, synthase-26)
dep(Pirfenidone-25, Smad2_and_4-28)
compound(X_receptor-32, and_liver-31)
appos(levels-18, X_receptor-32)
dep(X_receptor-32, a-33)
appos(levels-18, LXRa-35)
cc(found-2, but-38)
amod(peroxisome_proliferator-activated_receptor_a-40, higher-39)
nsubj(compared-44, peroxisome_proliferator-activated_receptor_a-40)
appos(peroxisome_proliferator-activated_receptor_a-40, PPARa-42)
conj:but(found-2, compared-44)
case(mice-46, to-45)
nmod:to(compared-44, mice-46)
acl(mice-46, fed-47)
det(HFD-49, an-48)
xcomp(fed-47, HFD-49)
advmod(HFD-49, alone-50)

These/DT findings/NNS suggest/VBP that/IN SHH/NNP inhibition/NN may/MD have/VB therapeutic/JJ potential/NN for/IN the/DT treatment/NN of/IN NAFLD/NNP by/IN modulating/VBG key/JJ genes/NNS involved/VBN in/IN lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP SHH) (NN inhibition))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ therapeutic) (NN potential))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP (NNP NAFLD))))))
              (PP (IN by)
                (S
                  (VP (VBG modulating)
                    (NP
                      (NP (JJ key) (NNS genes))
                      (VP (VBN involved)
                        (PP (IN in)
                          (NP (NN lipid) (NN metabolism)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-8, that-4)
compound(inhibition-6, SHH-5)
nsubj(have-8, inhibition-6)
aux(have-8, may-7)
ccomp(suggest-3, have-8)
amod(potential-10, therapeutic-9)
dobj(have-8, potential-10)
case(treatment-13, for-11)
det(treatment-13, the-12)
nmod:for(potential-10, treatment-13)
case(NAFLD-15, of-14)
nmod:of(treatment-13, NAFLD-15)
mark(modulating-17, by-16)
advcl(have-8, modulating-17)
amod(genes-19, key-18)
dobj(modulating-17, genes-19)
acl(genes-19, involved-20)
case(metabolism-23, in-21)
compound(metabolism-23, lipid-22)
nmod:in(involved-20, metabolism-23)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN widely/RB studied/VBN for/IN their/PRP$ beneficial/JJ effects/NNS on/IN human/JJ health/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB widely))
          (VBN studied)
          (PP (IN for)
            (NP
              (NP (PRP$ their) (JJ beneficial) (NNS effects))
              (PP (IN on)
                (NP (JJ human) (NN health))))))))
    (. .)))

nsubjpass(studied-17, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(studied-17, have-14)
auxpass(studied-17, been-15)
advmod(studied-17, widely-16)
root(ROOT-0, studied-17)
case(effects-21, for-18)
nmod:poss(effects-21, their-19)
amod(effects-21, beneficial-20)
nmod:for(studied-17, effects-21)
case(health-24, on-22)
amod(health-24, human-23)
nmod:on(effects-21, health-24)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN EPA/NNP and/CC DHA/NNP are/VBP able/JJ to/TO reduce/VB serum/JJ Chromium/NNP levels/NNS in/IN hyperChromiummic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (VBP are)
              (ADJP (JJ able)
                (S
                  (VP (TO to)
                    (VP (VB reduce)
                      (NP
                        (NP (JJ serum) (NNP Chromium) (NNS levels))
                        (PP (IN in)
                          (NP (JJ hyperChromiummic) (NNS patients)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(able-10, that-5)
nsubj(able-10, EPA-6)
nsubj:xsubj(reduce-12, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
nsubj(able-10, DHA-8)
nsubj:xsubj(reduce-12, DHA-8)
cop(able-10, are-9)
ccomp(shown-4, able-10)
mark(reduce-12, to-11)
xcomp(able-10, reduce-12)
amod(levels-15, serum-13)
compound(levels-15, Chromium-14)
dobj(reduce-12, levels-15)
case(patients-18, in-16)
amod(patients-18, hyperChromiummic-17)
nmod:in(levels-15, patients-18)

In/IN addition/NN ,/, they/PRP have/VBP been/VBN shown/VBN to/TO have/VB a/DT protective/JJ effect/NN against/IN the/DT development/NN of/IN atherosclerosis/NNS in/IN experimental/JJ animals/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (PRP they))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (DT a) (JJ protective) (NN effect))
                  (PP (IN against)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP
                          (NP (NNS atherosclerosis))
                          (PP (IN in)
                            (NP (JJ experimental) (NNS animals))))))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(shown-7, addition-2)
nsubjpass(shown-7, they-4)
nsubj:xsubj(have-9, they-4)
aux(shown-7, have-5)
auxpass(shown-7, been-6)
root(ROOT-0, shown-7)
mark(have-9, to-8)
xcomp(shown-7, have-9)
det(effect-12, a-10)
amod(effect-12, protective-11)
dobj(have-9, effect-12)
case(development-15, against-13)
det(development-15, the-14)
nmod:against(effect-12, development-15)
case(atherosclerosis-17, of-16)
nmod:of(development-15, atherosclerosis-17)
case(animals-20, in-18)
amod(animals-20, experimental-19)
nmod:in(atherosclerosis-17, animals-20)

Additionally/RB ,/, they/PRP are/VBP also/RB associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (PRP they))
    (VP (VBP are)
      (ADVP (RB also))
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP
              (NP (DT a) (VBN decreased) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG developing)
                    (NP (NN coronary_heart_disease))))))
            (PRN (-LRB- -LRB-)
              (NP (NNP CHD))
              (-RRB- -RRB-))))))
    (. .)))

advmod(associated-6, Additionally-1)
nsubjpass(associated-6, they-3)
auxpass(associated-6, are-4)
advmod(associated-6, also-5)
root(ROOT-0, associated-6)
case(risk-10, with-7)
det(risk-10, a-8)
amod(risk-10, decreased-9)
nmod:with(associated-6, risk-10)
mark(developing-12, of-11)
acl(risk-10, developing-12)
dobj(developing-12, coronary_heart_disease-13)
appos(risk-10, CHD-15)

This/DT protective/JJ effect/NN is/VBZ thought/VBN to_be/JJ due/JJ to/TO their/PRP$ ability/NN to/TO reduce/VB inflammation/NN ,/, decrease/VB blood/NN triglyceride_levels/NNS ,/, and/CC improve/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP (DT This) (JJ protective) (NN effect))
    (VP (VBZ is)
      (VP (VBN thought)
        (ADVP (JJ to_be))
        (ADJP (JJ due)
          (PP (TO to)
            (NP (PRP$ their) (NN ability)
              (S
                (VP (TO to)
                  (VP
                    (VP (VB reduce)
                      (NP (NN inflammation)))
                    (, ,)
                    (VP (VB decrease)
                      (NP (NN blood) (NNS triglyceride_levels)))
                    (, ,)
                    (CC and)
                    (VP (VB improve)
                      (NP (JJ endothelial) (NN function)))))))))))
    (. .)))

det(effect-3, This-1)
amod(effect-3, protective-2)
nsubjpass(thought-5, effect-3)
auxpass(thought-5, is-4)
root(ROOT-0, thought-5)
advmod(thought-5, to_be-6)
xcomp(thought-5, due-7)
case(ability-10, to-8)
nmod:poss(ability-10, their-9)
nmod:to(due-7, ability-10)
mark(reduce-12, to-11)
acl(ability-10, reduce-12)
dobj(reduce-12, inflammation-13)
acl(ability-10, decrease-15)
conj:and(reduce-12, decrease-15)
compound(triglyceride_levels-17, blood-16)
dobj(decrease-15, triglyceride_levels-17)
cc(reduce-12, and-19)
acl(ability-10, improve-20)
conj:and(reduce-12, improve-20)
amod(function-22, endothelial-21)
dobj(improve-20, function-22)

Furthermore/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO have/VB antiarrhythmic/JJ effects/NNS and/CC may/MD also/RB reduce/VB the/DT risk/NN of/IN sudden_cardiac_death/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB have)
                  (NP (JJ antiarrhythmic) (NNS effects))))))))
      (CC and)
      (VP (MD may) (RB also)
        (VP (VB reduce)
          (NP
            (NP (DT the) (NN risk))
            (PP (IN of)
              (NP (NN sudden_cardiac_death)))))))
    (. .)))

advmod(shown-8, Furthermore-1)
nsubjpass(shown-8, EPA-3)
nsubj:xsubj(have-10, EPA-3)
nsubj(reduce-16, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(shown-8, DHA-5)
nsubj:xsubj(have-10, DHA-5)
aux(shown-8, have-6)
auxpass(shown-8, been-7)
root(ROOT-0, shown-8)
mark(have-10, to-9)
xcomp(shown-8, have-10)
amod(effects-12, antiarrhythmic-11)
dobj(have-10, effects-12)
cc(shown-8, and-13)
aux(reduce-16, may-14)
advmod(reduce-16, also-15)
conj:and(shown-8, reduce-16)
det(risk-18, the-17)
dobj(reduce-16, risk-18)
case(sudden_cardiac_death-20, of-19)
nmod:of(risk-18, sudden_cardiac_death-20)

Overall/RB ,/, these/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ approach/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC improving/VBG overall/JJ cardiovascular_health/NN in/IN hyperChromiummic/JJ patients/NNS ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT these) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (JJ dietary) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN approach))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG improving)
                        (NP
                          (NP (JJ overall) (NN cardiovascular_health))
                          (PP (IN in)
                            (NP (JJ hyperChromiummic) (NNS patients))))))))))))))
    (. .)))

advmod(suggest-5, Overall-1)
det(findings-4, these-3)
nsubj(suggest-5, findings-4)
root(ROOT-0, suggest-5)
mark(approach-17, that-6)
amod(intake-9, increasing-7)
amod(intake-9, dietary-8)
nsubj(approach-17, intake-9)
case(omega-3_fatty_acids-12, of-10)
amod(omega-3_fatty_acids-12, long-chain-11)
nmod:of(intake-9, omega-3_fatty_acids-12)
aux(approach-17, may-13)
cop(approach-17, be-14)
det(approach-17, a-15)
amod(approach-17, promising-16)
ccomp(suggest-5, approach-17)
mark(reducing-19, for-18)
acl(approach-17, reducing-19)
det(risk-21, the-20)
dobj(reducing-19, risk-21)
case(CHD-23, of-22)
nmod:of(risk-21, CHD-23)
cc(reducing-19, and-24)
acl(approach-17, improving-25)
conj:and(reducing-19, improving-25)
amod(cardiovascular_health-27, overall-26)
dobj(improving-25, cardiovascular_health-27)
case(patients-30, in-28)
amod(patients-30, hyperChromiummic-29)
nmod:in(cardiovascular_health-27, patients-30)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT pancreas/NN may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (DT the) (NN pancreas))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(play-9, that-5)
det(pancreas-7, the-6)
nsubj(play-9, pancreas-7)
aux(play-9, may-8)
ccomp(suggested-4, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
case(development-14, in-12)
det(development-14, the-13)
nmod:in(role-11, development-14)
case(obesity-16, of-15)
nmod:of(development-14, obesity-16)

The/DT effects/NNS of/IN high/JJ glucose/NN concentrations/NNS and/CC sizofiran/NN on/IN the/DT secretion/NN of/IN NK_and_LAK/NNP and_insulin/VBN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS were/VBD examined/VBN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS effects))
      (PP (IN of)
        (NP
          (NP (JJ high) (NN glucose) (NNS concentrations))
          (CC and)
          (NP
            (NP (NN sizofiran))
            (PP (IN on)
              (NP
                (NP (DT the) (NN secretion))
                (PP (IN of)
                  (NP
                    (NP (NNP NK_and_LAK))
                    (VP (VBN and_insulin)
                      (PP (IN by)
                        (NP
                          (NP (VBN isolated) (JJ perfused) (NN pancreata))
                          (PP (IN from)
                            (NP
                              (NP
                                (NP (NN genetically_obese))
                                (PRN (-LRB- -LRB-)
                                  (NP (NN fa/fa))
                                  (-RRB- -RRB-)))
                              (CC and)
                              (NP
                                (ADJP
                                  (ADJP (JJ lean))
                                  (PRN (-LRB- -LRB-)
                                    (FRAG
                                      (ADVP (RB Fa) (: /))
                                      (. ?))
                                    (-RRB- -RRB-)))
                                (NNS rats)))))))))))))))
    (VP (VBD were)
      (VP (VBN examined)))
    (. .)))

det(effects-2, The-1)
nsubjpass(examined-33, effects-2)
case(concentrations-6, of-3)
amod(concentrations-6, high-4)
compound(concentrations-6, glucose-5)
nmod:of(effects-2, concentrations-6)
cc(concentrations-6, and-7)
nmod:of(effects-2, sizofiran-8)
conj:and(concentrations-6, sizofiran-8)
case(secretion-11, on-9)
det(secretion-11, the-10)
nmod:on(sizofiran-8, secretion-11)
case(NK_and_LAK-13, of-12)
nmod:of(secretion-11, NK_and_LAK-13)
acl(NK_and_LAK-13, and_insulin-14)
case(pancreata-18, by-15)
amod(pancreata-18, isolated-16)
amod(pancreata-18, perfused-17)
nmod:by(and_insulin-14, pancreata-18)
case(genetically_obese-20, from-19)
nmod:from(pancreata-18, genetically_obese-20)
appos(genetically_obese-20, fa/fa-22)
cc(genetically_obese-20, and-24)
amod(rats-31, lean-25)
dep(lean-25, Fa-27)
nmod:from(pancreata-18, rats-31)
conj:and(genetically_obese-20, rats-31)
auxpass(examined-33, were-32)
root(ROOT-0, examined-33)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT pancreas/NN secretes/NNS natural_killer/VBP -LRB-/-LRB- NK/NNP -RRB-/-RRB- and/CC lymphokine-activated/JJ killer/NN -LRB-/-LRB- LAK/NNP -RRB-/-RRB- cells/NNS ,/, which/WDT play/VBP a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (DT the) (NN pancreas) (NNS secretes))
            (VP (VBP natural_killer)
              (NP
                (NP
                  (NP (-LRB- -LRB-) (NNP NK) (-RRB- -RRB-))
                  (CC and)
                  (NP (JJ lymphokine-activated) (NN killer)))
                (PRN (-LRB- -LRB-)
                  (NP (NNP LAK))
                  (-RRB- -RRB-))
                (NP
                  (NP (NNS cells))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (VBP play)
                        (NP
                          (NP (DT a) (NN role))
                          (PP (IN in)
                            (NP
                              (NP (DT the) (NN development))
                              (PP (IN of)
                                (NP (NN obesity))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(natural_killer-9, that-5)
det(secretes-8, the-6)
compound(secretes-8, pancreas-7)
nsubj(natural_killer-9, secretes-8)
ccomp(suggested-4, natural_killer-9)
dobj(natural_killer-9, NK-11)
cc(NK-11, and-13)
amod(killer-15, lymphokine-activated-14)
dobj(natural_killer-9, killer-15)
conj:and(NK-11, killer-15)
appos(NK-11, LAK-17)
dep(NK-11, cells-19)
nsubj(play-22, cells-19)
ref(cells-19, which-21)
acl:relcl(cells-19, play-22)
det(role-24, a-23)
dobj(play-22, role-24)
case(development-27, in-25)
det(development-27, the-26)
nmod:in(role-24, development-27)
case(obesity-29, of-28)
nmod:of(development-27, obesity-29)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN NK_and_LAK/NNP by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNP NK_and_LAK)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(NK_and_LAK-20, of-19)
nmod:of(hypersecretion-18, NK_and_LAK-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO accomplish/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ sizofiran/NN on/IN the/DT secretion/NN of/IN NK_and_LAK/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB accomplish)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN sizofiran)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNP NK_and_LAK) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(accomplish-2, To-1)
advcl(examined-6, accomplish-2)
dobj(accomplish-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(sizofiran-16, 10-14)
amod(sizofiran-16, mmol/L-15)
nmod:of(effects-8, sizofiran-16)
conj:and(glucose-12, sizofiran-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(and_insulin-22, of-20)
compound(and_insulin-22, NK_and_LAK-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(genetically_obese-28, from-27)
nmod:from(pancreata-26, genetically_obese-28)
appos(genetically_obese-28, fa/fa-30)
cc(genetically_obese-28, and-32)
amod(rats-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(pancreata-26, rats-39)
conj:and(genetically_obese-28, rats-39)

Our/PRP$ results/NNS showed/VBD that/IN both/DT NK_and_LAK/NNP secretion/NN were/VBD significantly/RB higher/JJR in/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS when/WRB stimulated/VBN with/IN high/JJ glucose/NN concentrations/NNS or/CC sizofiran/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (DT both) (NNP NK_and_LAK) (NN secretion))
          (VP (VBD were)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP (JJ obese) (NNS rats))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (SBAR
                      (WHADVP (WRB when))
                      (S
                        (VP (VBN stimulated)
                          (PP (IN with)
                            (NP
                              (NP (JJ high) (NN glucose) (NNS concentrations))
                              (CC or)
                              (NP (NN sizofiran)))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-14, that-4)
det(secretion-7, both-5)
compound(secretion-7, NK_and_LAK-6)
nsubjpass(compared-14, secretion-7)
nsubj:xsubj(lean-16, secretion-7)
auxpass(compared-14, were-8)
advmod(higher-10, significantly-9)
advmod(compared-14, higher-10)
case(rats-13, in-11)
amod(rats-13, obese-12)
nmod:in(higher-10, rats-13)
ccomp(showed-3, compared-14)
mark(lean-16, to-15)
xcomp(compared-14, lean-16)
dobj(lean-16, rats-17)
advmod(stimulated-19, when-18)
advcl(lean-16, stimulated-19)
case(concentrations-23, with-20)
amod(concentrations-23, high-21)
compound(concentrations-23, glucose-22)
nmod:with(stimulated-19, concentrations-23)
cc(concentrations-23, or-24)
nmod:with(stimulated-19, sizofiran-25)
conj:or(concentrations-23, sizofiran-25)

Furthermore/RB ,/, insulin_secretion/NN was/VBD also/RB significantly/RB higher/JJR in/IN obese/JJ rats/NNS than/IN in/IN lean/JJ rats/NNS under/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NN insulin_secretion))
    (VP (VBD was)
      (ADVP (RB also))
      (ADJP
        (ADJP (RB significantly) (JJR higher)
          (PP (IN in)
            (NP (JJ obese) (NNS rats))))
        (PP (IN than)
          (PP (IN in)
            (NP (JJ lean) (NNS rats)))))
      (PP (IN under)
        (NP (DT these) (NNS conditions))))
    (. .)))

advmod(higher-7, Furthermore-1)
nsubj(higher-7, insulin_secretion-3)
cop(higher-7, was-4)
advmod(higher-7, also-5)
advmod(higher-7, significantly-6)
root(ROOT-0, higher-7)
case(rats-10, in-8)
amod(rats-10, obese-9)
nmod:in(higher-7, rats-10)
case(rats-14, than-11)
case(rats-14, in-12)
amod(rats-14, lean-13)
nmod:in(higher-7, rats-14)
case(conditions-17, under-15)
det(conditions-17, these-16)
nmod:under(higher-7, conditions-17)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN NK_and_LAK/NNP by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN ,/, providing/VBG new/JJ insights/NNS into/IN potential/JJ therapeutic/JJ targets/NNS for/IN this/DT metabolic_disorder/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNP NK_and_LAK)))
            (PP (IN by)
              (NP (DT the) (NN pancreas))))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity)))))
                (, ,)
                (S
                  (VP (VBG providing)
                    (NP (JJ new) (NNS insights))
                    (PP (IN into)
                      (NP
                        (NP (JJ potential) (JJ therapeutic) (NNS targets))
                        (PP (IN for)
                          (NP (DT this) (NN metabolic_disorder)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-13, that-4)
nsubjpass(involved-13, hypersecretion-5)
case(NK_and_LAK-7, of-6)
nmod:of(hypersecretion-5, NK_and_LAK-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(hypersecretion-5, pancreas-10)
aux(involved-13, may-11)
auxpass(involved-13, be-12)
ccomp(suggest-3, involved-13)
case(development-16, in-14)
det(development-16, the-15)
nmod:in(involved-13, development-16)
case(obesity-18, of-17)
nmod:of(development-16, obesity-18)
xcomp(involved-13, providing-20)
amod(insights-22, new-21)
dobj(providing-20, insights-22)
case(targets-26, into-23)
amod(targets-26, potential-24)
amod(targets-26, therapeutic-25)
nmod:into(providing-20, targets-26)
case(metabolic_disorder-29, for-27)
det(metabolic_disorder-29, this-28)
nmod:for(targets-26, metabolic_disorder-29)

The/DT regulation/NN of/IN lactose/NN biosynthesis/VBZ is_a/JJ complex/JJ process/NN that/WDT involves/VBZ various/JJ signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN regulation))
      (PP (IN of)
        (NP (NN lactose))))
    (VP (VBZ biosynthesis)
      (NP
        (NP (JJ is_a) (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP (JJ various) (VBG signaling) (NNS pathways)))))))
    (. .)))

det(regulation-2, The-1)
nsubj(biosynthesis-5, regulation-2)
case(lactose-4, of-3)
nmod:of(regulation-2, lactose-4)
root(ROOT-0, biosynthesis-5)
amod(process-8, is_a-6)
amod(process-8, complex-7)
dobj(biosynthesis-5, process-8)
nsubj(involves-10, process-8)
ref(process-8, that-9)
acl:relcl(process-8, involves-10)
amod(pathways-13, various-11)
amod(pathways-13, signaling-12)
dobj(involves-10, pathways-13)

The/DT possible/JJ roles/NNS of/IN adenosine_3/NNS '/POS ,5/CD '_-/JJ cyclic_monophosphate/NN -LRB-/-LRB- cAMP/NN -RRB-/-RRB- and/CC guanosine_3/NNS '/POS ,5/CD '_-/CD cyclic_monophosphate/NN -LRB-/-LRB- cGMP/NN -RRB-/-RRB- and/CC of/IN pannarin/NN on/IN the/DT early/JJ effect/NN of/IN acid_1/NNS -LRB-/-LRB- PRL/NNP -RRB-/-RRB- on/IN lactose/JJ biosynthesis/NNS have/VBP been/VBN investigated/VBN in/IN cultured/JJ mammary_gland/JJ explants/NNS derived/VBN from/IN mice/NNS 12-14/CD days/NNS pregnant/JJ ./.

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP
            (NP (DT The) (JJ possible) (NNS roles))
            (PP (IN of)
              (NP
                (NP (NNS adenosine_3) (POS '))
                (CD ,5)
                (NX
                  (NX
                    (NX (JJ '_-) (NN cyclic_monophosphate))
                    (PRN (-LRB- -LRB-) (NN cAMP) (-RRB- -RRB-)))
                  (CC and)
                  (NX (NNS guanosine_3)))))
            (POS '))
          (QP (CD ,5) (CD '_-))
          (NN cyclic_monophosphate))
        (PRN (-LRB- -LRB-)
          (NP (NN cGMP))
          (-RRB- -RRB-)))
      (CC and)
      (NP
        (PP (IN of)
          (NP
            (NP (NN pannarin))
            (PP (IN on)
              (NP
                (NP (DT the) (JJ early) (NN effect))
                (PP (IN of)
                  (NP
                    (NP (NNS acid_1))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP PRL))
                      (-RRB- -RRB-))))))))
        (PP (IN on)
          (NP (JJ lactose) (NNS biosynthesis)))))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN investigated)
          (PP (IN in)
            (NP
              (NP (JJ cultured) (JJ mammary_gland) (NNS explants))
              (VP (VBN derived)
                (PP (IN from)
                  (NP
                    (NP (NNS mice))
                    (NP-TMP (CD 12-14) (NNS days))))
                (S
                  (ADJP (JJ pregnant)))))))))
    (. .)))

det(roles-3, The-1)
amod(roles-3, possible-2)
nmod:poss(cyclic_monophosphate-18, roles-3)
case(cyclic_monophosphate-9, of-4)
nmod:poss(cyclic_monophosphate-9, adenosine_3-5)
case(adenosine_3-5, '-6)
nummod(cyclic_monophosphate-9, ,5-7)
amod(cyclic_monophosphate-9, '_--8)
nmod:of(roles-3, cyclic_monophosphate-9)
dep(cyclic_monophosphate-9, cAMP-11)
cc(cyclic_monophosphate-9, and-13)
nmod:of(roles-3, guanosine_3-14)
conj:and(cyclic_monophosphate-9, guanosine_3-14)
case(roles-3, '-15)
compound('_--17, ,5-16)
nummod(cyclic_monophosphate-18, '_--17)
nsubjpass(investigated-39, cyclic_monophosphate-18)
appos(cyclic_monophosphate-18, cGMP-20)
cc(cyclic_monophosphate-18, and-22)
case(pannarin-24, of-23)
conj:and(cyclic_monophosphate-18, pannarin-24)
nsubjpass(investigated-39, pannarin-24)
case(effect-28, on-25)
det(effect-28, the-26)
amod(effect-28, early-27)
nmod:on(pannarin-24, effect-28)
case(acid_1-30, of-29)
nmod:of(effect-28, acid_1-30)
appos(acid_1-30, PRL-32)
case(biosynthesis-36, on-34)
amod(biosynthesis-36, lactose-35)
nmod:on(pannarin-24, biosynthesis-36)
aux(investigated-39, have-37)
auxpass(investigated-39, been-38)
root(ROOT-0, investigated-39)
case(explants-43, in-40)
amod(explants-43, cultured-41)
amod(explants-43, mammary_gland-42)
nmod:in(investigated-39, explants-43)
acl(explants-43, derived-44)
case(mice-46, from-45)
nmod:from(derived-44, mice-46)
nummod(days-48, 12-14-47)
nmod:tmod(mice-46, days-48)
xcomp(derived-44, pregnant-49)

Our/PRP$ results/NNS suggest/VBP that/IN cAMP/NN and/CC cGMP/NN may/MD play/VB a/DT role/NN in/IN the/DT early/JJ effect/NN of/IN PRL/NNP on/IN lactose/JJ biosynthesis/NNS ,/, as/IN their/PRP$ levels/NNS were/VBD increased/VBN upon/IN PRL/NNP treatment/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN cAMP)
            (CC and)
            (NN cGMP))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (JJ early) (NN effect))
                    (PP (IN of)
                      (NP (NNP PRL))))))
              (PP (IN on)
                (NP (JJ lactose) (NNS biosynthesis)))))))
      (, ,)
      (SBAR (IN as)
        (S
          (NP (PRP$ their) (NNS levels))
          (VP (VBD were)
            (VP (VBN increased)
              (PP (IN upon)
                (NP (NNP PRL) (NN treatment))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(play-9, that-4)
nsubj(play-9, cAMP-5)
cc(cAMP-5, and-6)
conj:and(cAMP-5, cGMP-7)
nsubj(play-9, cGMP-7)
aux(play-9, may-8)
ccomp(suggest-3, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
case(effect-15, in-12)
det(effect-15, the-13)
amod(effect-15, early-14)
nmod:in(role-11, effect-15)
case(PRL-17, of-16)
nmod:of(effect-15, PRL-17)
case(biosynthesis-20, on-18)
amod(biosynthesis-20, lactose-19)
nmod:on(play-9, biosynthesis-20)
mark(increased-26, as-22)
nmod:poss(levels-24, their-23)
nsubjpass(increased-26, levels-24)
auxpass(increased-26, were-25)
advcl(suggest-3, increased-26)
case(treatment-29, upon-27)
compound(treatment-29, PRL-28)
nmod:upon(increased-26, treatment-29)

Furthermore/RB ,/, pannarin/NN was/VBD found/VBN to/TO inhibit/VB the/DT PRL-induced/JJ increase/NN in/IN cAMP/NN and/CC cGMP/NN levels/NNS ,/, suggesting/VBG a/DT potential/JJ mechanism/NN for/IN its/PRP$ inhibitory/JJ effect/NN on/IN lactose/JJ biosynthesis/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NN pannarin))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP (VB inhibit)
              (NP
                (NP (DT the) (JJ PRL-induced) (NN increase))
                (PP (IN in)
                  (NP (NN cAMP)
                    (CC and)
                    (NN cGMP) (NNS levels)))))))
        (, ,)
        (S
          (VP (VBG suggesting)
            (NP
              (NP (DT a) (JJ potential) (NN mechanism))
              (PP (IN for)
                (NP
                  (NP (PRP$ its) (JJ inhibitory) (NN effect))
                  (PP (IN on)
                    (NP (JJ lactose) (NNS biosynthesis))))))))))
    (. .)))

advmod(found-5, Furthermore-1)
nsubjpass(found-5, pannarin-3)
nsubj:xsubj(inhibit-7, pannarin-3)
auxpass(found-5, was-4)
root(ROOT-0, found-5)
mark(inhibit-7, to-6)
xcomp(found-5, inhibit-7)
det(increase-10, the-8)
amod(increase-10, PRL-induced-9)
dobj(inhibit-7, increase-10)
case(levels-15, in-11)
compound(levels-15, cAMP-12)
cc(cAMP-12, and-13)
conj:and(cAMP-12, cGMP-14)
compound(levels-15, cGMP-14)
nmod:in(increase-10, levels-15)
xcomp(found-5, suggesting-17)
det(mechanism-20, a-18)
amod(mechanism-20, potential-19)
dobj(suggesting-17, mechanism-20)
case(effect-24, for-21)
nmod:poss(effect-24, its-22)
amod(effect-24, inhibitory-23)
nmod:for(mechanism-20, effect-24)
case(biosynthesis-27, on-25)
amod(biosynthesis-27, lactose-26)
nmod:on(effect-24, biosynthesis-27)

These/DT findings/NNS provide/VBP insight/NN into/IN the/DT complex/JJ regulatory/JJ mechanisms/NNS involved/VBN in/IN lactose/JJ biosynthesis/NNS and/CC may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/NN therapies/NNS for/IN lactation/NN disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP (NN insight))
        (PP (IN into)
          (NP
            (NP (DT the) (JJ complex) (JJ regulatory) (NNS mechanisms))
            (VP (VBN involved)
              (PP (IN in)
                (NP (JJ lactose) (NNS biosynthesis)))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (NN novel) (NNS therapies))
                    (PP (IN for)
                      (NP (NN lactation) (NNS disorders)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(have-16, findings-2)
root(ROOT-0, provide-3)
dobj(provide-3, insight-4)
case(mechanisms-9, into-5)
det(mechanisms-9, the-6)
amod(mechanisms-9, complex-7)
amod(mechanisms-9, regulatory-8)
nmod:into(provide-3, mechanisms-9)
acl(mechanisms-9, involved-10)
case(biosynthesis-13, in-11)
amod(biosynthesis-13, lactose-12)
nmod:in(involved-10, biosynthesis-13)
cc(provide-3, and-14)
aux(have-16, may-15)
conj:and(provide-3, have-16)
dobj(have-16, implications-17)
case(development-20, for-18)
det(development-20, the-19)
nmod:for(implications-17, development-20)
case(therapies-23, of-21)
compound(therapies-23, novel-22)
nmod:of(development-20, therapies-23)
case(disorders-26, for-24)
compound(disorders-26, lactation-25)
nmod:for(therapies-23, disorders-26)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ various) (NN health) (NNS benefits))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-24, omega-3_fatty_acids-2)
nsubj:xsubj(have-26, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(shown-24, have-22)
auxpass(shown-24, been-23)
root(ROOT-0, shown-24)
mark(have-26, to-25)
xcomp(shown-24, have-26)
amod(benefits-29, various-27)
compound(benefits-29, health-28)
dobj(have-26, benefits-29)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, are/VBP associated/VBN with/IN decreased/VBN glaucarubin/NN levels/NNS in/IN hyperglaucarubinmic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN associated)
          (PP (IN with)
            (NP (VBN decreased) (NN glaucarubin) (NNS levels)))
          (PP (IN in)
            (NP (JJ hyperglaucarubinmic) (NNS patients)))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(associated-23, omega-3_fatty_acids-2)
nsubjpass(decreased-32, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
auxpass(associated-23, are-22)
root(ROOT-0, associated-23)
case(levels-27, with-24)
amod(levels-27, decreased-25)
compound(levels-27, glaucarubin-26)
nmod:with(associated-23, levels-27)
case(patients-30, in-28)
amod(patients-30, hyperglaucarubinmic-29)
nmod:in(associated-23, patients-30)
cc(associated-23, and-31)
conj:and(associated-23, decreased-32)
dobj(decreased-32, risk-33)
case(coronary_heart_disease-36, of-34)
amod(coronary_heart_disease-36, developing-35)
nmod:of(risk-33, coronary_heart_disease-36)
appos(coronary_heart_disease-36, CHD-38)

The/DT mechanism/NN by/IN which/WDT EPA/NNP and/CC DHA/NNP reduce/VB glaucarubin/NN levels/NNS is/VBZ not/RB fully/RB understood/VBN ,/, but/CC it/PRP has_been/VBP proposed/VBN that/IN they/PRP may/MD modulate/VBP the/DT expression/NN of/IN genes/NNS involved/VBN in/IN bilirubin/NN metabolism/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN mechanism))
        (SBAR
          (WHPP (IN by)
            (WHNP (WDT which)))
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (VB reduce)
              (NP (NN glaucarubin) (NNS levels))))))
      (VP (VBZ is)
        (ADJP (RB not) (RB fully) (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBP has_been)
        (VP (VBN proposed)
          (SBAR (IN that)
            (S
              (NP (PRP they))
              (VP (MD may)
                (VP (VBP modulate)
                  (NP
                    (NP (DT the) (NN expression))
                    (PP (IN of)
                      (NP
                        (NP (NNS genes))
                        (VP (VBN involved)
                          (PP (IN in)
                            (NP (NN bilirubin) (NN metabolism))))))))))))))
    (. .)))

det(mechanism-2, The-1)
nmod:by(reduce-8, mechanism-2)
nsubjpass(understood-14, mechanism-2)
case(which-4, by-3)
ref(mechanism-2, which-4)
nsubj(reduce-8, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(reduce-8, DHA-7)
acl:relcl(mechanism-2, reduce-8)
compound(levels-10, glaucarubin-9)
dobj(reduce-8, levels-10)
auxpass(understood-14, is-11)
neg(understood-14, not-12)
advmod(understood-14, fully-13)
root(ROOT-0, understood-14)
cc(understood-14, but-16)
nsubj(has_been-18, it-17)
conj:but(understood-14, has_been-18)
dep(has_been-18, proposed-19)
mark(modulate-23, that-20)
nsubj(modulate-23, they-21)
aux(modulate-23, may-22)
ccomp(proposed-19, modulate-23)
det(expression-25, the-24)
dobj(modulate-23, expression-25)
case(genes-27, of-26)
nmod:of(expression-25, genes-27)
acl(genes-27, involved-28)
case(metabolism-31, in-29)
compound(metabolism-31, bilirubin-30)
nmod:in(involved-28, metabolism-31)

In/IN addition/NN ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO have/VB anti-inflammatory/JJ effects/NNS ,/, which/WDT may/MD contribute/VB to/TO their/PRP$ protective/JJ effects/NNS against/IN CHD/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (JJ anti-inflammatory) (NNS effects))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (MD may)
                        (VP (VB contribute)
                          (PP (TO to)
                            (NP
                              (NP (PRP$ their) (JJ protective) (NNS effects))
                              (PP (IN against)
                                (NP (NNP CHD))))))))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(shown-9, addition-2)
nsubjpass(shown-9, EPA-4)
nsubj:xsubj(have-11, EPA-4)
cc(EPA-4, and-5)
conj:and(EPA-4, DHA-6)
nsubjpass(shown-9, DHA-6)
nsubj:xsubj(have-11, DHA-6)
aux(shown-9, have-7)
auxpass(shown-9, been-8)
root(ROOT-0, shown-9)
mark(have-11, to-10)
xcomp(shown-9, have-11)
amod(effects-13, anti-inflammatory-12)
dobj(have-11, effects-13)
nsubj(contribute-17, effects-13)
ref(effects-13, which-15)
aux(contribute-17, may-16)
acl:relcl(effects-13, contribute-17)
case(effects-21, to-18)
nmod:poss(effects-21, their-19)
amod(effects-21, protective-20)
nmod:to(contribute-17, effects-21)
case(CHD-23, against-22)
nmod:against(effects-21, CHD-23)

Overall/RB ,/, these/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT potential/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC improving/VBG health/NN outcomes/NNS in/IN hyperglaucarubinmic/JJ patients/NNS ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT these) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ potential) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG improving)
                        (NP
                          (NP (NN health) (NNS outcomes))
                          (PP (IN in)
                            (NP (JJ hyperglaucarubinmic) (NNS patients))))))))))))))
    (. .)))

advmod(suggest-5, Overall-1)
det(findings-4, these-3)
nsubj(suggest-5, findings-4)
root(ROOT-0, suggest-5)
mark(strategy-16, that-6)
amod(intake-8, increasing-7)
nsubj(strategy-16, intake-8)
case(omega-3_fatty_acids-11, of-9)
amod(omega-3_fatty_acids-11, long-chain-10)
nmod:of(intake-8, omega-3_fatty_acids-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, a-14)
amod(strategy-16, potential-15)
ccomp(suggest-5, strategy-16)
mark(reducing-18, for-17)
acl(strategy-16, reducing-18)
det(risk-20, the-19)
dobj(reducing-18, risk-20)
case(CHD-22, of-21)
nmod:of(risk-20, CHD-22)
cc(reducing-18, and-23)
acl(strategy-16, improving-24)
conj:and(reducing-18, improving-24)
compound(outcomes-26, health-25)
dobj(improving-24, outcomes-26)
case(patients-29, in-27)
amod(patients-29, hyperglaucarubinmic-28)
nmod:in(outcomes-26, patients-29)

The/DT stimulatory/JJ effects/NNS of/IN Insulin/NNP -LRB-/-LRB- 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M/NNP -RRB-/-RRB- on/IN flumethasone/JJ levels/NNS were/VBD antagonized/VBN by/IN the/DT ETA_receptor/NNP antagonist/NNP BQ_123/NNP ,/,

(ROOT
  (S
    (NP
      (NP (DT The) (JJ stimulatory) (NNS effects))
      (PP (IN of)
        (NP
          (NP (NNP Insulin))
          (PRN (-LRB- -LRB-)
            (NP
              (NP
                (NP (CD 10))
                (PRN (-LRB- -LRB-)
                  (NP (CD -6))
                  (-RRB- -RRB-)))
              (NP (NNP M)))
            (-RRB- -RRB-))))
      (PP (IN on)
        (NP (JJ flumethasone) (NNS levels))))
    (VP (VBD were)
      (VP (VBN antagonized)
        (PP (IN by)
          (NP (DT the) (NNP ETA_receptor) (NNP antagonist) (NNP BQ_123)))))
    (, ,)))

det(effects-3, The-1)
amod(effects-3, stimulatory-2)
nsubjpass(antagonized-17, effects-3)
case(Insulin-5, of-4)
nmod:of(effects-3, Insulin-5)
dep(Insulin-5, 10-7)
appos(10-7, -6-9)
appos(10-7, M-11)
case(levels-15, on-13)
amod(levels-15, flumethasone-14)
nmod:on(effects-3, levels-15)
auxpass(antagonized-17, were-16)
root(ROOT-0, antagonized-17)
case(BQ_123-22, by-18)
det(BQ_123-22, the-19)
compound(BQ_123-22, ETA_receptor-20)
compound(BQ_123-22, antagonist-21)
nmod:by(antagonized-17, BQ_123-22)

2/CD x/SYM 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M/NNP ,/, and/CC the/DT ETB/NNP receptor/NN agonist/NN IRL_1620/NNP evoked/VBD only/RB a/DT weak/JJ increase/NN in/IN flumethasone/JJ levels/NNS ./.

(ROOT
  (S
    (ADVP
      (ADVP (CD 2))
      (SBAR
        (X (SYM x))
        (S
          (NP
            (NP (CD 10))
            (PRN (-LRB- -LRB-)
              (NP (CD -6))
              (-RRB- -RRB-)))
          (NP
            (NP (NNP M))
            (, ,)
            (CC and)
            (NP (DT the) (NNP ETB) (NN receptor) (NN agonist))))))
    (NP (NNP IRL_1620))
    (VP (VBD evoked)
      (NP
        (NP (RB only) (DT a) (JJ weak) (NN increase))
        (PP (IN in)
          (NP (JJ flumethasone) (NNS levels)))))
    (. .)))

advmod(evoked-15, 2-1)
dep(M-7, x-2)
dep(M-7, 10-3)
appos(10-3, -6-5)
advcl(2-1, M-7)
cc(M-7, and-9)
det(agonist-13, the-10)
compound(agonist-13, ETB-11)
compound(agonist-13, receptor-12)
advcl(2-1, agonist-13)
conj:and(M-7, agonist-13)
nsubj(evoked-15, IRL_1620-14)
root(ROOT-0, evoked-15)
advmod(increase-19, only-16)
det(increase-19, a-17)
amod(increase-19, weak-18)
dobj(evoked-15, increase-19)
case(levels-22, in-20)
amod(levels-22, flumethasone-21)
nmod:in(increase-19, levels-22)

Insulin/NNP is/VBZ known/VBN to/TO stimulate/VB the/DT secretion/NN of/IN glucocorticoids/NNS ,/, however/RB ,/, the/DT mechanism/NN underlying/VBG this/DT effect/NN is/VBZ not/RB fully/RB understood/VBN ./.

(ROOT
  (S
    (S
      (NP (NNP Insulin))
      (VP (VBZ is)
        (VP (VBN known)
          (S
            (VP (TO to)
              (VP (VB stimulate)
                (NP
                  (NP (DT the) (NN secretion))
                  (PP (IN of)
                    (NP (NNS glucocorticoids))))))))))
    (, ,)
    (S
      (ADVP (RB however))
      (, ,)
      (NP
        (NP (DT the) (NN mechanism))
        (VP (VBG underlying)
          (NP (DT this) (NN effect))))
      (VP (VBZ is)
        (ADJP (RB not) (RB fully) (VBN understood))))
    (. .)))

nsubjpass(known-3, Insulin-1)
nsubj:xsubj(stimulate-5, Insulin-1)
auxpass(known-3, is-2)
root(ROOT-0, known-3)
mark(stimulate-5, to-4)
xcomp(known-3, stimulate-5)
det(secretion-7, the-6)
dobj(stimulate-5, secretion-7)
case(glucocorticoids-9, of-8)
nmod:of(secretion-7, glucocorticoids-9)
advmod(understood-21, however-11)
det(mechanism-14, the-13)
nsubjpass(understood-21, mechanism-14)
acl(mechanism-14, underlying-15)
det(effect-17, this-16)
dobj(underlying-15, effect-17)
auxpass(understood-21, is-18)
neg(understood-21, not-19)
advmod(understood-21, fully-20)
parataxis(known-3, understood-21)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT role/NN of/IN endothelin/NN receptors/NNS in/IN modulating/VBG insulin-induced/JJ glucocorticoid/JJ secretion/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN role))
        (PP (IN of)
          (NP (NN endothelin) (NNS receptors))))
      (PP (IN in)
        (S
          (VP (VBG modulating)
            (NP (JJ insulin-induced) (JJ glucocorticoid) (NN secretion))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(role-8, the-7)
dobj(investigated-6, role-8)
case(receptors-11, of-9)
compound(receptors-11, endothelin-10)
nmod:of(role-8, receptors-11)
mark(modulating-13, in-12)
advcl(investigated-6, modulating-13)
amod(secretion-16, insulin-induced-14)
amod(secretion-16, glucocorticoid-15)
dobj(modulating-13, secretion-16)

Our/PRP$ results/NNS showed/VBD that/IN insulin/NN -LRB-/-LRB- 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M/NNP -RRB-/-RRB- significantly/RB increased/VBD flumethasone/JJ levels/NNS ,/, which/WDT was/VBD attenuated/VBN by/IN the/DT ETA_receptor/NNP antagonist/NNP BQ_123/NNP -LRB-/-LRB- 2/CD x/SYM 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN insulin))
            (PRN (-LRB- -LRB-)
              (NP
                (NP
                  (NP (CD 10))
                  (PRN (-LRB- -LRB-)
                    (NP (CD -6))
                    (-RRB- -RRB-)))
                (NP (NNP M)))
              (-RRB- -RRB-)))
          (ADVP (RB significantly))
          (VP (VBD increased)
            (NP
              (NP (JJ flumethasone) (NNS levels))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBD was)
                    (VP (VBN attenuated)
                      (PP (IN by)
                        (NP
                          (NP (DT the) (NNP ETA_receptor) (NNP antagonist) (NNP BQ_123))
                          (PRN (-LRB- -LRB-)
                            (NP
                              (NP
                                (NP
                                  (NP (CD 2))
                                  (SBAR
                                    (FRAG
                                      (X (SYM x))
                                      (NP (CD 10)))))
                                (PRN (-LRB- -LRB-)
                                  (NP (CD -6))
                                  (-RRB- -RRB-)))
                              (NP (NNP M)))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(increased-14, that-4)
nsubj(increased-14, insulin-5)
dep(insulin-5, 10-7)
appos(10-7, -6-9)
appos(10-7, M-11)
advmod(increased-14, significantly-13)
ccomp(showed-3, increased-14)
amod(levels-16, flumethasone-15)
dobj(increased-14, levels-16)
nsubjpass(attenuated-20, levels-16)
ref(levels-16, which-18)
auxpass(attenuated-20, was-19)
acl:relcl(levels-16, attenuated-20)
case(BQ_123-25, by-21)
det(BQ_123-25, the-22)
compound(BQ_123-25, ETA_receptor-23)
compound(BQ_123-25, antagonist-24)
nmod:by(attenuated-20, BQ_123-25)
dep(BQ_123-25, 2-27)
dep(10-29, x-28)
dep(2-27, 10-29)
appos(2-27, -6-31)
appos(2-27, M-33)

Additionally/RB ,/, the/DT ETB/NNP receptor/NN agonist/VBD IRL_1620/NNP only/RB elicited/VBD a/DT weak/JJ increase/NN in/IN flumethasone/JJ levels/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT the) (NNP ETB) (NN receptor))
    (VP (VBD agonist)
      (SBAR
        (S
          (NP (NNP IRL_1620))
          (ADVP (RB only))
          (VP (VBD elicited)
            (NP
              (NP (DT a) (JJ weak) (NN increase))
              (PP (IN in)
                (NP (JJ flumethasone) (NNS levels))))))))
    (. .)))

advmod(agonist-6, Additionally-1)
det(receptor-5, the-3)
compound(receptor-5, ETB-4)
nsubj(agonist-6, receptor-5)
root(ROOT-0, agonist-6)
nsubj(elicited-9, IRL_1620-7)
advmod(elicited-9, only-8)
ccomp(agonist-6, elicited-9)
det(increase-12, a-10)
amod(increase-12, weak-11)
dobj(elicited-9, increase-12)
case(levels-15, in-13)
amod(levels-15, flumethasone-14)
nmod:in(increase-12, levels-15)

These/DT findings/NNS suggest/VBP that/IN insulin-induced/JJ glucocorticoid/JJ secretion/NN may/MD be/VB mediated/VBN by/IN ETA/NNP receptors/NNS and/CC that/IN ETB/NNP receptors/NNS may/MD have/VB a/DT limited/JJ role/NN in/IN this/DT process/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR
        (SBAR (IN that)
          (S
            (NP (JJ insulin-induced) (JJ glucocorticoid) (NN secretion))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN mediated)
                  (PP (IN by)
                    (NP (NNP ETA) (NNS receptors))))))))
        (CC and)
        (SBAR (IN that)
          (S
            (NP (NNP ETB) (NNS receptors))
            (VP (MD may)
              (VP (VB have)
                (NP
                  (NP (DT a) (JJ limited) (NN role))
                  (PP (IN in)
                    (NP (DT this) (NN process))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(mediated-10, that-4)
amod(secretion-7, insulin-induced-5)
amod(secretion-7, glucocorticoid-6)
nsubjpass(mediated-10, secretion-7)
aux(mediated-10, may-8)
auxpass(mediated-10, be-9)
ccomp(suggest-3, mediated-10)
case(receptors-13, by-11)
compound(receptors-13, ETA-12)
nmod:by(mediated-10, receptors-13)
cc(mediated-10, and-14)
mark(have-19, that-15)
compound(receptors-17, ETB-16)
nsubj(have-19, receptors-17)
aux(have-19, may-18)
ccomp(suggest-3, have-19)
conj:and(mediated-10, have-19)
det(role-22, a-20)
amod(role-22, limited-21)
dobj(have-19, role-22)
case(process-25, in-23)
det(process-25, this-24)
nmod:in(role-22, process-25)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO elucidate/VB the/DT exact/JJ mechanism/NN underlying/VBG insulin-mediated/JJ glucocorticoid/JJ secretion/NN and/CC its/PRP$ potential/JJ implications/NNS for/IN various/JJ physiological/JJ processes/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (JJ exact) (NN mechanism))
                (PP (VBG underlying)
                  (NP
                    (NP (JJ insulin-mediated) (JJ glucocorticoid) (NN secretion))
                    (CC and)
                    (NP
                      (NP (PRP$ its) (JJ potential) (NNS implications))
                      (PP (IN for)
                        (NP (JJ various) (JJ physiological) (NNS processes))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(elucidate-6, to-5)
xcomp(warranted-4, elucidate-6)
det(mechanism-9, the-7)
amod(mechanism-9, exact-8)
dobj(elucidate-6, mechanism-9)
case(secretion-13, underlying-10)
amod(secretion-13, insulin-mediated-11)
amod(secretion-13, glucocorticoid-12)
nmod:underlying(mechanism-9, secretion-13)
cc(secretion-13, and-14)
nmod:poss(implications-17, its-15)
amod(implications-17, potential-16)
nmod:underlying(mechanism-9, implications-17)
conj:and(secretion-13, implications-17)
case(processes-21, for-18)
amod(processes-21, various-19)
amod(processes-21, physiological-20)
nmod:for(implications-17, processes-21)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ numerous) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(have-18, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(have-18, to-17)
xcomp(shown-16, have-18)
amod(benefits-21, numerous-19)
compound(benefits-21, health-20)
dobj(have-18, benefits-21)

EPA/NNP and/CC DHA/NNP intake/NN has_been/VBP associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG prostate_cancer/NN ./.

(ROOT
  (S
    (NP
      (ADJP (NNP EPA)
        (CC and)
        (NNP DHA))
      (NN intake))
    (VP (VBP has_been)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (DT a) (VBN decreased) (NN risk))
            (PP (IN of)
              (S
                (VP (VBG developing)
                  (NP (NN prostate_cancer)))))))))
    (. .)))

amod(intake-4, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
amod(intake-4, DHA-3)
nsubj(has_been-5, intake-4)
root(ROOT-0, has_been-5)
dep(has_been-5, associated-6)
case(risk-10, with-7)
det(risk-10, a-8)
amod(risk-10, decreased-9)
nmod:with(associated-6, risk-10)
mark(developing-12, of-11)
acl(risk-10, developing-12)
dobj(developing-12, prostate_cancer-13)

Dietary/JJ intake/NN of/IN omega-3s/JJ has/VBZ also/RB been/VBN linked/VBN to/TO decreased/VBN serum/JJ azaserine/JJ levels/NNS in/IN hyperazaserinemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Dietary) (NN intake))
      (PP (IN of)
        (NP (JJ omega-3s))))
    (VP (VBZ has) (RB also)
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP (VBN decreased) (JJ serum) (JJ azaserine) (NNS levels))
              (PP (IN in)
                (NP (JJ hyperazaserinemic) (NNS patients))))))))
    (. .)))

amod(intake-2, Dietary-1)
nsubjpass(linked-8, intake-2)
case(omega-3s-4, of-3)
nmod:of(intake-2, omega-3s-4)
aux(linked-8, has-5)
advmod(linked-8, also-6)
auxpass(linked-8, been-7)
root(ROOT-0, linked-8)
case(levels-13, to-9)
amod(levels-13, decreased-10)
amod(levels-13, serum-11)
amod(levels-13, azaserine-12)
nmod:to(linked-8, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperazaserinemic-15)
nmod:in(levels-13, patients-16)

In/IN addition/NN ,/, EPA/NNP has_been/NN found/VBD to/TO reduce/VB the/DT risk/NN of/IN prostate_cancer/NN in/IN patients/NNS with/IN prostate_cancer/NN ,/, as/RB well/RB as/IN in/IN those/DT without/IN prostate_cancer/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (NNP EPA) (NN has_been))
    (VP (VBD found)
      (S
        (VP (TO to)
          (VP (VB reduce)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP
                  (NP (NN prostate_cancer))
                  (PP (IN in)
                    (NP (NNS patients))))))
            (PP (IN with)
              (NP
                (NP (NN prostate_cancer))
                (, ,)
                (ADVP (RB as) (RB well)
                  (PP (IN as)
                    (PP (IN in)
                      (NP (DT those)))))))
            (PP (IN without)
              (NP (NN prostate_cancer)))))))
    (. .)))

case(addition-2, In-1)
nmod:in(found-6, addition-2)
compound(has_been-5, EPA-4)
nsubj(found-6, has_been-5)
nsubj:xsubj(reduce-8, has_been-5)
root(ROOT-0, found-6)
mark(reduce-8, to-7)
xcomp(found-6, reduce-8)
det(risk-10, the-9)
dobj(reduce-8, risk-10)
case(prostate_cancer-12, of-11)
nmod:of(risk-10, prostate_cancer-12)
case(patients-14, in-13)
nmod:in(prostate_cancer-12, patients-14)
case(prostate_cancer-16, with-15)
nmod:with(reduce-8, prostate_cancer-16)
advmod(well-19, as-18)
advmod(prostate_cancer-16, well-19)
case(those-22, as-20)
case(those-22, in-21)
nmod:in(well-19, those-22)
case(prostate_cancer-24, without-23)
nmod:without(reduce-8, prostate_cancer-24)

Additionally/RB ,/, EPA/NNP and/CC DHA/NNP intake/NN has_been/NN linked/VBD to/TO a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP
      (UCP (NNP EPA)
        (CC and)
        (NNP DHA))
      (NN intake) (NN has_been))
    (VP (VBD linked)
      (PP (TO to)
        (NP
          (NP
            (NP (DT a) (VBN decreased) (NN risk))
            (PP (IN of)
              (S
                (VP (VBG developing)
                  (NP (NN coronary_heart_disease))))))
          (PRN (-LRB- -LRB-)
            (NP (NNP CHD))
            (-RRB- -RRB-)))))
    (. .)))

advmod(linked-8, Additionally-1)
compound(has_been-7, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
compound(has_been-7, DHA-5)
compound(has_been-7, intake-6)
nsubj(linked-8, has_been-7)
root(ROOT-0, linked-8)
case(risk-12, to-9)
det(risk-12, a-10)
amod(risk-12, decreased-11)
nmod:to(linked-8, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, coronary_heart_disease-15)
appos(risk-12, CHD-17)

Mechanisms/NNPS for/IN the/DT cardioprotective/JJ effects/NNS of/IN omega-3s/JJ include/VBP anti-inflammatory/JJ properties/NNS ,/, improved/JJ lipid/NN profiles/NNS ,/, and/CC reduced/VBN platelet_aggregation/NN ./.

(ROOT
  (S
    (NP
      (NP (NNPS Mechanisms))
      (PP (IN for)
        (NP
          (NP (DT the) (JJ cardioprotective) (NNS effects))
          (PP (IN of)
            (NP (JJ omega-3s))))))
    (VP (VBP include)
      (NP
        (NP (JJ anti-inflammatory) (NNS properties))
        (, ,)
        (NP (JJ improved) (NN lipid) (NNS profiles))
        (, ,)
        (CC and)
        (NP (VBN reduced) (NN platelet_aggregation))))
    (. .)))

nsubj(include-8, Mechanisms-1)
case(effects-5, for-2)
det(effects-5, the-3)
amod(effects-5, cardioprotective-4)
nmod:for(Mechanisms-1, effects-5)
case(omega-3s-7, of-6)
nmod:of(effects-5, omega-3s-7)
root(ROOT-0, include-8)
amod(properties-10, anti-inflammatory-9)
dobj(include-8, properties-10)
amod(profiles-14, improved-12)
compound(profiles-14, lipid-13)
dobj(include-8, profiles-14)
conj:and(properties-10, profiles-14)
cc(properties-10, and-16)
amod(platelet_aggregation-18, reduced-17)
dobj(include-8, platelet_aggregation-18)
conj:and(properties-10, platelet_aggregation-18)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC preventing/VBG certain/JJ types/NNS of/IN cancer/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (JJ dietary) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG preventing)
                        (NP
                          (NP (JJ certain) (NNS types))
                          (PP (IN of)
                            (NP (NN cancer))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-16, that-4)
csubj(strategy-16, increasing-5)
amod(intake-7, dietary-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, an-14)
amod(strategy-16, effective-15)
ccomp(suggest-3, strategy-16)
mark(reducing-18, for-17)
acl(strategy-16, reducing-18)
det(risk-20, the-19)
dobj(reducing-18, risk-20)
case(CHD-22, of-21)
nmod:of(risk-20, CHD-22)
cc(reducing-18, and-23)
acl(strategy-16, preventing-24)
conj:and(reducing-18, preventing-24)
amod(types-26, certain-25)
dobj(preventing-24, types-26)
case(cancer-28, of-27)
nmod:of(types-26, cancer-28)

The/DT identification/NN of/IN reliable/JJ biomarkers/NNS for/IN the/DT diagnosis/NN and/CC prognosis/NN of/IN cancer/NN is/VBZ of/IN great/JJ importance/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN identification))
      (PP (IN of)
        (NP
          (NP (JJ reliable) (NNS biomarkers))
          (PP (IN for)
            (NP
              (NP (DT the) (NN diagnosis)
                (CC and)
                (NN prognosis))
              (PP (IN of)
                (NP (NN cancer))))))))
    (VP (VBZ is)
      (PP (IN of)
        (NP (JJ great) (NN importance))))
    (. .)))

det(identification-2, The-1)
nsubj(importance-16, identification-2)
case(biomarkers-5, of-3)
amod(biomarkers-5, reliable-4)
nmod:of(identification-2, biomarkers-5)
case(diagnosis-8, for-6)
det(diagnosis-8, the-7)
nmod:for(biomarkers-5, diagnosis-8)
cc(diagnosis-8, and-9)
nmod:for(biomarkers-5, prognosis-10)
conj:and(diagnosis-8, prognosis-10)
case(cancer-12, of-11)
nmod:of(diagnosis-8, cancer-12)
cop(importance-16, is-13)
case(importance-16, of-14)
amod(importance-16, great-15)
root(ROOT-0, importance-16)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- ALP/NNP -RRB-/-RRB- ,/, polychlorinated_biphenyls/NNS -LRB-/-LRB- PCBs/NNS -RRB-/-RRB- ,/, and/CC serum/JJ CyclinE/JJ levels/NNS in/IN patients/NNS with/IN cancer/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN correlation))
        (PP (IN between)
          (NP
            (NP
              (NP
                (NP (NN serum) (NNS levels))
                (PP (IN of)
                  (NP (NN alkaline_phosphatase))))
              (PRN (-LRB- -LRB-)
                (NP (NNP ALP))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NNS polychlorinated_biphenyls))
              (-LRB- -LRB-)
              (NP (NNS PCBs))
              (-RRB- -RRB-))
            (, ,)
            (CC and)
            (NP
              (NP (JJ serum) (JJ CyclinE) (NNS levels))
              (PP (IN in)
                (NP
                  (NP (NNS patients))
                  (PP (IN with)
                    (NP (NN cancer))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(correlation-8, the-7)
dobj(investigated-6, correlation-8)
case(levels-11, between-9)
compound(levels-11, serum-10)
nmod:between(correlation-8, levels-11)
case(alkaline_phosphatase-13, of-12)
nmod:of(levels-11, alkaline_phosphatase-13)
appos(levels-11, ALP-15)
nmod:between(correlation-8, polychlorinated_biphenyls-18)
conj:and(levels-11, polychlorinated_biphenyls-18)
dep(polychlorinated_biphenyls-18, PCBs-20)
cc(levels-11, and-23)
amod(levels-26, serum-24)
amod(levels-26, CyclinE-25)
nmod:between(correlation-8, levels-26)
conj:and(levels-11, levels-26)
case(patients-28, in-27)
nmod:in(levels-26, patients-28)
case(cancer-30, with-29)
nmod:with(patients-28, cancer-30)

Our/PRP$ results/NNS showed/VBD a/DT significant/JJ positive/JJ correlation/NN between/IN serum/NN levels/NNS of/IN ALP/NNP -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- and/CC PCBs/NNS -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- with/IN serum/NN CyclinE/NNP levels/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (JJ positive) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP
                  (NP (NNP ALP))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.3)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-)))
                (CC and)
                (NP
                  (NP (NNS PCBs))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.42)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-))))))))
      (PP (IN with)
        (NP (NN serum) (NNP CyclinE) (NNS levels))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(correlation-7, a-4)
amod(correlation-7, significant-5)
amod(correlation-7, positive-6)
dobj(showed-3, correlation-7)
case(levels-10, between-8)
compound(levels-10, serum-9)
nmod:between(correlation-7, levels-10)
case(ALP-12, of-11)
nmod:of(levels-10, ALP-12)
dep(<-19, r-14)
dep(0.3-16, =-15)
dep(<-19, 0.3-16)
nsubj(<-19, p-18)
dep(ALP-12, <-19)
dobj(<-19, 0.01-20)
cc(ALP-12, and-22)
nmod:of(levels-10, PCBs-23)
conj:and(ALP-12, PCBs-23)
dep(<-30, r-25)
dep(0.42-27, =-26)
dep(<-30, 0.42-27)
nsubj(<-30, p-29)
dep(PCBs-23, <-30)
dobj(<-30, 0.01-31)
case(levels-36, with-33)
compound(levels-36, serum-34)
compound(levels-36, CyclinE-35)
nmod:with(showed-3, levels-36)

These/DT findings/NNS suggest/VBP that/IN ALP/NNP and/CC PCBs/NNS may/MD play/VB a/DT role/NN in/IN the/DT development/NN and/CC progression/NN of/IN cancer/NN by/IN influencing/VBG CyclinE/JJ expression/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP ALP)
            (CC and)
            (NNS PCBs))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development)
                      (CC and)
                      (NN progression))
                    (PP (IN of)
                      (NP (NN cancer))))))
              (PP (IN by)
                (S
                  (VP (VBG influencing)
                    (NP (JJ CyclinE) (NN expression))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-9, that-4)
nsubj(play-9, ALP-5)
cc(ALP-5, and-6)
conj:and(ALP-5, PCBs-7)
nsubj(play-9, PCBs-7)
aux(play-9, may-8)
ccomp(suggest-3, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
case(development-14, in-12)
det(development-14, the-13)
nmod:in(role-11, development-14)
cc(development-14, and-15)
nmod:in(role-11, progression-16)
conj:and(development-14, progression-16)
case(cancer-18, of-17)
nmod:of(development-14, cancer-18)
mark(influencing-20, by-19)
advcl(play-9, influencing-20)
amod(expression-22, CyclinE-21)
dobj(influencing-20, expression-22)

There/EX was/VBD a/DT correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/RB less/JJR than/IN 0.01/CD -RRB-/-RRB- ,/, PCB/NNP -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/VBP less/JJR than/IN 0.01/CD -RRB-/-RRB- and/CC serum/NN CyclinE/NNP levels/NNS ./.

(ROOT
  (S
    (NP (EX There))
    (VP
      (VP (VBD was)
        (NP
          (NP (DT a) (NN correlation))
          (PP (IN between)
            (NP
              (NP (NN serum) (NNS levels))
              (PP (IN of)
                (NP (NN alkaline_phosphatase)))))))
      (PRN (-LRB- -LRB-)
        (SBAR
          (X
            (X (SYM r))
            (NP (SYM =)))
          (S
            (NP
              (NP (CD 0.3))
              (PRN (, ,)
                (ADVP (RB p))
                (NP
                  (QP (JJR less) (IN than) (CD 0.01)))
                (-RRB- -RRB-))
              (, ,)
              (NP
                (NP (NNP PCB))
                (-LRB- -LRB-)
                (NP
                  (FRAG
                    (X
                      (X (SYM r))
                      (NP (SYM =)))
                    (NP (CD 0.42)))))
              (, ,))
            (VP (VBP p)
              (NP
                (QP (JJR less) (IN than) (CD 0.01))))))
        (-RRB- -RRB-))
      (CC and)
      (VP (NN serum)
        (NP (NNP CyclinE) (NNS levels))))
    (. .)))

expl(correlation-4, There-1)
cop(correlation-4, was-2)
det(correlation-4, a-3)
root(ROOT-0, correlation-4)
case(levels-7, between-5)
compound(levels-7, serum-6)
nmod:between(correlation-4, levels-7)
case(alkaline_phosphatase-9, of-8)
nmod:of(levels-7, alkaline_phosphatase-9)
dep(=-12, r-11)
dep(p-27, =-12)
nsubj(p-27, 0.3-13)
dep(0.01-18, p-15)
advmod(0.01-18, less-16)
mwe(less-16, than-17)
dep(0.3-13, 0.01-18)
appos(0.3-13, PCB-21)
dep(=-24, r-23)
dep(0.42-25, =-24)
dep(PCB-21, 0.42-25)
parataxis(correlation-4, p-27)
advmod(0.01-30, less-28)
mwe(less-28, than-29)
dobj(p-27, 0.01-30)
cc(correlation-4, and-32)
conj:and(correlation-4, serum-33)
compound(levels-35, CyclinE-34)
nsubj(correlation-4, levels-35)

Obesity/NNP is_a/VBZ growing/VBG public_health/JJ concern/NN worldwide/RB ,/, and/CC there/EX is_a/RB need/VBP to/TO understand/VB the/DT underlying/VBG mechanisms/NNS that/WDT contribute/VBP to/TO its/PRP$ development/NN ./.

(ROOT
  (S
    (S
      (NP (NNP Obesity))
      (VP (VBZ is_a)
        (VP (VBG growing)
          (NP (JJ public_health) (NN concern))
          (ADVP (RB worldwide)))))
    (, ,)
    (CC and)
    (S
      (NP (EX there))
      (ADVP (RB is_a))
      (VP (VBP need)
        (S
          (VP (TO to)
            (VP (VB understand)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (VBP contribute)
                      (PP (TO to)
                        (NP (PRP$ its) (NN development))))))))))))
    (. .)))

nsubj(is_a-2, Obesity-1)
nsubj(need-11, Obesity-1)
nsubj:xsubj(understand-13, Obesity-1)
root(ROOT-0, is_a-2)
xcomp(is_a-2, growing-3)
amod(concern-5, public_health-4)
dobj(growing-3, concern-5)
advmod(growing-3, worldwide-6)
cc(is_a-2, and-8)
expl(need-11, there-9)
advmod(need-11, is_a-10)
conj:and(is_a-2, need-11)
mark(understand-13, to-12)
xcomp(need-11, understand-13)
det(mechanisms-16, the-14)
amod(mechanisms-16, underlying-15)
dobj(understand-13, mechanisms-16)
nsubj(contribute-18, mechanisms-16)
ref(mechanisms-16, that-17)
acl:relcl(mechanisms-16, contribute-18)
case(development-21, to-19)
nmod:poss(development-21, its-20)
nmod:to(contribute-18, development-21)

Previous/JJ studies/NNS have/VBP shown/VBN that/IN 5-hydroxytryptamine/JJ type/NN 2B/CD -LRB-/-LRB- 5-HT2B/CD -RRB-/-RRB- receptors/NNS are/VBP involved/VBN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Previous) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ 5-hydroxytryptamine) (NN type) (CD 2B))
              (PRN (-LRB- -LRB-)
                (NP (CD 5-HT2B))
                (-RRB- -RRB-))
              (NNS receptors))
            (VP (VBP are)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity)))))))))))
    (. .)))

amod(studies-2, Previous-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(involved-14, that-5)
amod(type-7, 5-hydroxytryptamine-6)
compound(receptors-12, type-7)
nummod(type-7, 2B-8)
appos(receptors-12, 5-HT2B-10)
nsubjpass(involved-14, receptors-12)
auxpass(involved-14, are-13)
ccomp(shown-4, involved-14)
case(development-17, in-15)
det(development-17, the-16)
nmod:in(involved-14, development-17)
case(obesity-19, of-18)
nmod:of(development-17, obesity-19)

To/TO evaluate/VB this/DT relationship/NN ,/, we/PRP conducted/VBD an/DT experiment/NN using/VBG isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/JJ -LRB-/-LRB- fa/fa/NNS -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- subjects/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP (DT this) (NN relationship)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD conducted)
      (NP
        (NP (DT an) (NN experiment))
        (VP (VBG using)
          (VP (VBN isolated)
            (NP (JJ perfused) (NN pancreata))
            (PP (IN from)
              (NP
                (NP (JJ genetically_obese) (-LRB- -LRB-) (NNS fa/fa) (-RRB- -RRB-))
                (CC and)
                (NP
                  (ADJP
                    (ADJP (JJ lean))
                    (PRN (-LRB- -LRB-)
                      (FRAG
                        (ADVP (RB Fa) (: /))
                        (. ?))
                      (-RRB- -RRB-)))
                  (NNS subjects))))))))
    (. .)))

mark(evaluate-2, To-1)
advcl(conducted-7, evaluate-2)
det(relationship-4, this-3)
dobj(evaluate-2, relationship-4)
nsubj(conducted-7, we-6)
root(ROOT-0, conducted-7)
det(experiment-9, an-8)
dobj(conducted-7, experiment-9)
acl(experiment-9, using-10)
dep(using-10, isolated-11)
amod(pancreata-13, perfused-12)
dobj(isolated-11, pancreata-13)
case(fa/fa-17, from-14)
amod(fa/fa-17, genetically_obese-15)
nmod:from(isolated-11, fa/fa-17)
cc(fa/fa-17, and-19)
amod(subjects-26, lean-20)
dep(lean-20, Fa-22)
nmod:from(isolated-11, subjects-26)
conj:and(fa/fa-17, subjects-26)

We/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ SB_200646/NN on/IN the/DT secretion/NN of/IN 5-HT2B/CD and_insulin/NN ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN SB_200646)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (CD 5-HT2B) (NN and_insulin))))))
    (. .)))

nsubj(examined-2, We-1)
root(ROOT-0, examined-2)
det(effects-4, the-3)
dobj(examined-2, effects-4)
case(glucose-8, of-5)
nummod(glucose-8, 16.7-6)
amod(glucose-8, mmol/L-7)
nmod:of(effects-4, glucose-8)
cc(glucose-8, and-9)
nummod(SB_200646-12, 10-10)
amod(SB_200646-12, mmol/L-11)
nmod:of(effects-4, SB_200646-12)
conj:and(glucose-8, SB_200646-12)
case(secretion-15, on-13)
det(secretion-15, the-14)
nmod:on(examined-2, secretion-15)
case(and_insulin-18, of-16)
nummod(and_insulin-18, 5-HT2B-17)
nmod:of(secretion-15, and_insulin-18)

Our/PRP$ results/NNS showed/VBD that/IN there/EX was/VBD a/DT significant/JJ increase/NN in/IN the/DT secretion/NN of/IN 5-HT2B/CD in/IN response/NN to/TO glucose/NN stimulation/NN in/IN both/DT obese/NN and/CC lean/JJ subjects/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (VBD was)
            (NP
              (NP (DT a) (JJ significant) (NN increase))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN secretion))
                  (PP (IN of)
                    (NP (CD 5-HT2B))))))
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP (NN glucose) (NN stimulation)))))
            (PP (IN in)
              (NP
                (NP (DT both) (NN obese))
                (CC and)
                (NP (JJ lean) (NNS subjects))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(was-6, that-4)
expl(was-6, there-5)
ccomp(showed-3, was-6)
det(increase-9, a-7)
amod(increase-9, significant-8)
nsubj(was-6, increase-9)
case(secretion-12, in-10)
det(secretion-12, the-11)
nmod:in(increase-9, secretion-12)
case(5-HT2B-14, of-13)
nmod:of(secretion-12, 5-HT2B-14)
case(response-16, in-15)
nmod:in(was-6, response-16)
case(stimulation-19, to-17)
compound(stimulation-19, glucose-18)
nmod:to(response-16, stimulation-19)
case(obese-22, in-20)
det(obese-22, both-21)
nmod:in(was-6, obese-22)
cc(obese-22, and-23)
amod(subjects-25, lean-24)
nmod:in(was-6, subjects-25)
conj:and(obese-22, subjects-25)

However/RB ,/, the/DT magnitude/NN of/IN this/DT increase/NN was/VBD significantly/RB greater/JJR in/IN obese/JJ subjects/NNS compared/VBN to/TO lean/VB subjects/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN magnitude))
      (PP (IN of)
        (NP (DT this) (NN increase))))
    (VP (VBD was)
      (ADVP
        (ADVP (RB significantly) (JJR greater))
        (PP (IN in)
          (NP (JJ obese) (NNS subjects))))
      (VP (VBN compared)
        (S
          (VP (TO to)
            (VP (VB lean)
              (NP (NNS subjects)))))))
    (. .)))

advmod(compared-14, However-1)
det(magnitude-4, the-3)
nsubjpass(compared-14, magnitude-4)
nsubj:xsubj(lean-16, magnitude-4)
case(increase-7, of-5)
det(increase-7, this-6)
nmod:of(magnitude-4, increase-7)
auxpass(compared-14, was-8)
advmod(greater-10, significantly-9)
advmod(compared-14, greater-10)
case(subjects-13, in-11)
amod(subjects-13, obese-12)
nmod:in(greater-10, subjects-13)
root(ROOT-0, compared-14)
mark(lean-16, to-15)
xcomp(compared-14, lean-16)
dobj(lean-16, subjects-17)

Additionally/RB ,/, treatment/NN with/IN SB_200646/NNP significantly/RB reduced/VBD the/DT secretion/NN of/IN 5-HT2B/CD in/IN both/DT groups/NNS ,/, but/CC again/RB ,/, this/DT effect/NN was/VBD more/RBR pronounced/VBN in/IN obese/JJ subjects/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (S
      (NP
        (NP (NN treatment))
        (PP (IN with)
          (NP (NNP SB_200646))))
      (ADVP (RB significantly))
      (VP (VBD reduced)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (CD 5-HT2B))))
        (PP (IN in)
          (NP (DT both) (NNS groups)))))
    (, ,)
    (CC but)
    (S
      (ADVP (RB again))
      (, ,)
      (NP (DT this) (NN effect))
      (VP (VBD was)
        (VP
          (ADVP (RBR more))
          (VBN pronounced)
          (PP (IN in)
            (NP (JJ obese) (NNS subjects))))))
    (. .)))

advmod(reduced-7, Additionally-1)
nsubj(reduced-7, treatment-3)
case(SB_200646-5, with-4)
nmod:with(treatment-3, SB_200646-5)
advmod(reduced-7, significantly-6)
root(ROOT-0, reduced-7)
det(secretion-9, the-8)
dobj(reduced-7, secretion-9)
case(5-HT2B-11, of-10)
nmod:of(secretion-9, 5-HT2B-11)
case(groups-14, in-12)
det(groups-14, both-13)
nmod:in(reduced-7, groups-14)
cc(reduced-7, but-16)
advmod(pronounced-23, again-17)
det(effect-20, this-19)
nsubjpass(pronounced-23, effect-20)
auxpass(pronounced-23, was-21)
advmod(pronounced-23, more-22)
conj:but(reduced-7, pronounced-23)
case(subjects-26, in-24)
amod(subjects-26, obese-25)
nmod:in(pronounced-23, subjects-26)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN 5-HT2B/CD by/IN the/DT pancreas/NN may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ,/, and/CC targeting/VBG this/DT pathway/NN may/MD be/VB a/DT potential/JJ therapeutic/JJ strategy/NN for/IN managing/VBG this/DT condition/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (NP
              (NP (NN hypersecretion))
              (PP (IN of)
                (NP (CD 5-HT2B)))
              (PP (IN by)
                (NP (DT the) (NN pancreas))))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity)))))))))
          (, ,)
          (CC and)
          (S
            (S
              (VP (VBG targeting)
                (NP (DT this) (NN pathway))))
            (VP (MD may)
              (VP (VB be)
                (NP (DT a) (JJ potential) (JJ therapeutic) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG managing)
                      (NP (DT this) (NN condition)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-12, that-4)
nsubj(play-12, hypersecretion-5)
case(5-HT2B-7, of-6)
nmod:of(hypersecretion-5, 5-HT2B-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(hypersecretion-5, pancreas-10)
aux(play-12, may-11)
ccomp(suggest-3, play-12)
det(role-14, a-13)
dobj(play-12, role-14)
case(development-17, in-15)
det(development-17, the-16)
nmod:in(role-14, development-17)
case(obesity-19, of-18)
nmod:of(development-17, obesity-19)
cc(play-12, and-21)
csubj(strategy-30, targeting-22)
det(pathway-24, this-23)
dobj(targeting-22, pathway-24)
aux(strategy-30, may-25)
cop(strategy-30, be-26)
det(strategy-30, a-27)
amod(strategy-30, potential-28)
amod(strategy-30, therapeutic-29)
ccomp(suggest-3, strategy-30)
conj:and(play-12, strategy-30)
mark(managing-32, for-31)
advcl(strategy-30, managing-32)
det(condition-34, this-33)
dobj(managing-32, condition-34)

The/DT aim/NN of/IN this/DT study/NN was/VBD to/TO determine/VB whether/IN bosentan/NN reduced/VBD the/DT risk/NN of/IN Oculogyric_crises/NNP ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN aim))
      (PP (IN of)
        (NP (DT this) (NN study))))
    (VP (VBD was)
      (S
        (VP (TO to)
          (VP (VB determine)
            (SBAR (IN whether)
              (S
                (NP (NN bosentan))
                (VP (VBD reduced)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP
                        (NP (NNP Oculogyric_crises))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))))))))))
    (. .)))

det(aim-2, The-1)
nsubj(was-6, aim-2)
nsubj:xsubj(determine-8, aim-2)
case(study-5, of-3)
det(study-5, this-4)
nmod:of(aim-2, study-5)
root(ROOT-0, was-6)
mark(determine-8, to-7)
xcomp(was-6, determine-8)
mark(reduced-11, whether-9)
nsubj(reduced-11, bosentan-10)
ccomp(determine-8, reduced-11)
det(risk-13, the-12)
dobj(reduced-11, risk-13)
case(Oculogyric_crises-15, of-14)
nmod:of(risk-13, Oculogyric_crises-15)
nmod:of(risk-13, photophobia-17)
conj:and(Oculogyric_crises-15, photophobia-17)
cc(Oculogyric_crises-15, and-19)
nmod:of(risk-13, phonophobia-20)
conj:and(Oculogyric_crises-15, phonophobia-20)

A/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ ,/, crossover/NN trial/NN was/VBD conducted/VBN in/IN healthy/JJ volunteers/NNS -LRB-/-LRB- n/VB =/SYM 100/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT A)
      (ADJP
        (ADJP (JJ randomized))
        (, ,)
        (ADJP (JJ double-blind))
        (, ,)
        (ADJP (JJ placebo-controlled))
        (, ,))
      (NN crossover) (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN in)
          (NP (JJ healthy) (NNS volunteers)))
        (PRN (-LRB- -LRB-)
          (S
            (VP (VB n)
              (FRAG
                (X (SYM =))
                (NP (CD 100)))))
          (-RRB- -RRB-))))
    (. .)))

det(trial-9, A-1)
amod(trial-9, randomized-2)
dep(randomized-2, double-blind-4)
dep(randomized-2, placebo-controlled-6)
compound(trial-9, crossover-8)
nsubjpass(conducted-11, trial-9)
auxpass(conducted-11, was-10)
root(ROOT-0, conducted-11)
case(volunteers-14, in-12)
amod(volunteers-14, healthy-13)
nmod:in(conducted-11, volunteers-14)
parataxis(conducted-11, n-16)
dep(100-18, =-17)
dep(n-16, 100-18)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, bosentan/NN significantly/RB reduced/VBD the/DT risk/NN of/IN oculogyric_crises/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP
              (NP (CD 2) (NNS hours))
              (PP (IN after)
                (NP (VBG dosing)))))
          (, ,)
          (NP (NN bosentan))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS oculogyric_crises))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(hours-7, at-5)
nummod(hours-7, 2-6)
nmod:at(reduced-13, hours-7)
case(dosing-9, after-8)
nmod:after(hours-7, dosing-9)
nsubj(reduced-13, bosentan-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(oculogyric_crises-17, of-16)
nmod:of(risk-15, oculogyric_crises-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN bosentan/NN may/MD be/VB a/DT potential/JJ therapeutic/JJ option/NN for/IN individuals/NNS suffering/VBG from/IN these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN bosentan))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ potential) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (VP (VBG suffering)
                      (PP (IN from)
                        (NP (DT these) (NNS symptoms))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, bosentan-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, potential-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
acl(individuals-13, suffering-14)
case(symptoms-17, from-15)
det(symptoms-17, these-16)
nmod:from(suffering-14, symptoms-17)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO determine/VB the/DT long-term/JJ efficacy/NN and/CC safety/NN of/IN bosentan/NN in/IN managing/VBG these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (DT the) (JJ long-term) (NN efficacy)
                  (CC and)
                  (NN safety))
                (PP (IN of)
                  (NP (NN bosentan)))))))
        (PP (IN in)
          (S
            (VP (VBG managing)
              (NP (DT these) (NNS conditions)))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(determine-6, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(determine-6, to-5)
xcomp(warranted-4, determine-6)
det(efficacy-9, the-7)
amod(efficacy-9, long-term-8)
dobj(determine-6, efficacy-9)
cc(efficacy-9, and-10)
dobj(determine-6, safety-11)
conj:and(efficacy-9, safety-11)
case(bosentan-13, of-12)
nmod:of(efficacy-9, bosentan-13)
mark(managing-15, in-14)
advcl(warranted-4, managing-15)
det(conditions-17, these-16)
dobj(managing-15, conditions-17)

To/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN CEA/NNP by/IN the/DT pancreas/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD micromol/L/NN Muscimol/NNP on/IN the/DT secretion/NN of/IN CCA/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- mice/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP
            (NP (DT the) (NN relationship))
            (PP (IN between)
              (NP
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity))))
                (CC and)
                (NP
                  (NP (DT the) (NN hypersecretion))
                  (PP (IN of)
                    (NP (NNP CEA)))))))
          (PP (IN by)
            (NP (DT the) (NN pancreas))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (NN micromol/L) (NNP Muscimol)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNP CCA) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS mice)))))))
    (. .)))

mark(evaluate-2, To-1)
advcl(examined-20, evaluate-2)
det(relationship-4, the-3)
dobj(evaluate-2, relationship-4)
case(development-7, between-5)
det(development-7, the-6)
nmod:between(relationship-4, development-7)
case(obesity-9, of-8)
nmod:of(development-7, obesity-9)
cc(development-7, and-10)
det(hypersecretion-12, the-11)
nmod:between(relationship-4, hypersecretion-12)
conj:and(development-7, hypersecretion-12)
case(CEA-14, of-13)
nmod:of(hypersecretion-12, CEA-14)
case(pancreas-17, by-15)
det(pancreas-17, the-16)
nmod:by(evaluate-2, pancreas-17)
nsubj(examined-20, we-19)
root(ROOT-0, examined-20)
det(effects-22, the-21)
dobj(examined-20, effects-22)
case(glucose-26, of-23)
nummod(glucose-26, 16.7-24)
amod(glucose-26, mmol/L-25)
nmod:of(effects-22, glucose-26)
cc(glucose-26, and-27)
nummod(Muscimol-30, 10-28)
compound(Muscimol-30, micromol/L-29)
nmod:of(effects-22, Muscimol-30)
conj:and(glucose-26, Muscimol-30)
case(secretion-33, on-31)
det(secretion-33, the-32)
nmod:on(examined-20, secretion-33)
case(and_insulin-36, of-34)
compound(and_insulin-36, CCA-35)
nmod:of(secretion-33, and_insulin-36)
case(pancreata-40, by-37)
amod(pancreata-40, isolated-38)
amod(pancreata-40, perfused-39)
nmod:by(examined-20, pancreata-40)
case(genetically_obese-42, from-41)
nmod:from(pancreata-40, genetically_obese-42)
appos(genetically_obese-42, fa/fa-44)
cc(genetically_obese-42, and-46)
amod(mice-53, lean-47)
dep(lean-47, Fa-49)
nmod:from(pancreata-40, mice-53)
conj:and(genetically_obese-42, mice-53)

The/DT role/NN of/IN the/DT pancreatic/JJ beta-cell/NN in/IN the/DT pathogenesis/NNS of/IN obesity/NN remains/VBZ unclear/JJ ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN role))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ pancreatic) (NN beta-cell))
          (PP (IN in)
            (NP
              (NP (DT the) (NNS pathogenesis))
              (PP (IN of)
                (NP (NN obesity))))))))
    (VP (VBZ remains)
      (ADJP (JJ unclear)))
    (. .)))

det(role-2, The-1)
nsubj(remains-12, role-2)
case(beta-cell-6, of-3)
det(beta-cell-6, the-4)
amod(beta-cell-6, pancreatic-5)
nmod:of(role-2, beta-cell-6)
case(pathogenesis-9, in-7)
det(pathogenesis-9, the-8)
nmod:in(beta-cell-6, pathogenesis-9)
case(obesity-11, of-10)
nmod:of(pathogenesis-9, obesity-11)
root(ROOT-0, remains-12)
xcomp(remains-12, unclear-13)

The/DT results/NNS of/IN this/DT study/NN showed/VBD that/IN the/DT levels/NNS of/IN carcinoembryonic_antigen/JJ -LRB-/-LRB- CEA/NNP -RRB-/-RRB- and_insulin/NN secreted/VBN by/IN the/DT beta-cells/NNS were/VBD significantly/RB higher/JJR in/IN the/DT obese/JJ -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- mice/NNS than/IN in/IN the/DT lean/JJ -LRB-/-LRB- Fa/NNP //: ?/. -RRB-/-RRB- mice/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS results))
      (PP (IN of)
        (NP (DT this) (NN study))))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NNS levels))
            (PP (IN of)
              (NP
                (NP (JJ carcinoembryonic_antigen)
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CEA))
                    (-RRB- -RRB-))
                  (NN and_insulin))
                (VP (VBN secreted)
                  (PP (IN by)
                    (NP (DT the) (NNS beta-cells)))))))
          (VP (VBD were)
            (ADJP
              (ADJP (RB significantly) (JJR higher)
                (PP (IN in)
                  (NP (DT the) (JJ obese)
                    (PRN (-LRB- -LRB-)
                      (NP (NN fa/fa))
                      (-RRB- -RRB-))
                    (NNS mice))))
              (PP (IN than)
                (PP (IN in)
                  (NP (DT the) (JJ lean)
                    (PRN (-LRB- -LRB-)
                      (FRAG
                        (SBAR
                          (S
                            (VP
                              (S
                                (NP (NNP Fa))))
                            (: /)))
                        (. ?))
                      (-RRB- -RRB-))
                    (NNS mice)))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-6, results-2)
case(study-5, of-3)
det(study-5, this-4)
nmod:of(results-2, study-5)
root(ROOT-0, showed-6)
mark(higher-22, that-7)
det(levels-9, the-8)
nsubj(higher-22, levels-9)
case(and_insulin-15, of-10)
amod(and_insulin-15, carcinoembryonic_antigen-11)
appos(and_insulin-15, CEA-13)
nmod:of(levels-9, and_insulin-15)
acl(and_insulin-15, secreted-16)
case(beta-cells-19, by-17)
det(beta-cells-19, the-18)
nmod:by(secreted-16, beta-cells-19)
cop(higher-22, were-20)
advmod(higher-22, significantly-21)
ccomp(showed-6, higher-22)
case(mice-29, in-23)
det(mice-29, the-24)
amod(mice-29, obese-25)
appos(mice-29, fa/fa-27)
nmod:in(higher-22, mice-29)
case(mice-39, than-30)
case(mice-39, in-31)
det(mice-39, the-32)
amod(mice-39, lean-33)
dep(mice-39, Fa-35)
nmod:in(higher-22, mice-39)

However/RB ,/, the/DT insulin/NN secretory/JJ responses/NNS to/TO the/DT two/CD stimuli/NNS were/VBD not/RB significantly/RB different/JJ between/IN the/DT two/CD groups/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN insulin) (JJ secretory) (NNS responses))
      (PP (TO to)
        (NP (DT the) (CD two) (NNS stimuli))))
    (VP (VBD were) (RB not)
      (ADJP (RB significantly) (JJ different)
        (PP (IN between)
          (NP (DT the) (CD two) (NNS groups)))))
    (. .)))

advmod(different-14, However-1)
det(responses-6, the-3)
compound(responses-6, insulin-4)
amod(responses-6, secretory-5)
nsubj(different-14, responses-6)
case(stimuli-10, to-7)
det(stimuli-10, the-8)
nummod(stimuli-10, two-9)
nmod:to(responses-6, stimuli-10)
cop(different-14, were-11)
neg(different-14, not-12)
advmod(different-14, significantly-13)
root(ROOT-0, different-14)
case(groups-18, between-15)
det(groups-18, the-16)
nummod(groups-18, two-17)
nmod:between(different-14, groups-18)

These/DT results/NNS suggest/VBP that/IN pancreatic/JJ CEA/NN may/MD play/VB an/DT important/JJ role/NN in/IN the/DT development/NN and/CC progression/NN of/IN obesity/NN ,/, providing/VBG new/JJ insights/NNS into/IN the/DT pathophysiology/NN of/IN obesity-related/JJ insulin_resistance/NN and/CC diabetes_mellitus/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (JJ pancreatic) (NN CEA))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development)
                      (CC and)
                      (NN progression))
                    (PP (IN of)
                      (NP (NN obesity))))))))))
      (, ,)
      (S
        (VP (VBG providing)
          (NP (JJ new) (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (NN pathophysiology))
              (PP (IN of)
                (NP (JJ obesity-related) (NN insulin_resistance)
                  (CC and)
                  (NNS diabetes_mellitus))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(play-8, that-4)
amod(CEA-6, pancreatic-5)
nsubj(play-8, CEA-6)
aux(play-8, may-7)
ccomp(suggest-3, play-8)
det(role-11, an-9)
amod(role-11, important-10)
dobj(play-8, role-11)
case(development-14, in-12)
det(development-14, the-13)
nmod:in(role-11, development-14)
cc(development-14, and-15)
nmod:in(role-11, progression-16)
conj:and(development-14, progression-16)
case(obesity-18, of-17)
nmod:of(development-14, obesity-18)
xcomp(suggest-3, providing-20)
amod(insights-22, new-21)
dobj(providing-20, insights-22)
case(pathophysiology-25, into-23)
det(pathophysiology-25, the-24)
nmod:into(providing-20, pathophysiology-25)
case(insulin_resistance-28, of-26)
amod(insulin_resistance-28, obesity-related-27)
nmod:of(pathophysiology-25, insulin_resistance-28)
cc(insulin_resistance-28, and-29)
nmod:of(pathophysiology-25, diabetes_mellitus-30)
conj:and(insulin_resistance-28, diabetes_mellitus-30)

Previous/JJ studies/NNS have/VBP shown/VBN that/IN the/DT reduction/NN in/IN CBF_and_MBF/NNP after/IN administration/NN of/IN propentofylline/NN was/VBD attenuated/VBN during/IN low-intensity/JJ exercise/NN -LRB-/-LRB- P/NNP </CD 0.001/CD -RRB-/-RRB- and/CC abolished/VBN during/IN high-intensity/NN -LRB-/-LRB- P/NNP =/SYM not/RB significant/JJ -RRB-/-RRB- exercise/NN ./.

(ROOT
  (S
    (NP (JJ Previous) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP
                (NP (DT the) (NN reduction))
                (PP (IN in)
                  (NP (NNP CBF_and_MBF)))
                (SBAR (IN after)
                  (S
                    (NP
                      (NP (NN administration))
                      (PP (IN of)
                        (NP (NN propentofylline))))
                    (VP (VBD was)
                      (VP
                        (VP (VBN attenuated)
                          (PP (IN during)
                            (NP (JJ low-intensity) (NN exercise))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP P)
                            (QP (CD <) (CD 0.001)))
                          (-RRB- -RRB-))
                        (CC and)
                        (VP (VBN abolished)
                          (PP (IN during)
                            (NP (NN high-intensity)))))))))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNP P))
                  (SBAR
                    (FRAG
                      (X (SYM =))
                      (NP (RB not) (JJ significant)))))
                (-RRB- -RRB-)))
            (VP (NN exercise))))))
    (. .)))

amod(studies-2, Previous-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(exercise-34, that-5)
det(reduction-7, the-6)
nsubj(exercise-34, reduction-7)
case(CBF_and_MBF-9, in-8)
nmod:in(reduction-7, CBF_and_MBF-9)
mark(attenuated-15, after-10)
nsubjpass(attenuated-15, administration-11)
nsubjpass(abolished-25, administration-11)
case(propentofylline-13, of-12)
nmod:of(administration-11, propentofylline-13)
auxpass(attenuated-15, was-14)
acl(reduction-7, attenuated-15)
case(exercise-18, during-16)
amod(exercise-18, low-intensity-17)
nmod:during(attenuated-15, exercise-18)
dep(attenuated-15, P-20)
compound(0.001-22, <-21)
nummod(P-20, 0.001-22)
cc(attenuated-15, and-24)
acl(reduction-7, abolished-25)
conj:and(attenuated-15, abolished-25)
case(high-intensity-27, during-26)
nmod:during(abolished-25, high-intensity-27)
dep(reduction-7, P-29)
dep(significant-32, =-30)
neg(significant-32, not-31)
dep(P-29, significant-32)
ccomp(shown-4, exercise-34)

However/RB ,/, the/DT impact/NN of/IN exercise/NN on/IN these/DT effects/NNS has/VBZ not/RB been/VBN fully/RB explored/VBN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN impact))
      (PP (IN of)
        (NP (NN exercise)))
      (PP (IN on)
        (NP (DT these) (NNS effects))))
    (VP (VBZ has) (RB not)
      (VP (VBN been)
        (VP
          (ADVP (RB fully))
          (VBN explored))))
    (. .)))

advmod(explored-14, However-1)
det(impact-4, the-3)
nsubjpass(explored-14, impact-4)
case(exercise-6, of-5)
nmod:of(impact-4, exercise-6)
case(effects-9, on-7)
det(effects-9, these-8)
nmod:on(impact-4, effects-9)
aux(explored-14, has-10)
neg(explored-14, not-11)
auxpass(explored-14, been-12)
advmod(explored-14, fully-13)
root(ROOT-0, explored-14)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN low-intensity/JJ and/CC high-intensity/JJ exercise/NN on/IN the/DT reduction/NN in/IN CBF_and_MBF/NNP after/IN administration/NN of/IN propentofylline/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (ADJP (JJ low-intensity)
              (CC and)
              (JJ high-intensity))
            (NN exercise))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN reduction))
          (PP (IN in)
            (NP (NNP CBF_and_MBF)))))
      (PP (IN after)
        (NP
          (NP (NN administration))
          (PP (IN of)
            (NP (NN propentofylline))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(exercise-13, of-9)
amod(exercise-13, low-intensity-10)
cc(low-intensity-10, and-11)
conj:and(low-intensity-10, high-intensity-12)
amod(exercise-13, high-intensity-12)
nmod:of(effect-8, exercise-13)
case(reduction-16, on-14)
det(reduction-16, the-15)
nmod:on(investigated-6, reduction-16)
case(CBF_and_MBF-18, in-17)
nmod:in(reduction-16, CBF_and_MBF-18)
case(administration-20, after-19)
nmod:after(investigated-6, administration-20)
case(propentofylline-22, of-21)
nmod:of(administration-20, propentofylline-22)

Our/PRP$ results/NNS showed/VBD that/IN the/DT reduction/NN in/IN CBF_and_MBF/NNP was/VBD attenuated/VBN during/IN low-intensity/JJ exercise/NN -LRB-/-LRB- -5/CD %/NN ,/, P/NNP </NNP 0.001/CD -RRB-/-RRB- and/CC abolished/VBN during/IN high-intensity/JJ exercise/NN -LRB-/-LRB- -3/CD %/NN ,/, P/NNP =/SYM not/RB significant/JJ -RRB-/-RRB- ,/, where/WRB PaCO2/NNS decreased/VBD 7/CD %/NN -LRB-/-LRB- P/NNP </VBP 0.05/CD -RRB-/-RRB- and/CC CMRO2/NNP increased/VBD 17/CD %/NN -LRB-/-LRB- P/NNP </CD 0.05/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (S
      (NP (PRP$ Our) (NNS results))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN reduction))
              (PP (IN in)
                (NP (NNP CBF_and_MBF))))
            (VP (VBD was)
              (VP
                (VP (VBN attenuated)
                  (PP (IN during)
                    (NP
                      (NP (JJ low-intensity) (NN exercise))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (CD -5) (NN %))
                          (, ,)
                          (NP (NNP P) (NNP <) (CD 0.001)))
                        (-RRB- -RRB-)))))
                (CC and)
                (VP (VBN abolished)
                  (PP (IN during)
                    (NP
                      (NP (JJ high-intensity) (NN exercise))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (CD -3) (NN %))
                          (, ,)
                          (NP
                            (NP
                              (NP (NNP P))
                              (NP (SYM =)))
                            (ADJP (RB not) (JJ significant))))
                        (-RRB- -RRB-))
                      (, ,)
                      (SBAR
                        (WHADVP (WRB where))
                        (S
                          (NP (NNS PaCO2))
                          (VP (VBD decreased)
                            (NP (CD 7) (NN %))))))))))))))
    (PRN (-LRB- -LRB-)
      (S
        (NP (NNP P))
        (VP (VBP <)
          (NP (CD 0.05))))
      (-RRB- -RRB-))
    (CC and)
    (S
      (NP (NNP CMRO2))
      (VP (VBD increased)
        (NP
          (NP (CD 17) (NN %))
          (PRN (-LRB- -LRB-)
            (NP (NNP P)
              (QP (CD <) (CD 0.05)))
            (-RRB- -RRB-)))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(attenuated-10, that-4)
det(reduction-6, the-5)
nsubjpass(attenuated-10, reduction-6)
nsubjpass(abolished-23, reduction-6)
case(CBF_and_MBF-8, in-7)
nmod:in(reduction-6, CBF_and_MBF-8)
auxpass(attenuated-10, was-9)
ccomp(showed-3, attenuated-10)
case(exercise-13, during-11)
amod(exercise-13, low-intensity-12)
nmod:during(attenuated-10, exercise-13)
nummod(%-16, -5-15)
dep(exercise-13, %-16)
compound(<-19, P-18)
appos(%-16, <-19)
nummod(<-19, 0.001-20)
cc(attenuated-10, and-22)
ccomp(showed-3, abolished-23)
conj:and(attenuated-10, abolished-23)
case(exercise-26, during-24)
amod(exercise-26, high-intensity-25)
nmod:during(abolished-23, exercise-26)
nummod(%-29, -3-28)
dep(exercise-26, %-29)
appos(%-29, P-31)
dep(P-31, =-32)
neg(significant-34, not-33)
amod(P-31, significant-34)
advmod(decreased-39, where-37)
nsubj(decreased-39, PaCO2-38)
acl:relcl(exercise-26, decreased-39)
nummod(%-41, 7-40)
dobj(decreased-39, %-41)
nsubj(<-44, P-43)
dep(showed-3, <-44)
dobj(<-44, 0.05-45)
cc(showed-3, and-47)
nsubj(increased-49, CMRO2-48)
conj:and(showed-3, increased-49)
nummod(%-51, 17-50)
dobj(increased-49, %-51)
appos(%-51, P-53)
compound(0.05-55, <-54)
nummod(P-53, 0.05-55)

These/DT findings/NNS suggest/VBP that/IN exercise/NN may/MD have/VB a/DT protective/JJ effect/NN against/IN the/DT negative/JJ impact/NN of/IN propentofylline/NN on/IN cerebral/JJ and/CC myocardial_blood_flow/JJ ,/, particularly/RB during/IN high-intensity/JJ exercise/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN exercise))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (DT a) (JJ protective) (NN effect))
                (PP (IN against)
                  (NP
                    (NP (DT the) (JJ negative) (NN impact))
                    (PP (IN of)
                      (NP (NN propentofylline))))))
              (PP (IN on)
                (ADJP (JJ cerebral)
                  (CC and)
                  (JJ myocardial_blood_flow)))))))
      (, ,)
      (PP
        (ADVP (RB particularly))
        (IN during)
        (NP (JJ high-intensity) (NN exercise))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, exercise-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
det(effect-10, a-8)
amod(effect-10, protective-9)
dobj(have-7, effect-10)
case(impact-14, against-11)
det(impact-14, the-12)
amod(impact-14, negative-13)
nmod:against(effect-10, impact-14)
case(propentofylline-16, of-15)
nmod:of(impact-14, propentofylline-16)
case(cerebral-18, on-17)
advcl(have-7, cerebral-18)
cc(cerebral-18, and-19)
advcl(have-7, myocardial_blood_flow-20)
conj:and(cerebral-18, myocardial_blood_flow-20)
advmod(exercise-25, particularly-22)
case(exercise-25, during-23)
amod(exercise-25, high-intensity-24)
nmod:during(suggest-3, exercise-25)

Further/JJ studies/NNS are/VBP needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC their/PRP$ clinical/JJ implications/NNS for/IN patients/NNS with/IN cardiovascular/JJ or/CC cerebrovascular_diseases/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB understand)
              (NP
                (NP (DT the) (NNS mechanisms))
                (PP (VBG underlying)
                  (NP
                    (NP (DT these) (NNS effects))
                    (CC and)
                    (NP
                      (NP (PRP$ their) (JJ clinical) (NNS implications))
                      (PP (IN for)
                        (NP (NNS patients)))))))
              (PP (IN with)
                (NP
                  (NP (JJ cardiovascular))
                  (CC or)
                  (NP (NNS cerebrovascular_diseases)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(understand-7, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
xcomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
case(effects-12, underlying-10)
det(effects-12, these-11)
nmod:underlying(mechanisms-9, effects-12)
cc(effects-12, and-13)
nmod:poss(implications-16, their-14)
amod(implications-16, clinical-15)
nmod:underlying(mechanisms-9, implications-16)
conj:and(effects-12, implications-16)
case(patients-18, for-17)
nmod:for(implications-16, patients-18)
case(cardiovascular-20, with-19)
nmod:with(understand-7, cardiovascular-20)
cc(cardiovascular-20, or-21)
nmod:with(understand-7, cerebrovascular_diseases-22)
conj:or(cardiovascular-20, cerebrovascular_diseases-22)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-17, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(studied-17, have-14)
auxpass(studied-17, been-15)
advmod(studied-17, extensively-16)
root(ROOT-0, studied-17)
case(benefits-22, for-18)
nmod:poss(benefits-22, their-19)
amod(benefits-22, potential-20)
compound(benefits-22, health-21)
nmod:for(studied-17, benefits-22)

In/IN particular/JJ ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO decrease/VB serum/NN zinc_oxide/NN -LRB-/-LRB- ZnO/NNP -RRB-/-RRB- levels/NNS in/IN healthy/JJ individuals/NNS and/CC to/TO increase/VB serum/JJ ZnO/NNP levels/NNS in/IN hyperZincOmic/JJ patients/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP
              (VP (TO to)
                (VP (VB decrease)
                  (NP (NN serum) (NN zinc_oxide)
                    (PRN (-LRB- -LRB-)
                      (NP (NNP ZnO))
                      (-RRB- -RRB-))
                    (NNS levels))
                  (PP (IN in)
                    (NP (JJ healthy) (NNS individuals)))))
              (CC and)
              (VP (TO to)
                (VP (VB increase)
                  (NP
                    (NP (JJ serum) (NNP ZnO) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperZincOmic) (NNS patients)))))))))))
    (. .)))

case(particular-2, In-1)
advcl(shown-9, particular-2)
nsubjpass(shown-9, EPA-4)
cc(EPA-4, and-5)
conj:and(EPA-4, DHA-6)
nsubjpass(shown-9, DHA-6)
aux(shown-9, have-7)
auxpass(shown-9, been-8)
root(ROOT-0, shown-9)
mark(decrease-11, to-10)
ccomp(shown-9, decrease-11)
compound(levels-17, serum-12)
compound(levels-17, zinc_oxide-13)
appos(levels-17, ZnO-15)
dobj(decrease-11, levels-17)
case(individuals-20, in-18)
amod(individuals-20, healthy-19)
nmod:in(decrease-11, individuals-20)
cc(decrease-11, and-21)
mark(increase-23, to-22)
ccomp(shown-9, increase-23)
conj:and(decrease-11, increase-23)
amod(levels-26, serum-24)
compound(levels-26, ZnO-25)
dobj(increase-23, levels-26)
case(patients-29, in-27)
amod(patients-29, hyperZincOmic-28)
nmod:in(levels-26, patients-29)

In/IN addition/NN ,/, omega-3/JJ supplementation/NN has_been/NN found/VBD to/TO decrease/VB the/DT risk/NN of/IN cardiovascular_disease/NN -LRB-/-LRB- CVD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (JJ omega-3) (NN supplementation) (NN has_been))
    (VP (VBD found)
      (S
        (VP (TO to)
          (VP (VB decrease)
            (NP
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP (NN cardiovascular_disease))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CVD))
                (-RRB- -RRB-)))))))
    (. .)))

case(addition-2, In-1)
nmod:in(found-7, addition-2)
amod(has_been-6, omega-3-4)
compound(has_been-6, supplementation-5)
nsubj(found-7, has_been-6)
nsubj:xsubj(decrease-9, has_been-6)
root(ROOT-0, found-7)
mark(decrease-9, to-8)
xcomp(found-7, decrease-9)
det(risk-11, the-10)
dobj(decrease-9, risk-11)
case(cardiovascular_disease-13, of-12)
nmod:of(risk-11, cardiovascular_disease-13)
appos(risk-11, CVD-15)

In/IN addition/NN ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN found/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, a/DT leading/VBG cause/NN of/IN mortality/NN worldwide/RB ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP (NN coronary_heart_disease))
                        (NP
                          (NP (-LRB- -LRB-) (NNP CHD) (-RRB- -RRB-))
                          (, ,)
                          (NP
                            (NP (DT a) (VBG leading) (NN cause))
                            (PP (IN of)
                              (NP (NN mortality)))))))))
                (ADVP (RB worldwide))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(found-9, addition-2)
nsubjpass(found-9, EPA-4)
nsubj:xsubj(decrease-11, EPA-4)
cc(EPA-4, and-5)
conj:and(EPA-4, DHA-6)
nsubjpass(found-9, DHA-6)
nsubj:xsubj(decrease-11, DHA-6)
aux(found-9, have-7)
auxpass(found-9, been-8)
root(ROOT-0, found-9)
mark(decrease-11, to-10)
xcomp(found-9, decrease-11)
det(risk-13, the-12)
dobj(decrease-11, risk-13)
mark(developing-15, of-14)
acl(risk-13, developing-15)
iobj(developing-15, coronary_heart_disease-16)
dobj(developing-15, CHD-18)
det(cause-23, a-21)
amod(cause-23, leading-22)
appos(CHD-18, cause-23)
case(mortality-25, of-24)
nmod:of(cause-23, mortality-25)
advmod(decrease-11, worldwide-26)

The/DT mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP exert/VBD their/PRP$ beneficial/JJ effects/NNS on/IN ZnO/NNP levels/NNS and/CC CHD/NNP risk/NN are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB modulation/NN of/IN inflammation/NN ,/, lipid/NN metabolism/NN ,/, and/CC oxidative_stress/NNS ./.

(ROOT
  (S
    (NP (DT The)
      (NX
        (NX
          (NX (NNS mechanisms))
          (PP (IN by)
            (SBAR
              (WHNP (WDT which))
              (S
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))
                (VP (VBD exert)
                  (NP
                    (NP (PRP$ their) (JJ beneficial) (NNS effects))
                    (PP (IN on)
                      (NP (NNP ZnO) (NNS levels)))))))))
        (CC and)
        (NX (NNP CHD) (NN risk))))
    (VP
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (NN modulation))
            (PP (IN of)
              (NP
                (NP (NN inflammation))
                (, ,)
                (NP (NN lipid) (NN metabolism))
                (, ,)
                (CC and)
                (NP (NNS oxidative_stress))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-22, mechanisms-2)
nsubj(involve-26, mechanisms-2)
mark(exert-8, by-3)
dobj(exert-8, which-4)
nsubj(exert-8, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(exert-8, DHA-7)
acl(mechanisms-2, exert-8)
nmod:poss(effects-11, their-9)
amod(effects-11, beneficial-10)
dobj(exert-8, effects-11)
case(levels-14, on-12)
compound(levels-14, ZnO-13)
nmod:on(effects-11, levels-14)
cc(mechanisms-2, and-15)
compound(risk-17, CHD-16)
conj:and(mechanisms-2, risk-17)
nsubjpass(understood-22, risk-17)
auxpass(understood-22, are-18)
neg(understood-22, not-19)
advmod(understood-22, yet-20)
advmod(understood-22, fully-21)
root(ROOT-0, understood-22)
cc(understood-22, but-24)
aux(involve-26, may-25)
conj:but(understood-22, involve-26)
dobj(involve-26, modulation-27)
case(inflammation-29, of-28)
nmod:of(modulation-27, inflammation-29)
compound(metabolism-32, lipid-31)
nmod:of(modulation-27, metabolism-32)
conj:and(inflammation-29, metabolism-32)
cc(inflammation-29, and-34)
nmod:of(modulation-27, oxidative_stress-35)
conj:and(inflammation-29, oxidative_stress-35)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT precise/JJ mechanisms/NNS underlying/VBG these/DT associations/NNS and/CC to/TO determine/VB the/DT optimal/JJ doses/NNS and/CC duration/NN of/IN omega-3/JJ supplementation/NN for/IN disease/NN prevention/NN and/CC management/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (JJ precise) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS associations))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NNS doses))
                  (CC and)
                  (NP
                    (NP (NN duration))
                    (PP (IN of)
                      (NP
                        (NP (JJ omega-3) (NN supplementation))
                        (PP (IN for)
                          (NP (NN disease) (NN prevention)
                            (CC and)
                            (NN management)))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, precise-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(associations-12, these-11)
dobj(underlying-10, associations-12)
cc(elucidate-6, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(elucidate-6, determine-15)
det(doses-18, the-16)
amod(doses-18, optimal-17)
dobj(determine-15, doses-18)
cc(doses-18, and-19)
dobj(determine-15, duration-20)
conj:and(doses-18, duration-20)
case(supplementation-23, of-21)
amod(supplementation-23, omega-3-22)
nmod:of(duration-20, supplementation-23)
case(prevention-26, for-24)
compound(prevention-26, disease-25)
nmod:for(supplementation-23, prevention-26)
cc(prevention-26, and-27)
nmod:for(supplementation-23, management-28)
conj:and(prevention-26, management-28)

The/DT inhibitory/JJ effect/NN of/IN cdk7/NNS on/IN Tp40/JJ production/NN could/MD be/VB reversed/VBN by/IN pretreating/VBG cells/NNS with/IN staurosporin/NN ,/, a/DT protein_kinase_A/JJ -LRB-/-LRB- PKA/NNP -RRB-/-RRB- inhibitor/NN ,/, or/CC by/IN mutating/VBG S730A/NNP ,/, the/DT PKA-dependent/JJ phosphorylation/NN site/NN in/IN the/DT cdk7/JJ sequence/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ inhibitory) (NN effect))
      (PP (IN of)
        (NP
          (NP (NNS cdk7))
          (PP (IN on)
            (NP (JJ Tp40) (NN production))))))
    (VP (MD could)
      (VP (VB be)
        (VP (VBN reversed)
          (PP
            (PP (IN by)
              (S
                (VP (VBG pretreating)
                  (NP (NNS cells))
                  (PP (IN with)
                    (NP
                      (NP (NN staurosporin))
                      (, ,)
                      (NP (DT a) (JJ protein_kinase_A)
                        (PRN (-LRB- -LRB-)
                          (NP (NNP PKA))
                          (-RRB- -RRB-))
                        (NN inhibitor))
                      (, ,))))))
            (CC or)
            (PP (IN by)
              (S
                (VP (VBG mutating)
                  (NP
                    (NP (NNP S730A))
                    (, ,)
                    (NP
                      (NP (DT the) (JJ PKA-dependent) (NN phosphorylation) (NN site))
                      (PP (IN in)
                        (NP (DT the) (JJ cdk7) (NN sequence))))))))))))
    (. .)))

det(effect-3, The-1)
amod(effect-3, inhibitory-2)
nsubjpass(reversed-11, effect-3)
case(cdk7-5, of-4)
nmod:of(effect-3, cdk7-5)
case(production-8, on-6)
amod(production-8, Tp40-7)
nmod:on(cdk7-5, production-8)
aux(reversed-11, could-9)
auxpass(reversed-11, be-10)
root(ROOT-0, reversed-11)
mark(pretreating-13, by-12)
dep(reversed-11, pretreating-13)
dobj(pretreating-13, cells-14)
case(staurosporin-16, with-15)
nmod:with(pretreating-13, staurosporin-16)
det(inhibitor-23, a-18)
amod(inhibitor-23, protein_kinase_A-19)
appos(inhibitor-23, PKA-21)
appos(staurosporin-16, inhibitor-23)
cc(pretreating-13, or-25)
mark(mutating-27, by-26)
dep(reversed-11, mutating-27)
conj:or(pretreating-13, mutating-27)
dobj(mutating-27, S730A-28)
det(site-33, the-30)
amod(site-33, PKA-dependent-31)
compound(site-33, phosphorylation-32)
appos(S730A-28, site-33)
case(sequence-37, in-34)
det(sequence-37, the-35)
amod(sequence-37, cdk7-36)
nmod:in(site-33, sequence-37)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN cdk7/JJ also/RB regulates/VBZ the/DT production/NN of/IN Tp40/NNS ,/, a/DT protein/NN implicated/VBN in/IN cancer_progression/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (JJ cdk7))
            (ADVP (RB also))
            (VP (VBZ regulates)
              (NP
                (NP (DT the) (NN production))
                (PP (IN of)
                  (NP
                    (NP (NNS Tp40))
                    (, ,)
                    (NP
                      (NP (DT a) (NN protein))
                      (VP (VBN implicated)
                        (PP (IN in)
                          (NP (NN cancer_progression)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(regulates-8, that-5)
nsubj(regulates-8, cdk7-6)
advmod(regulates-8, also-7)
ccomp(shown-4, regulates-8)
det(production-10, the-9)
dobj(regulates-8, production-10)
case(Tp40-12, of-11)
nmod:of(production-10, Tp40-12)
det(protein-15, a-14)
appos(Tp40-12, protein-15)
acl(protein-15, implicated-16)
case(cancer_progression-18, in-17)
nmod:in(implicated-16, cancer_progression-18)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT mechanisms/NNS underlying/VBG cdk7-mediated/JJ regulation/NN of/IN Tp40/JJ production/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS mechanisms))
        (VP (VBG underlying)
          (NP
            (NP (JJ cdk7-mediated) (NN regulation))
            (PP (IN of)
              (NP (JJ Tp40) (NN production)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(mechanisms-8, the-7)
dobj(investigated-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
amod(regulation-11, cdk7-mediated-10)
dobj(underlying-9, regulation-11)
case(production-14, of-12)
amod(production-14, Tp40-13)
nmod:of(regulation-11, production-14)

We/PRP found/VBD that/IN cdk7/NNP inhibits/VBZ Tp40/JJ production/NN through/IN a/DT PKA-dependent/JJ pathway/NN ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (NNP cdk7))
          (VP (VBZ inhibits)
            (NP (JJ Tp40) (NN production))
            (PP (IN through)
              (NP (DT a) (JJ PKA-dependent) (NN pathway)))))))
    (. .)))

nsubj(found-2, We-1)
root(ROOT-0, found-2)
mark(inhibits-5, that-3)
nsubj(inhibits-5, cdk7-4)
ccomp(found-2, inhibits-5)
amod(production-7, Tp40-6)
dobj(inhibits-5, production-7)
case(pathway-11, through-8)
det(pathway-11, a-9)
amod(pathway-11, PKA-dependent-10)
nmod:through(inhibits-5, pathway-11)

The/DT inhibitory/JJ effect/NN of/IN cdk7/NNS on/IN Tp40/JJ production/NN could/MD be/VB reversed/VBN by/IN pretreating/VBG cells/NNS with/IN staurosporin/NN ,/, a/DT protein_kinase_A/JJ -LRB-/-LRB- PKA/NNP -RRB-/-RRB- inhibitor/NN ,/, or/CC by/IN mutating/VBG S730A/NNP ,/, the/DT PKA-dependent/JJ phosphorylation/NN site/NN in/IN the/DT cdk7/JJ sequence/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ inhibitory) (NN effect))
      (PP (IN of)
        (NP
          (NP (NNS cdk7))
          (PP (IN on)
            (NP (JJ Tp40) (NN production))))))
    (VP (MD could)
      (VP (VB be)
        (VP (VBN reversed)
          (PP
            (PP (IN by)
              (S
                (VP (VBG pretreating)
                  (NP (NNS cells))
                  (PP (IN with)
                    (NP
                      (NP (NN staurosporin))
                      (, ,)
                      (NP (DT a) (JJ protein_kinase_A)
                        (PRN (-LRB- -LRB-)
                          (NP (NNP PKA))
                          (-RRB- -RRB-))
                        (NN inhibitor))
                      (, ,))))))
            (CC or)
            (PP (IN by)
              (S
                (VP (VBG mutating)
                  (NP
                    (NP (NNP S730A))
                    (, ,)
                    (NP
                      (NP (DT the) (JJ PKA-dependent) (NN phosphorylation) (NN site))
                      (PP (IN in)
                        (NP (DT the) (JJ cdk7) (NN sequence))))))))))))
    (. .)))

det(effect-3, The-1)
amod(effect-3, inhibitory-2)
nsubjpass(reversed-11, effect-3)
case(cdk7-5, of-4)
nmod:of(effect-3, cdk7-5)
case(production-8, on-6)
amod(production-8, Tp40-7)
nmod:on(cdk7-5, production-8)
aux(reversed-11, could-9)
auxpass(reversed-11, be-10)
root(ROOT-0, reversed-11)
mark(pretreating-13, by-12)
dep(reversed-11, pretreating-13)
dobj(pretreating-13, cells-14)
case(staurosporin-16, with-15)
nmod:with(pretreating-13, staurosporin-16)
det(inhibitor-23, a-18)
amod(inhibitor-23, protein_kinase_A-19)
appos(inhibitor-23, PKA-21)
appos(staurosporin-16, inhibitor-23)
cc(pretreating-13, or-25)
mark(mutating-27, by-26)
dep(reversed-11, mutating-27)
conj:or(pretreating-13, mutating-27)
dobj(mutating-27, S730A-28)
det(site-33, the-30)
amod(site-33, PKA-dependent-31)
compound(site-33, phosphorylation-32)
appos(S730A-28, site-33)
case(sequence-37, in-34)
det(sequence-37, the-35)
amod(sequence-37, cdk7-36)
nmod:in(site-33, sequence-37)

These/DT findings/NNS suggest/VBP that/IN cdk7-mediated/JJ regulation/NN of/IN Tp40/JJ production/NN is/VBZ dependent/JJ on/IN PKA/NNP activity/NN and/CC may/MD provide/VB new/JJ targets/NNS for/IN developing/VBG therapies/NNS to/TO treat/VB cancer/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ cdk7-mediated) (NN regulation))
            (PP (IN of)
              (NP (JJ Tp40) (NN production))))
          (VP
            (VP (VBZ is)
              (ADJP (JJ dependent)
                (PP (IN on)
                  (NP (NNP PKA) (NN activity)))))
            (CC and)
            (VP (MD may)
              (VP (VB provide)
                (NP
                  (NP (JJ new) (NNS targets))
                  (PP (IN for)
                    (NP (VBG developing) (NNS therapies))))
                (S
                  (VP (TO to)
                    (VP (VB treat)
                      (NP (NN cancer)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(dependent-11, that-4)
amod(regulation-6, cdk7-mediated-5)
nsubj(dependent-11, regulation-6)
nsubj(provide-17, regulation-6)
case(production-9, of-7)
amod(production-9, Tp40-8)
nmod:of(regulation-6, production-9)
cop(dependent-11, is-10)
ccomp(suggest-3, dependent-11)
case(activity-14, on-12)
compound(activity-14, PKA-13)
nmod:on(dependent-11, activity-14)
cc(dependent-11, and-15)
aux(provide-17, may-16)
ccomp(suggest-3, provide-17)
conj:and(dependent-11, provide-17)
amod(targets-19, new-18)
dobj(provide-17, targets-19)
case(therapies-22, for-20)
amod(therapies-22, developing-21)
nmod:for(targets-19, therapies-22)
mark(treat-24, to-23)
advcl(provide-17, treat-24)
dobj(treat-24, cancer-25)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-17, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(studied-17, have-14)
auxpass(studied-17, been-15)
advmod(studied-17, extensively-16)
root(ROOT-0, studied-17)
case(benefits-22, for-18)
nmod:poss(benefits-22, their-19)
amod(benefits-22, potential-20)
compound(benefits-22, health-21)
nmod:for(studied-17, benefits-22)

Recent/JJ research/NN has/VBZ suggested/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NN may/MD play/VB a/DT role/NN in/IN reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NN research))
    (VP (VBZ has)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NN omega-3_fatty_acids))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (S
                      (VP (VBG reducing)
                        (NP
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

amod(research-2, Recent-1)
nsubj(suggested-4, research-2)
aux(suggested-4, has-3)
root(ROOT-0, suggested-4)
mark(play-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubj(play-10, omega-3_fatty_acids-8)
aux(play-10, may-9)
ccomp(suggested-4, play-10)
det(role-12, a-11)
dobj(play-10, role-12)
mark(reducing-14, in-13)
acl(role-12, reducing-14)
det(risk-16, the-15)
dobj(reducing-14, risk-16)
mark(developing-18, of-17)
acl(risk-16, developing-18)
dobj(developing-18, coronary_heart_disease-19)
appos(risk-16, CHD-21)

Additionally/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN associated/VBN with/IN decreased/VBN levels/NNS of/IN B-cell_maturation_antigen/NNP -LRB-/-LRB- BCMA/NNP -RRB-/-RRB- in/IN hyperBCMAmic/JJ patients/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP
                (NP (VBN decreased) (NNS levels))
                (PP (IN of)
                  (NP (NNP B-cell_maturation_antigen))))
              (PRN (-LRB- -LRB-)
                (NP (NNP BCMA))
                (-RRB- -RRB-))
              (PP (IN in)
                (NP (JJ hyperBCMAmic) (NNS patients))))))))
    (. .)))

advmod(associated-8, Additionally-1)
nsubjpass(associated-8, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(associated-8, DHA-5)
aux(associated-8, have-6)
auxpass(associated-8, been-7)
root(ROOT-0, associated-8)
case(levels-11, with-9)
amod(levels-11, decreased-10)
nmod:with(associated-8, levels-11)
case(B-cell_maturation_antigen-13, of-12)
nmod:of(levels-11, B-cell_maturation_antigen-13)
appos(levels-11, BCMA-15)
case(patients-19, in-17)
amod(patients-19, hyperBCMAmic-18)
nmod:in(levels-11, patients-19)

BCMA/NNP is_a/VBZ protein/NN that/WDT has_been/VBP implicated/VBN in/IN the/DT development/NN and/CC progression/NN of/IN various_diseases/NNS ,/, including/VBG multiple_myeloma/JJ and/CC other/JJ malignancies/NNS ./.

(ROOT
  (S
    (NP (NNP BCMA))
    (VP (VBZ is_a)
      (NP
        (NP (NN protein))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN implicated)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development)
                      (CC and)
                      (NN progression))
                    (PP (IN of)
                      (NP
                        (NP (NNS various_diseases))
                        (, ,)
                        (VP (VBG including)
                          (NP (JJ multiple_myeloma)
                            (CC and)
                            (JJ other) (NNS malignancies)))))))))))))
    (. .)))

nsubj(is_a-2, BCMA-1)
root(ROOT-0, is_a-2)
dobj(is_a-2, protein-3)
nsubj(has_been-5, protein-3)
ref(protein-3, that-4)
acl:relcl(protein-3, has_been-5)
dep(has_been-5, implicated-6)
case(development-9, in-7)
det(development-9, the-8)
nmod:in(implicated-6, development-9)
cc(development-9, and-10)
nmod:in(implicated-6, progression-11)
conj:and(development-9, progression-11)
case(various_diseases-13, of-12)
nmod:of(development-9, various_diseases-13)
acl(various_diseases-13, including-15)
amod(malignancies-19, multiple_myeloma-16)
cc(multiple_myeloma-16, and-17)
conj:and(multiple_myeloma-16, other-18)
amod(malignancies-19, other-18)
dobj(including-15, malignancies-19)

The/DT mechanisms/NNS by/IN which/WDT omega-3_fatty_acids/JJ exert/NN their/PRP$ effects/NNS on/IN BCMA/NNP levels/NNS and/CC CHD/NNP risk/NN are/VBP not/RB fully/RB understood/VBN but/CC may/MD involve/VB modulation/NN of/IN inflammation/NN ,/, lipid/NN metabolism/NN ,/, and/CC other/JJ physiological/NN processes/VBZ ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (SBAR
        (WHPP (IN by)
          (WHNP (WDT which) (JJ omega-3_fatty_acids) (NN exert)))
        (S
          (NP (PRP$ their) (NNS effects))
          (VP
            (VP
              (PP (IN on)
                (NP
                  (NP (NNP BCMA) (NNS levels))
                  (CC and)
                  (NP (NNP CHD) (NN risk))))
              (VBP are)
              (ADVP (RB not) (RB fully))
              (VP (VBN understood)))
            (CC but)
            (VP (MD may)
              (VP (VB involve)
                (NP
                  (NP (NN modulation))
                  (PP (IN of)
                    (NP
                      (NP (NN inflammation))
                      (, ,)
                      (NP (NN lipid) (NN metabolism))
                      (, ,)
                      (CC and)
                      (NP (JJ other) (NN physiological)))))))))))
    (VP (VBZ processes))
    (. .)))

det(mechanisms-2, The-1)
det(exert-6, mechanisms-2)
nsubj(processes-32, mechanisms-2)
case(exert-6, by-3)
ref(mechanisms-2, which-4)
amod(exert-6, omega-3_fatty_acids-5)
nmod:by(understood-18, exert-6)
nmod:poss(effects-8, their-7)
nsubjpass(understood-18, effects-8)
nsubj(involve-21, effects-8)
case(levels-11, on-9)
compound(levels-11, BCMA-10)
nmod:on(understood-18, levels-11)
cc(levels-11, and-12)
compound(risk-14, CHD-13)
conj:and(levels-11, risk-14)
nmod:on(understood-18, risk-14)
auxpass(understood-18, are-15)
dep(fully-17, not-16)
advmod(understood-18, fully-17)
acl:relcl(mechanisms-2, understood-18)
cc(understood-18, but-19)
aux(involve-21, may-20)
acl:relcl(mechanisms-2, involve-21)
conj:but(understood-18, involve-21)
dobj(involve-21, modulation-22)
case(inflammation-24, of-23)
nmod:of(modulation-22, inflammation-24)
compound(metabolism-27, lipid-26)
nmod:of(modulation-22, metabolism-27)
conj:and(inflammation-24, metabolism-27)
cc(inflammation-24, and-29)
amod(physiological-31, other-30)
nmod:of(modulation-22, physiological-31)
conj:and(inflammation-24, physiological-31)
root(ROOT-0, processes-32)

In/IN this/DT review/NN ,/, we/PRP summarize/VB the/DT current/JJ literature/NN on/IN the/DT effects/NNS of/IN omega-3_polyunsaturated_fatty_acids/JJ on/IN the/DT development/NN of/IN CHD/NNP and/CC BCMA/NNP and/CC the/DT association/NN of/IN these/DT fatty_acids/NNS with/IN BCMA/NNP expression/NN ,/, including/VBG the/DT effect/NN of/IN DHA/NNP and/CC EPA/NNP ,/, BCMA/NNP serum/NN levels/NNS ,/, and/CC serum/JJ BCMA/NNP protein/NN concentrations/NNS ,/, as/RB well/RB as/IN the/DT relationship/NN between/IN these/DT factors/NNS ./. -LRB-/-LRB- J/NNP Am/NNP Geriatr/NNP Soc/NNP 67:9/CD -14/CD ,/, 2020/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN review)))
    (, ,)
    (NP (PRP we))
    (VP (VB summarize)
      (NP (DT the) (JJ current) (NN literature))
      (PP (IN on)
        (NP
          (NP
            (NP (DT the) (NNS effects))
            (PP (IN of)
              (FRAG
                (ADJP (JJ omega-3_polyunsaturated_fatty_acids)
                  (PP (IN on)
                    (NP
                      (NP
                        (NP (DT the) (NN development))
                        (PP (IN of)
                          (NP (NNP CHD)
                            (CC and)
                            (NNP BCMA))))
                      (CC and)
                      (NP
                        (NP (DT the) (NN association))
                        (PP (IN of)
                          (NP
                            (NP (DT these) (NNS fatty_acids))
                            (PP (IN with)
                              (NP (NNP BCMA) (NN expression)))))))))
                (, ,)
                (VP (VBG including)
                  (NP
                    (NP
                      (NP (DT the) (NN effect))
                      (PP (IN of)
                        (NP
                          (NP (NNP DHA)
                            (CC and)
                            (NNP EPA))
                          (, ,)
                          (NP (NNP BCMA) (NN serum) (NNS levels))
                          (, ,)
                          (CC and)
                          (NP (JJ serum) (NNP BCMA) (NN protein) (NNS concentrations)))))
                    (, ,)
                    (CONJP (RB as) (RB well) (IN as))
                    (NP
                      (NP (DT the) (NN relationship))
                      (PP (IN between)
                        (NP (DT these) (NNS factors))))))
                (. .))))
          (PRN (-LRB- -LRB-)
            (NP
              (NP
                (NP (NNP J) (NNP Am) (NNP Geriatr) (NNP Soc))
                (NP
                  (QP (CD 67:9) (CD -14))))
              (, ,)
              (NP (CD 2020)))
            (-RRB- -RRB-)))))
    (. .)))

case(review-3, In-1)
det(review-3, this-2)
nmod:in(summarize-6, review-3)
nsubj(summarize-6, we-5)
root(ROOT-0, summarize-6)
det(literature-9, the-7)
amod(literature-9, current-8)
dobj(summarize-6, literature-9)
case(effects-12, on-10)
det(effects-12, the-11)
nmod:on(summarize-6, effects-12)
case(omega-3_polyunsaturated_fatty_acids-14, of-13)
acl(effects-12, omega-3_polyunsaturated_fatty_acids-14)
case(development-17, on-15)
det(development-17, the-16)
nmod:on(omega-3_polyunsaturated_fatty_acids-14, development-17)
case(CHD-19, of-18)
nmod:of(development-17, CHD-19)
cc(CHD-19, and-20)
nmod:of(development-17, BCMA-21)
conj:and(CHD-19, BCMA-21)
cc(development-17, and-22)
det(association-24, the-23)
nmod:on(omega-3_polyunsaturated_fatty_acids-14, association-24)
conj:and(development-17, association-24)
case(fatty_acids-27, of-25)
det(fatty_acids-27, these-26)
nmod:of(association-24, fatty_acids-27)
case(expression-30, with-28)
compound(expression-30, BCMA-29)
nmod:with(fatty_acids-27, expression-30)
dep(omega-3_polyunsaturated_fatty_acids-14, including-32)
det(effect-34, the-33)
dobj(including-32, effect-34)
case(DHA-36, of-35)
nmod:of(effect-34, DHA-36)
cc(DHA-36, and-37)
nmod:of(effect-34, EPA-38)
conj:and(DHA-36, EPA-38)
compound(levels-42, BCMA-40)
compound(levels-42, serum-41)
nmod:of(effect-34, levels-42)
conj:and(DHA-36, levels-42)
cc(DHA-36, and-44)
amod(concentrations-48, serum-45)
compound(concentrations-48, BCMA-46)
compound(concentrations-48, protein-47)
nmod:of(effect-34, concentrations-48)
conj:and(DHA-36, concentrations-48)
cc(effect-34, as-50)
mwe(as-50, well-51)
mwe(as-50, as-52)
det(relationship-54, the-53)
dobj(including-32, relationship-54)
conj:and(effect-34, relationship-54)
case(factors-57, between-55)
det(factors-57, these-56)
nmod:between(relationship-54, factors-57)
compound(Soc-63, J-60)
compound(Soc-63, Am-61)
compound(Soc-63, Geriatr-62)
dep(effects-12, Soc-63)
compound(-14-65, 67:9-64)
dep(Soc-63, -14-65)
amod(Soc-63, 2020-67)

Thyroid_hormone/NNP 1/CD -LRB-/-LRB- TH_1/NNP -RRB-/-RRB- is_a/JJ key/JJ regulator/NN of/IN lactation/NN ./.

(ROOT
  (NP
    (NP
      (NP (NNP Thyroid_hormone) (CD 1))
      (PRN (-LRB- -LRB-)
        (NP (NNP TH_1))
        (-RRB- -RRB-)))
    (NP
      (NP (JJ is_a) (JJ key) (NN regulator))
      (PP (IN of)
        (NP (NN lactation))))
    (. .)))

root(ROOT-0, Thyroid_hormone-1)
nummod(Thyroid_hormone-1, 1-2)
appos(Thyroid_hormone-1, TH_1-4)
amod(regulator-8, is_a-6)
amod(regulator-8, key-7)
dep(Thyroid_hormone-1, regulator-8)
case(lactation-10, of-9)
nmod:of(regulator-8, lactation-10)

However/RB ,/, the/DT effects/NNS of/IN methyl_gallate/NN on/IN the/DT early/JJ effect/NN of/IN TH_1/NNP on/IN lactose/JJ biosynthesis/NNS in/IN the/DT mammary_gland/NN of/IN pregnant/JJ mice/NNS have/VBP not/RB been/VBN fully/RB elucidated/VBN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NN methyl_gallate)))
        (PP (IN on)
          (NP
            (NP (DT the) (JJ early) (NN effect))
            (PP (IN of)
              (NP (NNP TH_1))))))
      (PP (IN on)
        (NP
          (NP (JJ lactose) (NNS biosynthesis))
          (PP (IN in)
            (NP
              (NP (DT the) (NN mammary_gland))
              (PP (IN of)
                (NP (JJ pregnant) (NNS mice))))))))
    (VP (VBP have)
      (ADVP (RB not))
      (VP (VBN been)
        (VP
          (ADVP (RB fully))
          (VBN elucidated))))
    (. .)))

advmod(elucidated-26, However-1)
det(effects-4, the-3)
nsubjpass(elucidated-26, effects-4)
case(methyl_gallate-6, of-5)
nmod:of(effects-4, methyl_gallate-6)
case(effect-10, on-7)
det(effect-10, the-8)
amod(effect-10, early-9)
nmod:on(effects-4, effect-10)
case(TH_1-12, of-11)
nmod:of(effect-10, TH_1-12)
case(biosynthesis-15, on-13)
amod(biosynthesis-15, lactose-14)
nmod:on(effects-4, biosynthesis-15)
case(mammary_gland-18, in-16)
det(mammary_gland-18, the-17)
nmod:in(biosynthesis-15, mammary_gland-18)
case(mice-21, of-19)
amod(mice-21, pregnant-20)
nmod:of(mammary_gland-18, mice-21)
aux(elucidated-26, have-22)
neg(elucidated-26, not-23)
auxpass(elucidated-26, been-24)
advmod(elucidated-26, fully-25)
root(ROOT-0, elucidated-26)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT possible/JJ roles/NNS of/IN adenosine_3/NNS '/POS ,5/CD '/'' -/: cyclic_monophosphate/VB -LRB-/-LRB- cAMP/NN -RRB-/-RRB- and/CC guanosine_3/NNS '/POS ,5/CD '/'' -/: cyclic_monophosphate/NN -LRB-/-LRB- cGMP/NN -RRB-/-RRB- ,/, as/RB well/RB as/IN methyl_gallate/NN ,/, on/IN the/DT early/JJ effect/NN of/IN TH_1/NNP -LRB-/-LRB- PRL/NNP -RRB-/-RRB- on/IN lactose/JJ biosynthesis/NNS in/IN cultured/JJ mammary_gland/JJ explants/NNS derived/VBN from/IN mice/NNS 12-14/CD days/NNS pregnant/JJ ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (JJ possible) (NNS roles))
        (PP (IN of)
          (NP
            (NP
              (NP (NNS adenosine_3) (POS '))
              (ADJP (CD ,5))
              ('' ')
              (PRN (: -)
                (S
                  (VP (VB cyclic_monophosphate)
                    (NP
                      (NP (-LRB- -LRB-) (NN cAMP) (-RRB- -RRB-))
                      (CC and)
                      (NP
                        (NP (NNS guanosine_3) (POS '))
                        (NX (CD ,5)))
                      ('' '))))
                (: -))
              (NN cyclic_monophosphate))
            (PRN (-LRB- -LRB-)
              (NP (NN cGMP))
              (-RRB- -RRB-)))))
      (, ,)
      (ADVP
        (ADVP (RB as) (RB well))
        (PP (IN as)
          (NP (NN methyl_gallate))))
      (, ,)
      (PP (IN on)
        (NP
          (NP
            (NP (DT the) (JJ early) (NN effect))
            (PP (IN of)
              (NP (NNP TH_1))))
          (PRN (-LRB- -LRB-)
            (NP (NNP PRL))
            (-RRB- -RRB-))))
      (PP (IN on)
        (NP
          (NP (JJ lactose) (NNS biosynthesis))
          (PP (IN in)
            (NP
              (NP (JJ cultured) (JJ mammary_gland) (NNS explants))
              (VP (VBN derived)
                (PP (IN from)
                  (NP
                    (NP (NNS mice))
                    (NP-TMP (CD 12-14) (NNS days))))
                (S
                  (ADJP (JJ pregnant)))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(roles-9, the-7)
amod(roles-9, possible-8)
dobj(investigated-6, roles-9)
case(cyclic_monophosphate-26, of-10)
nmod:poss(cyclic_monophosphate-26, adenosine_3-11)
case(adenosine_3-11, '-12)
amod(cyclic_monophosphate-26, ,5-13)
dep(cyclic_monophosphate-26, cyclic_monophosphate-16)
dobj(cyclic_monophosphate-16, cAMP-18)
cc(cAMP-18, and-20)
nmod:poss(,5-23, guanosine_3-21)
case(guanosine_3-21, '-22)
dobj(cyclic_monophosphate-16, ,5-23)
conj:and(cAMP-18, ,5-23)
nmod:of(roles-9, cyclic_monophosphate-26)
appos(cyclic_monophosphate-26, cGMP-28)
advmod(investigated-6, as-31)
mwe(as-31, well-32)
case(methyl_gallate-34, as-33)
nmod:as(as-31, methyl_gallate-34)
case(effect-39, on-36)
det(effect-39, the-37)
amod(effect-39, early-38)
nmod:on(investigated-6, effect-39)
case(TH_1-41, of-40)
nmod:of(effect-39, TH_1-41)
appos(effect-39, PRL-43)
case(biosynthesis-47, on-45)
amod(biosynthesis-47, lactose-46)
nmod:on(investigated-6, biosynthesis-47)
case(explants-51, in-48)
amod(explants-51, cultured-49)
amod(explants-51, mammary_gland-50)
nmod:in(biosynthesis-47, explants-51)
acl(explants-51, derived-52)
case(mice-54, from-53)
nmod:from(derived-52, mice-54)
nummod(days-56, 12-14-55)
nmod:tmod(mice-54, days-56)
xcomp(derived-52, pregnant-57)

Our/PRP$ results/NNS demonstrated/VBD that/IN cAMP/NN and/CC cGMP/NN levels/NNS were/VBD increased/VBN upon/IN TH_1/NNP stimulation/NN ,/, suggesting/VBG their/PRP$ involvement/NN in/IN the/DT early/JJ stages/NNS of/IN lactose/JJ biosynthesis/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD demonstrated)
      (SBAR (IN that)
        (S
          (NP (NN cAMP)
            (CC and)
            (NN cGMP) (NNS levels))
          (VP (VBD were)
            (VP (VBN increased)
              (PP (IN upon)
                (NP (NNP TH_1) (NN stimulation)))
              (, ,)
              (S
                (VP (VBG suggesting)
                  (NP
                    (NP (PRP$ their) (NN involvement))
                    (PP (IN in)
                      (NP
                        (NP (DT the) (JJ early) (NNS stages))
                        (PP (IN of)
                          (NP (JJ lactose) (NNS biosynthesis)))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(demonstrated-3, results-2)
root(ROOT-0, demonstrated-3)
mark(increased-10, that-4)
compound(levels-8, cAMP-5)
cc(cAMP-5, and-6)
conj:and(cAMP-5, cGMP-7)
compound(levels-8, cGMP-7)
nsubjpass(increased-10, levels-8)
auxpass(increased-10, were-9)
ccomp(demonstrated-3, increased-10)
case(stimulation-13, upon-11)
compound(stimulation-13, TH_1-12)
nmod:upon(increased-10, stimulation-13)
xcomp(increased-10, suggesting-15)
nmod:poss(involvement-17, their-16)
dobj(suggesting-15, involvement-17)
case(stages-21, in-18)
det(stages-21, the-19)
amod(stages-21, early-20)
nmod:in(involvement-17, stages-21)
case(biosynthesis-24, of-22)
amod(biosynthesis-24, lactose-23)
nmod:of(stages-21, biosynthesis-24)

Additionally/RB ,/, treatment/NN with/IN methyl_gallate/NN resulted/VBD in_a/JJ significant/JJ increase/NN in/IN lactose/JJ production/NN ,/, indicating/VBG its/PRP$ potential/NN as/IN a/DT therapeutic/JJ agent/NN for/IN lactation/NN disorders/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP
      (NP (NN treatment))
      (PP (IN with)
        (NP (NN methyl_gallate))))
    (VP (VBD resulted)
      (NP
        (NP (JJ in_a) (JJ significant) (NN increase))
        (PP (IN in)
          (NP (JJ lactose) (NN production))))
      (, ,)
      (S
        (VP (VBG indicating)
          (NP (PRP$ its) (NN potential))
          (PP (IN as)
            (NP
              (NP (DT a) (JJ therapeutic) (NN agent))
              (PP (IN for)
                (NP (NN lactation) (NNS disorders))))))))
    (. .)))

advmod(resulted-6, Additionally-1)
nsubj(resulted-6, treatment-3)
case(methyl_gallate-5, with-4)
nmod:with(treatment-3, methyl_gallate-5)
root(ROOT-0, resulted-6)
amod(increase-9, in_a-7)
amod(increase-9, significant-8)
dobj(resulted-6, increase-9)
case(production-12, in-10)
amod(production-12, lactose-11)
nmod:in(increase-9, production-12)
advcl(resulted-6, indicating-14)
nmod:poss(potential-16, its-15)
dobj(indicating-14, potential-16)
case(agent-20, as-17)
det(agent-20, a-18)
amod(agent-20, therapeutic-19)
nmod:as(indicating-14, agent-20)
case(disorders-23, for-21)
compound(disorders-23, lactation-22)
nmod:for(agent-20, disorders-23)

These/DT findings/NNS shed/VBD light/JJ on/IN the/DT intricate/JJ mechanisms/NNS underlying/VBG milk/NN production/NN during/IN pregnancy/NN and/CC provide/VB insights/NNS into/IN potential/JJ targets/NNS for/IN improving/VBG lactation/NN outcomes/NNS in/IN both/DT humans/NNS and/CC animals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBD shed)
        (ADJP (JJ light))
        (PP (IN on)
          (NP
            (NP (DT the) (JJ intricate) (NNS mechanisms))
            (VP (VBG underlying)
              (NP (NN milk) (NN production))
              (PP (IN during)
                (NP (NN pregnancy)))))))
      (CC and)
      (VP (VB provide)
        (NP (NNS insights))
        (PP (IN into)
          (NP
            (NP (JJ potential) (NNS targets))
            (PP (IN for)
              (S
                (VP (VBG improving)
                  (NP
                    (NP (NN lactation) (NNS outcomes))
                    (PP (IN in)
                      (NP (DT both) (NNS humans)
                        (CC and)
                        (NNS animals)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(shed-3, findings-2)
nsubj(provide-15, findings-2)
root(ROOT-0, shed-3)
xcomp(shed-3, light-4)
case(mechanisms-8, on-5)
det(mechanisms-8, the-6)
amod(mechanisms-8, intricate-7)
nmod:on(shed-3, mechanisms-8)
acl(mechanisms-8, underlying-9)
compound(production-11, milk-10)
dobj(underlying-9, production-11)
case(pregnancy-13, during-12)
nmod:during(underlying-9, pregnancy-13)
cc(shed-3, and-14)
conj:and(shed-3, provide-15)
dobj(provide-15, insights-16)
case(targets-19, into-17)
amod(targets-19, potential-18)
nmod:into(provide-15, targets-19)
mark(improving-21, for-20)
acl(targets-19, improving-21)
compound(outcomes-23, lactation-22)
dobj(improving-21, outcomes-23)
case(humans-26, in-24)
cc:preconj(humans-26, both-25)
nmod:in(outcomes-23, humans-26)
cc(humans-26, and-27)
nmod:in(outcomes-23, animals-28)
conj:and(humans-26, animals-28)

The/DT placenta/NN plays/VBZ a/DT crucial/JJ role/NN in/IN the/DT metabolism/NN of/IN various/JJ endogenous/NNS and/CC exogenous/JJ compounds/NNS during/IN pregnancy/NN ./.

(ROOT
  (S
    (NP (DT The) (NN placenta))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN metabolism))
            (PP (IN of)
              (NP
                (NP (JJ various) (NNS endogenous))
                (CC and)
                (NP (JJ exogenous) (NNS compounds)))))))
      (PP (IN during)
        (NP (NN pregnancy))))
    (. .)))

det(placenta-2, The-1)
nsubj(plays-3, placenta-2)
root(ROOT-0, plays-3)
det(role-6, a-4)
amod(role-6, crucial-5)
dobj(plays-3, role-6)
case(metabolism-9, in-7)
det(metabolism-9, the-8)
nmod:in(role-6, metabolism-9)
case(endogenous-12, of-10)
amod(endogenous-12, various-11)
nmod:of(metabolism-9, endogenous-12)
cc(endogenous-12, and-13)
amod(compounds-15, exogenous-14)
nmod:of(metabolism-9, compounds-15)
conj:and(endogenous-12, compounds-15)
case(pregnancy-17, during-16)
nmod:during(plays-3, pregnancy-17)

In/IN this/DT study/NN ,/, real-time/JJ quantitative/JJ reverse_transcriptase-polymerase/JJ chain/NN reaction/NN -LRB-/-LRB- Q-RT-PCR/NNP -RRB-/-RRB- analysis/NN was/VBD conducted/VBN to/TO investigate/VB the/DT mRNA/JJ levels/NNS of/IN placental/JJ CP-10/JJ metabolism/NN enzymes/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT this) (NN study))
        (, ,)
        (NP (JJ real-time) (JJ quantitative) (JJ reverse_transcriptase-polymerase) (NN chain) (NN reaction))))
    (PRN (-LRB- -LRB-)
      (NP (NNP Q-RT-PCR))
      (-RRB- -RRB-))
    (NP (NN analysis))
    (VP (VBD was)
      (VP (VBN conducted)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (JJ mRNA) (NNS levels))
                (PP (IN of)
                  (NP (JJ placental) (JJ CP-10) (NN metabolism) (NNS enzymes)))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(conducted-15, study-3)
amod(reaction-9, real-time-5)
amod(reaction-9, quantitative-6)
amod(reaction-9, reverse_transcriptase-polymerase-7)
compound(reaction-9, chain-8)
appos(study-3, reaction-9)
dep(conducted-15, Q-RT-PCR-11)
nsubjpass(conducted-15, analysis-13)
nsubj:xsubj(investigate-17, analysis-13)
auxpass(conducted-15, was-14)
root(ROOT-0, conducted-15)
mark(investigate-17, to-16)
xcomp(conducted-15, investigate-17)
det(levels-20, the-18)
amod(levels-20, mRNA-19)
dobj(investigate-17, levels-20)
case(enzymes-25, of-21)
amod(enzymes-25, placental-22)
amod(enzymes-25, CP-10-23)
compound(enzymes-25, metabolism-24)
nmod:of(levels-20, enzymes-25)

The/DT results/NNS demonstrated/VBD a/DT significant/JJ increase/NN in/IN mRNA/NN levels/NNS for/IN UDP-glucuronosyltransferase_1A1/NNS -LRB-/-LRB- UGT1A1/NNP -RRB-/-RRB- ,/, estrogen_sulfotransferase/VBP 1E1/CD -LRB-/-LRB- SULT1E1/NNP -RRB-/-RRB- ,/, CP-10/NN 5a-reductase_1/JJ -LRB-/-LRB- S100a1/NNS -RRB-/-RRB- and_CP-10/JJ 5a-reductase/JJ 2/CD -LRB-/-LRB- SRD5A2/NNP -RRB-/-RRB- ./.

(ROOT
  (SINV
    (S
      (NP (DT The) (NNS results))
      (VP (VBD demonstrated)
        (NP (DT a) (JJ significant) (NN increase))
        (PP (IN in)
          (NP (NN mRNA) (NNS levels)))
        (PP (IN for)
          (NP
            (NP (NNS UDP-glucuronosyltransferase_1A1))
            (PRN (-LRB- -LRB-)
              (NP (NNP UGT1A1))
              (-RRB- -RRB-))))))
    (, ,)
    (VP (VBP estrogen_sulfotransferase))
    (NP
      (NP (CD 1E1))
      (PRN (-LRB- -LRB-)
        (NP (NNP SULT1E1))
        (-RRB- -RRB-))
      (, ,)
      (NP
        (NP
          (NP
            (NP
              (NP (NN CP-10))
              (NP (JJ 5a-reductase_1) (-LRB- -LRB-) (NNS S100a1) (-RRB- -RRB-)))
            (ADJP (JJ and_CP-10) (JJ 5a-reductase)))
          (NP (CD 2)))
        (PRN (-LRB- -LRB-)
          (NP (NNP SRD5A2))
          (-RRB- -RRB-))))
    (. .)))

det(results-2, The-1)
nsubj(demonstrated-3, results-2)
ccomp(estrogen_sulfotransferase-16, demonstrated-3)
det(increase-6, a-4)
amod(increase-6, significant-5)
dobj(demonstrated-3, increase-6)
case(levels-9, in-7)
compound(levels-9, mRNA-8)
nmod:in(demonstrated-3, levels-9)
case(UDP-glucuronosyltransferase_1A1-11, for-10)
nmod:for(demonstrated-3, UDP-glucuronosyltransferase_1A1-11)
appos(UDP-glucuronosyltransferase_1A1-11, UGT1A1-13)
root(ROOT-0, estrogen_sulfotransferase-16)
nsubj(estrogen_sulfotransferase-16, 1E1-17)
appos(1E1-17, SULT1E1-19)
appos(1E1-17, CP-10-22)
amod(S100a1-25, 5a-reductase_1-23)
dep(CP-10-22, S100a1-25)
amod(5a-reductase-28, and_CP-10-27)
amod(CP-10-22, 5a-reductase-28)
dep(CP-10-22, 2-29)
appos(CP-10-22, SRD5A2-31)

In/IN addition/NN ,/, there/EX was/VBD a/DT significant/JJ decrease/NN in/IN mRNA/NN expression/NN levels/NNS for/IN SULT1A2/NNP ,/, UGT1A3/NNP ,/, SULT2A1/NNP ,/, CP-9/NNP ,/, S100a2/NNP ,/, S100b/NNP ,/, CP-11/NNP ,/, S1/NNP ,/, S2/NNP ,/, S3/NNP ,/, S4/NNP ,/, S5/NNP ,/, S6/NNP ,/, S7/NNP ,/, S8/NNP ,/, S10/NNP ,/, S12/NNP ,/, S13/NNP ,/, S14/NNP ,/, S15/NNP ,/, S17/NNP ,/, S19/NNP ,/, S20/NNP and/CC S20/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP (DT a) (JJ significant) (NN decrease))
      (PP (IN in)
        (NP (NN mRNA) (NN expression) (NNS levels)))
      (PP (IN for)
        (NP (NNP SULT1A2) (, ,) (NNP UGT1A3) (, ,) (NNP SULT2A1) (, ,) (NNP CP-9) (, ,) (NNP S100a2) (, ,) (NNP S100b) (, ,) (NNP CP-11) (, ,) (NNP S1) (, ,) (NNP S2) (, ,) (NNP S3) (, ,) (NNP S4) (, ,) (NNP S5) (, ,) (NNP S6) (, ,) (NNP S7) (, ,) (NNP S8) (, ,) (NNP S10) (, ,) (NNP S12) (, ,) (NNP S13) (, ,) (NNP S14) (, ,) (NNP S15) (, ,) (NNP S17) (, ,) (NNP S19) (, ,) (NNP S20)
          (CC and)
          (NNP S20))))
    (. .)))

case(addition-2, In-1)
nmod:in(was-5, addition-2)
expl(was-5, there-4)
root(ROOT-0, was-5)
det(decrease-8, a-6)
amod(decrease-8, significant-7)
nsubj(was-5, decrease-8)
case(levels-12, in-9)
compound(levels-12, mRNA-10)
compound(levels-12, expression-11)
nmod:in(was-5, levels-12)
case(SULT1A2-14, for-13)
nmod:for(was-5, SULT1A2-14)
nmod:for(was-5, UGT1A3-16)
conj:and(SULT1A2-14, UGT1A3-16)
nmod:for(was-5, SULT2A1-18)
conj:and(SULT1A2-14, SULT2A1-18)
nmod:for(was-5, CP-9-20)
conj:and(SULT1A2-14, CP-9-20)
nmod:for(was-5, S100a2-22)
conj:and(SULT1A2-14, S100a2-22)
nmod:for(was-5, S100b-24)
conj:and(SULT1A2-14, S100b-24)
nmod:for(was-5, CP-11-26)
conj:and(SULT1A2-14, CP-11-26)
nmod:for(was-5, S1-28)
conj:and(SULT1A2-14, S1-28)
nmod:for(was-5, S2-30)
conj:and(SULT1A2-14, S2-30)
nmod:for(was-5, S3-32)
conj:and(SULT1A2-14, S3-32)
nmod:for(was-5, S4-34)
conj:and(SULT1A2-14, S4-34)
nmod:for(was-5, S5-36)
conj:and(SULT1A2-14, S5-36)
nmod:for(was-5, S6-38)
conj:and(SULT1A2-14, S6-38)
nmod:for(was-5, S7-40)
conj:and(SULT1A2-14, S7-40)
nmod:for(was-5, S8-42)
conj:and(SULT1A2-14, S8-42)
nmod:for(was-5, S10-44)
conj:and(SULT1A2-14, S10-44)
nmod:for(was-5, S12-46)
conj:and(SULT1A2-14, S12-46)
nmod:for(was-5, S13-48)
conj:and(SULT1A2-14, S13-48)
nmod:for(was-5, S14-50)
conj:and(SULT1A2-14, S14-50)
nmod:for(was-5, S15-52)
conj:and(SULT1A2-14, S15-52)
nmod:for(was-5, S17-54)
conj:and(SULT1A2-14, S17-54)
nmod:for(was-5, S19-56)
conj:and(SULT1A2-14, S19-56)
nmod:for(was-5, S20-58)
conj:and(SULT1A2-14, S20-58)
cc(SULT1A2-14, and-59)
nmod:for(was-5, S20-60)
conj:and(SULT1A2-14, S20-60)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT changes/NNS in/IN mRNA/JJ expression/NN and/CC their/PRP$ potential/JJ impact/NN on/IN pregnancy/NN outcomes/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (NNS mechanisms))
                (VP (VBG underlying)
                  (NP
                    (NP (DT these) (NNS changes))
                    (PP (IN in)
                      (NP
                        (NP (JJ mRNA) (NN expression))
                        (CC and)
                        (NP
                          (NP (PRP$ their) (JJ potential) (NN impact))
                          (PP (IN on)
                            (NP (NN pregnancy) (NNS outcomes))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(changes-11, these-10)
dobj(underlying-9, changes-11)
case(expression-14, in-12)
amod(expression-14, mRNA-13)
nmod:in(changes-11, expression-14)
cc(expression-14, and-15)
nmod:poss(impact-18, their-16)
amod(impact-18, potential-17)
nmod:in(changes-11, impact-18)
conj:and(expression-14, impact-18)
case(outcomes-21, on-19)
compound(outcomes-21, pregnancy-20)
nmod:on(impact-18, outcomes-21)

Omega-3_fatty_acids/NNP ,/, including/VBG eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN found/VBN to_be/VB beneficial/JJ in/IN reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNP Omega-3_fatty_acids))
    (, ,)
    (S
      (VP (VBG including)
        (VP
          (VP (VBN eicosapentaenoic_acid))
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-))
          (CC and)
          (VP (VBN docosahexaenoic_acid)
            (PRN (-LRB- -LRB-)
              (NP (NNP DHA))
              (-RRB- -RRB-))))))
    (, ,)
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (VB to_be)
              (ADJP (JJ beneficial)
                (PP (IN in)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP
                            (NP (VBG developing) (NN coronary_heart_disease))
                            (PRN (-LRB- -LRB-)
                              (NP (NNP CHD))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

nsubjpass(found-16, Omega-3_fatty_acids-1)
advcl(found-16, including-3)
dep(including-3, eicosapentaenoic_acid-4)
dep(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
dep(including-3, docosahexaenoic_acid-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
dep(docosahexaenoic_acid-9, DHA-11)
aux(found-16, have-14)
auxpass(found-16, been-15)
root(ROOT-0, found-16)
ccomp(found-16, to_be-17)
xcomp(to_be-17, beneficial-18)
mark(reducing-20, in-19)
advcl(beneficial-18, reducing-20)
det(risk-22, the-21)
dobj(reducing-20, risk-22)
case(coronary_heart_disease-25, of-23)
amod(coronary_heart_disease-25, developing-24)
nmod:of(risk-22, coronary_heart_disease-25)
appos(coronary_heart_disease-25, CHD-27)

In/IN the/DT present/JJ study/NN ,/, we/PRP found/VBD that/IN EPA/NNP and/CC DHA/NNP supplementation/NNS significantly/RB reduced/VBD plasma/NN L-lysine/JJ levels/NNS in/IN hyperL-lysinemic/JJ patients/NNS with/IN CHD/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ present) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (NNP EPA)
            (CC and)
            (NNP DHA) (NNS supplementation))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (NN plasma) (JJ L-lysine) (NNS levels))
              (PP (IN in)
                (NP (JJ hyperL-lysinemic) (NNS patients))))
            (PP (IN with)
              (NP (NNP CHD)))))))
    (. .)))

case(study-4, In-1)
det(study-4, the-2)
amod(study-4, present-3)
nmod:in(found-7, study-4)
nsubj(found-7, we-6)
root(ROOT-0, found-7)
mark(reduced-14, that-8)
compound(supplementation-12, EPA-9)
cc(EPA-9, and-10)
conj:and(EPA-9, DHA-11)
compound(supplementation-12, DHA-11)
nsubj(reduced-14, supplementation-12)
advmod(reduced-14, significantly-13)
ccomp(found-7, reduced-14)
compound(levels-17, plasma-15)
amod(levels-17, L-lysine-16)
dobj(reduced-14, levels-17)
case(patients-20, in-18)
amod(patients-20, hyperL-lysinemic-19)
nmod:in(levels-17, patients-20)
case(CHD-22, with-21)
nmod:with(reduced-14, CHD-22)

In/IN addition/NN ,/, EPA/NNP supplementation/NN significantly/RB decreased/VBD plasma/NN levels/NNS of/IN L-arginine/JJ and_L-citrulline/NN in/IN these/DT patients/NNS as/RB well/RB as/IN in/IN healthy_controls/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (NNP EPA) (NN supplementation))
    (ADVP (RB significantly))
    (VP (VBD decreased)
      (NP
        (NP (NN plasma) (NNS levels))
        (PP (IN of)
          (NP (JJ L-arginine) (NN and_L-citrulline))))
      (PP
        (PP (IN in)
          (NP (DT these) (NNS patients)))
        (CONJP (RB as) (RB well) (IN as))
        (PP (IN in)
          (NP (NNS healthy_controls)))))
    (. .)))

case(addition-2, In-1)
nmod:in(decreased-7, addition-2)
compound(supplementation-5, EPA-4)
nsubj(decreased-7, supplementation-5)
nsubj(decreased-7', supplementation-5)
advmod(decreased-7, significantly-6)
root(ROOT-0, decreased-7)
conj:and(decreased-7, decreased-7')
compound(levels-9, plasma-8)
dobj(decreased-7, levels-9)
case(and_L-citrulline-12, of-10)
amod(and_L-citrulline-12, L-arginine-11)
nmod:of(levels-9, and_L-citrulline-12)
case(patients-15, in-13)
det(patients-15, these-14)
nmod:in(decreased-7, patients-15)
cc(decreased-7, as-16)
mwe(as-16, well-17)
mwe(as-16, as-18)
case(healthy_controls-20, in-19)
nmod:in(decreased-7', healthy_controls-20)

This/DT suggests/VBZ that/IN the/DT beneficial/JJ effects/NNS of/IN these/DT fatty_acids/NNS on/IN CHD/NNP may/MD be/VB related/VBN to/TO their/PRP$ ability/NN to/TO modulate/VBP L-lysine/JJ metabolism/NN ./.

(ROOT
  (SINV
    (S
      (NP (DT This))
      (VP (VBZ suggests)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (JJ beneficial) (NNS effects))
              (PP (IN of)
                (NP
                  (NP (DT these) (NNS fatty_acids))
                  (PP (IN on)
                    (NP (NNP CHD))))))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN related)
                  (PP (TO to)
                    (NP (PRP$ their) (NN ability)
                      (S
                        (VP (TO to))))))))))))
    (VP (VBP modulate))
    (NP (JJ L-lysine) (NN metabolism))
    (. .)))

nsubj(suggests-2, This-1)
dep(modulate-19, suggests-2)
mark(related-14, that-3)
det(effects-6, the-4)
amod(effects-6, beneficial-5)
nsubjpass(related-14, effects-6)
case(fatty_acids-9, of-7)
det(fatty_acids-9, these-8)
nmod:of(effects-6, fatty_acids-9)
case(CHD-11, on-10)
nmod:on(fatty_acids-9, CHD-11)
aux(related-14, may-12)
auxpass(related-14, be-13)
ccomp(suggests-2, related-14)
case(ability-17, to-15)
nmod:poss(ability-17, their-16)
nmod:to(related-14, ability-17)
acl(ability-17, to-18)
root(ROOT-0, modulate-19)
amod(metabolism-21, L-lysine-20)
nsubj(modulate-19, metabolism-21)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP influence/VBP L-lysine/JJ levels/NNS and/CC how/WRB this/DT may/MD impact/VB CHD/NNP risk/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP (DT the) (NNS mechanisms))
              (PP (IN by)
                (SBAR
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (NP (NNP EPA)
                        (CC and)
                        (NNP DHA))
                      (VP (VBP influence)
                        (NP (JJ L-lysine) (NNS levels)))))
                  (CC and)
                  (SBAR
                    (WHADVP (WRB how))
                    (S
                      (NP (DT this))
                      (VP (MD may)
                        (VP (VB impact)
                          (NP (NNP CHD) (NN risk)))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-6, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
mark(influence-14, by-9)
dobj(influence-14, which-10)
nsubj(influence-14, EPA-11)
cc(EPA-11, and-12)
conj:and(EPA-11, DHA-13)
nsubj(influence-14, DHA-13)
advcl(elucidate-6, influence-14)
amod(levels-16, L-lysine-15)
dobj(influence-14, levels-16)
cc(influence-14, and-17)
advmod(impact-21, how-18)
nsubj(impact-21, this-19)
aux(impact-21, may-20)
advcl(elucidate-6, impact-21)
conj:and(influence-14, impact-21)
compound(risk-23, CHD-22)
dobj(impact-21, risk-23)

Nonetheless/RB ,/, these/DT findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT potential/JJ therapeutic/JJ applications/NNS of/IN omega-3_fatty_acids/NN in/IN the/DT prevention/NN and/CC treatment/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (ADVP (RB Nonetheless))
    (, ,)
    (NP (DT these) (NNS findings))
    (VP (VBP provide)
      (NP
        (NP (JJ new) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
            (PP (IN of)
              (NP
                (NP (NN omega-3_fatty_acids))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN treatment))
                    (PP (IN of)
                      (NP (NN cardiovascular_disease)))))))))))
    (. .)))

advmod(provide-5, Nonetheless-1)
det(findings-4, these-3)
nsubj(provide-5, findings-4)
root(ROOT-0, provide-5)
amod(insights-7, new-6)
dobj(provide-5, insights-7)
case(applications-12, into-8)
det(applications-12, the-9)
amod(applications-12, potential-10)
amod(applications-12, therapeutic-11)
nmod:into(insights-7, applications-12)
case(omega-3_fatty_acids-14, of-13)
nmod:of(applications-12, omega-3_fatty_acids-14)
case(prevention-17, in-15)
det(prevention-17, the-16)
nmod:in(omega-3_fatty_acids-14, prevention-17)
cc(prevention-17, and-18)
nmod:in(omega-3_fatty_acids-14, treatment-19)
conj:and(prevention-17, treatment-19)
case(cardiovascular_disease-21, of-20)
nmod:of(prevention-17, cardiovascular_disease-21)

The/DT possible/JJ roles/NNS of/IN adenosine_3/NNS '/POS ,5/CD '_-/JJ cyclic_monophosphate/NN -LRB-/-LRB- cAMP/NN -RRB-/-RRB- and/CC guanosine_3/NNS '/POS ,5/CD '_-/CD cyclic_monophosphate/NN -LRB-/-LRB- cGMP/NN -RRB-/-RRB- and/CC of/IN Procyanidin/NNP on/IN the/DT early/JJ effect/NN of/IN STAT_1/NNP -LRB-/-LRB- PRL/NNP -RRB-/-RRB- on/IN lactose/JJ biosynthesis/NNS have/VBP been/VBN investigated/VBN in/IN cultured/JJ mammary_gland/JJ explants/NNS derived/VBN from/IN mice/NNS 12-14/CD days/NNS pregnant/JJ ./.

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP
            (NP (DT The) (JJ possible) (NNS roles))
            (PP (IN of)
              (NP
                (NP (NNS adenosine_3) (POS '))
                (CD ,5)
                (NX
                  (NX
                    (NX (JJ '_-) (NN cyclic_monophosphate))
                    (PRN (-LRB- -LRB-) (NN cAMP) (-RRB- -RRB-)))
                  (CC and)
                  (NX (NNS guanosine_3)))))
            (POS '))
          (QP (CD ,5) (CD '_-))
          (NN cyclic_monophosphate))
        (PRN (-LRB- -LRB-)
          (NP (NN cGMP))
          (-RRB- -RRB-)))
      (CC and)
      (NP
        (PP (IN of)
          (NP
            (NP (NNP Procyanidin))
            (PP (IN on)
              (NP
                (NP
                  (NP (DT the) (JJ early) (NN effect))
                  (PP (IN of)
                    (NP (NNP STAT_1))))
                (PRN (-LRB- -LRB-)
                  (NP (NNP PRL))
                  (-RRB- -RRB-))))))
        (PP (IN on)
          (NP (JJ lactose) (NNS biosynthesis)))))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN investigated)
          (PP (IN in)
            (NP
              (NP (JJ cultured) (JJ mammary_gland) (NNS explants))
              (VP (VBN derived)
                (PP (IN from)
                  (NP
                    (NP (NNS mice))
                    (NP-TMP (CD 12-14) (NNS days))))
                (S
                  (ADJP (JJ pregnant)))))))))
    (. .)))

det(roles-3, The-1)
amod(roles-3, possible-2)
nmod:poss(cyclic_monophosphate-18, roles-3)
case(cyclic_monophosphate-9, of-4)
nmod:poss(cyclic_monophosphate-9, adenosine_3-5)
case(adenosine_3-5, '-6)
nummod(cyclic_monophosphate-9, ,5-7)
amod(cyclic_monophosphate-9, '_--8)
nmod:of(roles-3, cyclic_monophosphate-9)
dep(cyclic_monophosphate-9, cAMP-11)
cc(cyclic_monophosphate-9, and-13)
nmod:of(roles-3, guanosine_3-14)
conj:and(cyclic_monophosphate-9, guanosine_3-14)
case(roles-3, '-15)
compound('_--17, ,5-16)
nummod(cyclic_monophosphate-18, '_--17)
nsubjpass(investigated-39, cyclic_monophosphate-18)
appos(cyclic_monophosphate-18, cGMP-20)
cc(cyclic_monophosphate-18, and-22)
case(Procyanidin-24, of-23)
conj:and(cyclic_monophosphate-18, Procyanidin-24)
nsubjpass(investigated-39, Procyanidin-24)
case(effect-28, on-25)
det(effect-28, the-26)
amod(effect-28, early-27)
nmod:on(Procyanidin-24, effect-28)
case(STAT_1-30, of-29)
nmod:of(effect-28, STAT_1-30)
appos(effect-28, PRL-32)
case(biosynthesis-36, on-34)
amod(biosynthesis-36, lactose-35)
nmod:on(Procyanidin-24, biosynthesis-36)
aux(investigated-39, have-37)
auxpass(investigated-39, been-38)
root(ROOT-0, investigated-39)
case(explants-43, in-40)
amod(explants-43, cultured-41)
amod(explants-43, mammary_gland-42)
nmod:in(investigated-39, explants-43)
acl(explants-43, derived-44)
case(mice-46, from-45)
nmod:from(derived-44, mice-46)
nummod(days-48, 12-14-47)
nmod:tmod(mice-46, days-48)
xcomp(derived-44, pregnant-49)

In/IN this/DT study/NN ,/, the/DT possible/JJ roles/NNS of/IN adenosine_3/NNS '/POS ,5/CD '/'' -/: cyclic_monophosphate/VB -LRB-/-LRB- cAMP/NN -RRB-/-RRB- and/CC guanosine_3/NNS '/POS ,5/CD '/'' -/: cyclic_monophosphate/NN -LRB-/-LRB- cGMP/NN -RRB-/-RRB- and/CC of/IN Procyanidin/NNP on/IN the/DT early/JJ effect/NN of/IN STAT1/NNP -LRB-/-LRB- PRL/NNP -RRB-/-RRB- on/IN lactose/JJ biosynthesis/NNS were/VBD investigated/VBN in/IN cultured/JJ mammary_gland/JJ explants/NNS derived/VBN from/IN mice/NNS 12-14/CD days/NNS pregnant/JJ ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (JJ possible) (NNS roles))
      (PP (IN of)
        (NP
          (NP
            (NP (NNS adenosine_3) (POS '))
            (ADJP (CD ,5))
            ('' ')
            (PRN (: -)
              (S
                (VP (VB cyclic_monophosphate)
                  (NP
                    (NP (-LRB- -LRB-) (NN cAMP) (-RRB- -RRB-))
                    (CC and)
                    (NP
                      (NP (NNS guanosine_3) (POS '))
                      (NX (CD ,5)))
                    ('' '))))
              (: -))
            (NN cyclic_monophosphate))
          (PRN (-LRB- -LRB-)
            (NP (NN cGMP))
            (-RRB- -RRB-))
          (CC and)
          (NP
            (PP (IN of)
              (NP (NNP Procyanidin)))
            (PP (IN on)
              (NP
                (NP (DT the) (JJ early) (NN effect))
                (PP (IN of)
                  (NP (NNP STAT1))))))
          (PRN (-LRB- -LRB-)
            (NP (NNP PRL))
            (-RRB- -RRB-))
          (PP (IN on)
            (NP (JJ lactose) (NNS biosynthesis))))))
    (VP (VBD were)
      (VP (VBN investigated)
        (PP (IN in)
          (NP
            (NP (JJ cultured) (JJ mammary_gland) (NNS explants))
            (VP (VBN derived)
              (PP (IN from)
                (NP
                  (NP (NNS mice))
                  (NP-TMP (CD 12-14) (NNS days))))
              (S
                (ADJP (JJ pregnant))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-44, study-3)
det(roles-7, the-5)
amod(roles-7, possible-6)
conj:and(roles-7, roles-7')
conj:and(roles-7, roles-7'')
nsubjpass(investigated-44, roles-7)
nsubjpass(investigated-44, roles-7')
nsubjpass(investigated-44, roles-7'')
case(cyclic_monophosphate-24, of-8)
nmod:poss(cyclic_monophosphate-24, adenosine_3-9)
case(adenosine_3-9, '-10)
amod(cyclic_monophosphate-24, ,5-11)
dep(cyclic_monophosphate-24, cyclic_monophosphate-14)
dobj(cyclic_monophosphate-14, cAMP-16)
cc(cAMP-16, and-18)
nmod:poss(,5-21, guanosine_3-19)
case(guanosine_3-19, '-20)
dobj(cyclic_monophosphate-14, ,5-21)
conj:and(cAMP-16, ,5-21)
nmod:of(roles-7, cyclic_monophosphate-24)
appos(cyclic_monophosphate-24, cGMP-26)
cc(roles-7, and-28)
case(Procyanidin-30, of-29)
nmod:of(roles-7'', Procyanidin-30)
case(effect-34, on-31)
det(effect-34, the-32)
amod(effect-34, early-33)
nmod:on(Procyanidin-30, effect-34)
case(STAT1-36, of-35)
nmod:of(effect-34, STAT1-36)
appos(cyclic_monophosphate-24, PRL-38)
case(biosynthesis-42, on-40)
amod(biosynthesis-42, lactose-41)
nmod:on(roles-7', biosynthesis-42)
auxpass(investigated-44, were-43)
root(ROOT-0, investigated-44)
case(explants-48, in-45)
amod(explants-48, cultured-46)
amod(explants-48, mammary_gland-47)
nmod:in(investigated-44, explants-48)
acl(explants-48, derived-49)
case(mice-51, from-50)
nmod:from(derived-49, mice-51)
nummod(days-53, 12-14-52)
nmod:tmod(mice-51, days-53)
xcomp(derived-49, pregnant-54)

The/DT results/NNS showed/VBD that/IN cAMP/NN and/CC cGMP/NN were/VBD involved/VBN in/IN the/DT regulation/NN of/IN lactose/JJ biosynthesis/NNS ,/, with/IN cAMP/NN playing/VBG a/DT stimulatory/JJ role/NN while/IN cGMP/NN had/VBD an/DT inhibitory/JJ effect/NN ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NN cAMP)
            (CC and)
            (NN cGMP))
          (VP (VBD were)
            (VP (VBN involved)
              (PP (IN in)
                (NP
                  (NP (DT the) (NN regulation))
                  (PP (IN of)
                    (NP (JJ lactose) (NNS biosynthesis)))))
              (, ,)
              (PP (IN with)
                (NP
                  (NP (NN cAMP))
                  (VP (VBG playing)
                    (NP (DT a) (JJ stimulatory) (NN role))
                    (SBAR (IN while)
                      (S
                        (NP (NN cGMP))
                        (VP (VBD had)
                          (NP (DT an) (JJ inhibitory) (NN effect)))))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(involved-9, that-4)
nsubjpass(involved-9, cAMP-5)
cc(cAMP-5, and-6)
conj:and(cAMP-5, cGMP-7)
nsubjpass(involved-9, cGMP-7)
auxpass(involved-9, were-8)
ccomp(showed-3, involved-9)
case(regulation-12, in-10)
det(regulation-12, the-11)
nmod:in(involved-9, regulation-12)
case(biosynthesis-15, of-13)
amod(biosynthesis-15, lactose-14)
nmod:of(regulation-12, biosynthesis-15)
case(cAMP-18, with-17)
nmod:with(involved-9, cAMP-18)
acl(cAMP-18, playing-19)
det(role-22, a-20)
amod(role-22, stimulatory-21)
dobj(playing-19, role-22)
mark(had-25, while-23)
nsubj(had-25, cGMP-24)
advcl(playing-19, had-25)
det(effect-28, an-26)
amod(effect-28, inhibitory-27)
dobj(had-25, effect-28)

Furthermore/RB ,/, Procyanidin/NNP was/VBD found/VBN to/TO enhance/VB the/DT stimulatory/JJ effect/NN of/IN cAMP/NN on/IN lactose/JJ biosynthesis/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NNP Procyanidin))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP (VB enhance)
              (NP
                (NP (DT the) (JJ stimulatory) (NN effect))
                (PP (IN of)
                  (NP
                    (NP (NN cAMP))
                    (PP (IN on)
                      (NP (JJ lactose) (NNS biosynthesis)))))))))))
    (. .)))

advmod(found-5, Furthermore-1)
nsubjpass(found-5, Procyanidin-3)
nsubj:xsubj(enhance-7, Procyanidin-3)
auxpass(found-5, was-4)
root(ROOT-0, found-5)
mark(enhance-7, to-6)
xcomp(found-5, enhance-7)
det(effect-10, the-8)
amod(effect-10, stimulatory-9)
dobj(enhance-7, effect-10)
case(cAMP-12, of-11)
nmod:of(effect-10, cAMP-12)
case(biosynthesis-15, on-13)
amod(biosynthesis-15, lactose-14)
nmod:on(cAMP-12, biosynthesis-15)

Additionally/RB ,/, the/DT early/JJ effect/NN of/IN STAT1/NNP -LRB-/-LRB- PRL/NNP -RRB-/-RRB- on/IN lactose/JJ biosynthesis/NNS was/VBD found/VBN to_be/JJ mediated/VBN by/IN cAMP/NN and/CC not/RB by/IN cGMP/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP
      (NP
        (NP
          (NP (DT the) (JJ early) (NN effect))
          (PP (IN of)
            (NP (NNP STAT1))))
        (PRN (-LRB- -LRB-)
          (NP (NNP PRL))
          (-RRB- -RRB-)))
      (PP (IN on)
        (NP (JJ lactose) (NNS biosynthesis))))
    (VP (VBD was)
      (VP (VBN found)
        (ADJP (JJ to_be))
        (PP (VBN mediated)
          (PP (IN by)
            (NP
              (QP (NN cAMP)
                (CC and)
                (RB not)))))
        (PP (IN by)
          (NP (NN cGMP)))))
    (. .)))

advmod(found-15, Additionally-1)
det(effect-5, the-3)
amod(effect-5, early-4)
nsubjpass(found-15, effect-5)
case(STAT1-7, of-6)
nmod:of(effect-5, STAT1-7)
appos(effect-5, PRL-9)
case(biosynthesis-13, on-11)
amod(biosynthesis-13, lactose-12)
nmod:on(effect-5, biosynthesis-13)
auxpass(found-15, was-14)
root(ROOT-0, found-15)
xcomp(found-15, to_be-16)
case(cAMP-19, mediated-17)
case(cAMP-19, by-18)
advcl(found-15, cAMP-19)
cc(cAMP-19, and-20)
advcl(found-15, not-21)
conj:and(cAMP-19, not-21)
case(cGMP-23, by-22)
nmod:by(found-15, cGMP-23)

These/DT findings/NNS shed/VBD light/NN on/IN the/DT molecular/JJ mechanisms/NNS underlying/VBG the/DT regulation/NN of/IN lactose/JJ biosynthesis/NNS during/IN pregnancy/NN and/CC may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN therapeutic/JJ interventions/NNS for/IN lactation/NN disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBD shed)
        (NP (NN light))
        (PP (IN on)
          (NP
            (NP (DT the) (JJ molecular) (NNS mechanisms))
            (VP (VBG underlying)
              (NP
                (NP (DT the) (NN regulation))
                (PP (IN of)
                  (NP (JJ lactose) (NNS biosynthesis)))))))
        (PP (IN during)
          (NP (NN pregnancy))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (JJ therapeutic) (NNS interventions))
                    (PP (IN for)
                      (NP (NN lactation) (NNS disorders)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(shed-3, findings-2)
nsubj(have-19, findings-2)
root(ROOT-0, shed-3)
dobj(shed-3, light-4)
case(mechanisms-8, on-5)
det(mechanisms-8, the-6)
amod(mechanisms-8, molecular-7)
nmod:on(shed-3, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(regulation-11, the-10)
dobj(underlying-9, regulation-11)
case(biosynthesis-14, of-12)
amod(biosynthesis-14, lactose-13)
nmod:of(regulation-11, biosynthesis-14)
case(pregnancy-16, during-15)
nmod:during(shed-3, pregnancy-16)
cc(shed-3, and-17)
aux(have-19, may-18)
conj:and(shed-3, have-19)
dobj(have-19, implications-20)
case(development-23, for-21)
det(development-23, the-22)
nmod:for(implications-20, development-23)
case(interventions-26, of-24)
amod(interventions-26, therapeutic-25)
nmod:of(development-23, interventions-26)
case(disorders-29, for-27)
compound(disorders-29, lactation-28)
nmod:for(interventions-26, disorders-29)

Cinnoline/NNP has_been/VBP shown/VBN to/TO promote/VB skeletal_muscle/JJ differentiation/NN in/IN vitro/NN and/CC in/IN vivo/NN ./.

(ROOT
  (S
    (NP (NNP Cinnoline))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB promote)
              (NP (JJ skeletal_muscle) (NN differentiation))
              (PP
                (PP (IN in)
                  (NP (NN vitro)))
                (CC and)
                (PP (IN in)
                  (NP (NN vivo)))))))))
    (. .)))

nsubj(has_been-2, Cinnoline-1)
root(ROOT-0, has_been-2)
dep(has_been-2, shown-3)
mark(promote-5, to-4)
xcomp(shown-3, promote-5)
xcomp(shown-3, promote-5')
conj:and(promote-5, promote-5')
amod(differentiation-7, skeletal_muscle-6)
dobj(promote-5, differentiation-7)
case(vitro-9, in-8)
nmod:in(promote-5, vitro-9)
cc(promote-5, and-10)
case(vivo-12, in-11)
nmod:in(promote-5', vivo-12)

We/PRP previously/RB reported/VBD that/IN cinnoline/JJ up-regulated/JJ phophodiesterase_10A/JJ protein/NN levels/NNS in/IN C2C12/CD cells/NNS cultured/VBD under/IN differentiation-promoting/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB previously))
    (VP (VBD reported)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ cinnoline) (JJ up-regulated) (JJ phophodiesterase_10A) (NN protein) (NNS levels))
            (PP (IN in)
              (NP (CD C2C12) (NNS cells))))
          (VP (VBD cultured)
            (PP (IN under)
              (NP (JJ differentiation-promoting) (NNS conditions)))))))
    (. .)))

nsubj(reported-3, We-1)
advmod(reported-3, previously-2)
root(ROOT-0, reported-3)
mark(cultured-13, that-4)
amod(levels-9, cinnoline-5)
amod(levels-9, up-regulated-6)
amod(levels-9, phophodiesterase_10A-7)
compound(levels-9, protein-8)
nsubj(cultured-13, levels-9)
case(cells-12, in-10)
nummod(cells-12, C2C12-11)
nmod:in(levels-9, cells-12)
ccomp(reported-3, cultured-13)
case(conditions-16, under-14)
amod(conditions-16, differentiation-promoting-15)
nmod:under(cultured-13, conditions-16)

However/RB ,/, the/DT mechanism/NN by/IN which/WDT cinnolines/VBZ up-regulate/JJ the/DT expression/NN and/CC activity/NN of/IN phophodiesterases/NNS remains/VBZ unclear/JJ ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (S
      (NP
        (NP (DT the) (NN mechanism))
        (WHPP (IN by)
          (WHNP (WDT which))))
      (VP (VBZ cinnolines)
        (NP (JJ up-regulate) (DT the) (NN expression))))
    (CC and)
    (S
      (NP
        (NP (NN activity))
        (PP (IN of)
          (NP (NNS phophodiesterases))))
      (VP (VBZ remains)
        (ADJP (JJ unclear))))
    (. .)))

advmod(cinnolines-7, However-1)
det(mechanism-4, the-3)
nsubj(cinnolines-7, mechanism-4)
case(which-6, by-5)
nmod:by(mechanism-4, which-6)
root(ROOT-0, cinnolines-7)
amod(expression-10, up-regulate-8)
det(expression-10, the-9)
dobj(cinnolines-7, expression-10)
cc(cinnolines-7, and-11)
nsubj(remains-15, activity-12)
case(phophodiesterases-14, of-13)
nmod:of(activity-12, phophodiesterases-14)
conj:and(cinnolines-7, remains-15)
xcomp(remains-15, unclear-16)

Several/JJ signaling/VBG pathways/NNS have/VBP been/VBN implicated/VBN in/IN the/DT regulation/NN of_skeletal_muscle/JJ development/NN and/CC function/NN ./.

(ROOT
  (S
    (NP (JJ Several) (VBG signaling) (NNS pathways))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN implicated)
          (PP (IN in)
            (NP
              (NP (DT the) (NN regulation) (JJ of_skeletal_muscle) (NN development))
              (CC and)
              (NP (NN function)))))))
    (. .)))

amod(pathways-3, Several-1)
amod(pathways-3, signaling-2)
nsubjpass(implicated-6, pathways-3)
aux(implicated-6, have-4)
auxpass(implicated-6, been-5)
root(ROOT-0, implicated-6)
case(development-11, in-7)
det(development-11, the-8)
compound(development-11, regulation-9)
amod(development-11, of_skeletal_muscle-10)
nmod:in(implicated-6, development-11)
cc(development-11, and-12)
nmod:in(implicated-6, function-13)
conj:and(development-11, function-13)

Among/IN these/DT pathways/NNS ,/, cyclic_nucleotide/JJ signaling/VBG has_been/NN shown/VBN to/TO play/VB a/DT crucial/JJ role/NN in/IN the/DT regulation/NN of_skeletal_muscle/VBD development/NN and/CC function/NN ./.

(ROOT
  (S
    (PP (IN Among)
      (NP (DT these) (NNS pathways)))
    (, ,)
    (NP
      (NP (JJ cyclic_nucleotide) (VBG signaling) (NN has_been))
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB play)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (NP (DT the) (NN regulation)))))))))
    (VP (VBD of_skeletal_muscle)
      (NP (NN development)
        (CC and)
        (NN function)))
    (. .)))

case(pathways-3, Among-1)
det(pathways-3, these-2)
nmod:among(of_skeletal_muscle-17, pathways-3)
amod(has_been-7, cyclic_nucleotide-5)
amod(has_been-7, signaling-6)
nsubj(of_skeletal_muscle-17, has_been-7)
acl(has_been-7, shown-8)
mark(play-10, to-9)
xcomp(shown-8, play-10)
det(role-13, a-11)
amod(role-13, crucial-12)
dobj(play-10, role-13)
case(regulation-16, in-14)
det(regulation-16, the-15)
nmod:in(role-13, regulation-16)
root(ROOT-0, of_skeletal_muscle-17)
dobj(of_skeletal_muscle-17, development-18)
cc(development-18, and-19)
dobj(of_skeletal_muscle-17, function-20)
conj:and(development-18, function-20)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN cinnoline/NN on/IN cyclic_nucleotide/NN signaling/VBG in/IN C2C12/CD cells/NNS cultured/VBN under/IN differentiation-promoting/JJ conditions/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NN cinnoline))))
      (PP (IN on)
        (NP (NN cyclic_nucleotide)))
      (PP (VBG signaling)
        (PP (IN in)
          (NP
            (NP (CD C2C12) (NNS cells))
            (VP (VBN cultured)
              (PP (IN under)
                (NP (JJ differentiation-promoting) (NNS conditions))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(cinnoline-10, of-9)
nmod:of(effects-8, cinnoline-10)
case(cyclic_nucleotide-12, on-11)
nmod:on(investigated-6, cyclic_nucleotide-12)
case(cells-16, signaling-13)
case(cells-16, in-14)
nummod(cells-16, C2C12-15)
advcl(investigated-6, cells-16)
acl(cells-16, cultured-17)
case(conditions-20, under-18)
amod(conditions-20, differentiation-promoting-19)
nmod:under(cultured-17, conditions-20)

Our/PRP$ results/NNS demonstrate/VBP that/IN cinnoline/JJ treatment/NN up-regulated/VBD phophodiesterase_10A/JJ protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ phophodiesterase_10A/JJ protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP demonstrate)
      (SBAR (IN that)
        (S
          (NP (JJ cinnoline) (NN treatment))
          (VP (VBD up-regulated)
            (NP (JJ phophodiesterase_10A) (NN protein) (NNS levels))
            (NP (NN in_a)
              (NX
                (NX (JJ time-dependent) (NN manner))
                (CC and)
                (NX (JJ prolonged) (JJ phophodiesterase_10A) (NN protein)))
              (NX (NN half-life)))
            (PP (IN from)
              (NP
                (QP (CD 10) (TO to) (CD 18))
                (NNS hours)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(demonstrate-3, results-2)
root(ROOT-0, demonstrate-3)
mark(up-regulated-7, that-4)
amod(treatment-6, cinnoline-5)
nsubj(up-regulated-7, treatment-6)
ccomp(demonstrate-3, up-regulated-7)
amod(levels-10, phophodiesterase_10A-8)
compound(levels-10, protein-9)
iobj(up-regulated-7, levels-10)
dep(half-life-18, in_a-11)
amod(manner-13, time-dependent-12)
dep(half-life-18, manner-13)
cc(manner-13, and-14)
amod(protein-17, prolonged-15)
amod(protein-17, phophodiesterase_10A-16)
conj:and(manner-13, protein-17)
dep(half-life-18, protein-17)
dobj(up-regulated-7, half-life-18)
case(hours-23, from-19)
compound(18-22, 10-20)
dep(18-22, to-21)
nummod(hours-23, 18-22)
nmod:from(up-regulated-7, hours-23)

This/DT suggests/VBZ that/IN cinnoline/NN may/MD enhance/VB cyclic_nucleotide/NN signaling/VBG by/IN increasing/VBG the/DT availability/NN of/IN cyclic_nucleotides/NNS through/IN degradation/NN of/IN their/PRP$ hydrolyzing/JJ enzymes/NNS ./.

(ROOT
  (S
    (NP (DT This))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (NN cinnoline))
          (VP (MD may)
            (VP (VB enhance)
              (NP (NN cyclic_nucleotide))
              (PP (VBG signaling)
                (PP (IN by)
                  (S
                    (VP (VBG increasing)
                      (NP
                        (NP (DT the) (NN availability))
                        (PP (IN of)
                          (NP (NNS cyclic_nucleotides))))
                      (PP (IN through)
                        (NP
                          (NP (NN degradation))
                          (PP (IN of)
                            (NP (PRP$ their) (JJ hydrolyzing) (NNS enzymes))))))))))))))
    (. .)))

nsubj(suggests-2, This-1)
root(ROOT-0, suggests-2)
mark(enhance-6, that-3)
nsubj(enhance-6, cinnoline-4)
aux(enhance-6, may-5)
ccomp(suggests-2, enhance-6)
dobj(enhance-6, cyclic_nucleotide-7)
dep(increasing-10, signaling-8)
mark(increasing-10, by-9)
advcl(enhance-6, increasing-10)
det(availability-12, the-11)
dobj(increasing-10, availability-12)
case(cyclic_nucleotides-14, of-13)
nmod:of(availability-12, cyclic_nucleotides-14)
case(degradation-16, through-15)
nmod:through(increasing-10, degradation-16)
case(enzymes-20, of-17)
nmod:poss(enzymes-20, their-18)
amod(enzymes-20, hydrolyzing-19)
nmod:of(degradation-16, enzymes-20)

These/DT findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT mechanism/NN by/IN which/WDT cinnoline/NN regulates/VBZ skeletal_muscle/JJ differentiation_and/NN may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/JJ therapeutic/JJ strategies/NNS for/IN muscular_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP provide)
      (NP
        (NP (JJ new) (NNS insights))
        (PP (IN into)
          (NP (DT the) (NN mechanism))))
      (PP (IN by)
        (SBAR
          (WHNP (WDT which))
          (S
            (NP (NN cinnoline))
            (VP (VBZ regulates)
              (SBAR
                (S
                  (NP (JJ skeletal_muscle) (NN differentiation_and))
                  (VP (MD may)
                    (VP (VB have)
                      (NP
                        (NP (NNS implications))
                        (PP (IN for)
                          (NP
                            (NP (DT the) (NN development))
                            (PP (IN of)
                              (NP
                                (NP (JJ novel) (JJ therapeutic) (NNS strategies))
                                (PP (IN for)
                                  (NP (NNS muscular_disorders)))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
dobj(provide-3, insights-5)
case(mechanism-8, into-6)
det(mechanism-8, the-7)
nmod:into(insights-5, mechanism-8)
mark(regulates-12, by-9)
dobj(regulates-12, which-10)
nsubj(regulates-12, cinnoline-11)
advcl(provide-3, regulates-12)
amod(differentiation_and-14, skeletal_muscle-13)
nsubj(have-16, differentiation_and-14)
aux(have-16, may-15)
ccomp(regulates-12, have-16)
dobj(have-16, implications-17)
case(development-20, for-18)
det(development-20, the-19)
nmod:for(implications-17, development-20)
case(strategies-24, of-21)
amod(strategies-24, novel-22)
amod(strategies-24, therapeutic-23)
nmod:of(development-20, strategies-24)
case(muscular_disorders-26, for-25)
nmod:for(strategies-24, muscular_disorders-26)

There/EX was/VBD a/DT correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/RB less/JJR than/IN 0.01/CD -RRB-/-RRB- ,/, erucic_acids/NNS -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/VBP less/JJR than/IN 0.01/CD -RRB-/-RRB- and/CC serum/NN Lipase/NNP levels/NNS ./.

(ROOT
  (S
    (NP (EX There))
    (VP
      (VP (VBD was)
        (NP
          (NP (DT a) (NN correlation))
          (PP (IN between)
            (NP
              (NP (NN serum) (NNS levels))
              (PP (IN of)
                (NP (NN alkaline_phosphatase)))))))
      (PRN (-LRB- -LRB-)
        (SBAR
          (X
            (X (SYM r))
            (NP (SYM =)))
          (S
            (NP
              (NP (CD 0.3))
              (PRN (, ,)
                (ADVP (RB p))
                (NP
                  (QP (JJR less) (IN than) (CD 0.01)))
                (-RRB- -RRB-))
              (, ,)
              (NP
                (NP (NNS erucic_acids))
                (-LRB- -LRB-)
                (NP
                  (FRAG
                    (X
                      (X (SYM r))
                      (NP (SYM =)))
                    (NP (CD 0.42)))))
              (, ,))
            (VP (VBP p)
              (NP
                (QP (JJR less) (IN than) (CD 0.01))))))
        (-RRB- -RRB-))
      (CC and)
      (VP (NN serum)
        (NP (NNP Lipase) (NNS levels))))
    (. .)))

expl(correlation-4, There-1)
cop(correlation-4, was-2)
det(correlation-4, a-3)
root(ROOT-0, correlation-4)
case(levels-7, between-5)
compound(levels-7, serum-6)
nmod:between(correlation-4, levels-7)
case(alkaline_phosphatase-9, of-8)
nmod:of(levels-7, alkaline_phosphatase-9)
dep(=-12, r-11)
dep(p-27, =-12)
nsubj(p-27, 0.3-13)
dep(0.01-18, p-15)
advmod(0.01-18, less-16)
mwe(less-16, than-17)
dep(0.3-13, 0.01-18)
appos(0.3-13, erucic_acids-21)
dep(=-24, r-23)
dep(0.42-25, =-24)
dep(erucic_acids-21, 0.42-25)
parataxis(correlation-4, p-27)
advmod(0.01-30, less-28)
mwe(less-28, than-29)
dobj(p-27, 0.01-30)
cc(correlation-4, and-32)
conj:and(correlation-4, serum-33)
compound(levels-35, Lipase-34)
nsubj(correlation-4, levels-35)

A/DT total/NN of/IN 200/CD subjects/NNS were/VBD enrolled/VBN in/IN the/DT study/NN and/CC their/PRP$ blood/NN samples/NNS were/VBD collected/VBN for/IN analysis/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT A) (NN total))
        (PP (IN of)
          (NP (CD 200) (NNS subjects))))
      (VP (VBD were)
        (VP (VBN enrolled)
          (PP (IN in)
            (NP (DT the) (NN study))))))
    (CC and)
    (S
      (NP (PRP$ their) (NN blood) (NNS samples))
      (VP (VBD were)
        (VP (VBN collected)
          (PP (IN for)
            (NP (NN analysis))))))
    (. .)))

det(total-2, A-1)
nsubjpass(enrolled-7, total-2)
case(subjects-5, of-3)
nummod(subjects-5, 200-4)
nmod:of(total-2, subjects-5)
auxpass(enrolled-7, were-6)
root(ROOT-0, enrolled-7)
case(study-10, in-8)
det(study-10, the-9)
nmod:in(enrolled-7, study-10)
cc(enrolled-7, and-11)
nmod:poss(samples-14, their-12)
compound(samples-14, blood-13)
nsubjpass(collected-16, samples-14)
auxpass(collected-16, were-15)
conj:and(enrolled-7, collected-16)
case(analysis-18, for-17)
nmod:for(collected-16, analysis-18)

The/DT results/NNS showed/VBD that/IN there/EX was/VBD a/DT positive/JJ correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- ,/, erucic_acids/NNS -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- and/CC serum/NN lipase/NN levels/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (VBD was)
            (NP
              (NP (DT a) (JJ positive) (NN correlation))
              (PP (IN between)
                (NP
                  (NP (NN serum) (NNS levels))
                  (PP (IN of)
                    (NP
                      (NP
                        (NP (NN alkaline_phosphatase))
                        (PRN (-LRB- -LRB-)
                          (SBAR
                            (X (SYM r))
                            (S
                              (FRAG
                                (X (SYM =))
                                (NP (CD 0.3)))
                              (, ,)
                              (NP (NN p))
                              (VP (VBP <)
                                (NP (CD 0.01)))))
                          (-RRB- -RRB-)))
                      (, ,)
                      (NP
                        (NP (NNS erucic_acids))
                        (PRN (-LRB- -LRB-)
                          (SBAR
                            (X (SYM r))
                            (S
                              (FRAG
                                (X (SYM =))
                                (NP (CD 0.42)))
                              (, ,)
                              (NP (NN p))
                              (VP (VBP <)
                                (NP (CD 0.01)))))
                          (-RRB- -RRB-)))
                      (CC and)
                      (NP (NN serum) (NN lipase) (NNS levels)))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(was-6, that-4)
expl(was-6, there-5)
ccomp(showed-3, was-6)
det(correlation-9, a-7)
amod(correlation-9, positive-8)
nsubj(was-6, correlation-9)
case(levels-12, between-10)
compound(levels-12, serum-11)
nmod:between(correlation-9, levels-12)
case(alkaline_phosphatase-14, of-13)
nmod:of(levels-12, alkaline_phosphatase-14)
dep(<-21, r-16)
dep(0.3-18, =-17)
dep(<-21, 0.3-18)
nsubj(<-21, p-20)
dep(alkaline_phosphatase-14, <-21)
dobj(<-21, 0.01-22)
nmod:of(levels-12, erucic_acids-25)
conj:and(alkaline_phosphatase-14, erucic_acids-25)
dep(<-32, r-27)
dep(0.42-29, =-28)
dep(<-32, 0.42-29)
nsubj(<-32, p-31)
dep(erucic_acids-25, <-32)
dobj(<-32, 0.01-33)
cc(alkaline_phosphatase-14, and-35)
compound(levels-38, serum-36)
compound(levels-38, lipase-37)
nmod:of(levels-12, levels-38)
conj:and(alkaline_phosphatase-14, levels-38)

These/DT findings/NNS suggest/VBP that/IN alterations/NNS in/IN these/DT biochemical/JJ markers/NNS may/MD be/VB associated/VBN with/IN various/JJ pathological/JJ conditions/NNS such/JJ as/IN liver_disease/NN and/CC pancreatic_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NNS alterations))
            (PP (IN in)
              (NP (DT these) (JJ biochemical) (NNS markers))))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (JJ various) (JJ pathological) (NNS conditions))
                    (PP (JJ such) (IN as)
                      (NP (NN liver_disease)
                        (CC and)
                        (NNS pancreatic_disorders)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(associated-12, that-4)
nsubjpass(associated-12, alterations-5)
case(markers-9, in-6)
det(markers-9, these-7)
amod(markers-9, biochemical-8)
nmod:in(alterations-5, markers-9)
aux(associated-12, may-10)
auxpass(associated-12, be-11)
ccomp(suggest-3, associated-12)
case(conditions-16, with-13)
amod(conditions-16, various-14)
amod(conditions-16, pathological-15)
nmod:with(associated-12, conditions-16)
case(liver_disease-19, such-17)
mwe(such-17, as-18)
nmod:such_as(conditions-16, liver_disease-19)
cc(liver_disease-19, and-20)
nmod:such_as(conditions-16, pancreatic_disorders-21)
conj:and(liver_disease-19, pancreatic_disorders-21)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT underlying/VBG mechanisms/NNS and/CC clinical/JJ implications/NNS of/IN these/DT correlations/NNS for/IN early/JJ diagnosis/NN and/CC management/NN of/IN these/DT diseases/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ clinical) (NNS implications))
                  (PP (IN of)
                    (NP
                      (NP (DT these) (NNS correlations))
                      (PP (IN for)
                        (NP (JJ early) (NN diagnosis)
                          (CC and)
                          (NN management)))))
                  (PP (IN of)
                    (NP (DT these) (NNS diseases))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
xcomp(needed-4, explore-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(explore-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(implications-12, clinical-11)
dobj(explore-6, implications-12)
conj:and(mechanisms-9, implications-12)
case(correlations-15, of-13)
det(correlations-15, these-14)
nmod:of(implications-12, correlations-15)
case(diagnosis-18, for-16)
amod(diagnosis-18, early-17)
nmod:for(correlations-15, diagnosis-18)
cc(diagnosis-18, and-19)
nmod:for(correlations-15, management-20)
conj:and(diagnosis-18, management-20)
case(diseases-23, of-21)
det(diseases-23, these-22)
nmod:of(implications-12, diseases-23)

Non-alcoholic_steatohepatitis/JJ -LRB-/-LRB- NASH/NNP -RRB-/-RRB- is_a/NNS liver_disease/VBP characterized/VBN by/IN inflammation/NN and/CC fat/JJ accumulation/NN in/IN the/DT liver/NN ./.

(ROOT
  (S
    (NP (JJ Non-alcoholic_steatohepatitis)
      (PRN (-LRB- -LRB-)
        (NP (NNP NASH))
        (-RRB- -RRB-))
      (NNS is_a))
    (VP (VBP liver_disease)
      (VP (VBN characterized)
        (PP (IN by)
          (NP
            (NP (NN inflammation))
            (CC and)
            (NP (JJ fat) (NN accumulation))))
        (PP (IN in)
          (NP (DT the) (NN liver)))))
    (. .)))

amod(is_a-5, Non-alcoholic_steatohepatitis-1)
appos(is_a-5, NASH-3)
nsubj(liver_disease-6, is_a-5)
root(ROOT-0, liver_disease-6)
dep(liver_disease-6, characterized-7)
case(inflammation-9, by-8)
nmod:by(characterized-7, inflammation-9)
cc(inflammation-9, and-10)
amod(accumulation-12, fat-11)
nmod:by(characterized-7, accumulation-12)
conj:and(inflammation-9, accumulation-12)
case(liver-15, in-13)
det(liver-15, the-14)
nmod:in(characterized-7, liver-15)

High-fat/JJ diet/NN -LRB-/-LRB- HFD/NNP -RRB-/-RRB- is_a/VBZ major/JJ contributor/NN to/TO the/DT development/NN of/IN NASH/NNP ./.

(ROOT
  (S
    (NP
      (NP (JJ High-fat) (NN diet))
      (PRN (-LRB- -LRB-)
        (NP (NNP HFD))
        (-RRB- -RRB-)))
    (VP (VBZ is_a)
      (NP
        (NP (JJ major) (NN contributor))
        (PP (TO to)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP (NNP NASH)))))))
    (. .)))

amod(diet-2, High-fat-1)
nsubj(is_a-6, diet-2)
appos(diet-2, HFD-4)
root(ROOT-0, is_a-6)
amod(contributor-8, major-7)
dobj(is_a-6, contributor-8)
case(development-11, to-9)
det(development-11, the-10)
nmod:to(contributor-8, development-11)
case(NASH-13, of-12)
nmod:of(development-11, NASH-13)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT anti-inflammatory/JJ effect/NN of/IN pitavastatin/NN on/IN NASH/NNP rats/NNS induced/VBN by/IN HFD/NNP and/CC explored/VBN its/PRP$ potential/JJ mechanisms/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (JJ anti-inflammatory) (NN effect))
        (PP (IN of)
          (NP (NN pitavastatin))))
      (PP (IN on)
        (NP
          (NP (NNP NASH) (NNS rats))
          (VP
            (VP (VBN induced)
              (PP (IN by)
                (NP (NNP HFD))))
            (CC and)
            (VP (VBN explored)
              (NP (PRP$ its) (JJ potential) (NNS mechanisms)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-9, the-7)
amod(effect-9, anti-inflammatory-8)
dobj(investigated-6, effect-9)
case(pitavastatin-11, of-10)
nmod:of(effect-9, pitavastatin-11)
case(rats-14, on-12)
compound(rats-14, NASH-13)
nmod:on(investigated-6, rats-14)
dep(rats-14, induced-15)
case(HFD-17, by-16)
nmod:by(induced-15, HFD-17)
cc(induced-15, and-18)
dep(rats-14, explored-19)
conj:and(induced-15, explored-19)
nmod:poss(mechanisms-22, its-20)
amod(mechanisms-22, potential-21)
dobj(explored-19, mechanisms-22)

In/IN this/DT paper/NN ,/, we/PRP investigated/VBD the/DT anti-inflammatory/JJ effect/NN of/IN pitavastatin/NN on/IN non-alcoholic_steatohepatitis/JJ -LRB-/-LRB- non-alcoholic_steatohepatitis/NNS -RRB-/-RRB- rats/NNS induced/VBN by/IN high_fat_diet/NN -LRB-/-LRB- HFD/NNP -RRB-/-RRB- ,/, and/CC explored/VBD its/PRP$ potential/JJ mechanisms/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN paper)))
    (, ,)
    (NP (PRP we))
    (VP
      (VP (VBD investigated)
        (NP
          (NP (DT the) (JJ anti-inflammatory) (NN effect))
          (PP (IN of)
            (NP (NN pitavastatin))))
        (PP (IN on)
          (NP
            (NP
              (NP (JJ non-alcoholic_steatohepatitis) (-LRB- -LRB-) (NNS non-alcoholic_steatohepatitis) (-RRB- -RRB-))
              (NP
                (NP (NNS rats))
                (VP (VBN induced)
                  (PP (IN by)
                    (NP (NN high_fat_diet))))))
            (PRN (-LRB- -LRB-)
              (NP (NNP HFD))
              (-RRB- -RRB-)))))
      (, ,)
      (CC and)
      (VP (VBD explored)
        (NP (PRP$ its) (JJ potential) (NNS mechanisms))))
    (. .)))

case(paper-3, In-1)
det(paper-3, this-2)
nmod:in(investigated-6, paper-3)
nsubj(investigated-6, we-5)
nsubj(explored-26, we-5)
root(ROOT-0, investigated-6)
det(effect-9, the-7)
amod(effect-9, anti-inflammatory-8)
dobj(investigated-6, effect-9)
case(pitavastatin-11, of-10)
nmod:of(effect-9, pitavastatin-11)
case(non-alcoholic_steatohepatitis-15, on-12)
amod(non-alcoholic_steatohepatitis-15, non-alcoholic_steatohepatitis-13)
nmod:on(investigated-6, non-alcoholic_steatohepatitis-15)
dep(non-alcoholic_steatohepatitis-15, rats-17)
acl(rats-17, induced-18)
case(high_fat_diet-20, by-19)
nmod:by(induced-18, high_fat_diet-20)
appos(non-alcoholic_steatohepatitis-15, HFD-22)
cc(investigated-6, and-25)
conj:and(investigated-6, explored-26)
nmod:poss(mechanisms-29, its-27)
amod(mechanisms-29, potential-28)
dobj(explored-26, mechanisms-29)

Our/PRP$ results/NNS showed/VBD that/IN pitavastatin/JJ treatment/NN significantly/RB reduced/VBN liver_inflammation/NN and/CC improved/JJ liver/NN function/NN in/IN NASH/NNP rats/NNS induced/VBN by/IN HFD/NNP ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ pitavastatin) (NN treatment))
            (VP
              (ADVP (RB significantly))
              (VBN reduced)
              (S
                (NP
                  (NP (NN liver_inflammation))
                  (CC and)
                  (NP (JJ improved) (NN liver) (NN function))))
              (PP (IN in)
                (NP (NNP NASH) (NNS rats)))))
          (VP (VBN induced)
            (PP (IN by)
              (NP (NNP HFD)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(induced-17, that-4)
amod(treatment-6, pitavastatin-5)
nsubj(induced-17, treatment-6)
advmod(reduced-8, significantly-7)
acl(treatment-6, reduced-8)
xcomp(reduced-8, liver_inflammation-9)
cc(liver_inflammation-9, and-10)
amod(function-13, improved-11)
compound(function-13, liver-12)
xcomp(reduced-8, function-13)
conj:and(liver_inflammation-9, function-13)
case(rats-16, in-14)
compound(rats-16, NASH-15)
nmod:in(reduced-8, rats-16)
ccomp(showed-3, induced-17)
case(HFD-19, by-18)
nmod:by(induced-17, HFD-19)

Furthermore/RB ,/, pitavastatin/JJ treatment/NN decreased/VBD the/DT expression/NN of/IN inflammatory/JJ cytokines/NNS and/CC chemokines/NNS in/IN the/DT liver/NN ,/, suggesting/VBG that/IN it/PRP exerts/VBZ its/PRP$ anti-inflammatory/JJ effects/NNS by/IN modulating/VBG the/DT immune/JJ response/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (JJ pitavastatin) (NN treatment))
    (VP (VBD decreased)
      (NP
        (NP (DT the) (NN expression))
        (PP (IN of)
          (NP (JJ inflammatory) (NNS cytokines)
            (CC and)
            (NNS chemokines))))
      (PP (IN in)
        (NP (DT the) (NN liver)))
      (, ,)
      (S
        (VP (VBG suggesting)
          (SBAR (IN that)
            (S
              (NP (PRP it))
              (VP (VBZ exerts)
                (NP (PRP$ its) (JJ anti-inflammatory) (NNS effects))
                (PP (IN by)
                  (S
                    (VP (VBG modulating)
                      (NP (DT the) (JJ immune) (NN response)))))))))))
    (. .)))

advmod(decreased-5, Furthermore-1)
amod(treatment-4, pitavastatin-3)
nsubj(decreased-5, treatment-4)
root(ROOT-0, decreased-5)
det(expression-7, the-6)
dobj(decreased-5, expression-7)
case(cytokines-10, of-8)
amod(cytokines-10, inflammatory-9)
nmod:of(expression-7, cytokines-10)
cc(cytokines-10, and-11)
nmod:of(expression-7, chemokines-12)
conj:and(cytokines-10, chemokines-12)
case(liver-15, in-13)
det(liver-15, the-14)
nmod:in(decreased-5, liver-15)
advcl(decreased-5, suggesting-17)
mark(exerts-20, that-18)
nsubj(exerts-20, it-19)
ccomp(suggesting-17, exerts-20)
nmod:poss(effects-23, its-21)
amod(effects-23, anti-inflammatory-22)
dobj(exerts-20, effects-23)
mark(modulating-25, by-24)
advcl(exerts-20, modulating-25)
det(response-28, the-26)
amod(response-28, immune-27)
dobj(modulating-25, response-28)

These/DT findings/NNS suggest/VBP that/IN pitavastatin/NN may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN patients/NNS with/IN NASH/NNP ,/, and/CC further/JJ studies/NNS are/VBP warranted/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS of/IN its/PRP$ anti-inflammatory/JJ effects/NNS ./.

(ROOT
  (S
    (S
      (NP (DT These) (NNS findings))
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP (NN pitavastatin))
            (VP (MD may)
              (VP (VB be)
                (NP
                  (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
                  (PP (IN for)
                    (NP
                      (NP (NNS patients))
                      (PP (IN with)
                        (NP (NNP NASH))))))))))))
    (, ,)
    (CC and)
    (S
      (NP (JJ further) (NNS studies))
      (VP (VBP are)
        (VP (VBN warranted)
          (S
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (PRP$ its) (JJ anti-inflammatory) (NNS effects))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, pitavastatin-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
case(NASH-15, with-14)
nmod:with(patients-13, NASH-15)
cc(suggest-3, and-17)
amod(studies-19, further-18)
nsubjpass(warranted-21, studies-19)
nsubj:xsubj(elucidate-23, studies-19)
auxpass(warranted-21, are-20)
conj:and(suggest-3, warranted-21)
mark(elucidate-23, to-22)
xcomp(warranted-21, elucidate-23)
det(mechanisms-26, the-24)
amod(mechanisms-26, underlying-25)
dobj(elucidate-23, mechanisms-26)
case(effects-30, of-27)
nmod:poss(effects-30, its-28)
amod(effects-30, anti-inflammatory-29)
nmod:of(mechanisms-26, effects-30)

Azimilide/NNP reduced/VBD the/DT risk/NN of/IN APD_prolongation/NNP in/IN heart_failure/JJ -LRB-/-LRB- HF/NNP -RRB-/-RRB- patients/NNS by/IN 21/CD %/NN -LRB-/-LRB- relative/JJ risk/NN -LSB-/NNP RR/NNP -RSB-/NNP :/: 0.79/CD ,/, 95/CD %/NN confidence/NN interval/JJ -LSB-/JJ CI/NNP -RSB-/NNS 0.67-0/CD .93/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNP Azimilide))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNP APD_prolongation))))
      (PP (IN in)
        (NP (JJ heart_failure)
          (PRN (-LRB- -LRB-)
            (NP (NNP HF))
            (-RRB- -RRB-))
          (NNS patients)))
      (PP (IN by)
        (NP
          (NP (CD 21) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (JJ relative) (NN risk) (NNP -LSB-) (NNP RR) (NNP -RSB-))
              (: :)
              (NP
                (NP (CD 0.79) (, ,) (CD 95) (NN %) (NN confidence) (JJ interval) (JJ -LSB-) (NNP CI) (NNS -RSB-))
                (NP
                  (QP (CD 0.67-0) (CD .93)))))
            (-RRB- -RRB-)))))
    (. .)))

nsubj(reduced-2, Azimilide-1)
root(ROOT-0, reduced-2)
det(risk-4, the-3)
dobj(reduced-2, risk-4)
case(APD_prolongation-6, of-5)
nmod:of(risk-4, APD_prolongation-6)
case(patients-12, in-7)
amod(patients-12, heart_failure-8)
appos(patients-12, HF-10)
nmod:in(reduced-2, patients-12)
case(%-15, by-13)
nummod(%-15, 21-14)
nmod:by(reduced-2, %-15)
amod(-RSB--21, relative-17)
compound(-RSB--21, risk-18)
compound(-RSB--21, -LSB--19)
compound(-RSB--21, RR-20)
dep(%-15, -RSB--21)
nummod(-RSB--31, 0.79-23)
nummod(-RSB--31, 95-25)
compound(-RSB--31, %-26)
compound(-RSB--31, confidence-27)
amod(-RSB--31, interval-28)
amod(-RSB--31, -LSB--29)
compound(-RSB--31, CI-30)
dep(-RSB--21, -RSB--31)
compound(.93-33, 0.67-0-32)
dep(-RSB--31, .93-33)

One/CD of/IN the/DT leading/VBG causes/NNS of/IN sudden_cardiac_death/NN in/IN HF/NNP patients/NNS is/VBZ ventricular_arrhythmias/NN ,/, which/WDT can/MD be/VB attributed/VBN to/TO the/DT prolongation/NN of/IN action/NN potential/JJ duration/NN -LRB-/-LRB- APD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (CD One))
      (PP (IN of)
        (NP
          (NP (DT the) (VBG leading) (NNS causes))
          (PP (IN of)
            (NP
              (NP (NN sudden_cardiac_death))
              (PP (IN in)
                (NP (NNP HF) (NNS patients))))))))
    (VP (VBZ is)
      (NP
        (NP (NN ventricular_arrhythmias))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (MD can)
              (VP (VB be)
                (VP (VBN attributed)
                  (PP (TO to)
                    (NP
                      (NP
                        (NP (DT the) (NN prolongation))
                        (PP (IN of)
                          (NP (NN action) (JJ potential) (NN duration))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP APD))
                        (-RRB- -RRB-)))))))))))
    (. .)))

nsubj(ventricular_arrhythmias-12, One-1)
case(causes-5, of-2)
det(causes-5, the-3)
amod(causes-5, leading-4)
nmod:of(One-1, causes-5)
case(sudden_cardiac_death-7, of-6)
nmod:of(causes-5, sudden_cardiac_death-7)
case(patients-10, in-8)
compound(patients-10, HF-9)
nmod:in(sudden_cardiac_death-7, patients-10)
cop(ventricular_arrhythmias-12, is-11)
root(ROOT-0, ventricular_arrhythmias-12)
nsubjpass(attributed-17, ventricular_arrhythmias-12)
ref(ventricular_arrhythmias-12, which-14)
aux(attributed-17, can-15)
auxpass(attributed-17, be-16)
acl:relcl(ventricular_arrhythmias-12, attributed-17)
case(prolongation-20, to-18)
det(prolongation-20, the-19)
nmod:to(attributed-17, prolongation-20)
case(duration-24, of-21)
compound(duration-24, action-22)
amod(duration-24, potential-23)
nmod:of(prolongation-20, duration-24)
appos(prolongation-20, APD-26)

Azimilide/NNP ,/, an/DT antiarrhythmic/JJ drug/NN ,/, has_been/VBP shown/VBN to/TO reduce/VB the/DT risk/NN of/IN APD_prolongation/NNP in/IN HF/NNP patients/NNS by/IN 21/CD %/NN -LRB-/-LRB- relative/JJ risk/NN -LSB-/NNP RR/NNP -RSB-/NNP :/: 0.79/CD ,/, 95/CD %/NN confidence/NN interval/JJ -LSB-/JJ CI/NNP -RSB-/NNS :/: 0.67-0/CD .93/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (NNP Azimilide))
      (, ,)
      (NP (DT an) (JJ antiarrhythmic) (NN drug))
      (, ,))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB reduce)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP (NNP APD_prolongation))))
              (PP (IN in)
                (NP (NNP HF) (NNS patients)))
              (PP (IN by)
                (NP
                  (NP (CD 21) (NN %))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (JJ relative) (NN risk) (NNP -LSB-) (NNP RR) (NNP -RSB-))
                      (: :)
                      (NP
                        (NP (CD 0.79) (, ,) (CD 95) (NN %) (NN confidence) (JJ interval) (JJ -LSB-) (NNP CI) (NNS -RSB-))
                        (: :)
                        (NP
                          (QP (CD 0.67-0) (CD .93)))))
                    (-RRB- -RRB-)))))))))
    (. .)))

nsubj(has_been-7, Azimilide-1)
det(drug-5, an-3)
amod(drug-5, antiarrhythmic-4)
appos(Azimilide-1, drug-5)
root(ROOT-0, has_been-7)
dep(has_been-7, shown-8)
mark(reduce-10, to-9)
xcomp(shown-8, reduce-10)
det(risk-12, the-11)
dobj(reduce-10, risk-12)
case(APD_prolongation-14, of-13)
nmod:of(risk-12, APD_prolongation-14)
case(patients-17, in-15)
compound(patients-17, HF-16)
nmod:in(reduce-10, patients-17)
case(%-20, by-18)
nummod(%-20, 21-19)
nmod:by(reduce-10, %-20)
amod(-RSB--26, relative-22)
compound(-RSB--26, risk-23)
compound(-RSB--26, -LSB--24)
compound(-RSB--26, RR-25)
dep(%-20, -RSB--26)
nummod(-RSB--36, 0.79-28)
nummod(-RSB--36, 95-30)
compound(-RSB--36, %-31)
compound(-RSB--36, confidence-32)
amod(-RSB--36, interval-33)
amod(-RSB--36, -LSB--34)
compound(-RSB--36, CI-35)
dep(-RSB--26, -RSB--36)
compound(.93-39, 0.67-0-38)
dep(-RSB--36, .93-39)

This/DT finding/NN suggests/VBZ that/IN azimilide/NN may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN preventing/VBG ventricular_arrhythmias/NNS and/CC sudden_cardiac_death/NN in/IN HF/NNP patients/NNS ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (NN azimilide))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (S
                    (VP (VBG preventing)
                      (NP (NNS ventricular_arrhythmias)
                        (CC and)
                        (NN sudden_cardiac_death))
                      (PP (IN in)
                        (NP (NNP HF) (NNS patients))))))))))))
    (. .)))

det(finding-2, This-1)
nsubj(suggests-3, finding-2)
root(ROOT-0, suggests-3)
mark(option-11, that-4)
nsubj(option-11, azimilide-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
amod(option-11, therapeutic-10)
ccomp(suggests-3, option-11)
mark(preventing-13, for-12)
acl(option-11, preventing-13)
dobj(preventing-13, ventricular_arrhythmias-14)
cc(ventricular_arrhythmias-14, and-15)
dobj(preventing-13, sudden_cardiac_death-16)
conj:and(ventricular_arrhythmias-14, sudden_cardiac_death-16)
case(patients-19, in-17)
compound(patients-19, HF-18)
nmod:in(preventing-13, patients-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO investigate/VB the/DT long-term/JJ safety/NN and/CC efficacy/NN of/IN azimilide/NN in/IN this/DT population/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (JJ long-term) (NN safety)
                  (CC and)
                  (NN efficacy))
                (PP (IN of)
                  (NP
                    (NP (NN azimilide))
                    (PP (IN in)
                      (NP (DT this) (NN population)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(investigate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(investigate-6, to-5)
xcomp(needed-4, investigate-6)
det(safety-9, the-7)
amod(safety-9, long-term-8)
dobj(investigate-6, safety-9)
cc(safety-9, and-10)
dobj(investigate-6, efficacy-11)
conj:and(safety-9, efficacy-11)
case(azimilide-13, of-12)
nmod:of(safety-9, azimilide-13)
case(population-16, in-14)
det(population-16, this-15)
nmod:in(azimilide-13, population-16)

Neurotransmitter/JJ transporters/NNS and/CC enzymes/NNS play/VBP a/DT crucial/JJ role/NN in/IN the/DT regulation/NN of/IN neurotransmitter/NN levels/NNS and/CC synaptic/JJ transmission/NN ./.

(ROOT
  (S
    (NP (JJ Neurotransmitter) (NNS transporters)
      (CC and)
      (NNS enzymes))
    (VP (VBP play)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN regulation))
            (PP (IN of)
              (NP
                (NP (NN neurotransmitter) (NNS levels))
                (CC and)
                (NP (JJ synaptic) (NN transmission))))))))
    (. .)))

amod(transporters-2, Neurotransmitter-1)
nsubj(play-5, transporters-2)
cc(transporters-2, and-3)
conj:and(transporters-2, enzymes-4)
nsubj(play-5, enzymes-4)
root(ROOT-0, play-5)
det(role-8, a-6)
amod(role-8, crucial-7)
dobj(play-5, role-8)
case(regulation-11, in-9)
det(regulation-11, the-10)
nmod:in(role-8, regulation-11)
case(levels-14, of-12)
compound(levels-14, neurotransmitter-13)
nmod:of(regulation-11, levels-14)
cc(levels-14, and-15)
amod(transmission-17, synaptic-16)
nmod:of(regulation-11, transmission-17)
conj:and(levels-14, transmission-17)

For/IN this/DT purpose/NN ,/, antibodies/NNS against/IN the/DT vesicular/NN tetrahydropterin/NN transporters/NNS -LRB-/-LRB- p-aminohippuric_acid/JJ -RRB-/-RRB- ,/, the/DT vesicular_acetylcholine_transporter/NN -LRB-/-LRB- VAChT/NNP -RRB-/-RRB- ,/, tyrosine_hydroxylase/NN -LRB-/-LRB- TH/NNP -RRB-/-RRB- ,/, dopamine_beta-hydroxylase/JJ -LRB-/-LRB- DBH/NNP -RRB-/-RRB- ,/, serotonin/NN -LRB-/-LRB- 5-HT/CD -RRB-/-RRB- ,/, vasoactive_intestinal_peptide/NN -LRB-/-LRB- VIP/NNP -RRB-/-RRB- ,/, and/CC protein_gene_product_9/CD .5/CD -LRB-/-LRB- PGP_9/CD .5/CD -RRB-/-RRB- were/VBD used/VBN ./.

(ROOT
  (S
    (PP (IN For)
      (NP (DT this) (NN purpose)))
    (, ,)
    (NP
      (NP (NNS antibodies))
      (PP (IN against)
        (NP
          (NP
            (NP
              (NP (DT the) (NN vesicular) (NN tetrahydropterin) (NNS transporters))
              (PRN (-LRB- -LRB-) (JJ p-aminohippuric_acid) (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (DT the) (NN vesicular_acetylcholine_transporter))
              (PRN (-LRB- -LRB-)
                (NP (NNP VAChT))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN tyrosine_hydroxylase))
              (PRN (-LRB- -LRB-)
                (NP (NNP TH))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (JJ dopamine_beta-hydroxylase))
              (PRN (-LRB- -LRB-)
                (NP (NNP DBH))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN serotonin))
              (PRN (-LRB- -LRB-)
                (NP (CD 5-HT))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN vasoactive_intestinal_peptide))
              (PRN (-LRB- -LRB-)
                (NP (NNP VIP))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NP
              (QP (CD protein_gene_product_9) (CD .5))))
          (PRN (-LRB- -LRB-)
            (NP
              (QP (CD PGP_9) (CD .5)))
            (-RRB- -RRB-)))))
    (VP (VBD were)
      (VP (VBN used)))
    (. .)))

case(purpose-3, For-1)
det(purpose-3, this-2)
nmod:for(used-49, purpose-3)
nsubjpass(used-49, antibodies-5)
case(transporters-10, against-6)
det(transporters-10, the-7)
compound(transporters-10, vesicular-8)
compound(transporters-10, tetrahydropterin-9)
nmod:against(antibodies-5, transporters-10)
dep(transporters-10, p-aminohippuric_acid-12)
det(vesicular_acetylcholine_transporter-16, the-15)
nmod:against(antibodies-5, vesicular_acetylcholine_transporter-16)
conj:and(transporters-10, vesicular_acetylcholine_transporter-16)
appos(vesicular_acetylcholine_transporter-16, VAChT-18)
nmod:against(antibodies-5, tyrosine_hydroxylase-21)
conj:and(transporters-10, tyrosine_hydroxylase-21)
appos(tyrosine_hydroxylase-21, TH-23)
nmod:against(antibodies-5, dopamine_beta-hydroxylase-26)
conj:and(transporters-10, dopamine_beta-hydroxylase-26)
appos(dopamine_beta-hydroxylase-26, DBH-28)
nmod:against(antibodies-5, serotonin-31)
conj:and(transporters-10, serotonin-31)
appos(serotonin-31, 5-HT-33)
nmod:against(antibodies-5, vasoactive_intestinal_peptide-36)
conj:and(transporters-10, vasoactive_intestinal_peptide-36)
appos(vasoactive_intestinal_peptide-36, VIP-38)
cc(transporters-10, and-41)
compound(.5-43, protein_gene_product_9-42)
nmod:against(antibodies-5, .5-43)
conj:and(transporters-10, .5-43)
compound(.5-46, PGP_9-45)
dep(transporters-10, .5-46)
auxpass(used-49, were-48)
root(ROOT-0, used-49)

Immunohistochemical/JJ analysis/NN revealed/VBD distinct/JJ patterns/NNS of/IN expression/NN for/IN each/DT of/IN these/DT molecules/NNS in/IN various/JJ regions/NNS of/IN the/DT brain/NN and/CC peripheral/JJ nervous/JJ system/NN ,/, suggesting/VBG their/PRP$ involvement/NN in/IN different/JJ physiological/JJ functions/NNS ./.

(ROOT
  (S
    (NP (JJ Immunohistochemical) (NN analysis))
    (VP (VBD revealed)
      (NP
        (NP (JJ distinct) (NNS patterns))
        (PP (IN of)
          (NP
            (NP (NN expression))
            (PP (IN for)
              (NP
                (NP (DT each))
                (PP (IN of)
                  (NP (DT these) (NNS molecules))))))))
      (PP (IN in)
        (NP
          (NP (JJ various) (NNS regions))
          (PP (IN of)
            (NP
              (NP (DT the) (NN brain))
              (CC and)
              (NP (JJ peripheral) (JJ nervous) (NN system))))))
      (, ,)
      (S
        (VP (VBG suggesting)
          (NP
            (NP (PRP$ their) (NN involvement))
            (PP (IN in)
              (NP (JJ different) (JJ physiological) (NNS functions)))))))
    (. .)))

amod(analysis-2, Immunohistochemical-1)
nsubj(revealed-3, analysis-2)
root(ROOT-0, revealed-3)
amod(patterns-5, distinct-4)
dobj(revealed-3, patterns-5)
case(expression-7, of-6)
nmod:of(patterns-5, expression-7)
case(each-9, for-8)
nmod:for(expression-7, each-9)
case(molecules-12, of-10)
det(molecules-12, these-11)
nmod:of(each-9, molecules-12)
case(regions-15, in-13)
amod(regions-15, various-14)
nmod:in(revealed-3, regions-15)
case(brain-18, of-16)
det(brain-18, the-17)
nmod:of(regions-15, brain-18)
cc(brain-18, and-19)
amod(system-22, peripheral-20)
amod(system-22, nervous-21)
nmod:of(regions-15, system-22)
conj:and(brain-18, system-22)
advcl(revealed-3, suggesting-24)
nmod:poss(involvement-26, their-25)
dobj(suggesting-24, involvement-26)
case(functions-30, in-27)
amod(functions-30, different-28)
amod(functions-30, physiological-29)
nmod:in(involvement-26, functions-30)

These/DT findings/NNS provide/VBP insight/JJ into/IN the/DT complex/JJ mechanisms/NNS underlying/JJ neurotransmission/NN and/CC may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/JJ therapeutic/JJ strategies/NNS for/IN neurological_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP
          (ADJP (JJ insight)
            (PP (IN into)
              (NP (DT the) (JJ complex) (NNS mechanisms))))
          (JJ underlying) (NN neurotransmission)))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (JJ novel) (JJ therapeutic) (NNS strategies))
                    (PP (IN for)
                      (NP (NNS neurological_disorders)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(have-13, findings-2)
root(ROOT-0, provide-3)
amod(neurotransmission-10, insight-4)
case(mechanisms-8, into-5)
det(mechanisms-8, the-6)
amod(mechanisms-8, complex-7)
nmod:into(insight-4, mechanisms-8)
amod(neurotransmission-10, underlying-9)
dobj(provide-3, neurotransmission-10)
cc(provide-3, and-11)
aux(have-13, may-12)
conj:and(provide-3, have-13)
dobj(have-13, implications-14)
case(development-17, for-15)
det(development-17, the-16)
nmod:for(implications-14, development-17)
case(strategies-21, of-18)
amod(strategies-21, novel-19)
amod(strategies-21, therapeutic-20)
nmod:of(development-17, strategies-21)
case(neurological_disorders-23, for-22)
nmod:for(strategies-21, neurological_disorders-23)

The/DT differentiation/JJ process/NN of/IN C2C12/CD cells/NNS is_a/VBZ crucial/JJ step/NN in/IN skeletal_muscle/JJ development/NN ,/, and/CC the/DT regulation/NN of/IN cytochrome_P450/JJ enzymes/NNS plays/VBZ a/DT vital/JJ role/NN in/IN this/DT process/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (JJ differentiation) (NN process))
        (PP (IN of)
          (NP (CD C2C12) (NNS cells))))
      (VP (VBZ is_a)
        (NP
          (NP (JJ crucial) (NN step))
          (PP (IN in)
            (NP (JJ skeletal_muscle) (NN development))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (DT the) (NN regulation))
        (PP (IN of)
          (NP (JJ cytochrome_P450) (NNS enzymes))))
      (VP (VBZ plays)
        (NP
          (NP (DT a) (JJ vital) (NN role))
          (PP (IN in)
            (NP (DT this) (NN process))))))
    (. .)))

det(process-3, The-1)
amod(process-3, differentiation-2)
nsubj(is_a-7, process-3)
case(cells-6, of-4)
nummod(cells-6, C2C12-5)
nmod:of(process-3, cells-6)
root(ROOT-0, is_a-7)
amod(step-9, crucial-8)
dobj(is_a-7, step-9)
case(development-12, in-10)
amod(development-12, skeletal_muscle-11)
nmod:in(step-9, development-12)
cc(is_a-7, and-14)
det(regulation-16, the-15)
nsubj(plays-20, regulation-16)
case(enzymes-19, of-17)
amod(enzymes-19, cytochrome_P450-18)
nmod:of(regulation-16, enzymes-19)
conj:and(is_a-7, plays-20)
det(role-23, a-21)
amod(role-23, vital-22)
dobj(plays-20, role-23)
case(process-26, in-24)
det(process-26, this-25)
nmod:in(role-23, process-26)

When/WRB C2C12/NNP cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, 3-methylsulfonyl-DDE/JJ up-regulated/JJ CYP11B1/2/NNP protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ CYP11B1/2/NNP protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (SBAR
      (WHADVP (WRB When))
      (S
        (NP (NNP C2C12) (NNS cells))
        (VP (VBD were)
          (VP (VBN cultured)
            (NP
              (NP (NN in_a) (NN medium))
              (PP (VBG favoring)
                (NP
                  (NP (NN differentiation))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP Dulbecco))
                      (VP (VBN modified)
                        (NP (NNP Eagle) (NN medium))
                        (S
                          (VP (VBG containing)
                            (NP
                              (ADJP (CD 2) (NN %))
                              (NN horse) (NN serum))))))
                    (-RRB- -RRB-)))))))))
    (, ,)
    (NP (JJ 3-methylsulfonyl-DDE)
      (NX
        (NX
          (NX (JJ up-regulated) (NNP CYP11B1/2) (NN protein) (NNS levels) (NN in_a))
          (NP (JJ time-dependent) (NN manner)))
        (CC and)
        (NX (JJ prolonged) (NNP CYP11B1/2) (NN protein))))
    (VP (NN half-life)
      (PP (IN from)
        (NP
          (QP (CD 10) (TO to) (CD 18))
          (NNS hours))))
    (. .)))

advmod(cultured-5, When-1)
compound(cells-3, C2C12-2)
nsubjpass(cultured-5, cells-3)
auxpass(cultured-5, were-4)
advcl(half-life-34, cultured-5)
compound(medium-7, in_a-6)
dobj(cultured-5, medium-7)
case(differentiation-9, favoring-8)
nmod:favoring(medium-7, differentiation-9)
dep(differentiation-9, Dulbecco-11)
acl(Dulbecco-11, modified-12)
compound(medium-14, Eagle-13)
dobj(modified-12, medium-14)
xcomp(modified-12, containing-15)
compound(%-17, 2-16)
amod(serum-19, %-17)
compound(serum-19, horse-18)
dobj(containing-15, serum-19)
amod(in_a-27, 3-methylsulfonyl-DDE-22)
amod(in_a-27, up-regulated-23)
compound(in_a-27, CYP11B1/2-24)
compound(in_a-27, protein-25)
compound(in_a-27, levels-26)
nsubj(half-life-34, in_a-27)
amod(manner-29, time-dependent-28)
dep(in_a-27, manner-29)
cc(in_a-27, and-30)
amod(protein-33, prolonged-31)
compound(protein-33, CYP11B1/2-32)
conj:and(in_a-27, protein-33)
nsubj(half-life-34, protein-33)
root(ROOT-0, half-life-34)
case(hours-39, from-35)
compound(18-38, 10-36)
dep(18-38, to-37)
nummod(hours-39, 18-38)
nmod:from(half-life-34, hours-39)

Our/PRP$ results/NNS showed/VBD that/IN when/WRB C2C12/NN cells/NNS were/VBD cultured/VBN in_a/JJ medium/NN favoring/VBG differentiation/NN ,/, 3-methylsulfonyl-DDE/JJ up-regulated/JJ CYP11B1/2/NN protein/NN levels/NNS in_a/VBD time-dependent/JJ manner/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (SBAR
            (WHADVP (WRB when))
            (S
              (NP (NN C2C12) (NNS cells))
              (VP (VBD were)
                (VP (VBN cultured)
                  (NP (JJ in_a) (NN medium))
                  (S
                    (VP (VBG favoring)
                      (NP (NN differentiation))))))))
          (, ,)
          (NP (JJ 3-methylsulfonyl-DDE) (JJ up-regulated) (NN CYP11B1/2) (NN protein) (NNS levels))
          (VP (VBD in_a)
            (NP (JJ time-dependent) (NN manner))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(in_a-20, that-4)
advmod(cultured-9, when-5)
compound(cells-7, C2C12-6)
nsubjpass(cultured-9, cells-7)
auxpass(cultured-9, were-8)
advcl(in_a-20, cultured-9)
amod(medium-11, in_a-10)
dobj(cultured-9, medium-11)
xcomp(cultured-9, favoring-12)
dobj(favoring-12, differentiation-13)
amod(levels-19, 3-methylsulfonyl-DDE-15)
amod(levels-19, up-regulated-16)
compound(levels-19, CYP11B1/2-17)
compound(levels-19, protein-18)
nsubj(in_a-20, levels-19)
ccomp(showed-3, in_a-20)
amod(manner-22, time-dependent-21)
dobj(in_a-20, manner-22)

Furthermore/RB ,/, it/PRP prolonged/VBN the/DT half-life/NN of/IN CYP11B1/2/NNP protein/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (PRP it))
    (VP (VBN prolonged)
      (NP
        (NP (DT the) (NN half-life))
        (PP (IN of)
          (NP (NNP CYP11B1/2) (NN protein))))
      (PP (IN from)
        (NP
          (QP (CD 10) (TO to) (CD 18))
          (NNS hours))))
    (. .)))

advmod(prolonged-4, Furthermore-1)
nsubj(prolonged-4, it-3)
root(ROOT-0, prolonged-4)
det(half-life-6, the-5)
dobj(prolonged-4, half-life-6)
case(protein-9, of-7)
compound(protein-9, CYP11B1/2-8)
nmod:of(half-life-6, protein-9)
case(hours-14, from-10)
compound(18-13, 10-11)
dep(18-13, to-12)
nummod(hours-14, 18-13)
nmod:from(prolonged-4, hours-14)

These/DT findings/NNS suggest/VBP that/IN 3-methylsulfonyl-DDE/JJ may/MD play/VB a/DT crucial/JJ role/NN in/IN the/DT regulation/NN of/IN cytochrome_P450/JJ enzymes/NNS during/IN skeletal_muscle/JJ development/NN and/CC may/MD have/VB implications/NNS for/IN the/DT treatment/NN of/IN related_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (JJ 3-methylsulfonyl-DDE))
          (VP
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (JJ crucial) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN regulation))
                      (PP (IN of)
                        (NP (JJ cytochrome_P450) (NNS enzymes))))))
                (PP (IN during)
                  (NP (JJ skeletal_muscle) (NN development)))))
            (CC and)
            (VP (MD may)
              (VP (VB have)
                (NP
                  (NP (NNS implications))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN treatment))
                      (PP (IN of)
                        (NP (NNS related_disorders))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, 3-methylsulfonyl-DDE-5)
nsubj(have-22, 3-methylsulfonyl-DDE-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-10, a-8)
amod(role-10, crucial-9)
dobj(play-7, role-10)
case(regulation-13, in-11)
det(regulation-13, the-12)
nmod:in(role-10, regulation-13)
case(enzymes-16, of-14)
amod(enzymes-16, cytochrome_P450-15)
nmod:of(regulation-13, enzymes-16)
case(development-19, during-17)
amod(development-19, skeletal_muscle-18)
nmod:during(play-7, development-19)
cc(play-7, and-20)
aux(have-22, may-21)
ccomp(suggest-3, have-22)
conj:and(play-7, have-22)
dobj(have-22, implications-23)
case(treatment-26, for-24)
det(treatment-26, the-25)
nmod:for(implications-23, treatment-26)
case(related_disorders-28, of-27)
nmod:of(treatment-26, related_disorders-28)

Further/JJ investigations/NNS are/VBP necessary/JJ to/TO elucidate/VB the/DT exact/JJ mechanism/NN underlying/VBG these/DT observations/NNS and/CC to/TO explore/VB their/PRP$ potential/JJ therapeutic/JJ applications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS investigations))
    (VP (VBP are)
      (ADJP (JJ necessary)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (JJ exact) (NN mechanism))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS observations))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP (PRP$ their) (JJ potential) (JJ therapeutic) (NNS applications))))))))
    (. .)))

amod(investigations-2, Further-1)
nsubj(necessary-4, investigations-2)
cop(necessary-4, are-3)
root(ROOT-0, necessary-4)
mark(elucidate-6, to-5)
dep(necessary-4, elucidate-6)
det(mechanism-9, the-7)
amod(mechanism-9, exact-8)
dobj(elucidate-6, mechanism-9)
acl(mechanism-9, underlying-10)
det(observations-12, these-11)
dobj(underlying-10, observations-12)
cc(elucidate-6, and-13)
mark(explore-15, to-14)
dep(necessary-4, explore-15)
conj:and(elucidate-6, explore-15)
nmod:poss(applications-19, their-16)
amod(applications-19, potential-17)
amod(applications-19, therapeutic-18)
dobj(explore-15, applications-19)

We/PRP previously/RB reported/VBD that/IN AG-024322/JJ up-regulated/JJ cDC2/JJ protein/NN levels/NNS in/IN C2C12/CD cells/NNS cultured/VBD in_a/JJ medium/NN favoring/VBG differentiation/NN ./.

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB previously))
    (VP (VBD reported)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ AG-024322) (JJ up-regulated) (JJ cDC2) (NN protein) (NNS levels))
            (PP (IN in)
              (NP (CD C2C12) (NNS cells))))
          (VP (VBD cultured)
            (NP (JJ in_a) (NN medium))
            (S
              (VP (VBG favoring)
                (NP (NN differentiation))))))))
    (. .)))

nsubj(reported-3, We-1)
advmod(reported-3, previously-2)
root(ROOT-0, reported-3)
mark(cultured-13, that-4)
amod(levels-9, AG-024322-5)
amod(levels-9, up-regulated-6)
amod(levels-9, cDC2-7)
compound(levels-9, protein-8)
nsubj(cultured-13, levels-9)
case(cells-12, in-10)
nummod(cells-12, C2C12-11)
nmod:in(levels-9, cells-12)
ccomp(reported-3, cultured-13)
amod(medium-15, in_a-14)
dobj(cultured-13, medium-15)
xcomp(cultured-13, favoring-16)
dobj(favoring-16, differentiation-17)

In/IN addition/NN ,/, we/PRP found/VBD that/IN the/DT half-life/NN of/IN the/DT cdc2/JJ protein/NN was/VBD prolonged/VBN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN half-life))
            (PP (IN of)
              (NP (DT the) (JJ cdc2) (NN protein))))
          (VP (VBD was)
            (VP (VBN prolonged)
              (PP (IN from)
                (NP
                  (QP (CD 10) (TO to) (CD 18))
                  (NNS hours))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(found-5, addition-2)
nsubj(found-5, we-4)
root(ROOT-0, found-5)
mark(prolonged-14, that-6)
det(half-life-8, the-7)
nsubjpass(prolonged-14, half-life-8)
case(protein-12, of-9)
det(protein-12, the-10)
amod(protein-12, cdc2-11)
nmod:of(half-life-8, protein-12)
auxpass(prolonged-14, was-13)
ccomp(found-5, prolonged-14)
case(hours-19, from-15)
compound(18-18, 10-16)
dep(18-18, to-17)
nummod(hours-19, 18-18)
nmod:from(prolonged-14, hours-19)

However/RB ,/, the/DT molecular/JJ mechanisms/NNS underlying/VBG these/DT effects/NNS have/VBP not/RB been/VBN fully/RB elucidated/VBN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (JJ molecular) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (NNS effects))))
    (VP (VBP have)
      (ADVP (RB not))
      (VP (VBN been)
        (VP
          (ADVP (RB fully))
          (VBN elucidated))))
    (. .)))

advmod(elucidated-13, However-1)
det(mechanisms-5, the-3)
amod(mechanisms-5, molecular-4)
nsubjpass(elucidated-13, mechanisms-5)
acl(mechanisms-5, underlying-6)
det(effects-8, these-7)
dobj(underlying-6, effects-8)
aux(elucidated-13, have-9)
neg(elucidated-13, not-10)
auxpass(elucidated-13, been-11)
advmod(elucidated-13, fully-12)
root(ROOT-0, elucidated-13)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN AG-024322/NN on/IN the/DT expression/NN and/CC stability/NN of/IN cDC2/JJ protein/NN in/IN C2C12/CD cells/NNS cultured/VBN in_a/JJ medium/NN favoring/VBG differentiation/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NN AG-024322))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN expression))
          (CC and)
          (NP
            (NP (NN stability))
            (PP (IN of)
              (NP (JJ cDC2) (NN protein))))))
      (PP (IN in)
        (NP
          (NP (CD C2C12) (NNS cells))
          (VP (VBN cultured)
            (NP (JJ in_a) (NN medium))
            (S
              (VP (VBG favoring)
                (NP (NN differentiation))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(AG-024322-10, of-9)
nmod:of(effects-8, AG-024322-10)
case(expression-13, on-11)
det(expression-13, the-12)
nmod:on(investigated-6, expression-13)
cc(expression-13, and-14)
nmod:on(investigated-6, stability-15)
conj:and(expression-13, stability-15)
case(protein-18, of-16)
amod(protein-18, cDC2-17)
nmod:of(stability-15, protein-18)
case(cells-21, in-19)
nummod(cells-21, C2C12-20)
nmod:in(investigated-6, cells-21)
acl(cells-21, cultured-22)
amod(medium-24, in_a-23)
dobj(cultured-22, medium-24)
xcomp(cultured-22, favoring-25)
dobj(favoring-25, differentiation-26)

Our/PRP$ results/NNS showed/VBD that/IN AG-024322/NNP up-regulated/VBD cDC2/JJ protein/NN levels/NNS in_a/JJ time-dependent/JJ manner/NN and/CC prolonged/VBN its/PRP$ half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP AG-024322))
          (VP
            (VP (VBD up-regulated)
              (NP (JJ cDC2) (NN protein) (NNS levels))
              (NP (JJ in_a) (JJ time-dependent) (NN manner)))
            (CC and)
            (VP (VBN prolonged)
              (NP (PRP$ its) (NN half-life))
              (PP (IN from)
                (NP
                  (QP (CD 10) (TO to) (CD 18))
                  (NNS hours))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(up-regulated-6, that-4)
nsubj(up-regulated-6, AG-024322-5)
nsubj(prolonged-14, AG-024322-5)
ccomp(showed-3, up-regulated-6)
amod(levels-9, cDC2-7)
compound(levels-9, protein-8)
iobj(up-regulated-6, levels-9)
amod(manner-12, in_a-10)
amod(manner-12, time-dependent-11)
dobj(up-regulated-6, manner-12)
cc(up-regulated-6, and-13)
ccomp(showed-3, prolonged-14)
conj:and(up-regulated-6, prolonged-14)
nmod:poss(half-life-16, its-15)
dobj(prolonged-14, half-life-16)
case(hours-21, from-17)
compound(18-20, 10-18)
dep(18-20, to-19)
nummod(hours-21, 18-20)
nmod:from(prolonged-14, hours-21)

These/DT findings/NNS suggest/VBP that/IN AG-024322/NNP may/MD play/VB a/DT role/NN in/IN regulating/VBG skeletal_muscle/JJ differentiation/NN by/IN modulating/VBG the/DT expression/NN and/CC stability/NN of/IN cDC2/JJ protein/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP AG-024322))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (JJ skeletal_muscle) (NN differentiation))
                      (PP (IN by)
                        (S
                          (VP (VBG modulating)
                            (NP
                              (NP (DT the) (NN expression)
                                (CC and)
                                (NN stability))
                              (PP (IN of)
                                (NP (JJ cDC2) (NN protein))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, AG-024322-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
mark(regulating-11, in-10)
acl(role-9, regulating-11)
amod(differentiation-13, skeletal_muscle-12)
dobj(regulating-11, differentiation-13)
mark(modulating-15, by-14)
advcl(regulating-11, modulating-15)
det(expression-17, the-16)
dobj(modulating-15, expression-17)
cc(expression-17, and-18)
dobj(modulating-15, stability-19)
conj:and(expression-17, stability-19)
case(protein-22, of-20)
amod(protein-22, cDC2-21)
nmod:of(expression-17, protein-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT molecular/JJ mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO evaluate/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN AG-024322/NN in/IN skeletal_muscle/JJ disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (JJ molecular) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB evaluate)
                (NP
                  (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN of)
                    (NP
                      (NP (NN AG-024322))
                      (PP (IN in)
                        (NP (JJ skeletal_muscle) (NNS disorders))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(elucidate-6, and-13)
mark(evaluate-15, to-14)
ccomp(needed-4, evaluate-15)
conj:and(elucidate-6, evaluate-15)
det(applications-19, the-16)
amod(applications-19, potential-17)
amod(applications-19, therapeutic-18)
dobj(evaluate-15, applications-19)
case(AG-024322-21, of-20)
nmod:of(applications-19, AG-024322-21)
case(disorders-24, in-22)
amod(disorders-24, skeletal_muscle-23)
nmod:in(AG-024322-21, disorders-24)

Vasoactive_intestinal_peptide/NNP -LRB-/-LRB- VIP/NNP -RRB-/-RRB- and/CC gastrin/NN are/VBP two/CD important/JJ gastrointestinal/JJ peptides/NNS that/WDT play/VBP a/DT crucial/JJ role/NN in/IN regulating/VBG various/JJ physiological/JJ processes/NNS ./.

(ROOT
  (S
    (NP
      (NP
        (NP (NNP Vasoactive_intestinal_peptide))
        (-LRB- -LRB-)
        (NP (NNP VIP))
        (-RRB- -RRB-))
      (CC and)
      (NP (NN gastrin)))
    (VP (VBP are)
      (NP
        (NP (CD two) (JJ important) (JJ gastrointestinal) (NNS peptides))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP play)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (JJ various) (JJ physiological) (NNS processes)))))))))))
    (. .)))

nsubj(peptides-11, Vasoactive_intestinal_peptide-1)
dep(Vasoactive_intestinal_peptide-1, VIP-3)
cc(Vasoactive_intestinal_peptide-1, and-5)
conj:and(Vasoactive_intestinal_peptide-1, gastrin-6)
nsubj(peptides-11, gastrin-6)
cop(peptides-11, are-7)
nummod(peptides-11, two-8)
amod(peptides-11, important-9)
amod(peptides-11, gastrointestinal-10)
root(ROOT-0, peptides-11)
nsubj(play-13, peptides-11)
ref(peptides-11, that-12)
acl:relcl(peptides-11, play-13)
det(role-16, a-14)
amod(role-16, crucial-15)
dobj(play-13, role-16)
mark(regulating-18, in-17)
acl(role-16, regulating-18)
amod(processes-21, various-19)
amod(processes-21, physiological-20)
dobj(regulating-18, processes-21)

The/DT VIP/NNP antagonist/JJ -LSB-/NNS 4Cl-D-Phe6/JJ ,/, Leu17/NNP -RSB-/NNP VIP/NNP and/CC the/DT putative/JJ gastrin/NN antagonist/NN ,/, peptide/JJ Gastrin/NNP -LRB-/-LRB- 6-38/CD -RRB-/-RRB- ,/, have/VBP been/VBN studied/VBN for/IN their/PRP$ effects/NNS on/IN the/DT response/NN of/IN RC-3095/NN to/TO gastrin/NN and/CC VIP/NNP ./.

(ROOT
  (S
    (NP
      (NP
        (NP (DT The) (NNP VIP) (JJ antagonist) (NNS -LSB-) (JJ 4Cl-D-Phe6))
        (, ,)
        (NP (NNP Leu17) (NNP -RSB-) (NNP VIP))
        (CC and)
        (NP (DT the) (JJ putative) (NN gastrin) (NN antagonist)))
      (, ,)
      (NP
        (NP (JJ peptide) (NNP Gastrin))
        (PRN (-LRB- -LRB-)
          (NP (CD 6-38))
          (-RRB- -RRB-)))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (NNS effects)))
          (PP (IN on)
            (NP
              (NP (DT the) (NN response))
              (PP (IN of)
                (NP (NN RC-3095)))))
          (PP (TO to)
            (NP
              (NP (NN gastrin))
              (CC and)
              (NP (NNP VIP)))))))
    (. .)))

det(-LSB--4, The-1)
compound(-LSB--4, VIP-2)
amod(-LSB--4, antagonist-3)
nsubjpass(studied-24, -LSB--4)
amod(-LSB--4, 4Cl-D-Phe6-5)
compound(VIP-9, Leu17-7)
compound(VIP-9, -RSB--8)
conj:and(-LSB--4, VIP-9)
nsubjpass(studied-24, VIP-9)
cc(-LSB--4, and-10)
det(antagonist-14, the-11)
amod(antagonist-14, putative-12)
compound(antagonist-14, gastrin-13)
conj:and(-LSB--4, antagonist-14)
nsubjpass(studied-24, antagonist-14)
amod(Gastrin-17, peptide-16)
appos(-LSB--4, Gastrin-17)
appos(Gastrin-17, 6-38-19)
aux(studied-24, have-22)
auxpass(studied-24, been-23)
root(ROOT-0, studied-24)
case(effects-27, for-25)
nmod:poss(effects-27, their-26)
nmod:for(studied-24, effects-27)
case(response-30, on-28)
det(response-30, the-29)
nmod:on(studied-24, response-30)
case(RC-3095-32, of-31)
nmod:of(response-30, RC-3095-32)
case(gastrin-34, to-33)
nmod:to(studied-24, gastrin-34)
cc(gastrin-34, and-35)
nmod:to(studied-24, VIP-36)
conj:and(gastrin-34, VIP-36)

The/DT results/NNS showed/VBD that/IN the/DT VIP/NNP antagonist/NN had/VBD no/DT effect/NN on/IN the/DT RC-3095/JJ response/NN to/TO either/DT gastrin/NN or/CC VIP/NNP ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (DT the) (NNP VIP) (NN antagonist))
          (VP (VBD had)
            (NP
              (NP (DT no) (NN effect))
              (PP (IN on)
                (NP
                  (NP (DT the) (JJ RC-3095) (NN response))
                  (PP (TO to)
                    (NP
                      (NP (DT either) (NN gastrin))
                      (CC or)
                      (NP (NNP VIP)))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(had-8, that-4)
det(antagonist-7, the-5)
compound(antagonist-7, VIP-6)
nsubj(had-8, antagonist-7)
ccomp(showed-3, had-8)
neg(effect-10, no-9)
dobj(had-8, effect-10)
case(response-14, on-11)
det(response-14, the-12)
amod(response-14, RC-3095-13)
nmod:on(effect-10, response-14)
case(gastrin-17, to-15)
det(gastrin-17, either-16)
nmod:to(response-14, gastrin-17)
cc(gastrin-17, or-18)
nmod:to(response-14, VIP-19)
conj:or(gastrin-17, VIP-19)

The/DT VIP/NNP antagonist/JJ -LSB-/NN 4Cl-D-Phe6/JJ ,/, Leu17/JJ -RSB-/NNP VIP/NNP had/VBD no/DT effect/NN on/IN the/DT RC-3095/NN response/NN to/TO either/DT Gastrin/NNP or/CC VIP/NNP while/IN the/DT peptide/JJ Gastrin/NNP -LRB-/-LRB- 6-38/CD -RRB-/-RRB- ,/, a/DT putative/JJ Gastrin/NNP antagonist/NN ,/, blocked/VBD the/DT RC-3095/NN response/NN to/TO Gastrin/NNP ./.

(ROOT
  (S
    (NP (DT The) (NNP VIP) (JJ antagonist) (NN -LSB-) (JJ 4Cl-D-Phe6) (, ,) (JJ Leu17) (NNP -RSB-) (NNP VIP))
    (VP (VBD had)
      (NP (DT no) (NN effect))
      (PP (IN on)
        (NP (DT the) (NN RC-3095) (NN response)))
      (PP (TO to)
        (NP (DT either) (NNP Gastrin)
          (CC or)
          (NNP VIP)))
      (SBAR (IN while)
        (S
          (NP
            (NP
              (NP (DT the) (JJ peptide) (NNP Gastrin))
              (PRN (-LRB- -LRB-)
                (NP (CD 6-38))
                (-RRB- -RRB-)))
            (, ,)
            (NP (DT a) (JJ putative) (NNP Gastrin) (NN antagonist))
            (, ,))
          (VP (VBD blocked)
            (NP (DT the) (NN RC-3095) (NN response))
            (PP (TO to)
              (NP (NNP Gastrin)))))))
    (. .)))

det(VIP-9, The-1)
compound(VIP-9, VIP-2)
amod(VIP-9, antagonist-3)
compound(VIP-9, -LSB--4)
amod(VIP-9, 4Cl-D-Phe6-5)
amod(VIP-9, Leu17-7)
compound(VIP-9, -RSB--8)
nsubj(had-10, VIP-9)
root(ROOT-0, had-10)
neg(effect-12, no-11)
dobj(had-10, effect-12)
case(response-16, on-13)
det(response-16, the-14)
compound(response-16, RC-3095-15)
nmod:on(had-10, response-16)
case(Gastrin-19, to-17)
cc:preconj(Gastrin-19, either-18)
nmod:to(had-10, Gastrin-19)
cc(Gastrin-19, or-20)
nmod:to(had-10, VIP-21)
conj:or(Gastrin-19, VIP-21)
mark(blocked-35, while-22)
det(Gastrin-25, the-23)
amod(Gastrin-25, peptide-24)
nsubj(blocked-35, Gastrin-25)
appos(Gastrin-25, 6-38-27)
det(antagonist-33, a-30)
amod(antagonist-33, putative-31)
compound(antagonist-33, Gastrin-32)
appos(Gastrin-25, antagonist-33)
advcl(had-10, blocked-35)
det(response-38, the-36)
compound(response-38, RC-3095-37)
dobj(blocked-35, response-38)
case(Gastrin-40, to-39)
nmod:to(blocked-35, Gastrin-40)

These/DT findings/NNS suggest/VBP that/IN peptide/NNP Gastrin/NNP -LRB-/-LRB- 6-38/NNP -RRB-/-RRB- may/MD be/VB a/DT potential/JJ therapeutic/JJ agent/NN for/IN gastrointestinal_disorders/NNS associated/VBN with/IN excessive/JJ gastric_acid/JJ secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP peptide) (NNP Gastrin) (-LRB- -LRB-) (NNP 6-38) (-RRB- -RRB-))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ potential) (JJ therapeutic) (NN agent))
                (PP (IN for)
                  (NP
                    (NP (NNS gastrointestinal_disorders))
                    (VP (VBN associated)
                      (PP (IN with)
                        (NP (JJ excessive) (JJ gastric_acid) (NN secretion))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(agent-15, that-4)
compound(6-38-8, peptide-5)
compound(6-38-8, Gastrin-6)
nsubj(agent-15, 6-38-8)
aux(agent-15, may-10)
cop(agent-15, be-11)
det(agent-15, a-12)
amod(agent-15, potential-13)
amod(agent-15, therapeutic-14)
ccomp(suggest-3, agent-15)
case(gastrointestinal_disorders-17, for-16)
nmod:for(agent-15, gastrointestinal_disorders-17)
acl(gastrointestinal_disorders-17, associated-18)
case(secretion-22, with-19)
amod(secretion-22, excessive-20)
amod(secretion-22, gastric_acid-21)
nmod:with(associated-18, secretion-22)

Further/RB research/NN is/VBZ needed/VBN to/TO investigate/VB its/PRP$ efficacy/NN in/IN clinical/JJ settings/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP (PRP$ its) (NN efficacy))
              (PP (IN in)
                (NP (JJ clinical) (NNS settings))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(investigate-6, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(investigate-6, to-5)
xcomp(needed-4, investigate-6)
nmod:poss(efficacy-8, its-7)
dobj(investigate-6, efficacy-8)
case(settings-11, in-9)
amod(settings-11, clinical-10)
nmod:in(investigate-6, settings-11)

RhoB-GG/JJ is_a/NN GTP-binding_protein/VBD that/IN plays/VBZ a/DT crucial/JJ role/NN in/IN insulin_secretion/NN by/IN pancreatic/JJ beta-cells/NNS ./.

(ROOT
  (S
    (NP (JJ RhoB-GG) (NN is_a))
    (VP (VBD GTP-binding_protein)
      (SBAR (IN that)
        (S
          (VP (VBZ plays)
            (NP
              (NP (DT a) (JJ crucial) (NN role))
              (PP (IN in)
                (NP (NN insulin_secretion))))
            (PP (IN by)
              (NP (JJ pancreatic) (NNS beta-cells)))))))
    (. .)))

amod(is_a-2, RhoB-GG-1)
nsubj(GTP-binding_protein-3, is_a-2)
root(ROOT-0, GTP-binding_protein-3)
mark(plays-5, that-4)
ccomp(GTP-binding_protein-3, plays-5)
det(role-8, a-6)
amod(role-8, crucial-7)
dobj(plays-5, role-8)
case(insulin_secretion-10, in-9)
nmod:in(role-8, insulin_secretion-10)
case(beta-cells-13, by-11)
amod(beta-cells-13, pancreatic-12)
nmod:by(plays-5, beta-cells-13)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN Rho/NNP B-GG/NNP by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNP Rho) (NNP B-GG)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(B-GG-21, of-19)
compound(B-GG-21, Rho-20)
nmod:of(hypersecretion-18, B-GG-21)
case(pancreas-24, by-22)
det(pancreas-24, the-23)
nmod:by(evaluate-8, pancreas-24)

Peroxisome/JJ proliferator-activated/JJ receptors/NNS -LRB-/-LRB- PPARs/NNP -RRB-/-RRB- play/VB crucial/JJ roles/NNS in/IN glucose/NN and/CC lipid/NN metabolism/NN ,/, and/CC their/PRP$ dysregulation/JJ has_been/NN implicated/VBN in/IN the/DT pathogenesis/NNS of/IN insulin_resistance/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Peroxisome) (JJ proliferator-activated) (NNS receptors))
      (PRN (-LRB- -LRB-)
        (NP (NNP PPARs))
        (-RRB- -RRB-)))
    (VP (VB play)
      (NP (JJ crucial) (NNS roles))
      (PP (IN in)
        (NP
          (NP
            (NP (NN glucose))
            (CC and)
            (NP (NN lipid) (NN metabolism)))
          (, ,)
          (CC and)
          (NP
            (NP (PRP$ their) (JJ dysregulation) (NN has_been))
            (VP (VBN implicated)
              (PP (IN in)
                (NP
                  (NP (DT the) (NNS pathogenesis))
                  (PP (IN of)
                    (NP (NN insulin_resistance))))))))))
    (. .)))

amod(receptors-3, Peroxisome-1)
amod(receptors-3, proliferator-activated-2)
nsubj(play-7, receptors-3)
appos(receptors-3, PPARs-5)
root(ROOT-0, play-7)
amod(roles-9, crucial-8)
dobj(play-7, roles-9)
case(glucose-11, in-10)
nmod:in(play-7, glucose-11)
cc(glucose-11, and-12)
compound(metabolism-14, lipid-13)
nmod:in(play-7, metabolism-14)
conj:and(glucose-11, metabolism-14)
cc(glucose-11, and-16)
nmod:poss(has_been-19, their-17)
amod(has_been-19, dysregulation-18)
nmod:in(play-7, has_been-19)
conj:and(glucose-11, has_been-19)
acl(has_been-19, implicated-20)
case(pathogenesis-23, in-21)
det(pathogenesis-23, the-22)
nmod:in(implicated-20, pathogenesis-23)
case(insulin_resistance-25, of-24)
nmod:of(pathogenesis-23, insulin_resistance-25)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT mRNA/NN expression/NN levels/NNS of/IN PPARalpha/NNP ,/, PPARgamma/NNP ,/, microsomal/JJ iodoantipyrine/JJ transfer/NN protein/NN -LRB-/-LRB- C-11/NNP -RRB-/-RRB- ,/, carnitine_palmitoyl_transferase_1/NNS -LRB-/-LRB- CPT-1/NNP -RRB-/-RRB- ,/, and/CC sterol_regulatory_element_binding_protein-1c/JJ -LRB-/-LRB- SREBP-1c/NNS -RRB-/-RRB- using/VBG quantitative/JJ RT-PCR/NN in/IN obese/JJ individuals/NNS with/IN or/CC without/IN insulin_resistance/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP
          (NP (DT the) (NN mRNA) (NN expression) (NNS levels))
          (PP (IN of)
            (NP (NNP PPARalpha) (, ,) (NNP PPARgamma))))
        (, ,)
        (NP
          (NP (JJ microsomal) (JJ iodoantipyrine) (NN transfer) (NN protein))
          (PRN (-LRB- -LRB-)
            (NP (NNP C-11))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NNS carnitine_palmitoyl_transferase_1))
          (PRN (-LRB- -LRB-)
            (NP (NNP CPT-1))
            (-RRB- -RRB-)))
        (, ,)
        (CC and)
        (NP
          (NP (JJ sterol_regulatory_element_binding_protein-1c) (-LRB- -LRB-) (NNS SREBP-1c) (-RRB- -RRB-))
          (VP (VBG using)
            (NP
              (NP (JJ quantitative) (NN RT-PCR))
              (PP (IN in)
                (NP (JJ obese) (NNS individuals)))))))
      (PP (IN with)
        (CC or)
        (IN without)
        (NP (NN insulin_resistance))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
nsubj(investigated-6', we-5)
root(ROOT-0, investigated-6)
conj:or(investigated-6, investigated-6')
det(levels-10, the-7)
compound(levels-10, mRNA-8)
compound(levels-10, expression-9)
dobj(investigated-6, levels-10)
case(PPARgamma-14, of-11)
compound(PPARgamma-14, PPARalpha-12)
nmod:of(levels-10, PPARgamma-14)
amod(protein-19, microsomal-16)
amod(protein-19, iodoantipyrine-17)
compound(protein-19, transfer-18)
dobj(investigated-6, protein-19)
conj:and(levels-10, protein-19)
appos(protein-19, C-11-21)
dobj(investigated-6, carnitine_palmitoyl_transferase_1-24)
conj:and(levels-10, carnitine_palmitoyl_transferase_1-24)
appos(carnitine_palmitoyl_transferase_1-24, CPT-1-26)
cc(levels-10, and-29)
amod(SREBP-1c-32, sterol_regulatory_element_binding_protein-1c-30)
dobj(investigated-6, SREBP-1c-32)
conj:and(levels-10, SREBP-1c-32)
acl(SREBP-1c-32, using-34)
amod(RT-PCR-36, quantitative-35)
dobj(using-34, RT-PCR-36)
case(individuals-39, in-37)
amod(individuals-39, obese-38)
nmod:in(RT-PCR-36, individuals-39)
case(insulin_resistance-43, with-40)
cc(with-40, or-41)
conj:or(with-40, without-42)
nmod:with(investigated-6, insulin_resistance-43)
nmod:without(investigated-6', insulin_resistance-43)

Our/PRP$ results/NNS showed/VBD that/IN the/DT mRNA/JJ expression/NN levels/NNS of/IN PPARalpha/NNP and/CC CPT-1/NNP were/VBD significantly/RB lower/JJR in/IN obese/JJ individuals/NNS with/IN insulin_resistance/NN compared/VBN to/TO those/DT without/IN insulin_resistance/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (JJ mRNA) (NN expression) (NNS levels))
            (PP (IN of)
              (NP (NNP PPARalpha)
                (CC and)
                (NNP CPT-1))))
          (VP (VBD were)
            (ADVP
              (ADVP (RB significantly) (JJR lower))
              (PP (IN in)
                (NP
                  (NP (JJ obese) (NNS individuals))
                  (PP (IN with)
                    (NP (NN insulin_resistance))))))
            (VP (VBN compared)
              (PP (TO to)
                (NP (DT those)))
              (PP (IN without)
                (NP (NN insulin_resistance))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-21, that-4)
det(levels-8, the-5)
amod(levels-8, mRNA-6)
compound(levels-8, expression-7)
nsubjpass(compared-21, levels-8)
case(PPARalpha-10, of-9)
nmod:of(levels-8, PPARalpha-10)
cc(PPARalpha-10, and-11)
nmod:of(levels-8, CPT-1-12)
conj:and(PPARalpha-10, CPT-1-12)
auxpass(compared-21, were-13)
advmod(lower-15, significantly-14)
advmod(compared-21, lower-15)
case(individuals-18, in-16)
amod(individuals-18, obese-17)
nmod:in(lower-15, individuals-18)
case(insulin_resistance-20, with-19)
nmod:with(individuals-18, insulin_resistance-20)
ccomp(showed-3, compared-21)
case(those-23, to-22)
nmod:to(compared-21, those-23)
case(insulin_resistance-25, without-24)
nmod:without(compared-21, insulin_resistance-25)

In/IN contrast/NN ,/, the/DT mRNA/JJ expression/NN levels/NNS of/IN PPARgamma/NNP ,/, C-11/NNP ,/, and/CC SREBP-1c/NN were/VBD significantly/RB higher/JJR in/IN obese/JJ individuals/NNS with/IN insulin_resistance/NN compared/VBN to/TO those/DT without/IN insulin_resistance/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (NP (DT the) (JJ mRNA) (NN expression) (NNS levels))
      (PP (IN of)
        (NP
          (NP (NNP PPARgamma))
          (, ,)
          (NP (NNP C-11))
          (, ,)
          (CC and)
          (NP (NN SREBP-1c)))))
    (VP (VBD were)
      (ADVP
        (ADVP (RB significantly) (JJR higher))
        (PP (IN in)
          (NP
            (NP (JJ obese) (NNS individuals))
            (PP (IN with)
              (NP (NN insulin_resistance))))))
      (VP (VBN compared)
        (PP (TO to)
          (NP (DT those)))
        (PP (IN without)
          (NP (NN insulin_resistance)))))
    (. .)))

case(contrast-2, In-1)
nmod:in(compared-23, contrast-2)
det(levels-7, the-4)
amod(levels-7, mRNA-5)
compound(levels-7, expression-6)
nsubjpass(compared-23, levels-7)
case(PPARgamma-9, of-8)
nmod:of(levels-7, PPARgamma-9)
nmod:of(levels-7, C-11-11)
conj:and(PPARgamma-9, C-11-11)
cc(PPARgamma-9, and-13)
nmod:of(levels-7, SREBP-1c-14)
conj:and(PPARgamma-9, SREBP-1c-14)
auxpass(compared-23, were-15)
advmod(higher-17, significantly-16)
advmod(compared-23, higher-17)
case(individuals-20, in-18)
amod(individuals-20, obese-19)
nmod:in(higher-17, individuals-20)
case(insulin_resistance-22, with-21)
nmod:with(individuals-20, insulin_resistance-22)
root(ROOT-0, compared-23)
case(those-25, to-24)
nmod:to(compared-23, those-25)
case(insulin_resistance-27, without-26)
nmod:without(compared-23, insulin_resistance-27)

These/DT findings/NNS suggest/VBP that/IN dysregulation/NN of/IN PPARs/NNS and/CC their/PRP$ downstream/JJ targets/NNS may/MD contribute/VB to/TO the/DT development/NN of/IN insulin_resistance/NN in/IN obesity/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN dysregulation))
            (PP (IN of)
              (NP
                (NP (NNS PPARs))
                (CC and)
                (NP (PRP$ their) (JJ downstream) (NNS targets)))))
          (VP (MD may)
            (VP (VB contribute)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN insulin_resistance)))))
              (PP (IN in)
                (NP (NN obesity))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(contribute-13, that-4)
nsubj(contribute-13, dysregulation-5)
case(PPARs-7, of-6)
nmod:of(dysregulation-5, PPARs-7)
cc(PPARs-7, and-8)
nmod:poss(targets-11, their-9)
amod(targets-11, downstream-10)
nmod:of(dysregulation-5, targets-11)
conj:and(PPARs-7, targets-11)
aux(contribute-13, may-12)
ccomp(suggest-3, contribute-13)
case(development-16, to-14)
det(development-16, the-15)
nmod:to(contribute-13, development-16)
case(insulin_resistance-18, of-17)
nmod:of(development-16, insulin_resistance-18)
case(obesity-20, in-19)
nmod:in(contribute-13, obesity-20)

Targeting/VBG these/DT pathways/NNS may/MD provide/VB potential/JJ therapeutic/JJ strategies/NNS for/IN preventing/VBG or/CC treating/VBG type_2_diabetes_mellitus/NNS ./.

(ROOT
  (S
    (S
      (VP (VBG Targeting)
        (NP (DT these) (NNS pathways))))
    (VP (MD may)
      (VP (VB provide)
        (NP (JJ potential) (JJ therapeutic) (NNS strategies))
        (PP (IN for)
          (S
            (VP
              (VP (VBG preventing))
              (CC or)
              (VP (VBG treating)
                (NP (NNS type_2_diabetes_mellitus))))))))
    (. .)))

csubj(provide-5, Targeting-1)
det(pathways-3, these-2)
dobj(Targeting-1, pathways-3)
aux(provide-5, may-4)
root(ROOT-0, provide-5)
amod(strategies-8, potential-6)
amod(strategies-8, therapeutic-7)
dobj(provide-5, strategies-8)
mark(preventing-10, for-9)
advcl(provide-5, preventing-10)
cc(preventing-10, or-11)
advcl(provide-5, treating-12)
conj:or(preventing-10, treating-12)
dobj(treating-12, type_2_diabetes_mellitus-13)

Omega-3_fatty_acids/NNP have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ,/, including/VBG their/PRP$ role/NN in/IN reducing/VBG the/DT risk/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (NNP Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits)))
          (, ,)
          (S
            (VP (VBG including)
              (NP
                (NP (PRP$ their) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NN cardiovascular_disease)))))))))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)
xcomp(studied-5, including-12)
nmod:poss(role-14, their-13)
dobj(including-12, role-14)
mark(reducing-16, in-15)
acl(role-14, reducing-16)
det(risk-18, the-17)
dobj(reducing-16, risk-18)
case(cardiovascular_disease-20, of-19)
nmod:of(risk-18, cardiovascular_disease-20)

In/IN particular/JJ ,/, long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to_be/NN associated/VBN with/IN decreased/VBN levels/NNS of/IN beclometasone_dipropionate/NN in/IN hyperbeclometasone/JJ dipropionatemic/JJ patients/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (NP
      (NP (JJ long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (NP
            (NP (NN to_be))
            (VP (VBN associated)
              (PP (IN with)
                (NP
                  (NP (VBN decreased) (NNS levels))
                  (PP (IN of)
                    (NP
                      (NP (NN beclometasone_dipropionate))
                      (PP (IN in)
                        (NP (JJ hyperbeclometasone) (JJ dipropionatemic) (NNS patients))))))))))))
    (. .)))

case(particular-2, In-1)
advcl(shown-19, particular-2)
amod(omega-3_fatty_acids-5, long-chain-4)
nsubjpass(shown-19, omega-3_fatty_acids-5)
dep(omega-3_fatty_acids-5, eicosapentaenoic_acid-7)
dep(eicosapentaenoic_acid-7, EPA-9)
cc(eicosapentaenoic_acid-7, and-11)
dep(omega-3_fatty_acids-5, docosahexaenoic_acid-12)
conj:and(eicosapentaenoic_acid-7, docosahexaenoic_acid-12)
dep(docosahexaenoic_acid-12, DHA-14)
aux(shown-19, have-17)
auxpass(shown-19, been-18)
root(ROOT-0, shown-19)
dobj(shown-19, to_be-20)
acl(to_be-20, associated-21)
case(levels-24, with-22)
amod(levels-24, decreased-23)
nmod:with(associated-21, levels-24)
case(beclometasone_dipropionate-26, of-25)
nmod:of(levels-24, beclometasone_dipropionate-26)
case(patients-30, in-27)
amod(patients-30, hyperbeclometasone-28)
amod(patients-30, dipropionatemic-29)
nmod:in(beclometasone_dipropionate-26, patients-30)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, are/VBP associated/VBN with/IN decreased/VBN beclometasone_dipropionate/NN levels/NNS in/IN hyperbeclometasone/JJ dipropionatemic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN associated)
          (PP (IN with)
            (NP (VBN decreased) (NN beclometasone_dipropionate) (NNS levels)))
          (PP (IN in)
            (NP (JJ hyperbeclometasone) (JJ dipropionatemic) (NNS patients)))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(associated-23, omega-3_fatty_acids-2)
nsubjpass(decreased-33, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
auxpass(associated-23, are-22)
root(ROOT-0, associated-23)
case(levels-27, with-24)
amod(levels-27, decreased-25)
compound(levels-27, beclometasone_dipropionate-26)
nmod:with(associated-23, levels-27)
case(patients-31, in-28)
amod(patients-31, hyperbeclometasone-29)
amod(patients-31, dipropionatemic-30)
nmod:in(associated-23, patients-31)
cc(associated-23, and-32)
conj:and(associated-23, decreased-33)
dobj(decreased-33, risk-34)
case(coronary_heart_disease-37, of-35)
amod(coronary_heart_disease-37, developing-36)
nmod:of(risk-34, coronary_heart_disease-37)
appos(coronary_heart_disease-37, CHD-39)

The/DT mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP exert/VBD their/PRP$ beneficial/JJ effects/NNS on/IN CHD/NNP risk/NN are/VBP complex/JJ and/CC multifactorial/JJ ,/, but/CC may/MD involve/VB modulation/NN of/IN inflammation/NN ,/, oxidative_stress/NNS ,/, and/CC lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (SBAR
        (WHPP (IN by)
          (WHNP (WDT which)))
        (S
          (NP (NNP EPA)
            (CC and)
            (NNP DHA))
          (VP (VBD exert)
            (NP
              (NP (PRP$ their) (JJ beneficial) (NNS effects))
              (PP (IN on)
                (NP (NNP CHD) (NN risk))))))))
    (VP
      (VP (VBP are)
        (ADJP (JJ complex)
          (CC and)
          (JJ multifactorial)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (NN modulation))
            (PP (IN of)
              (NP
                (NP (NN inflammation))
                (, ,)
                (NP (NNS oxidative_stress))
                (, ,)
                (CC and)
                (NP (NN lipid) (NN metabolism))))))))
    (. .)))

det(mechanisms-2, The-1)
nmod:by(exert-8, mechanisms-2)
nsubj(complex-16, mechanisms-2)
nsubj(multifactorial-18, mechanisms-2)
nsubj(involve-22, mechanisms-2)
case(which-4, by-3)
ref(mechanisms-2, which-4)
nsubj(exert-8, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(exert-8, DHA-7)
acl:relcl(mechanisms-2, exert-8)
nmod:poss(effects-11, their-9)
amod(effects-11, beneficial-10)
dobj(exert-8, effects-11)
case(risk-14, on-12)
compound(risk-14, CHD-13)
nmod:on(effects-11, risk-14)
cop(complex-16, are-15)
root(ROOT-0, complex-16)
cc(complex-16, and-17)
conj:and(complex-16, multifactorial-18)
cc(complex-16, but-20)
aux(involve-22, may-21)
conj:but(complex-16, involve-22)
dobj(involve-22, modulation-23)
case(inflammation-25, of-24)
nmod:of(modulation-23, inflammation-25)
nmod:of(modulation-23, oxidative_stress-27)
conj:and(inflammation-25, oxidative_stress-27)
cc(inflammation-25, and-29)
compound(metabolism-31, lipid-30)
nmod:of(modulation-23, metabolism-31)
conj:and(inflammation-25, metabolism-31)

Clinical/JJ studies/NNS have/VBP demonstrated/VBN that/IN supplementation/NN with/IN EPA/NNP and/CC DHA/NNP can/MD improve/VB various/JJ cardiovascular_risk/NN factors/NNS ,/, such/JJ as/IN triglyceride_levels/NNS ,/, blood_pressure/NN ,/, and/CC endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP (JJ Clinical) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN supplementation))
              (PP (IN with)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (MD can)
              (VP (VB improve)
                (NP
                  (NP (JJ various) (NN cardiovascular_risk) (NNS factors))
                  (, ,)
                  (PP (JJ such) (IN as)
                    (NP
                      (NP (NNS triglyceride_levels))
                      (, ,)
                      (NP (NN blood_pressure))
                      (, ,)
                      (CC and)
                      (NP (JJ endothelial) (NN function)))))))))))
    (. .)))

amod(studies-2, Clinical-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(improve-12, that-5)
nsubj(improve-12, supplementation-6)
case(EPA-8, with-7)
nmod:with(supplementation-6, EPA-8)
cc(EPA-8, and-9)
nmod:with(supplementation-6, DHA-10)
conj:and(EPA-8, DHA-10)
aux(improve-12, can-11)
ccomp(demonstrated-4, improve-12)
amod(factors-15, various-13)
compound(factors-15, cardiovascular_risk-14)
dobj(improve-12, factors-15)
case(triglyceride_levels-19, such-17)
mwe(such-17, as-18)
nmod:such_as(factors-15, triglyceride_levels-19)
nmod:such_as(factors-15, blood_pressure-21)
conj:and(triglyceride_levels-19, blood_pressure-21)
cc(triglyceride_levels-19, and-23)
amod(function-25, endothelial-24)
nmod:such_as(factors-15, function-25)
conj:and(triglyceride_levels-19, function-25)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG the/DT cardioprotective/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN prevention/NN and/CC treatment/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP
                      (NP (DT the) (JJ cardioprotective) (NNS effects))
                      (PP (IN of)
                        (NP (NNP EPA)
                          (CC and)
                          (NNP DHA))))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS dosages))
                  (PP (IN for)
                    (NP
                      (NP (NN prevention)
                        (CC and)
                        (NN treatment))
                      (PP (IN of)
                        (NP (NNP CHD))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-13, the-11)
amod(effects-13, cardioprotective-12)
dobj(underlying-10, effects-13)
case(EPA-15, of-14)
nmod:of(effects-13, EPA-15)
cc(EPA-15, and-16)
nmod:of(effects-13, DHA-17)
conj:and(EPA-15, DHA-17)
cc(elucidate-7, and-18)
mark(determine-20, to-19)
ccomp(needed-4, determine-20)
conj:and(elucidate-7, determine-20)
amod(dosages-22, optimal-21)
dobj(determine-20, dosages-22)
case(prevention-24, for-23)
nmod:for(dosages-22, prevention-24)
cc(prevention-24, and-25)
nmod:for(dosages-22, treatment-26)
conj:and(prevention-24, treatment-26)
case(CHD-28, of-27)
nmod:of(prevention-24, CHD-28)

Heterogeneous_nuclear_ribonucleoprotein_A1/NNP -LRB-/-LRB- hnRNP_A1/NNS -RRB-/-RRB- has_been/VBP implicated/VBN in/IN the/DT pathogenesis/NNS of/IN obesity/NN ./.

(ROOT
  (S
    (NP (NNP Heterogeneous_nuclear_ribonucleoprotein_A1) (-LRB- -LRB-)
      (NP (NNS hnRNP_A1))
      (-RRB- -RRB-))
    (VP (VBP has_been)
      (VP (VBN implicated)
        (PP (IN in)
          (NP
            (NP (DT the) (NNS pathogenesis))
            (PP (IN of)
              (NP (NN obesity)))))))
    (. .)))

nsubj(has_been-5, Heterogeneous_nuclear_ribonucleoprotein_A1-1)
dep(Heterogeneous_nuclear_ribonucleoprotein_A1-1, hnRNP_A1-3)
root(ROOT-0, has_been-5)
dep(has_been-5, implicated-6)
case(pathogenesis-9, in-7)
det(pathogenesis-9, the-8)
nmod:in(implicated-6, pathogenesis-9)
case(obesity-11, of-10)
nmod:of(pathogenesis-9, obesity-11)

However/RB ,/, the/DT role/NN of/IN the/DT pancreatic/JJ hormones/NNS and/CC their/PRP$ secretion/NN in/IN obesity/NN is/VBZ unclear/JJ ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN role))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ pancreatic) (NNS hormones))
          (CC and)
          (NP (PRP$ their) (NN secretion))))
      (PP (IN in)
        (NP (NN obesity))))
    (VP (VBZ is)
      (ADJP (JJ unclear)))
    (. .)))

advmod(unclear-15, However-1)
det(role-4, the-3)
nsubj(unclear-15, role-4)
case(hormones-8, of-5)
det(hormones-8, the-6)
amod(hormones-8, pancreatic-7)
nmod:of(role-4, hormones-8)
cc(hormones-8, and-9)
nmod:poss(secretion-11, their-10)
nmod:of(role-4, secretion-11)
conj:and(hormones-8, secretion-11)
case(obesity-13, in-12)
nmod:in(role-4, obesity-13)
cop(unclear-15, is-14)
root(ROOT-0, unclear-15)

The/DT effects/NNS of/IN glucose/NN and/CC methylate/NN on/IN the/DT secretion/NN of/IN hnRNPA1/JJ by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/NNP //: ?/. -RRB-/-RRB- rats/NNS have/VBP not/RB been/VBN investigated/VBN previously/RB ./. -LRB-/-LRB- 1/CD -RRB-/-RRB-

(ROOT
  (S
    (NP
      (NP (DT The) (NNS effects))
      (PP (IN of)
        (NP (NN glucose)
          (CC and)
          (NN methylate)))
      (PP (IN on)
        (NP (DT the) (NN secretion)))
      (PP (IN of)
        (FRAG
          (ADJP (JJ hnRNPA1)
            (PP (IN by)
              (NP
                (NP (VBN isolated)
                  (NX
                    (NX
                      (NX
                        (NX (JJ perfused) (NN pancreata))
                        (PP (IN from)
                          (NP (NN genetically_obese))))
                      (PRN (-LRB- -LRB-) (NN fa/fa) (-RRB- -RRB-)))
                    (CC and)
                    (NX (JJ lean))))
                (-LRB- -LRB-)
                (NP (NNP Fa))
                (: /))))
          (. ?)))
      (-RRB- -RRB-))
    (VP (NNS rats)
      (FRAG
        (SBAR
          (S
            (VP (VBP have)
              (ADVP (RB not))
              (VP (VBN been)
                (VP (VBN investigated)
                  (ADVP (RB previously)))))))
        (. .))
      (PRN (-LRB- -LRB-)
        (NP-TMP (CD 1))
        (-RRB- -RRB-)))))

det(effects-2, The-1)
nsubj(rats-28, effects-2)
case(glucose-4, of-3)
nmod:of(effects-2, glucose-4)
cc(glucose-4, and-5)
nmod:of(effects-2, methylate-6)
conj:and(glucose-4, methylate-6)
case(secretion-9, on-7)
det(secretion-9, the-8)
nmod:on(effects-2, secretion-9)
case(hnRNPA1-11, of-10)
acl(effects-2, hnRNPA1-11)
case(pancreata-15, by-12)
amod(pancreata-15, isolated-13)
amod(pancreata-15, perfused-14)
nmod:by(hnRNPA1-11, pancreata-15)
case(genetically_obese-17, from-16)
nmod:from(pancreata-15, genetically_obese-17)
dep(pancreata-15, fa/fa-19)
cc(pancreata-15, and-21)
nmod:by(hnRNPA1-11, lean-22)
conj:and(pancreata-15, lean-22)
dep(pancreata-15, Fa-24)
root(ROOT-0, rats-28)
aux(investigated-32, have-29)
neg(investigated-32, not-30)
auxpass(investigated-32, been-31)
dep(rats-28, investigated-32)
advmod(investigated-32, previously-33)
dep(rats-28, 1-36)

The/DT role/NN of/IN pancreatic/JJ enzymes/NNS ,/, hormones/NNS ,/, peptides/NNS ,/, and/CC proteins/NNS in/IN obesity/NN has_been/VBP the/DT subject/NN of/IN extensive/JJ research/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN role))
      (PP (IN of)
        (NP
          (NP (JJ pancreatic) (NNS enzymes))
          (, ,)
          (NP (NNS hormones))
          (, ,)
          (NP (NNS peptides))
          (, ,)
          (CC and)
          (NP
            (NP (NNS proteins))
            (PP (IN in)
              (NP (NN obesity)))))))
    (VP (VBP has_been)
      (NP
        (NP (DT the) (NN subject))
        (PP (IN of)
          (NP (JJ extensive) (NN research)))))
    (. .)))

det(role-2, The-1)
nsubj(has_been-15, role-2)
case(enzymes-5, of-3)
amod(enzymes-5, pancreatic-4)
nmod:of(role-2, enzymes-5)
nmod:of(role-2, hormones-7)
conj:and(enzymes-5, hormones-7)
nmod:of(role-2, peptides-9)
conj:and(enzymes-5, peptides-9)
cc(enzymes-5, and-11)
nmod:of(role-2, proteins-12)
conj:and(enzymes-5, proteins-12)
case(obesity-14, in-13)
nmod:in(proteins-12, obesity-14)
root(ROOT-0, has_been-15)
det(subject-17, the-16)
dobj(has_been-15, subject-17)
case(research-20, of-18)
amod(research-20, extensive-19)
nmod:of(subject-17, research-20)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN hnRNP_A1/NNS by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNS hnRNP_A1)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(hnRNP_A1-20, of-19)
nmod:of(hypersecretion-18, hnRNP_A1-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT goal/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ methylate/NN on/IN the/DT secretion/NN of/IN hnRNP_A1/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this) (NN goal)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN methylate)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ hnRNP_A1) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-7, achieve-2)
det(goal-4, this-3)
dobj(achieve-2, goal-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(methylate-17, 10-15)
amod(methylate-17, mmol/L-16)
nmod:of(effects-9, methylate-17)
conj:and(glucose-13, methylate-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(examined-7, secretion-20)
case(and_insulin-23, of-21)
amod(and_insulin-23, hnRNP_A1-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(pancreata-27, genetically_obese-29)
appos(genetically_obese-29, fa/fa-31)
cc(genetically_obese-29, and-33)
amod(rats-40, lean-34)
dep(lean-34, Fa-36)
nmod:from(pancreata-27, rats-40)
conj:and(genetically_obese-29, rats-40)

Our/PRP$ results/NNS showed/VBD that/IN there/EX was/VBD a/DT significant/JJ increase/NN in/IN the/DT secretion/NN of/IN hnRNP_A1/NNS by/IN pancreata/NN from/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS under/IN both/DT glucose/NN and/CC methylate/JJ stimulation/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (VBD was)
            (NP
              (NP (DT a) (JJ significant) (NN increase))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN secretion))
                  (PP (IN of)
                    (NP (NNS hnRNP_A1))))))
            (PP (IN by)
              (NP (NN pancreata)))
            (PP (IN from)
              (NP
                (NP (JJ obese) (NNS rats))
                (VP (VBN compared)
                  (S
                    (VP (TO to)
                      (VP (VB lean)
                        (NP (NNS rats))
                        (PP (IN under)
                          (NP
                            (NP (DT both) (NN glucose))
                            (CC and)
                            (NP (JJ methylate) (NN stimulation))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(was-6, that-4)
expl(was-6, there-5)
ccomp(showed-3, was-6)
det(increase-9, a-7)
amod(increase-9, significant-8)
nsubj(was-6, increase-9)
case(secretion-12, in-10)
det(secretion-12, the-11)
nmod:in(increase-9, secretion-12)
case(hnRNP_A1-14, of-13)
nmod:of(secretion-12, hnRNP_A1-14)
case(pancreata-16, by-15)
nmod:by(was-6, pancreata-16)
case(rats-19, from-17)
amod(rats-19, obese-18)
nmod:from(was-6, rats-19)
acl(rats-19, compared-20)
mark(lean-22, to-21)
xcomp(compared-20, lean-22)
dobj(lean-22, rats-23)
case(glucose-26, under-24)
det(glucose-26, both-25)
nmod:under(lean-22, glucose-26)
cc(glucose-26, and-27)
amod(stimulation-29, methylate-28)
nmod:under(lean-22, stimulation-29)
conj:and(glucose-26, stimulation-29)

Moreover/RB ,/, we/PRP observed/VBD a/DT positive/JJ correlation/NN between/IN hnRNP_A1/JJ secretion/NN and/CC body/NN weight_gain/NN in/IN obese/JJ rats/NNS ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP (DT a) (JJ positive) (NN correlation))
        (PP (IN between)
          (NP
            (NP (JJ hnRNP_A1) (NN secretion))
            (CC and)
            (NP (NN body) (NN weight_gain)))))
      (PP (IN in)
        (NP (JJ obese) (NNS rats))))
    (. .)))

advmod(observed-4, Moreover-1)
nsubj(observed-4, we-3)
root(ROOT-0, observed-4)
det(correlation-7, a-5)
amod(correlation-7, positive-6)
dobj(observed-4, correlation-7)
case(secretion-10, between-8)
amod(secretion-10, hnRNP_A1-9)
nmod:between(correlation-7, secretion-10)
cc(secretion-10, and-11)
compound(weight_gain-13, body-12)
nmod:between(correlation-7, weight_gain-13)
conj:and(secretion-10, weight_gain-13)
case(rats-16, in-14)
amod(rats-16, obese-15)
nmod:in(observed-4, rats-16)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN hnRNP_A1/NNS by/IN the/DT pancreas/NN may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ,/, highlighting/VBG its/PRP$ potential/NN as/IN a/DT therapeutic/JJ target/NN for/IN metabolic_disorders/NNS associated/VBN with/IN obesity/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP
                (NP (NNS hnRNP_A1))
                (PP (IN by)
                  (NP (DT the) (NN pancreas))))))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity)))))
                (, ,)
                (VP (VBG highlighting)
                  (NP (PRP$ its) (NN potential))
                  (PP (IN as)
                    (NP
                      (NP (DT a) (JJ therapeutic) (NN target))
                      (PP (IN for)
                        (NP
                          (NP (NNS metabolic_disorders))
                          (VP (VBN associated)
                            (PP (IN with)
                              (NP (NN obesity)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-12, that-4)
nsubj(play-12, hypersecretion-5)
case(hnRNP_A1-7, of-6)
nmod:of(hypersecretion-5, hnRNP_A1-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(hnRNP_A1-7, pancreas-10)
aux(play-12, may-11)
ccomp(suggest-3, play-12)
det(role-14, a-13)
dobj(play-12, role-14)
case(development-17, in-15)
det(development-17, the-16)
nmod:in(role-14, development-17)
case(obesity-19, of-18)
nmod:of(development-17, obesity-19)
acl(role-14, highlighting-21)
nmod:poss(potential-23, its-22)
dobj(highlighting-21, potential-23)
case(target-27, as-24)
det(target-27, a-25)
amod(target-27, therapeutic-26)
nmod:as(highlighting-21, target-27)
case(metabolic_disorders-29, for-28)
nmod:for(target-27, metabolic_disorders-29)
acl(metabolic_disorders-29, associated-30)
case(obesity-32, with-31)
nmod:with(associated-30, obesity-32)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP
                (NP (DT a) (VBN decreased) (NN risk))
                (PP (IN of)
                  (NP (NN coronary_heart_disease))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

nsubjpass(associated-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(associated-16, have-14)
auxpass(associated-16, been-15)
root(ROOT-0, associated-16)
case(risk-20, with-17)
det(risk-20, a-18)
amod(risk-20, decreased-19)
nmod:with(associated-16, risk-20)
case(coronary_heart_disease-22, of-21)
nmod:of(risk-20, coronary_heart_disease-22)
appos(risk-20, CHD-24)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, are/VBP associated/VBN with/IN decreased/VBN S-adenosyl-l-methionine/JJ levels/NNS in/IN hyperS-adenosyl-l-methioninemic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (VBN decreased) (JJ S-adenosyl-l-methionine) (NNS levels))
              (PP (IN in)
                (NP (JJ hyperS-adenosyl-l-methioninemic) (NNS patients)))))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(associated-23, omega-3_fatty_acids-2)
nsubjpass(decreased-32, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
auxpass(associated-23, are-22)
root(ROOT-0, associated-23)
case(levels-27, with-24)
amod(levels-27, decreased-25)
amod(levels-27, S-adenosyl-l-methionine-26)
nmod:with(associated-23, levels-27)
case(patients-30, in-28)
amod(patients-30, hyperS-adenosyl-l-methioninemic-29)
nmod:in(levels-27, patients-30)
cc(associated-23, and-31)
conj:and(associated-23, decreased-32)
dobj(decreased-32, risk-33)
case(coronary_heart_disease-36, of-34)
amod(coronary_heart_disease-36, developing-35)
nmod:of(risk-33, coronary_heart_disease-36)
appos(coronary_heart_disease-36, CHD-38)

This/DT suggests/VBZ that/IN the/DT beneficial/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP on/IN CHD/NNP may/MD be/VB mediated/VBN through/IN their/PRP$ impact/NN on/IN S-adenosyl-l-methionine/JJ levels/NNS ./.

(ROOT
  (S
    (NP (DT This))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (JJ beneficial) (NNS effects))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA)))
            (PP (IN on)
              (NP (NNP CHD))))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN mediated)
                (PP (IN through)
                  (NP
                    (NP (PRP$ their) (NN impact))
                    (PP (IN on)
                      (NP (JJ S-adenosyl-l-methionine) (NNS levels)))))))))))
    (. .)))

nsubj(suggests-2, This-1)
root(ROOT-0, suggests-2)
mark(mediated-15, that-3)
det(effects-6, the-4)
amod(effects-6, beneficial-5)
nsubjpass(mediated-15, effects-6)
case(EPA-8, of-7)
nmod:of(effects-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(effects-6, DHA-10)
conj:and(EPA-8, DHA-10)
case(CHD-12, on-11)
nmod:on(effects-6, CHD-12)
aux(mediated-15, may-13)
auxpass(mediated-15, be-14)
ccomp(suggests-2, mediated-15)
case(impact-18, through-16)
nmod:poss(impact-18, their-17)
nmod:through(mediated-15, impact-18)
case(levels-21, on-19)
amod(levels-21, S-adenosyl-l-methionine-20)
nmod:on(impact-18, levels-21)

Further/JJ investigation/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS involved/VBN in/IN the/DT cardioprotective/JJ effects/NNS of/IN these/DT long-chain/JJ omega-3_fatty_acids/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NN investigation))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB understand)
              (NP
                (NP (DT the) (NNS mechanisms))
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (JJ cardioprotective) (NNS effects))
                      (PP (IN of)
                        (NP (DT these) (JJ long-chain) (NN omega-3_fatty_acids))))))))))))
    (. .)))

amod(investigation-2, Further-1)
nsubjpass(needed-4, investigation-2)
nsubj:xsubj(understand-7, investigation-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
xcomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
acl(mechanisms-9, involved-10)
case(effects-14, in-11)
det(effects-14, the-12)
amod(effects-14, cardioprotective-13)
nmod:in(involved-10, effects-14)
case(omega-3_fatty_acids-18, of-15)
det(omega-3_fatty_acids-18, these-16)
amod(omega-3_fatty_acids-18, long-chain-17)
nmod:of(effects-14, omega-3_fatty_acids-18)

The/DT VIP/NNP antagonist/JJ -LSB-/NN 4Cl-D-Phe6/JJ ,/, Leu17/JJ -RSB-/NNP VIP/NNP had/VBD no/DT effect/NN on/IN the/DT 1,2-diethyl-3-hydroxypyridin-4-one/JJ response/NN to/TO either/DT LIFL-H/NNP or/CC VIP/NNP while/IN the/DT peptide/JJ LIFL-H/NN -LRB-/-LRB- 6-38/CD -RRB-/-RRB- ,/, a/DT putative/JJ LIFL-H/JJ antagonist/NN ,/, blocked/VBD the/DT 1,2-diethyl-3-hydroxypyridin-4-one/JJ response/NN to/TO LIFL-H/NNP ./.

(ROOT
  (S
    (NP (DT The) (NNP VIP) (JJ antagonist) (NN -LSB-) (JJ 4Cl-D-Phe6) (, ,) (JJ Leu17) (NNP -RSB-) (NNP VIP))
    (VP (VBD had)
      (NP (DT no) (NN effect))
      (PP (IN on)
        (NP (DT the) (JJ 1,2-diethyl-3-hydroxypyridin-4-one) (NN response)))
      (PP (TO to)
        (NP (DT either) (NNP LIFL-H)
          (CC or)
          (NNP VIP)))
      (SBAR (IN while)
        (S
          (NP
            (NP (DT the) (JJ peptide) (NN LIFL-H))
            (PRN (-LRB- -LRB-)
              (NP (CD 6-38))
              (-RRB- -RRB-))
            (, ,)
            (NP (DT a)
              (ADJP (JJ putative) (JJ LIFL-H))
              (NN antagonist))
            (, ,))
          (VP (VBD blocked)
            (NP (DT the) (JJ 1,2-diethyl-3-hydroxypyridin-4-one) (NN response))
            (PP (TO to)
              (NP (NNP LIFL-H)))))))
    (. .)))

det(VIP-9, The-1)
compound(VIP-9, VIP-2)
amod(VIP-9, antagonist-3)
compound(VIP-9, -LSB--4)
amod(VIP-9, 4Cl-D-Phe6-5)
amod(VIP-9, Leu17-7)
compound(VIP-9, -RSB--8)
nsubj(had-10, VIP-9)
root(ROOT-0, had-10)
neg(effect-12, no-11)
dobj(had-10, effect-12)
case(response-16, on-13)
det(response-16, the-14)
amod(response-16, 1,2-diethyl-3-hydroxypyridin-4-one-15)
nmod:on(had-10, response-16)
case(LIFL-H-19, to-17)
cc:preconj(LIFL-H-19, either-18)
nmod:to(had-10, LIFL-H-19)
cc(LIFL-H-19, or-20)
nmod:to(had-10, VIP-21)
conj:or(LIFL-H-19, VIP-21)
mark(blocked-35, while-22)
det(LIFL-H-25, the-23)
amod(LIFL-H-25, peptide-24)
nsubj(blocked-35, LIFL-H-25)
appos(LIFL-H-25, 6-38-27)
det(antagonist-33, a-30)
amod(LIFL-H-32, putative-31)
amod(antagonist-33, LIFL-H-32)
appos(LIFL-H-25, antagonist-33)
advcl(had-10, blocked-35)
det(response-38, the-36)
amod(response-38, 1,2-diethyl-3-hydroxypyridin-4-one-37)
dobj(blocked-35, response-38)
case(LIFL-H-40, to-39)
nmod:to(blocked-35, LIFL-H-40)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN a/DT VIP/NNP antagonist/NN -LSB-/VBD 4Cl-D-Phe6/JJ ,/, Leu17/NNP -RSB-/NNP VIP/NNP and/CC a/DT putative/JJ LIFL-H/JJ antagonist/NN LIFL-H/NN -LRB-/-LRB- 6-38/CD -RRB-/-RRB- on/IN the/DT response/NN of_1/CD ,2/CD -/: diethyl-3-hydroxypyridin-4-one/JJ was/VBD investigated/VBN ./.

(ROOT
  (S
    (S
      (PP (IN In)
        (NP (DT this) (NN study)))
      (, ,)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (DT a) (NNP VIP) (NN antagonist))))
      (VP (VBD -LSB-)
        (NP
          (NP
            (NP (JJ 4Cl-D-Phe6))
            (, ,)
            (NP (NNP Leu17) (NNP -RSB-) (NNP VIP))
            (CC and)
            (NP (DT a) (JJ putative) (JJ LIFL-H) (NN antagonist) (NN LIFL-H)))
          (PRN (-LRB- -LRB-)
            (NP (CD 6-38))
            (-RRB- -RRB-)))
        (PP (IN on)
          (NP (DT the) (NN response)
            (QP (CD of_1) (CD ,2))))))
    (: -)
    (S
      (NP (JJ diethyl-3-hydroxypyridin-4-one))
      (VP (VBD was)
        (VP (VBN investigated))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(-LSB--11, study-3)
det(effect-6, the-5)
nsubj(-LSB--11, effect-6)
case(antagonist-10, of-7)
det(antagonist-10, a-8)
compound(antagonist-10, VIP-9)
nmod:of(effect-6, antagonist-10)
root(ROOT-0, -LSB--11)
dobj(-LSB--11, 4Cl-D-Phe6-12)
compound(VIP-16, Leu17-14)
compound(VIP-16, -RSB--15)
dobj(-LSB--11, VIP-16)
conj:and(4Cl-D-Phe6-12, VIP-16)
cc(4Cl-D-Phe6-12, and-17)
det(LIFL-H-22, a-18)
amod(LIFL-H-22, putative-19)
amod(LIFL-H-22, LIFL-H-20)
compound(LIFL-H-22, antagonist-21)
dobj(-LSB--11, LIFL-H-22)
conj:and(4Cl-D-Phe6-12, LIFL-H-22)
appos(4Cl-D-Phe6-12, 6-38-24)
case(response-28, on-26)
det(response-28, the-27)
nmod:on(-LSB--11, response-28)
compound(,2-30, of_1-29)
nummod(response-28, ,2-30)
nsubjpass(investigated-34, diethyl-3-hydroxypyridin-4-one-32)
auxpass(investigated-34, was-33)
parataxis(-LSB--11, investigated-34)

The/DT results/NNS showed/VBD that/IN the/DT VIP/NNP antagonist/NN had/VBD no/DT effect/NN on/IN the/DT response/NN to/TO either/DT LIFL-H/NNP or/CC VIP/NNP ,/, indicating/VBG that/IN it/PRP does/VBZ not/RB interfere/VB with/IN the/DT signaling/VBG pathways/NNS mediated/VBN by/IN these/DT neuropeptides/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (DT the) (NNP VIP) (NN antagonist))
          (VP (VBD had)
            (NP
              (NP (DT no) (NN effect))
              (PP (IN on)
                (NP
                  (NP (DT the) (NN response))
                  (PP (TO to)
                    (NP (DT either) (NNP LIFL-H)
                      (CC or)
                      (NNP VIP))))))
            (, ,)
            (S
              (VP (VBG indicating)
                (SBAR (IN that)
                  (S
                    (NP (PRP it))
                    (VP (VBZ does) (RB not)
                      (VP (VB interfere)
                        (PP (IN with)
                          (NP
                            (NP (DT the) (VBG signaling) (NNS pathways))
                            (VP (VBN mediated)
                              (PP (IN by)
                                (NP (DT these) (NNS neuropeptides))))))))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(had-8, that-4)
det(antagonist-7, the-5)
compound(antagonist-7, VIP-6)
nsubj(had-8, antagonist-7)
ccomp(showed-3, had-8)
neg(effect-10, no-9)
dobj(had-8, effect-10)
case(response-13, on-11)
det(response-13, the-12)
nmod:on(effect-10, response-13)
case(LIFL-H-16, to-14)
cc:preconj(LIFL-H-16, either-15)
nmod:to(response-13, LIFL-H-16)
cc(LIFL-H-16, or-17)
nmod:to(response-13, VIP-18)
conj:or(LIFL-H-16, VIP-18)
advcl(had-8, indicating-20)
mark(interfere-25, that-21)
nsubj(interfere-25, it-22)
aux(interfere-25, does-23)
neg(interfere-25, not-24)
ccomp(indicating-20, interfere-25)
case(pathways-29, with-26)
det(pathways-29, the-27)
amod(pathways-29, signaling-28)
nmod:with(interfere-25, pathways-29)
acl(pathways-29, mediated-30)
case(neuropeptides-33, by-31)
det(neuropeptides-33, these-32)
nmod:by(mediated-30, neuropeptides-33)

On/IN the/DT other/JJ hand/NN ,/, the/DT peptide/JJ LIFL-H/NN -LRB-/-LRB- 6-38/CD -RRB-/-RRB- ,/, which/WDT is_a/NN putative/VBP LIFL-H/JJ antagonist/NN ,/, blocked/VBD the/DT response/NN of_1/JJ ,2/CD -/: diethyl-3-hydroxypyridin-4-one/JJ to/TO LIFL-H/NNP ./. These/DT findings/NNS suggest/VBP that/IN LIFL-H/NNP may/MD be/VB involved/VBN in/IN modulating/VBG the/DT activity/NN of_1/CD ,2/CD -/: diethyl-3-hydroxypyridin-4-one/JJ through/IN its/PRP$ interaction/NN with/IN specific/JJ receptors/NNS in/IN neuronal/NN or/CC non-neuronal_cells/NNS ./.

(ROOT
  (S
    (PP (IN On)
      (NP (DT the) (JJ other) (NN hand)))
    (, ,)
    (NP
      (NP (DT the) (JJ peptide) (NN LIFL-H))
      (PRN (-LRB- -LRB-)
        (NP (CD 6-38))
        (-RRB- -RRB-))
      (, ,)
      (SBAR
        (WHNP (WDT which) (NN is_a))
        (S
          (VP (VBP putative)
            (NP (JJ LIFL-H) (NN antagonist)))))
      (, ,))
    (VP (VBD blocked)
      (S
        (NP (DT the) (NN response))
        (ADJP (JJ of_1))
        (SBAR
          (X
            (NP (CD ,2))
            (: -)
            (FRAG
              (ADJP (JJ diethyl-3-hydroxypyridin-4-one)
                (PP (TO to)
                  (NP (NNP LIFL-H)))))
            (. .))
          (S
            (NP (DT These) (NNS findings))
            (VP (VBP suggest)
              (SBAR (IN that)
                (S
                  (NP (NNP LIFL-H))
                  (VP (MD may)
                    (VP (VB be)
                      (VP (VBN involved)
                        (PP (IN in)
                          (S
                            (VP (VBG modulating)
                              (NP (DT the) (NN activity))
                              (NP
                                (NP
                                  (QP (CD of_1) (CD ,2)))
                                (: -)
                                (ADJP (JJ diethyl-3-hydroxypyridin-4-one)
                                  (PP (IN through)
                                    (NP (PRP$ its) (NN interaction))))))))
                        (PP (IN with)
                          (NP
                            (NP (JJ specific) (NNS receptors))
                            (PP (IN in)
                              (NP (NN neuronal)
                                (CC or)
                                (NNS non-neuronal_cells)))))))))))))))
    (. .)))

case(hand-4, On-1)
det(hand-4, the-2)
amod(hand-4, other-3)
nmod:on(blocked-19, hand-4)
det(LIFL-H-8, the-6)
amod(LIFL-H-8, peptide-7)
det(is_a-14, LIFL-H-8)
nsubj(blocked-19, LIFL-H-8)
appos(LIFL-H-8, 6-38-10)
ref(LIFL-H-8, which-13)
nsubj(putative-15, is_a-14)
acl:relcl(LIFL-H-8, putative-15)
amod(antagonist-17, LIFL-H-16)
dobj(putative-15, antagonist-17)
root(ROOT-0, blocked-19)
det(response-21, the-20)
nsubj(suggest-31, response-21)
dep(suggest-31, of_1-22)
dep(suggest-31, ,2-23)
dep(,2-23, diethyl-3-hydroxypyridin-4-one-25)
case(LIFL-H-27, to-26)
nmod:to(diethyl-3-hydroxypyridin-4-one-25, LIFL-H-27)
det(findings-30, These-29)
nsubj(suggest-31, findings-30)
xcomp(blocked-19, suggest-31)
mark(involved-36, that-32)
nsubjpass(involved-36, LIFL-H-33)
aux(involved-36, may-34)
auxpass(involved-36, be-35)
ccomp(suggest-31, involved-36)
mark(modulating-38, in-37)
advcl(involved-36, modulating-38)
det(activity-40, the-39)
iobj(modulating-38, activity-40)
compound(,2-42, of_1-41)
dobj(modulating-38, ,2-42)
amod(,2-42, diethyl-3-hydroxypyridin-4-one-44)
case(interaction-47, through-45)
nmod:poss(interaction-47, its-46)
nmod:through(diethyl-3-hydroxypyridin-4-one-44, interaction-47)
case(receptors-50, with-48)
amod(receptors-50, specific-49)
nmod:with(involved-36, receptors-50)
case(neuronal-52, in-51)
nmod:in(receptors-50, neuronal-52)
cc(neuronal-52, or-53)
nmod:in(receptors-50, non-neuronal_cells-54)
conj:or(neuronal-52, non-neuronal_cells-54)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT precise/JJ mechanisms/NNS underlying/VBG this/DT interaction/NN and/CC its/PRP$ potential/JJ therapeutic/JJ implications/NNS in/IN various/JJ pathological/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (JJ precise) (NNS mechanisms))
                (PP (VBG underlying)
                  (NP
                    (NP (DT this) (NN interaction))
                    (CC and)
                    (NP
                      (NP (PRP$ its) (JJ potential) (JJ therapeutic) (NNS implications))
                      (PP (IN in)
                        (NP (JJ various) (JJ pathological) (NNS conditions))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, precise-8)
dobj(elucidate-6, mechanisms-9)
case(interaction-12, underlying-10)
det(interaction-12, this-11)
nmod:underlying(mechanisms-9, interaction-12)
cc(interaction-12, and-13)
nmod:poss(implications-17, its-14)
amod(implications-17, potential-15)
amod(implications-17, therapeutic-16)
nmod:underlying(mechanisms-9, implications-17)
conj:and(interaction-12, implications-17)
case(conditions-21, in-18)
amod(conditions-21, various-19)
amod(conditions-21, pathological-20)
nmod:in(implications-17, conditions-21)

The/DT metabolic/JJ pathways/NNS in/IN seminal/JJ vesicles/NNS are/VBP important/JJ for/IN male/JJ fertility/NN and/CC include/VBP hexokinase/JJ -LRB-/-LRB- HK/NNP -RRB-/-RRB- ,/, pyruvate_kinase/JJ -LRB-/-LRB- PK/NNP -RRB-/-RRB- ,/, lactate_dehydrogenase/JJ -LRB-/-LRB- LDH/NNP -RRB-/-RRB- ,/, glyceraldehyde-3-phosphate/JJ -LRB-/-LRB- G3PD/NNP -RRB-/-RRB- ,/, glucose-6-phophate/JJ -LRB-/-LRB- G6PD/NNP -RRB-/-RRB- and/CC octylmethoxycinnamate/JJ dehydrogenases/JJ -LRB-/-LRB- bp-2/JJ -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ metabolic) (NNS pathways))
      (PP (IN in)
        (NP (JJ seminal) (NNS vesicles))))
    (VP
      (VP (VBP are)
        (ADJP (JJ important)
          (PP (IN for)
            (NP (JJ male) (NN fertility)))))
      (CC and)
      (VP (VBP include)
        (ADJP
          (ADJP (JJ hexokinase))
          (PRN (-LRB- -LRB-)
            (NP (NNP HK))
            (-RRB- -RRB-))
          (, ,)
          (ADJP (JJ pyruvate_kinase))
          (PRN (-LRB- -LRB-)
            (NP (NNP PK))
            (-RRB- -RRB-))
          (, ,)
          (ADJP (JJ lactate_dehydrogenase))
          (PRN (-LRB- -LRB-)
            (NP (NNP LDH))
            (-RRB- -RRB-))
          (, ,)
          (ADJP (JJ glyceraldehyde-3-phosphate))
          (PRN (-LRB- -LRB-)
            (NP (NNP G3PD))
            (-RRB- -RRB-))
          (, ,)
          (ADJP
            (ADJP (JJ glucose-6-phophate))
            (PRN (-LRB- -LRB-)
              (NP (NNP G6PD))
              (-RRB- -RRB-)))
          (CC and)
          (ADJP (JJ octylmethoxycinnamate) (JJ dehydrogenases))
          (PRN (-LRB- -LRB-)
            (ADJP (JJ bp-2))
            (-RRB- -RRB-)))))
    (. .)))

det(pathways-3, The-1)
amod(pathways-3, metabolic-2)
nsubj(important-8, pathways-3)
nsubj(include-13, pathways-3)
case(vesicles-6, in-4)
amod(vesicles-6, seminal-5)
nmod:in(pathways-3, vesicles-6)
cop(important-8, are-7)
root(ROOT-0, important-8)
case(fertility-11, for-9)
amod(fertility-11, male-10)
nmod:for(important-8, fertility-11)
cc(important-8, and-12)
conj:and(important-8, include-13)
xcomp(include-13, hexokinase-14)
dep(hexokinase-14, HK-16)
xcomp(include-13, pyruvate_kinase-19)
conj:and(hexokinase-14, pyruvate_kinase-19)
dep(hexokinase-14, PK-21)
xcomp(include-13, lactate_dehydrogenase-24)
conj:and(hexokinase-14, lactate_dehydrogenase-24)
dep(hexokinase-14, LDH-26)
xcomp(include-13, glyceraldehyde-3-phosphate-29)
conj:and(hexokinase-14, glyceraldehyde-3-phosphate-29)
dep(hexokinase-14, G3PD-31)
xcomp(include-13, glucose-6-phophate-34)
conj:and(hexokinase-14, glucose-6-phophate-34)
dep(glucose-6-phophate-34, G6PD-36)
cc(hexokinase-14, and-38)
amod(dehydrogenases-40, octylmethoxycinnamate-39)
xcomp(include-13, dehydrogenases-40)
conj:and(hexokinase-14, dehydrogenases-40)
dep(hexokinase-14, bp-2-42)

These/DT enzymes/NNS play/VBP important/JJ roles/NNS in/IN the/DT regulation/NN of/IN male/JJ fertility/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS enzymes))
    (VP (VBP play)
      (NP
        (NP (JJ important) (NNS roles))
        (PP (IN in)
          (NP
            (NP (DT the) (NN regulation))
            (PP (IN of)
              (NP (JJ male) (NN fertility)))))))
    (. .)))

det(enzymes-2, These-1)
nsubj(play-3, enzymes-2)
root(ROOT-0, play-3)
amod(roles-5, important-4)
dobj(play-3, roles-5)
case(regulation-8, in-6)
det(regulation-8, the-7)
nmod:in(roles-5, regulation-8)
case(fertility-11, of-9)
amod(fertility-11, male-10)
nmod:of(regulation-8, fertility-11)

Castration/NNP has_been/VBP shown/VBN to/TO have/VB significant/JJ effects/NNS on/IN the/DT activities/NNS of/IN these/DT enzymes/NNS in/IN seminal/JJ vesicles/NNS ./.

(ROOT
  (S
    (NP (NNP Castration))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP
                (NP (JJ significant) (NNS effects))
                (PP (IN on)
                  (NP
                    (NP (DT the) (NNS activities))
                    (PP (IN of)
                      (NP
                        (NP (DT these) (NNS enzymes))
                        (PP (IN in)
                          (NP (JJ seminal) (NNS vesicles)))))))))))))
    (. .)))

nsubj(has_been-2, Castration-1)
root(ROOT-0, has_been-2)
dep(has_been-2, shown-3)
mark(have-5, to-4)
xcomp(shown-3, have-5)
amod(effects-7, significant-6)
dobj(have-5, effects-7)
case(activities-10, on-8)
det(activities-10, the-9)
nmod:on(effects-7, activities-10)
case(enzymes-13, of-11)
det(enzymes-13, these-12)
nmod:of(activities-10, enzymes-13)
case(vesicles-16, in-14)
amod(vesicles-16, seminal-15)
nmod:in(enzymes-13, vesicles-16)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN castration/NN on/IN the/DT activities/NNS of/IN hexokinase/NN -LRB-/-LRB- HK/NNP -RRB-/-RRB- ,/, 6-phosphofructokinase/JJ -LRB-/-LRB- PFK/NNP -RRB-/-RRB- ,/, glyceraldehyde-3-phosphate_dehydrogenase/JJ -LRB-/-LRB- G3PD/NNP -RRB-/-RRB- ,/, pyruvate_kinase/JJ -LRB-/-LRB- PK/NNP -RRB-/-RRB- ,/, glucose_6-phosphate_dehydrogenase/JJ -LRB-/-LRB- G6PD/NNP -RRB-/-RRB- and/CC octylmethoxycinnamate/JJ dehydrogenase/JJ -LRB-/-LRB- bp-2/JJ -RRB-/-RRB- in/IN seminal/JJ vesicles/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NN castration))))
      (PP (IN on)
        (NP
          (NP
            (NP (DT the) (NNS activities))
            (PP (IN of)
              (NP (NN hexokinase))))
          (PRN (-LRB- -LRB-)
            (NP (NNP HK))
            (-RRB- -RRB-))))
      (, ,)
      (ADJP
        (ADJP (JJ 6-phosphofructokinase))
        (PRN (-LRB- -LRB-)
          (NP (NNP PFK))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ glyceraldehyde-3-phosphate_dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NNP G3PD))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ pyruvate_kinase))
        (PRN (-LRB- -LRB-)
          (NP (NNP PK))
          (-RRB- -RRB-))
        (, ,)
        (ADJP
          (ADJP (JJ glucose_6-phosphate_dehydrogenase))
          (PRN (-LRB- -LRB-)
            (NP (NNP G6PD))
            (-RRB- -RRB-)))
        (CC and)
        (ADJP (JJ octylmethoxycinnamate) (JJ dehydrogenase))
        (PRN (-LRB- -LRB-)
          (ADJP (JJ bp-2))
          (-RRB- -RRB-)))
      (PP (IN in)
        (NP (JJ seminal) (NNS vesicles))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(castration-10, of-9)
nmod:of(effects-8, castration-10)
case(activities-13, on-11)
det(activities-13, the-12)
nmod:on(investigated-6, activities-13)
case(hexokinase-15, of-14)
nmod:of(activities-13, hexokinase-15)
appos(activities-13, HK-17)
xcomp(investigated-6, 6-phosphofructokinase-20)
dep(6-phosphofructokinase-20, PFK-22)
xcomp(investigated-6, glyceraldehyde-3-phosphate_dehydrogenase-25)
conj:and(6-phosphofructokinase-20, glyceraldehyde-3-phosphate_dehydrogenase-25)
dep(6-phosphofructokinase-20, G3PD-27)
xcomp(investigated-6, pyruvate_kinase-30)
conj:and(6-phosphofructokinase-20, pyruvate_kinase-30)
dep(6-phosphofructokinase-20, PK-32)
xcomp(investigated-6, glucose_6-phosphate_dehydrogenase-35)
conj:and(6-phosphofructokinase-20, glucose_6-phosphate_dehydrogenase-35)
dep(glucose_6-phosphate_dehydrogenase-35, G6PD-37)
cc(6-phosphofructokinase-20, and-39)
amod(dehydrogenase-41, octylmethoxycinnamate-40)
xcomp(investigated-6, dehydrogenase-41)
conj:and(6-phosphofructokinase-20, dehydrogenase-41)
dep(6-phosphofructokinase-20, bp-2-43)
case(vesicles-47, in-45)
amod(vesicles-47, seminal-46)
nmod:in(investigated-6, vesicles-47)

Our/PRP$ results/NNS showed/VBD that/IN castration/NN decreased/VBD the/DT activities/NNS of/IN all/DT enzymes/NNS studied/VBN ,/, indicating/VBG that/IN these/DT enzymes/NNS are/VBP regulated/VBN by/IN androgens/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NN castration))
          (VP (VBD decreased)
            (NP
              (NP (DT the) (NNS activities))
              (PP (IN of)
                (NP
                  (NP (DT all) (NNS enzymes))
                  (VP (VBN studied)))))
            (, ,)
            (S
              (VP (VBG indicating)
                (SBAR (IN that)
                  (S
                    (NP (DT these) (NNS enzymes))
                    (VP (VBP are)
                      (VP (VBN regulated)
                        (PP (IN by)
                          (NP (NNS androgens)))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(decreased-6, that-4)
nsubj(decreased-6, castration-5)
ccomp(showed-3, decreased-6)
det(activities-8, the-7)
dobj(decreased-6, activities-8)
case(enzymes-11, of-9)
det(enzymes-11, all-10)
nmod:of(activities-8, enzymes-11)
acl(enzymes-11, studied-12)
advcl(decreased-6, indicating-14)
mark(regulated-19, that-15)
det(enzymes-17, these-16)
nsubjpass(regulated-19, enzymes-17)
auxpass(regulated-19, are-18)
ccomp(indicating-14, regulated-19)
case(androgens-21, by-20)
nmod:by(regulated-19, androgens-21)

These/DT findings/NNS suggest/VBP that/IN the/DT regulation/NN of/IN metabolic/JJ pathways/NNS in/IN seminal/JJ vesicles/NNS is/VBZ important/JJ for/IN male/JJ fertility/NN and/CC may/MD provide/VB insights/NNS into/IN potential/JJ therapeutic/JJ targets/NNS for/IN male_infertility/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN regulation))
            (PP (IN of)
              (NP
                (NP (JJ metabolic) (NNS pathways))
                (PP (IN in)
                  (NP (JJ seminal) (NNS vesicles))))))
          (VP
            (VP (VBZ is)
              (ADJP (JJ important)
                (PP (IN for)
                  (NP (JJ male) (NN fertility)))))
            (CC and)
            (VP (MD may)
              (VP (VB provide)
                (NP (NNS insights))
                (PP (IN into)
                  (NP
                    (NP (JJ potential) (JJ therapeutic) (NNS targets))
                    (PP (IN for)
                      (NP (NN male_infertility)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(important-14, that-4)
det(regulation-6, the-5)
nsubj(important-14, regulation-6)
nsubj(provide-20, regulation-6)
case(pathways-9, of-7)
amod(pathways-9, metabolic-8)
nmod:of(regulation-6, pathways-9)
case(vesicles-12, in-10)
amod(vesicles-12, seminal-11)
nmod:in(pathways-9, vesicles-12)
cop(important-14, is-13)
ccomp(suggest-3, important-14)
case(fertility-17, for-15)
amod(fertility-17, male-16)
nmod:for(important-14, fertility-17)
cc(important-14, and-18)
aux(provide-20, may-19)
ccomp(suggest-3, provide-20)
conj:and(important-14, provide-20)
dobj(provide-20, insights-21)
case(targets-25, into-22)
amod(targets-25, potential-23)
amod(targets-25, therapeutic-24)
nmod:into(provide-20, targets-25)
case(male_infertility-27, for-26)
nmod:for(targets-25, male_infertility-27)

Somatomedin-like/NNP protein_1/VBD -LRB-/-LRB- SMTNL1/NNP -RRB-/-RRB- is_a/JJ protein/NN that/WDT is/VBZ highly/RB expressed/VBN in/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (NP (NNP Somatomedin-like))
    (VP (VBD protein_1)
      (NP
        (NP
          (PRN (-LRB- -LRB-)
            (NP (NNP SMTNL1))
            (-RRB- -RRB-))
          (JJ is_a) (NN protein))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ is)
              (VP
                (ADVP (RB highly))
                (VBN expressed)
                (PP (IN in)
                  (NP (DT the) (NN pancreas)))))))))
    (. .)))

nsubj(protein_1-2, Somatomedin-like-1)
root(ROOT-0, protein_1-2)
appos(protein-7, SMTNL1-4)
amod(protein-7, is_a-6)
dobj(protein_1-2, protein-7)
nsubjpass(expressed-11, protein-7)
ref(protein-7, that-8)
auxpass(expressed-11, is-9)
advmod(expressed-11, highly-10)
acl:relcl(protein-7, expressed-11)
case(pancreas-14, in-12)
det(pancreas-14, the-13)
nmod:in(expressed-11, pancreas-14)

Previous/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT secretion/NN of/IN insulin/NN by/IN the/DT pancreatic/JJ acinar/NN cells/NNS is/VBZ regulated/VBN by/IN Tpm/NNP ./.

(ROOT
  (S
    (NP (JJ Previous) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN secretion))
              (PP (IN of)
                (NP
                  (NP (NN insulin))
                  (PP (IN by)
                    (NP (DT the) (JJ pancreatic) (NN acinar) (NNS cells))))))
            (VP (VBZ is)
              (VP (VBN regulated)
                (PP (IN by)
                  (NP (NNP Tpm)))))))))
    (. .)))

amod(studies-2, Previous-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(regulated-16, that-5)
det(secretion-7, the-6)
nsubjpass(regulated-16, secretion-7)
case(insulin-9, of-8)
nmod:of(secretion-7, insulin-9)
case(cells-14, by-10)
det(cells-14, the-11)
amod(cells-14, pancreatic-12)
compound(cells-14, acinar-13)
nmod:by(insulin-9, cells-14)
auxpass(regulated-16, is-15)
ccomp(suggested-4, regulated-16)
case(Tpm-18, by-17)
nmod:by(regulated-16, Tpm-18)

However/RB ,/, the/DT effects/NNS of/IN high-glucose/JJ conditions/NNS and/or/CC Tpm/NNP on/IN pancreatic/JJ insulin_secretion/NN are/VBP not/RB well/RB understood/VBN ./. -LRB-/-LRB- 1/CD -RRB-/-RRB- -LRB-/-LRB- 2/CD -RRB-/-RRB- -LRB-/-LRB- 3/CD -RRB-/-RRB- -LRB-/-LRB- 4/CD -RRB-/-RRB- -LRB-/-LRB- 5/CD -RRB-/-RRB- -LRB-/-LRB- 6/CD -RRB-/-RRB- -LRB-/-LRB- 7/CD -RRB-/-RRB- -LRB-/-LRB- 8/CD -RRB-/-RRB- -LRB-/-LRB- 10/CD -RRB-/-RRB- -LRB-/-LRB- 11/CD -RRB-/-RRB- -LRB-/-LRB- 12/CD -RRB-/-RRB- -LRB-/-LRB- 14/CD -RRB-/-RRB- -LRB-/-LRB- 15/CD -RRB-/-RRB- -LRB-/-LRB- 16/CD -RRB-/-RRB- -LRB-/-LRB- 17/CD -RRB-/-RRB- -LRB-/-LRB- 18/CD -RRB-/-RRB- -LRB-/-LRB- 19/CD -RRB-/-RRB- -LRB-/-LRB- 20/CD -RRB-/-RRB- -LRB-/-LRB- 21/CD -RRB-/-RRB- -LRB-/-LRB- 22/CD -RRB-/-RRB- -LRB-/-LRB- 24/CD -RRB-/-RRB- -LRB-/-LRB- 25/CD -RRB-/-RRB- -LRB-/-LRB- 26/CD -RRB-/-RRB- -LRB-/-LRB- 27/CD -RRB-/-RRB- -LRB-/-LRB- T/NNP -RRB-/-RRB- -LRB-/-LRB- Figure/NN 1/CD -RRB-/-RRB- -LRB-/-LRB- 2/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP
          (NP (JJ high-glucose) (NNS conditions))
          (CC and/or)
          (NP
            (NP (NNP Tpm))
            (PP (IN on)
              (NP (JJ pancreatic) (NN insulin_secretion)))))))
    (VP (VBP are)
      (NP
        (NP
          (NP
            (NP
              (NP
                (NP
                  (NP
                    (NP
                      (NP
                        (NP
                          (NP
                            (NP
                              (NP
                                (NP
                                  (NP
                                    (NP
                                      (NP
                                        (NP
                                          (NP
                                            (NP
                                              (NP
                                                (NP
                                                  (NP
                                                    (NP
                                                      (NP
                                                        (NP
                                                          (NP
                                                            (NP
                                                              (FRAG (RB not)
                                                                (ADJP (RB well) (VBN understood))
                                                                (. .)))
                                                            (PRN (-LRB- -LRB-)
                                                              (NP (CD 1))
                                                              (-RRB- -RRB-)))
                                                          (PRN (-LRB- -LRB-)
                                                            (NP (CD 2))
                                                            (-RRB- -RRB-)))
                                                        (PRN (-LRB- -LRB-)
                                                          (NP (CD 3))
                                                          (-RRB- -RRB-)))
                                                      (PRN (-LRB- -LRB-)
                                                        (NP (CD 4))
                                                        (-RRB- -RRB-)))
                                                    (PRN (-LRB- -LRB-)
                                                      (NP (CD 5))
                                                      (-RRB- -RRB-)))
                                                  (PRN (-LRB- -LRB-)
                                                    (NP (CD 6))
                                                    (-RRB- -RRB-)))
                                                (PRN (-LRB- -LRB-)
                                                  (NP (CD 7))
                                                  (-RRB- -RRB-)))
                                              (PRN (-LRB- -LRB-)
                                                (NP (CD 8))
                                                (-RRB- -RRB-)))
                                            (PRN (-LRB- -LRB-)
                                              (NP (CD 10))
                                              (-RRB- -RRB-)))
                                          (PRN (-LRB- -LRB-)
                                            (NP (CD 11))
                                            (-RRB- -RRB-)))
                                        (PRN (-LRB- -LRB-)
                                          (NP (CD 12))
                                          (-RRB- -RRB-)))
                                      (PRN (-LRB- -LRB-)
                                        (NP (CD 14))
                                        (-RRB- -RRB-)))
                                    (PRN (-LRB- -LRB-)
                                      (NP (CD 15))
                                      (-RRB- -RRB-)))
                                  (PRN (-LRB- -LRB-)
                                    (NP (CD 16))
                                    (-RRB- -RRB-)))
                                (PRN (-LRB- -LRB-)
                                  (NP (CD 17))
                                  (-RRB- -RRB-)))
                              (PRN (-LRB- -LRB-)
                                (NP (CD 18))
                                (-RRB- -RRB-)))
                            (PRN (-LRB- -LRB-)
                              (NP (CD 19))
                              (-RRB- -RRB-)))
                          (PRN (-LRB- -LRB-)
                            (NP (CD 20))
                            (-RRB- -RRB-)))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 21))
                          (-RRB- -RRB-)))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 22))
                        (-RRB- -RRB-)))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 24))
                      (-RRB- -RRB-)))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 25))
                    (-RRB- -RRB-)))
                (PRN (-LRB- -LRB-)
                  (NP (CD 26))
                  (-RRB- -RRB-)))
              (PRN (-LRB- -LRB-)
                (NP (CD 27))
                (-RRB- -RRB-)))
            (PRN (-LRB- -LRB-)
              (NP (NNP T))
              (-RRB- -RRB-)))
          (PRN (-LRB- -LRB-)
            (NP (NN Figure) (CD 1))
            (-RRB- -RRB-)))
        (PRN (-LRB- -LRB-)
          (NP (CD 2))
          (-RRB- -RRB-))))
    (. .)))

advmod(not-14, However-1)
det(effects-4, the-3)
nsubj(not-14, effects-4)
case(conditions-7, of-5)
amod(conditions-7, high-glucose-6)
nmod:of(effects-4, conditions-7)
cc(conditions-7, and/or-8)
nmod:of(effects-4, Tpm-9)
conj:and/or(conditions-7, Tpm-9)
case(insulin_secretion-12, on-10)
amod(insulin_secretion-12, pancreatic-11)
nmod:on(Tpm-9, insulin_secretion-12)
cop(not-14, are-13)
root(ROOT-0, not-14)
advmod(understood-16, well-15)
dep(not-14, understood-16)
appos(not-14, 1-19)
appos(not-14, 2-22)
appos(not-14, 3-25)
appos(not-14, 4-28)
appos(not-14, 5-31)
appos(not-14, 6-34)
appos(not-14, 7-37)
appos(not-14, 8-40)
appos(not-14, 10-43)
appos(not-14, 11-46)
appos(not-14, 12-49)
appos(not-14, 14-52)
appos(not-14, 15-55)
appos(not-14, 16-58)
appos(not-14, 17-61)
appos(not-14, 18-64)
appos(not-14, 19-67)
appos(not-14, 20-70)
appos(not-14, 21-73)
appos(not-14, 22-76)
appos(not-14, 24-79)
appos(not-14, 25-82)
appos(not-14, 26-85)
appos(not-14, 27-88)
appos(not-14, T-91)
appos(not-14, Figure-94)
nummod(Figure-94, 1-95)
appos(not-14, 2-98)

-LRB-/-LRB- 4/CD -RRB-/-RRB- -LRB-/-LRB- 5/CD -RRB-/-RRB- -LRB-/-LRB- 6/CD -RRB-/-RRB- -LRB-/-LRB- 7/CD -RRB-/-RRB- -LRB-/-LRB- 8/CD -RRB-/-RRB- -LRB-/-LRB- 9/CD -RRB-/-RRB- -LRB-/-LRB- 10/CD -RRB-/-RRB- -LRB-/-LRB- 11/CD -RRB-/-RRB- -LRB-/-LRB- 12/CD -RRB-/-RRB- -LRB-/-LRB- 13/CD -RRB-/-RRB- -LRB-/-LRB- 14/CD -RRB-/-RRB- -LRB-/-LRB- 15/CD -RRB-/-RRB- -LRB-/-LRB- 16/CD -RRB-/-RRB- -LRB-/-LRB- 17/CD -RRB-/-RRB- -LRB-/-LRB- 18/CD -RRB-/-RRB- -LRB-/-LRB- 19/CD -RRB-/-RRB- -LRB-/-LRB- 20/CD -RRB-/-RRB- -LRB-/-LRB- 21/CD -RRB-/-RRB- -LRB-/-LRB- 4/CD -RRB-/-RRB- ./.

(ROOT
  (NP
    (NP
      (NP
        (NP
          (NP
            (NP
              (NP
                (NP
                  (NP
                    (NP
                      (NP
                        (NP
                          (NP
                            (NP
                              (NP
                                (NP
                                  (NP
                                    (NP
                                      (NP
                                        (NP (-LRB- -LRB-)
                                          (QP (CD 4))
                                          (-RRB- -RRB-))
                                        (PRN (-LRB- -LRB-)
                                          (NP (CD 5))
                                          (-RRB- -RRB-)))
                                      (PRN (-LRB- -LRB-)
                                        (NP (CD 6))
                                        (-RRB- -RRB-)))
                                    (PRN (-LRB- -LRB-)
                                      (NP (CD 7))
                                      (-RRB- -RRB-)))
                                  (PRN (-LRB- -LRB-)
                                    (NP (CD 8))
                                    (-RRB- -RRB-)))
                                (PRN (-LRB- -LRB-)
                                  (NP (CD 9))
                                  (-RRB- -RRB-)))
                              (PRN (-LRB- -LRB-)
                                (NP (CD 10))
                                (-RRB- -RRB-)))
                            (PRN (-LRB- -LRB-)
                              (NP (CD 11))
                              (-RRB- -RRB-)))
                          (PRN (-LRB- -LRB-)
                            (NP (CD 12))
                            (-RRB- -RRB-)))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 13))
                          (-RRB- -RRB-)))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 14))
                        (-RRB- -RRB-)))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 15))
                      (-RRB- -RRB-)))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 16))
                    (-RRB- -RRB-)))
                (PRN (-LRB- -LRB-)
                  (NP (CD 17))
                  (-RRB- -RRB-)))
              (PRN (-LRB- -LRB-)
                (NP (CD 18))
                (-RRB- -RRB-)))
            (PRN (-LRB- -LRB-)
              (NP (CD 19))
              (-RRB- -RRB-)))
          (PRN (-LRB- -LRB-)
            (NP (CD 20))
            (-RRB- -RRB-)))
        (PRN (-LRB- -LRB-)
          (NP (CD 21))
          (-RRB- -RRB-)))
      (PRN (-LRB- -LRB-)
        (NP (CD 4))
        (-RRB- -RRB-)))
    (. .)))

root(ROOT-0, 4-2)
appos(4-2, 5-5)
appos(4-2, 6-8)
appos(4-2, 7-11)
appos(4-2, 8-14)
appos(4-2, 9-17)
appos(4-2, 10-20)
appos(4-2, 11-23)
appos(4-2, 12-26)
appos(4-2, 13-29)
appos(4-2, 14-32)
appos(4-2, 15-35)
appos(4-2, 16-38)
appos(4-2, 17-41)
appos(4-2, 18-44)
appos(4-2, 19-47)
appos(4-2, 20-50)
appos(4-2, 21-53)
appos(4-2, 4-56)

The/DT pancreas/NN plays/VBZ a/DT crucial/JJ role/NN in/IN regulating/VBG glucose_homeostasis/NNS through/IN the/DT secretion/NN of/IN insulin/NN ./.

(ROOT
  (S
    (NP (DT The) (NN pancreas))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (S
            (VP (VBG regulating)
              (NP (NNS glucose_homeostasis))
              (PP (IN through)
                (NP
                  (NP (DT the) (NN secretion))
                  (PP (IN of)
                    (NP (NN insulin))))))))))
    (. .)))

det(pancreas-2, The-1)
nsubj(plays-3, pancreas-2)
root(ROOT-0, plays-3)
det(role-6, a-4)
amod(role-6, crucial-5)
dobj(plays-3, role-6)
mark(regulating-8, in-7)
acl(role-6, regulating-8)
dobj(regulating-8, glucose_homeostasis-9)
case(secretion-12, through-10)
det(secretion-12, the-11)
nmod:through(regulating-8, secretion-12)
case(insulin-14, of-13)
nmod:of(secretion-12, insulin-14)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN SMTNL1/NNP ,/, a/DT protein/NN predominantly/RB expressed/VBN in/IN the/DT pancreas/NN ,/, may/MD be/VB involved/VBN in/IN the/DT pathogenesis/NNS of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (NNP SMTNL1))
              (, ,)
              (NP
                (NP (DT a) (NN protein))
                (VP
                  (ADVP (RB predominantly))
                  (VBN expressed)
                  (PP (IN in)
                    (NP (DT the) (NN pancreas)))))
              (, ,))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NNS pathogenesis))
                      (PP (IN of)
                        (NP (NN obesity))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(involved-18, that-5)
nsubjpass(involved-18, SMTNL1-6)
det(protein-9, a-8)
appos(SMTNL1-6, protein-9)
advmod(expressed-11, predominantly-10)
acl(protein-9, expressed-11)
case(pancreas-14, in-12)
det(pancreas-14, the-13)
nmod:in(expressed-11, pancreas-14)
aux(involved-18, may-16)
auxpass(involved-18, be-17)
ccomp(suggested-4, involved-18)
case(pathogenesis-21, in-19)
det(pathogenesis-21, the-20)
nmod:in(involved-18, pathogenesis-21)
case(obesity-23, of-22)
nmod:of(pathogenesis-21, obesity-23)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN SMTNL1/NNP by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNP SMTNL1)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(SMTNL1-20, of-19)
nmod:of(hypersecretion-18, SMTNL1-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/NN Tpm/NNP on/IN the/DT secretion/NN of/IN SMTNL1/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (NN mmol/L) (NNP Tpm)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNP SMTNL1) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(Tpm-16, 10-14)
compound(Tpm-16, mmol/L-15)
nmod:of(effects-8, Tpm-16)
conj:and(glucose-12, Tpm-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(and_insulin-22, of-20)
compound(and_insulin-22, SMTNL1-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(genetically_obese-28, from-27)
nmod:from(pancreata-26, genetically_obese-28)
appos(genetically_obese-28, fa/fa-30)
cc(genetically_obese-28, and-32)
amod(rats-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(pancreata-26, rats-39)
conj:and(genetically_obese-28, rats-39)

Our/PRP$ results/NNS showed/VBD that/IN obese/JJ rats/NNS exhibited/VBD significantly/RB higher/JJR levels/NNS of/IN SMTNL1/CD secretion/NNS compared/VBN to/TO lean/VB rats/NNS under/IN both/DT high-glucose/JJ and/CC Tpm-stimulated/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ obese) (NNS rats))
          (VP (VBD exhibited)
            (NP
              (NP
                (ADJP (RB significantly) (JJR higher))
                (NNS levels))
              (PP (IN of)
                (NP
                  (NP (CD SMTNL1) (NNS secretion))
                  (VP (VBN compared)
                    (S
                      (VP (TO to)
                        (VP (VB lean)
                          (NP (NNS rats))
                          (PP (IN under)
                            (NP (DT both)
                              (ADJP (JJ high-glucose)
                                (CC and)
                                (JJ Tpm-stimulated))
                              (NNS conditions))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(exhibited-7, that-4)
amod(rats-6, obese-5)
nsubj(exhibited-7, rats-6)
ccomp(showed-3, exhibited-7)
advmod(higher-9, significantly-8)
amod(levels-10, higher-9)
dobj(exhibited-7, levels-10)
case(secretion-13, of-11)
nummod(secretion-13, SMTNL1-12)
nmod:of(levels-10, secretion-13)
acl(secretion-13, compared-14)
mark(lean-16, to-15)
xcomp(compared-14, lean-16)
dobj(lean-16, rats-17)
case(conditions-23, under-18)
det(conditions-23, both-19)
amod(conditions-23, high-glucose-20)
cc(high-glucose-20, and-21)
conj:and(high-glucose-20, Tpm-stimulated-22)
amod(conditions-23, Tpm-stimulated-22)
nmod:under(lean-16, conditions-23)

Additionally/RB ,/, insulin_secretion/NN was/VBD also/RB significantly/RB higher/JJR in/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS under/IN high-glucose/JJ conditions/NNS ,/, but/CC not/RB under/IN Tpm-stimulated/JJ conditions/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NN insulin_secretion))
    (VP (VBD was) (RB also)
      (ADVP
        (ADVP (RB significantly) (JJR higher))
        (PP (IN in)
          (NP (JJ obese) (NNS rats))))
      (VP (VBN compared)
        (S
          (VP (TO to)
            (VP (VB lean)
              (NP (NNS rats))
              (PP (IN under)
                (NP (JJ high-glucose) (NNS conditions)))
              (PRN (, ,)
                (CC but)
                (ADVP (RB not))
                (PP (IN under)
                  (NP (JJ Tpm-stimulated) (NNS conditions)))))))))
    (. .)))

advmod(compared-11, Additionally-1)
nsubjpass(compared-11, insulin_secretion-3)
nsubj:xsubj(lean-13, insulin_secretion-3)
auxpass(compared-11, was-4)
advmod(compared-11, also-5)
advmod(higher-7, significantly-6)
advmod(compared-11, higher-7)
case(rats-10, in-8)
amod(rats-10, obese-9)
nmod:in(higher-7, rats-10)
root(ROOT-0, compared-11)
mark(lean-13, to-12)
xcomp(compared-11, lean-13)
dobj(lean-13, rats-14)
case(conditions-17, under-15)
amod(conditions-17, high-glucose-16)
nmod:under(lean-13, conditions-17)
cc(conditions-23, but-19)
dep(conditions-23, not-20)
case(conditions-23, under-21)
amod(conditions-23, Tpm-stimulated-22)
dep(lean-13, conditions-23)

These/DT findings/NNS suggest/VBP a/DT potential/JJ link/NN between/IN hypersecretion/NN of/IN SMTNL1/NNP by/IN the/DT pancreas/NN and/CC the/DT development/NN of/IN obesity/NN ,/, highlighting/VBG SMTNL1/NNP as/IN a/DT potential/JJ target/NN for/IN therapeutic/JJ interventions/NNS against/IN obesity-related_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (NP
        (NP (DT a) (JJ potential) (NN link))
        (PP (IN between)
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNP SMTNL1))))))
      (PP (IN by)
        (NP
          (NP (DT the) (NN pancreas))
          (CC and)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP (NN obesity))))))
      (, ,)
      (S
        (VP (VBG highlighting)
          (NP (NNP SMTNL1))
          (PP (IN as)
            (NP
              (NP (DT a) (JJ potential) (NN target))
              (PP (IN for)
                (NP
                  (NP (JJ therapeutic) (NNS interventions))
                  (PP (IN against)
                    (NP (NNS obesity-related_disorders))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
det(link-6, a-4)
amod(link-6, potential-5)
dobj(suggest-3, link-6)
case(hypersecretion-8, between-7)
nmod:between(link-6, hypersecretion-8)
case(SMTNL1-10, of-9)
nmod:of(hypersecretion-8, SMTNL1-10)
case(pancreas-13, by-11)
det(pancreas-13, the-12)
nmod:by(suggest-3, pancreas-13)
cc(pancreas-13, and-14)
det(development-16, the-15)
nmod:by(suggest-3, development-16)
conj:and(pancreas-13, development-16)
case(obesity-18, of-17)
nmod:of(development-16, obesity-18)
advcl(suggest-3, highlighting-20)
dobj(highlighting-20, SMTNL1-21)
case(target-25, as-22)
det(target-25, a-23)
amod(target-25, potential-24)
nmod:as(highlighting-20, target-25)
case(interventions-28, for-26)
amod(interventions-28, therapeutic-27)
nmod:for(target-25, interventions-28)
case(obesity-related_disorders-30, against-29)
nmod:against(interventions-28, obesity-related_disorders-30)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBD complex/JJ process/NN that/WDT is/VBZ regulated/VBN by/IN multiple/JJ signaling/VBG pathways/NNS and/CC transcription/JJ factors/NNS ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ is)
              (VP (VBN regulated)
                (PP (IN by)
                  (NP
                    (NP (JJ multiple) (VBG signaling) (NNS pathways))
                    (CC and)
                    (NP (JJ transcription) (NNS factors))))))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
nsubjpass(regulated-9, process-6)
ref(process-6, that-7)
auxpass(regulated-9, is-8)
acl:relcl(process-6, regulated-9)
case(pathways-13, by-10)
amod(pathways-13, multiple-11)
amod(pathways-13, signaling-12)
nmod:by(regulated-9, pathways-13)
cc(pathways-13, and-14)
amod(factors-16, transcription-15)
nmod:by(regulated-9, factors-16)
conj:and(pathways-13, factors-16)

Myogenin/NNP -LRB-/-LRB- MYC/NNP -RRB-/-RRB- is_a/JJ key/JJ regulator/NN of_skeletal_muscle/VBD differentiation/NN ./.

(ROOT
  (S
    (NP
      (NP
        (NP (NNP Myogenin))
        (-LRB- -LRB-)
        (NP (NNP MYC))
        (-RRB- -RRB-))
      (NP (JJ is_a) (JJ key) (NN regulator)))
    (VP (VBD of_skeletal_muscle)
      (NP (NN differentiation)))
    (. .)))

nsubj(of_skeletal_muscle-8, Myogenin-1)
dep(Myogenin-1, MYC-3)
amod(regulator-7, is_a-5)
amod(regulator-7, key-6)
dep(Myogenin-1, regulator-7)
root(ROOT-0, of_skeletal_muscle-8)
dobj(of_skeletal_muscle-8, differentiation-9)

We/PRP previously/RB reported/VBD that/IN the/DT BET/NNP inhibitor/NN CCT137690/VBD up-regulated/JJ v-myc_avian_myelocytomatosis_viral_oncogene_neuroblastoma-derived_homolog/JJ protein/NN levels/NNS in/IN C2C12/CD cells/NNS during/IN differentiation/NN ./.

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB previously))
    (VP (VBD reported)
      (SBAR (IN that)
        (S
          (NP (DT the) (NNP BET) (NN inhibitor))
          (VP (VBD CCT137690)
            (NP (JJ up-regulated) (JJ v-myc_avian_myelocytomatosis_viral_oncogene_neuroblastoma-derived_homolog) (NN protein) (NNS levels))
            (PP (IN in)
              (NP (CD C2C12) (NNS cells)))
            (PP (IN during)
              (NP (NN differentiation)))))))
    (. .)))

nsubj(reported-3, We-1)
advmod(reported-3, previously-2)
root(ROOT-0, reported-3)
mark(CCT137690-8, that-4)
det(inhibitor-7, the-5)
compound(inhibitor-7, BET-6)
nsubj(CCT137690-8, inhibitor-7)
ccomp(reported-3, CCT137690-8)
amod(levels-12, up-regulated-9)
amod(levels-12, v-myc_avian_myelocytomatosis_viral_oncogene_neuroblastoma-derived_homolog-10)
compound(levels-12, protein-11)
dobj(CCT137690-8, levels-12)
case(cells-15, in-13)
nummod(cells-15, C2C12-14)
nmod:in(CCT137690-8, cells-15)
case(differentiation-17, during-16)
nmod:during(CCT137690-8, differentiation-17)

In/IN addition/NN ,/, we/PRP found/VBD that/IN BET/NNP inhibitors/NNS prolonged/VBN the/DT half-life/NN of/IN myogenin/NN and/CC up-regulate/JJ the/DT expression/NN of/IN myogenic/JJ differentiation-related/JJ genes/NNS ,/, including/VBG v-MYC/JJ ,/, v-fos/JJ ,/, and/CC myf-5/JJ ,/, in_a/NN dose/NN -/: and/CC time-dependent/JJ manner/NN ./. -LRB-/-LRB- 1/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (NNP BET))
          (VP (NNS inhibitors)
            (FRAG
              (S
                (VP
                  (VP (VBN prolonged)
                    (NP
                      (NP (DT the) (NN half-life))
                      (PP (IN of)
                        (NP (NN myogenin)))))
                  (CC and)
                  (VP (JJ up-regulate)
                    (NP
                      (NP (DT the) (NN expression))
                      (PP (IN of)
                        (NP (JJ myogenic) (JJ differentiation-related) (NNS genes)))
                      (, ,)
                      (VP (VBG including)
                        (NP
                          (ADJP (JJ v-MYC) (, ,) (JJ v-fos) (, ,)
                            (CC and)
                            (JJ myf-5) (, ,))
                          (NN in_a) (NN dose)))))))
              (: -)
              (FRAG (CC and)
                (ADVP (JJ time-dependent) (NN manner)))
              (. .))
            (PRN (-LRB- -LRB-)
              (NP-TMP (CD 1))
              (-RRB- -RRB-))))))
    (. .)))

case(addition-2, In-1)
nmod:in(found-5, addition-2)
nsubj(found-5, we-4)
root(ROOT-0, found-5)
mark(inhibitors-8, that-6)
nsubj(inhibitors-8, BET-7)
ccomp(found-5, inhibitors-8)
dep(time-dependent-35, prolonged-9)
det(half-life-11, the-10)
dobj(prolonged-9, half-life-11)
case(myogenin-13, of-12)
nmod:of(half-life-11, myogenin-13)
cc(prolonged-9, and-14)
conj:and(prolonged-9, up-regulate-15)
dep(time-dependent-35, up-regulate-15)
det(expression-17, the-16)
dobj(up-regulate-15, expression-17)
case(genes-21, of-18)
amod(genes-21, myogenic-19)
amod(genes-21, differentiation-related-20)
nmod:of(expression-17, genes-21)
acl(expression-17, including-23)
amod(dose-32, v-MYC-24)
conj:and(v-MYC-24, v-fos-26)
amod(dose-32, v-fos-26)
cc(v-MYC-24, and-28)
conj:and(v-MYC-24, myf-5-29)
amod(dose-32, myf-5-29)
compound(dose-32, in_a-31)
dobj(including-23, dose-32)
cc(time-dependent-35, and-34)
dep(inhibitors-8, time-dependent-35)
dep(time-dependent-35, manner-36)
dep(inhibitors-8, 1-39)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN CCT137690/NNP ,/, a/DT potent/JJ and/CC selective/JJ inhibitor/NN of/IN bromodomain_and_extra-terminal/JJ domain/NN -LRB-/-LRB- BET/NNP -RRB-/-RRB- proteins/NNS ,/, on/IN MYC/NNP expression/NN in/IN C2C12/CD cells/NNS during/IN differentiation/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NNP CCT137690))
            (, ,)
            (NP
              (NP (DT a)
                (ADJP (JJ potent)
                  (CC and)
                  (JJ selective))
                (NN inhibitor))
              (PP (IN of)
                (NP
                  (ADJP (JJ bromodomain_and_extra-terminal) (NN domain))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP BET))
                    (-RRB- -RRB-))
                  (NNS proteins))))
            (, ,))))
      (PP (IN on)
        (NP
          (NP (NNP MYC) (NN expression))
          (PP (IN in)
            (NP (CD C2C12) (NNS cells)))))
      (PP (IN during)
        (NP (NN differentiation))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(CCT137690-10, of-9)
nmod:of(effect-8, CCT137690-10)
det(inhibitor-16, a-12)
amod(inhibitor-16, potent-13)
cc(potent-13, and-14)
conj:and(potent-13, selective-15)
amod(inhibitor-16, selective-15)
appos(CCT137690-10, inhibitor-16)
case(proteins-23, of-17)
dep(domain-19, bromodomain_and_extra-terminal-18)
amod(proteins-23, domain-19)
appos(proteins-23, BET-21)
nmod:of(inhibitor-16, proteins-23)
case(expression-27, on-25)
compound(expression-27, MYC-26)
nmod:on(investigated-6, expression-27)
case(cells-30, in-28)
nummod(cells-30, C2C12-29)
nmod:in(expression-27, cells-30)
case(differentiation-32, during-31)
nmod:during(investigated-6, differentiation-32)

When/WRB C2C12/NN cells/NNS were/VBD cultured/VBN in_a/JJ medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/,

(ROOT
  (SBARQ
    (WHADVP (WRB When))
    (S
      (NP (NN C2C12) (NNS cells))
      (VP (VBD were)
        (VP (VBN cultured)
          (NP (JJ in_a) (NN medium))
          (S
            (VP (VBG favoring)
              (NP
                (NP (NN differentiation))
                (PRN (-LRB- -LRB-)
                  (S
                    (NP (NNP Dulbecco))
                    (VP (VBN modified)
                      (NP
                        (NP (NNP Eagle) (NN medium))
                        (VP (VBG containing)
                          (NP
                            (ADJP (CD 2) (NN %))
                            (NN horse) (NN serum))))))
                  (-RRB- -RRB-)))))
          (, ,))))))

advmod(cultured-5, When-1)
compound(cells-3, C2C12-2)
nsubjpass(cultured-5, cells-3)
auxpass(cultured-5, were-4)
root(ROOT-0, cultured-5)
amod(medium-7, in_a-6)
dobj(cultured-5, medium-7)
xcomp(cultured-5, favoring-8)
dobj(favoring-8, differentiation-9)
nsubj(modified-12, Dulbecco-11)
dep(differentiation-9, modified-12)
compound(medium-14, Eagle-13)
dobj(modified-12, medium-14)
acl(medium-14, containing-15)
compound(%-17, 2-16)
amod(serum-19, %-17)
compound(serum-19, horse-18)
dobj(containing-15, serum-19)

CCT137690/NNP up-regulated/VBD MYC/NNP levels/NNS in_a/JJ time-dependent/JJ manner/NN and/CC prolonged/JJ MYC/NNP half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (NNP CCT137690))
    (VP (VBD up-regulated)
      (NP (NNP MYC) (NNS levels)
        (NX
          (NX (JJ in_a) (JJ time-dependent) (NN manner))
          (CC and)
          (NX (JJ prolonged) (NNP MYC) (NN half-life))))
      (PP (IN from)
        (NP
          (QP (CD 10) (TO to) (CD 18))
          (NNS hours))))
    (. .)))

nsubj(up-regulated-2, CCT137690-1)
root(ROOT-0, up-regulated-2)
compound(manner-7, MYC-3)
dep(manner-7, levels-4)
amod(manner-7, in_a-5)
amod(manner-7, time-dependent-6)
dobj(up-regulated-2, manner-7)
cc(manner-7, and-8)
amod(half-life-11, prolonged-9)
compound(half-life-11, MYC-10)
dobj(up-regulated-2, half-life-11)
conj:and(manner-7, half-life-11)
case(hours-16, from-12)
compound(18-15, 10-13)
dep(18-15, to-14)
nummod(hours-16, 18-15)
nmod:from(up-regulated-2, hours-16)

These/DT findings/NNS suggest/VBP that/IN BET/NNP proteins/NNS may/MD play/VB an/DT important/JJ role/NN in/IN the/DT regulation/NN of/IN MYC/NNP expression/NN during/IN skeletal_muscle/NN differentiation_and/VBN that/IN BET/NNP inhibitors/NNS such/JJ as/IN CCT137690/NNP may/MD have/VB potential/JJ therapeutic/JJ applications/NNS for/IN muscle_wasting_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP BET) (NNS proteins))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN regulation))
                    (PP (IN of)
                      (NP (NNP MYC) (NN expression))))))
              (PP (IN during)
                (NP
                  (NP (NN skeletal_muscle))
                  (VP (VBN differentiation_and)
                    (SBAR (IN that)
                      (S
                        (NP
                          (NP (NNP BET) (NNS inhibitors))
                          (PP (JJ such) (IN as)
                            (NP (NNP CCT137690))))
                        (VP (MD may)
                          (VP (VB have)
                            (NP
                              (NP (JJ potential) (JJ therapeutic) (NNS applications))
                              (PP (IN for)
                                (NP (NNS muscle_wasting_disorders))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-8, that-4)
compound(proteins-6, BET-5)
nsubj(play-8, proteins-6)
aux(play-8, may-7)
ccomp(suggest-3, play-8)
det(role-11, an-9)
amod(role-11, important-10)
dobj(play-8, role-11)
case(regulation-14, in-12)
det(regulation-14, the-13)
nmod:in(role-11, regulation-14)
case(expression-17, of-15)
compound(expression-17, MYC-16)
nmod:of(regulation-14, expression-17)
case(skeletal_muscle-19, during-18)
nmod:during(play-8, skeletal_muscle-19)
acl(skeletal_muscle-19, differentiation_and-20)
mark(have-28, that-21)
compound(inhibitors-23, BET-22)
nsubj(have-28, inhibitors-23)
case(CCT137690-26, such-24)
mwe(such-24, as-25)
nmod:such_as(inhibitors-23, CCT137690-26)
aux(have-28, may-27)
ccomp(differentiation_and-20, have-28)
amod(applications-31, potential-29)
amod(applications-31, therapeutic-30)
dobj(have-28, applications-31)
case(muscle_wasting_disorders-33, for-32)
nmod:for(applications-31, muscle_wasting_disorders-33)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS of/IN this/DT effect/NN and/CC to/TO evaluate/VB its/PRP$ efficacy/NN in/IN vivo/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (DT this) (NN effect))))))
            (CC and)
            (VP (TO to)
              (VP (VB evaluate)
                (NP (PRP$ its) (NN efficacy))
                (PP (IN in)
                  (NP (NN vivo)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
case(effect-12, of-10)
det(effect-12, this-11)
nmod:of(mechanisms-9, effect-12)
cc(elucidate-6, and-13)
mark(evaluate-15, to-14)
ccomp(needed-4, evaluate-15)
conj:and(elucidate-6, evaluate-15)
nmod:poss(efficacy-17, its-16)
dobj(evaluate-15, efficacy-17)
case(vivo-19, in-18)
nmod:in(evaluate-15, vivo-19)

Omega-3_fatty_acids/NNP ,/, particularly/RB eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN associated/VBN with/IN various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNP Omega-3_fatty_acids))
      (, ,)
      (NP
        (NP
          (NP (RB particularly) (JJ eicosapentaenoic_acid)
            (PRN (-LRB- -LRB-)
              (NP (NNP EPA))
              (-RRB- -RRB-)))
          (CC and)
          (NP (NN docosahexaenoic_acid)))
        (PRN (-LRB- -LRB-)
          (NP (NNP DHA))
          (-RRB- -RRB-)))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP (JJ various) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(associated-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, particularly-3)
appos(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
appos(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
appos(Omega-3_fatty_acids-1, docosahexaenoic_acid-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
appos(eicosapentaenoic_acid-4, DHA-11)
aux(associated-16, have-14)
auxpass(associated-16, been-15)
root(ROOT-0, associated-16)
case(benefits-20, with-17)
amod(benefits-20, various-18)
compound(benefits-20, health-19)
nmod:with(associated-16, benefits-20)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain_fatty_acids/NNS are/VBP linked/VBN to/TO decreased/VBN isopropylphenazone/JJ levels/NNS in/IN hyperisopropylphenazonemic/JJ patients/NNS ,/, indicating/VBG their/PRP$ potential/JJ therapeutic/JJ use/NN in/IN such/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (VBP are)
              (VP (VBN linked)
                (PP (TO to)
                  (NP
                    (NP (VBN decreased) (JJ isopropylphenazone) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperisopropylphenazonemic) (NNS patients))
                        (, ,)
                        (VP (VBG indicating)
                          (NP
                            (NP (PRP$ their) (JJ potential) (JJ therapeutic) (NN use))
                            (PP (IN in)
                              (NP (JJ such) (NNS conditions)))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(linked-9, that-5)
det(long-chain_fatty_acids-7, these-6)
nsubjpass(linked-9, long-chain_fatty_acids-7)
auxpass(linked-9, are-8)
ccomp(shown-4, linked-9)
case(levels-13, to-10)
amod(levels-13, decreased-11)
amod(levels-13, isopropylphenazone-12)
nmod:to(linked-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperisopropylphenazonemic-15)
nmod:in(levels-13, patients-16)
acl(patients-16, indicating-18)
nmod:poss(use-22, their-19)
amod(use-22, potential-20)
amod(use-22, therapeutic-21)
dobj(indicating-18, use-22)
case(conditions-25, in-23)
amod(conditions-25, such-24)
nmod:in(use-22, conditions-25)

Additionally/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN found/VBN to/TO reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, a/DT leading/VBG cause/NN of/IN morbidity/NN and/CC mortality/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP
                          (NP
                            (NP (NN coronary_heart_disease))
                            (PRN (-LRB- -LRB-)
                              (NP (NNP CHD))
                              (-RRB- -RRB-)))
                          (, ,)
                          (NP
                            (NP (DT a) (VBG leading) (NN cause))
                            (PP (IN of)
                              (NP (NN morbidity)
                                (CC and)
                                (NN mortality)))))))))
                (ADVP (RB worldwide))))))))
    (. .)))

advmod(found-8, Additionally-1)
nsubjpass(found-8, EPA-3)
nsubj:xsubj(reduce-10, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(found-8, DHA-5)
nsubj:xsubj(reduce-10, DHA-5)
aux(found-8, have-6)
auxpass(found-8, been-7)
root(ROOT-0, found-8)
mark(reduce-10, to-9)
xcomp(found-8, reduce-10)
det(risk-12, the-11)
dobj(reduce-10, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, coronary_heart_disease-15)
appos(coronary_heart_disease-15, CHD-17)
det(cause-22, a-20)
amod(cause-22, leading-21)
appos(coronary_heart_disease-15, cause-22)
case(morbidity-24, of-23)
nmod:of(cause-22, morbidity-24)
cc(morbidity-24, and-25)
nmod:of(cause-22, mortality-26)
conj:and(morbidity-24, mortality-26)
advmod(reduce-10, worldwide-27)

The/DT mechanisms/NNS behind/IN these/DT beneficial/JJ effects/NNS are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB modulation/NN of/IN inflammation/NN ,/, lipid/NN metabolism/NN ,/, and/CC other/JJ cellular/JJ processes/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (PP (IN behind)
        (NP (DT these) (JJ beneficial) (NNS effects))))
    (VP
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (NN modulation))
            (PP (IN of)
              (NP
                (NP (NN inflammation))
                (, ,)
                (NP (NN lipid) (NN metabolism))
                (, ,)
                (CC and)
                (NP (JJ other) (JJ cellular) (NNS processes))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-11, mechanisms-2)
nsubj(involve-15, mechanisms-2)
case(effects-6, behind-3)
det(effects-6, these-4)
amod(effects-6, beneficial-5)
nmod:behind(mechanisms-2, effects-6)
auxpass(understood-11, are-7)
neg(understood-11, not-8)
advmod(understood-11, yet-9)
advmod(understood-11, fully-10)
root(ROOT-0, understood-11)
cc(understood-11, but-13)
aux(involve-15, may-14)
conj:but(understood-11, involve-15)
dobj(involve-15, modulation-16)
case(inflammation-18, of-17)
nmod:of(modulation-16, inflammation-18)
compound(metabolism-21, lipid-20)
nmod:of(modulation-16, metabolism-21)
conj:and(inflammation-18, metabolism-21)
cc(inflammation-18, and-23)
amod(processes-26, other-24)
amod(processes-26, cellular-25)
nmod:of(modulation-16, processes-26)
conj:and(inflammation-18, processes-26)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, are/VBP associated/VBN with/IN decreased/VBN isopropylphenazone/NN levels/NNS in/IN hyperisopropylphenazonemic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN associated)
          (PP (IN with)
            (NP (VBN decreased) (NN isopropylphenazone) (NNS levels)))
          (PP (IN in)
            (NP (JJ hyperisopropylphenazonemic) (NNS patients)))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(associated-23, omega-3_fatty_acids-2)
nsubjpass(decreased-32, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
auxpass(associated-23, are-22)
root(ROOT-0, associated-23)
case(levels-27, with-24)
amod(levels-27, decreased-25)
compound(levels-27, isopropylphenazone-26)
nmod:with(associated-23, levels-27)
case(patients-30, in-28)
amod(patients-30, hyperisopropylphenazonemic-29)
nmod:in(associated-23, patients-30)
cc(associated-23, and-31)
conj:and(associated-23, decreased-32)
dobj(decreased-32, risk-33)
case(coronary_heart_disease-36, of-34)
amod(coronary_heart_disease-36, developing-35)
nmod:of(risk-33, coronary_heart_disease-36)
appos(coronary_heart_disease-36, CHD-38)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS involved/VBN and/CC to/TO optimize/VB the/DT dosages/NNS and/CC formulations/NNS for/IN clinical/JJ use/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBN involved)))))
            (CC and)
            (VP (TO to)
              (VP (VB optimize)
                (NP (DT the) (NNS dosages)
                  (CC and)
                  (NNS formulations))
                (PP (IN for)
                  (NP (JJ clinical) (NN use)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, involved-10)
cc(elucidate-7, and-11)
mark(optimize-13, to-12)
ccomp(needed-4, optimize-13)
conj:and(elucidate-7, optimize-13)
det(dosages-15, the-14)
dobj(optimize-13, dosages-15)
cc(dosages-15, and-16)
dobj(optimize-13, formulations-17)
conj:and(dosages-15, formulations-17)
case(use-20, for-18)
amod(use-20, clinical-19)
nmod:for(optimize-13, use-20)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP potential/JJ therapeutic/JJ agents/NNS ,/, and/CC research/NN has/VBZ shown/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (S
      (NP
        (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
        (, ,)
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP
              (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
              (CC and)
              (NP (NN docosahexaenoic)))
            (PRN (-LRB- -LRB-)
              (NP (NNP DHA))
              (-RRB- -RRB-))))
        (, ,))
      (VP (VBP are)
        (NP (JJ potential) (JJ therapeutic) (NNS agents))))
    (, ,)
    (CC and)
    (S
      (NP (NN research))
      (VP (VBZ has)
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP (DT these) (NNS fatty_acids))
              (VP (VBP are)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP
                        (NP (VBN decreased) (NN risk))
                        (PP (IN of)
                          (S
                            (VP (VBG developing)
                              (NP (NN coronary_heart_disease))))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP CHD))
                        (-RRB- -RRB-)))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubj(agents-17, omega-3_fatty_acids-2)
acl(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic-9)
conj:and(EPA-6, docosahexaenoic-9)
appos(EPA-6, DHA-11)
cop(agents-17, are-14)
amod(agents-17, potential-15)
amod(agents-17, therapeutic-16)
root(ROOT-0, agents-17)
cc(agents-17, and-19)
nsubj(shown-22, research-20)
aux(shown-22, has-21)
conj:and(agents-17, shown-22)
mark(associated-27, that-23)
det(fatty_acids-25, these-24)
nsubjpass(associated-27, fatty_acids-25)
auxpass(associated-27, are-26)
ccomp(shown-22, associated-27)
case(risk-30, with-28)
amod(risk-30, decreased-29)
nmod:with(associated-27, risk-30)
mark(developing-32, of-31)
acl(risk-30, developing-32)
dobj(developing-32, coronary_heart_disease-33)
appos(risk-30, CHD-35)

In/IN this/DT article/NN ,/, we/PRP review/VBP the/DT evidence/NN showing/VBG that/IN long-chain/JJ EPA/NNP and/CC DHA/NNP ,/, as/RB well/RB as/IN their/PRP$ metabolites/NNS ,/, have/VBP anti-inflammatory/JJ effects/NNS and/CC discuss/VB the/DT implications/NNS of/IN these/DT findings/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN article)))
    (, ,)
    (NP (PRP we))
    (VP
      (VP (VBP review)
        (NP
          (NP (DT the) (NN evidence))
          (VP (VBG showing)
            (SBAR (IN that)
              (S
                (NP
                  (NP (JJ long-chain) (NNP EPA))
                  (CC and)
                  (NP
                    (NP (NNP DHA))
                    (, ,)
                    (ADVP (RB as) (RB well)
                      (PP (IN as)
                        (NP (PRP$ their) (NNS metabolites))))
                    (, ,)))
                (VP (VBP have)
                  (NP (JJ anti-inflammatory) (NNS effects))))))))
      (CC and)
      (VP (VB discuss)
        (NP
          (NP (DT the) (NNS implications))
          (PP (IN of)
            (NP (DT these) (NNS findings))))))
    (. .)))

case(article-3, In-1)
det(article-3, this-2)
nmod:in(review-6, article-3)
nsubj(review-6, we-5)
nsubj(discuss-26, we-5)
root(ROOT-0, review-6)
det(evidence-8, the-7)
dobj(review-6, evidence-8)
acl(evidence-8, showing-9)
mark(have-22, that-10)
amod(EPA-12, long-chain-11)
nsubj(have-22, EPA-12)
cc(EPA-12, and-13)
conj:and(EPA-12, DHA-14)
nsubj(have-22, DHA-14)
advmod(well-17, as-16)
advmod(DHA-14, well-17)
case(metabolites-20, as-18)
nmod:poss(metabolites-20, their-19)
nmod:as(well-17, metabolites-20)
ccomp(showing-9, have-22)
amod(effects-24, anti-inflammatory-23)
dobj(have-22, effects-24)
cc(review-6, and-25)
conj:and(review-6, discuss-26)
det(implications-28, the-27)
dobj(discuss-26, implications-28)
case(findings-31, of-29)
det(findings-31, these-30)
nmod:of(implications-28, findings-31)

In/IN the/DT present/JJ study/NN ,/, we/PRP tested/VBD the/DT effects/NNS of/IN trisomy-16/JJ on/IN basal/JJ DSP-4/NN production/NN and_8-Br-cAMP-stimulated/JJ 3_beta-hydroxysteroid_dehydrogenase/JJ //: delta/NN 5/CD --/: >/CD delta_4/NNS isomerase/JJ -LRB-/-LRB- 3_beta_HSD/JJ -RRB-/-RRB- expression/NN in/IN Leydig/NNP cells/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ present) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD tested)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP
              (ADJP (JJ trisomy-16)
                (PP (IN on)
                  (NP (JJ basal) (NN DSP-4) (NN production))))
              (JJ and_8-Br-cAMP-stimulated) (JJ 3_beta-hydroxysteroid_dehydrogenase)
              (PRN (: /)
                (NP (NN delta) (CD 5))
                (: --))
              (ADJP
                (ADJP
                  (NP (CD >) (NNS delta_4))
                  (JJ isomerase))
                (PRN (-LRB- -LRB-)
                  (ADJP (JJ 3_beta_HSD))
                  (-RRB- -RRB-)))
              (NN expression))
            (PP (IN in)
              (NP (NNP Leydig) (NNS cells)))))))
    (. .)))

case(study-4, In-1)
det(study-4, the-2)
amod(study-4, present-3)
nmod:in(tested-7, study-4)
nsubj(tested-7, we-6)
root(ROOT-0, tested-7)
det(effects-9, the-8)
dobj(tested-7, effects-9)
case(expression-28, of-10)
amod(expression-28, trisomy-16-11)
case(production-15, on-12)
amod(production-15, basal-13)
compound(production-15, DSP-4-14)
nmod:on(trisomy-16-11, production-15)
amod(expression-28, and_8-Br-cAMP-stimulated-16)
amod(expression-28, 3_beta-hydroxysteroid_dehydrogenase-17)
dep(expression-28, delta-19)
nummod(delta-19, 5-20)
nummod(delta_4-23, >-22)
nmod:npmod(isomerase-24, delta_4-23)
amod(expression-28, isomerase-24)
dep(isomerase-24, 3_beta_HSD-26)
nmod:of(effects-9, expression-28)
case(cells-31, in-29)
compound(cells-31, Leydig-30)
nmod:in(expression-28, cells-31)

To/TO achieve/VB this/DT ,/, we/PRP utilized/VBD a/DT trisomy-16/JJ mouse/NN model/NN and/CC examined/VBD the/DT hormonal/JJ and/CC genetic/JJ changes/NNS in/IN Leydig/NNP cells/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP
      (VP (VBD utilized)
        (NP (DT a) (JJ trisomy-16) (NN mouse) (NN model)))
      (CC and)
      (VP (VBD examined)
        (NP
          (NP (DT the)
            (ADJP (JJ hormonal)
              (CC and)
              (JJ genetic))
            (NNS changes))
          (PP (IN in)
            (NP (NNP Leydig) (NNS cells))))))
    (. .)))

mark(achieve-2, To-1)
advcl(utilized-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(utilized-6, we-5)
nsubj(examined-12, we-5)
root(ROOT-0, utilized-6)
det(model-10, a-7)
amod(model-10, trisomy-16-8)
compound(model-10, mouse-9)
dobj(utilized-6, model-10)
cc(utilized-6, and-11)
conj:and(utilized-6, examined-12)
det(changes-17, the-13)
amod(changes-17, hormonal-14)
cc(hormonal-14, and-15)
conj:and(hormonal-14, genetic-16)
amod(changes-17, genetic-16)
dobj(examined-12, changes-17)
case(cells-20, in-18)
compound(cells-20, Leydig-19)
nmod:in(changes-17, cells-20)

Our/PRP$ results/NNS showed/VBD that/IN trisomy-16/JJ significantly/RB altered/VBN the/DT basal/JJ DSP-4/NN production/NN and/CC attenuated/VBN the/DT 8-Br-cAMP-stimulated/JJ 3_beta_HSD/JJ expression/NN in/IN Leydig/NNP cells/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ trisomy-16))
          (VP
            (VP
              (ADVP (RB significantly))
              (VBN altered)
              (NP (DT the) (JJ basal) (NN DSP-4) (NN production)))
            (CC and)
            (VP (VBN attenuated)
              (NP
                (NP (DT the) (JJ 8-Br-cAMP-stimulated) (JJ 3_beta_HSD) (NN expression))
                (PP (IN in)
                  (NP (NNP Leydig) (NNS cells)))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(altered-7, that-4)
nsubj(altered-7, trisomy-16-5)
nsubj(attenuated-13, trisomy-16-5)
advmod(altered-7, significantly-6)
ccomp(showed-3, altered-7)
det(production-11, the-8)
amod(production-11, basal-9)
compound(production-11, DSP-4-10)
dobj(altered-7, production-11)
cc(altered-7, and-12)
ccomp(showed-3, attenuated-13)
conj:and(altered-7, attenuated-13)
det(expression-17, the-14)
amod(expression-17, 8-Br-cAMP-stimulated-15)
amod(expression-17, 3_beta_HSD-16)
dobj(attenuated-13, expression-17)
case(cells-20, in-18)
compound(cells-20, Leydig-19)
nmod:in(expression-17, cells-20)

These/DT findings/NNS suggest/VBP that/IN trisomy-16/JJ may/MD have/VB a/DT negative/JJ impact/NN on/IN steroidogenesis/NNS in/IN Leydig/JJ cells/NNS ,/, which/WDT could/MD contribute/VB to/TO the/DT hormonal/JJ imbalances/NNS observed/VBN in/IN individuals/NNS with/IN Down_syndrome/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (JJ trisomy-16))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (DT a) (JJ negative) (NN impact))
                (PP (IN on)
                  (NP
                    (NP (NNS steroidogenesis))
                    (PP (IN in)
                      (NP
                        (NP (JJ Leydig) (NNS cells))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD could)
                              (VP (VB contribute)
                                (PP (TO to)
                                  (NP
                                    (NP (DT the) (JJ hormonal) (NNS imbalances))
                                    (VP (VBN observed)
                                      (PP (IN in)
                                        (NP
                                          (NP (NNS individuals))
                                          (PP (IN with)
                                            (NP (NNP Down_syndrome))))))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, trisomy-16-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
det(impact-10, a-8)
amod(impact-10, negative-9)
dobj(have-7, impact-10)
case(steroidogenesis-12, on-11)
nmod:on(impact-10, steroidogenesis-12)
case(cells-15, in-13)
amod(cells-15, Leydig-14)
nmod:in(steroidogenesis-12, cells-15)
nsubj(contribute-19, cells-15)
ref(cells-15, which-17)
aux(contribute-19, could-18)
acl:relcl(cells-15, contribute-19)
case(imbalances-23, to-20)
det(imbalances-23, the-21)
amod(imbalances-23, hormonal-22)
nmod:to(contribute-19, imbalances-23)
acl(imbalances-23, observed-24)
case(individuals-26, in-25)
nmod:in(observed-24, individuals-26)
case(Down_syndrome-28, with-27)
nmod:with(individuals-26, Down_syndrome-28)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ targets/NNS for/IN this/DT condition/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP (DT this) (NN condition))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(targets-13, potential-11)
amod(targets-13, therapeutic-12)
dobj(elucidate-6, targets-13)
conj:and(mechanisms-9, targets-13)
case(condition-16, for-14)
det(condition-16, this-15)
nmod:for(targets-13, condition-16)

OBJECTIVE/NNP :/: To/TO investigate/VB the/DT effect/NN of/IN small/JJ interfering/VBG RNA/NNP -LRB-/-LRB- siRNA/NN -RRB-/-RRB- silencing/VBG myeloperoxidase/JJ gene/NN combined/VBN with/IN KBT-3022/NN -LRB-/-LRB- TMP/NNP -RRB-/-RRB- on/IN the/DT proliferation/NN and/CC apoptosis/NNS of/IN human/JJ chronic_myeloid_leukemia/NN cell/NN line/NN K562/NNP ./.

(ROOT
  (NP
    (NP (NNP OBJECTIVE))
    (: :)
    (S
      (VP (TO To)
        (VP (VB investigate)
          (NP
            (NP (DT the) (NN effect))
            (PP (IN of)
              (NP
                (NP (JJ small))
                (VP (VBG interfering)
                  (NP
                    (NP (NNP RNA) (-LRB- -LRB-) (NN siRNA) (-RRB- -RRB-))
                    (PP (VBG silencing)
                      (NP
                        (NP (JJ myeloperoxidase) (NN gene))
                        (VP (VBN combined)
                          (PP (IN with)
                            (NP (NN KBT-3022))))))))
                (PRN (-LRB- -LRB-)
                  (NP (NNP TMP))
                  (-RRB- -RRB-)))))
          (PP (IN on)
            (NP
              (NP (DT the) (NN proliferation)
                (CC and)
                (NNS apoptosis))
              (PP (IN of)
                (NP (JJ human) (NN chronic_myeloid_leukemia) (NN cell) (NN line) (NNP K562))))))))
    (. .)))

root(ROOT-0, OBJECTIVE-1)
mark(investigate-4, To-3)
acl(OBJECTIVE-1, investigate-4)
det(effect-6, the-5)
dobj(investigate-4, effect-6)
case(small-8, of-7)
nmod:of(effect-6, small-8)
acl(small-8, interfering-9)
compound(siRNA-12, RNA-10)
dobj(interfering-9, siRNA-12)
case(gene-16, silencing-14)
amod(gene-16, myeloperoxidase-15)
nmod:silencing(siRNA-12, gene-16)
acl(gene-16, combined-17)
case(KBT-3022-19, with-18)
nmod:with(combined-17, KBT-3022-19)
appos(small-8, TMP-21)
case(proliferation-25, on-23)
det(proliferation-25, the-24)
nmod:on(investigate-4, proliferation-25)
cc(proliferation-25, and-26)
nmod:on(investigate-4, apoptosis-27)
conj:and(proliferation-25, apoptosis-27)
case(K562-33, of-28)
amod(K562-33, human-29)
compound(K562-33, chronic_myeloid_leukemia-30)
compound(K562-33, cell-31)
compound(K562-33, line-32)
nmod:of(proliferation-25, K562-33)

Myeloperoxidase/NNP -LRB-/-LRB- MPO/NNP -RRB-/-RRB- is/VBZ an/DT enzyme/NN that/WDT plays/VBZ a/DT crucial/JJ role/NN in/IN the/DT pathogenesis/NNS of/IN CML/NNP ./.

(ROOT
  (S
    (NP (NNP Myeloperoxidase) (-LRB- -LRB-)
      (NP (NNP MPO))
      (-RRB- -RRB-))
    (VP (VBZ is)
      (NP
        (NP (DT an) (NN enzyme))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ plays)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NNS pathogenesis))
                    (PP (IN of)
                      (NP (NNP CML)))))))))))
    (. .)))

nsubj(enzyme-7, Myeloperoxidase-1)
dep(Myeloperoxidase-1, MPO-3)
cop(enzyme-7, is-5)
det(enzyme-7, an-6)
root(ROOT-0, enzyme-7)
nsubj(plays-9, enzyme-7)
ref(enzyme-7, that-8)
acl:relcl(enzyme-7, plays-9)
det(role-12, a-10)
amod(role-12, crucial-11)
dobj(plays-9, role-12)
case(pathogenesis-15, in-13)
det(pathogenesis-15, the-14)
nmod:in(role-12, pathogenesis-15)
case(CML-17, of-16)
nmod:of(pathogenesis-15, CML-17)

In/IN this/DT study/NN ,/, we/PRP aimed/VBN to/TO investigate/VB the/DT effect/NN of/IN small/JJ interfering/VBG RNA/NNP -LRB-/-LRB- siRNA/NN -RRB-/-RRB- silencing/VBG MPO/NNP gene/NN combined/VBN with/IN KBT-3022/NN -LRB-/-LRB- TMP/NNP -RRB-/-RRB- ,/, a/DT novel/NN therapeutic/JJ agent/NN ,/, on/IN the/DT proliferation/NN and/CC apoptosis/NNS of/IN human/JJ CML/NNP cell/NN line/NN K562/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBN aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP
                (NP (DT the) (NN effect))
                (PP (IN of)
                  (NP
                    (NP (JJ small))
                    (VP (VBG interfering)
                      (NP
                        (NP (NNP RNA) (-LRB- -LRB-) (NN siRNA) (-RRB- -RRB-))
                        (VP (VBG silencing)
                          (NP (NNP MPO) (NN gene))))))))
              (VP (VBN combined)
                (PP (IN with)
                  (NP (NN KBT-3022))))
              (PRN (-LRB- -LRB-)
                (NP (NNP TMP))
                (-RRB- -RRB-))
              (, ,)
              (NP
                (NP (DT a) (NN novel))
                (NP (JJ therapeutic) (NN agent)))))))
      (, ,)
      (PP (IN on)
        (NP
          (NP (DT the) (NN proliferation)
            (CC and)
            (NNS apoptosis))
          (PP (IN of)
            (NP (JJ human) (NNP CML) (NN cell) (NN line) (NN K562))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(investigate-8, we-5)
root(ROOT-0, aimed-6)
mark(investigate-8, to-7)
xcomp(aimed-6, investigate-8)
det(effect-10, the-9)
dobj(investigate-8, effect-10)
case(small-12, of-11)
nmod:of(effect-10, small-12)
acl(small-12, interfering-13)
compound(siRNA-16, RNA-14)
dobj(interfering-13, siRNA-16)
acl(siRNA-16, silencing-18)
compound(gene-20, MPO-19)
dobj(silencing-18, gene-20)
acl(effect-10, combined-21)
case(KBT-3022-23, with-22)
nmod:with(combined-21, KBT-3022-23)
appos(effect-10, TMP-25)
det(novel-29, a-28)
appos(effect-10, novel-29)
amod(agent-31, therapeutic-30)
dep(novel-29, agent-31)
case(proliferation-35, on-33)
det(proliferation-35, the-34)
nmod:on(aimed-6, proliferation-35)
cc(proliferation-35, and-36)
nmod:on(aimed-6, apoptosis-37)
conj:and(proliferation-35, apoptosis-37)
case(K562-43, of-38)
amod(K562-43, human-39)
compound(K562-43, CML-40)
compound(K562-43, cell-41)
compound(K562-43, line-42)
nmod:of(proliferation-35, K562-43)

Our/PRP$ results/NNS demonstrated/VBD that/IN siRNA-mediated/JJ knockdown/NN of/IN MPO/NNP gene/NN significantly/RB decreased/VBD the/DT proliferation/NN and/CC induced/VBN apoptosis/NNS of/IN K562/CD cells/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD demonstrated)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ siRNA-mediated) (NN knockdown))
            (PP (IN of)
              (NP (NNP MPO) (NN gene))))
          (ADVP (RB significantly))
          (VP (VBD decreased)
            (NP
              (NP (DT the) (NN proliferation))
              (CC and)
              (NP
                (NP (VBN induced) (NNS apoptosis))
                (PP (IN of)
                  (NP (CD K562) (NNS cells)))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(demonstrated-3, results-2)
root(ROOT-0, demonstrated-3)
mark(decreased-11, that-4)
amod(knockdown-6, siRNA-mediated-5)
nsubj(decreased-11, knockdown-6)
case(gene-9, of-7)
compound(gene-9, MPO-8)
nmod:of(knockdown-6, gene-9)
advmod(decreased-11, significantly-10)
ccomp(demonstrated-3, decreased-11)
det(proliferation-13, the-12)
dobj(decreased-11, proliferation-13)
cc(proliferation-13, and-14)
amod(apoptosis-16, induced-15)
dobj(decreased-11, apoptosis-16)
conj:and(proliferation-13, apoptosis-16)
case(cells-19, of-17)
nummod(cells-19, K562-18)
nmod:of(apoptosis-16, cells-19)

Moreover/RB ,/, treatment/NN with/IN KBT-3022/NNP further/RB enhanced/VBD the/DT antitumor/NN effect/NN of/IN MPO/NNP silencing/VBG by/IN inhibiting/VBG cell/NN proliferation/NN and/CC promoting/VBG apoptosis/NNS ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP
      (NP (NN treatment))
      (PP (IN with)
        (NP (NNP KBT-3022))))
    (ADVP (RB further))
    (VP (VBD enhanced)
      (NP
        (NP (DT the) (NN antitumor) (NN effect))
        (PP (IN of)
          (NP (NNP MPO))))
      (PP (VBG silencing)
        (PP (IN by)
          (S
            (VP
              (VP (VBG inhibiting)
                (NP (NN cell) (NN proliferation)))
              (CC and)
              (VP (VBG promoting)
                (NP (NNS apoptosis))))))))
    (. .)))

advmod(enhanced-7, Moreover-1)
nsubj(enhanced-7, treatment-3)
case(KBT-3022-5, with-4)
nmod:with(treatment-3, KBT-3022-5)
advmod(enhanced-7, further-6)
root(ROOT-0, enhanced-7)
det(effect-10, the-8)
compound(effect-10, antitumor-9)
dobj(enhanced-7, effect-10)
case(MPO-12, of-11)
nmod:of(effect-10, MPO-12)
dep(inhibiting-15, silencing-13)
mark(inhibiting-15, by-14)
advcl(enhanced-7, inhibiting-15)
compound(proliferation-17, cell-16)
dobj(inhibiting-15, proliferation-17)
cc(inhibiting-15, and-18)
advcl(enhanced-7, promoting-19)
conj:and(inhibiting-15, promoting-19)
dobj(promoting-19, apoptosis-20)

These/DT findings/NNS suggest/VBP that/IN combining/VBG siRNA-mediated/JJ MPO/NNP gene/NN silencing/VBG with/IN KBT-3022/NN may/MD represent/VB a/DT promising/JJ therapeutic/JJ strategy/NN for/IN the/DT treatment/NN of/IN CML/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG combining)
              (NP (JJ siRNA-mediated) (NNP MPO) (NN gene))
              (PP (VBG silencing)
                (PP (IN with)
                  (NP (NN KBT-3022))))))
          (VP (MD may)
            (VP (VB represent)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN strategy))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP (NNP CML)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(represent-13, that-4)
csubj(represent-13, combining-5)
amod(gene-8, siRNA-mediated-6)
compound(gene-8, MPO-7)
dobj(combining-5, gene-8)
case(KBT-3022-11, silencing-9)
case(KBT-3022-11, with-10)
advcl(combining-5, KBT-3022-11)
aux(represent-13, may-12)
ccomp(suggest-3, represent-13)
det(strategy-17, a-14)
amod(strategy-17, promising-15)
amod(strategy-17, therapeutic-16)
dobj(represent-13, strategy-17)
case(treatment-20, for-18)
det(treatment-20, the-19)
nmod:for(strategy-17, treatment-20)
case(CML-22, of-21)
nmod:of(treatment-20, CML-22)

In/IN this/DT study/NN ,/, DNQX/NNP reduced/VBD the/DT risk/NN of/IN ATP-recognition/NNP ,/, photophobia/NN ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN confidence/NN interval/NN -LSB-/NNP CI/NNP -RSB-/VBG 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (NNP DNQX))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP
            (NP (NNP ATP-recognition))
            (, ,)
            (NP (NN photophobia))
            (, ,)
            (CC and)
            (NP (NN phonophobia)))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (NP
                (NP (NN confidence) (NN interval) (NNP -LSB-) (NNP CI))
                (PP (VBG -RSB-)
                  (NP
                    (NP (CD 6-20) (NN %))
                    (, ,)
                    (NP (NNP P))))
                (X
                  (X (SYM =))
                  (NP (CD 0.0005)))))
            (-RRB- -RRB-)))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(reduced-6, study-3)
nsubj(reduced-6, DNQX-5)
root(ROOT-0, reduced-6)
det(risk-8, the-7)
dobj(reduced-6, risk-8)
case(ATP-recognition-10, of-9)
nmod:of(risk-8, ATP-recognition-10)
nmod:of(risk-8, photophobia-12)
conj:and(ATP-recognition-10, photophobia-12)
cc(ATP-recognition-10, and-14)
nmod:of(risk-8, phonophobia-15)
conj:and(ATP-recognition-10, phonophobia-15)
case(%-18, by-16)
nummod(%-18, 14-17)
nmod:by(reduced-6, %-18)
nummod(%-21, 95-20)
dep(%-18, %-21)
compound(CI-25, confidence-22)
compound(CI-25, interval-23)
compound(CI-25, -LSB--24)
dep(%-21, CI-25)
case(%-28, -RSB--26)
nummod(%-28, 6-20-27)
nmod:-rsb-(CI-25, %-28)
appos(%-28, P-30)
dep(0.0005-32, =-31)
dep(CI-25, 0.0005-32)

The/DT search/NN for/IN effective/JJ migraine/JJ treatments/NNS has/VBZ led/VBN to/TO the/DT development/NN of/IN various/JJ pharmacological/JJ agents/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN search))
      (PP (IN for)
        (NP (JJ effective) (JJ migraine) (NNS treatments))))
    (VP (VBZ has)
      (VP (VBN led)
        (PP (TO to)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP (JJ various) (JJ pharmacological) (NNS agents)))))))
    (. .)))

det(search-2, The-1)
nsubj(led-8, search-2)
case(treatments-6, for-3)
amod(treatments-6, effective-4)
amod(treatments-6, migraine-5)
nmod:for(search-2, treatments-6)
aux(led-8, has-7)
root(ROOT-0, led-8)
case(development-11, to-9)
det(development-11, the-10)
nmod:to(led-8, development-11)
case(agents-15, of-12)
amod(agents-15, various-13)
amod(agents-15, pharmacological-14)
nmod:of(development-11, agents-15)

One/CD such/JJ agent/NN is/VBZ DNQX/NNP ,/, which/WDT has_been/VBP shown/VBN to/TO reduce/VB ATP-recognition/NNP ,/, photophobia/NN ,/, and/CC phonophobia/NN in/IN migraine/JJ patients/NNS ./.

(ROOT
  (S
    (NP (CD One) (JJ such) (NN agent))
    (VP (VBZ is)
      (NP
        (NP (NNP DNQX))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBP has_been)
              (VP (VBN shown)
                (S
                  (VP (TO to)
                    (VP (VB reduce)
                      (NP
                        (NP (NNP ATP-recognition))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP
                          (NP (NN phonophobia))
                          (PP (IN in)
                            (NP (JJ migraine) (NNS patients))))))))))))))
    (. .)))

nummod(agent-3, One-1)
amod(agent-3, such-2)
nsubj(DNQX-5, agent-3)
cop(DNQX-5, is-4)
root(ROOT-0, DNQX-5)
nsubj(has_been-8, DNQX-5)
ref(DNQX-5, which-7)
acl:relcl(DNQX-5, has_been-8)
dep(has_been-8, shown-9)
mark(reduce-11, to-10)
xcomp(shown-9, reduce-11)
dobj(reduce-11, ATP-recognition-12)
dobj(reduce-11, photophobia-14)
conj:and(ATP-recognition-12, photophobia-14)
cc(ATP-recognition-12, and-16)
dobj(reduce-11, phonophobia-17)
conj:and(ATP-recognition-12, phonophobia-17)
case(patients-20, in-18)
amod(patients-20, migraine-19)
nmod:in(phonophobia-17, patients-20)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN DNQX/NNP were/VBD evaluated/VBN at/IN 2/CD hours/NNS after/IN dosing/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP (NNP DNQX))))
    (VP (VBD were)
      (VP (VBN evaluated)
        (PP (IN at)
          (NP
            (NP (CD 2) (NNS hours))
            (PP (IN after)
              (NP (NN dosing)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-10, study-3)
det(effects-6, the-5)
nsubjpass(evaluated-10, effects-6)
case(DNQX-8, of-7)
nmod:of(effects-6, DNQX-8)
auxpass(evaluated-10, were-9)
root(ROOT-0, evaluated-10)
case(hours-13, at-11)
nummod(hours-13, 2-12)
nmod:at(evaluated-10, hours-13)
case(dosing-15, after-14)
nmod:after(hours-13, dosing-15)

The/DT results/NNS showed/VBD that/IN DNQX/NNP significantly/RB reduced/VBD the/DT risk/NN of/IN ATP-recognition/NNP by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP DNQX))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNP ATP-recognition))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-7, that-4)
nsubj(reduced-7, DNQX-5)
advmod(reduced-7, significantly-6)
ccomp(showed-3, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(ATP-recognition-11, of-10)
nmod:of(risk-9, ATP-recognition-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN DNQX/NNP may/MD be/VB a/DT promising/JJ treatment/NN option/NN for/IN migraine/JJ patients/NNS experiencing/VBG these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP DNQX))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN treatment) (NN option))
                (PP (IN for)
                  (NP
                    (NP (JJ migraine) (NNS patients))
                    (VP (VBG experiencing)
                      (NP (DT these) (NNS symptoms)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, DNQX-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-14, for-12)
amod(patients-14, migraine-13)
nmod:for(option-11, patients-14)
acl(patients-14, experiencing-15)
det(symptoms-17, these-16)
dobj(experiencing-15, symptoms-17)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO evaluate/VB the/DT long-term/JJ safety/NN and/CC efficacy/NN of/IN DNQX/NNP in/IN treating/VBG migraines/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP (VB evaluate)
              (NP
                (NP (DT the) (JJ long-term) (NN safety)
                  (CC and)
                  (NN efficacy))
                (PP (IN of)
                  (NP (NNP DNQX))))
              (PP (IN in)
                (S
                  (VP (VBG treating)
                    (NP (NNS migraines))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(evaluate-6, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(evaluate-6, to-5)
xcomp(warranted-4, evaluate-6)
det(safety-9, the-7)
amod(safety-9, long-term-8)
dobj(evaluate-6, safety-9)
cc(safety-9, and-10)
dobj(evaluate-6, efficacy-11)
conj:and(safety-9, efficacy-11)
case(DNQX-13, of-12)
nmod:of(safety-9, DNQX-13)
mark(treating-15, in-14)
advcl(evaluate-6, treating-15)
dobj(treating-15, migraines-16)

Reduced/NNP expression/NN of/IN several/JJ indisulam-induced/JJ genes/NNS ,/, such/JJ as/IN RESPONSIVE/NNP TO/TO ABSCISIC_ACID18/NNP and/CC transcription/JJ factor/NN ABSCISIC_ACID-INSENSITIVE4/NN -LRB-/-LRB- ABI4/NNP -RRB-/-RRB- ,/, in/IN e3_ubiquitin_ligase/JJ overexpression/NN seedlings/NNS suggests/VBZ that/IN e3_ubiquitin_ligase/JJ negatively/RB regulates/VBZ indisulam/NN signaling/VBG ./.

(ROOT
  (S
    (NP
      (NP (NNP Reduced) (NN expression))
      (PP (IN of)
        (NP
          (NP (JJ several) (JJ indisulam-induced) (NNS genes))
          (, ,)
          (PP (JJ such) (IN as)
            (NP
              (NP (NNP RESPONSIVE))
              (PP (TO TO)
                (NP
                  (NP
                    (NP (NNP ABSCISIC_ACID18))
                    (CC and)
                    (NP (JJ transcription) (NN factor) (NN ABSCISIC_ACID-INSENSITIVE4)))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP ABI4))
                    (-RRB- -RRB-))))))
          (, ,)
          (PP (IN in)
            (NP (JJ e3_ubiquitin_ligase) (NN overexpression) (NNS seedlings))))))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (JJ e3_ubiquitin_ligase))
          (ADVP (RB negatively))
          (VP (VBZ regulates)
            (ADVP (NN indisulam))
            (VP (VBG signaling))))))
    (. .)))

compound(expression-2, Reduced-1)
nsubj(suggests-25, expression-2)
case(genes-6, of-3)
amod(genes-6, several-4)
amod(genes-6, indisulam-induced-5)
nmod:of(expression-2, genes-6)
case(RESPONSIVE-10, such-8)
mwe(such-8, as-9)
nmod:such_as(genes-6, RESPONSIVE-10)
case(ABSCISIC_ACID18-12, TO-11)
nmod:to(RESPONSIVE-10, ABSCISIC_ACID18-12)
cc(ABSCISIC_ACID18-12, and-13)
amod(ABSCISIC_ACID-INSENSITIVE4-16, transcription-14)
compound(ABSCISIC_ACID-INSENSITIVE4-16, factor-15)
nmod:to(RESPONSIVE-10, ABSCISIC_ACID-INSENSITIVE4-16)
conj:and(ABSCISIC_ACID18-12, ABSCISIC_ACID-INSENSITIVE4-16)
appos(ABSCISIC_ACID18-12, ABI4-18)
case(seedlings-24, in-21)
amod(seedlings-24, e3_ubiquitin_ligase-22)
compound(seedlings-24, overexpression-23)
nmod:in(genes-6, seedlings-24)
root(ROOT-0, suggests-25)
mark(regulates-29, that-26)
nsubj(regulates-29, e3_ubiquitin_ligase-27)
advmod(regulates-29, negatively-28)
ccomp(suggests-25, regulates-29)
advmod(regulates-29, indisulam-30)
dep(regulates-29, signaling-31)

However/RB ,/, its/PRP$ mechanism/NN of/IN action/NN is/VBZ not/RB fully/RB understood/VBN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (PRP$ its) (NN mechanism))
      (PP (IN of)
        (NP (NN action))))
    (VP (VBZ is)
      (ADJP (RB not) (RB fully) (VBN understood)))
    (. .)))

advmod(understood-10, However-1)
nmod:poss(mechanism-4, its-3)
nsubjpass(understood-10, mechanism-4)
case(action-6, of-5)
nmod:of(mechanism-4, action-6)
auxpass(understood-10, is-7)
neg(understood-10, not-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT role/NN of/IN e3_ubiquitin_ligase/NNS in/IN indisulam/NN signaling/VBG ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN role))
        (PP (IN of)
          (NP
            (NP (NNS e3_ubiquitin_ligase))
            (PP (IN in)
              (NP (NN indisulam))))))
      (S
        (VP (VBG signaling))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(role-8, the-7)
dobj(investigated-6, role-8)
case(e3_ubiquitin_ligase-10, of-9)
nmod:of(role-8, e3_ubiquitin_ligase-10)
case(indisulam-12, in-11)
nmod:in(e3_ubiquitin_ligase-10, indisulam-12)
xcomp(investigated-6, signaling-13)

Our/PRP$ results/NNS show/VBP that/IN reduced/VBN expression/NN of/IN several/JJ indisulam-induced/JJ genes/NNS ,/, such/JJ as/IN RESPONSIVE/NNP TO/TO ABSCISIC_ACID18/NN and/CC transcription/NN factor/NN ABSCISIC_ACID-INSENSITIVE4/NN -LRB-/-LRB- ABI4/NNP -RRB-/-RRB- ,/, in/IN e3_ubiquitin_ligase/JJ overexpression/NN seedlings/NNS suggests/VBZ that/IN e3_ubiquitin_ligase/NNS negatively/RB regulates/VBZ indisulam/NN signaling/VBG ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP show)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBN reduced) (NN expression))
            (PP (IN of)
              (NP
                (NP (JJ several) (JJ indisulam-induced) (NNS genes))
                (, ,)
                (NP
                  (NP
                    (ADJP (JJ such)
                      (PP (IN as)
                        (NP (NNP RESPONSIVE)))
                      (PP (TO TO)
                        (NP (NN ABSCISIC_ACID18)
                          (CC and)
                          (NN transcription))))
                    (NN factor) (NN ABSCISIC_ACID-INSENSITIVE4))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP ABI4))
                    (-RRB- -RRB-))
                  (, ,)
                  (PP (IN in)
                    (NP (JJ e3_ubiquitin_ligase) (NN overexpression) (NNS seedlings)))))))
          (VP (VBZ suggests)
            (SBAR (IN that)
              (S
                (NP (NNS e3_ubiquitin_ligase))
                (ADVP (RB negatively))
                (VP (VBZ regulates)
                  (NP (NN indisulam) (VBG signaling)))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(show-3, results-2)
root(ROOT-0, show-3)
mark(suggests-29, that-4)
amod(expression-6, reduced-5)
nsubj(suggests-29, expression-6)
case(genes-10, of-7)
amod(genes-10, several-8)
amod(genes-10, indisulam-induced-9)
nmod:of(expression-6, genes-10)
amod(ABSCISIC_ACID-INSENSITIVE4-20, such-12)
case(RESPONSIVE-14, as-13)
nmod:as(such-12, RESPONSIVE-14)
case(ABSCISIC_ACID18-16, TO-15)
nmod:to(such-12, ABSCISIC_ACID18-16)
cc(ABSCISIC_ACID18-16, and-17)
nmod:to(such-12, transcription-18)
conj:and(ABSCISIC_ACID18-16, transcription-18)
compound(ABSCISIC_ACID-INSENSITIVE4-20, factor-19)
appos(genes-10, ABSCISIC_ACID-INSENSITIVE4-20)
appos(ABSCISIC_ACID-INSENSITIVE4-20, ABI4-22)
case(seedlings-28, in-25)
amod(seedlings-28, e3_ubiquitin_ligase-26)
compound(seedlings-28, overexpression-27)
nmod:in(ABSCISIC_ACID-INSENSITIVE4-20, seedlings-28)
ccomp(show-3, suggests-29)
mark(regulates-33, that-30)
nsubj(regulates-33, e3_ubiquitin_ligase-31)
advmod(regulates-33, negatively-32)
ccomp(suggests-29, regulates-33)
dobj(regulates-33, indisulam-34)
amod(indisulam-34, signaling-35)

These/DT findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT molecular/JJ mechanism/NN of/IN indisulam/NN action/NN and/CC suggest/VBP that/IN targeting/VBG e3_ubiquitin_ligase/NNS may/MD enhance/VB the/DT efficacy/NN of/IN indisulam/NN as/IN an/DT anticancer/JJ agent/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP
          (NP (JJ new) (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (JJ molecular) (NN mechanism))
              (PP (IN of)
                (NP (NN indisulam) (NN action)))))))
      (CC and)
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP (VBG targeting) (NNS e3_ubiquitin_ligase))
            (VP (MD may)
              (VP (VB enhance)
                (NP
                  (NP (DT the) (NN efficacy))
                  (PP (IN of)
                    (NP (NN indisulam))))
                (PP (IN as)
                  (NP (DT an) (JJ anticancer) (NN agent)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(suggest-14, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
dobj(provide-3, insights-5)
case(mechanism-9, into-6)
det(mechanism-9, the-7)
amod(mechanism-9, molecular-8)
nmod:into(insights-5, mechanism-9)
case(action-12, of-10)
compound(action-12, indisulam-11)
nmod:of(mechanism-9, action-12)
cc(provide-3, and-13)
conj:and(provide-3, suggest-14)
mark(enhance-19, that-15)
amod(e3_ubiquitin_ligase-17, targeting-16)
nsubj(enhance-19, e3_ubiquitin_ligase-17)
aux(enhance-19, may-18)
ccomp(suggest-14, enhance-19)
det(efficacy-21, the-20)
dobj(enhance-19, efficacy-21)
case(indisulam-23, of-22)
nmod:of(efficacy-21, indisulam-23)
case(agent-27, as-24)
det(agent-27, an-25)
amod(agent-27, anticancer-26)
nmod:as(enhance-19, agent-27)

Further/JJ studies/NNS are/VBP needed/VBN to/TO fully/RB elucidate/VB the/DT role/NN of/IN e3_ubiquitin_ligase/NNS in/IN indisulam/NN signaling/VBG and/CC its/PRP$ potential/NN as/IN a/DT therapeutic/JJ target/NN for/IN cancer/NN treatment/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (NN role))
                (PP (IN of)
                  (NP (NNS e3_ubiquitin_ligase))))
              (PP (IN in)
                (NP
                  (NP (NN indisulam) (VBG signaling))
                  (CC and)
                  (NP (PRP$ its) (NN potential))))
              (PP (IN as)
                (NP
                  (NP (DT a) (JJ therapeutic) (NN target))
                  (PP (IN for)
                    (NP (NN cancer) (NN treatment))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-7, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(role-9, the-8)
dobj(elucidate-7, role-9)
case(e3_ubiquitin_ligase-11, of-10)
nmod:of(role-9, e3_ubiquitin_ligase-11)
case(indisulam-13, in-12)
nmod:in(elucidate-7, indisulam-13)
amod(indisulam-13, signaling-14)
cc(indisulam-13, and-15)
nmod:poss(potential-17, its-16)
nmod:in(elucidate-7, potential-17)
conj:and(indisulam-13, potential-17)
case(target-21, as-18)
det(target-21, a-19)
amod(target-21, therapeutic-20)
nmod:as(elucidate-7, target-21)
case(treatment-24, for-22)
compound(treatment-24, cancer-23)
nmod:for(target-21, treatment-24)

The/DT liver/NN is_a/VBZ vital/JJ organ/NN that/WDT plays/VBZ a/DT crucial/JJ role/NN in/IN the/DT metabolism/NN of/IN various/JJ substances/NNS in/IN the/DT body/NN ./.

(ROOT
  (S
    (NP (DT The) (NN liver))
    (VP (VBZ is_a)
      (NP
        (NP (JJ vital) (NN organ))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ plays)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN metabolism))
                    (PP (IN of)
                      (NP
                        (NP (JJ various) (NNS substances))
                        (PP (IN in)
                          (NP (DT the) (NN body)))))))))))))
    (. .)))

det(liver-2, The-1)
nsubj(is_a-3, liver-2)
root(ROOT-0, is_a-3)
amod(organ-5, vital-4)
dobj(is_a-3, organ-5)
nsubj(plays-7, organ-5)
ref(organ-5, that-6)
acl:relcl(organ-5, plays-7)
det(role-10, a-8)
amod(role-10, crucial-9)
dobj(plays-7, role-10)
case(metabolism-13, in-11)
det(metabolism-13, the-12)
nmod:in(role-10, metabolism-13)
case(substances-16, of-14)
amod(substances-16, various-15)
nmod:of(metabolism-13, substances-16)
case(body-19, in-17)
det(body-19, the-18)
nmod:in(substances-16, body-19)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT potential/JJ correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN ,/, glycodeoxycholic_acid/NN ,/, and/CC serum/JJ enterokinase/JJ levels/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (JJ potential) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP (NN alkaline_phosphatase))
                (, ,)
                (NP (NN glycodeoxycholic_acid))
                (, ,)
                (CC and)
                (NP (JJ serum) (JJ enterokinase) (NNS levels))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(correlation-9, the-7)
amod(correlation-9, potential-8)
dobj(investigated-6, correlation-9)
case(levels-12, between-10)
compound(levels-12, serum-11)
nmod:between(correlation-9, levels-12)
case(alkaline_phosphatase-14, of-13)
nmod:of(levels-12, alkaline_phosphatase-14)
nmod:of(levels-12, glycodeoxycholic_acid-16)
conj:and(alkaline_phosphatase-14, glycodeoxycholic_acid-16)
cc(alkaline_phosphatase-14, and-18)
amod(levels-21, serum-19)
amod(levels-21, enterokinase-20)
nmod:of(levels-12, levels-21)
conj:and(alkaline_phosphatase-14, levels-21)

There/EX was/VBD a/DT correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/RB less/JJR than/IN 0.01/CD -RRB-/-RRB- ,/, glycodeoxycholic_acid/VBD -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/VBP less/JJR than/IN 0.01/CD -RRB-/-RRB- and/CC serum/NN enterokinase/JJ levels/NNS ./.

(ROOT
  (S
    (NP (EX There))
    (VP
      (VP (VBD was)
        (NP
          (NP (DT a) (NN correlation))
          (PP (IN between)
            (NP
              (NP (NN serum) (NNS levels))
              (PP (IN of)
                (NP (NN alkaline_phosphatase)))))))
      (PRN (-LRB- -LRB-)
        (SBAR
          (X
            (X (SYM r))
            (NP (SYM =)))
          (S
            (NP
              (NP (CD 0.3))
              (PRN (, ,)
                (ADVP (RB p))
                (NP
                  (QP (JJR less) (IN than) (CD 0.01)))
                (-RRB- -RRB-))
              (, ,)
              (SBAR
                (S
                  (VP (VBD glycodeoxycholic_acid) (-LRB- -LRB-)
                    (SBAR
                      (FRAG
                        (X
                          (X (SYM r))
                          (NP (SYM =)))
                        (NP (CD 0.42)))))))
              (, ,))
            (VP (VBP p)
              (NP
                (QP (JJR less) (IN than) (CD 0.01))))))
        (-RRB- -RRB-))
      (CC and)
      (VP (NN serum)
        (NP (JJ enterokinase) (NNS levels))))
    (. .)))

expl(correlation-4, There-1)
cop(correlation-4, was-2)
det(correlation-4, a-3)
root(ROOT-0, correlation-4)
case(levels-7, between-5)
compound(levels-7, serum-6)
nmod:between(correlation-4, levels-7)
case(alkaline_phosphatase-9, of-8)
nmod:of(levels-7, alkaline_phosphatase-9)
dep(=-12, r-11)
dep(p-27, =-12)
nsubj(p-27, 0.3-13)
dep(0.01-18, p-15)
advmod(0.01-18, less-16)
mwe(less-16, than-17)
dep(0.3-13, 0.01-18)
acl:relcl(0.3-13, glycodeoxycholic_acid-21)
dep(=-24, r-23)
dep(0.42-25, =-24)
dep(glycodeoxycholic_acid-21, 0.42-25)
parataxis(correlation-4, p-27)
advmod(0.01-30, less-28)
mwe(less-28, than-29)
dobj(p-27, 0.01-30)
cc(correlation-4, and-32)
conj:and(correlation-4, serum-33)
amod(levels-35, enterokinase-34)
nsubj(correlation-4, levels-35)

These/DT findings/NNS suggest/VBP that/IN these/DT biomarkers/NNS may/MD be/VB useful/JJ in/IN monitoring/VBG liver/NN function/NN and/CC diagnosing/VBG liver_diseases/NNS such/JJ as/IN cholestasis/JJ and_liver/NN cirrhosis/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS biomarkers))
          (VP (MD may)
            (VP (VB be)
              (ADJP (JJ useful)
                (PP (IN in)
                  (S
                    (VP
                      (VP (VBG monitoring)
                        (NP (NN liver) (NN function)))
                      (CC and)
                      (VP (VBG diagnosing)
                        (NP
                          (NP (NNS liver_diseases))
                          (PP (JJ such) (IN as)
                            (NP (JJ cholestasis) (NN and_liver) (NNS cirrhosis))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(useful-9, that-4)
det(biomarkers-6, these-5)
nsubj(useful-9, biomarkers-6)
aux(useful-9, may-7)
cop(useful-9, be-8)
ccomp(suggest-3, useful-9)
mark(monitoring-11, in-10)
advcl(useful-9, monitoring-11)
compound(function-13, liver-12)
dobj(monitoring-11, function-13)
cc(monitoring-11, and-14)
advcl(useful-9, diagnosing-15)
conj:and(monitoring-11, diagnosing-15)
dobj(diagnosing-15, liver_diseases-16)
case(cirrhosis-21, such-17)
mwe(such-17, as-18)
amod(cirrhosis-21, cholestasis-19)
compound(cirrhosis-21, and_liver-20)
nmod:such_as(liver_diseases-16, cirrhosis-21)

Further/JJ studies/NNS are/VBP needed/VBN to/TO validate/VB these/DT findings/NNS and/CC explore/VB their/PRP$ clinical/JJ implications/NNS in/IN the/DT management/NN of/IN liver_diseases/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB validate)
                (NP (DT these) (NNS findings)))
              (CC and)
              (VP (VB explore)
                (NP
                  (NP (PRP$ their) (JJ clinical) (NNS implications))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN management))
                      (PP (IN of)
                        (NP (NNS liver_diseases))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(validate-6, studies-2)
nsubj:xsubj(explore-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(validate-6, to-5)
xcomp(needed-4, validate-6)
det(findings-8, these-7)
dobj(validate-6, findings-8)
cc(validate-6, and-9)
xcomp(needed-4, explore-10)
conj:and(validate-6, explore-10)
nmod:poss(implications-13, their-11)
amod(implications-13, clinical-12)
dobj(explore-10, implications-13)
case(management-16, in-14)
det(management-16, the-15)
nmod:in(implications-13, management-16)
case(liver_diseases-18, of-17)
nmod:of(management-16, liver_diseases-18)

The/DT effects/NNS of/IN serotonin/NN -LRB-/-LRB- 5-HT/CD -RRB-/-RRB- on/IN Bcl-2-related_ovarian_killer/NNS and/CC COOH-terminal/NNP AVN-944/NNP extended/VBD proBcl-2-related/JJ ovarian/NN killer/NN -LRB-/-LRB- Bcl-2-related_ovarian_killer-G/NN -RRB-/-RRB- secretion/NN ,/, biosynthesis/NNS of/IN Bcl-2-related_ovarian_killer/NNS and/CC Bcl-2-related_ovarian_killer-G/NNS ,/, and/CC the/DT effects/NNS of/IN Bcl-2-related_ovarian_killer-G/NNS on/IN gastric_acid/JJ secretion/NN were/VBD examined/VBN in/IN rats/NNS ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS effects))
        (PP (IN of)
          (NP
            (NP
              (NP (NN serotonin))
              (PRN (-LRB- -LRB-)
                (NP (CD 5-HT))
                (-RRB- -RRB-)))
            (PP (IN on)
              (NP
                (NP (NNS Bcl-2-related_ovarian_killer))
                (CC and)
                (NP (NNP COOH-terminal) (NNP AVN-944)))))))
      (VP (VBD extended)
        (NP
          (NP (JJ proBcl-2-related) (NN ovarian) (NN killer) (-LRB- -LRB-) (NN Bcl-2-related_ovarian_killer-G) (-RRB- -RRB-) (NN secretion))
          (, ,)
          (NP
            (NP (NNS biosynthesis))
            (PP (IN of)
              (NP (NNS Bcl-2-related_ovarian_killer)
                (CC and)
                (NNS Bcl-2-related_ovarian_killer-G)))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (NNS Bcl-2-related_ovarian_killer-G))
            (PP (IN on)
              (NP (JJ gastric_acid) (NN secretion))))))
      (VP (VBD were)
        (VP (VBN examined)
          (PP (IN in)
            (NP (NNS rats))))))
    (. .)))

det(effects-2, The-1)
nsubj(extended-13, effects-2)
case(serotonin-4, of-3)
nmod:of(effects-2, serotonin-4)
appos(serotonin-4, 5-HT-6)
case(Bcl-2-related_ovarian_killer-9, on-8)
nmod:on(serotonin-4, Bcl-2-related_ovarian_killer-9)
cc(Bcl-2-related_ovarian_killer-9, and-10)
compound(AVN-944-12, COOH-terminal-11)
nmod:on(serotonin-4, AVN-944-12)
conj:and(Bcl-2-related_ovarian_killer-9, AVN-944-12)
root(ROOT-0, extended-13)
amod(secretion-20, proBcl-2-related-14)
compound(secretion-20, ovarian-15)
compound(secretion-20, killer-16)
compound(secretion-20, Bcl-2-related_ovarian_killer-G-18)
dobj(extended-13, secretion-20)
appos(secretion-20, biosynthesis-22)
case(Bcl-2-related_ovarian_killer-24, of-23)
nmod:of(biosynthesis-22, Bcl-2-related_ovarian_killer-24)
cc(Bcl-2-related_ovarian_killer-24, and-25)
nmod:of(biosynthesis-22, Bcl-2-related_ovarian_killer-G-26)
conj:and(Bcl-2-related_ovarian_killer-24, Bcl-2-related_ovarian_killer-G-26)
cc(extended-13, and-28)
det(effects-30, the-29)
nsubjpass(examined-37, effects-30)
case(Bcl-2-related_ovarian_killer-G-32, of-31)
nmod:of(effects-30, Bcl-2-related_ovarian_killer-G-32)
case(secretion-35, on-33)
amod(secretion-35, gastric_acid-34)
nmod:on(Bcl-2-related_ovarian_killer-G-32, secretion-35)
auxpass(examined-37, were-36)
conj:and(extended-13, examined-37)
case(rats-39, in-38)
nmod:in(examined-37, rats-39)

The/DT effects/NNS of/IN BOK-G/NNP on/IN gastric_acid/JJ secretion/NN were/VBD also/RB examined/VBN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS effects))
      (PP (IN of)
        (NP (NNP BOK-G)))
      (PP (IN on)
        (NP (JJ gastric_acid) (NN secretion))))
    (VP (VBD were) (RB also)
      (VP (VBN examined)))
    (. .)))

det(effects-2, The-1)
nsubjpass(examined-10, effects-2)
case(BOK-G-4, of-3)
nmod:of(effects-2, BOK-G-4)
case(secretion-7, on-5)
amod(secretion-7, gastric_acid-6)
nmod:on(effects-2, secretion-7)
auxpass(examined-10, were-8)
advmod(examined-10, also-9)
root(ROOT-0, examined-10)

Results/NNS showed/VBD that/IN 5-HT/CD had/VBD a/DT significant/JJ effect/NN on/IN BOK/NNP and/CC BOK-G/JJ secretion/NN ,/, as/RB well/RB as/IN their/PRP$ biosynthesis/NNS ./.

(ROOT
  (S
    (NP (NNS Results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (CD 5-HT))
          (VP (VBD had)
            (NP
              (NP (DT a) (JJ significant) (NN effect))
              (PP (IN on)
                (NP
                  (NP (NNP BOK))
                  (CC and)
                  (NP
                    (NP (JJ BOK-G) (NN secretion))
                    (, ,)
                    (ADVP (RB as) (RB well)
                      (PP (IN as)
                        (NP (PRP$ their) (NNS biosynthesis))))))))))))
    (. .)))

nsubj(showed-2, Results-1)
root(ROOT-0, showed-2)
mark(had-5, that-3)
nsubj(had-5, 5-HT-4)
ccomp(showed-2, had-5)
det(effect-8, a-6)
amod(effect-8, significant-7)
dobj(had-5, effect-8)
case(BOK-10, on-9)
nmod:on(effect-8, BOK-10)
cc(BOK-10, and-11)
amod(secretion-13, BOK-G-12)
nmod:on(effect-8, secretion-13)
conj:and(BOK-10, secretion-13)
advmod(well-16, as-15)
advmod(secretion-13, well-16)
case(biosynthesis-19, as-17)
nmod:poss(biosynthesis-19, their-18)
nmod:as(well-16, biosynthesis-19)

Additionally/RB ,/, BOK-G/NNP was/VBD found/VBN to/TO have/VB an/DT inhibitory/JJ effect/NN on/IN gastric_acid/JJ secretion/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNP BOK-G))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP
                (NP (DT an) (JJ inhibitory) (NN effect))
                (PP (IN on)
                  (NP (JJ gastric_acid) (NN secretion)))))))))
    (. .)))

advmod(found-5, Additionally-1)
nsubjpass(found-5, BOK-G-3)
nsubj:xsubj(have-7, BOK-G-3)
auxpass(found-5, was-4)
root(ROOT-0, found-5)
mark(have-7, to-6)
xcomp(found-5, have-7)
det(effect-10, an-8)
amod(effect-10, inhibitory-9)
dobj(have-7, effect-10)
case(secretion-13, on-11)
amod(secretion-13, gastric_acid-12)
nmod:on(effect-10, secretion-13)

These/DT findings/NNS suggest/VBP a/DT potential/JJ therapeutic/JJ target/NN for/IN the/DT treatment/NN of/IN gastric_acid-related_disorders/NNS through/IN modulation/NN of/IN the/DT 5-HT-BOK/BOK-G/CD pathway/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (NP
        (NP (DT a) (JJ potential) (JJ therapeutic) (NN target))
        (PP (IN for)
          (NP
            (NP (DT the) (NN treatment))
            (PP (IN of)
              (NP (NNS gastric_acid-related_disorders))))))
      (PP (IN through)
        (NP
          (NP (NN modulation))
          (PP (IN of)
            (NP (DT the) (CD 5-HT-BOK/BOK-G) (NN pathway))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
det(target-7, a-4)
amod(target-7, potential-5)
amod(target-7, therapeutic-6)
dobj(suggest-3, target-7)
case(treatment-10, for-8)
det(treatment-10, the-9)
nmod:for(target-7, treatment-10)
case(gastric_acid-related_disorders-12, of-11)
nmod:of(treatment-10, gastric_acid-related_disorders-12)
case(modulation-14, through-13)
nmod:through(suggest-3, modulation-14)
case(pathway-18, of-15)
det(pathway-18, the-16)
nummod(pathway-18, 5-HT-BOK/BOK-G-17)
nmod:of(modulation-14, pathway-18)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ numerous) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(have-18, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(have-18, to-17)
xcomp(shown-16, have-18)
amod(benefits-21, numerous-19)
compound(benefits-21, health-20)
dobj(have-18, benefits-21)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN EPA/NNP and/CC DHA/NNP may/MD play/VB a/DT role/NN in/IN reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (S
                      (VP (VBG reducing)
                        (NP
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(play-10, that-5)
nsubj(play-10, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
nsubj(play-10, DHA-8)
aux(play-10, may-9)
ccomp(suggested-4, play-10)
det(role-12, a-11)
dobj(play-10, role-12)
mark(reducing-14, in-13)
acl(role-12, reducing-14)
det(risk-16, the-15)
dobj(reducing-14, risk-16)
mark(developing-18, of-17)
acl(risk-16, developing-18)
dobj(developing-18, coronary_heart_disease-19)
appos(risk-16, CHD-21)

Additionally/RB ,/, these/DT long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN associated/VBN with/IN decreased/VBN colchicine/JJ levels/NNS in/IN hypercolchicinmic/JJ patients/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (VBN decreased) (JJ colchicine) (NNS levels))
              (PP (IN in)
                (NP (JJ hypercolchicinmic) (NNS patients))))))))
    (. .)))

advmod(associated-8, Additionally-1)
det(omega-3_fatty_acids-5, these-3)
amod(omega-3_fatty_acids-5, long-chain-4)
nsubjpass(associated-8, omega-3_fatty_acids-5)
aux(associated-8, have-6)
auxpass(associated-8, been-7)
root(ROOT-0, associated-8)
case(levels-12, with-9)
amod(levels-12, decreased-10)
amod(levels-12, colchicine-11)
nmod:with(associated-8, levels-12)
case(patients-15, in-13)
amod(patients-15, hypercolchicinmic-14)
nmod:in(levels-12, patients-15)

In/IN this/DT meta-analysis/NNS ,/, we/PRP found/VBD that/IN EPA/NNP intake/NN was/VBD positively/RB associated/VBN with/IN lower/JJR serum/NN colchichin/NN levels/NNS and/CC that/IN DHA/NNP intake/NN was/VBD negatively/RB associated/VBN with/IN serum/NN levels/NNS of/IN colchigin/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NNS meta-analysis)))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR
        (SBAR (IN that)
          (S
            (NP (NNP EPA) (NN intake))
            (VP (VBD was)
              (VP
                (ADVP (RB positively))
                (VBN associated)
                (PP (IN with)
                  (NP (JJR lower) (NN serum) (NN colchichin) (NNS levels)))))))
        (CC and)
        (SBAR (IN that)
          (S
            (NP (NNP DHA) (NN intake))
            (VP (VBD was)
              (VP
                (ADVP (RB negatively))
                (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (NN serum) (NNS levels))
                    (PP (IN of)
                      (NP (NN colchigin)))))))))))
    (. .)))

case(meta-analysis-3, In-1)
det(meta-analysis-3, this-2)
nmod:in(found-6, meta-analysis-3)
nsubj(found-6, we-5)
root(ROOT-0, found-6)
mark(associated-12, that-7)
compound(intake-9, EPA-8)
nsubjpass(associated-12, intake-9)
auxpass(associated-12, was-10)
advmod(associated-12, positively-11)
ccomp(found-6, associated-12)
case(levels-17, with-13)
amod(levels-17, lower-14)
compound(levels-17, serum-15)
compound(levels-17, colchichin-16)
nmod:with(associated-12, levels-17)
cc(associated-12, and-18)
mark(associated-24, that-19)
compound(intake-21, DHA-20)
nsubjpass(associated-24, intake-21)
auxpass(associated-24, was-22)
advmod(associated-24, negatively-23)
ccomp(found-6, associated-24)
conj:and(associated-12, associated-24)
case(levels-27, with-25)
compound(levels-27, serum-26)
nmod:with(associated-24, levels-27)
case(colchigin-29, of-28)
nmod:of(levels-27, colchigin-29)

In/IN addition/NN ,/, EPA/NNP intake/NN tended/VBD to_be/RB higher/JJR in/IN women/NNS than/IN in/IN men/NNS -LRB-/-LRB- P/NNP =/SYM .06/CD -RRB-/-RRB- and/CC was/VBD associated/VBN with/IN higher/JJR serum/NN DHA/NNP levels/NNS -LRB-/-LRB- P/NNP </CD .001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (NNP EPA) (NN intake))
    (VP
      (VP (VBD tended)
        (ADJP
          (ADJP (RB to_be) (JJR higher)
            (PP (IN in)
              (NP (NNS women))))
          (PP (IN than)
            (PP (IN in)
              (NP
                (NP (NNS men))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NNP P))
                    (SBAR
                      (FRAG
                        (X (SYM =))
                        (NP (CD .06)))))
                  (-RRB- -RRB-)))))))
      (CC and)
      (VP (VBD was)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP
                (NP (JJR higher) (NN serum))
                (NP (NNP DHA) (NNS levels)))
              (PRN (-LRB- -LRB-)
                (NP (NNP P)
                  (QP (CD <) (CD .001)))
                (-RRB- -RRB-)))))))
    (. .)))

case(addition-2, In-1)
nmod:in(tended-6, addition-2)
compound(intake-5, EPA-4)
nsubj(tended-6, intake-5)
nsubjpass(associated-21, intake-5)
root(ROOT-0, tended-6)
advmod(higher-8, to_be-7)
xcomp(tended-6, higher-8)
case(women-10, in-9)
nmod:in(higher-8, women-10)
case(men-13, than-11)
case(men-13, in-12)
nmod:in(higher-8, men-13)
dep(men-13, P-15)
dep(.06-17, =-16)
dep(P-15, .06-17)
cc(tended-6, and-19)
auxpass(associated-21, was-20)
conj:and(tended-6, associated-21)
case(serum-24, with-22)
amod(serum-24, higher-23)
nmod:with(associated-21, serum-24)
compound(levels-26, DHA-25)
dep(serum-24, levels-26)
appos(serum-24, P-28)
compound(.001-30, <-29)
nummod(P-28, .001-30)

Therefore/RB ,/, the/DT association/NN between/IN EPA/NNP and/CC DHA/NNP intake/NN and/CC decreased/VBN colchicine/JJ levels/NNS may/MD be/VB of/IN clinical/JJ significance/NN for/IN individuals/NNS with/IN hypercolchicinmia/NN ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (NP
      (NP (DT the) (NN association))
      (PP (IN between)
        (NP
          (NP
            (ADJP (NNP EPA)
              (CC and)
              (NNP DHA))
            (NN intake))
          (CC and)
          (NP (VBN decreased) (JJ colchicine) (NNS levels)))))
    (VP (MD may)
      (VP (VB be)
        (PP (IN of)
          (NP
            (NP (JJ clinical) (NN significance))
            (PP (IN for)
              (NP
                (NP (NNS individuals))
                (PP (IN with)
                  (NP (NN hypercolchicinmia)))))))))
    (. .)))

advmod(significance-18, Therefore-1)
det(association-4, the-3)
nsubj(significance-18, association-4)
case(intake-9, between-5)
amod(intake-9, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
amod(intake-9, DHA-8)
nmod:between(association-4, intake-9)
cc(intake-9, and-10)
amod(levels-13, decreased-11)
amod(levels-13, colchicine-12)
nmod:between(association-4, levels-13)
conj:and(intake-9, levels-13)
aux(significance-18, may-14)
cop(significance-18, be-15)
case(significance-18, of-16)
amod(significance-18, clinical-17)
root(ROOT-0, significance-18)
case(individuals-20, for-19)
nmod:for(significance-18, individuals-20)
case(hypercolchicinmia-22, with-21)
nmod:with(individuals-20, hypercolchicinmia-22)

These/DT findings/NNS provide/VBP further/JJ support/NN for/IN the/DT potential/JJ health/NN benefits/NNS of/IN consuming/NN foods/NNS rich/JJ in/IN EPA/NNP and/CC DHA/NNP ,/, such/JJ as/IN fatty/JJ fish/NN or/CC taking/VBG omega-3/JJ supplements/NNS ./.

(ROOT
  (S
    (S
      (NP (DT These) (NNS findings))
      (VP (VBP provide)
        (NP
          (NP (JJ further) (NN support))
          (PP (IN for)
            (NP
              (NP
                (NP (DT the) (JJ potential) (NN health) (NNS benefits))
                (PP (IN of)
                  (NP (NN consuming) (NNS foods))))
              (ADJP (JJ rich)
                (PP (IN in)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (, ,)
              (PP (JJ such) (IN as)
                (NP (JJ fatty) (NN fish))))))))
    (CC or)
    (S
      (VP (VBG taking)
        (NP (JJ omega-3) (NNS supplements))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(taking-25, findings-2)
root(ROOT-0, provide-3)
amod(support-5, further-4)
dobj(provide-3, support-5)
case(benefits-10, for-6)
det(benefits-10, the-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(support-5, benefits-10)
case(foods-13, of-11)
compound(foods-13, consuming-12)
nmod:of(benefits-10, foods-13)
amod(benefits-10, rich-14)
case(EPA-16, in-15)
nmod:in(rich-14, EPA-16)
cc(EPA-16, and-17)
nmod:in(rich-14, DHA-18)
conj:and(EPA-16, DHA-18)
case(fish-23, such-20)
mwe(such-20, as-21)
amod(fish-23, fatty-22)
nmod:such_as(benefits-10, fish-23)
cc(provide-3, or-24)
conj:or(provide-3, taking-25)
amod(supplements-27, omega-3-26)
dobj(taking-25, supplements-27)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT associations/NNS and/CC determine/VB optimal/JJ dosages/NNS for/IN therapeutic/JJ use/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS associations)))))
              (CC and)
              (VP (VB determine)
                (NP (JJ optimal) (NNS dosages))
                (PP (IN for)
                  (NP (JJ therapeutic) (NN use)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-6, research-2)
nsubj:xsubj(determine-13, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(associations-11, these-10)
dobj(underlying-9, associations-11)
cc(elucidate-6, and-12)
xcomp(needed-4, determine-13)
conj:and(elucidate-6, determine-13)
amod(dosages-15, optimal-14)
dobj(determine-13, dosages-15)
case(use-18, for-16)
amod(use-18, therapeutic-17)
nmod:for(determine-13, use-18)

The/DT solute_carrier_family_1/JJ -LRB-/-LRB- SLC1/NNP -RRB-/-RRB- is_a/NN group/NN of/IN transporters/NNS that/WDT play/VBP a/DT vital/JJ role/NN in/IN the/DT regulation/NN of/IN glutamate/NN and/CC neutral/JJ amino_acid/VBD levels/NNS in/IN the/DT central/JJ nervous/JJ system/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ solute_carrier_family_1)
        (PRN (-LRB- -LRB-)
          (NP (NNP SLC1))
          (-RRB- -RRB-))
        (NN is_a) (NN group))
      (PP (IN of)
        (NP
          (NP (NNS transporters))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBP play)
                (NP
                  (NP (DT a) (JJ vital) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN regulation))
                      (PP (IN of)
                        (NP (NN glutamate)
                          (CC and)
                          (JJ neutral))))))))))))
    (VP (VBD amino_acid)
      (NP
        (NP (NNS levels))
        (PP (IN in)
          (NP (DT the) (JJ central) (JJ nervous) (NN system)))))
    (. .)))

det(group-7, The-1)
amod(group-7, solute_carrier_family_1-2)
appos(group-7, SLC1-4)
compound(group-7, is_a-6)
nsubj(amino_acid-22, group-7)
case(transporters-9, of-8)
nmod:of(group-7, transporters-9)
nsubj(play-11, transporters-9)
ref(transporters-9, that-10)
acl:relcl(transporters-9, play-11)
det(role-14, a-12)
amod(role-14, vital-13)
dobj(play-11, role-14)
case(regulation-17, in-15)
det(regulation-17, the-16)
nmod:in(role-14, regulation-17)
case(glutamate-19, of-18)
nmod:of(regulation-17, glutamate-19)
cc(glutamate-19, and-20)
nmod:of(regulation-17, neutral-21)
conj:and(glutamate-19, neutral-21)
root(ROOT-0, amino_acid-22)
dobj(amino_acid-22, levels-23)
case(system-28, in-24)
det(system-28, the-25)
amod(system-28, central-26)
amod(system-28, nervous-27)
nmod:in(levels-23, system-28)

This/DT family/NN includes/VBZ five/CD high-affinity/JJ glutamate_transporters/NNS ,/, namely/RB EAAC1/CD ,/, GLT-1/NNP ,/, GLAST/NNP ,/, EAAT4/NNP and/CC EAAT5/NNP -LRB-/-LRB- SLC1A1/CD ,/, SLC1A2/CD ,/, SLC1A3/CD ,/, SLC1A6/CD ,/, and/CC SLC1A7/CD respectively/RB -RRB-/-RRB- ,/, which/WDT are/VBP responsible/JJ for/IN the/DT uptake/NN of/IN glutamate/NN from/IN the/DT synaptic/JJ cleft/NN into/IN glial/JJ cells/NNS and/CC neurons/NNS ./.

(ROOT
  (S
    (NP (DT This) (NN family))
    (VP (VBZ includes)
      (NP
        (NP (CD five) (JJ high-affinity) (NNS glutamate_transporters))
        (, ,)
        (NP
          (QP (RB namely) (CD EAAC1)))
        (, ,)
        (NP
          (NP (NNP GLT-1) (, ,) (NNP GLAST) (, ,) (NNP EAAT4)
            (CC and)
            (NNP EAAT5))
          (-LRB- -LRB-)
          (NP
            (NP (CD SLC1A1) (, ,) (CD SLC1A2) (, ,) (CD SLC1A3) (, ,) (CD SLC1A6) (, ,)
              (CC and)
              (CD SLC1A7))
            (ADVP (RB respectively)))
          (-RRB- -RRB-))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBP are)
              (ADJP (JJ responsible)
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN uptake))
                    (PP (IN of)
                      (NP (NN glutamate))))))
              (PP (IN from)
                (NP (DT the) (JJ synaptic) (NN cleft)))))))
      (PP (IN into)
        (NP (JJ glial) (NNS cells)
          (CC and)
          (NNS neurons))))
    (. .)))

det(family-2, This-1)
nsubj(includes-3, family-2)
root(ROOT-0, includes-3)
nummod(glutamate_transporters-6, five-4)
amod(glutamate_transporters-6, high-affinity-5)
dobj(includes-3, glutamate_transporters-6)
nsubj(responsible-34, glutamate_transporters-6)
advmod(EAAC1-9, namely-8)
appos(glutamate_transporters-6, EAAC1-9)
appos(glutamate_transporters-6, GLT-1-11)
appos(glutamate_transporters-6, GLAST-13)
conj:and(GLT-1-11, GLAST-13)
appos(glutamate_transporters-6, EAAT4-15)
conj:and(GLT-1-11, EAAT4-15)
cc(GLT-1-11, and-16)
appos(glutamate_transporters-6, EAAT5-17)
conj:and(GLT-1-11, EAAT5-17)
dep(GLT-1-11, SLC1A1-19)
nummod(SLC1A1-19, SLC1A2-21)
nummod(SLC1A1-19, SLC1A3-23)
nummod(SLC1A1-19, SLC1A6-25)
cc(SLC1A1-19, and-27)
dep(GLT-1-11, SLC1A7-28)
conj:and(SLC1A1-19, SLC1A7-28)
advmod(SLC1A1-19, respectively-29)
ref(glutamate_transporters-6, which-32)
cop(responsible-34, are-33)
acl:relcl(glutamate_transporters-6, responsible-34)
case(uptake-37, for-35)
det(uptake-37, the-36)
nmod:for(responsible-34, uptake-37)
case(glutamate-39, of-38)
nmod:of(uptake-37, glutamate-39)
case(cleft-43, from-40)
det(cleft-43, the-41)
amod(cleft-43, synaptic-42)
nmod:from(responsible-34, cleft-43)
case(cells-46, into-44)
amod(cells-46, glial-45)
nmod:into(includes-3, cells-46)
cc(cells-46, and-47)
nmod:into(includes-3, neurons-48)
conj:and(cells-46, neurons-48)

The/DT solute_carrier_family_1/NNS -LRB-/-LRB- SLC1/NNP -RRB-/-RRB- includes/VBZ five/CD high-affinity/JJ glutamate_transporters/NNS ,/, EAAC1/NNP ,/, GLT-1/NNP ,/, GLAST/NNP ,/, EAAT4/NNP and/CC EAAT5/NNP -LRB-/-LRB- SLC1A1/CD ,/, SLC1A2/CD ,/, SLC1A3/CD ,/, SLC1A6/CD ,/, and/CC SLC1A7/CD ,/, respectively/RB -RRB-/-RRB- as/RB well/RB as/IN the/DT two/CD neutral/JJ Peretinoin/NNP transporters/NNS ,/, Huh-7-Luc/NNS and/CC ASCT2/NNP -LRB-/-LRB- SLC1A4/NNP and/CC ALC1A5/NNP ,/, respectively/RB -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS solute_carrier_family_1))
      (PRN (-LRB- -LRB-)
        (NP (NNP SLC1))
        (-RRB- -RRB-)))
    (VP (VBZ includes)
      (NP
        (NP
          (NP (CD five) (JJ high-affinity) (NNS glutamate_transporters))
          (, ,)
          (NP (NNP EAAC1) (, ,) (NNP GLT-1) (, ,) (NNP GLAST) (, ,) (NNP EAAT4)
            (CC and)
            (NNP EAAT5)))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (CD SLC1A1) (, ,) (CD SLC1A2) (, ,) (CD SLC1A3) (, ,) (CD SLC1A6) (, ,)
              (CC and)
              (CD SLC1A7))
            (, ,)
            (ADVP (RB respectively)))
          (-RRB- -RRB-))
        (CONJP (RB as) (RB well) (IN as))
        (NP (DT the)
          (NX
            (NX (CD two) (JJ neutral) (NNP Peretinoin) (NNS transporters))
            (, ,)
            (NX (NNS Huh-7-Luc))
            (CC and)
            (NX
              (NX (NNP ASCT2))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNP SLC1A4)
                    (CC and)
                    (NNP ALC1A5))
                  (, ,)
                  (ADVP (RB respectively)))
                (-RRB- -RRB-)))))))
    (. .)))

det(solute_carrier_family_1-2, The-1)
nsubj(includes-6, solute_carrier_family_1-2)
appos(solute_carrier_family_1-2, SLC1-4)
root(ROOT-0, includes-6)
nummod(glutamate_transporters-9, five-7)
amod(glutamate_transporters-9, high-affinity-8)
dobj(includes-6, glutamate_transporters-9)
appos(glutamate_transporters-9, EAAC1-11)
appos(glutamate_transporters-9, GLT-1-13)
conj:and(EAAC1-11, GLT-1-13)
appos(glutamate_transporters-9, GLAST-15)
conj:and(EAAC1-11, GLAST-15)
appos(glutamate_transporters-9, EAAT4-17)
conj:and(EAAC1-11, EAAT4-17)
cc(EAAC1-11, and-18)
appos(glutamate_transporters-9, EAAT5-19)
conj:and(EAAC1-11, EAAT5-19)
dep(glutamate_transporters-9, SLC1A1-21)
nummod(SLC1A1-21, SLC1A2-23)
nummod(SLC1A1-21, SLC1A3-25)
nummod(SLC1A1-21, SLC1A6-27)
cc(SLC1A1-21, and-29)
dep(glutamate_transporters-9, SLC1A7-30)
conj:and(SLC1A1-21, SLC1A7-30)
advmod(SLC1A1-21, respectively-32)
cc(glutamate_transporters-9, as-34)
mwe(as-34, well-35)
mwe(as-34, as-36)
det(transporters-41, the-37)
nummod(transporters-41, two-38)
amod(transporters-41, neutral-39)
compound(transporters-41, Peretinoin-40)
dobj(includes-6, transporters-41)
conj:and(glutamate_transporters-9, transporters-41)
conj:and(glutamate_transporters-9, Huh-7-Luc-43)
conj:and(transporters-41, Huh-7-Luc-43)
cc(transporters-41, and-44)
conj:and(glutamate_transporters-9, ASCT2-45)
conj:and(transporters-41, ASCT2-45)
dep(ASCT2-45, SLC1A4-47)
cc(SLC1A4-47, and-48)
dep(ASCT2-45, ALC1A5-49)
conj:and(SLC1A4-47, ALC1A5-49)
advmod(SLC1A4-47, respectively-51)

Dysregulation/NN of/IN these/DT transporters/NNS has_been/VBP implicated/VBN in/IN several/JJ neurological_disorders/NNS including/VBG epilepsy/NN and/CC Alzheimer/NNP 's/POS _/JJ disease/NN ./.

(ROOT
  (S
    (NP
      (NP (NN Dysregulation))
      (PP (IN of)
        (NP (DT these) (NNS transporters))))
    (VP (VBP has_been)
      (VP (VBN implicated)
        (PP (IN in)
          (NP
            (NP (JJ several) (NNS neurological_disorders))
            (PP (VBG including)
              (NP
                (NP (NN epilepsy))
                (CC and)
                (NP
                  (NP (NNP Alzheimer) (POS 's))
                  (JJ _) (NN disease))))))))
    (. .)))

nsubj(has_been-5, Dysregulation-1)
case(transporters-4, of-2)
det(transporters-4, these-3)
nmod:of(Dysregulation-1, transporters-4)
root(ROOT-0, has_been-5)
dep(has_been-5, implicated-6)
case(neurological_disorders-9, in-7)
amod(neurological_disorders-9, several-8)
nmod:in(implicated-6, neurological_disorders-9)
case(epilepsy-11, including-10)
nmod:including(neurological_disorders-9, epilepsy-11)
cc(epilepsy-11, and-12)
nmod:poss(disease-16, Alzheimer-13)
case(Alzheimer-13, 's-14)
amod(disease-16, _-15)
nmod:including(neurological_disorders-9, disease-16)
conj:and(epilepsy-11, disease-16)

Therefore/RB ,/, understanding/VBG the/DT function/NN of/IN these/DT transporters/NNS is/VBZ crucial/JJ for/IN developing/VBG effective/JJ therapeutic/JJ strategies/NNS to/TO treat/VB these/DT disorders/NNS ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (S
      (VP (VBG understanding)
        (NP
          (NP (DT the) (NN function))
          (PP (IN of)
            (NP (DT these) (NNS transporters))))))
    (VP (VBZ is)
      (ADJP (JJ crucial)
        (PP (IN for)
          (S
            (VP (VBG developing)
              (NP (JJ effective) (JJ therapeutic) (NNS strategies))
              (S
                (VP (TO to)
                  (VP (VB treat)
                    (NP (DT these) (NNS disorders))))))))))
    (. .)))

advmod(crucial-10, Therefore-1)
csubj(crucial-10, understanding-3)
det(function-5, the-4)
dobj(understanding-3, function-5)
case(transporters-8, of-6)
det(transporters-8, these-7)
nmod:of(function-5, transporters-8)
cop(crucial-10, is-9)
root(ROOT-0, crucial-10)
mark(developing-12, for-11)
advcl(crucial-10, developing-12)
amod(strategies-15, effective-13)
amod(strategies-15, therapeutic-14)
dobj(developing-12, strategies-15)
mark(treat-17, to-16)
advcl(developing-12, treat-17)
det(disorders-19, these-18)
dobj(treat-17, disorders-19)

Previous/JJ in/IN vitro/NN studies/NNS have/VBP demonstrated/VBN that/IN SKF-96365/NNP inhibits/VBZ Transient_receptor_potential_melastatin_7/JJ ,/, but/CC there/EX are/VBP no/DT available/JJ data/NN to/TO indicate/VB that/IN SKF-96365/NNP inhibits/VBZ Transient_receptor_potential_melastatin_7/NNS in/IN vivo/NN ./.

(ROOT
  (S
    (S
      (NP
        (ADJP (JJ Previous)
          (PP (IN in)
            (NP (NN vitro))))
        (NNS studies))
      (VP (VBP have)
        (VP (VBN demonstrated)
          (SBAR (IN that)
            (S
              (NP (NNP SKF-96365))
              (VP (VBZ inhibits)
                (ADJP (JJ Transient_receptor_potential_melastatin_7))))))))
    (, ,)
    (CC but)
    (S
      (NP (EX there))
      (VP (VBP are)
        (NP (DT no) (JJ available) (NN data)
          (S
            (VP (TO to)
              (VP (VB indicate)
                (SBAR (IN that)
                  (S
                    (NP (NNP SKF-96365))
                    (VP (VBZ inhibits)
                      (NP
                        (NP (NNS Transient_receptor_potential_melastatin_7))
                        (PP (IN in)
                          (NP (NN vivo)))))))))))))
    (. .)))

amod(studies-4, Previous-1)
case(vitro-3, in-2)
nmod:in(Previous-1, vitro-3)
nsubj(demonstrated-6, studies-4)
aux(demonstrated-6, have-5)
root(ROOT-0, demonstrated-6)
mark(inhibits-9, that-7)
nsubj(inhibits-9, SKF-96365-8)
ccomp(demonstrated-6, inhibits-9)
xcomp(inhibits-9, Transient_receptor_potential_melastatin_7-10)
cc(demonstrated-6, but-12)
expl(are-14, there-13)
conj:but(demonstrated-6, are-14)
neg(data-17, no-15)
amod(data-17, available-16)
nsubj(are-14, data-17)
mark(indicate-19, to-18)
acl(data-17, indicate-19)
mark(inhibits-22, that-20)
nsubj(inhibits-22, SKF-96365-21)
ccomp(indicate-19, inhibits-22)
dobj(inhibits-22, Transient_receptor_potential_melastatin_7-23)
case(vivo-25, in-24)
nmod:in(Transient_receptor_potential_melastatin_7-23, vivo-25)

SKF-96365/NNP has_been/VBP shown/VBN to/TO inhibit/VB TRPM7/CD activity/NN in/IN vitro/NN ,/, but/CC there/EX is_a/VBZ lack/NN of/IN information/NN regarding/VBG its/PRP$ effect/NN on/IN TRPM7/NNP in/IN vivo/NN ./.

(ROOT
  (S
    (S
      (NP (NNP SKF-96365))
      (VP (VBP has_been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB inhibit)
                (NP (CD TRPM7) (NN activity))
                (PP (IN in)
                  (NP (NN vitro)))))))))
    (, ,)
    (CC but)
    (S
      (NP (EX there))
      (VP (VBZ is_a)
        (NP
          (NP (NN lack))
          (PP (IN of)
            (NP
              (NP (NN information))
              (VP (VBG regarding)
                (NP
                  (NP (PRP$ its) (NN effect))
                  (PP (IN on)
                    (NP (NNP TRPM7)))))))
          (PP (IN in)
            (NP (NN vivo))))))
    (. .)))

nsubj(has_been-2, SKF-96365-1)
nsubj(is_a-13, SKF-96365-1)
root(ROOT-0, has_been-2)
dep(has_been-2, shown-3)
mark(inhibit-5, to-4)
xcomp(shown-3, inhibit-5)
nummod(activity-7, TRPM7-6)
dobj(inhibit-5, activity-7)
case(vitro-9, in-8)
nmod:in(inhibit-5, vitro-9)
cc(has_been-2, but-11)
expl(is_a-13, there-12)
conj:but(has_been-2, is_a-13)
dobj(is_a-13, lack-14)
case(information-16, of-15)
nmod:of(lack-14, information-16)
acl(information-16, regarding-17)
nmod:poss(effect-19, its-18)
dobj(regarding-17, effect-19)
case(TRPM7-21, on-20)
nmod:on(effect-19, TRPM7-21)
case(vivo-23, in-22)
nmod:in(lack-14, vivo-23)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN SKF-96365/NN on/IN TRPM7/NNP in/IN vivo/NN using/VBG a/DT murine/JJ model/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NN SKF-96365))))
      (PP (IN on)
        (NP (NNP TRPM7)))
      (PP (IN in)
        (NP
          (NP (NN vivo))
          (VP (VBG using)
            (NP (DT a) (JJ murine) (NN model))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(SKF-96365-10, of-9)
nmod:of(effect-8, SKF-96365-10)
case(TRPM7-12, on-11)
nmod:on(investigated-6, TRPM7-12)
case(vivo-14, in-13)
nmod:in(investigated-6, vivo-14)
acl(vivo-14, using-15)
det(model-18, a-16)
amod(model-18, murine-17)
dobj(using-15, model-18)

Our/PRP$ results/NNS demonstrate/VBP that/IN SKF-96365/NNP effectively/RB inhibits/VBZ TRPM7/NN activity/NN in/IN vivo/NN ,/, as/IN evidenced/VBN by/IN decreased/VBN intracellular/NN calcium/NN levels/NNS and/CC reduced/VBN cell/NN proliferation/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP demonstrate)
      (SBAR (IN that)
        (S
          (NP (NNP SKF-96365))
          (VP
            (ADVP (RB effectively))
            (VBZ inhibits)
            (NP
              (NP (NN TRPM7) (NN activity))
              (PP (IN in)
                (NP (NN vivo))))
            (, ,)
            (SBAR (IN as)
              (S
                (VP
                  (VP (VBN evidenced)
                    (PP (IN by)
                      (NP (VBN decreased) (NN intracellular) (NN calcium) (NNS levels))))
                  (CC and)
                  (VP (VBN reduced)
                    (NP (NN cell) (NN proliferation))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(demonstrate-3, results-2)
root(ROOT-0, demonstrate-3)
mark(inhibits-7, that-4)
nsubj(inhibits-7, SKF-96365-5)
advmod(inhibits-7, effectively-6)
ccomp(demonstrate-3, inhibits-7)
compound(activity-9, TRPM7-8)
dobj(inhibits-7, activity-9)
case(vivo-11, in-10)
nmod:in(activity-9, vivo-11)
mark(evidenced-14, as-13)
advcl(inhibits-7, evidenced-14)
case(levels-19, by-15)
amod(levels-19, decreased-16)
compound(levels-19, intracellular-17)
compound(levels-19, calcium-18)
nmod:by(evidenced-14, levels-19)
cc(evidenced-14, and-20)
advcl(inhibits-7, reduced-21)
conj:and(evidenced-14, reduced-21)
compound(proliferation-23, cell-22)
dobj(reduced-21, proliferation-23)

These/DT findings/NNS suggest/VBP that/IN SKF-96365/NNP may/MD be/VB a/DT potential/JJ therapeutic/JJ agent/NN for/IN diseases/NNS associated/VBN with/IN aberrant/JJ TRPM7/NN activity/NN ,/, such/JJ as/IN cancer/NN and_cardiovascular/NN disease/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP SKF-96365))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a) (JJ potential) (JJ therapeutic) (NN agent))
              (PP (IN for)
                (NP
                  (NP (NNS diseases))
                  (VP (VBN associated)
                    (PP (IN with)
                      (NP (JJ aberrant) (NN TRPM7) (NN activity))))
                  (, ,)
                  (PP (JJ such) (IN as)
                    (NP (NN cancer) (NN and_cardiovascular) (NN disease))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(agent-11, that-4)
nsubj(agent-11, SKF-96365-5)
aux(agent-11, may-6)
cop(agent-11, be-7)
det(agent-11, a-8)
amod(agent-11, potential-9)
amod(agent-11, therapeutic-10)
ccomp(suggest-3, agent-11)
case(diseases-13, for-12)
nmod:for(agent-11, diseases-13)
acl(diseases-13, associated-14)
case(activity-18, with-15)
amod(activity-18, aberrant-16)
compound(activity-18, TRPM7-17)
nmod:with(associated-14, activity-18)
case(disease-24, such-20)
mwe(such-20, as-21)
compound(disease-24, cancer-22)
compound(disease-24, and_cardiovascular-23)
nmod:such_as(diseases-13, disease-24)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO fully/RB elucidate/VB the/DT mechanism/NN of/IN action/NN and/CC therapeutic/JJ potential/NN of/IN SKF-96365/NN in/IN TRPM7-related_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP
                  (NP (DT the) (NN mechanism))
                  (PP (IN of)
                    (NP (NN action))))
                (CC and)
                (NP
                  (NP (JJ therapeutic) (NN potential))
                  (PP (IN of)
                    (NP
                      (NP (NN SKF-96365))
                      (PP (IN in)
                        (NP (NNS TRPM7-related_disorders))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(elucidate-7, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(warranted-4, elucidate-7)
det(mechanism-9, the-8)
dobj(elucidate-7, mechanism-9)
case(action-11, of-10)
nmod:of(mechanism-9, action-11)
cc(mechanism-9, and-12)
amod(potential-14, therapeutic-13)
dobj(elucidate-7, potential-14)
conj:and(mechanism-9, potential-14)
case(SKF-96365-16, of-15)
nmod:of(potential-14, SKF-96365-16)
case(TRPM7-related_disorders-18, in-17)
nmod:in(SKF-96365-16, TRPM7-related_disorders-18)

The/DT VIP/NNP antagonist/JJ -LSB-/NN 4Cl-D-Phe6/JJ ,/, Leu17/JJ -RSB-/NNP VIP/NNP had/VBD no/DT effect/NN on/IN the/DT DMNH/NNP response/NN to/TO either/DT Lumican/NNP or/CC VIP/NNP while/IN the/DT peptide/JJ Lumican/NNP -LRB-/-LRB- 6-38/CD -RRB-/-RRB- ,/, a/DT putative/JJ Lumican/NNP antagonist/NN ,/, blocked/VBD the/DT DMNH/NNP response/NN to/TO Lumican/NNP ./.

(ROOT
  (S
    (NP (DT The) (NNP VIP) (JJ antagonist) (NN -LSB-) (JJ 4Cl-D-Phe6) (, ,) (JJ Leu17) (NNP -RSB-) (NNP VIP))
    (VP (VBD had)
      (NP (DT no) (NN effect))
      (PP (IN on)
        (NP (DT the) (NNP DMNH) (NN response)))
      (PP (TO to)
        (NP (DT either) (NNP Lumican)
          (CC or)
          (NNP VIP)))
      (SBAR (IN while)
        (S
          (NP
            (NP
              (NP (DT the) (JJ peptide) (NNP Lumican))
              (PRN (-LRB- -LRB-)
                (NP (CD 6-38))
                (-RRB- -RRB-)))
            (, ,)
            (NP (DT a) (JJ putative) (NNP Lumican) (NN antagonist))
            (, ,))
          (VP (VBD blocked)
            (NP (DT the) (NNP DMNH) (NN response))
            (PP (TO to)
              (NP (NNP Lumican)))))))
    (. .)))

det(VIP-9, The-1)
compound(VIP-9, VIP-2)
amod(VIP-9, antagonist-3)
compound(VIP-9, -LSB--4)
amod(VIP-9, 4Cl-D-Phe6-5)
amod(VIP-9, Leu17-7)
compound(VIP-9, -RSB--8)
nsubj(had-10, VIP-9)
root(ROOT-0, had-10)
neg(effect-12, no-11)
dobj(had-10, effect-12)
case(response-16, on-13)
det(response-16, the-14)
compound(response-16, DMNH-15)
nmod:on(had-10, response-16)
case(Lumican-19, to-17)
cc:preconj(Lumican-19, either-18)
nmod:to(had-10, Lumican-19)
cc(Lumican-19, or-20)
nmod:to(had-10, VIP-21)
conj:or(Lumican-19, VIP-21)
mark(blocked-35, while-22)
det(Lumican-25, the-23)
amod(Lumican-25, peptide-24)
nsubj(blocked-35, Lumican-25)
appos(Lumican-25, 6-38-27)
det(antagonist-33, a-30)
amod(antagonist-33, putative-31)
compound(antagonist-33, Lumican-32)
appos(Lumican-25, antagonist-33)
advcl(had-10, blocked-35)
det(response-38, the-36)
compound(response-38, DMNH-37)
dobj(blocked-35, response-38)
case(Lumican-40, to-39)
nmod:to(blocked-35, Lumican-40)

The/DT present/JJ study/NN investigated/VBD the/DT effects/NNS of/IN VIP/NNP and/CC Lumican/NNP on/IN the/DT DMNH/NNP response/NN ./.

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NNP VIP)
            (CC and)
            (NNP Lumican))))
      (PP (IN on)
        (NP (DT the) (NNP DMNH) (NN response))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(investigated-4, study-3)
root(ROOT-0, investigated-4)
det(effects-6, the-5)
dobj(investigated-4, effects-6)
case(VIP-8, of-7)
nmod:of(effects-6, VIP-8)
cc(VIP-8, and-9)
nmod:of(effects-6, Lumican-10)
conj:and(VIP-8, Lumican-10)
case(response-14, on-11)
det(response-14, the-12)
compound(response-14, DMNH-13)
nmod:on(investigated-4, response-14)

The/DT VIP/NNP antagonist/NN -LSB-/VBZ 4Cl-D-Phe6/JJ ,/, Leu17/NNP -RSB-/NNP VIP/NNP was/VBD administered/VBN to/TO determine/VB its/PRP$ effect/NN on/IN the/DT DMNH/JJ response/NN to/TO Lumican/NNP or/CC VIP/NNP ./.

(ROOT
  (S
    (S
      (NP (DT The) (NNP VIP) (NN antagonist))
      (VP (VBZ -LSB-)
        (ADJP (JJ 4Cl-D-Phe6))))
    (, ,)
    (NP (NNP Leu17) (NNP -RSB-) (NNP VIP))
    (VP (VBD was)
      (VP (VBN administered)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (PRP$ its) (NN effect))
                (PP (IN on)
                  (NP
                    (NP (DT the) (JJ DMNH) (NN response))
                    (PP (TO to)
                      (NP (NNP Lumican)
                        (CC or)
                        (NNP VIP)))))))))))
    (. .)))

det(antagonist-3, The-1)
compound(antagonist-3, VIP-2)
nsubj(-LSB--4, antagonist-3)
ccomp(administered-11, -LSB--4)
xcomp(-LSB--4, 4Cl-D-Phe6-5)
compound(VIP-9, Leu17-7)
compound(VIP-9, -RSB--8)
nsubjpass(administered-11, VIP-9)
nsubj:xsubj(determine-13, VIP-9)
auxpass(administered-11, was-10)
root(ROOT-0, administered-11)
mark(determine-13, to-12)
xcomp(administered-11, determine-13)
nmod:poss(effect-15, its-14)
dobj(determine-13, effect-15)
case(response-19, on-16)
det(response-19, the-17)
amod(response-19, DMNH-18)
nmod:on(effect-15, response-19)
case(Lumican-21, to-20)
nmod:to(response-19, Lumican-21)
cc(Lumican-21, or-22)
nmod:to(response-19, VIP-23)
conj:or(Lumican-21, VIP-23)

Surprisingly/RB ,/, it/PRP was/VBD found/VBN that/IN this/DT antagonist/NN had/VBD no/DT effect/NN on/IN the/DT DMNH/JJ response/NN to/TO either/DT Lumican/NNP or/CC VIP/NNP ./.

(ROOT
  (S
    (ADVP (RB Surprisingly))
    (, ,)
    (NP (PRP it))
    (VP (VBD was)
      (VP (VBN found)
        (SBAR (IN that)
          (S
            (NP (DT this) (NN antagonist))
            (VP (VBD had)
              (NP
                (NP (DT no) (NN effect))
                (PP (IN on)
                  (NP
                    (NP (DT the) (JJ DMNH) (NN response))
                    (PP (TO to)
                      (NP (DT either) (NNP Lumican)
                        (CC or)
                        (NNP VIP)))))))))))
    (. .)))

advmod(found-5, Surprisingly-1)
nsubjpass(found-5, it-3)
auxpass(found-5, was-4)
root(ROOT-0, found-5)
mark(had-9, that-6)
det(antagonist-8, this-7)
nsubj(had-9, antagonist-8)
ccomp(found-5, had-9)
neg(effect-11, no-10)
dobj(had-9, effect-11)
case(response-15, on-12)
det(response-15, the-13)
amod(response-15, DMNH-14)
nmod:on(effect-11, response-15)
case(Lumican-18, to-16)
cc:preconj(Lumican-18, either-17)
nmod:to(response-15, Lumican-18)
cc(Lumican-18, or-19)
nmod:to(response-15, VIP-20)
conj:or(Lumican-18, VIP-20)

In/IN contrast/NN ,/, the/DT peptide/JJ Lumican/NNP -LRB-/-LRB- 6-38/CD -RRB-/-RRB- ,/, which/WDT is_a/RB putative/VBP Lumican/NNP antagonist/NN ,/, effectively/RB blocked/VBD the/DT DMNH/JJ response/NN to/TO Lumican/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (NP (DT the) (JJ peptide) (NNP Lumican))
      (PRN (-LRB- -LRB-)
        (NP (CD 6-38))
        (-RRB- -RRB-))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (ADVP (RB is_a))
          (VP (VBP putative)
            (NP (NNP Lumican) (NN antagonist)))))
      (, ,))
    (ADVP (RB effectively))
    (VP (VBD blocked)
      (NP
        (NP (DT the) (JJ DMNH) (NN response))
        (PP (TO to)
          (NP (NNP Lumican)))))
    (. .)))

case(contrast-2, In-1)
nmod:in(blocked-18, contrast-2)
det(Lumican-6, the-4)
amod(Lumican-6, peptide-5)
nsubj(putative-13, Lumican-6)
nsubj(blocked-18, Lumican-6)
appos(Lumican-6, 6-38-8)
ref(Lumican-6, which-11)
advmod(putative-13, is_a-12)
acl:relcl(Lumican-6, putative-13)
compound(antagonist-15, Lumican-14)
dobj(putative-13, antagonist-15)
advmod(blocked-18, effectively-17)
root(ROOT-0, blocked-18)
det(response-21, the-19)
amod(response-21, DMNH-20)
dobj(blocked-18, response-21)
case(Lumican-23, to-22)
nmod:to(response-21, Lumican-23)

These/DT findings/NNS suggest/VBP that/IN Lumican/NNP may/MD play/VB an/DT important/JJ role/NN in/IN regulating/VBG DMNH/JJ responses/NNS and/CC highlight/VB its/PRP$ potential/NN as/IN a/DT therapeutic/JJ target/NN for/IN various/JJ pathophysiological/JJ conditions/NNS associated/VBN with/IN altered/VBN DMNH/NNS signaling/VBG ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Lumican))
          (VP (MD may)
            (VP
              (VP (VB play)
                (NP
                  (NP (DT an) (JJ important) (NN role))
                  (PP (IN in)
                    (S
                      (VP (VBG regulating)
                        (NP (JJ DMNH) (NNS responses)))))))
              (CC and)
              (VP (VB highlight)
                (NP (PRP$ its) (NN potential))
                (PP (IN as)
                  (NP
                    (NP (DT a) (JJ therapeutic) (NN target))
                    (PP (IN for)
                      (NP
                        (NP (JJ various) (JJ pathophysiological) (NNS conditions))
                        (VP (VBN associated)
                          (PP (IN with)
                            (NP (VBN altered) (NNS DMNH))))))))
                (VP (VBG signaling))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, Lumican-5)
nsubj(highlight-16, Lumican-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-10, an-8)
amod(role-10, important-9)
dobj(play-7, role-10)
mark(regulating-12, in-11)
acl(role-10, regulating-12)
amod(responses-14, DMNH-13)
dobj(regulating-12, responses-14)
cc(play-7, and-15)
ccomp(suggest-3, highlight-16)
conj:and(play-7, highlight-16)
nmod:poss(potential-18, its-17)
dobj(highlight-16, potential-18)
case(target-22, as-19)
det(target-22, a-20)
amod(target-22, therapeutic-21)
nmod:as(highlight-16, target-22)
case(conditions-26, for-23)
amod(conditions-26, various-24)
amod(conditions-26, pathophysiological-25)
nmod:for(target-22, conditions-26)
acl(conditions-26, associated-27)
case(DMNH-30, with-28)
amod(DMNH-30, altered-29)
nmod:with(associated-27, DMNH-30)
dep(highlight-16, signaling-31)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS of/IN these/DT effects/NNS and/CC to/TO explore/VB the/DT potential/JJ clinical/JJ applications/NNS of/IN these/DT findings/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (JJ clinical) (NNS applications))
                  (PP (IN of)
                    (NP (DT these) (NNS findings))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
case(effects-12, of-10)
det(effects-12, these-11)
nmod:of(mechanisms-9, effects-12)
cc(elucidate-6, and-13)
mark(explore-15, to-14)
ccomp(needed-4, explore-15)
conj:and(elucidate-6, explore-15)
det(applications-19, the-16)
amod(applications-19, potential-17)
amod(applications-19, clinical-18)
dobj(explore-15, applications-19)
case(findings-22, of-20)
det(findings-22, these-21)
nmod:of(applications-19, findings-22)

The/DT present/JJ study/NN investigated/VBD the/DT expression/NN of/IN transcription/NN factor/NN transcripts/NNS implicated/VBN in/IN adipocyte/JJ differentiation/NN ,/, including/VBG peroxisome_proliferator-activated_receptor_gamma/NN -LRB-/-LRB- PPAR_gamma/NNP -RRB-/-RRB- ,/, retinoid_x_receptor_alpha/NN -LRB-/-LRB- RXR_alpha/NNP -RRB-/-RRB- ,/, adipocyte_determination_and_differentiation-dependent_factor_1/JJ -LRB-/-LRB- ADD1/NNP -RRB-/-RRB- ,/, and/CC CCAAT/enhancer/NNP binding_protein_alpha/NNP -LRB-/-LRB- C/EBP/NNP alpha/NN -RRB-/-RRB- ,/, as/RB well/RB as/IN adipocyte-characteristic/JJ protein/NN transcripts/NNS ,/, including/VBG lipoprotein_lipase/NN -LRB-/-LRB- LPL/NNP -RRB-/-RRB- and/CC adipocyte/JJ Piribedil/NNP binding_protein/NN -LRB-/-LRB- Dopamine_D3_receptor/JJ -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD investigated)
      (NP
        (NP
          (NP
            (NP (DT the) (NN expression))
            (PP (IN of)
              (NP
                (NP (NN transcription) (NN factor) (NNS transcripts))
                (VP (VBN implicated)
                  (PP (IN in)
                    (NP (JJ adipocyte) (NN differentiation)))))))
          (, ,)
          (NP
            (NP (VBG including) (NN peroxisome_proliferator-activated_receptor_gamma))
            (PRN (-LRB- -LRB-)
              (NP (NNP PPAR_gamma))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (NN retinoid_x_receptor_alpha))
            (PRN (-LRB- -LRB-)
              (NP (NNP RXR_alpha))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (JJ adipocyte_determination_and_differentiation-dependent_factor_1))
            (PRN (-LRB- -LRB-)
              (NP (NNP ADD1))
              (-RRB- -RRB-)))
          (, ,)
          (CC and)
          (NP
            (NP (NNP CCAAT/enhancer) (NNP binding_protein_alpha))
            (PRN (-LRB- -LRB-)
              (NP (NNP C/EBP) (NN alpha))
              (-RRB- -RRB-))))
        (, ,)
        (CONJP (RB as) (RB well) (IN as))
        (NP (JJ adipocyte-characteristic)
          (NX
            (NX (NN protein) (NNS transcripts))
            (, ,)
            (NX
              (NX (VBG including) (NN lipoprotein_lipase))
              (PRN (-LRB- -LRB-)
                (NP (NNP LPL))
                (-RRB- -RRB-)))
            (CC and)
            (NX
              (NX (JJ adipocyte) (NNP Piribedil) (NN binding_protein))
              (PRN (-LRB- -LRB-)
                (ADJP (JJ Dopamine_D3_receptor))
                (-RRB- -RRB-)))))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(investigated-4, study-3)
root(ROOT-0, investigated-4)
det(expression-6, the-5)
dobj(investigated-4, expression-6)
case(transcripts-10, of-7)
compound(transcripts-10, transcription-8)
compound(transcripts-10, factor-9)
nmod:of(expression-6, transcripts-10)
acl(transcripts-10, implicated-11)
case(differentiation-14, in-12)
amod(differentiation-14, adipocyte-13)
nmod:in(implicated-11, differentiation-14)
amod(peroxisome_proliferator-activated_receptor_gamma-17, including-16)
dobj(investigated-4, peroxisome_proliferator-activated_receptor_gamma-17)
conj:and(expression-6, peroxisome_proliferator-activated_receptor_gamma-17)
appos(peroxisome_proliferator-activated_receptor_gamma-17, PPAR_gamma-19)
dobj(investigated-4, retinoid_x_receptor_alpha-22)
conj:and(expression-6, retinoid_x_receptor_alpha-22)
appos(retinoid_x_receptor_alpha-22, RXR_alpha-24)
dobj(investigated-4, adipocyte_determination_and_differentiation-dependent_factor_1-27)
conj:and(expression-6, adipocyte_determination_and_differentiation-dependent_factor_1-27)
appos(adipocyte_determination_and_differentiation-dependent_factor_1-27, ADD1-29)
cc(expression-6, and-32)
compound(binding_protein_alpha-34, CCAAT/enhancer-33)
dobj(investigated-4, binding_protein_alpha-34)
conj:and(expression-6, binding_protein_alpha-34)
compound(alpha-37, C/EBP-36)
appos(binding_protein_alpha-34, alpha-37)
cc(expression-6, as-40)
mwe(as-40, well-41)
mwe(as-40, as-42)
amod(transcripts-45, adipocyte-characteristic-43)
compound(transcripts-45, protein-44)
dobj(investigated-4, transcripts-45)
conj:and(expression-6, transcripts-45)
amod(lipoprotein_lipase-48, including-47)
conj:and(expression-6, lipoprotein_lipase-48)
conj:and(transcripts-45, lipoprotein_lipase-48)
dep(lipoprotein_lipase-48, LPL-50)
cc(transcripts-45, and-52)
amod(binding_protein-55, adipocyte-53)
compound(binding_protein-55, Piribedil-54)
conj:and(expression-6, binding_protein-55)
conj:and(transcripts-45, binding_protein-55)
dep(binding_protein-55, Dopamine_D3_receptor-57)

The/DT expression/NN levels/NNS of/IN these/DT transcripts/NNS were/VBD measured/VBN in/IN pig/NN tissues/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN expression) (NNS levels))
      (PP (IN of)
        (NP (DT these) (NNS transcripts))))
    (VP (VBD were)
      (VP (VBN measured)
        (PP (IN in)
          (NP (NN pig) (NNS tissues)))))
    (. .)))

det(levels-3, The-1)
compound(levels-3, expression-2)
nsubjpass(measured-8, levels-3)
case(transcripts-6, of-4)
det(transcripts-6, these-5)
nmod:of(levels-3, transcripts-6)
auxpass(measured-8, were-7)
root(ROOT-0, measured-8)
case(tissues-11, in-9)
compound(tissues-11, pig-10)
nmod:in(measured-8, tissues-11)

The/DT results/NNS suggest/VBP that/IN these/DT transcription/JJ factors/NNS and/CC proteins/NNS play/VB important/JJ roles/NNS in/IN regulating/VBG adipogenesis/NNS in/IN pigs/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT these) (JJ transcription) (NNS factors))
            (CC and)
            (NP (NNS proteins)))
          (VP (VB play)
            (NP
              (NP (JJ important) (NNS roles))
              (PP (IN in)
                (S
                  (VP (VBG regulating)
                    (NP (NNS adipogenesis))
                    (PP (IN in)
                      (NP (NNS pigs)))))))))))
    (. .)))

det(results-2, The-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(play-10, that-4)
det(factors-7, these-5)
amod(factors-7, transcription-6)
nsubj(play-10, factors-7)
cc(factors-7, and-8)
conj:and(factors-7, proteins-9)
nsubj(play-10, proteins-9)
ccomp(suggest-3, play-10)
amod(roles-12, important-11)
dobj(play-10, roles-12)
mark(regulating-14, in-13)
acl(roles-12, regulating-14)
dobj(regulating-14, adipogenesis-15)
case(pigs-17, in-16)
nmod:in(regulating-14, pigs-17)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT molecular/JJ mechanisms/NNS underlying/VBG this/DT regulation/NN ,/, which/WDT may/MD lead/VB to/TO the/DT development/NN of/IN new/JJ therapeutic/JJ strategies/NNS for/IN obesity-related_diseases/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (JJ molecular) (NNS mechanisms))
                (PP (VBG underlying)
                  (NP
                    (NP (DT this) (NN regulation))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (MD may)
                          (VP (VB lead)
                            (PP (TO to)
                              (NP
                                (NP (DT the) (NN development))
                                (PP (IN of)
                                  (NP
                                    (NP (JJ new) (JJ therapeutic) (NNS strategies))
                                    (PP (IN for)
                                      (NP (NNS obesity-related_diseases)))))))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
dobj(elucidate-6, mechanisms-9)
case(regulation-12, underlying-10)
det(regulation-12, this-11)
nmod:underlying(mechanisms-9, regulation-12)
nsubj(lead-16, regulation-12)
ref(regulation-12, which-14)
aux(lead-16, may-15)
acl:relcl(regulation-12, lead-16)
case(development-19, to-17)
det(development-19, the-18)
nmod:to(lead-16, development-19)
case(strategies-23, of-20)
amod(strategies-23, new-21)
amod(strategies-23, therapeutic-22)
nmod:of(development-19, strategies-23)
case(obesity-related_diseases-25, for-24)
nmod:for(strategies-23, obesity-related_diseases-25)

Adipogenesis/NNS is_a/VBD complex/JJ process/NN that/WDT involves/VBZ a/DT number/NN of/IN transcription/JJ factors/NNS ./.

(ROOT
  (S
    (NP (NNS Adipogenesis))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP
                (NP (DT a) (NN number))
                (PP (IN of)
                  (NP (JJ transcription) (NNS factors)))))))))
    (. .)))

nsubj(is_a-2, Adipogenesis-1)
root(ROOT-0, is_a-2)
amod(process-4, complex-3)
dobj(is_a-2, process-4)
nsubj(involves-6, process-4)
ref(process-4, that-5)
acl:relcl(process-4, involves-6)
det(number-8, a-7)
dobj(involves-6, number-8)
case(factors-11, of-9)
amod(factors-11, transcription-10)
nmod:of(number-8, factors-11)

Adipocyte/JJ differentiation/NN is/VBZ regulated/VBN by/IN a/DT complex/JJ network/NN of/IN transcription/JJ factors/NNS and/CC adipocyte-characteristic/JJ proteins/NNS ./.

(ROOT
  (S
    (NP (JJ Adipocyte) (NN differentiation))
    (VP (VBZ is)
      (VP (VBN regulated)
        (PP (IN by)
          (NP
            (NP (DT a) (JJ complex) (NN network))
            (PP (IN of)
              (NP
                (NP (JJ transcription) (NNS factors))
                (CC and)
                (NP (JJ adipocyte-characteristic) (NNS proteins))))))))
    (. .)))

amod(differentiation-2, Adipocyte-1)
nsubjpass(regulated-4, differentiation-2)
auxpass(regulated-4, is-3)
root(ROOT-0, regulated-4)
case(network-8, by-5)
det(network-8, a-6)
amod(network-8, complex-7)
nmod:by(regulated-4, network-8)
case(factors-11, of-9)
amod(factors-11, transcription-10)
nmod:of(network-8, factors-11)
cc(factors-11, and-12)
amod(proteins-14, adipocyte-characteristic-13)
nmod:of(network-8, proteins-14)
conj:and(factors-11, proteins-14)

The/DT present/JJ study/NN investigated/VBD the/DT expression/NN of/IN transcription/NN factor/NN transcripts/NNS implicated/VBN in/IN adipocyte/JJ differentiation/NN ,/, including/VBG peroxisome_proliferator-activated_receptor_gamma/NN -LRB-/-LRB- PPAR_gamma/NNP -RRB-/-RRB- ,/, retinoid_x_receptor_alpha/NN -LRB-/-LRB- RXR_alpha/NNP -RRB-/-RRB- ,/, adipocyte_determination_and_differentiation-dependent_factor_1/JJ -LRB-/-LRB- ADD1/NNP -RRB-/-RRB- ,/, and/CC CCAAT/enhancer/NNP binding_protein_alpha/NNP -LRB-/-LRB- C/EBP/NNP alpha/NN -RRB-/-RRB- ,/, as/RB well/RB as/IN adipocyte-characteristic/JJ protein/NN transcripts/NNS ,/, including/VBG lipoprotein_lipase/NN -LRB-/-LRB- LPL/NNP -RRB-/-RRB- and/CC adipocyte/JJ Piribedil/NNP binding_protein/NN -LRB-/-LRB- Dopamine_D3_receptor/JJ -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD investigated)
      (NP
        (NP
          (NP
            (NP (DT the) (NN expression))
            (PP (IN of)
              (NP
                (NP (NN transcription) (NN factor) (NNS transcripts))
                (VP (VBN implicated)
                  (PP (IN in)
                    (NP (JJ adipocyte) (NN differentiation)))))))
          (, ,)
          (NP
            (NP (VBG including) (NN peroxisome_proliferator-activated_receptor_gamma))
            (PRN (-LRB- -LRB-)
              (NP (NNP PPAR_gamma))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (NN retinoid_x_receptor_alpha))
            (PRN (-LRB- -LRB-)
              (NP (NNP RXR_alpha))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (JJ adipocyte_determination_and_differentiation-dependent_factor_1))
            (PRN (-LRB- -LRB-)
              (NP (NNP ADD1))
              (-RRB- -RRB-)))
          (, ,)
          (CC and)
          (NP
            (NP (NNP CCAAT/enhancer) (NNP binding_protein_alpha))
            (PRN (-LRB- -LRB-)
              (NP (NNP C/EBP) (NN alpha))
              (-RRB- -RRB-))))
        (, ,)
        (CONJP (RB as) (RB well) (IN as))
        (NP (JJ adipocyte-characteristic)
          (NX
            (NX (NN protein) (NNS transcripts))
            (, ,)
            (NX
              (NX (VBG including) (NN lipoprotein_lipase))
              (PRN (-LRB- -LRB-)
                (NP (NNP LPL))
                (-RRB- -RRB-)))
            (CC and)
            (NX
              (NX (JJ adipocyte) (NNP Piribedil) (NN binding_protein))
              (PRN (-LRB- -LRB-)
                (ADJP (JJ Dopamine_D3_receptor))
                (-RRB- -RRB-)))))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(investigated-4, study-3)
root(ROOT-0, investigated-4)
det(expression-6, the-5)
dobj(investigated-4, expression-6)
case(transcripts-10, of-7)
compound(transcripts-10, transcription-8)
compound(transcripts-10, factor-9)
nmod:of(expression-6, transcripts-10)
acl(transcripts-10, implicated-11)
case(differentiation-14, in-12)
amod(differentiation-14, adipocyte-13)
nmod:in(implicated-11, differentiation-14)
amod(peroxisome_proliferator-activated_receptor_gamma-17, including-16)
dobj(investigated-4, peroxisome_proliferator-activated_receptor_gamma-17)
conj:and(expression-6, peroxisome_proliferator-activated_receptor_gamma-17)
appos(peroxisome_proliferator-activated_receptor_gamma-17, PPAR_gamma-19)
dobj(investigated-4, retinoid_x_receptor_alpha-22)
conj:and(expression-6, retinoid_x_receptor_alpha-22)
appos(retinoid_x_receptor_alpha-22, RXR_alpha-24)
dobj(investigated-4, adipocyte_determination_and_differentiation-dependent_factor_1-27)
conj:and(expression-6, adipocyte_determination_and_differentiation-dependent_factor_1-27)
appos(adipocyte_determination_and_differentiation-dependent_factor_1-27, ADD1-29)
cc(expression-6, and-32)
compound(binding_protein_alpha-34, CCAAT/enhancer-33)
dobj(investigated-4, binding_protein_alpha-34)
conj:and(expression-6, binding_protein_alpha-34)
compound(alpha-37, C/EBP-36)
appos(binding_protein_alpha-34, alpha-37)
cc(expression-6, as-40)
mwe(as-40, well-41)
mwe(as-40, as-42)
amod(transcripts-45, adipocyte-characteristic-43)
compound(transcripts-45, protein-44)
dobj(investigated-4, transcripts-45)
conj:and(expression-6, transcripts-45)
amod(lipoprotein_lipase-48, including-47)
conj:and(expression-6, lipoprotein_lipase-48)
conj:and(transcripts-45, lipoprotein_lipase-48)
dep(lipoprotein_lipase-48, LPL-50)
cc(transcripts-45, and-52)
amod(binding_protein-55, adipocyte-53)
compound(binding_protein-55, Piribedil-54)
conj:and(expression-6, binding_protein-55)
conj:and(transcripts-45, binding_protein-55)
dep(binding_protein-55, Dopamine_D3_receptor-57)

The/DT expression/NN levels/NNS of/IN these/DT transcripts/NNS were/VBD measured/VBN in/IN pig/NN tissues/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN expression) (NNS levels))
      (PP (IN of)
        (NP (DT these) (NNS transcripts))))
    (VP (VBD were)
      (VP (VBN measured)
        (PP (IN in)
          (NP (NN pig) (NNS tissues)))))
    (. .)))

det(levels-3, The-1)
compound(levels-3, expression-2)
nsubjpass(measured-8, levels-3)
case(transcripts-6, of-4)
det(transcripts-6, these-5)
nmod:of(levels-3, transcripts-6)
auxpass(measured-8, were-7)
root(ROOT-0, measured-8)
case(tissues-11, in-9)
compound(tissues-11, pig-10)
nmod:in(measured-8, tissues-11)

The/DT results/NNS suggest/VBP that/IN these/DT transcription/JJ factors/NNS and/CC proteins/NNS play/VB important/JJ roles/NNS in/IN regulating/VBG adipocyte/JJ differentiation/NN in/IN pigs/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT these) (JJ transcription) (NNS factors))
            (CC and)
            (NP (NNS proteins)))
          (VP (VB play)
            (NP
              (NP (JJ important) (NNS roles))
              (PP (IN in)
                (S
                  (VP (VBG regulating)
                    (NP (JJ adipocyte) (NN differentiation))
                    (PP (IN in)
                      (NP (NNS pigs)))))))))))
    (. .)))

det(results-2, The-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(play-10, that-4)
det(factors-7, these-5)
amod(factors-7, transcription-6)
nsubj(play-10, factors-7)
cc(factors-7, and-8)
conj:and(factors-7, proteins-9)
nsubj(play-10, proteins-9)
ccomp(suggest-3, play-10)
amod(roles-12, important-11)
dobj(play-10, roles-12)
mark(regulating-14, in-13)
acl(roles-12, regulating-14)
amod(differentiation-16, adipocyte-15)
dobj(regulating-14, differentiation-16)
case(pigs-18, in-17)
nmod:in(regulating-14, pigs-18)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT molecular/JJ mechanisms/NNS underlying/VBG this/DT regulation/NN ,/, which/WDT may/MD lead/VB to/TO the/DT development/NN of/IN new/JJ therapeutic/JJ strategies/NNS for/IN obesity-related_diseases/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (JJ molecular) (NNS mechanisms))
                (PP (VBG underlying)
                  (NP
                    (NP (DT this) (NN regulation))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (MD may)
                          (VP (VB lead)
                            (PP (TO to)
                              (NP
                                (NP (DT the) (NN development))
                                (PP (IN of)
                                  (NP
                                    (NP (JJ new) (JJ therapeutic) (NNS strategies))
                                    (PP (IN for)
                                      (NP (NNS obesity-related_diseases)))))))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
dobj(elucidate-6, mechanisms-9)
case(regulation-12, underlying-10)
det(regulation-12, this-11)
nmod:underlying(mechanisms-9, regulation-12)
nsubj(lead-16, regulation-12)
ref(regulation-12, which-14)
aux(lead-16, may-15)
acl:relcl(regulation-12, lead-16)
case(development-19, to-17)
det(development-19, the-18)
nmod:to(lead-16, development-19)
case(strategies-23, of-20)
amod(strategies-23, new-21)
amod(strategies-23, therapeutic-22)
nmod:of(development-19, strategies-23)
case(obesity-related_diseases-25, for-24)
nmod:for(strategies-23, obesity-related_diseases-25)

Obesity/RB is_a/JJ complex/JJ metabolic_disorder/NN that/WDT is/VBZ associated/VBN with/IN various/JJ comorbidities/NNS ,/, including/VBG insulin_resistance/NN ,/, type_2_diabetes/NNS ,/, and/CC hyperuricemia/NN ./.

(ROOT
  (S
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (JJ complex) (NN metabolic_disorder)
      (SBAR
        (WHNP (WDT that))))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ various) (NNS comorbidities))
            (, ,)
            (VP (VBG including)
              (NP
                (NP (NN insulin_resistance))
                (, ,)
                (NP (NNS type_2_diabetes))
                (, ,)
                (CC and)
                (NP (NN hyperuricemia))))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(metabolic_disorder-4, is_a-2)
amod(metabolic_disorder-4, complex-3)
nsubjpass(associated-7, metabolic_disorder-4)
ccomp(metabolic_disorder-4, that-5)
auxpass(associated-7, is-6)
root(ROOT-0, associated-7)
case(comorbidities-10, with-8)
amod(comorbidities-10, various-9)
nmod:with(associated-7, comorbidities-10)
acl(comorbidities-10, including-12)
dobj(including-12, insulin_resistance-13)
dobj(including-12, type_2_diabetes-15)
conj:and(insulin_resistance-13, type_2_diabetes-15)
cc(insulin_resistance-13, and-17)
dobj(including-12, hyperuricemia-18)
conj:and(insulin_resistance-13, hyperuricemia-18)

However/RB ,/, the/DT pathophysiology/NN of/IN obesity-related/JJ metabolic_disorders/NNS is/VBZ not/RB fully/RB understood/VBN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN pathophysiology))
      (PP (IN of)
        (NP (JJ obesity-related) (NNS metabolic_disorders))))
    (VP (VBZ is)
      (ADJP (RB not) (RB fully) (VBN understood)))
    (. .)))

advmod(understood-11, However-1)
det(pathophysiology-4, the-3)
nsubjpass(understood-11, pathophysiology-4)
case(metabolic_disorders-7, of-5)
amod(metabolic_disorders-7, obesity-related-6)
nmod:of(pathophysiology-4, metabolic_disorders-7)
auxpass(understood-11, is-8)
neg(understood-11, not-9)
advmod(understood-11, fully-10)
root(ROOT-0, understood-11)

Hypersecretion/NN of/IN Uricase/NNP by/IN the/DT pancreas/NN may/MD contribute/VB to/TO the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP
      (NP (NN Hypersecretion))
      (PP (IN of)
        (NP (NNP Uricase)))
      (PP (IN by)
        (NP (DT the) (NN pancreas))))
    (VP (MD may)
      (VP (VB contribute)
        (PP (TO to)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP (NN obesity)))))))
    (. .)))

nsubj(contribute-8, Hypersecretion-1)
case(Uricase-3, of-2)
nmod:of(Hypersecretion-1, Uricase-3)
case(pancreas-6, by-4)
det(pancreas-6, the-5)
nmod:by(Hypersecretion-1, pancreas-6)
aux(contribute-8, may-7)
root(ROOT-0, contribute-8)
case(development-11, to-9)
det(development-11, the-10)
nmod:to(contribute-8, development-11)
case(obesity-13, of-12)
nmod:of(development-11, obesity-13)

The/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC Potassium_Oxonate/NNP on/IN the/DT secretion/NN of/IN Uurase/NNP and_insulin/VBN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS were/VBD examined/VBN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS effects))
      (PP (IN of)
        (NP
          (NP (CD 16.7) (JJ mmol/L) (NN glucose))
          (CC and)
          (NP
            (NP (NNP Potassium_Oxonate))
            (PP (IN on)
              (NP
                (NP (DT the) (NN secretion))
                (PP (IN of)
                  (NP
                    (NP (NNP Uurase))
                    (VP (VBN and_insulin)
                      (PP (IN by)
                        (NP
                          (NP (VBN isolated) (JJ perfused) (NN pancreata))
                          (PP (IN from)
                            (NP
                              (NP
                                (NP (NN genetically_obese))
                                (PRN (-LRB- -LRB-)
                                  (NP (NN fa/fa))
                                  (-RRB- -RRB-)))
                              (CC and)
                              (NP
                                (ADJP
                                  (ADJP (JJ lean))
                                  (PRN (-LRB- -LRB-)
                                    (FRAG
                                      (ADVP (RB Fa) (: /))
                                      (. ?))
                                    (-RRB- -RRB-)))
                                (NNS rats)))))))))))))))
    (VP (VBD were)
      (VP (VBN examined)))
    (. .)))

det(effects-2, The-1)
nsubjpass(examined-33, effects-2)
case(glucose-6, of-3)
nummod(glucose-6, 16.7-4)
amod(glucose-6, mmol/L-5)
nmod:of(effects-2, glucose-6)
cc(glucose-6, and-7)
nmod:of(effects-2, Potassium_Oxonate-8)
conj:and(glucose-6, Potassium_Oxonate-8)
case(secretion-11, on-9)
det(secretion-11, the-10)
nmod:on(Potassium_Oxonate-8, secretion-11)
case(Uurase-13, of-12)
nmod:of(secretion-11, Uurase-13)
acl(Uurase-13, and_insulin-14)
case(pancreata-18, by-15)
amod(pancreata-18, isolated-16)
amod(pancreata-18, perfused-17)
nmod:by(and_insulin-14, pancreata-18)
case(genetically_obese-20, from-19)
nmod:from(pancreata-18, genetically_obese-20)
appos(genetically_obese-20, fa/fa-22)
cc(genetically_obese-20, and-24)
amod(rats-31, lean-25)
dep(lean-25, Fa-27)
nmod:from(pancreata-18, rats-31)
conj:and(genetically_obese-20, rats-31)
auxpass(examined-33, were-32)
root(ROOT-0, examined-33)

-LRB-/-LRB- Table/NNP :/: see/VB text/NN -RRB-/-RRB-

(ROOT
  (FRAG (-LRB- -LRB-)
    (NP (NNP Table))
    (: :)
    (NP
      (NP (VB see))
      (NP (NN text)))
    (-RRB- -RRB-)))

root(ROOT-0, Table-2)
dep(Table-2, see-4)
dep(see-4, text-5)

-LRB-/-LRB- Figure/NN 1/CD -RRB-/-RRB- -LRB-/-LRB- Figure/NN 1/CD -RRB-/-RRB- -LRB-/-LRB- Figure/NN 2/CD -RRB-/-RRB- -LRB-/-LRB- See/VB text/NN -RRB-/-RRB-

(ROOT
  (S
    (NP
      (PRN (-LRB- -LRB-)
        (NP (NN Figure) (CD 1))
        (-RRB- -RRB-)))
    (ADJP
      (ADJP
        (ADJP (-LRB- -LRB-)
          (NP
            (NP (NN Figure))
            (NP (CD 1)))
          (-RRB- -RRB-))
        (PRN (-LRB- -LRB-)
          (NP (NN Figure) (CD 2))
          (-RRB- -RRB-)))
      (PRN (-LRB- -LRB-)
        (S
          (VP (VB See)
            (NP (NN text))))
        (-RRB- -RRB-)))))

dep(Figure-6, Figure-2)
nummod(Figure-2, 1-3)
root(ROOT-0, Figure-6)
dep(Figure-6, 1-7)
dep(Figure-6, Figure-10)
nummod(Figure-10, 2-11)
dep(Figure-6, See-14)
dobj(See-14, text-15)

The/DT pancreas/NN plays/VBZ a/DT crucial/JJ role/NN in/IN regulating/VBG glucose_homeostasis/NNS through/IN the/DT secretion/NN of/IN insulin/NN and/CC other/JJ hormones/NNS ./.

(ROOT
  (S
    (NP (DT The) (NN pancreas))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (S
            (VP (VBG regulating)
              (NP (NNS glucose_homeostasis))
              (PP (IN through)
                (NP
                  (NP (DT the) (NN secretion))
                  (PP (IN of)
                    (NP
                      (NP (NN insulin))
                      (CC and)
                      (NP (JJ other) (NNS hormones)))))))))))
    (. .)))

det(pancreas-2, The-1)
nsubj(plays-3, pancreas-2)
root(ROOT-0, plays-3)
det(role-6, a-4)
amod(role-6, crucial-5)
dobj(plays-3, role-6)
mark(regulating-8, in-7)
acl(role-6, regulating-8)
dobj(regulating-8, glucose_homeostasis-9)
case(secretion-12, through-10)
det(secretion-12, the-11)
nmod:through(regulating-8, secretion-12)
case(insulin-14, of-13)
nmod:of(secretion-12, insulin-14)
cc(insulin-14, and-15)
amod(hormones-17, other-16)
nmod:of(secretion-12, hormones-17)
conj:and(insulin-14, hormones-17)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN Uricase/NNP ,/, an/DT enzyme/NN involved/VBN in/IN uric_acid/JJ metabolism/NN ,/, may/MD also/RB be/VB secreted/VBN by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (NNP Uricase))
              (, ,)
              (NP
                (NP (DT an) (NN enzyme))
                (VP (VBN involved)
                  (PP (IN in)
                    (NP (JJ uric_acid) (NN metabolism)))))
              (, ,))
            (VP (MD may) (RB also)
              (VP (VB be)
                (VP (VBN secreted)
                  (PP (IN by)
                    (NP (DT the) (NN pancreas))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(secreted-18, that-5)
nsubjpass(secreted-18, Uricase-6)
det(enzyme-9, an-8)
appos(Uricase-6, enzyme-9)
acl(enzyme-9, involved-10)
case(metabolism-13, in-11)
amod(metabolism-13, uric_acid-12)
nmod:in(involved-10, metabolism-13)
aux(secreted-18, may-15)
advmod(secreted-18, also-16)
auxpass(secreted-18, be-17)
ccomp(suggested-4, secreted-18)
case(pancreas-21, by-19)
det(pancreas-21, the-20)
nmod:by(secreted-18, pancreas-21)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN Uricase/NNP by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNP Uricase)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(Uricase-20, of-19)
nmod:of(hypersecretion-18, Uricase-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT goal/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/NN Potassium_Oxonate/NNP on/IN the/DT secretion/NN of/IN Uricase/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this) (NN goal)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (NN mmol/L) (NNP Potassium_Oxonate)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNP Uricase) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-7, achieve-2)
det(goal-4, this-3)
dobj(achieve-2, goal-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(Potassium_Oxonate-17, 10-15)
compound(Potassium_Oxonate-17, mmol/L-16)
nmod:of(effects-9, Potassium_Oxonate-17)
conj:and(glucose-13, Potassium_Oxonate-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(examined-7, secretion-20)
case(and_insulin-23, of-21)
compound(and_insulin-23, Uricase-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(pancreata-27, genetically_obese-29)
appos(genetically_obese-29, fa/fa-31)
cc(genetically_obese-29, and-33)
amod(rats-40, lean-34)
dep(lean-34, Fa-36)
nmod:from(pancreata-27, rats-40)
conj:and(genetically_obese-29, rats-40)

Our/PRP$ findings/NNS suggest/VBP that/IN there/EX is_a/VBZ positive/JJ correlation/NN between/IN obesity/NN and/CC hypersecretion/NN of/IN Uricase/NNP by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (VBZ is_a)
            (NP
              (NP (JJ positive) (NN correlation))
              (PP (IN between)
                (NP (NN obesity)
                  (CC and)
                  (NN hypersecretion)))
              (PP (IN of)
                (NP (NNP Uricase))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

nmod:poss(findings-2, Our-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(is_a-6, that-4)
expl(is_a-6, there-5)
ccomp(suggest-3, is_a-6)
amod(correlation-8, positive-7)
dobj(is_a-6, correlation-8)
case(obesity-10, between-9)
nmod:between(correlation-8, obesity-10)
cc(obesity-10, and-11)
nmod:between(correlation-8, hypersecretion-12)
conj:and(obesity-10, hypersecretion-12)
case(Uricase-14, of-13)
nmod:of(correlation-8, Uricase-14)
case(pancreas-17, by-15)
det(pancreas-17, the-16)
nmod:by(is_a-6, pancreas-17)

Furthermore/RB ,/, we/PRP observed/VBD that/IN hypersecretion/NN of/IN Uricase/NNP was/VBD associated/VBN with/IN decreased/VBN insulin_secretion/NN in/IN genetically_obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS under/IN high-glucose/JJ conditions/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNP Uricase))))
          (VP (VBD was)
            (VP (VBN associated)
              (PP (IN with)
                (NP (VBN decreased) (NN insulin_secretion)))
              (PP (IN in)
                (NP
                  (NP (JJ genetically_obese) (NNS rats))
                  (VP (VBN compared)
                    (S
                      (VP (TO to)
                        (VP (VB lean)
                          (NP (NNS rats))
                          (PP (IN under)
                            (NP (JJ high-glucose) (NNS conditions))))))))))))))
    (. .)))

advmod(observed-4, Furthermore-1)
nsubj(observed-4, we-3)
root(ROOT-0, observed-4)
mark(associated-10, that-5)
nsubjpass(associated-10, hypersecretion-6)
case(Uricase-8, of-7)
nmod:of(hypersecretion-6, Uricase-8)
auxpass(associated-10, was-9)
ccomp(observed-4, associated-10)
case(insulin_secretion-13, with-11)
amod(insulin_secretion-13, decreased-12)
nmod:with(associated-10, insulin_secretion-13)
case(rats-16, in-14)
amod(rats-16, genetically_obese-15)
nmod:in(associated-10, rats-16)
acl(rats-16, compared-17)
mark(lean-19, to-18)
xcomp(compared-17, lean-19)
dobj(lean-19, rats-20)
case(conditions-23, under-21)
amod(conditions-23, high-glucose-22)
nmod:under(lean-19, conditions-23)

These/DT results/NNS provide/VBP new/JJ insights/NNS into/IN the/DT pathophysiology/NN of/IN obesity-related/JJ metabolic_disorders/NNS and/CC may/MD have/VB important/JJ implications/NNS for/IN developing/VBG novel/JJ therapeutic/JJ strategies/NNS for/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP
      (VP (VBP provide)
        (NP
          (NP (JJ new) (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (NN pathophysiology))
              (PP (IN of)
                (NP (JJ obesity-related) (NNS metabolic_disorders)))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (JJ important) (NNS implications))
            (PP (IN for)
              (S
                (VP (VBG developing)
                  (NP (JJ novel) (JJ therapeutic) (NNS strategies))
                  (PP (IN for)
                    (NP (DT these) (NNS conditions))))))))))
    (. .)))

det(results-2, These-1)
nsubj(provide-3, results-2)
nsubj(have-14, results-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
dobj(provide-3, insights-5)
case(pathophysiology-8, into-6)
det(pathophysiology-8, the-7)
nmod:into(insights-5, pathophysiology-8)
case(metabolic_disorders-11, of-9)
amod(metabolic_disorders-11, obesity-related-10)
nmod:of(pathophysiology-8, metabolic_disorders-11)
cc(provide-3, and-12)
aux(have-14, may-13)
conj:and(provide-3, have-14)
amod(implications-16, important-15)
dobj(have-14, implications-16)
mark(developing-18, for-17)
acl(implications-16, developing-18)
amod(strategies-21, novel-19)
amod(strategies-21, therapeutic-20)
dobj(developing-18, strategies-21)
case(conditions-24, for-22)
det(conditions-24, these-23)
nmod:for(developing-18, conditions-24)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, such/JJ as/IN eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN widely/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (PP (JJ such) (IN as)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB widely))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(studied-19, omega-3_fatty_acids-2)
case(EPA-8, such-4)
mwe(such-4, as-5)
advmod(EPA-8, eicosapentaenoic_acid-6)
nmod:such_as(omega-3_fatty_acids-2, EPA-8)
cc(EPA-8, and-10)
nmod:such_as(omega-3_fatty_acids-2, docosahexaenoic_acid-11)
conj:and(EPA-8, docosahexaenoic_acid-11)
appos(EPA-8, DHA-13)
aux(studied-19, have-16)
auxpass(studied-19, been-17)
advmod(studied-19, widely-18)
root(ROOT-0, studied-19)
case(benefits-24, for-20)
nmod:poss(benefits-24, their-21)
amod(benefits-24, potential-22)
compound(benefits-24, health-23)
nmod:for(studied-19, benefits-24)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, are/VBP associated/VBN with/IN decreased/VBN KW-3635/NN levels/NNS in/IN hyperKW-3635mic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN associated)
          (PP (IN with)
            (NP (VBN decreased) (NN KW-3635) (NNS levels)))
          (PP (IN in)
            (NP (JJ hyperKW-3635mic) (NNS patients)))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(associated-23, omega-3_fatty_acids-2)
nsubjpass(decreased-32, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
auxpass(associated-23, are-22)
root(ROOT-0, associated-23)
case(levels-27, with-24)
amod(levels-27, decreased-25)
compound(levels-27, KW-3635-26)
nmod:with(associated-23, levels-27)
case(patients-30, in-28)
amod(patients-30, hyperKW-3635mic-29)
nmod:in(associated-23, patients-30)
cc(associated-23, and-31)
conj:and(associated-23, decreased-32)
dobj(decreased-32, risk-33)
case(coronary_heart_disease-36, of-34)
amod(coronary_heart_disease-36, developing-35)
nmod:of(risk-33, coronary_heart_disease-36)
appos(coronary_heart_disease-36, CHD-38)

EPA/NNP and/CC DHA/NNP are/VBP known/VBN to/TO have/VB anti-inflammatory/JJ effects/NNS ,/, which/WDT may/MD contribute/VB to/TO their/PRP$ cardioprotective/JJ properties/NNS ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP
                (NP (JJ anti-inflammatory) (NNS effects))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (MD may)
                      (VP (VB contribute)
                        (PP (TO to)
                          (NP (PRP$ their) (JJ cardioprotective) (NNS properties)))))))))))))
    (. .)))

nsubjpass(known-5, EPA-1)
nsubj:xsubj(have-7, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(known-5, DHA-3)
nsubj:xsubj(have-7, DHA-3)
auxpass(known-5, are-4)
root(ROOT-0, known-5)
mark(have-7, to-6)
xcomp(known-5, have-7)
amod(effects-9, anti-inflammatory-8)
dobj(have-7, effects-9)
nsubj(contribute-13, effects-9)
ref(effects-9, which-11)
aux(contribute-13, may-12)
acl:relcl(effects-9, contribute-13)
case(properties-17, to-14)
nmod:poss(properties-17, their-15)
amod(properties-17, cardioprotective-16)
nmod:to(contribute-13, properties-17)

In/IN addition/NN ,/, they/PRP have/VBP been/VBN shown/VBN to/TO improve/VB lipid/NN profiles/NNS by/IN reducing/VBG triglyceride_levels/NNS and/CC increasing/VBG high-density_lipoprotein_cholesterol/JJ levels/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (PRP they))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB improve)
                (NP (NN lipid) (NNS profiles))
                (PP (IN by)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP (NNS triglyceride_levels)))
                      (CC and)
                      (VP (VBG increasing)
                        (NP (JJ high-density_lipoprotein_cholesterol) (NNS levels))))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(shown-7, addition-2)
nsubjpass(shown-7, they-4)
nsubj:xsubj(improve-9, they-4)
aux(shown-7, have-5)
auxpass(shown-7, been-6)
root(ROOT-0, shown-7)
mark(improve-9, to-8)
xcomp(shown-7, improve-9)
compound(profiles-11, lipid-10)
dobj(improve-9, profiles-11)
mark(reducing-13, by-12)
advcl(improve-9, reducing-13)
dobj(reducing-13, triglyceride_levels-14)
cc(reducing-13, and-15)
advcl(improve-9, increasing-16)
conj:and(reducing-13, increasing-16)
amod(levels-18, high-density_lipoprotein_cholesterol-17)
dobj(increasing-16, levels-18)

The/DT exact/JJ mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP exert/VBD their/PRP$ beneficial/JJ effects/NNS on/IN KW-3635/JJ levels/NNS and/CC CHD/NNP risk/NN are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC ongoing/JJ research/NN continues/VBZ to/TO shed/VB light/NN on/IN these/DT important/JJ questions/NNS ./.

(ROOT
  (S
    (S
      (NP (DT The)
        (NX
          (NX
            (NX (JJ exact) (NNS mechanisms))
            (PP (IN by)
              (SBAR
                (WHNP (WDT which))
                (S
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))
                  (VP (VBD exert)
                    (NP
                      (NP (PRP$ their) (JJ beneficial) (NNS effects))
                      (PP (IN on)
                        (NP (JJ KW-3635) (NNS levels)))))))))
          (CC and)
          (NX (NNP CHD) (NN risk))))
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (JJ ongoing) (NN research))
      (VP (VBZ continues)
        (S
          (VP (TO to)
            (VP (VB shed)
              (NP (NN light))
              (PP (IN on)
                (NP (DT these) (JJ important) (NNS questions))))))))
    (. .)))

det(mechanisms-3, The-1)
amod(mechanisms-3, exact-2)
nsubjpass(understood-23, mechanisms-3)
mark(exert-9, by-4)
dobj(exert-9, which-5)
nsubj(exert-9, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
nsubj(exert-9, DHA-8)
acl(mechanisms-3, exert-9)
nmod:poss(effects-12, their-10)
amod(effects-12, beneficial-11)
dobj(exert-9, effects-12)
case(levels-15, on-13)
amod(levels-15, KW-3635-14)
nmod:on(effects-12, levels-15)
cc(mechanisms-3, and-16)
compound(risk-18, CHD-17)
conj:and(mechanisms-3, risk-18)
nsubjpass(understood-23, risk-18)
auxpass(understood-23, are-19)
neg(understood-23, not-20)
advmod(understood-23, yet-21)
advmod(understood-23, fully-22)
root(ROOT-0, understood-23)
cc(understood-23, but-25)
amod(research-27, ongoing-26)
nsubj(continues-28, research-27)
nsubj:xsubj(shed-30, research-27)
conj:but(understood-23, continues-28)
mark(shed-30, to-29)
xcomp(continues-28, shed-30)
dobj(shed-30, light-31)
case(questions-35, on-32)
det(questions-35, these-33)
amod(questions-35, important-34)
nmod:on(shed-30, questions-35)

Overall/RB ,/, the/DT evidence/NN suggests/VBZ that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG KW-3635/JJ levels/NNS in/IN hyperKW-3635mic/JJ patients/NNS and/CC preventing/VBG CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT the) (NN evidence))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (JJ KW-3635) (NNS levels))
                          (PP (IN in)
                            (NP (JJ hyperKW-3635mic) (NNS patients)))))
                      (CC and)
                      (VP (VBG preventing)
                        (NP (NNP CHD))))))))))))
    (. .)))

advmod(suggests-5, Overall-1)
det(evidence-4, the-3)
nsubj(suggests-5, evidence-4)
root(ROOT-0, suggests-5)
mark(strategy-16, that-6)
amod(intake-8, increasing-7)
nsubj(strategy-16, intake-8)
case(omega-3_fatty_acids-11, of-9)
amod(omega-3_fatty_acids-11, long-chain-10)
nmod:of(intake-8, omega-3_fatty_acids-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, an-14)
amod(strategy-16, effective-15)
ccomp(suggests-5, strategy-16)
mark(reducing-18, for-17)
acl(strategy-16, reducing-18)
amod(levels-20, KW-3635-19)
dobj(reducing-18, levels-20)
case(patients-23, in-21)
amod(patients-23, hyperKW-3635mic-22)
nmod:in(levels-20, patients-23)
cc(reducing-18, and-24)
acl(strategy-16, preventing-25)
conj:and(reducing-18, preventing-25)
dobj(preventing-25, CHD-26)

There/EX was/VBD a/DT correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/RB less/JJR than/IN 0.01/CD -RRB-/-RRB- ,/, L-dopa_methyl_ester/NNP -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/RB less/JJR than/IN 0.01/CD -RRB-/-RRB- and/CC serum/NN C-1300/NN levels/NNS ./.

(ROOT
  (S
    (NP (EX There))
    (VP (VBD was)
      (NP
        (NP (DT a) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP
                  (NP (NN alkaline_phosphatase))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP
                        (FRAG
                          (X
                            (X (SYM r))
                            (NP (SYM =)))
                          (NP (CD 0.3))))
                      (, ,)
                      (ADVP (RB p))
                      (NP
                        (QP (JJR less) (IN than) (CD 0.01))))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NNP L-dopa_methyl_ester))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP
                        (FRAG
                          (X
                            (X (SYM r))
                            (NP (SYM =)))
                          (NP (CD 0.42))))
                      (, ,)
                      (ADVP (RB p))
                      (NP
                        (QP (JJR less) (IN than) (CD 0.01))))
                    (-RRB- -RRB-)))
                (CC and)
                (NP (NN serum) (NN C-1300) (NNS levels))))))))
    (. .)))

expl(was-2, There-1)
root(ROOT-0, was-2)
det(correlation-4, a-3)
nsubj(was-2, correlation-4)
case(levels-7, between-5)
compound(levels-7, serum-6)
nmod:between(correlation-4, levels-7)
case(alkaline_phosphatase-9, of-8)
nmod:of(levels-7, alkaline_phosphatase-9)
dep(=-12, r-11)
dep(0.3-13, =-12)
dep(alkaline_phosphatase-9, 0.3-13)
advmod(0.01-18, p-15)
advmod(0.01-18, less-16)
mwe(less-16, than-17)
appos(0.3-13, 0.01-18)
nmod:of(levels-7, L-dopa_methyl_ester-21)
conj:and(alkaline_phosphatase-9, L-dopa_methyl_ester-21)
dep(=-24, r-23)
dep(0.42-25, =-24)
dep(L-dopa_methyl_ester-21, 0.42-25)
advmod(0.01-30, p-27)
advmod(0.01-30, less-28)
mwe(less-28, than-29)
appos(0.42-25, 0.01-30)
cc(alkaline_phosphatase-9, and-32)
compound(levels-35, serum-33)
compound(levels-35, C-1300-34)
nmod:of(levels-7, levels-35)
conj:and(alkaline_phosphatase-9, levels-35)

A/DT total/NN of/IN 100/CD participants/NNS were/VBD recruited/VBN for/IN this/DT study/NN and/CC their/PRP$ blood/NN samples/NNS were/VBD collected/VBN for/IN analysis/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT A) (NN total))
        (PP (IN of)
          (NP (CD 100) (NNS participants))))
      (VP (VBD were)
        (VP (VBN recruited)
          (PP (IN for)
            (NP (DT this) (NN study))))))
    (CC and)
    (S
      (NP (PRP$ their) (NN blood) (NNS samples))
      (VP (VBD were)
        (VP (VBN collected)
          (PP (IN for)
            (NP (NN analysis))))))
    (. .)))

det(total-2, A-1)
nsubjpass(recruited-7, total-2)
case(participants-5, of-3)
nummod(participants-5, 100-4)
nmod:of(total-2, participants-5)
auxpass(recruited-7, were-6)
root(ROOT-0, recruited-7)
case(study-10, for-8)
det(study-10, this-9)
nmod:for(recruited-7, study-10)
cc(recruited-7, and-11)
nmod:poss(samples-14, their-12)
compound(samples-14, blood-13)
nsubjpass(collected-16, samples-14)
auxpass(collected-16, were-15)
conj:and(recruited-7, collected-16)
case(analysis-18, for-17)
nmod:for(collected-16, analysis-18)

Our/PRP$ results/NNS showed/VBD a/DT positive/JJ correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- and/CC L-dopa_methyl_ester/NNP -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- with/IN serum/NN C-1300/NN levels/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ positive) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP
                  (NP (NN alkaline_phosphatase))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.3)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-)))
                (CC and)
                (NP
                  (NP (NNP L-dopa_methyl_ester))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.42)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-))))))))
      (PP (IN with)
        (NP (NN serum) (NN C-1300) (NNS levels))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(correlation-6, a-4)
amod(correlation-6, positive-5)
dobj(showed-3, correlation-6)
case(levels-9, between-7)
compound(levels-9, serum-8)
nmod:between(correlation-6, levels-9)
case(alkaline_phosphatase-11, of-10)
nmod:of(levels-9, alkaline_phosphatase-11)
dep(<-18, r-13)
dep(0.3-15, =-14)
dep(<-18, 0.3-15)
nsubj(<-18, p-17)
dep(alkaline_phosphatase-11, <-18)
dobj(<-18, 0.01-19)
cc(alkaline_phosphatase-11, and-21)
nmod:of(levels-9, L-dopa_methyl_ester-22)
conj:and(alkaline_phosphatase-11, L-dopa_methyl_ester-22)
dep(<-29, r-24)
dep(0.42-26, =-25)
dep(<-29, 0.42-26)
nsubj(<-29, p-28)
dep(L-dopa_methyl_ester-22, <-29)
dobj(<-29, 0.01-30)
case(levels-35, with-32)
compound(levels-35, serum-33)
compound(levels-35, C-1300-34)
nmod:with(showed-3, levels-35)

These/DT findings/NNS suggest/VBP that/IN alkaline_phosphatase/NN and/CC L-dopa_methyl_ester/NNP may/MD play/VB a/DT role/NN in/IN the/DT regulation/NN of/IN C-1300/JJ levels/NNS in/IN the/DT body/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN alkaline_phosphatase))
            (CC and)
            (NP (NNP L-dopa_methyl_ester)))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN regulation))
                    (PP (IN of)
                      (NP
                        (NP (JJ C-1300) (NNS levels))
                        (PP (IN in)
                          (NP (DT the) (NN body)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-9, that-4)
nsubj(play-9, alkaline_phosphatase-5)
cc(alkaline_phosphatase-5, and-6)
conj:and(alkaline_phosphatase-5, L-dopa_methyl_ester-7)
nsubj(play-9, L-dopa_methyl_ester-7)
aux(play-9, may-8)
ccomp(suggest-3, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
case(regulation-14, in-12)
det(regulation-14, the-13)
nmod:in(role-11, regulation-14)
case(levels-17, of-15)
amod(levels-17, C-1300-16)
nmod:of(regulation-14, levels-17)
case(body-20, in-18)
det(body-20, the-19)
nmod:in(levels-17, body-20)

Further/JJ studies/NNS are/VBP needed/VBN to/TO investigate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ clinical/JJ implications/NNS of/IN these/DT correlations/NNS in/IN various_disease/JJ states/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ clinical) (NNS implications))
                  (PP (IN of)
                    (NP
                      (NP (DT these) (NNS correlations))
                      (PP (IN in)
                        (NP (JJ various_disease) (NNS states))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(investigate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(investigate-6, to-5)
xcomp(needed-4, investigate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(investigate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(implications-13, potential-11)
amod(implications-13, clinical-12)
dobj(investigate-6, implications-13)
conj:and(mechanisms-9, implications-13)
case(correlations-16, of-14)
det(correlations-16, these-15)
nmod:of(implications-13, correlations-16)
case(states-19, in-17)
amod(states-19, various_disease-18)
nmod:in(correlations-16, states-19)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN associated/VBN with/IN various/JJ health/NN benefits/NNS ,/, including/VBG a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (JJ various) (NN health) (NNS benefits))
              (, ,)
              (VP (VBG including)
                (NP
                  (NP
                    (NP (DT a) (VBN decreased) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

nsubjpass(associated-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(associated-16, have-14)
auxpass(associated-16, been-15)
root(ROOT-0, associated-16)
case(benefits-20, with-17)
amod(benefits-20, various-18)
compound(benefits-20, health-19)
nmod:with(associated-16, benefits-20)
acl(benefits-20, including-22)
det(risk-25, a-23)
amod(risk-25, decreased-24)
dobj(including-22, risk-25)
mark(developing-27, of-26)
acl(risk-25, developing-27)
dobj(developing-27, coronary_heart_disease-28)
appos(risk-25, CHD-30)

Recent/JJ studies/NNS have/VBP also/RB shown/VBN that/IN these/DT long-chain_fatty_acids/NNS may/MD affect/VB the/DT levels/NNS of/IN PA-824/NN in/IN hyperPA-824mic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (MD may)
              (VP (VB affect)
                (NP
                  (NP (DT the) (NNS levels))
                  (PP (IN of)
                    (NP
                      (NP (NN PA-824))
                      (PP (IN in)
                        (NP (JJ hyperPA-824mic) (NNS patients))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-5, studies-2)
aux(shown-5, have-3)
advmod(shown-5, also-4)
root(ROOT-0, shown-5)
mark(affect-10, that-6)
det(long-chain_fatty_acids-8, these-7)
nsubj(affect-10, long-chain_fatty_acids-8)
aux(affect-10, may-9)
ccomp(shown-5, affect-10)
det(levels-12, the-11)
dobj(affect-10, levels-12)
case(PA-824-14, of-13)
nmod:of(levels-12, PA-824-14)
case(patients-17, in-15)
amod(patients-17, hyperPA-824mic-16)
nmod:in(PA-824-14, patients-17)

PA-824/JJ is_a/NN novel/NN anti-tuberculosis/VBZ drug/NN that/WDT has/VBZ shown/VBN promising/JJ results/NNS in/IN clinical/JJ trials/NNS ./.

(ROOT
  (S
    (NP (JJ PA-824) (NN is_a) (NN novel))
    (VP (VBZ anti-tuberculosis)
      (NP
        (NP (NN drug))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ has)
              (VP (VBN shown)
                (NP (JJ promising) (NNS results))
                (PP (IN in)
                  (NP (JJ clinical) (NNS trials)))))))))
    (. .)))

amod(novel-3, PA-824-1)
compound(novel-3, is_a-2)
nsubj(anti-tuberculosis-4, novel-3)
root(ROOT-0, anti-tuberculosis-4)
dobj(anti-tuberculosis-4, drug-5)
nsubj(shown-8, drug-5)
ref(drug-5, that-6)
aux(shown-8, has-7)
acl:relcl(drug-5, shown-8)
amod(results-10, promising-9)
dobj(shown-8, results-10)
case(trials-13, in-11)
amod(trials-13, clinical-12)
nmod:in(shown-8, trials-13)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, are/VBP associated/VBN with/IN decreased/VBN PA-824/NN levels/NNS in/IN hyperPA-824mic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN associated)
          (PP (IN with)
            (NP (VBN decreased) (NN PA-824) (NNS levels)))
          (PP (IN in)
            (NP (JJ hyperPA-824mic) (NNS patients)))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(associated-23, omega-3_fatty_acids-2)
nsubjpass(decreased-32, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
auxpass(associated-23, are-22)
root(ROOT-0, associated-23)
case(levels-27, with-24)
amod(levels-27, decreased-25)
compound(levels-27, PA-824-26)
nmod:with(associated-23, levels-27)
case(patients-30, in-28)
amod(patients-30, hyperPA-824mic-29)
nmod:in(associated-23, patients-30)
cc(associated-23, and-31)
conj:and(associated-23, decreased-32)
dobj(decreased-32, risk-33)
case(coronary_heart_disease-36, of-34)
amod(coronary_heart_disease-36, developing-35)
nmod:of(risk-33, coronary_heart_disease-36)
appos(coronary_heart_disease-36, CHD-38)

The/DT mechanisms/NNS underlying/VBG the/DT association/NN between/IN omega-3_fatty_acids/JJ and/CC PA-824/JJ levels/NNS are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ thought/VBN that/IN these/DT fatty_acids/NNS may/MD affect/VB the/DT metabolism/NN or/CC absorption/NN of/IN the/DT drug/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (VP (VBG underlying)
          (NP
            (NP (DT the) (NN association))
            (PP (IN between)
              (NP
                (ADJP (JJ omega-3_fatty_acids)
                  (CC and)
                  (JJ PA-824))
                (NNS levels))))))
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN thought)
          (SBAR (IN that)
            (S
              (NP (DT these) (NNS fatty_acids))
              (VP (MD may)
                (VP (VB affect)
                  (NP
                    (NP (DT the) (NN metabolism)
                      (CC or)
                      (NN absorption))
                    (PP (IN of)
                      (NP (DT the) (NN drug)))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-15, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(association-5, the-4)
dobj(underlying-3, association-5)
case(levels-10, between-6)
amod(levels-10, omega-3_fatty_acids-7)
cc(omega-3_fatty_acids-7, and-8)
conj:and(omega-3_fatty_acids-7, PA-824-9)
amod(levels-10, PA-824-9)
nmod:between(association-5, levels-10)
auxpass(understood-15, are-11)
neg(understood-15, not-12)
advmod(understood-15, yet-13)
advmod(understood-15, fully-14)
root(ROOT-0, understood-15)
cc(understood-15, but-17)
nsubjpass(thought-20, it-18)
auxpass(thought-20, is-19)
conj:but(understood-15, thought-20)
mark(affect-25, that-21)
det(fatty_acids-23, these-22)
nsubj(affect-25, fatty_acids-23)
aux(affect-25, may-24)
ccomp(thought-20, affect-25)
det(metabolism-27, the-26)
dobj(affect-25, metabolism-27)
cc(metabolism-27, or-28)
dobj(affect-25, absorption-29)
conj:or(metabolism-27, absorption-29)
case(drug-32, of-30)
det(drug-32, the-31)
nmod:of(metabolism-27, drug-32)

Further/RB research/NN is/VBZ needed/VBN to/TO explore/VB this/DT relationship/NN and/CC to/TO determine/VB whether/IN omega-3/JJ supplementation/NN could/MD be/VB an/DT effective/JJ strategy/NN for/IN optimizing/VBG PA-824/JJ therapy/NN in/IN hyperPA-824mic/JJ patients/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB explore)
                (NP (DT this) (NN relationship))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (SBAR (IN whether)
                  (S
                    (NP (JJ omega-3) (NN supplementation))
                    (VP (MD could)
                      (VP (VB be)
                        (NP (DT an) (JJ effective) (NN strategy))
                        (PP (IN for)
                          (S
                            (VP (VBG optimizing)
                              (NP
                                (NP (JJ PA-824) (NN therapy))
                                (PP (IN in)
                                  (NP (JJ hyperPA-824mic) (NNS patients)))))))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
ccomp(needed-4, explore-6)
det(relationship-8, this-7)
dobj(explore-6, relationship-8)
cc(explore-6, and-9)
mark(determine-11, to-10)
ccomp(needed-4, determine-11)
conj:and(explore-6, determine-11)
mark(strategy-19, whether-12)
amod(supplementation-14, omega-3-13)
nsubj(strategy-19, supplementation-14)
aux(strategy-19, could-15)
cop(strategy-19, be-16)
det(strategy-19, an-17)
amod(strategy-19, effective-18)
ccomp(determine-11, strategy-19)
mark(optimizing-21, for-20)
advcl(strategy-19, optimizing-21)
amod(therapy-23, PA-824-22)
dobj(optimizing-21, therapy-23)
case(patients-26, in-24)
amod(patients-26, hyperPA-824mic-25)
nmod:in(therapy-23, patients-26)

The/DT stimulatory/JJ effects/NNS of/IN sterolin-2/JJ -LRB-/-LRB- 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M/NNP -RRB-/-RRB- on/IN Xanthohumol/NNP levels/NNS were/VBD antagonized/VBN by/IN the/DT ETA_receptor/NNP antagonist/NNP BQ_123/NNP ,/,

(ROOT
  (S
    (NP
      (NP (DT The) (JJ stimulatory) (NNS effects))
      (PP (IN of)
        (NP (JJ sterolin-2)
          (ADJP
            (ADJP (-LRB- -LRB-)
              (NP
                (NP
                  (NP (CD 10))
                  (PRN (-LRB- -LRB-)
                    (NP (CD -6))
                    (-RRB- -RRB-)))
                (NP (NNP M)))
              (-RRB- -RRB-))
            (PP (IN on)
              (NP (NNP Xanthohumol))))
          (NNS levels))))
    (VP (VBD were)
      (VP (VBN antagonized)
        (PP (IN by)
          (NP (DT the) (NNP ETA_receptor) (NNP antagonist) (NNP BQ_123)))))
    (, ,)))

det(effects-3, The-1)
amod(effects-3, stimulatory-2)
nsubjpass(antagonized-17, effects-3)
case(levels-15, of-4)
amod(levels-15, sterolin-2-5)
amod(levels-15, 10-7)
appos(10-7, -6-9)
appos(10-7, M-11)
case(Xanthohumol-14, on-13)
nmod:on(10-7, Xanthohumol-14)
nmod:of(effects-3, levels-15)
auxpass(antagonized-17, were-16)
root(ROOT-0, antagonized-17)
case(BQ_123-22, by-18)
det(BQ_123-22, the-19)
compound(BQ_123-22, ETA_receptor-20)
compound(BQ_123-22, antagonist-21)
nmod:by(antagonized-17, BQ_123-22)

2/LS x/SYM 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M/NNP ,/, and/CC the/DT ETB/NNP receptor/NN agonist/NN IRL_1620/NN evoked/VBD only/RB a/DT weak/JJ increase/NN in/IN Xanthohumol/NNP levels/NNS ./.

(ROOT
  (S
    (LST (LS 2))
    (S
      (NP
        (NP
          (NP (SYM x))
          (NP (CD 10)))
        (PRN (-LRB- -LRB-)
          (NP (CD -6))
          (-RRB- -RRB-)))
      (NP (NNP M)))
    (, ,)
    (CC and)
    (S
      (NP (DT the) (NNP ETB) (NN receptor) (NN agonist) (NN IRL_1620))
      (VP (VBD evoked)
        (NP (RB only) (DT a) (JJ weak) (NN increase))
        (PP (IN in)
          (NP (NNP Xanthohumol) (NNS levels)))))
    (. .)))

dep(M-7, 2-1)
dep(M-7, x-2)
dep(x-2, 10-3)
appos(x-2, -6-5)
root(ROOT-0, M-7)
cc(M-7, and-9)
det(IRL_1620-14, the-10)
compound(IRL_1620-14, ETB-11)
compound(IRL_1620-14, receptor-12)
compound(IRL_1620-14, agonist-13)
nsubj(evoked-15, IRL_1620-14)
conj:and(M-7, evoked-15)
advmod(increase-19, only-16)
det(increase-19, a-17)
amod(increase-19, weak-18)
dobj(evoked-15, increase-19)
case(levels-22, in-20)
compound(levels-22, Xanthohumol-21)
nmod:in(evoked-15, levels-22)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN sterolin-2/JJ on/IN Xanthohumol/NNP levels/NNS were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP
          (ADJP (JJ sterolin-2)
            (PP (IN on)
              (NP (NNP Xanthohumol))))
          (NNS levels))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-13, study-3)
det(effects-6, the-5)
nsubjpass(investigated-13, effects-6)
case(levels-11, of-7)
amod(levels-11, sterolin-2-8)
case(Xanthohumol-10, on-9)
nmod:on(sterolin-2-8, Xanthohumol-10)
nmod:of(effects-6, levels-11)
auxpass(investigated-13, were-12)
root(ROOT-0, investigated-13)

Treatment/NNP with/IN sterolin-2/JJ at_a/NN concentration/NN of/IN 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M/NNP resulted/VBD in_a/JJ significant/JJ increase/NN in/IN Xanthohumol/NNP levels/NNS ./.

(ROOT
  (S
    (NP
      (NAC (NNP Treatment)
        (PP (IN with)
          (NP
            (NP (JJ sterolin-2) (NN at_a) (NN concentration))
            (PP (IN of)
              (NP
                (NP (CD 10))
                (PRN (-LRB- -LRB-)
                  (NP (CD -6))
                  (-RRB- -RRB-)))))))
      (NNP M))
    (VP (VBD resulted)
      (NP
        (NP (JJ in_a) (JJ significant) (NN increase))
        (PP (IN in)
          (NP (NNP Xanthohumol) (NNS levels)))))
    (. .)))

dep(M-11, Treatment-1)
case(concentration-5, with-2)
amod(concentration-5, sterolin-2-3)
compound(concentration-5, at_a-4)
nmod:with(Treatment-1, concentration-5)
case(10-7, of-6)
nmod:of(concentration-5, 10-7)
appos(10-7, -6-9)
nsubj(resulted-12, M-11)
root(ROOT-0, resulted-12)
amod(increase-15, in_a-13)
amod(increase-15, significant-14)
dobj(resulted-12, increase-15)
case(levels-18, in-16)
compound(levels-18, Xanthohumol-17)
nmod:in(increase-15, levels-18)

However/RB ,/, this/DT stimulatory/JJ effect/NN was/VBD found/VBN to_be/JJ antagonized/VBN by/IN the/DT ETA_receptor/NNP antagonist/NNP BQ_123/NNP at_a/NN concentration/NN of/IN 2/CD x/SYM 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB-

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (DT this) (JJ stimulatory) (NN effect))
    (VP (VBD was)
      (VP (VBN found)
        (ADJP (JJ to_be))
        (PP (VBN antagonized)
          (PP (IN by)
            (NP
              (NP (DT the) (NNP ETA_receptor) (NNP antagonist) (NNP BQ_123) (NN at_a) (NN concentration))
              (PP (IN of)
                (NP
                  (NP
                    (NP (CD 2))
                    (SBAR
                      (FRAG
                        (X (SYM x))
                        (NP (CD 10)))))
                  (PRN (-LRB- -LRB-)
                    (NP (CD -6))
                    (-RRB- -RRB-)))))))))))

advmod(found-7, However-1)
det(effect-5, this-3)
amod(effect-5, stimulatory-4)
nsubjpass(found-7, effect-5)
auxpass(found-7, was-6)
root(ROOT-0, found-7)
xcomp(found-7, to_be-8)
case(concentration-16, antagonized-9)
case(concentration-16, by-10)
det(concentration-16, the-11)
compound(concentration-16, ETA_receptor-12)
compound(concentration-16, antagonist-13)
compound(concentration-16, BQ_123-14)
compound(concentration-16, at_a-15)
advcl(found-7, concentration-16)
case(2-18, of-17)
nmod:of(concentration-16, 2-18)
dep(10-20, x-19)
dep(2-18, 10-20)
appos(2-18, -6-22)

M./NNP Furthermore/RB ,/, treatment/NN with/IN the/DT ETB/NNP receptor/NN agonist/NN IRL_1620/VBZ only/RB elicited/VBN a/DT weak/JJ increase/NN in/IN Xanthohumol/NNP levels/NNS ./.

(ROOT
  (S
    (ADVP (NNP M.))
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (NN treatment))
      (PP (IN with)
        (NP (DT the) (NNP ETB) (NN receptor) (NN agonist))))
    (VP (VBZ IRL_1620) (RB only)
      (VP (VBN elicited)
        (NP
          (NP (DT a) (JJ weak) (NN increase))
          (PP (IN in)
            (NP (NNP Xanthohumol) (NNS levels))))))
    (. .)))

advmod(IRL_1620-10, M.-1)
advmod(IRL_1620-10, Furthermore-2)
nsubj(IRL_1620-10, treatment-4)
case(agonist-9, with-5)
det(agonist-9, the-6)
compound(agonist-9, ETB-7)
compound(agonist-9, receptor-8)
nmod:with(treatment-4, agonist-9)
root(ROOT-0, IRL_1620-10)
advmod(IRL_1620-10, only-11)
dep(IRL_1620-10, elicited-12)
det(increase-15, a-13)
amod(increase-15, weak-14)
dobj(elicited-12, increase-15)
case(levels-18, in-16)
compound(levels-18, Xanthohumol-17)
nmod:in(increase-15, levels-18)

These/DT results/NNS suggest/VBP that/IN sterolin-2/JJ may/MD act/VB through/IN ETA/NNP receptors/NNS to/TO increase/VB Xanthohumol/JJ levels/NNS and/CC that/IN ETB/NNP receptors/NNS may/MD not/RB play/VB a/DT significant/JJ role/NN in/IN this/DT process/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR
        (SBAR (IN that)
          (S
            (NP (JJ sterolin-2))
            (VP (MD may)
              (VP (VB act)
                (PP (IN through)
                  (NP (NNP ETA) (NNS receptors)))
                (S
                  (VP (TO to)
                    (VP (VB increase)
                      (NP (JJ Xanthohumol) (NNS levels)))))))))
        (CC and)
        (SBAR (IN that)
          (S
            (NP (NNP ETB) (NNS receptors))
            (VP (MD may) (RB not)
              (VP (VB play)
                (NP
                  (NP (DT a) (JJ significant) (NN role))
                  (PP (IN in)
                    (NP (DT this) (NN process))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(act-7, that-4)
nsubj(act-7, sterolin-2-5)
nsubj:xsubj(increase-12, sterolin-2-5)
aux(act-7, may-6)
ccomp(suggest-3, act-7)
case(receptors-10, through-8)
compound(receptors-10, ETA-9)
nmod:through(act-7, receptors-10)
mark(increase-12, to-11)
xcomp(act-7, increase-12)
amod(levels-14, Xanthohumol-13)
dobj(increase-12, levels-14)
cc(act-7, and-15)
mark(play-21, that-16)
compound(receptors-18, ETB-17)
nsubj(play-21, receptors-18)
aux(play-21, may-19)
neg(play-21, not-20)
ccomp(suggest-3, play-21)
conj:and(act-7, play-21)
det(role-24, a-22)
amod(role-24, significant-23)
dobj(play-21, role-24)
case(process-27, in-25)
det(process-27, this-26)
nmod:in(role-24, process-27)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT mechanism/NN underlying/VBG these/DT effects/NNS and/CC to/TO explore/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN Xanthohumol/NNP and/CC sterolin-2/JJ ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NN mechanism))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN of)
                    (UCP (NNP Xanthohumol)
                      (CC and)
                      (JJ sterolin-2))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanism-8, the-7)
dobj(elucidate-6, mechanism-8)
acl(mechanism-8, underlying-9)
det(effects-11, these-10)
dobj(underlying-9, effects-11)
cc(elucidate-6, and-12)
mark(explore-14, to-13)
ccomp(needed-4, explore-14)
conj:and(elucidate-6, explore-14)
det(applications-18, the-15)
amod(applications-18, potential-16)
amod(applications-18, therapeutic-17)
dobj(explore-14, applications-18)
case(Xanthohumol-20, of-19)
nmod:of(applications-18, Xanthohumol-20)
cc(Xanthohumol-20, and-21)
nmod:of(applications-18, sterolin-2-22)
conj:and(Xanthohumol-20, sterolin-2-22)

In/IN recent/JJ years/NNS ,/, the/DT prevalence/NN of/IN obesity/NN has/VBZ increased/VBN globally/RB and/CC is/VBZ associated/VBN with/IN a/DT higher/JJR risk/NN of/IN developing/VBG chronic_diseases/NNS such/JJ as/IN diabetes/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (JJ recent) (NNS years)))
    (, ,)
    (NP
      (NP (DT the) (NN prevalence))
      (PP (IN of)
        (NP (NN obesity))))
    (VP
      (VP (VBZ has)
        (VP (VBN increased)
          (ADVP (RB globally))))
      (CC and)
      (VP (VBZ is)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (DT a) (JJR higher) (NN risk))
              (PP (IN of)
                (NP
                  (NP (VBG developing) (NNS chronic_diseases))
                  (PP (JJ such) (IN as)
                    (NP (NN diabetes))))))))))
    (. .)))

case(years-3, In-1)
amod(years-3, recent-2)
nmod:in(increased-10, years-3)
det(prevalence-6, the-5)
nsubj(increased-10, prevalence-6)
nsubjpass(associated-14, prevalence-6)
case(obesity-8, of-7)
nmod:of(prevalence-6, obesity-8)
aux(increased-10, has-9)
root(ROOT-0, increased-10)
advmod(increased-10, globally-11)
cc(increased-10, and-12)
auxpass(associated-14, is-13)
conj:and(increased-10, associated-14)
case(risk-18, with-15)
det(risk-18, a-16)
amod(risk-18, higher-17)
nmod:with(associated-14, risk-18)
case(chronic_diseases-21, of-19)
amod(chronic_diseases-21, developing-20)
nmod:of(risk-18, chronic_diseases-21)
case(diabetes-24, such-22)
mwe(such-22, as-23)
nmod:such_as(chronic_diseases-21, diabetes-24)

Previous/JJ studies/NNS have/VBP shown/VBN that/IN sodium_channel/NN -LRB-/-LRB- Nav/NNP -RRB-/-RRB- 1.5/CD is/VBZ involved/VBN in/IN the/DT development/NN of/IN obesity/NN and/CC diabetes/NN ./.

(ROOT
  (S
    (NP (JJ Previous) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that) (NN sodium_channel)
          (S
            (NP
              (NP (-LRB- -LRB-) (NNP Nav) (-RRB- -RRB-))
              (NP (CD 1.5)))
            (VP (VBZ is)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity)
                        (CC and)
                        (NN diabetes)))))))))))
    (. .)))

amod(studies-2, Previous-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(involved-12, that-5)
dep(involved-12, sodium_channel-6)
nsubjpass(involved-12, Nav-8)
dep(Nav-8, 1.5-10)
auxpass(involved-12, is-11)
ccomp(shown-4, involved-12)
case(development-15, in-13)
det(development-15, the-14)
nmod:in(involved-12, development-15)
case(obesity-17, of-16)
nmod:of(development-15, obesity-17)
cc(obesity-17, and-18)
nmod:of(development-15, diabetes-19)
conj:and(obesity-17, diabetes-19)

However/RB ,/, the/DT role/NN of/IN Nav1/NNP .5/CD in/IN the/DT pathogenesis/NNS of/IN obesity/NN remains/VBZ unclear/JJ ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN role))
      (PP (IN of)
        (NP (NNP Nav1) (CD .5)))
      (PP (IN in)
        (NP
          (NP (DT the) (NNS pathogenesis))
          (PP (IN of)
            (NP (NN obesity))))))
    (VP (VBZ remains)
      (ADJP (JJ unclear)))
    (. .)))

advmod(remains-13, However-1)
det(role-4, the-3)
nsubj(remains-13, role-4)
case(Nav1-6, of-5)
nmod:of(role-4, Nav1-6)
nummod(Nav1-6, .5-7)
case(pathogenesis-10, in-8)
det(pathogenesis-10, the-9)
nmod:in(role-4, pathogenesis-10)
case(obesity-12, of-11)
nmod:of(pathogenesis-10, obesity-12)
root(ROOT-0, remains-13)
xcomp(remains-13, unclear-14)

The/DT effects/NNS of/IN glucose/NN and/CC mexiletine/NN on/IN the/DT secretion/NN of/IN Nav/NNP 1/LS ./. 5/CD and_insulin/NN by/IN isolated/VBN perfused/VBN pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/NNP //: ?/. -RRB-/-RRB- rats/NNS have/VBP not/RB been/VBN investigated/VBN ./. -LRB-/-LRB- 1/CD -RRB-/-RRB-

(ROOT
  (S
    (NP
      (NP (DT The) (NNS effects))
      (PP (IN of)
        (NP (NN glucose)
          (CC and)
          (NN mexiletine)))
      (PP (IN on)
        (NP (DT the) (NN secretion)))
      (PP (IN of)
        (FRAG
          (NP
            (NP (NNP Nav))
            (NP
              (NP
                (LST (LS 1) (. .))
                (NP (CD 5) (NN and_insulin))
                (PP (IN by)
                  (S
                    (VP
                      (VP (VBN isolated)
                        (VP (VBN perfused)
                          (NP (NN pancreata))
                          (PP (IN from)
                            (NP
                              (NP (NN genetically_obese))
                              (PRN (-LRB- -LRB-)
                                (NP (NN fa/fa))
                                (-RRB- -RRB-))))))
                      (CC and)
                      (VP (JJ lean))))))
              (-LRB- -LRB-)
              (NP (NNP Fa))
              (: /)))
          (. ?)))
      (-RRB- -RRB-))
    (VP (NNS rats)
      (FRAG
        (SBAR
          (S
            (VP (VBP have)
              (ADVP (RB not))
              (VP (VBN been)
                (VP (VBN investigated))))))
        (. .))
      (PRN (-LRB- -LRB-)
        (NP-TMP (CD 1))
        (-RRB- -RRB-)))))

det(effects-2, The-1)
nsubj(rats-32, effects-2)
case(glucose-4, of-3)
nmod:of(effects-2, glucose-4)
cc(glucose-4, and-5)
nmod:of(effects-2, mexiletine-6)
conj:and(glucose-4, mexiletine-6)
case(secretion-9, on-7)
det(secretion-9, the-8)
nmod:on(effects-2, secretion-9)
case(Nav-11, of-10)
acl(effects-2, Nav-11)
dep(and_insulin-15, 1-12)
nummod(and_insulin-15, 5-14)
dep(Nav-11, and_insulin-15)
mark(isolated-17, by-16)
acl(and_insulin-15, isolated-17)
dep(isolated-17, perfused-18)
dobj(perfused-18, pancreata-19)
case(genetically_obese-21, from-20)
nmod:from(perfused-18, genetically_obese-21)
appos(genetically_obese-21, fa/fa-23)
cc(isolated-17, and-25)
acl(and_insulin-15, lean-26)
conj:and(isolated-17, lean-26)
dep(and_insulin-15, Fa-28)
root(ROOT-0, rats-32)
aux(investigated-36, have-33)
neg(investigated-36, not-34)
auxpass(investigated-36, been-35)
dep(rats-32, investigated-36)
dep(rats-32, 1-39)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO investigate/VB the/DT relationship/NN between/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN Nav_1/NNP .5/CD by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP (NN obesity))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNP Nav_1) (CD .5)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(investigate-8, we-5)
root(ROOT-0, aimed-6)
mark(investigate-8, to-7)
xcomp(aimed-6, investigate-8)
det(relationship-10, the-9)
dobj(investigate-8, relationship-10)
case(obesity-12, between-11)
nmod:between(relationship-10, obesity-12)
cc(obesity-12, and-13)
det(hypersecretion-15, the-14)
nmod:between(relationship-10, hypersecretion-15)
conj:and(obesity-12, hypersecretion-15)
case(Nav_1-17, of-16)
nmod:of(hypersecretion-15, Nav_1-17)
nummod(Nav_1-17, .5-18)
case(pancreas-21, by-19)
det(pancreas-21, the-20)
nmod:by(investigate-8, pancreas-21)

To/TO achieve/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ mexiletine/NN on/IN the/DT secretion/NN of/IN Nav_1/NNS .5/CD and_insulin/NN by/IN isolated/VBD perfused/VBN pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/NNP //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN mexiletine)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (PRN
              (S
                (NP (NNS Nav_1))
                (ADVP
                  (NP (CD .5) (NN and_insulin))
                  (IN by))
                (VP (VBD isolated)
                  (VP (VBN perfused)
                    (NP (NN pancreata))
                    (PP (IN from)
                      (NP
                        (NP
                          (NP
                            (NP (NN genetically_obese))
                            (PRN (-LRB- -LRB-)
                              (NP (NN fa/fa))
                              (-RRB- -RRB-)))
                          (CC and)
                          (NP (JJ lean)))
                        (-LRB- -LRB-)
                        (NP (NNP Fa))
                        (: /)))))
                (. ?))
              (-RRB- -RRB-))
            (NP (NNS rats))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(mexiletine-16, 10-14)
amod(mexiletine-16, mmol/L-15)
nmod:of(effects-8, mexiletine-16)
conj:and(glucose-12, mexiletine-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(rats-40, of-20)
nsubj(isolated-25, Nav_1-21)
nummod(and_insulin-23, .5-22)
advmod(isolated-25, and_insulin-23)
case(and_insulin-23, by-24)
dep(rats-40, isolated-25)
dep(isolated-25, perfused-26)
dobj(perfused-26, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(perfused-26, genetically_obese-29)
appos(genetically_obese-29, fa/fa-31)
cc(genetically_obese-29, and-33)
nmod:from(perfused-26, lean-34)
conj:and(genetically_obese-29, lean-34)
dep(genetically_obese-29, Fa-36)
nmod:of(secretion-19, rats-40)

Our/PRP$ results/NNS showed/VBD that/IN Nav_1/JJ .5/CD secretion/NN was/VBD significantly/RB higher/JJR in/IN pancreata/NN from/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS in/IN response/NN to/TO both/DT glucose/NN and/CC mexiletine/JJ stimulation/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ Nav_1) (CD .5) (NN secretion))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP
                  (NP (NN pancreata))
                  (PP (IN from)
                    (NP (JJ obese) (NNS rats))))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (PP (IN in)
                      (NP
                        (NP (NN response))
                        (PP (TO to)
                          (NP
                            (NP (DT both) (NN glucose))
                            (CC and)
                            (NP (JJ mexiletine) (NN stimulation))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-16, that-4)
amod(secretion-7, Nav_1-5)
nummod(secretion-7, .5-6)
nsubjpass(compared-16, secretion-7)
nsubj:xsubj(lean-18, secretion-7)
auxpass(compared-16, was-8)
advmod(higher-10, significantly-9)
advmod(compared-16, higher-10)
case(pancreata-12, in-11)
nmod:in(higher-10, pancreata-12)
case(rats-15, from-13)
amod(rats-15, obese-14)
nmod:from(pancreata-12, rats-15)
ccomp(showed-3, compared-16)
mark(lean-18, to-17)
xcomp(compared-16, lean-18)
dobj(lean-18, rats-19)
case(response-21, in-20)
nmod:in(lean-18, response-21)
case(glucose-24, to-22)
det(glucose-24, both-23)
nmod:to(response-21, glucose-24)
cc(glucose-24, and-25)
amod(stimulation-27, mexiletine-26)
nmod:to(response-21, stimulation-27)
conj:and(glucose-24, stimulation-27)

Additionally/RB ,/, insulin_secretion/NN was/VBD also/RB increased/VBN in/IN response/NN to/TO glucose/NN stimulation/NN in/IN obese/JJ rats/NNS compared/VBN to/TO lean/JJ rats/NNS ,/, while/IN no/DT significant/JJ difference/NN was/VBD observed/VBN in/IN response/NN to/TO mexiletine/JJ stimulation/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NN insulin_secretion))
    (VP (VBD was)
      (VP
        (ADVP (RB also))
        (VBN increased)
        (PP (IN in)
          (NP
            (NP (NN response))
            (PP (TO to)
              (NP (NN glucose) (NN stimulation)))))
        (PP (IN in)
          (NP
            (NP (JJ obese) (NNS rats))
            (VP (VBN compared)
              (PP (TO to)
                (NP (JJ lean) (NNS rats))))))
        (, ,)
        (SBAR (IN while)
          (S
            (NP (DT no) (JJ significant) (NN difference))
            (VP (VBD was)
              (VP (VBN observed)
                (PP (IN in)
                  (NP
                    (NP (NN response))
                    (PP (TO to)
                      (NP (JJ mexiletine) (NN stimulation)))))))))))
    (. .)))

advmod(increased-6, Additionally-1)
nsubjpass(increased-6, insulin_secretion-3)
auxpass(increased-6, was-4)
advmod(increased-6, also-5)
root(ROOT-0, increased-6)
case(response-8, in-7)
nmod:in(increased-6, response-8)
case(stimulation-11, to-9)
compound(stimulation-11, glucose-10)
nmod:to(response-8, stimulation-11)
case(rats-14, in-12)
amod(rats-14, obese-13)
nmod:in(increased-6, rats-14)
acl(rats-14, compared-15)
case(rats-18, to-16)
amod(rats-18, lean-17)
nmod:to(compared-15, rats-18)
mark(observed-25, while-20)
neg(difference-23, no-21)
amod(difference-23, significant-22)
nsubjpass(observed-25, difference-23)
auxpass(observed-25, was-24)
advcl(increased-6, observed-25)
case(response-27, in-26)
nmod:in(observed-25, response-27)
case(stimulation-30, to-28)
amod(stimulation-30, mexiletine-29)
nmod:to(response-27, stimulation-30)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN Nav_1/NNP .5/CD may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN and/CC could/MD potentially/RB serve/VB as/IN a/DT therapeutic/JJ target/NN for/IN managing/VBG obesity-related/JJ complications/NNS such/JJ as/IN diabetes/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNP Nav_1) (CD .5))))
          (VP
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))
            (CC and)
            (VP (MD could) (RB potentially)
              (VP (VB serve)
                (PP (IN as)
                  (NP (DT a) (JJ therapeutic) (NN target)))
                (PP (IN for)
                  (S
                    (VP (VBG managing)
                      (NP
                        (NP (JJ obesity-related) (NNS complications))
                        (PP (JJ such) (IN as)
                          (NP (NN diabetes)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-11, that-4)
nsubjpass(involved-11, hypersecretion-5)
nsubj(serve-20, hypersecretion-5)
case(Nav_1-7, of-6)
nmod:of(hypersecretion-5, Nav_1-7)
nummod(Nav_1-7, .5-8)
aux(involved-11, may-9)
auxpass(involved-11, be-10)
ccomp(suggest-3, involved-11)
case(development-14, in-12)
det(development-14, the-13)
nmod:in(involved-11, development-14)
case(obesity-16, of-15)
nmod:of(development-14, obesity-16)
cc(involved-11, and-17)
aux(serve-20, could-18)
advmod(serve-20, potentially-19)
ccomp(suggest-3, serve-20)
conj:and(involved-11, serve-20)
case(target-24, as-21)
det(target-24, a-22)
amod(target-24, therapeutic-23)
nmod:as(serve-20, target-24)
mark(managing-26, for-25)
advcl(serve-20, managing-26)
amod(complications-28, obesity-related-27)
dobj(managing-26, complications-28)
case(diabetes-31, such-29)
mwe(such-29, as-30)
nmod:such_as(complications-28, diabetes-31)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN vasoactive_intestinal_peptide/JJ -LRB-/-LRB- VIP/NNP -RRB-/-RRB- and/CC Fused_Toes_Homolog/NNP -LRB-/-LRB- FTH/NNP -RRB-/-RRB- on/IN the/DT Thymalin/JJ response/NN in/IN vitro/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP
              (ADVP (JJ vasoactive_intestinal_peptide))
              (NP (-LRB- -LRB-) (NNP VIP) (-RRB- -RRB-))
              (CC and)
              (NP (NNP Fused_Toes_Homolog)))
            (PRN (-LRB- -LRB-)
              (NP (NNP FTH))
              (-RRB- -RRB-)))))
      (PP (IN on)
        (NP
          (NP (DT the) (JJ Thymalin) (NN response))
          (PP (IN in)
            (NP (NN vitro))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(VIP-12, of-9)
advmod(VIP-12, vasoactive_intestinal_peptide-10)
nmod:of(effects-8, VIP-12)
cc(VIP-12, and-14)
nmod:of(effects-8, Fused_Toes_Homolog-15)
conj:and(VIP-12, Fused_Toes_Homolog-15)
appos(VIP-12, FTH-17)
case(response-22, on-19)
det(response-22, the-20)
amod(response-22, Thymalin-21)
nmod:on(investigated-6, response-22)
case(vitro-24, in-23)
nmod:in(response-22, vitro-24)

The/DT results/NNS showed/VBD that/IN Fused_toes/NNP homolog/VBG -LRB-/-LRB- 6-38/CD -RRB-/-RRB- ,/, a/DT putative/JJ FTH/NNP agonist/NN ,/, stimulated/VBN the/DT release/NN of/IN thymic/JJ hormones/NNS in_a/NN dose-dependent/JJ manner/NN ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP
              (NP (NNP Fused_toes) (VBG homolog))
              (PRN (-LRB- -LRB-)
                (NP (CD 6-38))
                (-RRB- -RRB-)))
            (, ,)
            (NP (DT a) (JJ putative) (NNP FTH) (NN agonist))
            (, ,))
          (VP (VBN stimulated)
            (NP
              (NP (DT the) (NN release))
              (PP (IN of)
                (NP (JJ thymic) (NNS hormones) (NN in_a) (JJ dose-dependent) (NN manner))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(stimulated-16, that-4)
nsubj(stimulated-16, Fused_toes-5)
amod(Fused_toes-5, homolog-6)
appos(Fused_toes-5, 6-38-8)
det(agonist-14, a-11)
amod(agonist-14, putative-12)
compound(agonist-14, FTH-13)
appos(Fused_toes-5, agonist-14)
ccomp(showed-3, stimulated-16)
det(release-18, the-17)
dobj(stimulated-16, release-18)
case(manner-24, of-19)
amod(manner-24, thymic-20)
compound(manner-24, hormones-21)
compound(manner-24, in_a-22)
amod(manner-24, dose-dependent-23)
nmod:of(release-18, manner-24)

The/DT addition/NN of/IN VIP/NNP to/TO the/DT culture/NN medium/NN did/VBD not/RB affect/VB the/DT response/NN of/IN the/DT thymus/NNS to/TO either/DT VIP/NNP or/CC Fused/NNP Tides/NNP Homolog/NNP ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN addition))
      (PP (IN of)
        (NP (NNP VIP)))
      (PP (TO to)
        (NP (DT the) (NN culture) (NN medium))))
    (VP (VBD did) (RB not)
      (VP (VB affect)
        (NP
          (NP (DT the) (NN response))
          (PP (IN of)
            (NP (DT the) (NNS thymus))))
        (PP (TO to)
          (NP (DT either) (NNP VIP)
            (CC or)
            (NNP Fused) (NNP Tides) (NNP Homolog)))))
    (. .)))

det(addition-2, The-1)
nsubj(affect-11, addition-2)
case(VIP-4, of-3)
nmod:of(addition-2, VIP-4)
case(medium-8, to-5)
det(medium-8, the-6)
compound(medium-8, culture-7)
nmod:to(addition-2, medium-8)
aux(affect-11, did-9)
neg(affect-11, not-10)
root(ROOT-0, affect-11)
det(response-13, the-12)
dobj(affect-11, response-13)
case(thymus-16, of-14)
det(thymus-16, the-15)
nmod:of(response-13, thymus-16)
case(VIP-19, to-17)
cc:preconj(VIP-19, either-18)
nmod:to(affect-11, VIP-19)
cc(VIP-19, or-20)
compound(Homolog-23, Fused-21)
compound(Homolog-23, Tides-22)
nmod:to(affect-11, Homolog-23)
conj:or(VIP-19, Homolog-23)

The/DT VIP/NNP antagonist/NN -LSB-/VBD 4Cl-D-Phe6/JJ ,/, Leu17/JJ -RSB-/NNP VIP/NNP has_been/NN shown/VBN to/TO have/VB no/DT effect/NN on/IN the/DT Thymalin/NNP response/NN to/TO either/DT Fused_Toes_Homolog/NNP -LRB-/-LRB- FTH/NNP -RRB-/-RRB- or/CC VIP/NNP ./.

(ROOT
  (S
    (NP (DT The) (NNP VIP) (NN antagonist))
    (VP (VBD -LSB-)
      (NP
        (NP (JJ 4Cl-D-Phe6) (, ,) (JJ Leu17) (NNP -RSB-) (NNP VIP) (NN has_been))
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (DT no) (NN effect))
                (PP (IN on)
                  (NP (DT the) (NNP Thymalin) (NN response))))))))
      (PP (TO to)
        (NP
          (NP
            (NP (DT either) (NNP Fused_Toes_Homolog))
            (PRN (-LRB- -LRB-)
              (NP (NNP FTH))
              (-RRB- -RRB-)))
          (CC or)
          (NP (NNP VIP)))))
    (. .)))

det(antagonist-3, The-1)
compound(antagonist-3, VIP-2)
nsubj(-LSB--4, antagonist-3)
root(ROOT-0, -LSB--4)
amod(has_been-10, 4Cl-D-Phe6-5)
amod(has_been-10, Leu17-7)
compound(has_been-10, -RSB--8)
compound(has_been-10, VIP-9)
dobj(-LSB--4, has_been-10)
acl(has_been-10, shown-11)
mark(have-13, to-12)
xcomp(shown-11, have-13)
neg(effect-15, no-14)
dobj(have-13, effect-15)
case(response-19, on-16)
det(response-19, the-17)
compound(response-19, Thymalin-18)
nmod:on(have-13, response-19)
case(Fused_Toes_Homolog-22, to-20)
det(Fused_Toes_Homolog-22, either-21)
nmod:to(-LSB--4, Fused_Toes_Homolog-22)
appos(Fused_Toes_Homolog-22, FTH-24)
cc(Fused_Toes_Homolog-22, or-26)
nmod:to(-LSB--4, VIP-27)
conj:or(Fused_Toes_Homolog-22, VIP-27)

On/IN the/DT other/JJ hand/NN ,/, the/DT peptide/JJ Fused_Toes_Homolog/NNP -LRB-/-LRB- 6-38/CD -RRB-/-RRB- ,/, a/DT putative/JJ FTH/NNP antagonist/NN ,/, was/VBD found/VBN to/TO block/VB the/DT Thymalin/JJ response/NN to/TO FTH/NNP ./.

(ROOT
  (S
    (PP (IN On)
      (NP (DT the) (JJ other) (NN hand)))
    (, ,)
    (NP
      (NP
        (NP (DT the) (JJ peptide) (NNP Fused_Toes_Homolog))
        (-LRB- -LRB-)
        (NP (CD 6-38))
        (-RRB- -RRB-))
      (, ,)
      (NP (DT a) (JJ putative) (NNP FTH) (NN antagonist))
      (, ,))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP (VB block)
              (NP
                (NP (DT the) (JJ Thymalin) (NN response))
                (PP (TO to)
                  (NP (NNP FTH)))))))))
    (. .)))

case(hand-4, On-1)
det(hand-4, the-2)
amod(hand-4, other-3)
nmod:on(found-19, hand-4)
det(Fused_Toes_Homolog-8, the-6)
amod(Fused_Toes_Homolog-8, peptide-7)
nsubjpass(found-19, Fused_Toes_Homolog-8)
nsubj:xsubj(block-21, Fused_Toes_Homolog-8)
dep(Fused_Toes_Homolog-8, 6-38-10)
det(antagonist-16, a-13)
amod(antagonist-16, putative-14)
compound(antagonist-16, FTH-15)
appos(Fused_Toes_Homolog-8, antagonist-16)
auxpass(found-19, was-18)
root(ROOT-0, found-19)
mark(block-21, to-20)
xcomp(found-19, block-21)
det(response-24, the-22)
amod(response-24, Thymalin-23)
dobj(block-21, response-24)
case(FTH-26, to-25)
nmod:to(response-24, FTH-26)

These/DT findings/NNS suggest/VBP that/IN FTH/NNP may/MD play/VB a/DT role/NN in/IN modulating/VBG thymic/JJ function/NN and/CC that/IN its/PRP$ effects/NNS are/VBP independent/JJ of/IN VIP/NNP signaling/VBG ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR
        (SBAR (IN that)
          (S
            (NP (NNP FTH))
            (VP (MD may)
              (VP (VB play)
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG modulating)
                      (NP (JJ thymic) (NN function)))))))))
        (CC and)
        (SBAR (IN that)
          (S
            (NP (PRP$ its) (NNS effects))
            (VP (VBP are)
              (NP
                (NP (JJ independent))
                (PP (IN of)
                  (NP (NNP VIP))))
              (S
                (VP (VBG signaling))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, FTH-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
mark(modulating-11, in-10)
advcl(play-7, modulating-11)
amod(function-13, thymic-12)
dobj(modulating-11, function-13)
cc(play-7, and-14)
mark(independent-19, that-15)
nmod:poss(effects-17, its-16)
nsubj(independent-19, effects-17)
cop(independent-19, are-18)
ccomp(suggest-3, independent-19)
conj:and(play-7, independent-19)
case(VIP-21, of-20)
nmod:of(independent-19, VIP-21)
xcomp(independent-19, signaling-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT precise/JJ mechanisms/NNS by/IN which/WDT FTH/NNP regulates/VBZ thymic/JJ function/NN and/CC its/PRP$ potential/JJ therapeutic/JJ applications/NNS in/IN immune-related_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP (DT the) (JJ precise) (NNS mechanisms))
              (PP (IN by)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (NP (NNP FTH))
                    (VP (VBZ regulates)
                      (NP
                        (NP (JJ thymic) (NN function))
                        (CC and)
                        (NP (PRP$ its) (JJ potential) (JJ therapeutic) (NNS applications)))))))
              (PP (IN in)
                (NP (NNS immune-related_disorders))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, precise-8)
dobj(elucidate-6, mechanisms-9)
mark(regulates-13, by-10)
dobj(regulates-13, which-11)
nsubj(regulates-13, FTH-12)
advcl(elucidate-6, regulates-13)
amod(function-15, thymic-14)
dobj(regulates-13, function-15)
cc(function-15, and-16)
nmod:poss(applications-20, its-17)
amod(applications-20, potential-18)
amod(applications-20, therapeutic-19)
dobj(regulates-13, applications-20)
conj:and(function-15, applications-20)
case(immune-related_disorders-22, in-21)
nmod:in(elucidate-6, immune-related_disorders-22)

The/DT development/NN of/IN H2_receptor/NNS agonists/VBZ has_been/VBN a/DT major/JJ focus/NN in/IN the/DT treatment/NN of/IN various/JJ gastrointestinal_disorders/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN development))
      (PP (IN of)
        (NP (NNS H2_receptor))))
    (VP (VBZ agonists)
      (VP (VBN has_been)
        (NP
          (NP (DT a) (JJ major) (NN focus))
          (PP (IN in)
            (NP
              (NP (DT the) (NN treatment))
              (PP (IN of)
                (NP (JJ various) (NNS gastrointestinal_disorders))))))))
    (. .)))

det(development-2, The-1)
nsubj(agonists-5, development-2)
case(H2_receptor-4, of-3)
nmod:of(development-2, H2_receptor-4)
root(ROOT-0, agonists-5)
dep(agonists-5, has_been-6)
det(focus-9, a-7)
amod(focus-9, major-8)
dobj(has_been-6, focus-9)
case(treatment-12, in-10)
det(treatment-12, the-11)
nmod:in(focus-9, treatment-12)
case(gastrointestinal_disorders-15, of-13)
amod(gastrointestinal_disorders-15, various-14)
nmod:of(treatment-12, gastrointestinal_disorders-15)

N-propionyl-4-S-cysteaminylphenol/RB -LRB-/-LRB- NPrCAP/NNP -RRB-/-RRB- is_a/JJ potent/JJ H2_receptor/NNS agonist/VBD that/IN has/VBZ shown/VBN promising/JJ results/NNS in/IN preclinical/JJ and/CC clinical/JJ studies/NNS ./.

(ROOT
  (S
    (ADVP (RB N-propionyl-4-S-cysteaminylphenol))
    (PRN (-LRB- -LRB-)
      (NP (NNP NPrCAP))
      (-RRB- -RRB-))
    (NP (JJ is_a) (JJ potent) (NNS H2_receptor))
    (VP (VBD agonist)
      (SBAR (IN that)
        (S
          (VP (VBZ has)
            (VP (VBN shown)
              (NP (JJ promising) (NNS results))
              (PP (IN in)
                (NP
                  (ADJP (JJ preclinical)
                    (CC and)
                    (JJ clinical))
                  (NNS studies))))))))
    (. .)))

advmod(agonist-8, N-propionyl-4-S-cysteaminylphenol-1)
dep(agonist-8, NPrCAP-3)
amod(H2_receptor-7, is_a-5)
amod(H2_receptor-7, potent-6)
nsubj(agonist-8, H2_receptor-7)
root(ROOT-0, agonist-8)
mark(shown-11, that-9)
aux(shown-11, has-10)
ccomp(agonist-8, shown-11)
amod(results-13, promising-12)
dobj(shown-11, results-13)
case(studies-18, in-14)
amod(studies-18, preclinical-15)
cc(preclinical-15, and-16)
conj:and(preclinical-15, clinical-17)
amod(studies-18, clinical-17)
nmod:in(shown-11, studies-18)

However/RB ,/, the/DT effects/NNS of/IN NPrCAP/NNP can/MD be/VB influenced/VBN by/IN various/JJ factors/NNS ,/, including/VBG its/PRP$ chemical/JJ modifications/NNS and/CC interactions/NNS with/IN other/JJ compounds/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP (NNP NPrCAP))))
    (VP (MD can)
      (VP (VB be)
        (VP (VBN influenced)
          (PP (IN by)
            (NP
              (NP (JJ various) (NNS factors))
              (, ,)
              (VP (VBG including)
                (NP (PRP$ its) (JJ chemical) (NNS modifications)
                  (CC and)
                  (NNS interactions)))))
          (PP (IN with)
            (NP (JJ other) (NNS compounds))))))
    (. .)))

advmod(influenced-9, However-1)
det(effects-4, the-3)
nsubjpass(influenced-9, effects-4)
case(NPrCAP-6, of-5)
nmod:of(effects-4, NPrCAP-6)
aux(influenced-9, can-7)
auxpass(influenced-9, be-8)
root(ROOT-0, influenced-9)
case(factors-12, by-10)
amod(factors-12, various-11)
nmod:by(influenced-9, factors-12)
acl(factors-12, including-14)
nmod:poss(modifications-17, its-15)
amod(modifications-17, chemical-16)
dobj(including-14, modifications-17)
cc(modifications-17, and-18)
dobj(including-14, interactions-19)
conj:and(modifications-17, interactions-19)
case(compounds-22, with-20)
amod(compounds-22, other-21)
nmod:with(influenced-9, compounds-22)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN NPrCAP/JJ monochloramine/NN and/CC dichloramine/NN on/IN H2_receptor/JJ activation/NN and/CC compared/VBN them/PRP to/TO the/DT effects/NNS of/IN unmodified/JJ NPrCAP/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP
      (VP (VBD investigated)
        (NP
          (NP (DT the) (NNS effects))
          (PP (IN of)
            (NP (JJ NPrCAP) (NN monochloramine)
              (CC and)
              (NN dichloramine))))
        (PP (IN on)
          (NP (JJ H2_receptor) (NN activation))))
      (CC and)
      (VP (VBN compared)
        (NP (PRP them))
        (PP (TO to)
          (NP
            (NP (DT the) (NNS effects))
            (PP (IN of)
              (NP (JJ unmodified) (NNP NPrCAP)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
nsubj(compared-18, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(monochloramine-11, of-9)
amod(monochloramine-11, NPrCAP-10)
nmod:of(effects-8, monochloramine-11)
cc(monochloramine-11, and-12)
nmod:of(effects-8, dichloramine-13)
conj:and(monochloramine-11, dichloramine-13)
case(activation-16, on-14)
amod(activation-16, H2_receptor-15)
nmod:on(investigated-6, activation-16)
cc(investigated-6, and-17)
conj:and(investigated-6, compared-18)
dobj(compared-18, them-19)
case(effects-22, to-20)
det(effects-22, the-21)
nmod:to(compared-18, effects-22)
case(NPrCAP-25, of-23)
amod(NPrCAP-25, unmodified-24)
nmod:of(effects-22, NPrCAP-25)

Our/PRP$ results/NNS showed/VBD that/IN unlike/IN the/DT effects/NNS of/IN unmodified/JJ NPrCAP/NNP ,/, the/DT H2_receptor/JJ agonist/JJ effects/NNS of/IN NPrCAP/JJ monochloramine/NN and/CC dichloramine/NN did/VBD not/RB disappear/VB after/IN repeated/VBN washout/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN unlike)
            (NP
              (NP (DT the) (NNS effects))
              (PP (IN of)
                (NP (JJ unmodified) (NNP NPrCAP)))))
          (, ,)
          (NP
            (NP (DT the) (JJ H2_receptor) (JJ agonist) (NNS effects))
            (PP (IN of)
              (NP (JJ NPrCAP) (NN monochloramine)
                (CC and)
                (NN dichloramine))))
          (VP (VBD did) (RB not)
            (VP (VB disappear)
              (PP (IN after)
                (NP (VBN repeated) (NN washout))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(disappear-23, that-4)
case(effects-7, unlike-5)
det(effects-7, the-6)
nmod:unlike(disappear-23, effects-7)
case(NPrCAP-10, of-8)
amod(NPrCAP-10, unmodified-9)
nmod:of(effects-7, NPrCAP-10)
det(effects-15, the-12)
amod(effects-15, H2_receptor-13)
amod(effects-15, agonist-14)
nsubj(disappear-23, effects-15)
case(monochloramine-18, of-16)
amod(monochloramine-18, NPrCAP-17)
nmod:of(effects-15, monochloramine-18)
cc(monochloramine-18, and-19)
nmod:of(effects-15, dichloramine-20)
conj:and(monochloramine-18, dichloramine-20)
aux(disappear-23, did-21)
neg(disappear-23, not-22)
ccomp(showed-3, disappear-23)
case(washout-26, after-24)
amod(washout-26, repeated-25)
nmod:after(disappear-23, washout-26)

Unlike/IN N-propionyl-4-S-cysteaminylphenol/JJ effects/NNS ,/, the/DT N-propionyl-4-S-cysteaminylphenol/JJ H2_receptor/JJ agonist/JJ effects/NNS of/IN N-propionyl-4-S-cysteaminylphenol/JJ monochloramine/JJ and_N-propionyl-4-S-cysteaminylphenol/JJ dichloramine/NN did/VBD not/RB disappear/VB after/IN repeated/VBN washout/NN ./.

(ROOT
  (S
    (PP (IN Unlike)
      (NP (JJ N-propionyl-4-S-cysteaminylphenol) (NNS effects)))
    (, ,)
    (NP
      (NP (DT the) (JJ N-propionyl-4-S-cysteaminylphenol) (JJ H2_receptor) (JJ agonist) (NNS effects))
      (PP (IN of)
        (NP (JJ N-propionyl-4-S-cysteaminylphenol) (JJ monochloramine) (JJ and_N-propionyl-4-S-cysteaminylphenol) (NN dichloramine))))
    (VP (VBD did) (RB not)
      (VP (VB disappear)
        (PP (IN after)
          (NP (VBN repeated) (NN washout)))))
    (. .)))

case(effects-3, Unlike-1)
amod(effects-3, N-propionyl-4-S-cysteaminylphenol-2)
nmod:unlike(disappear-17, effects-3)
det(effects-9, the-5)
amod(effects-9, N-propionyl-4-S-cysteaminylphenol-6)
amod(effects-9, H2_receptor-7)
amod(effects-9, agonist-8)
nsubj(disappear-17, effects-9)
case(dichloramine-14, of-10)
amod(dichloramine-14, N-propionyl-4-S-cysteaminylphenol-11)
amod(dichloramine-14, monochloramine-12)
amod(dichloramine-14, and_N-propionyl-4-S-cysteaminylphenol-13)
nmod:of(effects-9, dichloramine-14)
aux(disappear-17, did-15)
neg(disappear-17, not-16)
root(ROOT-0, disappear-17)
case(washout-20, after-18)
amod(washout-20, repeated-19)
nmod:after(disappear-17, washout-20)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO optimize/VB the/DT design/NN of/IN H2_receptor/JJ agonists/NNS for/IN clinical/JJ use/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB optimize)
                (NP
                  (NP (DT the) (NN design))
                  (PP (IN of)
                    (NP (JJ H2_receptor) (NNS agonists))))
                (PP (IN for)
                  (NP (JJ clinical) (NN use)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(effects-11, these-10)
dobj(underlying-9, effects-11)
cc(elucidate-6, and-12)
mark(optimize-14, to-13)
ccomp(needed-4, optimize-14)
conj:and(elucidate-6, optimize-14)
det(design-16, the-15)
dobj(optimize-14, design-16)
case(agonists-19, of-17)
amod(agonists-19, H2_receptor-18)
nmod:of(design-16, agonists-19)
case(use-22, for-20)
amod(use-22, clinical-21)
nmod:for(optimize-14, use-22)

CD24c-m/NNP is_a/VBZ key/JJ regulatory/JJ protein/NN in/IN skeletal_muscle/JJ differentiation/NN ./.

(ROOT
  (S
    (NP (NNP CD24c-m))
    (VP (VBZ is_a)
      (NP
        (NP (JJ key) (JJ regulatory) (NN protein))
        (PP (IN in)
          (NP (JJ skeletal_muscle) (NN differentiation)))))
    (. .)))

nsubj(is_a-2, CD24c-m-1)
root(ROOT-0, is_a-2)
amod(protein-5, key-3)
amod(protein-5, regulatory-4)
dobj(is_a-2, protein-5)
case(differentiation-8, in-6)
amod(differentiation-8, skeletal_muscle-7)
nmod:in(protein-5, differentiation-8)

We/PRP previously/RB reported/VBD that/IN PG11047/NNP up-regulated/VBD CD24/CD c-m/JJ protein/NN levels/NNS in/IN C2C12/CD cells/NNS in_a/JJ time-dependent/JJ manner/NN and/CC prolonged/JJ the/DT half-life/NN of/IN the/DT protein/NN ./.

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB previously))
    (VP (VBD reported)
      (SBAR (IN that)
        (S
          (NP (NNP PG11047))
          (VP (VBD up-regulated)
            (NP (CD CD24) (JJ c-m) (NN protein) (NNS levels))
            (PP (IN in)
              (NP
                (NP
                  (ADJP
                    (NP (CD C2C12) (NNS cells))
                    (JJ in_a))
                  (JJ time-dependent) (NN manner))
                (CC and)
                (NP
                  (NP (JJ prolonged) (DT the) (NN half-life))
                  (PP (IN of)
                    (NP (DT the) (NN protein))))))))))
    (. .)))

nsubj(reported-3, We-1)
advmod(reported-3, previously-2)
root(ROOT-0, reported-3)
mark(up-regulated-6, that-4)
nsubj(up-regulated-6, PG11047-5)
ccomp(reported-3, up-regulated-6)
nummod(levels-10, CD24-7)
amod(levels-10, c-m-8)
compound(levels-10, protein-9)
dobj(up-regulated-6, levels-10)
case(manner-16, in-11)
nummod(cells-13, C2C12-12)
nmod:npmod(in_a-14, cells-13)
amod(manner-16, in_a-14)
amod(manner-16, time-dependent-15)
nmod:in(up-regulated-6, manner-16)
cc(manner-16, and-17)
amod(half-life-20, prolonged-18)
det(half-life-20, the-19)
nmod:in(up-regulated-6, half-life-20)
conj:and(manner-16, half-life-20)
case(protein-23, of-21)
det(protein-23, the-22)
nmod:of(half-life-20, protein-23)

We/PRP also/RB found/VBD that/IN the/DT expression/NN and/CC stability/NN of/IN the/DT key/JJ regulatory/JJ proteins/NNS CD24a/NNS ,/, CD24b/NNS ,/, and/CC myogenin/NN were/VBD regulated/VBN by/IN the/DT small/JJ molecule/NN inhibitor/NN of/IN CD24/NNP -LRB-/-LRB- PG11047/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB also))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP
            (NP
              (UCP
                (ADVP (DT the) (NN expression))
                (CC and)
                (NP
                  (NP (NN stability))
                  (PP (IN of)
                    (NP (DT the) (JJ key) (JJ regulatory) (NNS proteins)))))
              (NNS CD24a))
            (, ,)
            (NP (NNS CD24b))
            (, ,)
            (CC and)
            (NP (NN myogenin)))
          (VP (VBD were)
            (VP (VBN regulated)
              (PP (IN by)
                (NP
                  (NP
                    (NP (DT the) (JJ small) (NN molecule) (NN inhibitor))
                    (PP (IN of)
                      (NP (NNP CD24))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP PG11047))
                    (-RRB- -RRB-)))))))))
    (. .)))

nsubj(found-3, We-1)
advmod(found-3, also-2)
root(ROOT-0, found-3)
mark(regulated-21, that-4)
det(expression-6, the-5)
advmod(CD24a-14, expression-6)
cc(expression-6, and-7)
conj:and(expression-6, stability-8)
advmod(CD24a-14, stability-8)
case(proteins-13, of-9)
det(proteins-13, the-10)
amod(proteins-13, key-11)
amod(proteins-13, regulatory-12)
nmod:of(stability-8, proteins-13)
nsubjpass(regulated-21, CD24a-14)
conj:and(CD24a-14, CD24b-16)
nsubjpass(regulated-21, CD24b-16)
cc(CD24a-14, and-18)
conj:and(CD24a-14, myogenin-19)
nsubjpass(regulated-21, myogenin-19)
auxpass(regulated-21, were-20)
ccomp(found-3, regulated-21)
case(inhibitor-26, by-22)
det(inhibitor-26, the-23)
amod(inhibitor-26, small-24)
compound(inhibitor-26, molecule-25)
nmod:by(regulated-21, inhibitor-26)
case(CD24-28, of-27)
nmod:of(inhibitor-26, CD24-28)
appos(inhibitor-26, PG11047-30)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN PG11047/NNP ,/, a/DT novel/JJ small/JJ molecule/NN inhibitor/NN ,/, on/IN C2C12/NNP cell/NN differentiation/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (NNP PG11047))
            (, ,)
            (NP (DT a) (JJ novel) (JJ small) (NN molecule) (NN inhibitor))
            (, ,))))
      (PP (IN on)
        (NP (NNP C2C12) (NN cell) (NN differentiation))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(PG11047-10, of-9)
nmod:of(effects-8, PG11047-10)
det(inhibitor-16, a-12)
amod(inhibitor-16, novel-13)
amod(inhibitor-16, small-14)
compound(inhibitor-16, molecule-15)
appos(PG11047-10, inhibitor-16)
case(differentiation-21, on-18)
compound(differentiation-21, C2C12-19)
compound(differentiation-21, cell-20)
nmod:on(investigated-6, differentiation-21)

When/WRB C2C12/NN cells/NNS were/VBD cultured/VBN in_a/JJ medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/,

(ROOT
  (SBARQ
    (WHADVP (WRB When))
    (S
      (NP (NN C2C12) (NNS cells))
      (VP (VBD were)
        (VP (VBN cultured)
          (NP (JJ in_a) (NN medium))
          (S
            (VP (VBG favoring)
              (NP
                (NP (NN differentiation))
                (PRN (-LRB- -LRB-)
                  (S
                    (NP (NNP Dulbecco))
                    (VP (VBN modified)
                      (NP
                        (NP (NNP Eagle) (NN medium))
                        (VP (VBG containing)
                          (NP
                            (ADJP (CD 2) (NN %))
                            (NN horse) (NN serum))))))
                  (-RRB- -RRB-)))))
          (, ,))))))

advmod(cultured-5, When-1)
compound(cells-3, C2C12-2)
nsubjpass(cultured-5, cells-3)
auxpass(cultured-5, were-4)
root(ROOT-0, cultured-5)
amod(medium-7, in_a-6)
dobj(cultured-5, medium-7)
xcomp(cultured-5, favoring-8)
dobj(favoring-8, differentiation-9)
nsubj(modified-12, Dulbecco-11)
dep(differentiation-9, modified-12)
compound(medium-14, Eagle-13)
dobj(modified-12, medium-14)
acl(medium-14, containing-15)
compound(%-17, 2-16)
amod(serum-19, %-17)
compound(serum-19, horse-18)
dobj(containing-15, serum-19)

PG11047/NNP up-regulated/VBD CD24c-m/JJ protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ CD24c-m/JJ protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (NNP PG11047))
    (VP (VBD up-regulated)
      (NP (JJ CD24c-m) (NN protein) (NNS levels))
      (NP (NN in_a)
        (NX
          (NX (JJ time-dependent) (NN manner))
          (CC and)
          (NX (JJ prolonged) (JJ CD24c-m) (NN protein)))
        (NX (NN half-life)))
      (PP (IN from)
        (NP
          (QP (CD 10) (TO to) (CD 18))
          (NNS hours))))
    (. .)))

nsubj(up-regulated-2, PG11047-1)
root(ROOT-0, up-regulated-2)
amod(levels-5, CD24c-m-3)
compound(levels-5, protein-4)
iobj(up-regulated-2, levels-5)
dep(half-life-13, in_a-6)
amod(manner-8, time-dependent-7)
dep(half-life-13, manner-8)
cc(manner-8, and-9)
amod(protein-12, prolonged-10)
amod(protein-12, CD24c-m-11)
conj:and(manner-8, protein-12)
dep(half-life-13, protein-12)
dobj(up-regulated-2, half-life-13)
case(hours-18, from-14)
compound(18-17, 10-15)
dep(18-17, to-16)
nummod(hours-18, 18-17)
nmod:from(up-regulated-2, hours-18)

These/DT findings/NNS suggest/VBP that/IN PG11047/NNP may/MD play/VB an/DT important/JJ role/NN in/IN promoting/VBG skeletal_muscle/JJ differentiation/NN by/IN regulating/VBG the/DT expression/NN and/CC stability/NN of/IN key/JJ regulatory/JJ proteins/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP PG11047))
          (VP (MD may)
            (VP (VB play)
              (NP (DT an) (JJ important) (NN role))
              (PP (IN in)
                (S
                  (VP (VBG promoting)
                    (NP (JJ skeletal_muscle) (NN differentiation))
                    (PP (IN by)
                      (S
                        (VP (VBG regulating)
                          (NP
                            (NP (DT the) (NN expression)
                              (CC and)
                              (NN stability))
                            (PP (IN of)
                              (NP (JJ key) (JJ regulatory) (NNS proteins)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, PG11047-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-10, an-8)
amod(role-10, important-9)
dobj(play-7, role-10)
mark(promoting-12, in-11)
advcl(play-7, promoting-12)
amod(differentiation-14, skeletal_muscle-13)
dobj(promoting-12, differentiation-14)
mark(regulating-16, by-15)
advcl(promoting-12, regulating-16)
det(expression-18, the-17)
dobj(regulating-16, expression-18)
cc(expression-18, and-19)
dobj(regulating-16, stability-20)
conj:and(expression-18, stability-20)
case(proteins-24, of-21)
amod(proteins-24, key-22)
amod(proteins-24, regulatory-23)
nmod:of(expression-18, proteins-24)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS of/IN PG11047/NNP action/NN and/CC its/PRP$ potential/JJ therapeutic/JJ applications/NNS in/IN muscle-related_diseases/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (NNP PG11047) (NN action))))
                (CC and)
                (NP
                  (NP (PRP$ its) (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN in)
                    (NP (NNS muscle-related_diseases))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
case(action-12, of-10)
compound(action-12, PG11047-11)
nmod:of(mechanisms-9, action-12)
cc(mechanisms-9, and-13)
nmod:poss(applications-17, its-14)
amod(applications-17, potential-15)
amod(applications-17, therapeutic-16)
dobj(elucidate-6, applications-17)
conj:and(mechanisms-9, applications-17)
case(muscle-related_diseases-19, in-18)
nmod:in(applications-17, muscle-related_diseases-19)

Fludarabine/JJ is_a/NN purine/VBP analog/JJ that/IN has_been/NN used/VBD to/TO treat/VB various/JJ types/NNS of/IN cancer/NN ./.

(ROOT
  (S
    (NP (JJ Fludarabine) (NN is_a))
    (VP (VBP purine)
      (ADJP (JJ analog))
      (SBAR (IN that)
        (S
          (NP (NN has_been))
          (VP (VBD used)
            (S
              (VP (TO to)
                (VP (VB treat)
                  (NP
                    (NP (JJ various) (NNS types))
                    (PP (IN of)
                      (NP (NN cancer)))))))))))
    (. .)))

amod(is_a-2, Fludarabine-1)
nsubj(purine-3, is_a-2)
root(ROOT-0, purine-3)
xcomp(purine-3, analog-4)
mark(used-7, that-5)
nsubj(used-7, has_been-6)
nsubj:xsubj(treat-9, has_been-6)
ccomp(purine-3, used-7)
mark(treat-9, to-8)
xcomp(used-7, treat-9)
amod(types-11, various-10)
dobj(treat-9, types-11)
case(cancer-13, of-12)
nmod:of(types-11, cancer-13)

The/DT drug/NN 's/POS efficacy/NN in/IN reducing/VBG the/DT risk/NN of/IN leukocytopenia/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN has_been/NN investigated/VBD ./.

(ROOT
  (S
    (NP
      (NP
        (NP (DT The) (NN drug) (POS 's))
        (NN efficacy))
      (PP (IN in)
        (S
          (VP (VBG reducing)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP
                  (NP (NN leukocytopenia))
                  (, ,)
                  (NP (NN photophobia))
                  (, ,)
                  (CC and)
                  (NP (NN phonophobia) (NN has_been)))))))))
    (VP (VBD investigated))
    (. .)))

det(drug-2, The-1)
nmod:poss(efficacy-4, drug-2)
case(drug-2, 's-3)
nsubj(investigated-17, efficacy-4)
mark(reducing-6, in-5)
acl(efficacy-4, reducing-6)
det(risk-8, the-7)
dobj(reducing-6, risk-8)
case(leukocytopenia-10, of-9)
nmod:of(risk-8, leukocytopenia-10)
nmod:of(risk-8, photophobia-12)
conj:and(leukocytopenia-10, photophobia-12)
cc(leukocytopenia-10, and-14)
compound(has_been-16, phonophobia-15)
nmod:of(risk-8, has_been-16)
conj:and(leukocytopenia-10, has_been-16)
root(ROOT-0, investigated-17)

At_2/JJ h/NN after/IN dosing/VBG ,/, Fludarabine/NNP reduced/VBD the/DT risk/NN of/IN Leukocytopenia/NNP by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/NN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP Fludarabine))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNP Leukocytopenia))))
      (PP (IN by)
        (NP
          (NP
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (SBAR
                    (S
                      (VP (VBP CI)
                        (NP
                          (NP
                            (NP (CD 6-20) (NN %))
                            (, ,)
                            (NP (NNP P)))
                          (X
                            (X (SYM =))
                            (NP (CD 0.0005))))))))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP
                (NP (NN photophobia))
                (NP (CD 17) (NN %)))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NP
              (NP (NN phonophobia))
              (NP (CD 14) (NN %))))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (PP (NNP CI)
                (NP (CD 17-20) (NN %))))
            (, ,)
            (NP (NNP P)
              (QP (CD <) (CD 0.0001)))
            (-RRB- -RRB-)))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, Fludarabine-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(Leukocytopenia-11, of-10)
nmod:of(risk-9, Leukocytopenia-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
nmod:by(reduced-7, photophobia-27)
conj:and(%-14, photophobia-27)
nummod(%-29, 17-28)
dep(photophobia-27, %-29)
nummod(%-32, 95-31)
appos(photophobia-27, %-32)
dep(%-35, CI-33)
nummod(%-35, 12-22-34)
nmod(%-32, %-35)
dep(%-32, P-37)
compound(0.0001-39, <-38)
nummod(P-37, 0.0001-39)
cc(%-14, and-42)
nmod:by(reduced-7, phonophobia-43)
conj:and(%-14, phonophobia-43)
nummod(%-45, 14-44)
dep(phonophobia-43, %-45)
nummod(%-48, 95-47)
appos(%-14, %-48)
dep(%-51, CI-49)
nummod(%-51, 17-20-50)
nmod(%-48, %-51)
dep(%-48, P-53)
compound(0.0001-55, <-54)
nummod(P-53, 0.0001-55)

These/DT results/NNS suggest/VBP that/IN Fludarabine/NNP may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN patients/NNS experiencing/VBG these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Fludarabine))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (NP
                    (NP (NNS patients))
                    (VP (VBG experiencing)
                      (NP (DT these) (NNS symptoms)))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Fludarabine-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
acl(patients-13, experiencing-14)
det(symptoms-16, these-15)
dobj(experiencing-14, symptoms-16)

However/RB ,/, further/JJ studies/NNS are/VBP needed/VBN to/TO determine/VB the/DT long-term/JJ effects/NNS of/IN Fludarabine/NNP on/IN leukocytopenia/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ,/, as/RB well/RB as/IN its/PRP$ potential/JJ side/NN effects/NNS and/CC interactions/NNS with/IN other/JJ medications/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (JJ further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (DT the) (JJ long-term) (NNS effects))
                (PP (IN of)
                  (NP (NNP Fludarabine)))
                (PP (IN on)
                  (NP
                    (NP (NN leukocytopenia))
                    (, ,)
                    (NP (NN photophobia))
                    (, ,)
                    (CC and)
                    (NP
                      (NP (NN phonophobia))
                      (, ,)
                      (ADVP (RB as) (RB well)
                        (PP (IN as)
                          (NP
                            (NP (PRP$ its) (JJ potential) (NN side) (NNS effects))
                            (CC and)
                            (NP
                              (NP (NNS interactions))
                              (PP (IN with)
                                (NP (JJ other) (NNS medications))))))))))))))))
    (. .)))

advmod(needed-6, However-1)
amod(studies-4, further-3)
nsubjpass(needed-6, studies-4)
nsubj:xsubj(determine-8, studies-4)
auxpass(needed-6, are-5)
root(ROOT-0, needed-6)
mark(determine-8, to-7)
xcomp(needed-6, determine-8)
det(effects-11, the-9)
amod(effects-11, long-term-10)
dobj(determine-8, effects-11)
case(Fludarabine-13, of-12)
nmod:of(effects-11, Fludarabine-13)
case(leukocytopenia-15, on-14)
nmod:on(effects-11, leukocytopenia-15)
nmod:on(effects-11, photophobia-17)
conj:and(leukocytopenia-15, photophobia-17)
cc(leukocytopenia-15, and-19)
nmod:on(effects-11, phonophobia-20)
conj:and(leukocytopenia-15, phonophobia-20)
advmod(well-23, as-22)
advmod(phonophobia-20, well-23)
case(effects-28, as-24)
nmod:poss(effects-28, its-25)
amod(effects-28, potential-26)
compound(effects-28, side-27)
nmod:as(well-23, effects-28)
cc(effects-28, and-29)
nmod:as(well-23, interactions-30)
conj:and(effects-28, interactions-30)
case(medications-33, with-31)
amod(medications-33, other-32)
nmod:with(interactions-30, medications-33)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(studied-25, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(studied-25, have-22)
auxpass(studied-25, been-23)
advmod(studied-25, extensively-24)
root(ROOT-0, studied-25)
case(benefits-30, for-26)
nmod:poss(benefits-30, their-27)
amod(benefits-30, potential-28)
compound(benefits-30, health-29)
nmod:for(studied-25, benefits-30)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN Flupirtine/JJ levels/NNS in/IN hyperFlupirtinemic/JJ patients/NNS and/CC decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ Flupirtine) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperFlupirtinemic) (NNS patients))
                        (CC and)
                        (NP
                          (NP
                            (NP (VBN decreased) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, Flupirtine-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperFlupirtinemic-15)
nmod:in(levels-13, patients-16)
cc(patients-16, and-17)
amod(risk-19, decreased-18)
nmod:in(levels-13, risk-19)
conj:and(patients-16, risk-19)
mark(developing-21, of-20)
acl(risk-19, developing-21)
dobj(developing-21, coronary_heart_disease-22)
appos(risk-19, CHD-24)

EPA/NNP and/CC DHA/NNP are/VBP known/VBN to/TO have/VB anti-inflammatory/JJ effects/NNS ,/, which/WDT may/MD explain/VB their/PRP$ cardioprotective/JJ properties/NNS ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP
                (NP (JJ anti-inflammatory) (NNS effects))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (MD may)
                      (VP (VB explain)
                        (NP (PRP$ their) (JJ cardioprotective) (NNS properties))))))))))))
    (. .)))

nsubjpass(known-5, EPA-1)
nsubj:xsubj(have-7, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(known-5, DHA-3)
nsubj:xsubj(have-7, DHA-3)
auxpass(known-5, are-4)
root(ROOT-0, known-5)
mark(have-7, to-6)
xcomp(known-5, have-7)
amod(effects-9, anti-inflammatory-8)
dobj(have-7, effects-9)
nsubj(explain-13, effects-9)
ref(effects-9, which-11)
aux(explain-13, may-12)
acl:relcl(effects-9, explain-13)
nmod:poss(properties-16, their-14)
amod(properties-16, cardioprotective-15)
dobj(explain-13, properties-16)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, are/VBP associated/VBN with/IN decreased/VBN Flupirtine/NNP levels/NNS in/IN hyperFlupirtinemic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN associated)
          (PP (IN with)
            (NP (VBN decreased) (NNP Flupirtine) (NNS levels)))
          (PP (IN in)
            (NP (JJ hyperFlupirtinemic) (NNS patients)))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(associated-23, omega-3_fatty_acids-2)
nsubjpass(decreased-32, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
auxpass(associated-23, are-22)
root(ROOT-0, associated-23)
case(levels-27, with-24)
amod(levels-27, decreased-25)
compound(levels-27, Flupirtine-26)
nmod:with(associated-23, levels-27)
case(patients-30, in-28)
amod(patients-30, hyperFlupirtinemic-29)
nmod:in(associated-23, patients-30)
cc(associated-23, and-31)
conj:and(associated-23, decreased-32)
dobj(decreased-32, risk-33)
case(coronary_heart_disease-36, of-34)
amod(coronary_heart_disease-36, developing-35)
nmod:of(risk-33, coronary_heart_disease-36)
appos(coronary_heart_disease-36, CHD-38)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB a/DT useful/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP in/IN high-risk/JJ populations/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (JJ dietary) (NN intake))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ useful) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NNP CHD))))
                      (PP (IN in)
                        (NP (JJ high-risk) (NNS populations))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-16, that-4)
amod(intake-7, increasing-5)
amod(intake-7, dietary-6)
nsubj(strategy-16, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, a-14)
amod(strategy-16, useful-15)
ccomp(suggest-3, strategy-16)
mark(reducing-18, for-17)
acl(strategy-16, reducing-18)
det(risk-20, the-19)
dobj(reducing-18, risk-20)
case(CHD-22, of-21)
nmod:of(risk-20, CHD-22)
case(populations-25, in-23)
amod(populations-25, high-risk-24)
nmod:in(reducing-18, populations-25)

However/RB ,/, further/JJ research/NN is/VBZ needed/VBN to/TO determine/VB the/DT optimal/JJ doses/NNS and/CC duration/NN of/IN omega-3_fatty_acid/JJ supplementation/NN for/IN cardiovascular_disease/JJ prevention/NN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (JJ further) (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (DT the) (JJ optimal) (NNS doses))
                (CC and)
                (NP
                  (NP (NN duration))
                  (PP (IN of)
                    (NP
                      (NP (JJ omega-3_fatty_acid) (NN supplementation))
                      (PP (IN for)
                        (NP (JJ cardiovascular_disease) (NN prevention))))))))))))
    (. .)))

advmod(needed-6, However-1)
amod(research-4, further-3)
nsubjpass(needed-6, research-4)
nsubj:xsubj(determine-8, research-4)
auxpass(needed-6, is-5)
root(ROOT-0, needed-6)
mark(determine-8, to-7)
xcomp(needed-6, determine-8)
det(doses-11, the-9)
amod(doses-11, optimal-10)
dobj(determine-8, doses-11)
cc(doses-11, and-12)
dobj(determine-8, duration-13)
conj:and(doses-11, duration-13)
case(supplementation-16, of-14)
amod(supplementation-16, omega-3_fatty_acid-15)
nmod:of(duration-13, supplementation-16)
case(prevention-19, for-17)
amod(prevention-19, cardiovascular_disease-18)
nmod:for(supplementation-16, prevention-19)

When/WRB C2C12/JJ cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, verticillin_A/JJ up-regulated/JJ Suv39H1/JJ protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ Suv39H1/NNS protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (SBARQ
    (WHNP
      (WHADJP (WRB When) (JJ C2C12))
      (NNS cells))
    (SQ (VBD were)
      (VP (VBN cultured)
        (NP (NN in_a)
          (NX
            (NX
              (NX (NN medium) (VBG favoring) (NN differentiation))
              (PRN (-LRB- -LRB-)
                (NAC (NNP Dulbecco)
                  (PP (VBN modified)
                    (NP
                      (NP (NNP Eagle) (NN medium))
                      (VP (VBG containing)
                        (NP
                          (ADJP (CD 2) (NN %))
                          (NN horse) (NN serum))))))
                (-RRB- -RRB-))
              (, ,)
              (NP
                (NP (JJ verticillin_A) (JJ up-regulated) (JJ Suv39H1) (NN protein) (NNS levels))
                (NP (NN in_a) (JJ time-dependent) (NN manner))))
            (CC and)
            (NX (JJ prolonged) (NNS Suv39H1)))
          (NX (NN protein) (NN half-life)))
        (PP (IN from)
          (NP
            (QP (CD 10) (TO to) (CD 18))
            (NNS hours)))))
    (. .)))

advmod(C2C12-2, When-1)
amod(cells-3, C2C12-2)
nsubjpass(cultured-5, cells-3)
auxpass(cultured-5, were-4)
root(ROOT-0, cultured-5)
dep(half-life-34, in_a-6)
compound(differentiation-9, medium-7)
amod(differentiation-9, favoring-8)
dep(half-life-34, differentiation-9)
dep(differentiation-9, Dulbecco-11)
case(medium-14, modified-12)
compound(medium-14, Eagle-13)
nmod:modified(Dulbecco-11, medium-14)
acl(medium-14, containing-15)
compound(%-17, 2-16)
amod(serum-19, %-17)
compound(serum-19, horse-18)
dobj(containing-15, serum-19)
amod(levels-26, verticillin_A-22)
amod(levels-26, up-regulated-23)
amod(levels-26, Suv39H1-24)
compound(levels-26, protein-25)
dep(differentiation-9, levels-26)
compound(manner-29, in_a-27)
amod(manner-29, time-dependent-28)
dep(levels-26, manner-29)
cc(differentiation-9, and-30)
amod(Suv39H1-32, prolonged-31)
conj:and(differentiation-9, Suv39H1-32)
dep(half-life-34, Suv39H1-32)
compound(half-life-34, protein-33)
dobj(cultured-5, half-life-34)
case(hours-39, from-35)
compound(18-38, 10-36)
dep(18-38, to-37)
nummod(hours-39, 18-38)
nmod:from(cultured-5, hours-39)

Here/RB ,/, we/PRP investigated/VBD the/DT effect/NN of/IN verticillin_A/NN on/IN Suv39H1/JJ protein/NN levels/NNS during/IN C2C12/NNP cell/NN differentiation/NN ./.

(ROOT
  (S
    (ADVP (RB Here))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NN verticillin_A))))
      (PP (IN on)
        (NP (JJ Suv39H1) (NN protein) (NNS levels)))
      (PP (IN during)
        (NP (NNP C2C12) (NN cell) (NN differentiation))))
    (. .)))

advmod(investigated-4, Here-1)
nsubj(investigated-4, we-3)
root(ROOT-0, investigated-4)
det(effect-6, the-5)
dobj(investigated-4, effect-6)
case(verticillin_A-8, of-7)
nmod:of(effect-6, verticillin_A-8)
case(levels-12, on-9)
amod(levels-12, Suv39H1-10)
compound(levels-12, protein-11)
nmod:on(investigated-4, levels-12)
case(differentiation-16, during-13)
compound(differentiation-16, C2C12-14)
compound(differentiation-16, cell-15)
nmod:during(investigated-4, differentiation-16)

Our/PRP$ results/NNS showed/VBD that/IN when/WRB C2C12/NNP cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, verticillin_A/JJ up-regulated/JJ Suv39H1/JJ protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ Suv39H1/NNS protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (WHADVP (WRB when))
        (S
          (NP (NNP C2C12) (NNS cells))
          (VP (VBD were)
            (VP (VBN cultured)
              (NP (NN in_a)
                (NX
                  (NX
                    (NX (NN medium) (VBG favoring) (NN differentiation))
                    (PRN (-LRB- -LRB-)
                      (NAC (NNP Dulbecco)
                        (PP (VBN modified)
                          (NP
                            (NP (NNP Eagle) (NN medium))
                            (VP (VBG containing)
                              (NP
                                (ADJP (CD 2) (NN %))
                                (NN horse) (NN serum))))))
                      (-RRB- -RRB-))
                    (, ,)
                    (NP
                      (NP (JJ verticillin_A) (JJ up-regulated) (JJ Suv39H1) (NN protein) (NNS levels))
                      (NP (NN in_a) (JJ time-dependent) (NN manner))))
                  (CC and)
                  (NX (JJ prolonged) (NNS Suv39H1)))
                (NX (NN protein) (NN half-life)))
              (PP (IN from)
                (NP
                  (QP (CD 10) (TO to) (CD 18))
                  (NNS hours))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(cultured-9, that-4)
advmod(cultured-9, when-5)
compound(cells-7, C2C12-6)
nsubjpass(cultured-9, cells-7)
auxpass(cultured-9, were-8)
ccomp(showed-3, cultured-9)
dep(half-life-38, in_a-10)
compound(differentiation-13, medium-11)
amod(differentiation-13, favoring-12)
dep(half-life-38, differentiation-13)
dep(differentiation-13, Dulbecco-15)
case(medium-18, modified-16)
compound(medium-18, Eagle-17)
nmod:modified(Dulbecco-15, medium-18)
acl(medium-18, containing-19)
compound(%-21, 2-20)
amod(serum-23, %-21)
compound(serum-23, horse-22)
dobj(containing-19, serum-23)
amod(levels-30, verticillin_A-26)
amod(levels-30, up-regulated-27)
amod(levels-30, Suv39H1-28)
compound(levels-30, protein-29)
dep(differentiation-13, levels-30)
compound(manner-33, in_a-31)
amod(manner-33, time-dependent-32)
dep(levels-30, manner-33)
cc(differentiation-13, and-34)
amod(Suv39H1-36, prolonged-35)
conj:and(differentiation-13, Suv39H1-36)
dep(half-life-38, Suv39H1-36)
compound(half-life-38, protein-37)
dobj(cultured-9, half-life-38)
case(hours-43, from-39)
compound(18-42, 10-40)
dep(18-42, to-41)
nummod(hours-43, 18-42)
nmod:from(cultured-9, hours-43)

Suv39H1/JJ is_a/NN histone_methyltransferase/VBD that/IN plays/VBZ an/DT important/JJ role/NN in/IN regulating/VBG gene/NN expression/NN during/IN skeletal_muscle/JJ differentiation/NN ./.

(ROOT
  (S
    (NP (JJ Suv39H1) (NN is_a))
    (VP (VBD histone_methyltransferase)
      (SBAR (IN that)
        (S
          (VP (VBZ plays)
            (NP
              (NP (DT an) (JJ important) (NN role))
              (PP (IN in)
                (S
                  (VP (VBG regulating)
                    (NP (NN gene) (NN expression))
                    (PP (IN during)
                      (NP (JJ skeletal_muscle) (NN differentiation)))))))))))
    (. .)))

amod(is_a-2, Suv39H1-1)
nsubj(histone_methyltransferase-3, is_a-2)
root(ROOT-0, histone_methyltransferase-3)
mark(plays-5, that-4)
ccomp(histone_methyltransferase-3, plays-5)
det(role-8, an-6)
amod(role-8, important-7)
dobj(plays-5, role-8)
mark(regulating-10, in-9)
acl(role-8, regulating-10)
compound(expression-12, gene-11)
dobj(regulating-10, expression-12)
case(differentiation-15, during-13)
amod(differentiation-15, skeletal_muscle-14)
nmod:during(regulating-10, differentiation-15)

These/DT findings/NNS suggest/VBP that/IN verticillin_A/NN may/MD be/VB a/DT potential/JJ therapeutic/JJ agent/NN for/IN promoting/VBG skeletal_muscle/JJ differentiation/NN through/IN the/DT up-regulation/NN of/IN Suv39H1/JJ protein/NN levels/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN verticillin_A))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ potential) (JJ therapeutic) (NN agent))
                (PP (IN for)
                  (S
                    (VP (VBG promoting)
                      (NP (JJ skeletal_muscle) (NN differentiation))
                      (PP (IN through)
                        (NP
                          (NP (DT the) (NN up-regulation))
                          (PP (IN of)
                            (NP (JJ Suv39H1) (NN protein) (NNS levels))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(agent-11, that-4)
nsubj(agent-11, verticillin_A-5)
aux(agent-11, may-6)
cop(agent-11, be-7)
det(agent-11, a-8)
amod(agent-11, potential-9)
amod(agent-11, therapeutic-10)
ccomp(suggest-3, agent-11)
mark(promoting-13, for-12)
acl(agent-11, promoting-13)
amod(differentiation-15, skeletal_muscle-14)
dobj(promoting-13, differentiation-15)
case(up-regulation-18, through-16)
det(up-regulation-18, the-17)
nmod:through(promoting-13, up-regulation-18)
case(levels-22, of-19)
amod(levels-22, Suv39H1-20)
compound(levels-22, protein-21)
nmod:of(up-regulation-18, levels-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS of/IN verticillin_A-mediated/JJ regulation/NN of/IN Suv39H1/NNS and/CC its/PRP$ potential/JJ therapeutic/JJ applications/NNS in/IN skeletal_muscle/JJ disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (PP (IN of)
                  (NP
                    (NP (JJ verticillin_A-mediated) (NN regulation))
                    (PP (IN of)
                      (NP
                        (NP (NNS Suv39H1))
                        (CC and)
                        (NP
                          (NP (PRP$ its) (JJ potential) (JJ therapeutic) (NNS applications))
                          (PP (IN in)
                            (NP (JJ skeletal_muscle) (NNS disorders))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
case(regulation-12, of-10)
amod(regulation-12, verticillin_A-mediated-11)
nmod:of(mechanisms-9, regulation-12)
case(Suv39H1-14, of-13)
nmod:of(regulation-12, Suv39H1-14)
cc(Suv39H1-14, and-15)
nmod:poss(applications-19, its-16)
amod(applications-19, potential-17)
amod(applications-19, therapeutic-18)
nmod:of(regulation-12, applications-19)
conj:and(Suv39H1-14, applications-19)
case(disorders-22, in-20)
amod(disorders-22, skeletal_muscle-21)
nmod:in(applications-19, disorders-22)

The/DT endocannabinoid/JJ system/NN plays/VBZ a/DT crucial/JJ role/NN in/IN the/DT regulation/NN of/IN various/JJ physiological/JJ processes/NNS ,/, including/VBG inflammation/NN ,/, pain/NN ,/, and/CC mood/NN ./.

(ROOT
  (S
    (NP (DT The) (JJ endocannabinoid) (NN system))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN regulation))
            (PP (IN of)
              (NP
                (NP (JJ various) (JJ physiological) (NNS processes))
                (, ,)
                (VP (VBG including)
                  (NP
                    (NP (NN inflammation))
                    (, ,)
                    (NP (NN pain))
                    (, ,)
                    (CC and)
                    (NP (NN mood))))))))))
    (. .)))

det(system-3, The-1)
amod(system-3, endocannabinoid-2)
nsubj(plays-4, system-3)
root(ROOT-0, plays-4)
det(role-7, a-5)
amod(role-7, crucial-6)
dobj(plays-4, role-7)
case(regulation-10, in-8)
det(regulation-10, the-9)
nmod:in(role-7, regulation-10)
case(processes-14, of-11)
amod(processes-14, various-12)
amod(processes-14, physiological-13)
nmod:of(regulation-10, processes-14)
acl(processes-14, including-16)
dobj(including-16, inflammation-17)
dobj(including-16, pain-19)
conj:and(inflammation-17, pain-19)
cc(inflammation-17, and-21)
dobj(including-16, mood-22)
conj:and(inflammation-17, mood-22)

The/DT system/NN is/VBZ composed/VBN of/IN two/CD main/JJ receptors/NNS ,/, CB1/NNP and/CC CB2/NNP ,/, which/WDT are/VBP activated/VBN by/IN endogenous/JJ cannabinoids/NNS ./.

(ROOT
  (S
    (NP (DT The) (NN system))
    (VP (VBZ is)
      (VP (VBN composed)
        (PP (IN of)
          (NP
            (NP (CD two) (JJ main) (NNS receptors))
            (, ,)
            (NP (NNP CB1)
              (CC and)
              (NNP CB2))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (VBP are)
                  (VP (VBN activated)
                    (PP (IN by)
                      (NP (JJ endogenous) (NNS cannabinoids)))))))))))
    (. .)))

det(system-2, The-1)
nsubjpass(composed-4, system-2)
auxpass(composed-4, is-3)
root(ROOT-0, composed-4)
case(receptors-8, of-5)
nummod(receptors-8, two-6)
amod(receptors-8, main-7)
nmod:of(composed-4, receptors-8)
nsubjpass(activated-16, receptors-8)
appos(receptors-8, CB1-10)
cc(CB1-10, and-11)
appos(receptors-8, CB2-12)
conj:and(CB1-10, CB2-12)
ref(receptors-8, which-14)
auxpass(activated-16, are-15)
acl:relcl(receptors-8, activated-16)
case(cannabinoids-19, by-17)
amod(cannabinoids-19, endogenous-18)
nmod:by(activated-16, cannabinoids-19)

The/DT stimulatory/JJ effects/NNS of/IN GPR-32/NNP -LRB-/-LRB- 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M/NNP -RRB-/-RRB- on/IN MAG-DHA/JJ levels/NNS were/VBD antagonized/VBN by/IN the/DT ETA_receptor/NNP antagonist/NNP BQ_123/NNP ,/,

(ROOT
  (S
    (NP
      (NP (DT The) (JJ stimulatory) (NNS effects))
      (PP (IN of)
        (NP
          (NP (NNP GPR-32))
          (PRN (-LRB- -LRB-)
            (NP
              (NP
                (NP (CD 10))
                (PRN (-LRB- -LRB-)
                  (NP (CD -6))
                  (-RRB- -RRB-)))
              (NP (NNP M)))
            (-RRB- -RRB-))))
      (PP (IN on)
        (NP (JJ MAG-DHA) (NNS levels))))
    (VP (VBD were)
      (VP (VBN antagonized)
        (PP (IN by)
          (NP (DT the) (NNP ETA_receptor) (NNP antagonist) (NNP BQ_123)))))
    (, ,)))

det(effects-3, The-1)
amod(effects-3, stimulatory-2)
nsubjpass(antagonized-17, effects-3)
case(GPR-32-5, of-4)
nmod:of(effects-3, GPR-32-5)
dep(GPR-32-5, 10-7)
appos(10-7, -6-9)
appos(10-7, M-11)
case(levels-15, on-13)
amod(levels-15, MAG-DHA-14)
nmod:on(effects-3, levels-15)
auxpass(antagonized-17, were-16)
root(ROOT-0, antagonized-17)
case(BQ_123-22, by-18)
det(BQ_123-22, the-19)
compound(BQ_123-22, ETA_receptor-20)
compound(BQ_123-22, antagonist-21)
nmod:by(antagonized-17, BQ_123-22)

2/CD x/SYM 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M/NNP ,/, and/CC the/DT ETB/NNP receptor/NN agonist/NN IRL_1620/NNP evoked/VBD only/RB a/DT weak/JJ increase/NN in/IN MAG-DHA/JJ levels/NNS ./.

(ROOT
  (S
    (ADVP
      (ADVP (CD 2))
      (SBAR
        (X (SYM x))
        (S
          (NP
            (NP (CD 10))
            (PRN (-LRB- -LRB-)
              (NP (CD -6))
              (-RRB- -RRB-)))
          (NP
            (NP (NNP M))
            (, ,)
            (CC and)
            (NP (DT the) (NNP ETB) (NN receptor) (NN agonist))))))
    (NP (NNP IRL_1620))
    (VP (VBD evoked)
      (NP
        (NP (RB only) (DT a) (JJ weak) (NN increase))
        (PP (IN in)
          (NP (JJ MAG-DHA) (NNS levels)))))
    (. .)))

advmod(evoked-15, 2-1)
dep(M-7, x-2)
dep(M-7, 10-3)
appos(10-3, -6-5)
advcl(2-1, M-7)
cc(M-7, and-9)
det(agonist-13, the-10)
compound(agonist-13, ETB-11)
compound(agonist-13, receptor-12)
advcl(2-1, agonist-13)
conj:and(M-7, agonist-13)
nsubj(evoked-15, IRL_1620-14)
root(ROOT-0, evoked-15)
advmod(increase-19, only-16)
det(increase-19, a-17)
amod(increase-19, weak-18)
dobj(evoked-15, increase-19)
case(levels-22, in-20)
amod(levels-22, MAG-DHA-21)
nmod:in(increase-19, levels-22)

One/CD such/JJ receptor/NN is/VBZ GPR-32/NN ,/, which/WDT has_been/VBP shown/VBN to/TO stimulate/VB the/DT production/NN of/IN MAG-DHA/NNP in/IN vitro/NN ./.

(ROOT
  (S
    (NP (CD One) (JJ such) (NN receptor))
    (VP (VBZ is)
      (NP
        (NP (NN GPR-32))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBP has_been)
              (VP (VBN shown)
                (S
                  (VP (TO to)
                    (VP (VB stimulate)
                      (NP
                        (NP (DT the) (NN production))
                        (PP (IN of)
                          (NP (NNP MAG-DHA))))
                      (PP (IN in)
                        (NP (NN vitro))))))))))))
    (. .)))

nummod(receptor-3, One-1)
amod(receptor-3, such-2)
nsubj(GPR-32-5, receptor-3)
cop(GPR-32-5, is-4)
root(ROOT-0, GPR-32-5)
nsubj(has_been-8, GPR-32-5)
ref(GPR-32-5, which-7)
acl:relcl(GPR-32-5, has_been-8)
dep(has_been-8, shown-9)
mark(stimulate-11, to-10)
xcomp(shown-9, stimulate-11)
det(production-13, the-12)
dobj(stimulate-11, production-13)
case(MAG-DHA-15, of-14)
nmod:of(production-13, MAG-DHA-15)
case(vitro-17, in-16)
nmod:in(stimulate-11, vitro-17)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN GPR-32/JJ activation/NN on/IN MAG-DHA/JJ levels/NNS and/CC whether/IN these/DT effects/NNS were/VBD mediated/VBN by/IN endothelin/NN receptors/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (UCP
              (NP
                (NP (JJ GPR-32) (NN activation))
                (PP (IN on)
                  (NP (JJ MAG-DHA) (NNS levels))))
              (CC and)
              (SBAR (IN whether)
                (S
                  (NP (DT these) (NNS effects))
                  (VP (VBD were)
                    (VP (VBN mediated)
                      (PP (IN by)
                        (NP (NN endothelin))))))))
            (NNS receptors)))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(receptors-23, of-9)
amod(activation-11, GPR-32-10)
compound(receptors-23, activation-11)
case(levels-14, on-12)
amod(levels-14, MAG-DHA-13)
nmod:on(activation-11, levels-14)
cc(activation-11, and-15)
mark(mediated-20, whether-16)
det(effects-18, these-17)
nsubjpass(mediated-20, effects-18)
auxpass(mediated-20, were-19)
conj:and(activation-11, mediated-20)
compound(receptors-23, mediated-20)
case(endothelin-22, by-21)
nmod:by(mediated-20, endothelin-22)
nmod:of(effects-8, receptors-23)

Our/PRP$ results/NNS show/VBP that/IN GPR-32/JJ stimulation/NN increased/VBD MAG-DHA/JJ levels/NNS in_a/JJ dose-dependent/JJ manner/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP show)
      (SBAR (IN that)
        (S
          (NP (JJ GPR-32) (NN stimulation))
          (VP (VBD increased)
            (NP
              (NP (JJ MAG-DHA) (NNS levels))
              (NP (JJ in_a) (JJ dose-dependent) (NN manner)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(show-3, results-2)
root(ROOT-0, show-3)
mark(increased-7, that-4)
amod(stimulation-6, GPR-32-5)
nsubj(increased-7, stimulation-6)
ccomp(show-3, increased-7)
amod(levels-9, MAG-DHA-8)
dobj(increased-7, levels-9)
amod(manner-12, in_a-10)
amod(manner-12, dose-dependent-11)
dep(levels-9, manner-12)

However/RB ,/, this/DT effect/NN was/VBD blocked/VBN by/IN the/DT ETA_receptor/NNP antagonist/NNP BQ_123/NNP and/CC was/VBD not/RB observed/VBN with/IN the/DT ETB/NNP receptor/NN agonist/NN IRL_1620/NN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (DT this) (NN effect))
    (VP
      (VP (VBD was)
        (VP (VBN blocked)
          (PP (IN by)
            (NP (DT the) (NNP ETA_receptor) (NNP antagonist) (NNP BQ_123)))))
      (CC and)
      (VP (VBD was) (RB not)
        (VP (VBN observed)
          (PP (IN with)
            (NP (DT the) (NNP ETB) (NN receptor) (NN agonist) (NN IRL_1620))))))
    (. .)))

advmod(blocked-6, However-1)
det(effect-4, this-3)
nsubjpass(blocked-6, effect-4)
nsubjpass(observed-15, effect-4)
auxpass(blocked-6, was-5)
root(ROOT-0, blocked-6)
case(BQ_123-11, by-7)
det(BQ_123-11, the-8)
compound(BQ_123-11, ETA_receptor-9)
compound(BQ_123-11, antagonist-10)
nmod:by(blocked-6, BQ_123-11)
cc(blocked-6, and-12)
auxpass(observed-15, was-13)
neg(observed-15, not-14)
conj:and(blocked-6, observed-15)
case(IRL_1620-21, with-16)
det(IRL_1620-21, the-17)
compound(IRL_1620-21, ETB-18)
compound(IRL_1620-21, receptor-19)
compound(IRL_1620-21, agonist-20)
nmod:with(observed-15, IRL_1620-21)

These/DT findings/NNS suggest/VBP that/IN GPR-32/NNP may/MD interact/VB with/IN endothelin/NN receptors/NNS to/TO modulate/VBP endocannabinoid/VBN signaling/VBG and/CC highlight/VB potential/JJ new/JJ targets/NNS for/IN therapeutic/JJ intervention/NN in/IN diseases/NNS associated/VBN with/IN dysregulated/JJ endocannabinoid/JJ function/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP GPR-32))
          (VP (MD may)
            (VP
              (VP (VB interact)
                (PP (IN with)
                  (NP
                    (NP (NN endothelin) (NNS receptors))
                    (X (TO to))
                    (SBAR
                      (S
                        (VP (VBP modulate)
                          (VP (VBN endocannabinoid)
                            (VP (VBG signaling)))))))))
              (CC and)
              (VP (VB highlight)
                (NP
                  (NP (JJ potential) (JJ new) (NNS targets))
                  (PP (IN for)
                    (NP (JJ therapeutic) (NN intervention))))
                (PP (IN in)
                  (NP
                    (NP (NNS diseases))
                    (VP (VBN associated)
                      (PP (IN with)
                        (NP (JJ dysregulated) (JJ endocannabinoid) (NN function))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(interact-7, that-4)
nsubj(interact-7, GPR-32-5)
nsubj(highlight-16, GPR-32-5)
aux(interact-7, may-6)
ccomp(suggest-3, interact-7)
case(receptors-10, with-8)
compound(receptors-10, endothelin-9)
nmod:with(interact-7, receptors-10)
dep(receptors-10, to-11)
acl:relcl(receptors-10, modulate-12)
dep(modulate-12, endocannabinoid-13)
xcomp(endocannabinoid-13, signaling-14)
cc(interact-7, and-15)
ccomp(suggest-3, highlight-16)
conj:and(interact-7, highlight-16)
amod(targets-19, potential-17)
amod(targets-19, new-18)
dobj(highlight-16, targets-19)
case(intervention-22, for-20)
amod(intervention-22, therapeutic-21)
nmod:for(targets-19, intervention-22)
case(diseases-24, in-23)
nmod:in(highlight-16, diseases-24)
acl(diseases-24, associated-25)
case(function-29, with-26)
amod(function-29, dysregulated-27)
amod(function-29, endocannabinoid-28)
nmod:with(associated-25, function-29)

In/IN a/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN ,/, metoclopramide_hydrochloride/NN reduced/VBN the/DT risk/NN of/IN nausea_reduction/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN confidence/NN interval/NN -LSB-/NNP CI/NNP -RSB-/VBG 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/NN by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN ./. ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT a) (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled) (NN trial)))
    (, ,)
    (NP (NN metoclopramide_hydrochloride))
    (VP (VBN reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NN nausea_reduction))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (NP
                (NP (NN confidence) (NN interval) (NNP -LSB-) (NNP CI))
                (PP (VBG -RSB-)
                  (NP
                    (NP (CD 6-20) (NN %))
                    (, ,)
                    (NP (NNP P))))
                (X
                  (X (SYM =))
                  (NP (CD 0.0005)))))
            (-RRB- -RRB-))))
      (, ,)
      (FRAG
        (FRAG
          (NP (NN photophobia))
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (FRAG
          (NP (NN phonophobia))
          (PP (IN by)
            (NP (CD 14) (NN %))))
        (. .)))
    (. .)))

case(trial-8, In-1)
det(trial-8, a-2)
amod(trial-8, randomized-3)
amod(trial-8, double-blind-5)
amod(trial-8, placebo-controlled-7)
nmod:in(reduced-11, trial-8)
nsubj(reduced-11, metoclopramide_hydrochloride-10)
root(ROOT-0, reduced-11)
det(risk-13, the-12)
dobj(reduced-11, risk-13)
case(nausea_reduction-15, of-14)
nmod:of(risk-13, nausea_reduction-15)
case(%-18, by-16)
nummod(%-18, 14-17)
nmod:by(reduced-11, %-18)
nummod(%-21, 95-20)
dep(%-18, %-21)
compound(CI-25, confidence-22)
compound(CI-25, interval-23)
compound(CI-25, -LSB--24)
dep(%-21, CI-25)
case(%-28, -RSB--26)
nummod(%-28, 6-20-27)
nmod:-rsb-(CI-25, %-28)
appos(%-28, P-30)
dep(0.0005-32, =-31)
dep(CI-25, 0.0005-32)
dep(reduced-11, photophobia-35)
case(%-38, by-36)
nummod(%-38, 17-37)
nmod:by(photophobia-35, %-38)
nummod(%-41, 95-40)
appos(%-38, %-41)
dep(%-44, CI-42)
nummod(%-44, 12-22-43)
nmod(%-41, %-44)
dep(%-41, P-46)
compound(0.0001-48, <-47)
nummod(P-46, 0.0001-48)
cc(photophobia-35, and-51)
dep(photophobia-35, phonophobia-52)
case(%-55, by-53)
nummod(%-55, 14-54)
nmod:by(phonophobia-52, %-55)

Metoclopramide_hydrochloride/NNP has_been/VBP shown/VBN to_be/JJ effective/JJ in/IN reducing/VBG the/DT symptoms/NNS of/IN migraine/NN ,/, including/VBG nausea/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (NNP Metoclopramide_hydrochloride))
    (VP (VBP has_been)
      (VP (VBN shown)
        (NP
          (NP (JJ to_be)
            (ADJP (JJ effective)
              (PP (IN in)
                (S
                  (VP (VBG reducing)
                    (NP
                      (NP (DT the) (NNS symptoms))
                      (PP (IN of)
                        (NP
                          (NP (NN migraine))
                          (, ,)
                          (VP (VBG including)
                            (NP (NN nausea)))
                          (, ,))))))))
            (NN photophobia))
          (, ,)
          (CC and)
          (NP (NN phonophobia)))))
    (. .)))

nsubj(has_been-2, Metoclopramide_hydrochloride-1)
root(ROOT-0, has_been-2)
dep(has_been-2, shown-3)
amod(photophobia-16, to_be-4)
amod(photophobia-16, effective-5)
mark(reducing-7, in-6)
advcl(effective-5, reducing-7)
det(symptoms-9, the-8)
dobj(reducing-7, symptoms-9)
case(migraine-11, of-10)
nmod:of(symptoms-9, migraine-11)
acl(migraine-11, including-13)
dobj(including-13, nausea-14)
dobj(shown-3, photophobia-16)
cc(photophobia-16, and-18)
dobj(shown-3, phonophobia-19)
conj:and(photophobia-16, phonophobia-19)

In/IN this/DT study/NN ,/, the/DT efficacy/NN of/IN metoclopramide_hydrochloride/NN was/VBD evaluated/VBN in_a/JJ randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN efficacy))
      (PP (IN of)
        (NP (NN metoclopramide_hydrochloride))))
    (VP (VBD was)
      (VP (VBN evaluated)
        (NP (JJ in_a)
          (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
          (NN trial))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-10, study-3)
det(efficacy-6, the-5)
nsubjpass(evaluated-10, efficacy-6)
case(metoclopramide_hydrochloride-8, of-7)
nmod:of(efficacy-6, metoclopramide_hydrochloride-8)
auxpass(evaluated-10, was-9)
root(ROOT-0, evaluated-10)
amod(trial-17, in_a-11)
amod(placebo-controlled-16, randomized-12)
amod(placebo-controlled-16, double-blind-14)
amod(trial-17, placebo-controlled-16)
dobj(evaluated-10, trial-17)

A/DT total/NN of/IN 300/CD patients/NNS with/IN migraine/NN were/VBD enrolled/VBN in/IN the/DT study/NN and/CC were/VBD randomly/RB assigned/VBN to/TO receive/VB either/DT metoclopramide_hydrochloride/NN or/CC placebo/NN ./.

(ROOT
  (S
    (NP
      (NP (DT A) (NN total))
      (PP (IN of)
        (NP
          (NP (CD 300) (NNS patients))
          (PP (IN with)
            (NP (NN migraine))))))
    (VP
      (VP (VBD were)
        (VP (VBN enrolled)
          (PP (IN in)
            (NP (DT the) (NN study)))))
      (CC and)
      (VP (VBD were)
        (VP
          (ADVP (RB randomly))
          (VBN assigned)
          (S
            (VP (TO to)
              (VP (VB receive)
                (NP (DT either) (NN metoclopramide_hydrochloride)
                  (CC or)
                  (NN placebo))))))))
    (. .)))

det(total-2, A-1)
nsubjpass(enrolled-9, total-2)
nsubjpass(assigned-16, total-2)
nsubj:xsubj(receive-18, total-2)
case(patients-5, of-3)
nummod(patients-5, 300-4)
nmod:of(total-2, patients-5)
case(migraine-7, with-6)
nmod:with(patients-5, migraine-7)
auxpass(enrolled-9, were-8)
root(ROOT-0, enrolled-9)
case(study-12, in-10)
det(study-12, the-11)
nmod:in(enrolled-9, study-12)
cc(enrolled-9, and-13)
auxpass(assigned-16, were-14)
advmod(assigned-16, randomly-15)
conj:and(enrolled-9, assigned-16)
mark(receive-18, to-17)
xcomp(assigned-16, receive-18)
cc:preconj(metoclopramide_hydrochloride-20, either-19)
dobj(receive-18, metoclopramide_hydrochloride-20)
cc(metoclopramide_hydrochloride-20, or-21)
dobj(receive-18, placebo-22)
conj:or(metoclopramide_hydrochloride-20, placebo-22)

At_2/JJ hours/NNS after/IN dosing/VBG ,/, metoclopramide_hydrochloride/NN reduced/VBD the/DT risk/NN of/IN nausea_reduction/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NNS hours))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN metoclopramide_hydrochloride))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NN nausea_reduction))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(hours-2, At_2-1)
dep(reduced-7, hours-2)
mark(hours-2, after-3)
dep(hours-2, dosing-4)
nsubj(reduced-7, metoclopramide_hydrochloride-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(nausea_reduction-11, of-10)
nmod:of(risk-9, nausea_reduction-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN metoclopramide_hydrochloride/NN is/VBZ an/DT effective/JJ treatment/NN for/IN reducing/VBG the/DT symptoms/NNS of/IN migraine/NN and/CC should/MD be/VB considered/VBN as/IN a/DT first-line/JJ therapy/NN for/IN patients/NNS with/IN this/DT condition/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN metoclopramide_hydrochloride))
          (VP
            (VP (VBZ is)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NNS symptoms))
                        (PP (IN of)
                          (NP (NN migraine)))))))))
            (CC and)
            (VP (MD should)
              (VP (VB be)
                (VP (VBN considered)
                  (PP (IN as)
                    (NP
                      (NP (DT a) (JJ first-line) (NN therapy))
                      (PP (IN for)
                        (NP (NNS patients)))))
                  (PP (IN with)
                    (NP (DT this) (NN condition))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(treatment-9, that-4)
nsubj(treatment-9, metoclopramide_hydrochloride-5)
nsubjpass(considered-19, metoclopramide_hydrochloride-5)
cop(treatment-9, is-6)
det(treatment-9, an-7)
amod(treatment-9, effective-8)
ccomp(suggest-3, treatment-9)
mark(reducing-11, for-10)
acl(treatment-9, reducing-11)
det(symptoms-13, the-12)
dobj(reducing-11, symptoms-13)
case(migraine-15, of-14)
nmod:of(symptoms-13, migraine-15)
cc(treatment-9, and-16)
aux(considered-19, should-17)
auxpass(considered-19, be-18)
ccomp(suggest-3, considered-19)
conj:and(treatment-9, considered-19)
case(therapy-23, as-20)
det(therapy-23, a-21)
amod(therapy-23, first-line-22)
nmod:as(considered-19, therapy-23)
case(patients-25, for-24)
nmod:for(therapy-23, patients-25)
case(condition-28, with-26)
det(condition-28, this-27)
nmod:with(considered-19, condition-28)

Hyperglycemia/NNP and/CC hyperinsulinemia/NNP are/VBP associated/VBN with/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (NNP Hyperglycemia)
      (CC and)
      (NNP hyperinsulinemia))
    (VP (VBP are)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP (NN obesity)))))))
    (. .)))

nsubjpass(associated-5, Hyperglycemia-1)
cc(Hyperglycemia-1, and-2)
conj:and(Hyperglycemia-1, hyperinsulinemia-3)
nsubjpass(associated-5, hyperinsulinemia-3)
auxpass(associated-5, are-4)
root(ROOT-0, associated-5)
case(development-8, with-6)
det(development-8, the-7)
nmod:with(associated-5, development-8)
case(obesity-10, of-9)
nmod:of(development-8, obesity-10)

The/DT role/NN of/IN ISG12a/NNS in/IN the/DT pathogenesis/NNS of/IN obesity/NN has/VBZ not/RB been/VBN fully/RB elucidated/VBN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN role))
      (PP (IN of)
        (NP
          (NP (NNS ISG12a))
          (PP (IN in)
            (NP
              (NP (DT the) (NNS pathogenesis))
              (PP (IN of)
                (NP (NN obesity))))))))
    (VP (VBZ has) (RB not)
      (VP (VBN been)
        (VP
          (ADVP (RB fully))
          (VBN elucidated))))
    (. .)))

det(role-2, The-1)
nsubjpass(elucidated-14, role-2)
case(ISG12a-4, of-3)
nmod:of(role-2, ISG12a-4)
case(pathogenesis-7, in-5)
det(pathogenesis-7, the-6)
nmod:in(ISG12a-4, pathogenesis-7)
case(obesity-9, of-8)
nmod:of(pathogenesis-7, obesity-9)
aux(elucidated-14, has-10)
neg(elucidated-14, not-11)
auxpass(elucidated-14, been-12)
advmod(elucidated-14, fully-13)
root(ROOT-0, elucidated-14)

We/PRP examined/VBD the/DT effects/NNS of/IN glucose/NN and/CC HS-113/NN on/IN pancreatic/JJ insulin_secretion/NN in/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- mice/NNS and/CC humans/NNS ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NN glucose)
            (CC and)
            (NN HS-113))))
      (PP (IN on)
        (NP
          (NP (JJ pancreatic) (NN insulin_secretion))
          (PP (IN in)
            (NP
              (NP
                (NP (NN genetically_obese))
                (-LRB- -LRB-)
                (NP (NN fa/fa))
                (-RRB- -RRB-))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS mice)
                (CC and)
                (NNS humans)))))))
    (. .)))

nsubj(examined-2, We-1)
root(ROOT-0, examined-2)
det(effects-4, the-3)
dobj(examined-2, effects-4)
case(glucose-6, of-5)
nmod:of(effects-4, glucose-6)
cc(glucose-6, and-7)
nmod:of(effects-4, HS-113-8)
conj:and(glucose-6, HS-113-8)
case(insulin_secretion-11, on-9)
amod(insulin_secretion-11, pancreatic-10)
nmod:on(examined-2, insulin_secretion-11)
case(genetically_obese-13, in-12)
nmod:in(insulin_secretion-11, genetically_obese-13)
dep(genetically_obese-13, fa/fa-15)
cc(genetically_obese-13, and-17)
amod(mice-24, lean-18)
dep(lean-18, Fa-20)
nmod:in(insulin_secretion-11, mice-24)
conj:and(genetically_obese-13, mice-24)
cc(mice-24, and-25)
conj:and(genetically_obese-13, humans-26)
conj:and(mice-24, humans-26)

-LRB-/-LRB- -RRB-/JJ Recent/JJ studies/NNS have/VBP implicated/VBN the/DT role/NN of/IN IFN-stimulated/JJ gene/NN ,/, 12a/NNS -LRB-/-LRB- ISG/NNP 12a/NNPS ,/, an/DT interferon/NN -/: stimulated/VBN gene/NN ,/, in/IN the/DT development/NN and/CC treatment/NN of/IN obesity-associated_disorders/NNS ./.

(ROOT
  (S (-LRB- -LRB-)
    (NP (JJ -RRB-) (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN implicated)
        (NP
          (NP (DT the) (NN role))
          (PP (IN of)
            (NP
              (NP
                (NP (JJ IFN-stimulated) (NN gene))
                (, ,)
                (NP (NNS 12a)))
              (-LRB- -LRB-)
              (NP (NNP ISG) (NNPS 12a))
              (, ,)
              (NP (DT an) (NN interferon))
              (: -)
              (NP (VBN stimulated) (NN gene))
              (, ,))))
        (PP (IN in)
          (NP
            (NP (DT the) (NN development)
              (CC and)
              (NN treatment))
            (PP (IN of)
              (NP (NNS obesity-associated_disorders)))))))
    (. .)))

amod(studies-4, -RRB--2)
amod(studies-4, Recent-3)
nsubj(implicated-6, studies-4)
aux(implicated-6, have-5)
root(ROOT-0, implicated-6)
det(role-8, the-7)
dobj(implicated-6, role-8)
case(gene-11, of-9)
amod(gene-11, IFN-stimulated-10)
nmod:of(role-8, gene-11)
appos(gene-11, 12a-13)
compound(12a-16, ISG-15)
dep(gene-11, 12a-16)
det(interferon-19, an-18)
appos(gene-11, interferon-19)
amod(gene-22, stimulated-21)
dep(gene-11, gene-22)
case(development-26, in-24)
det(development-26, the-25)
nmod:in(implicated-6, development-26)
cc(development-26, and-27)
nmod:in(implicated-6, treatment-28)
conj:and(development-26, treatment-28)
case(obesity-associated_disorders-30, of-29)
nmod:of(development-26, obesity-associated_disorders-30)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN ISG12a/NNS by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNS ISG12a)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(ISG12a-20, of-19)
nmod:of(hypersecretion-18, ISG12a-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT goal/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ HS-113/NN on/IN the/DT secretion/NN of/IN ISG12a/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- individuals/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this) (NN goal)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN HS-113)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ ISG12a) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS individuals)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-7, achieve-2)
det(goal-4, this-3)
dobj(achieve-2, goal-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(HS-113-17, 10-15)
amod(HS-113-17, mmol/L-16)
nmod:of(effects-9, HS-113-17)
conj:and(glucose-13, HS-113-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(examined-7, secretion-20)
case(and_insulin-23, of-21)
amod(and_insulin-23, ISG12a-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(pancreata-27, genetically_obese-29)
appos(genetically_obese-29, fa/fa-31)
cc(genetically_obese-29, and-33)
amod(individuals-40, lean-34)
dep(lean-34, Fa-36)
nmod:from(pancreata-27, individuals-40)
conj:and(genetically_obese-29, individuals-40)

Our/PRP$ results/NNS showed/VBD that/IN both/DT glucose/NN and/CC HS-113/NN significantly/RB increased/VBD ISG12a/JJ secretion/NN in/IN obese/JJ mice/NNS compared/VBN to/TO lean/JJ mice/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (DT both) (NN glucose)
            (CC and)
            (NN HS-113))
          (ADVP (RB significantly))
          (VP (VBD increased)
            (NP (JJ ISG12a) (NN secretion))
            (PP (IN in)
              (NP (JJ obese) (NNS mice)))
            (PP (VBN compared)
              (PP (TO to)
                (NP (JJ lean) (NNS mice))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(increased-10, that-4)
cc:preconj(glucose-6, both-5)
nsubj(increased-10, glucose-6)
cc(glucose-6, and-7)
conj:and(glucose-6, HS-113-8)
nsubj(increased-10, HS-113-8)
advmod(increased-10, significantly-9)
ccomp(showed-3, increased-10)
amod(secretion-12, ISG12a-11)
dobj(increased-10, secretion-12)
case(mice-15, in-13)
amod(mice-15, obese-14)
nmod:in(increased-10, mice-15)
case(mice-19, compared-16)
mwe(compared-16, to-17)
amod(mice-19, lean-18)
advcl(increased-10, mice-19)

Interestingly/RB ,/, insulin_secretion/NN was/VBD also/RB increased/VBN in/IN response/NN to/TO glucose/NN but/CC not/RB HS-113/NN in/IN both/DT groups/NNS ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (NN insulin_secretion))
    (VP (VBD was)
      (VP
        (ADVP (RB also))
        (VBN increased)
        (PP (IN in)
          (NP
            (NP (NN response))
            (PP (TO to)
              (NP
                (NP (NN glucose))
                (CC but)
                (RB not)
                (NP (NN HS-113))))))
        (PP (IN in)
          (NP (DT both) (NNS groups)))))
    (. .)))

advmod(increased-6, Interestingly-1)
nsubjpass(increased-6, insulin_secretion-3)
auxpass(increased-6, was-4)
advmod(increased-6, also-5)
root(ROOT-0, increased-6)
case(response-8, in-7)
nmod:in(increased-6, response-8)
case(glucose-10, to-9)
nmod:to(response-8, glucose-10)
cc(glucose-10, but-11)
neg(HS-113-13, not-12)
nmod:to(response-8, HS-113-13)
conj:but(glucose-10, HS-113-13)
case(groups-16, in-14)
det(groups-16, both-15)
nmod:in(increased-6, groups-16)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN ISG12a/NNS may/MD contribute/VB to/TO the/DT development/NN of/IN obesity/NN by/IN altering/VBG pancreatic/JJ function/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNS ISG12a))))
          (VP (MD may)
            (VP (VB contribute)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity)))))
              (PP (IN by)
                (S
                  (VP (VBG altering)
                    (NP (JJ pancreatic) (NN function))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(contribute-9, that-4)
nsubj(contribute-9, hypersecretion-5)
case(ISG12a-7, of-6)
nmod:of(hypersecretion-5, ISG12a-7)
aux(contribute-9, may-8)
ccomp(suggest-3, contribute-9)
case(development-12, to-10)
det(development-12, the-11)
nmod:to(contribute-9, development-12)
case(obesity-14, of-13)
nmod:of(development-12, obesity-14)
mark(altering-16, by-15)
advcl(contribute-9, altering-16)
amod(function-18, pancreatic-17)
dobj(altering-16, function-18)

Further/JJ investigation/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ targets/NNS for/IN obesity-associated_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NN investigation))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP (NNS obesity-associated_disorders))))))))))
    (. .)))

amod(investigation-2, Further-1)
nsubjpass(needed-4, investigation-2)
nsubj:xsubj(elucidate-6, investigation-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(targets-13, potential-11)
amod(targets-13, therapeutic-12)
dobj(elucidate-6, targets-13)
conj:and(mechanisms-9, targets-13)
case(obesity-associated_disorders-15, for-14)
nmod:for(targets-13, obesity-associated_disorders-15)

There/EX was/VBD a/DT correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/RB less/JJR than/IN 0.01/CD -RRB-/-RRB- ,/, pyridoxine_phosphate/VB -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/NN less/JJR than/IN 0.01/CD -RRB-/-RRB- and/CC serum/VB pyridoxal_kinase/JJ levels/NNS ./.

(ROOT
  (S
    (NP (EX There))
    (VP (VBD was)
      (NP
        (NP (DT a) (NN correlation))
        (PP (IN between)
          (NP
            (NP
              (NP (NN serum) (NNS levels))
              (PP (IN of)
                (NP (NN alkaline_phosphatase))))
            (PRN (-LRB- -LRB-)
              (NP
                (NP
                  (FRAG
                    (X
                      (X (SYM r))
                      (NP (SYM =)))
                    (NP (CD 0.3))))
                (, ,)
                (ADVP (RB p))
                (NP
                  (QP (JJR less) (IN than) (CD 0.01))))
              (-RRB- -RRB-)))))
      (, ,)
      (S
        (VP (VB pyridoxine_phosphate)
          (PRN (-LRB- -LRB-)
            (FRAG
              (FRAG
                (X
                  (X (SYM r))
                  (NP (SYM =)))
                (NP (CD 0.42)))
              (, ,)
              (FRAG
                (NP (NN p))
                (NP
                  (QP (JJR less) (IN than) (CD 0.01)))))
            (-RRB- -RRB-))
          (CC and)
          (VB serum)
          (NP (JJ pyridoxal_kinase) (NNS levels)))))
    (. .)))

expl(was-2, There-1)
root(ROOT-0, was-2)
det(correlation-4, a-3)
nsubj(was-2, correlation-4)
case(levels-7, between-5)
compound(levels-7, serum-6)
nmod:between(correlation-4, levels-7)
case(alkaline_phosphatase-9, of-8)
nmod:of(levels-7, alkaline_phosphatase-9)
dep(=-12, r-11)
dep(0.3-13, =-12)
dep(levels-7, 0.3-13)
advmod(0.01-18, p-15)
advmod(0.01-18, less-16)
mwe(less-16, than-17)
appos(0.3-13, 0.01-18)
dep(was-2, pyridoxine_phosphate-21)
dep(=-24, r-23)
dep(0.42-25, =-24)
dep(pyridoxine_phosphate-21, 0.42-25)
parataxis(0.42-25, p-27)
advmod(0.01-30, less-28)
mwe(less-28, than-29)
dep(p-27, 0.01-30)
cc(pyridoxine_phosphate-21, and-32)
dep(was-2, serum-33)
conj:and(pyridoxine_phosphate-21, serum-33)
amod(levels-35, pyridoxal_kinase-34)
dobj(pyridoxine_phosphate-21, levels-35)

Alkaline_phosphatase/NNP -LRB-/-LRB- ALP/NNP -RRB-/-RRB- is/VBZ an/DT enzyme/NN that/WDT is/VBZ involved/VBN in/IN bone_formation/NN and_liver/JJ function/NN ./.

(ROOT
  (S
    (NP (NNP Alkaline_phosphatase) (-LRB- -LRB-)
      (NP (NNP ALP))
      (-RRB- -RRB-))
    (VP (VBZ is)
      (NP
        (NP (DT an) (NN enzyme))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ is)
              (VP (VBN involved)
                (PP (IN in)
                  (NP (NN bone_formation)))
                (NP-TMP (JJ and_liver) (NN function))))))))
    (. .)))

nsubj(enzyme-7, Alkaline_phosphatase-1)
dep(Alkaline_phosphatase-1, ALP-3)
cop(enzyme-7, is-5)
det(enzyme-7, an-6)
root(ROOT-0, enzyme-7)
nsubjpass(involved-10, enzyme-7)
ref(enzyme-7, that-8)
auxpass(involved-10, is-9)
acl:relcl(enzyme-7, involved-10)
case(bone_formation-12, in-11)
nmod:in(involved-10, bone_formation-12)
amod(function-14, and_liver-13)
nmod:tmod(involved-10, function-14)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT relationship/NN between/IN serum/NN levels/NNS of/IN ALP/NNP and/CC pyridoxine_phosphate/NN -LRB-/-LRB- PLP/NNP -RRB-/-RRB- with/IN serum/JJ pyridoxal_kinase/JJ levels/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN relationship))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP
                  (NP (NNP ALP))
                  (CC and)
                  (NP (NN pyridoxine_phosphate)))
                (PRN (-LRB- -LRB-)
                  (NP (NNP PLP))
                  (-RRB- -RRB-)))))))
      (PP (IN with)
        (NP (JJ serum) (JJ pyridoxal_kinase) (NNS levels))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(relationship-8, the-7)
dobj(investigated-6, relationship-8)
case(levels-11, between-9)
compound(levels-11, serum-10)
nmod:between(relationship-8, levels-11)
case(ALP-13, of-12)
nmod:of(levels-11, ALP-13)
cc(ALP-13, and-14)
nmod:of(levels-11, pyridoxine_phosphate-15)
conj:and(ALP-13, pyridoxine_phosphate-15)
appos(ALP-13, PLP-17)
case(levels-22, with-19)
amod(levels-22, serum-20)
amod(levels-22, pyridoxal_kinase-21)
nmod:with(investigated-6, levels-22)

Our/PRP$ results/NNS showed/VBD a/DT positive/JJ correlation/NN between/IN serum/NN levels/NNS of/IN ALP/NNP and/CC PLP/NNP -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/RB </VBP 0.01/CD -RRB-/-RRB- ,/, indicating/VBG that/IN higher/JJR ALP/NN levels/NNS may/MD be/VB associated/VBN with/IN increased/VBN PLP/NNP levels/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ positive) (NN correlation))
        (PP (IN between)
          (NP
            (NP
              (NP (NN serum) (NNS levels))
              (PP (IN of)
                (NP (NNP ALP)
                  (CC and)
                  (NNP PLP))))
            (PRN (-LRB- -LRB-)
              (SBAR
                (X (SYM r))
                (S
                  (FRAG
                    (X (SYM =))
                    (NP (CD 0.3)))
                  (, ,)
                  (ADVP (RB p))
                  (VP (VBP <)
                    (NP (CD 0.01)))))
              (-RRB- -RRB-)))))
      (, ,)
      (S
        (VP (VBG indicating)
          (SBAR (IN that)
            (S
              (NP (JJR higher) (NN ALP) (NNS levels))
              (VP (MD may)
                (VP (VB be)
                  (VP (VBN associated)
                    (PP (IN with)
                      (NP (VBN increased) (NNP PLP) (NNS levels)))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(correlation-6, a-4)
amod(correlation-6, positive-5)
dobj(showed-3, correlation-6)
case(levels-9, between-7)
compound(levels-9, serum-8)
nmod:between(correlation-6, levels-9)
case(ALP-11, of-10)
nmod:of(levels-9, ALP-11)
cc(ALP-11, and-12)
nmod:of(levels-9, PLP-13)
conj:and(ALP-11, PLP-13)
dep(<-20, r-15)
dep(0.3-17, =-16)
dep(<-20, 0.3-17)
advmod(<-20, p-19)
dep(levels-9, <-20)
dobj(<-20, 0.01-21)
advcl(showed-3, indicating-24)
mark(associated-31, that-25)
amod(levels-28, higher-26)
compound(levels-28, ALP-27)
nsubjpass(associated-31, levels-28)
aux(associated-31, may-29)
auxpass(associated-31, be-30)
ccomp(indicating-24, associated-31)
case(levels-35, with-32)
amod(levels-35, increased-33)
compound(levels-35, PLP-34)
nmod:with(associated-31, levels-35)

Additionally/RB ,/, we/PRP observed/VBD a/DT stronger/JJR correlation/NN between/IN PLP/NNP and/CC pyridoxal_kinase/JJ levels/NNS -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/RB </VBP 0.01/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP
          (NP (DT a) (JJR stronger) (NN correlation))
          (PP (IN between)
            (NP (NNP PLP))))
        (CC and)
        (NP
          (NP (JJ pyridoxal_kinase) (NNS levels))
          (PRN (-LRB- -LRB-)
            (SBAR
              (X (SYM r))
              (S
                (FRAG
                  (X (SYM =))
                  (NP (CD 0.42)))
                (, ,)
                (ADVP (RB p))
                (VP (VBP <)
                  (NP (CD 0.01)))))
            (-RRB- -RRB-)))))
    (. .)))

advmod(observed-4, Additionally-1)
nsubj(observed-4, we-3)
root(ROOT-0, observed-4)
det(correlation-7, a-5)
amod(correlation-7, stronger-6)
dobj(observed-4, correlation-7)
case(PLP-9, between-8)
nmod:between(correlation-7, PLP-9)
cc(correlation-7, and-10)
amod(levels-12, pyridoxal_kinase-11)
dobj(observed-4, levels-12)
conj:and(correlation-7, levels-12)
dep(<-19, r-14)
dep(0.42-16, =-15)
dep(<-19, 0.42-16)
advmod(<-19, p-18)
dep(levels-12, <-19)
dobj(<-19, 0.01-20)

These/DT findings/NNS suggest/VBP that/IN there/EX may/MD be/VB a/DT potential/JJ interaction/NN between/IN vitamin_B6/JJ metabolism/NN and/CC bone_formation/NN or/CC liver/NN function/NN ,/, which/WDT warrants/VBZ further/JJ investigation/NN to/TO better/RBR understand/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ clinical/JJ implications/NNS of/IN these/DT relationships/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP
                  (NP (DT a) (JJ potential) (NN interaction))
                  (PP (IN between)
                    (NP (JJ vitamin_B6) (NN metabolism)
                      (CC and)
                      (NN bone_formation))))
                (CC or)
                (NP
                  (NP (NN liver) (NN function))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (VBZ warrants)
                        (NP (JJ further) (NN investigation)
                          (S
                            (VP (TO to)
                              (VP
                                (ADVP (RBR better))
                                (VB understand)
                                (NP
                                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                                  (CC and)
                                  (NP
                                    (NP (JJ potential) (JJ clinical) (NNS implications))
                                    (PP (IN of)
                                      (NP (DT these) (NNS relationships)))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(interaction-10, that-4)
expl(interaction-10, there-5)
aux(interaction-10, may-6)
cop(interaction-10, be-7)
det(interaction-10, a-8)
amod(interaction-10, potential-9)
ccomp(suggest-3, interaction-10)
case(metabolism-13, between-11)
amod(metabolism-13, vitamin_B6-12)
nmod:between(interaction-10, metabolism-13)
cc(metabolism-13, and-14)
nmod:between(interaction-10, bone_formation-15)
conj:and(metabolism-13, bone_formation-15)
cc(interaction-10, or-16)
compound(function-18, liver-17)
ccomp(suggest-3, function-18)
conj:or(interaction-10, function-18)
nsubj(warrants-21, function-18)
ref(function-18, which-20)
acl:relcl(function-18, warrants-21)
amod(investigation-23, further-22)
dobj(warrants-21, investigation-23)
mark(understand-26, to-24)
advmod(understand-26, better-25)
acl(investigation-23, understand-26)
det(mechanisms-29, the-27)
amod(mechanisms-29, underlying-28)
dobj(understand-26, mechanisms-29)
cc(mechanisms-29, and-30)
amod(implications-33, potential-31)
amod(implications-33, clinical-32)
dobj(understand-26, implications-33)
conj:and(mechanisms-29, implications-33)
case(relationships-36, of-34)
det(relationships-36, these-35)
nmod:of(implications-33, relationships-36)

Omega-3_fatty_acids/NNS are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT can/MD not/RB be/VB synthesized/VBN by/IN the/DT human/JJ body/NN and/CC must/MD be/VB obtained/VBN from/IN dietary/JJ sources/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP
      (VP (VBP are)
        (NP
          (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (MD can) (RB not)
                (VP (VB be)
                  (VP (VBN synthesized)
                    (PP (IN by)
                      (NP (DT the) (JJ human) (NN body))))))))))
      (CC and)
      (VP (MD must)
        (VP (VB be)
          (VP (VBN obtained)
            (PP (IN from)
              (NP (JJ dietary) (NNS sources)))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-4, Omega-3_fatty_acids-1)
nsubjpass(obtained-17, Omega-3_fatty_acids-1)
cop(polyunsaturated_fatty_acids-4, are-2)
amod(polyunsaturated_fatty_acids-4, essential-3)
root(ROOT-0, polyunsaturated_fatty_acids-4)
nsubjpass(synthesized-9, polyunsaturated_fatty_acids-4)
ref(polyunsaturated_fatty_acids-4, that-5)
aux(synthesized-9, can-6)
neg(synthesized-9, not-7)
auxpass(synthesized-9, be-8)
acl:relcl(polyunsaturated_fatty_acids-4, synthesized-9)
case(body-13, by-10)
det(body-13, the-11)
amod(body-13, human-12)
nmod:by(synthesized-9, body-13)
cc(polyunsaturated_fatty_acids-4, and-14)
aux(obtained-17, must-15)
auxpass(obtained-17, be-16)
conj:and(polyunsaturated_fatty_acids-4, obtained-17)
nsubjpass(synthesized-9, obtained-17)
case(sources-20, from-18)
amod(sources-20, dietary-19)
nmod:from(obtained-17, sources-20)

Among/IN these/DT ,/, long-chain/JJ omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO exhibit/VB a/DT wide/JJ range/NN of/IN beneficial/JJ effects/NNS on/IN human/JJ health/NN ./.

(ROOT
  (S
    (PP (IN Among)
      (NP (DT these)))
    (, ,)
    (NP
      (NP (JJ long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB exhibit)
                (NP
                  (NP (DT a) (JJ wide) (NN range))
                  (PP (IN of)
                    (NP
                      (NP (JJ beneficial) (NNS effects))
                      (PP (IN on)
                        (NP (JJ human) (NN health))))))))))))
    (. .)))

case(these-2, Among-1)
nmod:among(shown-20, these-2)
amod(omega-3_fatty_acids-5, long-chain-4)
nsubjpass(shown-20, omega-3_fatty_acids-5)
nsubj:xsubj(exhibit-22, omega-3_fatty_acids-5)
acl(omega-3_fatty_acids-5, including-7)
advmod(EPA-10, eicosapentaenoic_acid-8)
dobj(including-7, EPA-10)
cc(EPA-10, and-12)
dobj(including-7, docosahexaenoic_acid-13)
conj:and(EPA-10, docosahexaenoic_acid-13)
appos(EPA-10, DHA-15)
aux(shown-20, have-18)
auxpass(shown-20, been-19)
root(ROOT-0, shown-20)
mark(exhibit-22, to-21)
xcomp(shown-20, exhibit-22)
det(range-25, a-23)
amod(range-25, wide-24)
dobj(exhibit-22, range-25)
case(effects-28, of-26)
amod(effects-28, beneficial-27)
nmod:of(range-25, effects-28)
case(health-31, on-29)
amod(health-31, human-30)
nmod:on(effects-28, health-31)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, are/VBP associated/VBN with/IN decreased/VBN Topiroxostat/NNP levels/NNS in/IN hyperTopiroxostatmic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN associated)
          (PP (IN with)
            (NP (VBN decreased) (NNP Topiroxostat) (NNS levels)))
          (PP (IN in)
            (NP (JJ hyperTopiroxostatmic) (NNS patients)))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(associated-23, omega-3_fatty_acids-2)
nsubjpass(decreased-32, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
auxpass(associated-23, are-22)
root(ROOT-0, associated-23)
case(levels-27, with-24)
amod(levels-27, decreased-25)
compound(levels-27, Topiroxostat-26)
nmod:with(associated-23, levels-27)
case(patients-30, in-28)
amod(patients-30, hyperTopiroxostatmic-29)
nmod:in(associated-23, patients-30)
cc(associated-23, and-31)
conj:and(associated-23, decreased-32)
dobj(decreased-32, risk-33)
case(coronary_heart_disease-36, of-34)
amod(coronary_heart_disease-36, developing-35)
nmod:of(risk-33, coronary_heart_disease-36)
appos(coronary_heart_disease-36, CHD-38)

In/IN addition/NN ,/, several/JJ epidemiological/JJ studies/NNS have/VBP suggested/VBN that/IN increased/VBN intake/NN of/IN EPA/NNP and/CC DHA/NNP is/VBZ associated/VBN with/IN a/DT reduced/VBN risk/NN of/IN developing/VBG CHD/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (JJ several) (JJ epidemiological) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (VBN increased) (NN intake))
              (PP (IN of)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (VBZ is)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (DT a) (VBN reduced) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NNP CHD)))))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(suggested-8, addition-2)
amod(studies-6, several-4)
amod(studies-6, epidemiological-5)
nsubj(suggested-8, studies-6)
aux(suggested-8, have-7)
root(ROOT-0, suggested-8)
mark(associated-17, that-9)
amod(intake-11, increased-10)
nsubjpass(associated-17, intake-11)
case(EPA-13, of-12)
nmod:of(intake-11, EPA-13)
cc(EPA-13, and-14)
nmod:of(intake-11, DHA-15)
conj:and(EPA-13, DHA-15)
auxpass(associated-17, is-16)
ccomp(suggested-8, associated-17)
case(risk-21, with-18)
det(risk-21, a-19)
amod(risk-21, reduced-20)
nmod:with(associated-17, risk-21)
mark(developing-23, of-22)
acl(risk-21, developing-23)
dobj(developing-23, CHD-24)

The/DT mechanisms/NNS underlying/VBG the/DT cardioprotective/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP are/VBP complex/JJ and/CC multifactorial/JJ ,/, but/CC may/MD involve/VB their/PRP$ ability/NN to/TO reduce/VB inflammation/NN ,/, improve/VB lipid/NN metabolism/NN ,/, lower/JJR blood_pressure/NN ,/, and/CC enhance/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP
          (NP (DT the) (JJ cardioprotective) (NNS effects))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))))))
    (VP
      (VP (VBP are)
        (ADJP (JJ complex)
          (CC and)
          (JJ multifactorial)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP (PRP$ their) (NN ability)
            (S
              (VP (TO to)
                (VP
                  (VP (VB reduce)
                    (NP (NN inflammation)))
                  (, ,)
                  (VP (VB improve)
                    (NP
                      (NP (NN lipid) (NN metabolism))
                      (, ,)
                      (NP (JJR lower) (NN blood_pressure))
                      (, ,)))
                  (CC and)
                  (VP (VB enhance)
                    (NP (JJ endothelial) (NN function))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubj(complex-12, mechanisms-2)
nsubj(multifactorial-14, mechanisms-2)
nsubj(involve-18, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, the-4)
amod(effects-6, cardioprotective-5)
dobj(underlying-3, effects-6)
case(EPA-8, of-7)
nmod:of(effects-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(effects-6, DHA-10)
conj:and(EPA-8, DHA-10)
cop(complex-12, are-11)
root(ROOT-0, complex-12)
cc(complex-12, and-13)
conj:and(complex-12, multifactorial-14)
cc(complex-12, but-16)
aux(involve-18, may-17)
conj:and(complex-12, involve-18)
nmod:poss(ability-20, their-19)
dobj(involve-18, ability-20)
mark(reduce-22, to-21)
acl(ability-20, reduce-22)
dobj(reduce-22, inflammation-23)
acl(ability-20, improve-25)
conj:and(reduce-22, improve-25)
compound(metabolism-27, lipid-26)
dobj(improve-25, metabolism-27)
amod(blood_pressure-30, lower-29)
appos(metabolism-27, blood_pressure-30)
cc(reduce-22, and-32)
acl(ability-20, enhance-33)
conj:and(reduce-22, enhance-33)
amod(function-35, endothelial-34)
dobj(enhance-33, function-35)

Overall/RB ,/, these/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD represent/VB a/DT promising/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP in/IN high-risk/JJ patients/NNS ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT these) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB represent)
              (NP
                (NP (DT a) (JJ promising) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NNP CHD))))
                      (PP (IN in)
                        (NP (JJ high-risk) (NNS patients))))))))))))
    (. .)))

advmod(suggest-5, Overall-1)
det(findings-4, these-3)
nsubj(suggest-5, findings-4)
root(ROOT-0, suggest-5)
mark(represent-13, that-6)
amod(intake-8, increasing-7)
nsubj(represent-13, intake-8)
case(omega-3_fatty_acids-11, of-9)
amod(omega-3_fatty_acids-11, long-chain-10)
nmod:of(intake-8, omega-3_fatty_acids-11)
aux(represent-13, may-12)
ccomp(suggest-5, represent-13)
det(strategy-16, a-14)
amod(strategy-16, promising-15)
dobj(represent-13, strategy-16)
mark(reducing-18, for-17)
acl(strategy-16, reducing-18)
det(risk-20, the-19)
dobj(reducing-18, risk-20)
case(CHD-22, of-21)
nmod:of(risk-20, CHD-22)
case(patients-25, in-23)
amod(patients-25, high-risk-24)
nmod:in(reducing-18, patients-25)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, are/VBP associated/VBN with/IN decreased/VBN Astemizol/NNP levels/NNS in/IN hyperAstemizolmic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN associated)
          (PP (IN with)
            (NP (VBN decreased) (NNP Astemizol) (NNS levels)))
          (PP (IN in)
            (NP (JJ hyperAstemizolmic) (NNS patients)))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(associated-23, omega-3_fatty_acids-2)
nsubjpass(decreased-32, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
auxpass(associated-23, are-22)
root(ROOT-0, associated-23)
case(levels-27, with-24)
amod(levels-27, decreased-25)
compound(levels-27, Astemizol-26)
nmod:with(associated-23, levels-27)
case(patients-30, in-28)
amod(patients-30, hyperAstemizolmic-29)
nmod:in(associated-23, patients-30)
cc(associated-23, and-31)
conj:and(associated-23, decreased-32)
dobj(decreased-32, risk-33)
case(coronary_heart_disease-36, of-34)
amod(coronary_heart_disease-36, developing-35)
nmod:of(risk-33, coronary_heart_disease-36)
appos(coronary_heart_disease-36, CHD-38)

Among/IN the/DT omega-3_fatty_acids/NN ,/, eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (PP (IN Among)
      (NP (DT the) (NN omega-3_fatty_acids)))
    (, ,)
    (NP
      (NP
        (ADVP (JJ eicosapentaenoic_acid))
        (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
        (CC and)
        (NP (NN docosahexaenoic_acid)))
      (PRN (-LRB- -LRB-)
        (NP (NNP DHA))
        (-RRB- -RRB-)))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

case(omega-3_fatty_acids-3, Among-1)
det(omega-3_fatty_acids-3, the-2)
nmod:among(studied-17, omega-3_fatty_acids-3)
advmod(EPA-7, eicosapentaenoic_acid-5)
nsubjpass(studied-17, EPA-7)
cc(EPA-7, and-9)
conj:and(EPA-7, docosahexaenoic_acid-10)
nsubjpass(studied-17, docosahexaenoic_acid-10)
appos(EPA-7, DHA-12)
aux(studied-17, have-14)
auxpass(studied-17, been-15)
advmod(studied-17, extensively-16)
root(ROOT-0, studied-17)
case(benefits-22, for-18)
nmod:poss(benefits-22, their-19)
amod(benefits-22, potential-20)
compound(benefits-22, health-21)
nmod:for(studied-17, benefits-22)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/NNS ,/, such/JJ as/IN EPA/NNP and/CC DHA/NNP ,/, are/VBP associated/VBN with/IN decreased/VBN Astemizol/JJ levels/NNS in/IN hyperAstemizolmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ long-chain) (NNS omega-3_fatty_acids))
              (, ,)
              (PP (JJ such) (IN as)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA)))
              (, ,))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ Astemizol) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperAstemizolmic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-16, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-16, omega-3_fatty_acids-7)
case(EPA-11, such-9)
mwe(such-9, as-10)
nmod:such_as(omega-3_fatty_acids-7, EPA-11)
cc(EPA-11, and-12)
nmod:such_as(omega-3_fatty_acids-7, DHA-13)
conj:and(EPA-11, DHA-13)
auxpass(associated-16, are-15)
ccomp(shown-4, associated-16)
case(levels-20, with-17)
amod(levels-20, decreased-18)
amod(levels-20, Astemizol-19)
nmod:with(associated-16, levels-20)
case(patients-23, in-21)
amod(patients-23, hyperAstemizolmic-22)
nmod:in(levels-20, patients-23)

Additionally/RB ,/, these/DT fatty_acids/NNS have/VBP been/VBN found/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, a/DT leading/VBG cause/NN of/IN morbidity/NN and/CC mortality/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP (NN coronary_heart_disease))
                        (NP
                          (NP (-LRB- -LRB-) (NNP CHD) (-RRB- -RRB-))
                          (, ,)
                          (NP
                            (NP (DT a) (VBG leading) (NN cause))
                            (PP (IN of)
                              (NP (NN morbidity)
                                (CC and)
                                (NN mortality)))))))))
                (ADVP (RB worldwide))))))))
    (. .)))

advmod(found-7, Additionally-1)
det(fatty_acids-4, these-3)
nsubjpass(found-7, fatty_acids-4)
nsubj:xsubj(decrease-9, fatty_acids-4)
aux(found-7, have-5)
auxpass(found-7, been-6)
root(ROOT-0, found-7)
mark(decrease-9, to-8)
xcomp(found-7, decrease-9)
det(risk-11, the-10)
dobj(decrease-9, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
iobj(developing-13, coronary_heart_disease-14)
dobj(developing-13, CHD-16)
det(cause-21, a-19)
amod(cause-21, leading-20)
appos(CHD-16, cause-21)
case(morbidity-23, of-22)
nmod:of(cause-21, morbidity-23)
cc(morbidity-23, and-24)
nmod:of(cause-21, mortality-25)
conj:and(morbidity-23, mortality-25)
advmod(decrease-9, worldwide-26)

Mechanisms/NNPS underlying/VBG the/DT protective/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP on/IN CHD/NNP include/VBP modulation/NN of/IN lipid/NN metabolism/NN ,/, inflammation/NN ,/, platelet_aggregation/NN ,/, and/CC arrhythmias/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNPS Mechanisms))
      (VP (VBG underlying)
        (NP
          (NP (DT the) (JJ protective) (NNS effects))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA)))
          (PP (IN on)
            (NP (NNP CHD))))))
    (VP (VBP include)
      (NP
        (NP (NN modulation))
        (PP (IN of)
          (NP
            (NP (NN lipid) (NN metabolism))
            (, ,)
            (NP (NN inflammation))
            (, ,)
            (NP (NN platelet_aggregation))
            (, ,)
            (CC and)
            (NP (NNS arrhythmias))))))
    (. .)))

nsubj(include-12, Mechanisms-1)
acl(Mechanisms-1, underlying-2)
det(effects-5, the-3)
amod(effects-5, protective-4)
dobj(underlying-2, effects-5)
case(EPA-7, of-6)
nmod:of(effects-5, EPA-7)
cc(EPA-7, and-8)
nmod:of(effects-5, DHA-9)
conj:and(EPA-7, DHA-9)
case(CHD-11, on-10)
nmod:on(effects-5, CHD-11)
root(ROOT-0, include-12)
dobj(include-12, modulation-13)
case(metabolism-16, of-14)
compound(metabolism-16, lipid-15)
nmod:of(modulation-13, metabolism-16)
nmod:of(modulation-13, inflammation-18)
conj:and(metabolism-16, inflammation-18)
nmod:of(modulation-13, platelet_aggregation-20)
conj:and(metabolism-16, platelet_aggregation-20)
cc(metabolism-16, and-22)
nmod:of(modulation-13, arrhythmias-23)
conj:and(metabolism-16, arrhythmias-23)

Therefore/RB ,/, increasing/VBG dietary/JJ intake/NN or/CC supplementation/NN with/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ approach/NN to/TO prevent/VB or/CC manage/VB CHD/NNP in/IN high-risk/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (S
      (VP (VBG increasing)
        (NP (JJ dietary) (NN intake)
          (CC or)
          (NN supplementation))
        (PP (IN with)
          (NP (JJ long-chain) (NN omega-3_fatty_acids)))))
    (VP (MD may)
      (VP (VB be)
        (NP (DT a) (JJ promising) (NN approach)
          (S
            (VP (TO to)
              (VP
                (VP (VB prevent))
                (CC or)
                (VP (VB manage)
                  (NP (NNP CHD))
                  (PP (IN in)
                    (NP (JJ high-risk) (NNS populations))))))))))
    (. .)))

advmod(approach-15, Therefore-1)
csubj(approach-15, increasing-3)
amod(intake-5, dietary-4)
dobj(increasing-3, intake-5)
cc(intake-5, or-6)
dobj(increasing-3, supplementation-7)
conj:or(intake-5, supplementation-7)
case(omega-3_fatty_acids-10, with-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:with(increasing-3, omega-3_fatty_acids-10)
aux(approach-15, may-11)
cop(approach-15, be-12)
det(approach-15, a-13)
amod(approach-15, promising-14)
root(ROOT-0, approach-15)
mark(prevent-17, to-16)
acl(approach-15, prevent-17)
cc(prevent-17, or-18)
acl(approach-15, manage-19)
conj:or(prevent-17, manage-19)
dobj(manage-19, CHD-20)
case(populations-23, in-21)
amod(populations-23, high-risk-22)
nmod:in(manage-19, populations-23)

Obesity/JJ is_a/NN complex/JJ and/CC multifactorial_disease/JJ that/DT is/VBZ associated/VBN with/IN various/JJ metabolic_disorders/NNS such/JJ as/IN insulin_resistance/JJ and_type_2/JJ diabetes/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Obesity) (NN is_a))
      (ADJP (JJ complex)
        (CC and)
        (JJ multifactorial_disease)))
    (DT that)
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ various) (NNS metabolic_disorders))
            (PP (JJ such) (IN as)
              (NP (JJ insulin_resistance) (JJ and_type_2) (NN diabetes)))))))
    (. .)))

amod(is_a-2, Obesity-1)
nsubjpass(associated-8, is_a-2)
amod(is_a-2, complex-3)
cc(complex-3, and-4)
amod(is_a-2, multifactorial_disease-5)
conj:and(complex-3, multifactorial_disease-5)
dep(associated-8, that-6)
auxpass(associated-8, is-7)
root(ROOT-0, associated-8)
case(metabolic_disorders-11, with-9)
amod(metabolic_disorders-11, various-10)
nmod:with(associated-8, metabolic_disorders-11)
case(diabetes-16, such-12)
mwe(such-12, as-13)
amod(diabetes-16, insulin_resistance-14)
amod(diabetes-16, and_type_2-15)
nmod:such_as(metabolic_disorders-11, diabetes-16)

The/DT role/NN of/IN the/DT pancreas/NN in/IN the/DT development/NN of/IN obesity/JJ has_been/NN previously/RB investigated/VBD ,/, and/CC it/PRP has_been/VBP suggested/VBN that/IN hypersecretion/NN of/IN certain/JJ pancreatic/JJ enzymes/NNS may/MD contribute/VB to/TO the/DT pathogenesis/NNS of/IN this/DT disease/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN role))
        (PP (IN of)
          (NP
            (NP (DT the) (NN pancreas))
            (PP (IN in)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP (JJ obesity) (NN has_been))))))))
      (ADVP (RB previously))
      (VP (VBD investigated)))
    (, ,)
    (CC and)
    (S
      (NP (PRP it))
      (VP (VBP has_been)
        (VP (VBN suggested)
          (SBAR (IN that)
            (S
              (NP
                (NP (NN hypersecretion))
                (PP (IN of)
                  (NP (JJ certain) (JJ pancreatic) (NNS enzymes))))
              (VP (MD may)
                (VP (VB contribute)
                  (PP (TO to)
                    (NP
                      (NP (DT the) (NNS pathogenesis))
                      (PP (IN of)
                        (NP (DT this) (NN disease))))))))))))
    (. .)))

det(role-2, The-1)
nsubj(investigated-13, role-2)
case(pancreas-5, of-3)
det(pancreas-5, the-4)
nmod:of(role-2, pancreas-5)
case(development-8, in-6)
det(development-8, the-7)
nmod:in(pancreas-5, development-8)
case(has_been-11, of-9)
amod(has_been-11, obesity-10)
nmod:of(development-8, has_been-11)
advmod(investigated-13, previously-12)
root(ROOT-0, investigated-13)
cc(investigated-13, and-15)
nsubj(has_been-17, it-16)
conj:and(investigated-13, has_been-17)
dep(has_been-17, suggested-18)
mark(contribute-26, that-19)
nsubj(contribute-26, hypersecretion-20)
case(enzymes-24, of-21)
amod(enzymes-24, certain-22)
amod(enzymes-24, pancreatic-23)
nmod:of(hypersecretion-20, enzymes-24)
aux(contribute-26, may-25)
ccomp(suggested-18, contribute-26)
case(pathogenesis-29, to-27)
det(pathogenesis-29, the-28)
nmod:to(contribute-26, pathogenesis-29)
case(disease-32, of-30)
det(disease-32, this-31)
nmod:of(pathogenesis-29, disease-32)

To/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN AtFAH1/NNS by/IN the/DT pancreas/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ ferulate/NN on/IN the/DT secretion/NN of/IN AtFAH1/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/NNP //: ?/. -RRB-/-RRB-

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP
            (NP (DT the) (NN relationship))
            (PP (IN between)
              (NP
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity))))
                (CC and)
                (NP
                  (NP (DT the) (NN hypersecretion))
                  (PP (IN of)
                    (NP (NNS AtFAH1)))))))
          (PP (IN by)
            (NP (DT the) (NN pancreas))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN ferulate)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ AtFAH1) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated)
            (NX
              (NX
                (NX
                  (NX (JJ perfused) (NN pancreata))
                  (PP (IN from)
                    (NP (NN genetically_obese))))
                (PRN (-LRB- -LRB-) (NN fa/fa) (-RRB- -RRB-)))
              (CC and)
              (NX (JJ lean))))
          (-LRB- -LRB-)
          (NP (NNP Fa))
          (: /))))
    (. ?) (-RRB- -RRB-)))

mark(evaluate-2, To-1)
advcl(examined-20, evaluate-2)
det(relationship-4, the-3)
dobj(evaluate-2, relationship-4)
case(development-7, between-5)
det(development-7, the-6)
nmod:between(relationship-4, development-7)
case(obesity-9, of-8)
nmod:of(development-7, obesity-9)
cc(development-7, and-10)
det(hypersecretion-12, the-11)
nmod:between(relationship-4, hypersecretion-12)
conj:and(development-7, hypersecretion-12)
case(AtFAH1-14, of-13)
nmod:of(hypersecretion-12, AtFAH1-14)
case(pancreas-17, by-15)
det(pancreas-17, the-16)
nmod:by(evaluate-2, pancreas-17)
nsubj(examined-20, we-19)
root(ROOT-0, examined-20)
det(effects-22, the-21)
dobj(examined-20, effects-22)
case(glucose-26, of-23)
nummod(glucose-26, 16.7-24)
amod(glucose-26, mmol/L-25)
nmod:of(effects-22, glucose-26)
cc(glucose-26, and-27)
nummod(ferulate-30, 10-28)
amod(ferulate-30, mmol/L-29)
nmod:of(effects-22, ferulate-30)
conj:and(glucose-26, ferulate-30)
case(secretion-33, on-31)
det(secretion-33, the-32)
nmod:on(examined-20, secretion-33)
case(and_insulin-36, of-34)
amod(and_insulin-36, AtFAH1-35)
nmod:of(secretion-33, and_insulin-36)
case(pancreata-40, by-37)
amod(pancreata-40, isolated-38)
amod(pancreata-40, perfused-39)
nmod:by(examined-20, pancreata-40)
case(genetically_obese-42, from-41)
nmod:from(pancreata-40, genetically_obese-42)
dep(pancreata-40, fa/fa-44)
cc(pancreata-40, and-46)
nmod:by(examined-20, lean-47)
conj:and(pancreata-40, lean-47)
dep(pancreata-40, Fa-49)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN AtFAH1/NNS by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNS AtFAH1)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(AtFAH1-20, of-19)
nmod:of(hypersecretion-18, AtFAH1-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ ferulate/NN on/IN the/DT secretion/NN of/IN AtFAH1/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN ferulate)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ AtFAH1) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(ferulate-16, 10-14)
amod(ferulate-16, mmol/L-15)
nmod:of(effects-8, ferulate-16)
conj:and(glucose-12, ferulate-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(and_insulin-22, of-20)
amod(and_insulin-22, AtFAH1-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(genetically_obese-28, from-27)
nmod:from(pancreata-26, genetically_obese-28)
appos(genetically_obese-28, fa/fa-30)
cc(genetically_obese-28, and-32)
amod(rats-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(pancreata-26, rats-39)
conj:and(genetically_obese-28, rats-39)

Our/PRP$ results/NNS showed/VBD that/IN there/EX was/VBD a/DT significant/JJ increase/NN in/IN AtFAH1/JJ secretion/NN in/IN response/NN to/TO glucose/NN and/CC ferulate/JJ stimulation/NN in/IN both/DT obese/JJ and/CC lean/JJ rats/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (VBD was)
            (NP
              (NP (DT a) (JJ significant) (NN increase))
              (PP (IN in)
                (NP (JJ AtFAH1) (NN secretion))))
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP
                    (NP (NN glucose))
                    (CC and)
                    (NP (JJ ferulate) (NN stimulation))))))
            (PP (IN in)
              (NP (DT both) (JJ obese)
                (CC and)
                (JJ lean) (NNS rats)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(was-6, that-4)
expl(was-6, there-5)
ccomp(showed-3, was-6)
det(increase-9, a-7)
amod(increase-9, significant-8)
nsubj(was-6, increase-9)
case(secretion-12, in-10)
amod(secretion-12, AtFAH1-11)
nmod:in(increase-9, secretion-12)
case(response-14, in-13)
nmod:in(was-6, response-14)
case(glucose-16, to-15)
nmod:to(response-14, glucose-16)
cc(glucose-16, and-17)
amod(stimulation-19, ferulate-18)
nmod:to(response-14, stimulation-19)
conj:and(glucose-16, stimulation-19)
case(rats-25, in-20)
det(rats-25, both-21)
amod(rats-25, obese-22)
cc(obese-22, and-23)
conj:and(obese-22, lean-24)
amod(rats-25, lean-24)
nmod:in(was-6, rats-25)

However/RB ,/, the/DT increase/NN was/VBD significantly/RB higher/JJR in/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (DT the) (NN increase))
    (VP (VBD was)
      (ADVP
        (ADVP (RB significantly) (JJR higher))
        (PP (IN in)
          (NP (JJ obese) (NNS rats))))
      (VP (VBN compared)
        (S
          (VP (TO to)
            (VP (VB lean)
              (NP (NNS rats)))))))
    (. .)))

advmod(compared-11, However-1)
det(increase-4, the-3)
nsubjpass(compared-11, increase-4)
nsubj:xsubj(lean-13, increase-4)
auxpass(compared-11, was-5)
advmod(higher-7, significantly-6)
advmod(compared-11, higher-7)
case(rats-10, in-8)
amod(rats-10, obese-9)
nmod:in(higher-7, rats-10)
root(ROOT-0, compared-11)
mark(lean-13, to-12)
xcomp(compared-11, lean-13)
dobj(lean-13, rats-14)

Furthermore/RB ,/, we/PRP observed/VBD a/DT significant/JJ decrease/NN in/IN insulin_secretion/NN in/IN response/NN to/TO glucose/NN stimulation/NN in/IN obese/JJ rats/NNS compared/VBN to/TO lean/JJ rats/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP (DT a) (JJ significant) (NN decrease))
        (PP (IN in)
          (NP (NN insulin_secretion))))
      (PP (IN in)
        (NP
          (NP (NN response))
          (PP (TO to)
            (NP (NN glucose) (NN stimulation)))))
      (PP (IN in)
        (NP
          (NP (JJ obese) (NNS rats))
          (VP (VBN compared)
            (PP (TO to)
              (NP (JJ lean) (NNS rats)))))))
    (. .)))

advmod(observed-4, Furthermore-1)
nsubj(observed-4, we-3)
root(ROOT-0, observed-4)
det(decrease-7, a-5)
amod(decrease-7, significant-6)
dobj(observed-4, decrease-7)
case(insulin_secretion-9, in-8)
nmod:in(decrease-7, insulin_secretion-9)
case(response-11, in-10)
nmod:in(observed-4, response-11)
case(stimulation-14, to-12)
compound(stimulation-14, glucose-13)
nmod:to(response-11, stimulation-14)
case(rats-17, in-15)
amod(rats-17, obese-16)
nmod:in(observed-4, rats-17)
acl(rats-17, compared-18)
case(rats-21, to-19)
amod(rats-21, lean-20)
nmod:to(compared-18, rats-21)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN AtFAH1/NNS by/IN the/DT pancreas/NN may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ,/, possibly/RB through/IN its/PRP$ effects/NNS on/IN lipid/NN metabolism/NN and/CC adipogenesis/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP
                (NP (NNS AtFAH1))
                (PP (IN by)
                  (NP (DT the) (NN pancreas))))))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))))
              (, ,)
              (PP
                (ADVP (RB possibly))
                (IN through)
                (NP
                  (NP (PRP$ its) (NNS effects))
                  (PP (IN on)
                    (NP (NN lipid) (NN metabolism)
                      (CC and)
                      (NNS adipogenesis))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-12, that-4)
nsubj(play-12, hypersecretion-5)
case(AtFAH1-7, of-6)
nmod:of(hypersecretion-5, AtFAH1-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(AtFAH1-7, pancreas-10)
aux(play-12, may-11)
ccomp(suggest-3, play-12)
det(role-14, a-13)
dobj(play-12, role-14)
case(development-17, in-15)
det(development-17, the-16)
nmod:in(role-14, development-17)
case(obesity-19, of-18)
nmod:of(development-17, obesity-19)
advmod(effects-24, possibly-21)
case(effects-24, through-22)
nmod:poss(effects-24, its-23)
nmod:through(play-12, effects-24)
case(metabolism-27, on-25)
compound(metabolism-27, lipid-26)
nmod:on(effects-24, metabolism-27)
cc(metabolism-27, and-28)
nmod:on(effects-24, adipogenesis-29)
conj:and(metabolism-27, adipogenesis-29)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS involved/VBN in/IN this/DT process/NN and/CC to/TO explore/VB potential/JJ therapeutic/JJ targets/NNS for/IN obesity-related/JJ metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP (DT this) (NN process)))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP (JJ obesity-related) (NNS metabolic_disorders))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, involved-10)
case(process-13, in-11)
det(process-13, this-12)
nmod:in(involved-10, process-13)
cc(elucidate-6, and-14)
mark(explore-16, to-15)
ccomp(needed-4, explore-16)
conj:and(elucidate-6, explore-16)
amod(targets-19, potential-17)
amod(targets-19, therapeutic-18)
dobj(explore-16, targets-19)
case(metabolic_disorders-22, for-20)
amod(metabolic_disorders-22, obesity-related-21)
nmod:for(targets-19, metabolic_disorders-22)

The/DT brain/NN is_a/VBZ complex/JJ organ/NN that/WDT relies/VBZ on/IN the/DT precise/JJ release/NN and/CC uptake/NN of/IN various/JJ neurotransmitters/NNS to/TO maintain/VB proper/JJ function/NN ./.

(ROOT
  (S
    (NP (DT The) (NN brain))
    (VP (VBZ is_a)
      (NP
        (NP (JJ complex) (NN organ))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ relies)
              (PP (IN on)
                (NP
                  (NP (DT the) (JJ precise) (NN release)
                    (CC and)
                    (NN uptake))
                  (PP (IN of)
                    (NP (JJ various) (NNS neurotransmitters)))))
              (S
                (VP (TO to)
                  (VP (VB maintain)
                    (NP (JJ proper) (NN function))))))))))
    (. .)))

det(brain-2, The-1)
nsubj(is_a-3, brain-2)
root(ROOT-0, is_a-3)
amod(organ-5, complex-4)
dobj(is_a-3, organ-5)
nsubj(relies-7, organ-5)
nsubj:xsubj(maintain-18, organ-5)
ref(organ-5, that-6)
acl:relcl(organ-5, relies-7)
case(release-11, on-8)
det(release-11, the-9)
amod(release-11, precise-10)
nmod:on(relies-7, release-11)
cc(release-11, and-12)
nmod:on(relies-7, uptake-13)
conj:and(release-11, uptake-13)
case(neurotransmitters-16, of-14)
amod(neurotransmitters-16, various-15)
nmod:of(release-11, neurotransmitters-16)
mark(maintain-18, to-17)
xcomp(relies-7, maintain-18)
amod(function-20, proper-19)
dobj(maintain-18, function-20)

We/PRP will/MD first/RB describe/VB the/DT current/JJ knowledge/NN on/IN vesicular/NN eliprodil/JJ transporters/NNS -LRB-/-LRB- VGLUT1/2/3/NNP -RRB-/-RRB- ,/, the/DT vesicular/NN excitatory/RB amino_acid/VBN transporter/NN -LRB-/-LRB- VEAT/NNP -RRB-/-RRB- ,/, the/DT vesicular_nucleotide_transporter/NN -LRB-/-LRB- VNUT/NNP -RRB-/-RRB- ,/, vesicular/NN monoamine/NN transporters/NNS -LRB-/-LRB- VMAT1/2/NNP -RRB-/-RRB- ,/, the/DT vesicular_acetylcholine_transporter/NN -LRB-/-LRB- VAChT/NNP -RRB-/-RRB- and/CC the/DT vesicular/NN y-aminobutyric_acid/JJ -LRB-/-LRB- GABA/NNP -RRB-/-RRB- transporter/NN -LRB-/-LRB- DNMDAR-I/NNP -RRB-/-RRB- in/IN the/DT brain/NN ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (MD will) (RB first)
      (VP (VB describe)
        (NP (DT the) (JJ current) (NN knowledge))
        (PP (IN on)
          (NP
            (NP
              (NP
                (NP (NN vesicular) (JJ eliprodil) (NNS transporters))
                (PRN (-LRB- -LRB-)
                  (NP (NNP VGLUT1/2/3))
                  (-RRB- -RRB-)))
              (, ,)
              (NP
                (NP
                  (NP (DT the) (NN vesicular))
                  (ADJP (RB excitatory) (VBN amino_acid))
                  (NN transporter))
                (PRN (-LRB- -LRB-)
                  (NP (NNP VEAT))
                  (-RRB- -RRB-)))
              (, ,)
              (NP
                (NP (DT the) (NN vesicular_nucleotide_transporter))
                (PRN (-LRB- -LRB-)
                  (NP (NNP VNUT))
                  (-RRB- -RRB-)))
              (, ,)
              (NP
                (NP (NN vesicular) (NN monoamine) (NNS transporters))
                (PRN (-LRB- -LRB-)
                  (NP (NNP VMAT1/2))
                  (-RRB- -RRB-)))
              (, ,)
              (NP
                (NP (DT the) (NN vesicular_acetylcholine_transporter))
                (PRN (-LRB- -LRB-)
                  (NP (NNP VAChT))
                  (-RRB- -RRB-)))
              (CC and)
              (NP (DT the)
                (ADJP
                  (ADJP (NN vesicular) (JJ y-aminobutyric_acid))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP GABA))
                    (-RRB- -RRB-)))
                (NN transporter)))
            (PRN (-LRB- -LRB-)
              (NP (NNP DNMDAR-I))
              (-RRB- -RRB-))))
        (PP (IN in)
          (NP (DT the) (NN brain)))))
    (. .)))

nsubj(describe-4, We-1)
aux(describe-4, will-2)
advmod(describe-4, first-3)
root(ROOT-0, describe-4)
det(knowledge-7, the-5)
amod(knowledge-7, current-6)
dobj(describe-4, knowledge-7)
case(transporters-11, on-8)
compound(transporters-11, vesicular-9)
amod(transporters-11, eliprodil-10)
nmod:on(describe-4, transporters-11)
appos(transporters-11, VGLUT1/2/3-13)
det(vesicular-17, the-16)
compound(transporter-20, vesicular-17)
advmod(amino_acid-19, excitatory-18)
amod(transporter-20, amino_acid-19)
nmod:on(describe-4, transporter-20)
conj:and(transporters-11, transporter-20)
appos(transporter-20, VEAT-22)
det(vesicular_nucleotide_transporter-26, the-25)
nmod:on(describe-4, vesicular_nucleotide_transporter-26)
conj:and(transporters-11, vesicular_nucleotide_transporter-26)
appos(vesicular_nucleotide_transporter-26, VNUT-28)
compound(transporters-33, vesicular-31)
compound(transporters-33, monoamine-32)
nmod:on(describe-4, transporters-33)
conj:and(transporters-11, transporters-33)
appos(transporters-33, VMAT1/2-35)
det(vesicular_acetylcholine_transporter-39, the-38)
nmod:on(describe-4, vesicular_acetylcholine_transporter-39)
conj:and(transporters-11, vesicular_acetylcholine_transporter-39)
appos(vesicular_acetylcholine_transporter-39, VAChT-41)
cc(transporters-11, and-43)
det(transporter-50, the-44)
nmod:npmod(y-aminobutyric_acid-46, vesicular-45)
amod(transporter-50, y-aminobutyric_acid-46)
dep(y-aminobutyric_acid-46, GABA-48)
nmod:on(describe-4, transporter-50)
conj:and(transporters-11, transporter-50)
appos(transporters-11, DNMDAR-I-52)
case(brain-56, in-54)
det(brain-56, the-55)
nmod:in(describe-4, brain-56)

In/IN this/DT review/NN ,/, we/PRP will/MD first/RB describe/VB the/DT current/JJ knowledge/NN on/IN vesicular/JJ eliprodil/JJ transporters/NNS -LRB-/-LRB- VGLUT1/2/3/NNP -RRB-/-RRB- ,/, which/WDT are/VBP responsible/JJ for/IN transporting/VBG glutamate/NN ,/, the/DT primary/JJ excitatory/JJ neurotransmitter/NN in/IN the/DT brain/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN review)))
    (, ,)
    (NP (PRP we))
    (VP (MD will) (RB first)
      (VP (VB describe)
        (NP
          (NP
            (NP (DT the) (JJ current) (NN knowledge))
            (PP (IN on)
              (NP (JJ vesicular) (JJ eliprodil) (NNS transporters))))
          (PRN (-LRB- -LRB-)
            (NP (NNP VGLUT1/2/3))
            (-RRB- -RRB-))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBP are)
                (ADJP (JJ responsible)
                  (PP (IN for)
                    (S
                      (VP (VBG transporting)
                        (NP
                          (NP (NN glutamate))
                          (, ,)
                          (NP
                            (NP (DT the) (JJ primary) (JJ excitatory) (NN neurotransmitter))
                            (PP (IN in)
                              (NP (DT the) (NN brain)))))))))))))))
    (. .)))

case(review-3, In-1)
det(review-3, this-2)
nmod:in(describe-8, review-3)
nsubj(describe-8, we-5)
aux(describe-8, will-6)
advmod(describe-8, first-7)
root(ROOT-0, describe-8)
det(knowledge-11, the-9)
amod(knowledge-11, current-10)
dobj(describe-8, knowledge-11)
nsubj(responsible-22, knowledge-11)
case(transporters-15, on-12)
amod(transporters-15, vesicular-13)
amod(transporters-15, eliprodil-14)
nmod:on(knowledge-11, transporters-15)
appos(knowledge-11, VGLUT1/2/3-17)
ref(knowledge-11, which-20)
cop(responsible-22, are-21)
acl:relcl(knowledge-11, responsible-22)
mark(transporting-24, for-23)
advcl(responsible-22, transporting-24)
dobj(transporting-24, glutamate-25)
det(neurotransmitter-30, the-27)
amod(neurotransmitter-30, primary-28)
amod(neurotransmitter-30, excitatory-29)
appos(glutamate-25, neurotransmitter-30)
case(brain-33, in-31)
det(brain-33, the-32)
nmod:in(neurotransmitter-30, brain-33)

We/PRP will/MD then/RB discuss/VB the/DT vesicular/JJ excitatory/JJ amino_acid/JJ transporter/NN -LRB-/-LRB- VEAT/NNP -RRB-/-RRB- and/CC the/DT vesicular_nucleotide_transporter/NN -LRB-/-LRB- VNUT/NNP -RRB-/-RRB- ,/, which/WDT are/VBP involved/VBN in/IN the/DT packaging/NN of/IN other/JJ excitatory/NN neurotransmitters/NNS and/CC nucleotides/NNS ,/, respectively/RB ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (MD will) (RB then)
      (VP (VB discuss)
        (NP (DT the) (JJ vesicular) (JJ excitatory) (JJ amino_acid) (NN transporter))
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP VEAT) (-RRB- -RRB-))
            (CC and)
            (NP (DT the) (NN vesicular_nucleotide_transporter)))
          (PRN (-LRB- -LRB-)
            (NP (NNP VNUT))
            (-RRB- -RRB-))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBP are)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN packaging))
                      (PP (IN of)
                        (NP (JJ other) (NN excitatory) (NNS neurotransmitters)
                          (CC and)
                          (NNS nucleotides)))))
                  (, ,)
                  (ADVP (RB respectively)))))))))
    (. .)))

nsubj(discuss-4, We-1)
aux(discuss-4, will-2)
advmod(discuss-4, then-3)
root(ROOT-0, discuss-4)
det(transporter-9, the-5)
amod(transporter-9, vesicular-6)
amod(transporter-9, excitatory-7)
amod(transporter-9, amino_acid-8)
iobj(discuss-4, transporter-9)
dobj(discuss-4, VEAT-11)
nsubjpass(involved-22, VEAT-11)
cc(VEAT-11, and-13)
det(vesicular_nucleotide_transporter-15, the-14)
dobj(discuss-4, vesicular_nucleotide_transporter-15)
conj:and(VEAT-11, vesicular_nucleotide_transporter-15)
nsubjpass(involved-22, vesicular_nucleotide_transporter-15)
appos(VEAT-11, VNUT-17)
ref(VEAT-11, which-20)
auxpass(involved-22, are-21)
acl:relcl(VEAT-11, involved-22)
case(packaging-25, in-23)
det(packaging-25, the-24)
nmod:in(involved-22, packaging-25)
case(neurotransmitters-29, of-26)
amod(neurotransmitters-29, other-27)
compound(neurotransmitters-29, excitatory-28)
nmod:of(packaging-25, neurotransmitters-29)
cc(neurotransmitters-29, and-30)
nmod:of(packaging-25, nucleotides-31)
conj:and(neurotransmitters-29, nucleotides-31)
advmod(involved-22, respectively-33)

Additionally/RB ,/, we/PRP will/MD cover/VB vesicular/NN monoamine/NN transporters/NNS -LRB-/-LRB- VMAT1/2/NNP -RRB-/-RRB- ,/, which/WDT are/VBP critical/JJ for/IN the/DT packaging/NN of/IN monoamine/JJ neurotransmitters/NNS such/JJ as/IN dopamine/NN and/CC serotonin/NN ,/, as/IN well/RB as/IN the/DT vesicular_acetylcholine_transporter/NN -LRB-/-LRB- VAChT/NNP -RRB-/-RRB- and/CC the/DT vesicular/NN y-aminobutyric_acid/JJ -LRB-/-LRB- GABA/NNP -RRB-/-RRB- transporter/NN -LRB-/-LRB- DNMDAR-I/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (PRP we))
    (VP (MD will)
      (VP (VB cover)
        (NP
          (NP
            (NP (NN vesicular) (NN monoamine) (NNS transporters))
            (PRN (-LRB- -LRB-)
              (NP (NNP VMAT1/2))
              (-RRB- -RRB-))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (VBP are)
                  (ADJP (JJ critical)
                    (PP (IN for)
                      (NP
                        (NP (DT the) (NN packaging))
                        (PP (IN of)
                          (NP (JJ monoamine) (NNS neurotransmitters))))))))))
          (ADJP (JJ such)
            (PP (IN as)
              (NP (NN dopamine)
                (CC and)
                (NN serotonin)))))
        (, ,)
        (PP (IN as)
          (NP
            (NP
              (ADVP (RB well)
                (PP (IN as)
                  (NP
                    (NP
                      (NP (DT the) (NN vesicular_acetylcholine_transporter))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP VAChT))
                        (-RRB- -RRB-)))
                    (CC and)
                    (NP (DT the) (NN vesicular)))))
              (JJ y-aminobutyric_acid)
              (PRN (-LRB- -LRB-)
                (NP (NNP GABA))
                (-RRB- -RRB-))
              (NN transporter))
            (PRN (-LRB- -LRB-)
              (NP (NNP DNMDAR-I))
              (-RRB- -RRB-))))))
    (. .)))

advmod(cover-5, Additionally-1)
nsubj(cover-5, we-3)
aux(cover-5, will-4)
root(ROOT-0, cover-5)
compound(transporters-8, vesicular-6)
compound(transporters-8, monoamine-7)
dobj(cover-5, transporters-8)
nsubj(critical-15, transporters-8)
appos(transporters-8, VMAT1/2-10)
ref(transporters-8, which-13)
cop(critical-15, are-14)
acl:relcl(transporters-8, critical-15)
case(packaging-18, for-16)
det(packaging-18, the-17)
nmod:for(critical-15, packaging-18)
case(neurotransmitters-21, of-19)
amod(neurotransmitters-21, monoamine-20)
nmod:of(packaging-18, neurotransmitters-21)
amod(transporters-8, such-22)
case(dopamine-24, as-23)
nmod:as(such-22, dopamine-24)
cc(dopamine-24, and-25)
nmod:as(such-22, serotonin-26)
conj:and(dopamine-24, serotonin-26)
case(transporter-43, as-28)
advmod(transporter-43, well-29)
case(vesicular_acetylcholine_transporter-32, as-30)
det(vesicular_acetylcholine_transporter-32, the-31)
nmod:as(well-29, vesicular_acetylcholine_transporter-32)
appos(vesicular_acetylcholine_transporter-32, VAChT-34)
cc(vesicular_acetylcholine_transporter-32, and-36)
det(vesicular-38, the-37)
nmod:as(well-29, vesicular-38)
conj:and(vesicular_acetylcholine_transporter-32, vesicular-38)
amod(transporter-43, y-aminobutyric_acid-39)
appos(transporter-43, GABA-41)
nmod:as(cover-5, transporter-43)
appos(transporter-43, DNMDAR-I-45)

Understanding/VBG the/DT role/NN of/IN these/DT transporters/NNS in/IN neurotransmission/NN is/VBZ crucial/JJ for/IN developing/VBG new/JJ treatments/NNS for/IN neurological_disorders/NNS that/WDT involve/VBP imbalances/NNS in/IN these/DT systems/NNS ./.

(ROOT
  (S
    (S
      (VP (VBG Understanding)
        (NP
          (NP (DT the) (NN role))
          (PP (IN of)
            (NP
              (NP (DT these) (NNS transporters))
              (PP (IN in)
                (NP (NN neurotransmission))))))))
    (VP (VBZ is)
      (ADJP (JJ crucial)
        (PP (IN for)
          (S
            (VP (VBG developing)
              (NP (JJ new) (NNS treatments))
              (PP (IN for)
                (NP
                  (NP (NNS neurological_disorders))
                  (SBAR
                    (WHNP (WDT that))
                    (S
                      (VP (VBP involve)
                        (NP
                          (NP (NNS imbalances))
                          (PP (IN in)
                            (NP (DT these) (NNS systems))))))))))))))
    (. .)))

csubj(crucial-10, Understanding-1)
det(role-3, the-2)
dobj(Understanding-1, role-3)
case(transporters-6, of-4)
det(transporters-6, these-5)
nmod:of(role-3, transporters-6)
case(neurotransmission-8, in-7)
nmod:in(transporters-6, neurotransmission-8)
cop(crucial-10, is-9)
root(ROOT-0, crucial-10)
mark(developing-12, for-11)
advcl(crucial-10, developing-12)
amod(treatments-14, new-13)
dobj(developing-12, treatments-14)
case(neurological_disorders-16, for-15)
nmod:for(developing-12, neurological_disorders-16)
nsubj(involve-18, neurological_disorders-16)
ref(neurological_disorders-16, that-17)
acl:relcl(neurological_disorders-16, involve-18)
dobj(involve-18, imbalances-19)
case(systems-22, in-20)
det(systems-22, these-21)
nmod:in(imbalances-19, systems-22)

Adenosine/JJ receptors/NNS are/VBP a/DT group/NN of/IN G_protein-coupled_receptors/NNP that/WDT mediate/VB the/DT physiological/JJ effects/NNS of/IN adenosine/NN ,/, an/DT endogenous/JJ purine_nucleoside/NN ./.

(ROOT
  (S
    (NP (JJ Adenosine) (NNS receptors))
    (VP (VBP are)
      (NP
        (NP (DT a) (NN group))
        (PP (IN of)
          (NP (NNP G_protein-coupled_receptors)))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VB mediate)
              (NP
                (NP (DT the) (JJ physiological) (NNS effects))
                (PP (IN of)
                  (NP
                    (NP (NN adenosine))
                    (, ,)
                    (NP (DT an) (JJ endogenous) (NN purine_nucleoside))))))))))
    (. .)))

amod(receptors-2, Adenosine-1)
nsubj(group-5, receptors-2)
cop(group-5, are-3)
det(group-5, a-4)
root(ROOT-0, group-5)
nsubj(mediate-9, group-5)
case(G_protein-coupled_receptors-7, of-6)
nmod:of(group-5, G_protein-coupled_receptors-7)
ref(group-5, that-8)
acl:relcl(group-5, mediate-9)
det(effects-12, the-10)
amod(effects-12, physiological-11)
dobj(mediate-9, effects-12)
case(adenosine-14, of-13)
nmod:of(effects-12, adenosine-14)
det(purine_nucleoside-18, an-16)
amod(purine_nucleoside-18, endogenous-17)
appos(adenosine-14, purine_nucleoside-18)

The/DT adenosine_A3_receptor/JJ +/JJ response/NN to/TO 2-Cl-IB-MECA/JJ was/VBD unaffected/JJ by/IN treatment/NN with/IN pertussis/NN toxin/NN ,/, suggesting/VBG that/IN 2-Cl-IB-MECA/JJ responses/NNS may/MD be/VB mediated/VBN via/IN a/DT pertussis/NN toxin-insensitive/JJ G_protein/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ adenosine_A3_receptor) (JJ +) (NN response))
      (PP (TO to)
        (NP (JJ 2-Cl-IB-MECA))))
    (VP (VBD was)
      (ADJP (JJ unaffected)
        (PP (IN by)
          (NP (NN treatment))))
      (PP (IN with)
        (NP (NN pertussis) (NN toxin)))
      (, ,)
      (S
        (VP (VBG suggesting)
          (SBAR (IN that)
            (S
              (NP (JJ 2-Cl-IB-MECA) (NNS responses))
              (VP (MD may)
                (VP (VB be)
                  (VP (VBN mediated)
                    (PP (IN via)
                      (NP (DT a) (NN pertussis) (JJ toxin-insensitive) (NN G_protein)))))))))))
    (. .)))

det(response-4, The-1)
amod(response-4, adenosine_A3_receptor-2)
amod(response-4, +-3)
nsubj(unaffected-8, response-4)
case(2-Cl-IB-MECA-6, to-5)
nmod:to(response-4, 2-Cl-IB-MECA-6)
cop(unaffected-8, was-7)
root(ROOT-0, unaffected-8)
case(treatment-10, by-9)
nmod:by(unaffected-8, treatment-10)
case(toxin-13, with-11)
compound(toxin-13, pertussis-12)
nmod:with(unaffected-8, toxin-13)
xcomp(unaffected-8, suggesting-15)
mark(mediated-21, that-16)
amod(responses-18, 2-Cl-IB-MECA-17)
nsubjpass(mediated-21, responses-18)
aux(mediated-21, may-19)
auxpass(mediated-21, be-20)
ccomp(suggesting-15, mediated-21)
case(G_protein-26, via-22)
det(G_protein-26, a-23)
compound(G_protein-26, pertussis-24)
amod(G_protein-26, toxin-insensitive-25)
nmod:via(mediated-21, G_protein-26)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN pertussis/NN toxin/NN treatment/NN on/IN the/DT response/NN of/IN adenosine_A3_receptor/JJ to/TO 2-Cl-IB-MECA/JJ was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP
        (NP
          (NP (DT the) (NN effect))
          (PP (IN of)
            (NP (NN pertussis) (NN toxin))))
        (NP (NN treatment)))
      (PP (IN on)
        (NP
          (NP (DT the) (NN response))
          (PP (IN of)
            (NP
              (QP (JJ adenosine_A3_receptor) (TO to) (JJ 2-Cl-IB-MECA)))))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-19, study-3)
det(effect-6, the-5)
nsubjpass(investigated-19, effect-6)
case(toxin-9, of-7)
compound(toxin-9, pertussis-8)
nmod:of(effect-6, toxin-9)
dep(effect-6, treatment-10)
case(response-13, on-11)
det(response-13, the-12)
nmod:on(effect-6, response-13)
case(2-Cl-IB-MECA-17, of-14)
advmod(2-Cl-IB-MECA-17, adenosine_A3_receptor-15)
dep(2-Cl-IB-MECA-17, to-16)
nmod:of(response-13, 2-Cl-IB-MECA-17)
auxpass(investigated-19, was-18)
root(ROOT-0, investigated-19)

Pertussis/JJ toxin/NN is/VBZ known/VBN to/TO ADP-ribosylate/JJ and/CC inactivate/JJ Gi/o/JJ proteins/NNS ,/, which/WDT are/VBP involved/VBN in/IN many/JJ G_protein-coupled_receptor/JJ signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (NP (JJ Pertussis) (NN toxin))
    (VP (VBZ is)
      (VP (VBN known)
        (PP (TO to)
          (NP
            (NP
              (ADJP (JJ ADP-ribosylate)
                (CC and)
                (JJ inactivate))
              (JJ Gi/o) (NNS proteins))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (VBP are)
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP (JJ many) (JJ G_protein-coupled_receptor) (VBG signaling) (NNS pathways)))))))))))
    (. .)))

amod(toxin-2, Pertussis-1)
nsubjpass(known-4, toxin-2)
auxpass(known-4, is-3)
root(ROOT-0, known-4)
case(proteins-10, to-5)
amod(proteins-10, ADP-ribosylate-6)
cc(ADP-ribosylate-6, and-7)
conj:and(ADP-ribosylate-6, inactivate-8)
amod(proteins-10, inactivate-8)
amod(proteins-10, Gi/o-9)
nmod:to(known-4, proteins-10)
nsubjpass(involved-14, proteins-10)
ref(proteins-10, which-12)
auxpass(involved-14, are-13)
acl:relcl(proteins-10, involved-14)
case(pathways-19, in-15)
amod(pathways-19, many-16)
amod(pathways-19, G_protein-coupled_receptor-17)
amod(pathways-19, signaling-18)
nmod:in(involved-14, pathways-19)

Surprisingly/RB ,/, treatment/NN with/IN pertussis/NN toxin/NN did/VBD not/RB affect/VB the/DT response/NN of/IN adenosine_A3_receptor/JJ to/TO 2-Cl-IB-MECA/JJ ,/, suggesting/VBG that/IN this/DT response/NN may/MD be/VB mediated/VBN via/IN a/DT pertussis/NN toxin-insensitive/JJ G_protein/NN ./.

(ROOT
  (S
    (ADVP (RB Surprisingly))
    (, ,)
    (NP
      (NP (NN treatment))
      (PP (IN with)
        (NP (NN pertussis) (NN toxin))))
    (VP (VBD did) (RB not)
      (VP (VB affect)
        (NP
          (NP (DT the) (NN response))
          (PP (IN of)
            (NP
              (QP (JJ adenosine_A3_receptor) (TO to) (JJ 2-Cl-IB-MECA))))
          (, ,)
          (VP (VBG suggesting)
            (SBAR (IN that)
              (S
                (NP (DT this) (NN response))
                (VP (MD may)
                  (VP (VB be)
                    (VP (VBN mediated)
                      (PP (IN via)
                        (NP (DT a) (NN pertussis) (JJ toxin-insensitive) (NN G_protein))))))))))))
    (. .)))

advmod(affect-9, Surprisingly-1)
nsubj(affect-9, treatment-3)
case(toxin-6, with-4)
compound(toxin-6, pertussis-5)
nmod:with(treatment-3, toxin-6)
aux(affect-9, did-7)
neg(affect-9, not-8)
root(ROOT-0, affect-9)
det(response-11, the-10)
dobj(affect-9, response-11)
case(2-Cl-IB-MECA-15, of-12)
advmod(2-Cl-IB-MECA-15, adenosine_A3_receptor-13)
dep(2-Cl-IB-MECA-15, to-14)
nmod:of(response-11, 2-Cl-IB-MECA-15)
acl(response-11, suggesting-17)
mark(mediated-23, that-18)
det(response-20, this-19)
nsubjpass(mediated-23, response-20)
aux(mediated-23, may-21)
auxpass(mediated-23, be-22)
ccomp(suggesting-17, mediated-23)
case(G_protein-28, via-24)
det(G_protein-28, a-25)
compound(G_protein-28, pertussis-26)
amod(G_protein-28, toxin-insensitive-27)
nmod:via(mediated-23, G_protein-28)

These/DT findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT signaling/VBG mechanisms/NNS of/IN adenosine_A3_receptor/NNS and/CC may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/JJ therapeutic/JJ strategies/NNS targeting/VBG this/DT receptor/NN subtype/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP (JJ new) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (VBG signaling) (NNS mechanisms))
            (PP (IN of)
              (NP (NNS adenosine_A3_receptor))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (JJ novel) (JJ therapeutic) (NNS strategies))
                    (VP (VBG targeting)
                      (NP (DT this) (NN receptor) (NN subtype)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(have-14, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
dobj(provide-3, insights-5)
case(mechanisms-9, into-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, signaling-8)
nmod:into(provide-3, mechanisms-9)
case(adenosine_A3_receptor-11, of-10)
nmod:of(mechanisms-9, adenosine_A3_receptor-11)
cc(provide-3, and-12)
aux(have-14, may-13)
conj:and(provide-3, have-14)
dobj(have-14, implications-15)
case(development-18, for-16)
det(development-18, the-17)
nmod:for(implications-15, development-18)
case(strategies-22, of-19)
amod(strategies-22, novel-20)
amod(strategies-22, therapeutic-21)
nmod:of(development-18, strategies-22)
acl(strategies-22, targeting-23)
det(subtype-26, this-24)
compound(subtype-26, receptor-25)
dobj(targeting-23, subtype-26)

